<?xml version='1.0' encoding='utf-8'?>
<PubmedArticleSet>
  <PubmedArticle>
    <ArticleTitle>Dictamnine-induced hepatotoxicity in mice: the role of metabolic activation of furan.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30578885</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30559-3</DOI>
    <KeywordList>
      <Keywords>Cortex dictamni</Keywords>
      <Keywords>Dictamnine</Keywords>
      <Keywords>Furan moiety</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Metabolic activation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Fuguo Shi</Name>
        <Affiliation>Key Laboratory of Basic Pharmacology of Ministry of Education &amp; Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi 563003, China. Electronic address: fuguoshi@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Pan</Name>
        <Affiliation>Department of clinical pharmacy, Zunyi Medical University, Zunyi 563003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Baodong Cui</Name>
        <Affiliation>Department of pharmaceutical engineering, Zunyi Medical University, Zunyi 563003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Li</Name>
        <Affiliation>Key Laboratory of Basic Pharmacology of Ministry of Education &amp; Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi 563003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Linyan Huang</Name>
        <Affiliation>Department of clinical pharmacy, Zunyi Medical University, Zunyi 563003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanfu Lu</Name>
        <Affiliation>Key Laboratory of Basic Pharmacology of Ministry of Education &amp; Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi 563003, China. Electronic address: luyuanfu2000@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Modulating impacts of quercetin/sitagliptin combination on streptozotocin-induced diabetes mellitus in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30576699</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30558-1</DOI>
    <KeywordList>
      <Keywords>Adiponectin</Keywords>
      <Keywords>Diabetes mellitus</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Pancreatic islets</Keywords>
      <Keywords>Quercetin</Keywords>
      <Keywords>Sitagliptin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hebatollah E. Eitah</Name>
        <Affiliation>Medicinal and Pharmaceutical Chemistry Department, Pharmacology Group, National Research Centre, Dokki, Giza, Egypt. Electronic address: Noha.fawzy@pharma.cu.edu.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Yousreya A. Maklad</Name>
        <Affiliation>Medicinal and Pharmaceutical Chemistry Department, Pharmacology Group, National Research Centre, Dokki, Giza, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Noha F. Abdelkader</Name>
        <Affiliation>Pharmacology and Toxicology Department, Faculty of Pharmacy, Cairo University, Giza, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Amina A. Gamal El Din</Name>
        <Affiliation>Pathology Department, National Research Centre, Dokki, Giza, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Manal A. Badawi</Name>
        <Affiliation>Pathology Department, National Research Centre, Dokki, Giza, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Sanaa A. Kenawy</Name>
        <Affiliation>Pharmacology and Toxicology Department, Faculty of Pharmacy, Cairo University, Giza, Egypt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A case study of the translocation, bioprocessing and tissue interactions of EMP following inhalation exposure.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30563646</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30313-2</DOI>
    <KeywordList>
      <Keywords>Bioprocessing</Keywords>
      <Keywords>EMP</Keywords>
      <Keywords>Ferritin</Keywords>
      <Keywords>Human Lung</Keywords>
      <Keywords>Nanoparticles</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Uschi M. Graham</Name>
        <Affiliation>University of Kentucky, USA. Electronic address: graham@topasol.com.</Affiliation>
      </Author>
      <Author>
        <Name>Günter Oberdörster</Name>
        <Affiliation>University of Kentucky, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bruce Case</Name>
        <Affiliation>University of Kentucky, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alan Dozier</Name>
        <Affiliation>University of Kentucky, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Exposures estimates of the Wittenoom mining workforce and town residents - Implications associated with risk estimation for persons exposed to asbestiform riebeckite.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30563645</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30308-9</DOI>
    <KeywordList>
      <Keywords>Crocidolite mining</Keywords>
      <Keywords>Environmental exposure</Keywords>
      <Keywords>Mesothelioma</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alan John Rogers</Name>
        <Affiliation>Alan Rogers OH&amp;S Pty Ltd, Post Office Box 2128, Clovelly, NSW 2031, Australia. Electronic address: arogersohs@hotkey.net.au.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Proceedings of The Monticello Conference on Elongate Mineral Particles (EMP).</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30558741</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30502-7</DOI>
    <AuthorList>
      <Author>
        <Name>David Weill</Name>
        <Affiliation>Weill Consulting Group, New Orleans, LA. Electronic address: david@weillconsulting.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Alternative splicing of the vitamin D receptor modulates target gene expression and promotes ligand-independent functions.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30552932</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30547-7</DOI>
    <KeywordList>
      <Keywords>Alternative splicing</Keywords>
      <Keywords>Antisense oligonucleotides</Keywords>
      <Keywords>Exon skipping</Keywords>
      <Keywords>Gene-directed therapy</Keywords>
      <Keywords>Phosphorodiamidate morpholino oligomers</Keywords>
      <Keywords>Vitamin D receptor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Andrew J. Annalora</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, Oregon State University, 1007 Agriculture &amp; Life Sciences Building, Corvallis, OR 97331; USA. Electronic address: Andrew.Annalora@oregonstate.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Marija Jozic</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, Oregon State University, 1007 Agriculture &amp; Life Sciences Building, Corvallis, OR 97331; USA.</Affiliation>
      </Author>
      <Author>
        <Name>Craig B. Marcus</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, Oregon State University, 1007 Agriculture &amp; Life Sciences Building, Corvallis, OR 97331; USA.</Affiliation>
      </Author>
      <Author>
        <Name>Patrick L. Iversen</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, Oregon State University, 1007 Agriculture &amp; Life Sciences Building, Corvallis, OR 97331; USA; LS Pharma, 884 Park St., Lebanon, OR 97355; USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Long-term effects after treatment with platinum compounds, cisplatin and [Pt(O,O'-acac)(γ-acac)(DMS)]: Autophagy activation in rat B50 neuroblastoma cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30529627</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30541-6</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Autophagy</Keywords>
      <Keywords>CisPt</Keywords>
      <Keywords>Drug-resistance</Keywords>
      <Keywords>Neuroblastoma rat cells</Keywords>
      <Keywords>PtAcacDMS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Maddalena Grimaldi</Name>
        <Affiliation>Laboratory of Cell Biology and Neurobiology, Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Veronica Dal Bo</Name>
        <Affiliation>Laboratory of Cell Biology and Neurobiology, Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Beatrice Ferrari</Name>
        <Affiliation>Laboratory of Cell Biology and Neurobiology, Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Elisa Roda</Name>
        <Affiliation>Laboratory of Cell Biology and Neurobiology, Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, Italy; Laboratory of Clinical &amp; Experimental Toxicology, Pavia Poison Centre, National Toxicology Information Centre, Toxicology Unit, ICS Maugeri Spa, IRCCS Pavia, Via Maugeri 10, Pavia, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Fabrizio De Luca</Name>
        <Affiliation>Laboratory of Cell Biology and Neurobiology, Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Paola Veneroni</Name>
        <Affiliation>Laboratory of Cell Biology and Neurobiology, Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Sergio Barni</Name>
        <Affiliation>Laboratory of Cell Biology and Neurobiology, Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Manuela Verri</Name>
        <Affiliation>Laboratory of Cell Biology and Neurobiology, Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Sandra A. De Pascali</Name>
        <Affiliation>General and Inorganic Chemistry Laboratory, Department of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Lecce, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Francesco P. Fanizzi</Name>
        <Affiliation>General and Inorganic Chemistry Laboratory, Department of Biological and Environmental Sciences and Technologies (DiSTeBA), University of Lecce, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Graziella Bernocchi</Name>
        <Affiliation>Laboratory of Cell Biology and Neurobiology, Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Maria G. Bottone</Name>
        <Affiliation>Laboratory of Cell Biology and Neurobiology, Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, Italy. Electronic address: bottone@unipv.it.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cordycepin sensitizes breast cancer cells toward irradiation through elevating ROS production involving Nrf2.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30529626</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30542-8</DOI>
    <KeywordList>
      <Keywords>Breast Cancer</Keywords>
      <Keywords>Cordycepin</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>ROS</Keywords>
      <Keywords>Radiosensitivity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jiali Dong</Name>
        <Affiliation>Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Li</Name>
        <Affiliation>Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huiwen Xiao</Name>
        <Affiliation>Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dan Luo</Name>
        <Affiliation>Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuqin Zhang</Name>
        <Affiliation>Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Changchun Zhu</Name>
        <Affiliation>Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mian Jiang</Name>
        <Affiliation>Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Cui</Name>
        <Affiliation>Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China. Electronic address: cuiming0403@bjmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Lu</Name>
        <Affiliation>Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China. Electronic address: lulu@irm-cams.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Saijun Fan</Name>
        <Affiliation>Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China. Electronic address: fansaijun@irm-cams.ac.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Differences in uptake of 14 nm PEG-liganded gold nanoparticles into BEAS-2B cells is dependent on their functional groups.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30529166</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30534-9</DOI>
    <KeywordList>
      <Keywords>Caveolin-mediated</Keywords>
      <Keywords>CytoViva HSI</Keywords>
      <Keywords>Endocytosis</Keywords>
      <Keywords>Functional groups</Keywords>
      <Keywords>Gold nanoparticles</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Melissa Vetten</Name>
        <Affiliation>Toxicology Section, National Institute for Occupational Health, Johannesburg, South Africa; School of Pathology, University of the Witwatersrand, Johannesburg, South Africa. Electronic address: melissav@nioh.ac.za.</Affiliation>
      </Author>
      <Author>
        <Name>Mary Gulumian</Name>
        <Affiliation>Toxicology Section, National Institute for Occupational Health, Johannesburg, South Africa; School of Pathology, University of the Witwatersrand, Johannesburg, South Africa. Electronic address: mary.gulumian@nioh.nhls.ac.za.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Sulforaphane enriched transcriptome of lung mitochondrial energy metabolism and provided pulmonary injury protection via Nrf2 in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30529165</pubmedLink>
    <GrantList>
      <Grant>Z01 ES100513-06</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30540-4</DOI>
    <KeywordList>
      <Keywords>Antioxidant response element</Keywords>
      <Keywords>Broccoli</Keywords>
      <Keywords>Hyperoxia</Keywords>
      <Keywords>Lung</Keywords>
      <Keywords>Microarray</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hye Youn Cho</Name>
        <Affiliation>Immunity, Inflammation, and Disease Laboratory, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA. Electronic address: cho2@niehs.nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Miller-DeGraff</Name>
        <Affiliation>Immunity, Inflammation, and Disease Laboratory, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Terry Blankenship-Paris</Name>
        <Affiliation>Comparative Medicine Branch, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xuting Wang</Name>
        <Affiliation>Immunity, Inflammation, and Disease Laboratory, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Douglas A. Bell</Name>
        <Affiliation>Immunity, Inflammation, and Disease Laboratory, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Fred Lih</Name>
        <Affiliation>Epigenetics and Stem Cell Biology Laboratory, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Leesa Deterding</Name>
        <Affiliation>Epigenetics and Stem Cell Biology Laboratory, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Vijayalakshmi Panduri</Name>
        <Affiliation>Epigenetics and Stem Cell Biology Laboratory, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel L. Morgan</Name>
        <Affiliation>National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Masayuki Yamamoto</Name>
        <Affiliation>Tohoku University Graduate School of Medicine, Sendai, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Anita J. Reddy</Name>
        <Affiliation>Respiratory Institute, Cleveland Clinic, Cleveland, OH 44106, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Talalay</Name>
        <Affiliation>Department of Pharmacology and Molecular Sciences, The Johns Hopkins University School of Medicine, MD 21205, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Steven R. Kleeberger</Name>
        <Affiliation>Immunity, Inflammation, and Disease Laboratory, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Association of astragaloside IV-inhibited autophagy and mineralization in vascular smooth muscle cells with lncRNA H19 and DUSP5-mediated ERK signaling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30529164</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30538-6</DOI>
    <KeywordList>
      <Keywords>Astragaloside IV</Keywords>
      <Keywords>Atherosclerosis</Keywords>
      <Keywords>Autophagy</Keywords>
      <Keywords>DUSP5</Keywords>
      <Keywords>lncRNA H19</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhenhua Song</Name>
        <Affiliation>Treatment Centre For Traumatic Injuries, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510630, China.</Affiliation>
      </Author>
      <Author>
        <Name>Danian Wei</Name>
        <Affiliation>Treatment Centre For Traumatic Injuries, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510630, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Chen</Name>
        <Affiliation>Department of Pharmaceutical, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou 510080, China; School of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou 510080, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lili Chen</Name>
        <Affiliation>Department of Pharmaceutical, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou 510080, China; School of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou 510080, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Bian</Name>
        <Affiliation>School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yonggang Shen</Name>
        <Affiliation>Department of Pharmaceutical, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou 510080, China; School of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou 510080, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jisheng Chen</Name>
        <Affiliation>Department of Pharmaceutical, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou 510080, China; School of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou 510080, China. Electronic address: cjslym@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yunyun Pan</Name>
        <Affiliation>Department of Pharmaceutical, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou 510080, China; School of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou 510080, China. Electronic address: huiyun0117@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Bone loss in MPTP mouse model of Parkinson's disease is triggered by decreased osteoblastogenesis and increased osteoclastogenesis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30529163</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30539-8</DOI>
    <KeywordList>
      <Keywords>MPTP</Keywords>
      <Keywords>Osteoblast</Keywords>
      <Keywords>Osteoclast</Keywords>
      <Keywords>Osteoporosis</Keywords>
      <Keywords>Parkinsonism</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shaheen Jafri Ali</Name>
        <Affiliation>Department of Molecular Nutrition, CSIR-Central Food Technological Research Institute, Mysuru, India.</Affiliation>
      </Author>
      <Author>
        <Name>Govindraj Ellur</Name>
        <Affiliation>Department of Molecular Nutrition, CSIR-Central Food Technological Research Institute, Mysuru, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.</Affiliation>
      </Author>
      <Author>
        <Name>Md Touseef Khan</Name>
        <Affiliation>Department of Molecular Nutrition, CSIR-Central Food Technological Research Institute, Mysuru, India.</Affiliation>
      </Author>
      <Author>
        <Name>Kunal Sharan</Name>
        <Affiliation>Department of Molecular Nutrition, CSIR-Central Food Technological Research Institute, Mysuru, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India. Electronic address: kunalsharan@cftri.res.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Kaempferol-3-O-glucorhamnoside inhibits inflammatory responses via MAPK and NF-κB pathways in vitro and in vivo.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30528763</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30544-1</DOI>
    <KeywordList>
      <Keywords>Anti-inflammatory</Keywords>
      <Keywords>Kaempferol-3-O-glucorhamnoside</Keywords>
      <Keywords>Klebsiella pneumoniae</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhuojian Sun</Name>
        <Affiliation>College of Chemistry and Pharmaceutical Sciences, Qingdao Agricultural University, Qingdao, China; Agricultural Bio-Pharmaceutical Laboratory, Qingdao Agricultural University, Qingdao, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiu Li</Name>
        <Affiliation>College of Chemistry and Pharmaceutical Sciences, Qingdao Agricultural University, Qingdao, China; Agricultural Bio-Pharmaceutical Laboratory, Qingdao Agricultural University, Qingdao, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ranran Hou</Name>
        <Affiliation>College of Chemistry and Pharmaceutical Sciences, Qingdao Agricultural University, Qingdao, China; Agricultural Bio-Pharmaceutical Laboratory, Qingdao Agricultural University, Qingdao, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongxiang Sun</Name>
        <Affiliation>College of Animal Sciences, Zhejiang University, Hangzhou 310029, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qihe Tang</Name>
        <Affiliation>College of Chemistry and Pharmaceutical Sciences, Qingdao Agricultural University, Qingdao, China.</Affiliation>
      </Author>
      <Author>
        <Name>Haixia Wang</Name>
        <Affiliation>College of Chemistry and Pharmaceutical Sciences, Qingdao Agricultural University, Qingdao, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhihui Hao</Name>
        <Affiliation>College of Chemistry and Pharmaceutical Sciences, Qingdao Agricultural University, Qingdao, China; Agricultural Bio-Pharmaceutical Laboratory, Qingdao Agricultural University, Qingdao, China. Electronic address: abplab@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Songyao Kang</Name>
        <Affiliation>College of Chemistry and Pharmaceutical Sciences, Qingdao Agricultural University, Qingdao, China; Agricultural Bio-Pharmaceutical Laboratory, Qingdao Agricultural University, Qingdao, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tianli Xu</Name>
        <Affiliation>College of Chemistry and Pharmaceutical Sciences, Qingdao Agricultural University, Qingdao, China; Agricultural Bio-Pharmaceutical Laboratory, Qingdao Agricultural University, Qingdao, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuang Wu</Name>
        <Affiliation>College of Chemistry and Pharmaceutical Sciences, Qingdao Agricultural University, Qingdao, China; Agricultural Bio-Pharmaceutical Laboratory, Qingdao Agricultural University, Qingdao, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Metabolome-wide association study of anti-epileptic drug treatment during pregnancy.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30521819</pubmedLink>
    <GrantList>
      <Grant>R01 NS050659</Grant>
      <Grant>T32 ES012870</Grant>
      <Grant>U01 NS050659</Grant>
      <Grant>S10 OD018006</Grant>
      <Grant>R01 NS038455</Grant>
      <Grant>U2C ES026560</Grant>
      <Grant>R01 MH107205</Grant>
      <Grant>P30 ES019776</Grant>
      <Grant>U01 NS038455</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30537-4</DOI>
    <KeywordList>
      <Keywords>Epilepsy</Keywords>
      <Keywords>Folate</Keywords>
      <Keywords>High-resolution mass spectrometry</Keywords>
      <Keywords>Lamotrigine</Keywords>
      <Keywords>Levetiracetam</Keywords>
      <Keywords>Pharmacometabolomics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Douglas I. Walker</Name>
        <Affiliation>Clinical Biomarkers Laboratory, Division of Pulmonary, Allergy, and Critical Care Medicine, Emory University School of Medicine, Atlanta, GA, United States; Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, GA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Kayla Perry-Walker</Name>
        <Affiliation>Department of Obstetrics-Gynecology, Pennsylvania Hospital, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Richard H. Finnell</Name>
        <Affiliation>Departments of Molecular and Cellular Biology and Medicine, Baylor College of Medicine, Houston, TX, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Kurt D. Pennell</Name>
        <Affiliation>School of Engineering, Brown University, Providence, RI, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Vilinh Tran</Name>
        <Affiliation>Department of Environmental Health, Rollins School of Public Health, Emory University, Atlanta, GA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ryan C. May</Name>
        <Affiliation>The Emmes Corporation, Rockville, MD, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas F. McElrath</Name>
        <Affiliation>Division of Maternal-Fetal Medicine, Department of Obstetrics-Gynecology, Brigham &amp; Women's Hospital, Harvard Medical School, Boston, MA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Kimford J. Meador</Name>
        <Affiliation>Department of Neurology, Stanford University, Stanford, CA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Page B. Pennell</Name>
        <Affiliation>Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Dean P. Jones</Name>
        <Affiliation>Clinical Biomarkers Laboratory, Division of Pulmonary, Allergy, and Critical Care Medicine, Emory University School of Medicine, Atlanta, GA, United States. Electronic address: dpjones@emory.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Uterine histopathological changes induced by acute administration of tamoxifen and its modulation by sex steroid hormones.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30503537</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30535-0</DOI>
    <KeywordList>
      <Keywords>Estradiol</Keywords>
      <Keywords>Histopathology</Keywords>
      <Keywords>Stereology</Keywords>
      <Keywords>Tamoxifen</Keywords>
      <Keywords>Uterus</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Susana I. Sá</Name>
        <Affiliation>Department of Biomedicine, Unit of Anatomy, Faculty of Medicine, University of Porto, Portugal; CINTESIS, Center for Health Technology and Services Research, Faculty of Medicine, University of Porto, Porto, Portugal. Electronic address: sasusana@med.up.pt.</Affiliation>
      </Author>
      <Author>
        <Name>João Maia</Name>
        <Affiliation>UCIBIO, REQUIMTE, Departamento de Ciências Biológicas, Laboratório de Bioquímica, Faculdade de Farmácia, University of Porto, Porto, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Niloy Bhowmick</Name>
        <Affiliation>UCIBIO, REQUIMTE, Departamento de Ciências Biológicas, Laboratório de Bioquímica, Faculdade de Farmácia, University of Porto, Porto, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Samuel M. Silva</Name>
        <Affiliation>IUCS/CESPU, Institute of Research and Advanced Training in Health Sciences and Technologies (IINFACTS), Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Silva</Name>
        <Affiliation>Department of Biomedicine, Unit of Anatomy, Faculty of Medicine, University of Porto, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Georgina Correia-da-Silva</Name>
        <Affiliation>UCIBIO, REQUIMTE, Departamento de Ciências Biológicas, Laboratório de Bioquímica, Faculdade de Farmácia, University of Porto, Porto, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Natércia Teixeira</Name>
        <Affiliation>UCIBIO, REQUIMTE, Departamento de Ciências Biológicas, Laboratório de Bioquímica, Faculdade de Farmácia, University of Porto, Porto, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Bruno M. Fonseca</Name>
        <Affiliation>UCIBIO, REQUIMTE, Departamento de Ciências Biológicas, Laboratório de Bioquímica, Faculdade de Farmácia, University of Porto, Porto, Portugal.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Analysis of metabolome changes in the bile acid pool in feces and plasma of antibiotic-treated rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30502395</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30515-5</DOI>
    <KeywordList>
      <Keywords>Antibiotics</Keywords>
      <Keywords>Bile acid profiling</Keywords>
      <Keywords>Gut microbiome</Keywords>
      <Keywords>Metabolomics</Keywords>
      <Keywords>Microbiome-related metabolites</Keywords>
      <Keywords>Repeated dose oral toxicity study</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>C. Behr</Name>
        <Affiliation>BASF, SE, 67056 Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>M. Slopianka</Name>
        <Affiliation>metanomics GmbH, 10589 Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>V. Haake</Name>
        <Affiliation>metanomics GmbH, 10589 Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>V. Strauss</Name>
        <Affiliation>BASF, SE, 67056 Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>S. Sperber</Name>
        <Affiliation>BASF, SE, 67056 Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>H. Kamp</Name>
        <Affiliation>BASF, SE, 67056 Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>T. Walk</Name>
        <Affiliation>metanomics GmbH, 10589 Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>K. Beekmann</Name>
        <Affiliation>Division of Toxicology, Wageningen University, 6700, EA, Wageningen, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>I. M. C. M. Rietjens</Name>
        <Affiliation>Division of Toxicology, Wageningen University, 6700, EA, Wageningen, the Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>B. van Ravenzwaay</Name>
        <Affiliation>BASF, SE, 67056 Ludwigshafen, Germany. Electronic address: bennard.ravenzwaay@basf.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>γ-Mangostin alleviates liver fibrosis through Sirtuin 3-superoxide-high mobility group box 1 signaling axis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30502394</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30514-3</DOI>
    <KeywordList>
      <Keywords>Fibrogenesis</Keywords>
      <Keywords>HMGB1</Keywords>
      <Keywords>Liver fibrosis</Keywords>
      <Keywords>Sirtuin 3</Keywords>
      <Keywords>Superoxide</Keywords>
      <Keywords>γ-Mangostin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anqi Wang</Name>
        <Affiliation>Guangdong-Macau Traditional Chinese Medicine Technology Industrial Park Development Co., Ltd, Hengqin New Area, Zhuhai, Guangdong 519031, China; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macau 999078, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fayang Zhou</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macau 999078, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dan Li</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macau 999078, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Jian Lu</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macau 999078, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yitao Wang</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macau 999078, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ligen Lin</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macau 999078, China; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China. Electronic address: ligenl@umac.mo.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Candidate early predictive plasma protein markers of doxorubicin-induced chronic cardiotoxicity in B6C3F</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30517846</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30536-2</DOI>
    <KeywordList>
      <Keywords>Biomarkers</Keywords>
      <Keywords>Cardiotoxicity</Keywords>
      <Keywords>Dexrazoxane</Keywords>
      <Keywords>Doxorubicin</Keywords>
      <Keywords>Mouse Plasma</Keywords>
      <Keywords>SOMAscan™ Proteomic Assay</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Varsha G. Desai</Name>
        <Affiliation>Division of Systems Biology, National Center for Toxicological Research, U.S. Food and Drug Administration, Personalized Medicine Branch, Jefferson, AR 72079, United States. Electronic address: varsha.desai@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Taewon Lee</Name>
        <Affiliation>Division of Applied Mathematical Sciences, Korea University, Sejong Campus, Sejong-si, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Carrie L. Moland</Name>
        <Affiliation>Division of Systems Biology, National Center for Toxicological Research, U.S. Food and Drug Administration, Personalized Medicine Branch, Jefferson, AR 72079, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Vikrant Vijay</Name>
        <Affiliation>Division of Systems Biology, National Center for Toxicological Research, U.S. Food and Drug Administration, Personalized Medicine Branch, Jefferson, AR 72079, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Tao Han</Name>
        <Affiliation>Division of Systems Biology, National Center for Toxicological Research, U.S. Food and Drug Administration, Personalized Medicine Branch, Jefferson, AR 72079, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Sherry M. Lewis</Name>
        <Affiliation>Office of Scientific Coordination, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Eugene H. Herman</Name>
        <Affiliation>Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, The National Cancer Institute, 9609 Medical Center Drive, Rockville, MD 20850-9734, United States.</Affiliation>
      </Author>
      <Author>
        <Name>James C. Fuscoe</Name>
        <Affiliation>Division of Systems Biology, National Center for Toxicological Research, U.S. Food and Drug Administration, Personalized Medicine Branch, Jefferson, AR 72079, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pro-apoptotic effects of low doses of dimethoate in rat brain.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30502393</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30516-7</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Brain</Keywords>
      <Keywords>Dimethoate</Keywords>
      <Keywords>Mitochondria</Keywords>
      <Keywords>Rats</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nathalie Arnal</Name>
        <Affiliation>Neuroscience Lab, Instituto de Investigaciones Bioquímicas de La Plata (INIBIOLP), CONICET (Consejo Nacional de Investigaciones Científicas y técnicas) - UNLP (Universidad Nacional de La Plata), 60 and 120, 1900 La Plata, Argentina. Electronic address: narnal@med.unlp.edu.ar.</Affiliation>
      </Author>
      <Author>
        <Name>Gustavo Morel</Name>
        <Affiliation>Biochemistry of Aging Lab, INIBIOLP, CONICET-UNLP, 60 and 120, La Plata, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Carlos A. Marra</Name>
        <Affiliation>Neuroscience Lab, Instituto de Investigaciones Bioquímicas de La Plata (INIBIOLP), CONICET (Consejo Nacional de Investigaciones Científicas y técnicas) - UNLP (Universidad Nacional de La Plata), 60 and 120, 1900 La Plata, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Mariana Astiz</Name>
        <Affiliation>Neuroscience Lab, Instituto de Investigaciones Bioquímicas de La Plata (INIBIOLP), CONICET (Consejo Nacional de Investigaciones Científicas y técnicas) - UNLP (Universidad Nacional de La Plata), 60 and 120, 1900 La Plata, Argentina.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Differential response to lead toxicity in rat primary microglia and astrocytes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30476502</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30513-1</DOI>
    <KeywordList>
      <Keywords>Astrocytes</Keywords>
      <Keywords>Lead</Keywords>
      <Keywords>Microglia</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>Oxidative stress</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jiawen Peng</Name>
        <Affiliation>Department of Occupational Health and Occupational Medicine, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fan Zhou</Name>
        <Affiliation>Department of Occupational Health and Occupational Medicine, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuhao Wang</Name>
        <Affiliation>Department of Occupational Health and Occupational Medicine, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongjie Xu</Name>
        <Affiliation>Department of Occupational Health and Occupational Medicine, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongnan Zhang</Name>
        <Affiliation>Department of Occupational Health and Occupational Medicine, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fei Zou</Name>
        <Affiliation>Department of Occupational Health and Occupational Medicine, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China. Electronic address: zfei@smu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaojing Meng</Name>
        <Affiliation>Department of Occupational Health and Occupational Medicine, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, Guangdong, China. Electronic address: xiaojingmeng@smu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Prevention of acetaminophen-induced liver injury by alginate.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30468816</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30511-8</DOI>
    <KeywordList>
      <Keywords>Acetaminophen</Keywords>
      <Keywords>Alginate</Keywords>
      <Keywords>Diffusion coefficient</Keywords>
      <Keywords>Hepato-protection</Keywords>
      <Keywords>Interleukin-6</Keywords>
      <Keywords>Liver</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Eyal Shteyer</Name>
        <Affiliation>Liver Unit, Hebrew University- Hadassah Medical Center, Jerusalem, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Ami Ben Ya'acov</Name>
        <Affiliation>Liver Unit, Hebrew University- Hadassah Medical Center, Jerusalem, Israel. Electronic address: amib@szmc.org.il.</Affiliation>
      </Author>
      <Author>
        <Name>Lidia Zolotaryova</Name>
        <Affiliation>Liver Unit, Hebrew University- Hadassah Medical Center, Jerusalem, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Avital Sinai</Name>
        <Affiliation>Liver Unit, Hebrew University- Hadassah Medical Center, Jerusalem, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Mordechai Slae</Name>
        <Affiliation>Liver Unit, Hebrew University- Hadassah Medical Center, Jerusalem, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Smadar Cohen</Name>
        <Affiliation>Avram and Stella Goldstein-Goren Department of Biotechnology Engineering, Ben-Gurion University, Beer Sheva, Israel; Regenerative Medicine and Stem Cell (RMSC) Research Center, Ben-Gurion University, Beer Sheva, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Yaron Ilan</Name>
        <Affiliation>Liver Unit, Hebrew University- Hadassah Medical Center, Jerusalem, Israel.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Video-based kinetic analysis of calcification in live osteogenic human embryonic stem cell cultures reveals the developmentally toxic effect of Snus tobacco extract.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30468815</pubmedLink>
    <GrantList>
      <Grant>R01 DE025330</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30509-X</DOI>
    <KeywordList>
      <Keywords>Calcification</Keywords>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Embryonic stem cells</Keywords>
      <Keywords>Nicotine</Keywords>
      <Keywords>N′-nitrosonornicotine</Keywords>
      <Keywords>Osteogenesis</Keywords>
      <Keywords>Snus</Keywords>
      <Keywords>Tobacco</Keywords>
      <Keywords>Tobacco-specific nitrosamine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ivann K. C. Martinez</Name>
        <Affiliation>Department of Molecular, Cell &amp; Systems Biology and Stem Cell Center, College of Natural and Agricultural Sciences, University of California Riverside, Riverside, CA 92521, United States; IGERT Graduate Program in Video Bioinformatics and Cell, Molecular and Developmental Biology Graduate Program, University of California Riverside, Riverside, CA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Nicole R. L. Sparks</Name>
        <Affiliation>Department of Molecular, Cell &amp; Systems Biology and Stem Cell Center, College of Natural and Agricultural Sciences, University of California Riverside, Riverside, CA 92521, United States; Environmental Toxicology Graduate Program, University of California Riverside, Riverside, CA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph V. Madrid</Name>
        <Affiliation>Department of Molecular, Cell &amp; Systems Biology and Stem Cell Center, College of Natural and Agricultural Sciences, University of California Riverside, Riverside, CA 92521, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Henry Affeldt</Name>
        <Affiliation>Department of Molecular, Cell &amp; Systems Biology and Stem Cell Center, College of Natural and Agricultural Sciences, University of California Riverside, Riverside, CA 92521, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Madeline K. M. Vera</Name>
        <Affiliation>Department of Molecular, Cell &amp; Systems Biology and Stem Cell Center, College of Natural and Agricultural Sciences, University of California Riverside, Riverside, CA 92521, United States; Environmental Toxicology Graduate Program, University of California Riverside, Riverside, CA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Bir Bhanu</Name>
        <Affiliation>Center for Research in Intelligent Systems, Bourns College of Engineering, University of California Riverside, Riverside, CA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Nicole I. Zur Nieden</Name>
        <Affiliation>Department of Molecular, Cell &amp; Systems Biology and Stem Cell Center, College of Natural and Agricultural Sciences, University of California Riverside, Riverside, CA 92521, United States; IGERT Graduate Program in Video Bioinformatics and Cell, Molecular and Developmental Biology Graduate Program, University of California Riverside, Riverside, CA, United States; Environmental Toxicology Graduate Program, University of California Riverside, Riverside, CA, United States. Electronic address: nicolezn@ucr.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cuprizone-induced demyelination in the mouse hippocampus is alleviated by phytoestrogen genistein.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30468814</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30512-X</DOI>
    <KeywordList>
      <Keywords>Cuprizone</Keywords>
      <Keywords>Demyelination</Keywords>
      <Keywords>Genistein</Keywords>
      <Keywords>Hippocampus</Keywords>
      <Keywords>Oligodendrocyte</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tomohiro Ohgomori</Name>
        <Affiliation>Department of Anatomy and Neuroscience, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shozo Jinno</Name>
        <Affiliation>Department of Anatomy and Neuroscience, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan. Electronic address: sjnno@med.kyushu-u.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Clozapine-induced reduction of l-carnitine reabsorption via inhibition/down-regulation of renal carnitine/organic cation transporter 2 contributes to liver lipid metabolic disorder in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30465787</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30510-6</DOI>
    <KeywordList>
      <Keywords>Antipsychotics</Keywords>
      <Keywords>Clozapine</Keywords>
      <Keywords>Liver lipid metabolic disorder</Keywords>
      <Keywords>OCTN2</Keywords>
      <Keywords>Renal excretion</Keywords>
      <Keywords>l-carnitine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wei Wang</Name>
        <Affiliation>Laboratory of Pharmaceutical Analysis and Drug Metabolism, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mengru Bai</Name>
        <Affiliation>Laboratory of Pharmaceutical Analysis and Drug Metabolism, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ting Jiang</Name>
        <Affiliation>Laboratory of Pharmaceutical Analysis and Drug Metabolism, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cui Li</Name>
        <Affiliation>Laboratory of Pharmaceutical Analysis and Drug Metabolism, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Li</Name>
        <Affiliation>Laboratory of Pharmaceutical Analysis and Drug Metabolism, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Zhou</Name>
        <Affiliation>Laboratory of Pharmaceutical Analysis and Drug Metabolism, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zemin Wang</Name>
        <Affiliation>Mental Health Center, Zhejiang University, School of Medicine, Hangzhou Seventh People's Hospital, Hangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Liping Li</Name>
        <Affiliation>Laboratory of Pharmaceutical Analysis and Drug Metabolism, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huidi Jiang</Name>
        <Affiliation>Laboratory of Pharmaceutical Analysis and Drug Metabolism, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China. Electronic address: hdjiang@zju.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Activation of local bone RAS by maternal excessive glucocorticoid participated in the fetal programing of adult osteopenia induced by prenatal caffeine exposure.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30423288</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30500-3</DOI>
    <KeywordList>
      <Keywords>Caffeine</Keywords>
      <Keywords>Glucocorticoid</Keywords>
      <Keywords>Osteopenia</Keywords>
      <Keywords>Prenatal</Keywords>
      <Keywords>Renin angiotensin system</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yinxian Wen</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yangfan Shangguan</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhengqi Pan</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hang Hu</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jacques Magdalou</Name>
        <Affiliation>UMR 7365 CNRS, University of Lorraine, Nancy 54000, France.</Affiliation>
      </Author>
      <Author>
        <Name>Liaobin Chen</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan 430071, China. Electronic address: lbchen@whu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Wang</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan 430071, China. Electronic address: wanghui19@whu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparison of multi-wall carbon nanotube and nitrogen-doped multi-wall carbon nanotube effects on lung function and airway reactivity in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30423287</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30501-5</DOI>
    <KeywordList>
      <Keywords>Airway epithelium</Keywords>
      <Keywords>Airway reactivity</Keywords>
      <Keywords>Ion channels</Keywords>
      <Keywords>Ion transport</Keywords>
      <Keywords>Multi-wall carbon nanotubes</Keywords>
      <Keywords>Pulmonary function</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kristen A. Russ</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Janet A. Thompson</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Kashon</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Dale W. Porter</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sherri A. Friend</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Walter McKinney</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey S. Fedan</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, USA. Electronic address: jsf2@cdc.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Adaptive homeostasis of the vitamin D-vitamin D nuclear receptor axis in 8-methoxypsoralen-induced hepatotoxicity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30419252</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30491-5</DOI>
    <KeywordList>
      <Keywords>8-MOP</Keywords>
      <Keywords>Liver injury</Keywords>
      <Keywords>Vitamin D</Keywords>
      <Keywords>Vitamin D nuclear receptor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Guolin Zhao</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Muhanad Elhafiz</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingwei Jiang</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Debanjan Das</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhijian Li</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing 210009, China; Department of Pharmacology and Toxicology Laboratory, Xinjiang Institute of Traditional Uighur Medicine, Urumqi, Xinjiang 830049, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wang Zhou</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Sisi Fan</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Changling Wang</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ziqiao Yuan</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dengqiu Xu</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenzhou Jiang</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing 210009, China; Key Laboratory of Drug Quality Control and Pharmacovigilance, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Luyong Zhang</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing 210009, China; Center for Drug Screening and Pharmacodynamics Evaluation, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China; Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, Nanjing 210009, China; State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China. Electronic address: lyzhang@cpu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Tao Wang</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing 210009, China; Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, Nanjing 210009, China. Electronic address: wangtao1331@cpu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>6-gingerol ameliorates age-related hepatic steatosis: Association with regulating lipogenesis, fatty acid oxidation, oxidative stress and mitochondrial dysfunction.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30408433</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30490-3</DOI>
    <KeywordList>
      <Keywords>6-Gingerol</Keywords>
      <Keywords>Ageing</Keywords>
      <Keywords>Fatty Liver</Keywords>
      <Keywords>Mitochondria</Keywords>
      <Keywords>PPARα</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jinxiu Li</Name>
        <Affiliation>Chongqing Key Laboratory of Traditional Chinese Medicine for Prevention and Cure of Metabolic Diseases, Chongqing Medical University, Chongqing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shang Wang</Name>
        <Affiliation>Faculty of Basic Medical Sciences, Chongqing Medical University, Chongqing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ling Yao</Name>
        <Affiliation>Chongqing Key Laboratory of Traditional Chinese Medicine for Prevention and Cure of Metabolic Diseases, Chongqing Medical University, Chongqing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Peng Ma</Name>
        <Affiliation>Faculty of Basic Medical Sciences, Chongqing Medical University, Chongqing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhiwei Chen</Name>
        <Affiliation>Chongqing Key Laboratory of Traditional Chinese Medicine for Prevention and Cure of Metabolic Diseases, Chongqing Medical University, Chongqing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ting Li Han</Name>
        <Affiliation>Department of Obstetrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunlin Yuan</Name>
        <Affiliation>Chongqing Key Laboratory of Traditional Chinese Medicine for Prevention and Cure of Metabolic Diseases, Chongqing Medical University, Chongqing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Zhang</Name>
        <Affiliation>Faculty of Basic Medical Sciences, Chongqing Medical University, Chongqing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lirong Jiang</Name>
        <Affiliation>Faculty of Basic Medical Sciences, Chongqing Medical University, Chongqing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Liu</Name>
        <Affiliation>Faculty of Basic Medical Sciences, Chongqing Medical University, Chongqing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dazhi Ke</Name>
        <Affiliation>The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunli Li</Name>
        <Affiliation>Institute of Life Sciences, Chongqing Medical University, Chongqing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Johji Yamahara</Name>
        <Affiliation>Pharmafood Institute, Kyoto, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuhao Li</Name>
        <Affiliation>Endocrinology and Metabolism Group, Sydney Institute of Health Sciences/Sydney Institute of Traditional Chinese Medicine, Sydney, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Jianwei Wang</Name>
        <Affiliation>Chongqing Key Laboratory of Traditional Chinese Medicine for Prevention and Cure of Metabolic Diseases, Chongqing Medical University, Chongqing, China. Electronic address: wjwcq68@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>PPAR gamma agonist, pioglitazone, rescues liver damage induced by renal ischemia/reperfusion injury.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30393147</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30487-3</DOI>
    <KeywordList>
      <Keywords>Inflammation</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>PPARγ</Keywords>
      <Keywords>Remote injury</Keywords>
      <Keywords>Renal IR</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shimaa Elshazly</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Eman Soliman</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt. Electronic address: solimane@zu.edu.eg.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>CYP3C gene regulation by the aryl hydrocarbon and estrogen receptors in zebrafish.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30393146</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30486-1</DOI>
    <KeywordList>
      <Keywords>Aryl hydrocarbon receptor</Keywords>
      <Keywords>Cytochrome P450</Keywords>
      <Keywords>Estrogen receptor</Keywords>
      <Keywords>Expression</Keywords>
      <Keywords>Regulation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lana Shaya</Name>
        <Affiliation>Biology Department, McMaster University, Ontario, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Devon E. Jones</Name>
        <Affiliation>Biology Department, McMaster University, Ontario, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Joanna Y. Wilson</Name>
        <Affiliation>Biology Department, McMaster University, Ontario, Canada. Electronic address: joanna.wilson@mcmaster.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparative cytotoxicity of respirable surface-treated/untreated calcium carbonate rock dust particles in vitro.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30393145</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30485-X</DOI>
    <KeywordList>
      <Keywords>Limestone</Keywords>
      <Keywords>Macrophages</Keywords>
      <Keywords>Marble</Keywords>
      <Keywords>Rock dust</Keywords>
      <Keywords>Silica</Keywords>
      <Keywords>Stearate</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Timur O. Khaliullin</Name>
        <Affiliation>Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Health Effects Laboratory Division, Exposure Assessment Branch, 1095 Willowdale road, Morgantown, WV 26505, USA; West Virginia University, Department of Physiology and Pharmacology, PO Box 9229, Morgantown, WV, USA. Electronic address: ved2@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Elena R. Kisin</Name>
        <Affiliation>Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Health Effects Laboratory Division, Exposure Assessment Branch, 1095 Willowdale road, Morgantown, WV 26505, USA. Electronic address: edk8@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Naveena Yanamala</Name>
        <Affiliation>Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Health Effects Laboratory Division, Exposure Assessment Branch, 1095 Willowdale road, Morgantown, WV 26505, USA. Electronic address: wqu1@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Supraja Guppi</Name>
        <Affiliation>Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Health Effects Laboratory Division, Exposure Assessment Branch, 1095 Willowdale road, Morgantown, WV 26505, USA. Electronic address: mzi6@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Martin Harper</Name>
        <Affiliation>Zefon International, 5350 SW 1st Lane, Ocala, FL 34474, USA. Electronic address: mHarper@zefon.com.</Affiliation>
      </Author>
      <Author>
        <Name>Taekhee Lee</Name>
        <Affiliation>Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Pittsburgh Mining Research Division, 626 Cochrans Mill Road, Pittsburgh, PA 15236, USA. Electronic address: fwc8@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Anna A. Shvedova</Name>
        <Affiliation>Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Health Effects Laboratory Division, Exposure Assessment Branch, 1095 Willowdale road, Morgantown, WV 26505, USA; West Virginia University, Department of Physiology and Pharmacology, PO Box 9229, Morgantown, WV, USA. Electronic address: ats1@cdc.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30391378</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30489-7</DOI>
    <KeywordList>
      <Keywords>ABCB1</Keywords>
      <Keywords>ABCC1</Keywords>
      <Keywords>ABCG2</Keywords>
      <Keywords>Calcein AM</Keywords>
      <Keywords>Mitoxantrone</Keywords>
      <Keywords>Rhodamine 123</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sara Ranjbar</Name>
        <Affiliation>Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; Department of Medicinal Chemistry, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Ruttiros Khonkarn</Name>
        <Affiliation>Drug Resistance &amp; Membrane Protein (DRMP) Group, CNRS/Lyon I University UMR 5086 (MMSB), IBCP, 69367 Lyon, France; Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Alexis Moreno</Name>
        <Affiliation>Drug Resistance &amp; Membrane Protein (DRMP) Group, CNRS/Lyon I University UMR 5086 (MMSB), IBCP, 69367 Lyon, France.</Affiliation>
      </Author>
      <Author>
        <Name>Hélène Baubichon-Cortay</Name>
        <Affiliation>Drug Resistance &amp; Membrane Protein (DRMP) Group, CNRS/Lyon I University UMR 5086 (MMSB), IBCP, 69367 Lyon, France.</Affiliation>
      </Author>
      <Author>
        <Name>Ramin Miri</Name>
        <Affiliation>Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Mehdi Khoshneviszadeh</Name>
        <Affiliation>Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; Department of Medicinal Chemistry, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Luciano Saso</Name>
        <Affiliation>Department of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Najmeh Edraki</Name>
        <Affiliation>Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Pierre Falson</Name>
        <Affiliation>Drug Resistance &amp; Membrane Protein (DRMP) Group, CNRS/Lyon I University UMR 5086 (MMSB), IBCP, 69367 Lyon, France. Electronic address: pierre.falson@ibcp.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Omidreza Firuzi</Name>
        <Affiliation>Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Electronic address: firuzio@sums.ac.ir.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Astragaloside IV regulates differentiation and induces apoptosis of activated CD4</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30385269</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30488-5</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Astragaloside IV</Keywords>
      <Keywords>CD4(+) T cells</Keywords>
      <Keywords>Differentiation</Keywords>
      <Keywords>Th17 cells</Keywords>
      <Keywords>Treg cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Liu Yang</Name>
        <Affiliation>Shanghai Key Laboratory of Compound Chinese Medicines, the Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Faping Xing</Name>
        <Affiliation>Shanghai Key Laboratory of Compound Chinese Medicines, the Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xinyan Han</Name>
        <Affiliation>Shanghai Key Laboratory of Compound Chinese Medicines, the Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Li</Name>
        <Affiliation>Shanghai Key Laboratory of Compound Chinese Medicines, the Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Wu</Name>
        <Affiliation>Shanghai Key Laboratory of Compound Chinese Medicines, the Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hailian Shi</Name>
        <Affiliation>Shanghai Key Laboratory of Compound Chinese Medicines, the Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhifei Wang</Name>
        <Affiliation>Shanghai Key Laboratory of Compound Chinese Medicines, the Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fei Huang</Name>
        <Affiliation>Shanghai Key Laboratory of Compound Chinese Medicines, the Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Electronic address: Fei_H@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaojun Wu</Name>
        <Affiliation>Shanghai Key Laboratory of Compound Chinese Medicines, the Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Electronic address: xiaojunwu320@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chrysotile and chrysophosphate chemical modification of the chrysotile surface and its effect on biological behavior.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30381243</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30484-8</DOI>
    <AuthorList>
      <Author>
        <Name>A. M. Langer</Name>
        <Affiliation>Doctoral Program in Earth and Environmental Sciences, The Graduate School and University Center, The City University of New York, 365 Fifth Avenue, NY, New York 10016, United States. Electronic address: artlanger@aol.com.</Affiliation>
      </Author>
      <Author>
        <Name>R. P. Nolan</Name>
        <Affiliation>Doctoral Program in Chemistry, The Graduate School and University Center, The City University of New York, 365 Fifth Avenue, NY, New York 10016, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Characterization of lung burden E.M.P.S.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30367917</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30483-6</DOI>
    <AuthorList>
      <Author>
        <Name>F. D. Pooley</Name>
        <Affiliation>Dept. Cellular Path, Heath Hospital, Cardiff, Wales, United Kingdom. Electronic address: pooleyfd@btinternet.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The chemopreventive isothiocyanate sulforaphane reduces anoikis resistance and anchorage-independent growth in non-small cell human lung cancer cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30365975</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30482-4</DOI>
    <KeywordList>
      <Keywords>Anchorage-independent growth</Keywords>
      <Keywords>Anoikis</Keywords>
      <Keywords>Sulforaphane</Keywords>
      <Keywords>p53</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ju Ying Tsai</Name>
        <Affiliation>Graduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Shin Han Tsai</Name>
        <Affiliation>Graduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chin Chung Wu</Name>
        <Affiliation>Graduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; Research Center for Natural Products and Drug Development, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Marine Biotechnology and Resources, National Sun Yat-sen University, Kaohsiung, Taiwan. Electronic address: ccwu@kmu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Hormesis of methylmercury-human serum albumin conjugate on N9 microglia via ERK/MAPKs and STAT3 signaling pathways.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30352208</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30481-2</DOI>
    <AuthorList>
      <Author>
        <Name>Qiaozhu Tan</Name>
        <Affiliation>Qinghai Provincial Key Laboratory of Tibetan Medicine Pharmacology and Safety Evaluation, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining, China; University of Chinese Academy of Sciences, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Zhang</Name>
        <Affiliation>Qinghai Provincial Key Laboratory of Tibetan Medicine Pharmacology and Safety Evaluation, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining, China; University of Chinese Academy of Sciences, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lujing Geng</Name>
        <Affiliation>Qinghai Provincial Key Laboratory of Tibetan Medicine Pharmacology and Safety Evaluation, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining, China; University of Chinese Academy of Sciences, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenghua Xia</Name>
        <Affiliation>Qinghai Provincial Key Laboratory of Tibetan Medicine Pharmacology and Safety Evaluation, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining, China; University of Chinese Academy of Sciences, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cen Li</Name>
        <Affiliation>Qinghai Provincial Key Laboratory of Tibetan Medicine Pharmacology and Safety Evaluation, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining, China; Key Laboratory of Tibetan Medicine Research, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining, China.</Affiliation>
      </Author>
      <Author>
        <Name>Muhammad Usman</Name>
        <Affiliation>Department of Biotechnology, Virtual University of Pakistan, Lahore, Pakistan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuzhi Du</Name>
        <Affiliation>Qinghai Provincial Key Laboratory of Tibetan Medicine Pharmacology and Safety Evaluation, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining, China; Key Laboratory of Tibetan Medicine Research, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lixin Wei</Name>
        <Affiliation>Qinghai Provincial Key Laboratory of Tibetan Medicine Pharmacology and Safety Evaluation, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining, China; Key Laboratory of Tibetan Medicine Research, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining, China. Electronic address: lxwei@nwipb.cas.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Hongtao Bi</Name>
        <Affiliation>Qinghai Provincial Key Laboratory of Tibetan Medicine Pharmacology and Safety Evaluation, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining, China; Key Laboratory of Tibetan Medicine Research, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining, China. Electronic address: bihongtao@nwipb.cas.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cardiovascular variability and β-ARs gene expression at two stages of doxorubicin - Induced cardiomyopathy.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30342983</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30479-4</DOI>
    <KeywordList>
      <Keywords>Blood pressure variability</Keywords>
      <Keywords>Cardiotoxicity</Keywords>
      <Keywords>Doxorubicin</Keywords>
      <Keywords>Heart rate variability</Keywords>
      <Keywords>β-adrenergic receptors</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marko Vasić</Name>
        <Affiliation>Faculty of Medicine, University of Belgrade, Belgrade, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Tatjana Lončar-Turukalo</Name>
        <Affiliation>Faculty of Technical, Sciences University of Novi Sad, Novi Sad, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Tatjana Tasić</Name>
        <Affiliation>Faculty of Stomatology, University of Belgrade, Belgrade, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Marija Matić</Name>
        <Affiliation>Faculty of Medicine, University of Belgrade, Belgrade, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Sofija Glumac</Name>
        <Affiliation>Faculty of Medicine, University of Belgrade, Belgrade, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Dragana Bajić</Name>
        <Affiliation>Faculty of Technical, Sciences University of Novi Sad, Novi Sad, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Branka Popović</Name>
        <Affiliation>Faculty of Stomatology, University of Belgrade, Belgrade, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Nina Japundžić-Žigon</Name>
        <Affiliation>Faculty of Medicine, University of Belgrade, Belgrade, Serbia. Electronic address: nina.zigon@med.bg.ac.rs.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Role of ZIP8 in regulation of cisplatin sensitivity through Bcl-2.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30342059</pubmedLink>
    <GrantList>
      <Grant>R15 ES022800</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30480-0</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Bcl-2</Keywords>
      <Keywords>Cisplatin</Keywords>
      <Keywords>Drug-resistance</Keywords>
      <Keywords>Transporter</Keywords>
      <Keywords>ZIP8</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiangrong Geng</Name>
        <Affiliation>Department of Biological Sciences, Oakland University, Rochester, MI 48309, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Liu Liu</Name>
        <Affiliation>Department of Biological Sciences, Oakland University, Rochester, MI 48309, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kan Jen Tsai</Name>
        <Affiliation>Department of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Zijuan Liu</Name>
        <Affiliation>Department of Biological Sciences, Oakland University, Rochester, MI 48309, USA. Electronic address: liu2345@oakland.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Gene expression profiles in brain of male juvenile zebrafish (Danio rerio) treated with triclosan.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30336175</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30478-2</DOI>
    <KeywordList>
      <Keywords>Immune system process</Keywords>
      <Keywords>Microarray analysis</Keywords>
      <Keywords>Neurotoxicity</Keywords>
      <Keywords>Triclosan(TCS)</Keywords>
      <Keywords>Visual perception</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Fan Wang</Name>
        <Affiliation>School of Biological Science, Luoyang Normal University, Luoyang 471934, China; Cold water fish breeding Engineering Technology Research Center of Henan province, Luoyang 471934, China. Electronic address: wangfan7677@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ruiling Wang</Name>
        <Affiliation>School of Biological Science, Luoyang Normal University, Luoyang 471934, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fei Liu</Name>
        <Affiliation>School of Biological Science, Luoyang Normal University, Luoyang 471934, China; Cold water fish breeding Engineering Technology Research Center of Henan province, Luoyang 471934, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wanguang Chen</Name>
        <Affiliation>School of Biological Science, Luoyang Normal University, Luoyang 471934, China; Cold water fish breeding Engineering Technology Research Center of Henan province, Luoyang 471934, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>SIRT1 activation by butein attenuates sepsis-induced brain injury in mice subjected to cecal ligation and puncture via alleviating inflammatory and oxidative stress.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30336174</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30477-0</DOI>
    <KeywordList>
      <Keywords>Brain injury</Keywords>
      <Keywords>Butein</Keywords>
      <Keywords>Cecal ligation and puncture</Keywords>
      <Keywords>SIRT1</Keywords>
      <Keywords>Sepsis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yanrong Zhu</Name>
        <Affiliation>Department of Pharmacology, Xi'an Jiaotong University School of Medicine, 76 Yanta West Road, Xi'an 710061, China; Department of Pharmacy, Xijing Hospital, The Fourth Military Medical University, 127 Changle West Road, Xi'an 710032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ke Wang</Name>
        <Affiliation>Department of Radiology, Xijing Hospital, Fourth Military Medical University, 127 Changle West Road, Xi'an 710032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhiqiang Ma</Name>
        <Affiliation>Department of Thoracic Surgery, Tangdu Hospital, The Fourth Military Medical University, 1 Xinsi Road, Xi'an 710038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dong Liu</Name>
        <Affiliation>State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, 167 Beilishi Road, Beijing 100037, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Yang</Name>
        <Affiliation>Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Faculty of Life Sciences, Northwest University, 229 Taibai North Road, Xi'an 710069, China.</Affiliation>
      </Author>
      <Author>
        <Name>Meng Sun</Name>
        <Affiliation>Department of Cardiology, The First Hospital of Shanxi Medical University, 85 Jiefang South Road, Taiyuan 030001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Aidong Wen</Name>
        <Affiliation>Department of Pharmacy, Xijing Hospital, The Fourth Military Medical University, 127 Changle West Road, Xi'an 710032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuewen Hao</Name>
        <Affiliation>Department of Radiology, Xijing Hospital, Fourth Military Medical University, 127 Changle West Road, Xi'an 710032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shanbo Ma</Name>
        <Affiliation>Department of Pharmacy, Xijing Hospital, The Fourth Military Medical University, 127 Changle West Road, Xi'an 710032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fang Ren</Name>
        <Affiliation>Department of Radiology, Xijing Hospital, Fourth Military Medical University, 127 Changle West Road, Xi'an 710032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenlong Xin</Name>
        <Affiliation>Graduate School, Fourth Military Medical University, 169 Changle West Road, Xi'an 710032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yue Li</Name>
        <Affiliation>Graduate School, Fourth Military Medical University, 169 Changle West Road, Xi'an 710032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shouyin Di</Name>
        <Affiliation>Department of Thoracic Surgery, Tangdu Hospital, The Fourth Military Medical University, 1 Xinsi Road, Xi'an 710038, China. Electronic address: dsy2140@fmmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Juntian Liu</Name>
        <Affiliation>Department of Pharmacology, Xi'an Jiaotong University School of Medicine, 76 Yanta West Road, Xi'an 710061, China. Electronic address: ljt@xjtu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Contribution of poly(ADP-ribose)polymerase-1 activation and apoptosis in trichloroethene-mediated autoimmunity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30315841</pubmedLink>
    <GrantList>
      <Grant>R01 ES016302</Grant>
      <Grant>R01 ES026887</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30470-8</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Autoimmune disease</Keywords>
      <Keywords>N-acetylcysteine</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Poly(ADP-ribose)polymerase-1</Keywords>
      <Keywords>Trichloroethene</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gangduo Wang</Name>
        <Affiliation>Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Huaxian Ma</Name>
        <Affiliation>Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jianling Wang</Name>
        <Affiliation>Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, United States.</Affiliation>
      </Author>
      <Author>
        <Name>M. Firoze Khan</Name>
        <Affiliation>Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, United States. Electronic address: mfkhan@utmb.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Polychlorinated biphenyl exposures differentially regulate hepatic metabolism and pancreatic function: Implications for nonalcoholic steatohepatitis and diabetes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30312631</pubmedLink>
    <GrantList>
      <Grant>P20 GM113226</Grant>
      <Grant>P50 AA024337</Grant>
      <Grant>R01 ES021375</Grant>
      <Grant>F31 ES028982</Grant>
      <Grant>R35 ES028373</Grant>
      <Grant>P42 ES023716</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30469-1</DOI>
    <KeywordList>
      <Keywords>AhR</Keywords>
      <Keywords>FGF21</Keywords>
      <Keywords>Islet Identity</Keywords>
      <Keywords>PCB</Keywords>
      <Keywords>Pnpla3</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hongxue Shi</Name>
        <Affiliation>Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, KY, 40202, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jian Jan</Name>
        <Affiliation>Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, KY, 40202, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Josiah E. Hardesty</Name>
        <Affiliation>Department of Biochemistry and Molecular Genetics, School of Medicine, University of Louisville, Louisville, KY, 40202, United States.</Affiliation>
      </Author>
      <Author>
        <Name>K. Cameron Falkner</Name>
        <Affiliation>Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, School of Medicine, University of Louisville, Louisville, KY, 40202, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Russell A. Prough</Name>
        <Affiliation>Department of Biochemistry and Molecular Genetics, School of Medicine, University of Louisville, Louisville, KY, 40202, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Appakalai N. Balamurugan</Name>
        <Affiliation>Department of Surgery, School of Medicine, University of Louisville, Louisville, KY, 40202, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Sri Prakash Mokshagundam</Name>
        <Affiliation>Department of Medicine, Division of Endocrinology, Metabolism &amp; Diabetes, School of Medicine, University of Louisville, Louisville, KY, 40202, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Suresh T. Chari</Name>
        <Affiliation>Department of Internal Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, 55902, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew C. Cave</Name>
        <Affiliation>Department of Pharmacology and Toxicology, School of Medicine, University of Louisville, Louisville, KY, 40202, United States; Department of Biochemistry and Molecular Genetics, School of Medicine, University of Louisville, Louisville, KY, 40202, United States; Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, School of Medicine, University of Louisville, Louisville, KY, 40202, United States. Electronic address: matt.cave@louisville.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chrysophanol selectively represses breast cancer cell growth by inducing reactive oxygen species production and endoplasmic reticulum stress via AKT and mitogen-activated protein kinase signal pathways.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30300626</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30468-X</DOI>
    <KeywordList>
      <Keywords>BT-474</Keywords>
      <Keywords>Chrysophanol</Keywords>
      <Keywords>ER stress</Keywords>
      <Keywords>MCF-7</Keywords>
      <Keywords>Mitochondria-dependent apoptosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sunwoo Park</Name>
        <Affiliation>Institute of Animal Molecular Biotechnology and Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Whasun Lim</Name>
        <Affiliation>Department of Biomedical Sciences, Catholic Kwandong University, Gangneung 25601, Republic of Korea.. Electronic address: wslim@cku.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Gwonhwa Song</Name>
        <Affiliation>Institute of Animal Molecular Biotechnology and Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea. Electronic address: ghsong@korea.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Metabolic dynamics of human Sertoli cells are differentially modulated by physiological and pharmacological concentrations of GLP-1.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30296456</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30467-8</DOI>
    <KeywordList>
      <Keywords>Glucagon like peptide-1 (GLP-1)</Keywords>
      <Keywords>Mammalian target of rapamycin (mTOR)</Keywords>
      <Keywords>Metabolism</Keywords>
      <Keywords>Obesity</Keywords>
      <Keywords>Sertoli Cells</Keywords>
      <Keywords>Spermatogenesis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ana D. Martins</Name>
        <Affiliation>Department of Microscopy, Laboratory of Cell Biology, Abel Salazar Institute of Biomedical Sciences (ICBAS), University of Porto, Porto, Portugal; Unit for Multidisciplinary Research in Biomedicine, Abel Salazar Institute of Biomedical Sciences (UMIB-ICBAS), University of Porto, Porto, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Mariana P. Monteiro</Name>
        <Affiliation>Unit for Multidisciplinary Research in Biomedicine, Abel Salazar Institute of Biomedical Sciences (UMIB-ICBAS), University of Porto, Porto, Portugal; Department of Anatomy, Abel Salazar Institute of Biomedical Sciences, ICBAS, University of Porto, Porto, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Branca M. Silva</Name>
        <Affiliation>Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Alberto Barros</Name>
        <Affiliation>Centre for Reproductive Genetics Professor Alberto Barros, Porto, Portugal; Department of Genetics, Faculty of Medicine, University of Porto, Porto, Portugal; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Mário Sousa</Name>
        <Affiliation>Department of Microscopy, Laboratory of Cell Biology, Abel Salazar Institute of Biomedical Sciences (ICBAS), University of Porto, Porto, Portugal; Unit for Multidisciplinary Research in Biomedicine, Abel Salazar Institute of Biomedical Sciences (UMIB-ICBAS), University of Porto, Porto, Portugal; Centre for Reproductive Genetics Professor Alberto Barros, Porto, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Rui A. Carvalho</Name>
        <Affiliation>Department of Life Sciences, Faculty of Sciences and Technology and Centre for Functional Ecology, University of Coimbra, Coimbra, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Pedro F. Oliveira</Name>
        <Affiliation>Department of Microscopy, Laboratory of Cell Biology, Abel Salazar Institute of Biomedical Sciences (ICBAS), University of Porto, Porto, Portugal; Unit for Multidisciplinary Research in Biomedicine, Abel Salazar Institute of Biomedical Sciences (UMIB-ICBAS), University of Porto, Porto, Portugal; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Marco G. Alves</Name>
        <Affiliation>Department of Microscopy, Laboratory of Cell Biology, Abel Salazar Institute of Biomedical Sciences (ICBAS), University of Porto, Porto, Portugal; Unit for Multidisciplinary Research in Biomedicine, Abel Salazar Institute of Biomedical Sciences (UMIB-ICBAS), University of Porto, Porto, Portugal. Electronic address: alvesmarc@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cunaniol-elicited seizures: Behavior characterization and electroencephalographic analyses.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30296455</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30466-6</DOI>
    <KeywordList>
      <Keywords>Clibadium spp.</Keywords>
      <Keywords>Convulsant model</Keywords>
      <Keywords>Drug resistant</Keywords>
      <Keywords>Seizure</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Moisés Hamoy</Name>
        <Affiliation>Biological Sciences Institute, Federal University of Pará, Belém, Pará, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Luiz Dos Santos Batista</Name>
        <Affiliation>Biological Sciences Institute, Federal University of Pará, Belém, Pará, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Vanessa Joia de Mello</Name>
        <Affiliation>Biological Sciences Institute, Federal University of Pará, Belém, Pará, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Walace Gomes-Leal</Name>
        <Affiliation>Biological Sciences Institute, Federal University of Pará, Belém, Pará, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Rômulo Augusto Feio Farias</Name>
        <Affiliation>Biological Sciences Institute, Federal University of Pará, Belém, Pará, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Pedro Dos Santos Batista</Name>
        <Affiliation>Technology Institute, Federal University of Pará, Belém, Pará, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>José Luiz Martins do Nascimento</Name>
        <Affiliation>Technology Institute, Federal University of Pará, Belém, Pará, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Helcio Casemiro Marcondes</Name>
        <Affiliation>Chemistry Department, Federal University of Ouro Preto, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Jason G. Taylor</Name>
        <Affiliation>Chemistry Department, Federal University of Ouro Preto, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>William D. Hutchison</Name>
        <Affiliation>Department of Physiology, University of Toronto, Division of Neurosurgery, Department of Surgery, Toronto Western Hospital, Toronto, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Marcelo Ferreira Torres</Name>
        <Affiliation>Federal Institute of Education, Science and Technology of Pará, IFPA, Castanhal, Pará, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Luis André L. Barbas</Name>
        <Affiliation>Federal Institute of Education, Science and Technology of Pará, IFPA, Castanhal, Pará, Brazil. Electronic address: andre.barbas@hotmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Solubility changes of promyelocytic leukemia (PML) and SUMO monomers and dynamics of PML nuclear body proteins in arsenite-treated cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30292834</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30459-9</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>DAXX</Keywords>
      <Keywords>MDM2</Keywords>
      <Keywords>PML</Keywords>
      <Keywords>SUMOylation</Keywords>
      <Keywords>Solubility</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Seishiro Hirano</Name>
        <Affiliation>Center for Health and Environmental Risk Research, National Institute for Environmental Studies, Japan. Electronic address: seishiro@nies.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Osamu Udagawa</Name>
        <Affiliation>Center for Health and Environmental Risk Research, National Institute for Environmental Studies, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yayoi Kobayashi</Name>
        <Affiliation>Center for Health and Environmental Risk Research, National Institute for Environmental Studies, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Ayaka Kato</Name>
        <Affiliation>Center for Health and Environmental Risk Research, National Institute for Environmental Studies, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nicotinamide mononucleotide alleviates Aluminum induced bone loss by inhibiting the TXNIP-NLRP3 inflammasome.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30292833</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30464-2</DOI>
    <KeywordList>
      <Keywords>Aluminum exposure</Keywords>
      <Keywords>Bone damages</Keywords>
      <Keywords>NAD(+)</Keywords>
      <Keywords>Nicotinamide mononucleotide</Keywords>
      <Keywords>TXNIP-NLRP3</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Haipeng Liang</Name>
        <Affiliation>Department of Orthopaedics, the Second Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jian Gao</Name>
        <Affiliation>Department of Orthopaedics, the Second Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chi Zhang</Name>
        <Affiliation>Shanxi Dayi Hospital Affiliated to Shanxi Medical University, Taiyuan 030001, Shanxi, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunlin Li</Name>
        <Affiliation>Trauma Center, Shanghai General Hospital Affiliated to Shanghai Jiaotong University, Shanghai 201620, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Wang</Name>
        <Affiliation>Trauma Center, Shanghai General Hospital Affiliated to Shanghai Jiaotong University, Shanghai 201620, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiaojiao Fan</Name>
        <Affiliation>Shanghai Jiaotong University School of Mechanical Engineering, Shanghai 201620, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zizheng Wu</Name>
        <Affiliation>Department of Orthopaedics, Baoshan Branch of Shanghai General Hospital of Shanghai Jiaotong University, Shanghai 200940, China. Electronic address: zizheng_wu@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Qiugen Wang</Name>
        <Affiliation>Trauma Center, Shanghai General Hospital Affiliated to Shanghai Jiaotong University, Shanghai 201620, China. Electronic address: qiugen_wang001@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>FAK alleviates radiation-induced rectal injury by decreasing apoptosis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30292832</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30465-4</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>FAK</Keywords>
      <Keywords>Radiosensitivity</Keywords>
      <Keywords>Radiotherapy</Keywords>
      <Keywords>Rectal injury</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jun Jun Li</Name>
        <Affiliation>Department of Radiation Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Zhi Tu</Name>
        <Affiliation>Department of Radiation Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Ming Chen</Name>
        <Affiliation>Department of Radiation Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hou Yu Ying</Name>
        <Affiliation>Department of Radiation Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Chen</Name>
        <Affiliation>Department of Radiation Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Long Ge</Name>
        <Affiliation>Department of Radiation Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Wang</Name>
        <Affiliation>Department of Pathology, Cancer Hospital of Handan, Handan 056001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Xu</Name>
        <Affiliation>Department of Radiation Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ting Feng Chen</Name>
        <Affiliation>Department of Radiation Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Wei Zhang</Name>
        <Affiliation>Department of Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Jun Ye</Name>
        <Affiliation>Department of Radiation Oncology, Jiangsu Cancer Hospital, Nanjing Medical University, Nanjing 210009, China. Electronic address: jjye2004@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Liu</Name>
        <Affiliation>Department of Radiation Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China. Electronic address: liuyongrt@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Andrographolide simultaneously augments Nrf2 antioxidant defense and facilitates autophagic flux blockade in cigarette smoke-exposed human bronchial epithelial cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30291937</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30463-0</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Autophagic flux</Keywords>
      <Keywords>LC3B</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>p62</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>W. S. Daniel Tan</Name>
        <Affiliation>Department of Pharmacology, Yong Loo Lin School of Medicine, National University Health System, 16 Medical Drive, 117600, Singapore.</Affiliation>
      </Author>
      <Author>
        <Name>Wupeng Liao</Name>
        <Affiliation>Department of Pharmacology, Yong Loo Lin School of Medicine, National University Health System, 16 Medical Drive, 117600, Singapore.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Yong Peh</Name>
        <Affiliation>Department of Pharmacology, Yong Loo Lin School of Medicine, National University Health System, 16 Medical Drive, 117600, Singapore.</Affiliation>
      </Author>
      <Author>
        <Name>Merima Vila</Name>
        <Affiliation>Department of Pharmacology, Yong Loo Lin School of Medicine, National University Health System, 16 Medical Drive, 117600, Singapore; Department of Biology, University of Toronto Mississauga, 3359 Mississauga Road, Mississauga L5L 1C6, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Jinrui Dong</Name>
        <Affiliation>Department of Pharmacology, Yong Loo Lin School of Medicine, National University Health System, 16 Medical Drive, 117600, Singapore.</Affiliation>
      </Author>
      <Author>
        <Name>Han Ming Shen</Name>
        <Affiliation>Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, 2 Medical Drive, 117597, Singapore; NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, 28 Medical Drive, 117456, Singapore.</Affiliation>
      </Author>
      <Author>
        <Name>W. S. Fred Wong</Name>
        <Affiliation>Department of Pharmacology, Yong Loo Lin School of Medicine, National University Health System, 16 Medical Drive, 117600, Singapore; Immunology Program, Life Science Institute, National University of Singapore, 28 Medical Drive, 117456, Singapore; Singapore-HUJ Alliance for Research and Enterprise (SHARE), National University of Singapore, 1 CREATE Way, Innovation Wing, 138602, Singapore. Electronic address: phcwongf@nus.edu.sg.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The organophosphate pesticide methamidophos opens the blood-testis barrier and covalently binds to ZO-2 in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30291936</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30461-7</DOI>
    <KeywordList>
      <Keywords>Blood-testis barrier</Keywords>
      <Keywords>Methamidophos</Keywords>
      <Keywords>Organophosphates</Keywords>
      <Keywords>Spermatogenesis</Keywords>
      <Keywords>Tight junctions</Keywords>
      <Keywords>ZO-2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>José Mario Ortega-Olvera</Name>
        <Affiliation>Department of Physiology, Biophysics and Neuroscience, Cinvestav, Mexico City 07360, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Winkler</Name>
        <Affiliation>Department of Biotechnology and Biochemistry, Cinvestav, Irapuato 36824, Mexico; Max Planck Institute for Chemical Ecology, Jena 07745, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Betzabet Quintanilla-Vega</Name>
        <Affiliation>Department of Toxicology, Cinvestav, Mexico City 07360, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Mineko Shibayama</Name>
        <Affiliation>Department of Infectomics and Molecular Pathogenesis, Cinvestav, Mexico City 07360, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Bibiana Chávez-Munguía</Name>
        <Affiliation>Department of Infectomics and Molecular Pathogenesis, Cinvestav, Mexico City 07360, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Dolores Martín-Tapia</Name>
        <Affiliation>Department of Physiology, Biophysics and Neuroscience, Cinvestav, Mexico City 07360, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Lourdes Alarcón</Name>
        <Affiliation>Department of Physiology, Biophysics and Neuroscience, Cinvestav, Mexico City 07360, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Lorenza González-Mariscal</Name>
        <Affiliation>Department of Physiology, Biophysics and Neuroscience, Cinvestav, Mexico City 07360, Mexico. Electronic address: lorenza@fisio.cinvestav.mx.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Elongate mineral particles in the natural environment.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30291935</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30430-7</DOI>
    <KeywordList>
      <Keywords>Asbestiform</Keywords>
      <Keywords>Asbestos</Keywords>
      <Keywords>Elongate</Keywords>
      <Keywords>Mineral</Keywords>
      <Keywords>Particles</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mickey E. Gunter</Name>
        <Affiliation>Geological Sciences, University of Idaho, Moscow, ID, United States. Electronic address: mgunter@uidaho.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Salinomycin ameliorates oxidative hepatic damage through AMP-activated protein kinase, facilitating autophagy.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30290169</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30460-5</DOI>
    <KeywordList>
      <Keywords>AMP-activated protein kinase</Keywords>
      <Keywords>Autophagy</Keywords>
      <Keywords>Liver injury</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Salinomycin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kwang Youn Kim</Name>
        <Affiliation>Korean Medicine Application Center, Korea Institute of Oriental Medicine, Daegu 41062, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seul Gi Lee</Name>
        <Affiliation>College of Oriental Medicine, Daegu Haany University, Gyeongsan 38610, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Su Youn Baek</Name>
        <Affiliation>College of Oriental Medicine, Daegu Haany University, Gyeongsan 38610, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Hye Lee</Name>
        <Affiliation>Department of Pathology, Kyungpook National University School of Medicine, Daegu 41944, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Jeong Jang</Name>
        <Affiliation>College of Oriental Medicine, Daegu Haany University, Gyeongsan 38610, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ju Hee Lee</Name>
        <Affiliation>College of Oriental Medicine, Dongguk University, Gyeongju 38066, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Soon Cheol Ahn</Name>
        <Affiliation>Pusan National University School of Medicine, Yangsan 50612, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Hoon Chang</Name>
        <Affiliation>College of Pharmacy, Yeungnam University, Gyeongsan 38541, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Tae Woo Oh</Name>
        <Affiliation>Korean Medicine Application Center, Korea Institute of Oriental Medicine, Daegu 41062, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sang Hun Kim</Name>
        <Affiliation>Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06510, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Yeul Ma</Name>
        <Affiliation>Korean Medicine Application Center, Korea Institute of Oriental Medicine, Daegu 41062, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sang Chan Kim</Name>
        <Affiliation>College of Oriental Medicine, Daegu Haany University, Gyeongsan 38610, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kwang Il Park</Name>
        <Affiliation>Korean Medicine Application Center, Korea Institute of Oriental Medicine, Daegu 41062, Republic of Korea. Electronic address: kipark@kiom.re.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Young Woo Kim</Name>
        <Affiliation>College of Oriental Medicine, Daegu Haany University, Gyeongsan 38610, Republic of Korea. Electronic address: ywkim@dhu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Metformin attenuates cardiovascular and renal injury in uninephrectomized rats on DOCA-salt: Involvement of AMPK and miRNAs in cardioprotection.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30290168</pubmedLink>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30462-9</DOI>
    <KeywordList>
      <Keywords>Cardiovascular</Keywords>
      <Keywords>DOCA</Keywords>
      <Keywords>Hypertension</Keywords>
      <Keywords>Metformin</Keywords>
      <Keywords>Renal</Keywords>
      <Keywords>Renin Angiotensin System</Keywords>
      <Keywords>microRNA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Venkateswara Rao Amara</Name>
        <Affiliation>Laboratory of Epigenetics and Diseases, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sunil Kumar Surapaneni</Name>
        <Affiliation>Laboratory of Epigenetics and Diseases, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar, India.</Affiliation>
      </Author>
      <Author>
        <Name>Kulbhushan Tikoo</Name>
        <Affiliation>Laboratory of Epigenetics and Diseases, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar, India. Electronic address: tikoo.k@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inducible SHP-2 activation confers resistance to imatinib in drug-tolerant chronic myeloid leukemia cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30290167</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30458-7</DOI>
    <KeywordList>
      <Keywords>CML</Keywords>
      <Keywords>Imatinib resistance</Keywords>
      <Keywords>Non-mutational drug resistance</Keywords>
      <Keywords>PI3K/AKT/mTOR pathway</Keywords>
      <Keywords>RAF/MEK/ERK pathway</Keywords>
      <Keywords>SHP-2 activation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xin Li</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, China.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Pang</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenwen Xue</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yixuan Wang</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tian Tian</Name>
        <Affiliation>Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ahmed Elgehama</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xuefeng Wu</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xudong Wu</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Sun</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongxia Qiu</Name>
        <Affiliation>Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Shen</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, China. Electronic address: shenyan@nju.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Qiang Xu</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, China. Electronic address: molpharm@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mechanisms controlling the multistage post-translational processing of endogenous Nrf1α/TCF11 proteins to yield distinct isoforms within the coupled positive and negative feedback circuits.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30287392</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30442-3</DOI>
    <KeywordList>
      <Keywords>DDI-1/2</Keywords>
      <Keywords>ER Stress</Keywords>
      <Keywords>Hrd1</Keywords>
      <Keywords>Nrf1</Keywords>
      <Keywords>Post-Translational Modification</Keywords>
      <Keywords>Proteasome</Keywords>
      <Keywords>Proteoform</Keywords>
      <Keywords>Proteolysis</Keywords>
      <Keywords>p97</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yuancai Xiang</Name>
        <Affiliation>The Laboratory of Cell Biochemistry and Topogenetic Regulation, College of Bioengineering and Faculty of Sciences, Chongqing University, No. 174 Shazheng Street, Shapingba District, Chongqing 400044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Meng Wang</Name>
        <Affiliation>The Laboratory of Cell Biochemistry and Topogenetic Regulation, College of Bioengineering and Faculty of Sciences, Chongqing University, No. 174 Shazheng Street, Shapingba District, Chongqing 400044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shaofan Hu</Name>
        <Affiliation>The Laboratory of Cell Biochemistry and Topogenetic Regulation, College of Bioengineering and Faculty of Sciences, Chongqing University, No. 174 Shazheng Street, Shapingba District, Chongqing 400044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Qiu</Name>
        <Affiliation>The Laboratory of Cell Biochemistry and Topogenetic Regulation, College of Bioengineering and Faculty of Sciences, Chongqing University, No. 174 Shazheng Street, Shapingba District, Chongqing 400044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fang Yang</Name>
        <Affiliation>The Laboratory of Cell Biochemistry and Topogenetic Regulation, College of Bioengineering and Faculty of Sciences, Chongqing University, No. 174 Shazheng Street, Shapingba District, Chongqing 400044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhengwen Zhang</Name>
        <Affiliation>Institute of Neuroscience and Psychology, School of Life Sciences, University of Glasgow, 42 Western Common Road, G22 5PQ, Glasgow, Scotland, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Siwang Yu</Name>
        <Affiliation>State Key Laboratory of Natural and Biomimetic Drugs, and Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University Health Science Center, No 38 Xueyuan Rd., Haidian District, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingbo Pi</Name>
        <Affiliation>School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yiguo Zhang</Name>
        <Affiliation>The Laboratory of Cell Biochemistry and Topogenetic Regulation, College of Bioengineering and Faculty of Sciences, Chongqing University, No. 174 Shazheng Street, Shapingba District, Chongqing 400044, China. Electronic address: yiguozhang@cqu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effect of dose and exposure protocol on the toxicokinetics and first-pass elimination of trichloroethylene and 1,1,1-trichloroethane.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30287391</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30457-5</DOI>
    <KeywordList>
      <Keywords>1,1,1-trichloroethane</Keywords>
      <Keywords>Exposure protocol</Keywords>
      <Keywords>First-pass elimination</Keywords>
      <Keywords>Toxicokinetics</Keywords>
      <Keywords>Trichloroethylene</Keywords>
      <Keywords>Volatile organic chemical</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tanzir Mortuza</Name>
        <Affiliation>Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, GA 30602-2354, Georgia.</Affiliation>
      </Author>
      <Author>
        <Name>Srinivasa Muralidhara</Name>
        <Affiliation>Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, GA 30602-2354, Georgia.</Affiliation>
      </Author>
      <Author>
        <Name>Catherine A. White</Name>
        <Affiliation>Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, GA 30602-2354, Georgia.</Affiliation>
      </Author>
      <Author>
        <Name>Brian S. Cummings</Name>
        <Affiliation>Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, GA 30602-2354, Georgia.</Affiliation>
      </Author>
      <Author>
        <Name>Carey Hines</Name>
        <Affiliation>Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, GA 30602-2354, Georgia.</Affiliation>
      </Author>
      <Author>
        <Name>James V. Bruckner</Name>
        <Affiliation>Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, GA 30602-2354, Georgia. Electronic address: bruckner@uga.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Removal of hERG potassium channel affinity through introduction of an oxygen atom: Molecular insights from structure-activity relationships of strychnine and its analogs.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30282042</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30456-3</DOI>
    <KeywordList>
      <Keywords>Alanine-mutagenesis</Keywords>
      <Keywords>Brucine</Keywords>
      <Keywords>Docking simulations</Keywords>
      <Keywords>N-oxide</Keywords>
      <Keywords>Strychnine</Keywords>
      <Keywords>hERG channel</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chunhua Yuan</Name>
        <Affiliation>Key Laboratory of Mental Health of the Ministry of Education, Key Laboratory of Psychiatric Disorders of Guangdong Province, Department of Neurobiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhengyi Luo</Name>
        <Affiliation>Key Laboratory of Mental Health of the Ministry of Education, Key Laboratory of Psychiatric Disorders of Guangdong Province, Department of Neurobiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Zhou</Name>
        <Affiliation>Key Laboratory of Mental Health of the Ministry of Education, Key Laboratory of Psychiatric Disorders of Guangdong Province, Department of Neurobiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Sheng Lei</Name>
        <Affiliation>Key Laboratory of Mental Health of the Ministry of Education, Key Laboratory of Psychiatric Disorders of Guangdong Province, Department of Neurobiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Changxi Xu</Name>
        <Affiliation>Key Laboratory of Mental Health of the Ministry of Education, Key Laboratory of Psychiatric Disorders of Guangdong Province, Department of Neurobiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Peng</Name>
        <Affiliation>Key Laboratory of Mental Health of the Ministry of Education, Key Laboratory of Psychiatric Disorders of Guangdong Province, Department of Neurobiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuji Li</Name>
        <Affiliation>Key Laboratory of Mental Health of the Ministry of Education, Key Laboratory of Psychiatric Disorders of Guangdong Province, Department of Neurobiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaowen Li</Name>
        <Affiliation>Key Laboratory of Mental Health of the Ministry of Education, Key Laboratory of Psychiatric Disorders of Guangdong Province, Department of Neurobiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xinhong Zhu</Name>
        <Affiliation>Key Laboratory of Mental Health of the Ministry of Education, Key Laboratory of Psychiatric Disorders of Guangdong Province, Department of Neurobiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China; School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China. Electronic address: zhuxh@smu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Tianming Gao</Name>
        <Affiliation>Key Laboratory of Mental Health of the Ministry of Education, Key Laboratory of Psychiatric Disorders of Guangdong Province, Department of Neurobiology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China. Electronic address: tgao@smu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Carbon monoxide releasing molecule A-1 attenuates acetaminophen-mediated hepatotoxicity and improves survival of mice by induction of Nrf2 and related genes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30273691</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30440-X</DOI>
    <KeywordList>
      <Keywords>Acetaminophen</Keywords>
      <Keywords>CORM A-1</Keywords>
      <Keywords>Kelch-Like ECH-Associated Protein 1</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Nuclear Factor Erythroid 2-Related Factor 2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kapil K. Upadhyay</Name>
        <Affiliation>Phytotherapeutics and Metabolic Endocrinology Division, Department of Zoology, Faculty of Science, The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat 390002, India.</Affiliation>
      </Author>
      <Author>
        <Name>Ravirajsinh N. Jadeja</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, Augusta University, Augusta, GA, 30912,USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jaymesh M. Thadani</Name>
        <Affiliation>Phytotherapeutics and Metabolic Endocrinology Division, Department of Zoology, Faculty of Science, The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat 390002, India.</Affiliation>
      </Author>
      <Author>
        <Name>Apeksha Joshi</Name>
        <Affiliation>Phytotherapeutics and Metabolic Endocrinology Division, Department of Zoology, Faculty of Science, The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat 390002, India.</Affiliation>
      </Author>
      <Author>
        <Name>Aliasgar Vohra</Name>
        <Affiliation>Phytotherapeutics and Metabolic Endocrinology Division, Department of Zoology, Faculty of Science, The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat 390002, India.</Affiliation>
      </Author>
      <Author>
        <Name>Vishal Mevada</Name>
        <Affiliation>Hemchandracharya North Gujarat University, Patan, Gujarat 384265, India.</Affiliation>
      </Author>
      <Author>
        <Name>Rajesh Patel</Name>
        <Affiliation>Bioinformatics and Supercomputer lab, Department of Biosciences, Veer Narmad South Gujarat University, Surat, Gujarat 395007, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sandeep Khurana</Name>
        <Affiliation>Division of Gastroenterology, Hepatology and Nutrition and Weight Management, Geisinger Medical Center, Danville, PA 17822, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ranjitsinh V. Devkar</Name>
        <Affiliation>Phytotherapeutics and Metabolic Endocrinology Division, Department of Zoology, Faculty of Science, The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat 390002, India. Electronic address: rv.devkar-zoo@msubaroda.ac.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Topovectorial mechanisms control the juxtamembrane proteolytic processing of Nrf1 to remove its N-terminal polypeptides during maturation of the CNC-bZIP factor.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30268580</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30444-7</DOI>
    <KeywordList>
      <Keywords>Membrane cholesterol-recognized sensor</Keywords>
      <Keywords>Nrf1</Keywords>
      <Keywords>Regulated juxtamembrane proteolysis</Keywords>
      <Keywords>Topobiology</Keywords>
      <Keywords>Topovectorial regulation</Keywords>
      <Keywords>Ubiquitin-like (UBL) domain</Keywords>
      <Keywords>Ubiquitination</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yuancai Xiang</Name>
        <Affiliation>The Laboratory of Cell Biochemistry and Topogenetic Regulation, College of Bioengineering and Faculty of Sciences, Chongqing University, No. 174 Shazheng Street, Shapingba District, Chongqing 400044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Josefin Halin</Name>
        <Affiliation>Department of Biochemistry, Faculty of Science and Engineering, Åbo Akademi University, Artillerigatan 6A, III, BioCity, FI-20520 Turku, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>Zhuo Fan</Name>
        <Affiliation>The Laboratory of Cell Biochemistry and Topogenetic Regulation, College of Bioengineering and Faculty of Sciences, Chongqing University, No. 174 Shazheng Street, Shapingba District, Chongqing 400044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shaofan Hu</Name>
        <Affiliation>The Laboratory of Cell Biochemistry and Topogenetic Regulation, College of Bioengineering and Faculty of Sciences, Chongqing University, No. 174 Shazheng Street, Shapingba District, Chongqing 400044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Meng Wang</Name>
        <Affiliation>The Laboratory of Cell Biochemistry and Topogenetic Regulation, College of Bioengineering and Faculty of Sciences, Chongqing University, No. 174 Shazheng Street, Shapingba District, Chongqing 400044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Qiu</Name>
        <Affiliation>The Laboratory of Cell Biochemistry and Topogenetic Regulation, College of Bioengineering and Faculty of Sciences, Chongqing University, No. 174 Shazheng Street, Shapingba District, Chongqing 400044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhengwen Zhang</Name>
        <Affiliation>Institute of Neuroscience and Psychology, School of Life Sciences, University of Glasgow, 42 Western Common Road, G22 5PQ Glasgow, Scotland, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Mattjus</Name>
        <Affiliation>Department of Biochemistry, Faculty of Science and Engineering, Åbo Akademi University, Artillerigatan 6A, III, BioCity, FI-20520 Turku, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>Yiguo Zhang</Name>
        <Affiliation>The Laboratory of Cell Biochemistry and Topogenetic Regulation, College of Bioengineering and Faculty of Sciences, Chongqing University, No. 174 Shazheng Street, Shapingba District, Chongqing 400044, China. Electronic address: yiguozhang@cqu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Role of Mcl-1 in regulation of cell death in human induced pluripotent stem cell-derived cardiomyocytes in vitro.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30268579</pubmedLink>
    <GrantList>
      <Grant>HHSN261200800001E</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30447-2</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Bcl-xL</Keywords>
      <Keywords>Cardio-oncology</Keywords>
      <Keywords>Mcl-1</Keywords>
      <Keywords>Mitochondria</Keywords>
      <Keywords>hiPSC-cardiomyocyte</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Liang Guo</Name>
        <Affiliation>Laboratory of Investigative Toxicology, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21702, United States. Electronic address: liang.guo@nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Sandy Eldridge</Name>
        <Affiliation>Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, United States. Electronic address: sandy.eldridge@nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Furniss</Name>
        <Affiliation>Laboratory of Investigative Toxicology, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21702, United States. Electronic address: furnissm@mail.nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Jodie Mussio</Name>
        <Affiliation>Laboratory of Investigative Toxicology, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21702, United States. Electronic address: mussiojk@mail.nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Myrtle Davis</Name>
        <Affiliation>Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, United States. Electronic address: Myrtle.Davis@bms.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Roles of the KEAP1-NRF2 system in mammalian skin exposed to UV radiation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30268578</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30445-9</DOI>
    <KeywordList>
      <Keywords>Antioxidation</Keywords>
      <Keywords>NRF2</Keywords>
      <Keywords>Skin Carcinogenesis</Keywords>
      <Keywords>Skin Photoaging</Keywords>
      <Keywords>UV Radiation</Keywords>
      <Keywords>UVA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hironobu Ikehata</Name>
        <Affiliation>Department of Medical Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan. Electronic address: ikehata@med.tohoku.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Masayuki Yamamoto</Name>
        <Affiliation>Department of Medical Biochemistry, Tohoku University Graduate School of Medicine, Sendai, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Validation of a clinically-relevant rodent model of statin-associated muscle symptoms for use in pharmacological studies.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30268577</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30446-0</DOI>
    <KeywordList>
      <Keywords>Rodent model</Keywords>
      <Keywords>Simvastatin</Keywords>
      <Keywords>Statin-associated muscle symptoms</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jordon Candice Irwin</Name>
        <Affiliation>School of Health, Medical and Applied Sciences, Central Queensland University, Australia, Bruce Highway, North Rockhampton, Queensland 4702, Australia. Electronic address: j.irwin@cqu.edu.au.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Stuart Fenning</Name>
        <Affiliation>School of Health, Medical and Applied Sciences, Central Queensland University, Australia, Bruce Highway, North Rockhampton, Queensland 4702, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Kimberly Rene Ryan</Name>
        <Affiliation>School of Health, Medical and Applied Sciences, Central Queensland University, Australia, Bruce Highway, North Rockhampton, Queensland 4702, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Rebecca Kate Vella</Name>
        <Affiliation>School of Health, Medical and Applied Sciences, Central Queensland University, Australia, Bruce Highway, North Rockhampton, Queensland 4702, Australia.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nrf1 is paved as a new strategic avenue to prevent and treat cancer, neurodegenerative and other diseases.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30267745</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30443-5</DOI>
    <KeywordList>
      <Keywords>Cancer</Keywords>
      <Keywords>Chemoprevention</Keywords>
      <Keywords>Drug</Keywords>
      <Keywords>Neurodegenerative</Keywords>
      <Keywords>Nrf1</Keywords>
      <Keywords>Proteasome</Keywords>
      <Keywords>Therapy</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jianxin Yuan</Name>
        <Affiliation>Laboratory of Cell Biochemistry and Topogenetic Regulation, College of Bioengineering and Faculty of Sciences, Chongqing University, No. 174 Shazheng Street, Shapingba District, Chongqing 400044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuwei Zhang</Name>
        <Affiliation>Laboratory of Cell Biochemistry and Topogenetic Regulation, College of Bioengineering and Faculty of Sciences, Chongqing University, No. 174 Shazheng Street, Shapingba District, Chongqing 400044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yiguo Zhang</Name>
        <Affiliation>Laboratory of Cell Biochemistry and Topogenetic Regulation, College of Bioengineering and Faculty of Sciences, Chongqing University, No. 174 Shazheng Street, Shapingba District, Chongqing 400044, China. Electronic address: yiguozhang@cqu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>mGluR5 upregulation and the effects of repeated methamphetamine administration and withdrawal on the rewarding efficacy of ketamine and social interaction.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30267744</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30441-1</DOI>
    <KeywordList>
      <Keywords>Dopamine</Keywords>
      <Keywords>Ketamine</Keywords>
      <Keywords>Methamphetamine</Keywords>
      <Keywords>Superfusion</Keywords>
      <Keywords>mGluR5</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yi Han Liao</Name>
        <Affiliation>Department of Physiology, National Cheng Kung University College of Medicine, Tainan 70101, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Ya Hui Wang</Name>
        <Affiliation>Institute of Behavioral Medicine, National Cheng Kung University College of Medicine, Tainan 70101, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Li Han Sun</Name>
        <Affiliation>Department of Physiology, National Cheng Kung University College of Medicine, Tainan 70101, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Ting Deng</Name>
        <Affiliation>Department of Physiology, National Cheng Kung University College of Medicine, Tainan 70101, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Hsueh Te Lee</Name>
        <Affiliation>Institute of Anatomy and Cell Biology, National Yang-Ming University, Taipei 11221, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Lung Yu</Name>
        <Affiliation>Department of Physiology, National Cheng Kung University College of Medicine, Tainan 70101, Taiwan, ROC; Institute of Behavioral Medicine, National Cheng Kung University College of Medicine, Tainan 70101, Taiwan, ROC. Electronic address: lungyu@mail.ncku.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Zinc-binding triggers a conformational-switch in the cullin-3 substrate adaptor protein KEAP1 that controls transcription factor NRF2.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30261176</pubmedLink>
    <GrantList>
      <Grant>C4909/A5942</Grant>
      <Grant>C4909/A9990</Grant>
      <Grant>MR/N009851/1</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30439-3</DOI>
    <KeywordList>
      <Keywords>Danger signal</Keywords>
      <Keywords>KEAP1</Keywords>
      <Keywords>NRF2</Keywords>
      <Keywords>Ubiquitylation</Keywords>
      <Keywords>Zinc</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michael McMahon</Name>
        <Affiliation>Division of Cancer Research, School of Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, United Kingdom; Concept Life Sciences, Dundee DD1 5JJ, Scotland, United Kingdom. Electronic address: Michael.Mcmahon@conceptlifesciences.com.</Affiliation>
      </Author>
      <Author>
        <Name>Samuel R. Swift</Name>
        <Affiliation>MSI/WTB/JBC complex, College of Life Sciences, University of Dundee, Dundee DD1 4HN, Scotland, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>John D. Hayes</Name>
        <Affiliation>Division of Cancer Research, School of Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, United Kingdom. Electronic address: j.d.hayes@dundee.ac.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces hepatic steatosis and endoplasmic reticulum stress by inducing nuclear factor erythroid-derived 2-related factor 2 nuclear translocation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30253173</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30438-1</DOI>
    <KeywordList>
      <Keywords>Endoplasmic reticulum stress</Keywords>
      <Keywords>Exendin-4</Keywords>
      <Keywords>Glucagon-like peptide-1</Keywords>
      <Keywords>Nonalcoholic fatty liver disease</Keywords>
      <Keywords>Nuclear factor erythroid-derived 2-related factor 2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jin Yoo</Name>
        <Affiliation>Department of Biomedical Science, Graduate School, Kyung Hee University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>In Jin Cho</Name>
        <Affiliation>Department of Endocrinology and Metabolism, Kyung Hee University Hospital at Gangdong, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>In Kyung Jeong</Name>
        <Affiliation>Department of Endocrinology and Metabolism, Kyung Hee University Hospital at Gangdong, Seoul, Republic of Korea; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyu Jeung Ahn</Name>
        <Affiliation>Department of Endocrinology and Metabolism, Kyung Hee University Hospital at Gangdong, Seoul, Republic of Korea; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ho Yeon Chung</Name>
        <Affiliation>Department of Endocrinology and Metabolism, Kyung Hee University Hospital at Gangdong, Seoul, Republic of Korea; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>You Cheol Hwang</Name>
        <Affiliation>Department of Endocrinology and Metabolism, Kyung Hee University Hospital at Gangdong, Seoul, Republic of Korea; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, Republic of Korea. Electronic address: khmcilyong@naver.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Identification of 5-hydroxymethylfurfural in cigarette smoke extract as a new substrate metabolically activated by human cytochrome P450 2A13.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30253172</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30437-X</DOI>
    <KeywordList>
      <Keywords>5-hydroxymethylfurfural</Keywords>
      <Keywords>Cigarette smoke extract</Keywords>
      <Keywords>Cytochrome P450 2A13</Keywords>
      <Keywords>Metabolic activation</Keywords>
      <Keywords>Respiratory injuries</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Minghui Ji</Name>
        <Affiliation>Key Lab of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, PR China; School of Nursing, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhan Zhang</Name>
        <Affiliation>Key Lab of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, PR China; State Key Lab of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Na Li</Name>
        <Affiliation>Key Lab of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Rong Xia</Name>
        <Affiliation>Key Lab of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Wang</Name>
        <Affiliation>Key Lab of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, PR China; State Key Lab of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongquan Yu</Name>
        <Affiliation>Key Lab of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, PR China; State Key Lab of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shen Yao</Name>
        <Affiliation>Key Lab of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiemiao Shen</Name>
        <Affiliation>Key Lab of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shou Lin Wang</Name>
        <Affiliation>Key Lab of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, PR China; State Key Lab of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, PR China. Electronic address: wangshl@njmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>ERK1/2-mediated autophagy is essential for cell survival under Ochratoxin A exposure in IPEC-J2 cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30248419</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30433-2</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Autophagy</Keywords>
      <Keywords>Extracellular signal-regulated protein kinases 1 and 2</Keywords>
      <Keywords>IPEC-J2 cells</Keywords>
      <Keywords>Mitochondrial reactive oxygen species</Keywords>
      <Keywords>Ochratoxin A</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hong Wang</Name>
        <Affiliation>College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, Jiangsu Province 210095, China; Institute of Nutritional and Metabolic Disorders in Domestic Animals and Fowls, Nanjing Agricultural University, Nanjing, Jiangsu Province 210095, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hu Li</Name>
        <Affiliation>College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, Jiangsu Province 210095, China; Institute of Nutritional and Metabolic Disorders in Domestic Animals and Fowls, Nanjing Agricultural University, Nanjing, Jiangsu Province 210095, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xingxiang Chen</Name>
        <Affiliation>College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, Jiangsu Province 210095, China; Institute of Nutritional and Metabolic Disorders in Domestic Animals and Fowls, Nanjing Agricultural University, Nanjing, Jiangsu Province 210095, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kehe Huang</Name>
        <Affiliation>College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, Jiangsu Province 210095, China; Institute of Nutritional and Metabolic Disorders in Domestic Animals and Fowls, Nanjing Agricultural University, Nanjing, Jiangsu Province 210095, China. Electronic address: khhuang@njau.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nrf2 activator for the treatment of kidney diseases.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30248418</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30436-8</DOI>
    <KeywordList>
      <Keywords>Clinical endpoints</Keywords>
      <Keywords>Glomerular filtration rate (GFR)</Keywords>
      <Keywords>Kidney diseases</Keywords>
      <Keywords>Nuclear factor erythroid 2-related factor 2 (Nrf2)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kengo Yamawaki</Name>
        <Affiliation>Kyowa Hakko Kirin Co., Ltd., 1-9-2 Otemachi, Chiyoda-ku, Tokyo 100-0004, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hironori Kanda</Name>
        <Affiliation>Kyowa Hakko Kirin Co., Ltd., 1-9-2 Otemachi, Chiyoda-ku, Tokyo 100-0004, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Ryutaro Shimazaki</Name>
        <Affiliation>Kyowa Hakko Kirin Co., Ltd., 1-9-2 Otemachi, Chiyoda-ku, Tokyo 100-0004, Japan. Electronic address: ryutaro.shimazaki@kyowa-kirin.co.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>14-Deoxy-11,12-didehydroandrographolide suppresses adipogenesis of 3 T3-L1 preadipocytes by inhibiting CCAAT/enhancer-binding protein β activation and AMPK-mediated mitotic clonal expansion.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30248417</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30434-4</DOI>
    <KeywordList>
      <Keywords>14-Deoxy-11,12-didehydroandrographolide</Keywords>
      <Keywords>3 T3-L1</Keywords>
      <Keywords>AMP-activated protein kinase</Keywords>
      <Keywords>Adipogenesis</Keywords>
      <Keywords>CCAAT/enhancer-binding protein</Keywords>
      <Keywords>Mitotic clonal expansion</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chien Chun Li</Name>
        <Affiliation>Department of Nutrition, Chung Shan Medical University, Taichung, Taiwan; Department of Nutrition, Chung Shan Medical University Hospital, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chih Ching Yen</Name>
        <Affiliation>Department of Respiratory Therapy, China Medical University, Taichung, Taiwan; Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ciou Ting Fan</Name>
        <Affiliation>Department of Nutrition, China Medical University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Ting Chuang</Name>
        <Affiliation>Department of Nutrition, China Medical University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chin Shiu Huang</Name>
        <Affiliation>Department of Health and Nutrition Biotechnology, Asia University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Haw Wen Chen</Name>
        <Affiliation>Department of Nutrition, China Medical University, Taichung, Taiwan.. Electronic address: hwchen@mail.cmu.edu.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Chong Kuei Lii</Name>
        <Affiliation>Department of Nutrition, China Medical University, Taichung, Taiwan.; Department of Health and Nutrition Biotechnology, Asia University, Taichung, Taiwan. Electronic address: cklii@mail.cmu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Emodin-induced hepatotoxicity was exacerbated by probenecid through inhibiting UGTs and MRP2.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30248416</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30435-6</DOI>
    <KeywordList>
      <Keywords>Emodin</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>MRP2</Keywords>
      <Keywords>Probenecid</Keywords>
      <Keywords>Toxicokinetics</Keywords>
      <Keywords>UGT2B7</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lili Wu</Name>
        <Affiliation>Biopharmaceutics, Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yulian Chen</Name>
        <Affiliation>Biopharmaceutics, Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Han Liu</Name>
        <Affiliation>Biopharmaceutics, Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhikun Zhan</Name>
        <Affiliation>Biopharmaceutics, Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhi Liang</Name>
        <Affiliation>Biopharmaceutics, Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tao Zhang</Name>
        <Affiliation>Biopharmaceutics, Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zheng Cai</Name>
        <Affiliation>Biopharmaceutics, Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ling Ye</Name>
        <Affiliation>Biopharmaceutics, Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Menghua Liu</Name>
        <Affiliation>Biopharmaceutics, Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Zhao</Name>
        <Affiliation>Biopharmaceutics, Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuwen Liu</Name>
        <Affiliation>Biopharmaceutics, Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lan Tang</Name>
        <Affiliation>Biopharmaceutics, Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.. Electronic address: tl405@smu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effect of N-(2-aminoethyl) ethanolamine on hypertrophic scarring changes in vitro: Finding novel anti-fibrotic therapies.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30248415</pubmedLink>
    <GrantList>
      <Grant>R01 GM112936</Grant>
      <Grant>R21 ES013038</Grant>
      <Grant>R01 HL065416</Grant>
      <Grant>R01 GM056687</Grant>
      <Grant>P50 GM060338</Grant>
      <Grant>R21 ES022821</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30432-0</DOI>
    <KeywordList>
      <Keywords>Atomic Force Microscopy (AFM)</Keywords>
      <Keywords>Collagen</Keywords>
      <Keywords>Drug Discovery</Keywords>
      <Keywords>Scanning Electron Microscopy (SEM)</Keywords>
      <Keywords>Wound Healing</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhenping Chen</Name>
        <Affiliation>Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA; Department of Surgery, University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jianhua Gu</Name>
        <Affiliation>AFM/SEM Core Facility, The Houston Methodist Hospital Research Institute, Houston, TX 77030, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Amina El Ayadi</Name>
        <Affiliation>Department of Surgery, University of Texas Medical Branch, Galveston, TX 77555, USA; Shriners Hospitals for Children, Galveston, TX 77550, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andres F. Oberhauser</Name>
        <Affiliation>Department of Neuroscience and Cell Biology, University of Texas Medical Branch, Galveston, TX 77555, USA; Sealy Center for Structural Biology and Molecular Biophysics, University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jia Zhou</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Linda E. Sousse</Name>
        <Affiliation>Department of Surgery, University of Texas Medical Branch, Galveston, TX 77555, USA; Shriners Hospitals for Children, Galveston, TX 77550, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Celeste C. Finnerty</Name>
        <Affiliation>Department of Surgery, University of Texas Medical Branch, Galveston, TX 77555, USA; Shriners Hospitals for Children, Galveston, TX 77550, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David N. Herndon</Name>
        <Affiliation>Department of Surgery, University of Texas Medical Branch, Galveston, TX 77555, USA; Shriners Hospitals for Children, Galveston, TX 77550, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Paul J. Boor</Name>
        <Affiliation>Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA; Shriners Hospitals for Children, Galveston, TX 77550, USA. Electronic address: pboor@UTMB.EDU.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Knockdown of lncRNA H19 restores chemo-sensitivity in paclitaxel-resistant triple-negative breast cancer through triggering apoptosis and regulating Akt signaling pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30244121</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30424-1</DOI>
    <KeywordList>
      <Keywords>Akt</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Drug Resistance</Keywords>
      <Keywords>LncRNA</Keywords>
      <Keywords>Triple Negative Breast Cancer</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jiguang Han</Name>
        <Affiliation>Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Baojuan Han</Name>
        <Affiliation>Department of Internal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xueya Wu</Name>
        <Affiliation>Department of Internal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Hao</Name>
        <Affiliation>Department of Internal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoqun Dong</Name>
        <Affiliation>Department of Medicine, Brown University, Providence, RI 02912, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Qiang Shen</Name>
        <Affiliation>Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Pang</Name>
        <Affiliation>Department of Internal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, PR China. Electronic address: 18686770006@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The toxic effects of monosodium glutamate (MSG) - The involvement of nitric oxide, prostanoids and potassium channels in the reactivity of thoracic arteries in MSG-obese rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30244120</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30422-8</DOI>
    <KeywordList>
      <Keywords>Monosodium glutamate</Keywords>
      <Keywords>Nitric oxide</Keywords>
      <Keywords>Obesity</Keywords>
      <Keywords>Potassium channels</Keywords>
      <Keywords>Thromboxane A(2)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michał Majewski</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Medicine, UWM, Olsztyn, Poland. Electronic address: michal.majewski@uwm.edu.pl.</Affiliation>
      </Author>
      <Author>
        <Name>Adam Jurgoński</Name>
        <Affiliation>Division of Food Science, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Bartosz Fotschki</Name>
        <Affiliation>Division of Food Science, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Jerzy Juśkiewicz</Name>
        <Affiliation>Division of Food Science, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn, Poland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>TRPV1 mediates capsaicin-stimulated metabolic activity but not cell death or inhibition of interleukin-1β release in human THP-1 monocytes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30244119</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30431-9</DOI>
    <KeywordList>
      <Keywords>Capsaicin</Keywords>
      <Keywords>Cytokines</Keywords>
      <Keywords>Immunomodulation</Keywords>
      <Keywords>Monocytes</Keywords>
      <Keywords>TRPV1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dale A. Kunde</Name>
        <Affiliation>School of Health Sciences, University of Tasmania, Launceston, Tasmania, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Januttha Yingchoncharoen</Name>
        <Affiliation>School of Health Sciences, University of Tasmania, Launceston, Tasmania, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Saša Jurković</Name>
        <Affiliation>School of Health Sciences, University of Tasmania, Launceston, Tasmania, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Dominic P. Geraghty</Name>
        <Affiliation>School of Health Sciences, University of Tasmania, Launceston, Tasmania, Australia. Electronic address: D.Geraghty@utas.edu.au.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Physiologically-based pharmacokinetic modeling suggests similar bioavailability of Mn from diet and drinking water.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30243844</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30429-0</DOI>
    <KeywordList>
      <Keywords>Bioavailability</Keywords>
      <Keywords>Dietary exposure</Keywords>
      <Keywords>Dose-dependent regulation</Keywords>
      <Keywords>Drinking water exposure</Keywords>
      <Keywords>Manganese</Keywords>
      <Keywords>PBPK</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gina Song</Name>
        <Affiliation>ScitoVation, LLC., Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Cynthia B. Van Landingham</Name>
        <Affiliation>Ramboll US Corporation, Monroe, LA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>P. Robinan Gentry</Name>
        <Affiliation>Ramboll US Corporation, Monroe, LA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael D. Taylor</Name>
        <Affiliation>NiPERA Inc., Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Athena M. Keene</Name>
        <Affiliation>Afton Chemical Corporation, Richmond, VA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Melvin E. Andersen</Name>
        <Affiliation>ScitoVation, LLC., Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Harvey J. Clewell</Name>
        <Affiliation>ScitoVation, LLC., Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Miyoung Yoon</Name>
        <Affiliation>ScitoVation, LLC., Research Triangle Park, NC, USA; ToxStrategies, Inc., Cary, NC, USA. Electronic address: myoon@toxstrategies.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Genome-wide identification and analysis of Nrf2 binding sites - Antioxidant response elements in zebrafish.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30243843</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30419-8</DOI>
    <KeywordList>
      <Keywords>Antioxidant Response Element</Keywords>
      <Keywords>Genome</Keywords>
      <Keywords>Keap1/Nrf2/ARE Pathway</Keywords>
      <Keywords>Nrf2 Binding Site</Keywords>
      <Keywords>Oxidative Stress</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Azhwar Raghunath</Name>
        <Affiliation>Molecular Toxicology Laboratory, Department of Biotechnology, Bharathiar University, Coimbatore 641 046, Tamilnadu, India.</Affiliation>
      </Author>
      <Author>
        <Name>Raju Nagarajan</Name>
        <Affiliation>Department of Biotechnology, Indian Institute of Technology Madras, Chennai 600 036, Tamilnadu, India.</Affiliation>
      </Author>
      <Author>
        <Name>Kiruthika Sundarraj</Name>
        <Affiliation>Molecular Toxicology Laboratory, Department of Biotechnology, Bharathiar University, Coimbatore 641 046, Tamilnadu, India.</Affiliation>
      </Author>
      <Author>
        <Name>Lakshmikanthan Panneerselvam</Name>
        <Affiliation>Molecular Toxicology Laboratory, Department of Biotechnology, Bharathiar University, Coimbatore 641 046, Tamilnadu, India.</Affiliation>
      </Author>
      <Author>
        <Name>Ekambaram Perumal</Name>
        <Affiliation>Molecular Toxicology Laboratory, Department of Biotechnology, Bharathiar University, Coimbatore 641 046, Tamilnadu, India. Electronic address: ekas2009@buc.edu.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Bisphenol A (BPA) and bisphenol S (BPS) alter the promoter activity of the ABCB1 gene encoding P-glycoprotein in the human placenta in a haplotype-dependent manner.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30240697</pubmedLink>
    <GrantList>
      <Grant>U54 HD047891</Grant>
      <Grant>UL1 TR000071</Grant>
      <Grant>U10 HD047891</Grant>
      <Grant>T32 ES007254</Grant>
      <Grant>P30 ES006676</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30428-9</DOI>
    <KeywordList>
      <Keywords>ABCB1</Keywords>
      <Keywords>BPA/BPS</Keywords>
      <Keywords>Haplotypes</Keywords>
      <Keywords>P-Glycoprotein</Keywords>
      <Keywords>Placenta</Keywords>
      <Keywords>Polymorphisms</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jordan T. Speidel</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX 77555, USA; Department of Obstetrics and Gynecology, Maternal-fetal Pharmacology and Biodevelopment Laboratories, The University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Meixiang Xu</Name>
        <Affiliation>Department of Obstetrics and Gynecology, Maternal-fetal Pharmacology and Biodevelopment Laboratories, The University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sherif Z. Abdel-Rahman</Name>
        <Affiliation>Department of Obstetrics and Gynecology, Maternal-fetal Pharmacology and Biodevelopment Laboratories, The University of Texas Medical Branch, Galveston, TX 77555, USA. Electronic address: sabdelra@utmb.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Selenium-lentinan inhibits tumor progression by regulating epithelial-mesenchymal transition.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30240696</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30425-3</DOI>
    <KeywordList>
      <Keywords>Epithelial–mesenchymal transition</Keywords>
      <Keywords>Lentinan</Keywords>
      <Keywords>Selenium</Keywords>
      <Keywords>Tumor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yan Rong Liu</Name>
        <Affiliation>Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China; Drug Safety Evaluation Center, Tianjin International Joint Academy of Biomedicine, Tianjin, China. Electronic address: liuyanrong1984@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Sun</Name>
        <Affiliation>Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guo Hong Zhu</Name>
        <Affiliation>Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology and College of pharmacy, Nankai University, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Wei Li</Name>
        <Affiliation>Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology and College of pharmacy, Nankai University, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Xuan Tian</Name>
        <Affiliation>Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology and College of pharmacy, Nankai University, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Meng Wang</Name>
        <Affiliation>Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology and College of pharmacy, Nankai University, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shu Min Zong</Name>
        <Affiliation>Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology and College of pharmacy, Nankai University, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Peng Zhen Sheng</Name>
        <Affiliation>Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology and College of pharmacy, Nankai University, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Meng Li</Name>
        <Affiliation>Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology and College of pharmacy, Nankai University, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuang Chen</Name>
        <Affiliation>Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Qin</Name>
        <Affiliation>Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology and College of pharmacy, Nankai University, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Juan Liu</Name>
        <Affiliation>Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Gang Zhou</Name>
        <Affiliation>Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology and College of pharmacy, Nankai University, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tao Sun</Name>
        <Affiliation>Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology and College of pharmacy, Nankai University, Tianjin, China. Electronic address: sunrockmia@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Cheng Yang</Name>
        <Affiliation>Tianjin Key Laboratory of Molecular Drug Research, Tianjin International Joint Academy of Biomedicine, Tianjin, China; State Key Laboratory of Medicinal Chemical Biology and College of pharmacy, Nankai University, Tianjin, China. Electronic address: cyang66_2001@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Characterization of asbestiform glaucophane-winchite in the Franciscan Complex blueschist, northern Diablo Range, California.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30240695</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30426-5</DOI>
    <AuthorList>
      <Author>
        <Name>Bradley G. Erskine</Name>
        <Affiliation>Kleinfelder, 401 Marina Place, Benicia, CA 94510, USA. Electronic address: bradley.erskine@outlook.com.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Bailey</Name>
        <Affiliation>Asbestos TEM Laboratories, 600 Bancroft Way Ste. A, Berkeley, CA 94710, USA. Electronic address: mark@asbestostemlabs.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The epidemiologic evidence for elongate mineral particle (EMP)-related human cancer risk.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30240694</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30427-7</DOI>
    <AuthorList>
      <Author>
        <Name>Paolo Boffetta</Name>
        <Affiliation>Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: paolo.boffetta@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kenneth A. Mundt</Name>
        <Affiliation>Ramboll Environ, Amherst, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>William J. Thompson</Name>
        <Affiliation>Ramboll Environ, Amherst, MA, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Berberine modulates ASK1 signaling mediated through TLR4/TRAF2 via upregulation of miR-23a.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30240693</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30423-X</DOI>
    <KeywordList>
      <Keywords>ASK1/p38</Keywords>
      <Keywords>LPS</Keywords>
      <Keywords>TLR4/TRAF2</Keywords>
      <Keywords>TNFα</Keywords>
      <Keywords>miR-23a</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sali Sujitha</Name>
        <Affiliation>Immunopathology Lab, School of Bio Sciences and Technology, VIT University, Vellore 632 014, Tamil Nadu, India.</Affiliation>
      </Author>
      <Author>
        <Name>Palani Dinesh</Name>
        <Affiliation>Immunopathology Lab, School of Bio Sciences and Technology, VIT University, Vellore 632 014, Tamil Nadu, India.</Affiliation>
      </Author>
      <Author>
        <Name>Mahaboobkhan Rasool</Name>
        <Affiliation>Immunopathology Lab, School of Bio Sciences and Technology, VIT University, Vellore 632 014, Tamil Nadu, India. Electronic address: rasool.m@vit.ac.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Regulatory crosstalk between the oxidative stress-related transcription factor Nfe2l2/Nrf2 and mitochondria.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30236989</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30420-4</DOI>
    <KeywordList>
      <Keywords>Cancer</Keywords>
      <Keywords>Metabolism</Keywords>
      <Keywords>Mitochondria biogenesis</Keywords>
      <Keywords>Mitochondrial respiration</Keywords>
      <Keywords>Mitophagy</Keywords>
      <Keywords>Nfe2l2/Nrf2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>In Geun Ryoo</Name>
        <Affiliation>Integrated Research Institute for Pharmaceutical Sciences, The Catholic University of Korea, 43 Jibong-ro, Bucheon 14662, Gyeonggi-do, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Mi Kyoung Kwak</Name>
        <Affiliation>Integrated Research Institute for Pharmaceutical Sciences, The Catholic University of Korea, 43 Jibong-ro, Bucheon 14662, Gyeonggi-do, Republic of Korea; College of Pharmacy, The Catholic University of Korea, 43 Jibong-ro, Bucheon, Gyeonggi-do 14662, Republic of Korea. Electronic address: mkwak@catholic.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Met-enkephalin improves metabolic syndrome in high fat diet challenged mice through promotion of adipose tissue browning.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30222981</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30421-6</DOI>
    <KeywordList>
      <Keywords>Fat browning</Keywords>
      <Keywords>Hepatic steatosis</Keywords>
      <Keywords>High fat diet</Keywords>
      <Keywords>Insulin resistance</Keywords>
      <Keywords>Met-enkephalin</Keywords>
      <Keywords>Uncoupling protein 1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jinning Suo</Name>
        <Affiliation>Institute of Toxicology, School of Public Health, Shandong University, Jinan, Shandong 250012, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiangzhong Zhao</Name>
        <Affiliation>School of Food &amp; Engineering, Qilu University of Technology, Jinan, Shandong 250353, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Guo</Name>
        <Affiliation>Institute of Toxicology, School of Public Health, Shandong University, Jinan, Shandong 250012, PR China. Electronic address: xguo@sdu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xiulan Zhao</Name>
        <Affiliation>Institute of Toxicology, School of Public Health, Shandong University, Jinan, Shandong 250012, PR China. Electronic address: zhao.xl@sdu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Montelukast attenuates rotenone-induced microglial activation/p38 MAPK expression in rats: Possible role of its antioxidant, anti-inflammatory and antiapoptotic effects.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30222980</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30418-6</DOI>
    <KeywordList>
      <Keywords>Microglia</Keywords>
      <Keywords>Montelukast</Keywords>
      <Keywords>Neuroinflammation</Keywords>
      <Keywords>Parkinson's disease</Keywords>
      <Keywords>Rotenone</Keywords>
      <Keywords>p38MAPK</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Riham M. Mansour</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy and Drug Manufacturing, Misr University for Science and Technology (MUST), 6th October City, Giza, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Maha A. E. Ahmed</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy and Drug Manufacturing, Misr University for Science and Technology (MUST), 6th October City, Giza, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Ayman E. El-Sahar</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Nesrine S. El Sayed</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Egypt. Electronic address: nesrine.salah@pharma.cu.edu.eg.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Quinone and nitrofurantoin redox cycling by recombinant cytochrome b5 reductase.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30222979</pubmedLink>
    <GrantList>
      <Grant>U01 NS108956</Grant>
      <Grant>T32 ES007148</Grant>
      <Grant>R21 NS072097</Grant>
      <Grant>P30 ES005022</Grant>
      <Grant>U54 AR055073</Grant>
      <Grant>R01 ES004738</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30417-4</DOI>
    <KeywordList>
      <Keywords>Cytochrome b5</Keywords>
      <Keywords>Free radicals</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
      <Keywords>Redox cycling</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>John T. Szilagyi</Name>
        <Affiliation>Department of Environmental and Occupational Health, Rutgers University School of Public Health, Piscataway, NJ 08854, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Karma C. Fussell</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Yun Wang</Name>
        <Affiliation>Department of Environmental and Occupational Health, Rutgers University School of Public Health, Piscataway, NJ 08854, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Hua Jan</Name>
        <Affiliation>Department of Environmental and Occupational Health, Rutgers University School of Public Health, Piscataway, NJ 08854, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Vladimir Mishin</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jason R. Richardson</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Northeast Ohio Medical University, Rootstown, OH 44272, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Diane E. Heck</Name>
        <Affiliation>Department of Environmental Health Science, New York Medical College, Valhalla, NY 10595, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Shaojun Yang</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Lauren M. Aleksunes</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Debra L. Laskin</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey D. Laskin</Name>
        <Affiliation>Department of Environmental and Occupational Health, Rutgers University School of Public Health, Piscataway, NJ 08854, United States. Electronic address: jlaskin@eohsi.rutgers.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Proposed mechanism for understanding the dose- and time-dependency of the effects of fluoride in the liver.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30217653</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30410-1</DOI>
    <KeywordList>
      <Keywords>Chronic exposure</Keywords>
      <Keywords>Fluoride</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Proteomic</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Heloisa Aparecida Barbosa da Silva Pereira</Name>
        <Affiliation>Department of Genetics and Evolution, Center of Biological Sciences and the Health, Federal University of São Carlos, Washington Luis, km 235, 13560-970 São Carlos, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Aline Salgado Dionizio</Name>
        <Affiliation>Department of Biological Sciences, Bauru Dental School, University of São Paulo, Al. Octávio Pinheiro Brisolla, 9-75, 17012-901 Bauru, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Tamara Teodoro Araujo</Name>
        <Affiliation>Department of Biological Sciences, Bauru Dental School, University of São Paulo, Al. Octávio Pinheiro Brisolla, 9-75, 17012-901 Bauru, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Mileni da Silva Fernandes</Name>
        <Affiliation>Department of Genetics and Evolution, Center of Biological Sciences and the Health, Federal University of São Carlos, Washington Luis, km 235, 13560-970 São Carlos, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Flávia Godoy Iano</Name>
        <Affiliation>Department of Biological Sciences, Bauru Dental School, University of São Paulo, Al. Octávio Pinheiro Brisolla, 9-75, 17012-901 Bauru, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Marília Afonso Rabelo Buzalaf</Name>
        <Affiliation>Department of Biological Sciences, Bauru Dental School, University of São Paulo, Al. Octávio Pinheiro Brisolla, 9-75, 17012-901 Bauru, São Paulo, Brazil. Electronic address: mbuzalaf@fob.usp.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The suppressive effect of arsenic trioxide on TET2-FOXP3-Lyn-Akt axis-modulated MCL1 expression induces apoptosis in human leukemia cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30213730</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30408-3</DOI>
    <KeywordList>
      <Keywords>Arsenic trioxide</Keywords>
      <Keywords>Leukemia cells</Keywords>
      <Keywords>MCL1 Stability</Keywords>
      <Keywords>MCL1 Transcription</Keywords>
      <Keywords>TET2-FOXP3-Lyn-Akt Axis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ying Jung Chen</Name>
        <Affiliation>Department of Fragrance and Cosmetic Science, Kaohsiung Medical University, Kaohsiung 807, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chia Hui Huang</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Jun Shi</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Chin Lee</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Liang Jun Wang</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Long Sen Chang</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan; Department of Biotechnology, Kaohsiung Medical University, Kaohsiung 807, Taiwan. Electronic address: lschang@mail.nsysu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Folic acid magnetic nanotheranostics for delivering doxorubicin: Toxicological and biocompatibility studies on Zebrafish embryo and larvae.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30205093</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30409-5</DOI>
    <KeywordList>
      <Keywords>Biocompatibility</Keywords>
      <Keywords>Developmental-Toxicity</Keywords>
      <Keywords>Doxorubicin</Keywords>
      <Keywords>Magnetic Nanoparticles</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Daniela Edith Igartúa</Name>
        <Affiliation>Laboratorio de Biomembranas, Departamento de Ciencia y Tecnología, IMBICE-CONICET-CICPBA, Grupo de Biología Estructural y Biotecnología, Universidad Nacional de Quilmes, Roque Sáenz Peña 352, Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Pamela Liliana Azcona</Name>
        <Affiliation>Instituto de Química del Sur (INQUISUR), Departamento de Química, CONICET, Universidad Nacional del Sur, Avenida Alem 1253, Buenos Aires 8000, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Carolina Soledad Martinez</Name>
        <Affiliation>Laboratorio de Biomembranas, Departamento de Ciencia y Tecnología, IMBICE-CONICET-CICPBA, Grupo de Biología Estructural y Biotecnología, Universidad Nacional de Quilmes, Roque Sáenz Peña 352, Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Silvia Del Valle Alonso</Name>
        <Affiliation>Laboratorio de Biomembranas, Departamento de Ciencia y Tecnología, IMBICE-CONICET-CICPBA, Grupo de Biología Estructural y Biotecnología, Universidad Nacional de Quilmes, Roque Sáenz Peña 352, Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Verónica Leticia Lassalle</Name>
        <Affiliation>Instituto de Química del Sur (INQUISUR), Departamento de Química, CONICET, Universidad Nacional del Sur, Avenida Alem 1253, Buenos Aires 8000, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>María Jimena Prieto</Name>
        <Affiliation>Laboratorio de Biomembranas, Departamento de Ciencia y Tecnología, IMBICE-CONICET-CICPBA, Grupo de Biología Estructural y Biotecnología, Universidad Nacional de Quilmes, Roque Sáenz Peña 352, Buenos Aires, Argentina. Electronic address: jprieto@unq.edu.ar.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Baicalein represses TGF-β1-induced fibroblast differentiation through the inhibition of miR-21.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30201452</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30407-1</DOI>
    <KeywordList>
      <Keywords>Baicalein</Keywords>
      <Keywords>Fibroblast-To-Myofibroblast Differentiation</Keywords>
      <Keywords>Human Lung Fibroblast</Keywords>
      <Keywords>microRNA-21</Keywords>
      <Keywords>α-SMA Filament</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xinjian Cui</Name>
        <Affiliation>College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xionghua Sun</Name>
        <Affiliation>College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fanqing Lu</Name>
        <Affiliation>College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaogang Jiang</Name>
        <Affiliation>College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, China. Electronic address: jiangxiaogang@suda.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Triptolide enhances chemotherapeutic efficacy of antitumor drugs in non-small-cell lung cancer cells by inhibiting Nrf2-ARE activity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30196066</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30404-6</DOI>
    <KeywordList>
      <Keywords>Chemoresistance</Keywords>
      <Keywords>NSCLC</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>Triptolide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jiayu Zhu</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New area, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huihui Wang</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New area, Shenyang 110122, China. Electronic address: hhwang@cmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Feng Chen</Name>
        <Affiliation>Department of Interventional Radiology, The First Affiliated Hospital of China Medical University, No. 155 Nanjing North Road, Heping Area, Shenyang, 110001, China; Interventional Department, Qianfoshan Hospital, Shandong University, No.16766 Jingshi Road, Jinan 250014, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hang Lv</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New area, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zijin Xu</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New area, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingqi Fu</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New area, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongyong Hou</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New area, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanyuan Xu</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New area, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingbo Pi</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New area, Shenyang 110122, China. Electronic address: jbpi@cmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cellular, transcriptomic and methylome effects of individual and combined exposure to BPA, BPF, BPS on mouse spermatocyte GC-2 cell line.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30196065</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30406-X</DOI>
    <AuthorList>
      <Author>
        <Name>Iwona Sidorkiewicz</Name>
        <Affiliation>Department of Reproduction and Gynecological Endocrinology, Medical University of Bialystok, M. Sklodowskiej- Curie 24a, 15-276 Bialystok, Poland. Electronic address: iwona.sidorkiewicz@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jan Czerniecki</Name>
        <Affiliation>Department of Biology and Pathology of Human Reproduction, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn, Marii Sklodowskiej-Curie 24a, 15-276 Bialystok, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Katarzyna Jarząbek</Name>
        <Affiliation>Department of Biology and Pathology of Human Reproduction, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn, Marii Sklodowskiej-Curie 24a, 15-276 Bialystok, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Monika Zbucka-Krętowska</Name>
        <Affiliation>Department of Reproduction and Gynecological Endocrinology, Medical University of Bialystok, M. Sklodowskiej- Curie 24a, 15-276 Bialystok, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Sławomir Wołczyński</Name>
        <Affiliation>Department of Reproduction and Gynecological Endocrinology, Medical University of Bialystok, M. Sklodowskiej- Curie 24a, 15-276 Bialystok, Poland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The effects of Nrf2 knockout on regulation of benzene-induced mouse hematotoxicity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30195019</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30402-2</DOI>
    <KeywordList>
      <Keywords>Benzene-caused hematotoxicity</Keywords>
      <Keywords>Differentiation</Keywords>
      <Keywords>Hematopoietic stem/progenitor cells</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>Proliferation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Huiyao Li</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Daochuan Li</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhini He</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Junling Fan</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qingye Li</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoling Liu</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Guo</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Haiyan Zhang</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shen Chen</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiong Li</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Zhang</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiumei Xing</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaowen Zeng</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Aihua Zhang</Name>
        <Affiliation>Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Department of Toxicology, School of Public Health, Guizhou Medical University, Guiyang, Guizhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huanwen Tang</Name>
        <Affiliation>Dongguan Key Laboratory of Environmental Medicine, School of Public Health, Guangdong Medical University, Dongguan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guanghui Dong</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qing Wang</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongmei Xiao</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Liping Chen</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, China. Electronic address: chliping@mail.sysu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Chen</Name>
        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, China. Electronic address: chenwen@mail.sysu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Schisandrin B exhibits potent anticancer activity in triple negative breast cancer by inhibiting STAT3.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30195018</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30405-8</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>STAT3</Keywords>
      <Keywords>Schisandrin B</Keywords>
      <Keywords>Triple negative breast cancer</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xuanxuan Dai</Name>
        <Affiliation>Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, China; Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Changtian Yin</Name>
        <Affiliation>Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, China; Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guilong Guo</Name>
        <Affiliation>Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Zhang</Name>
        <Affiliation>Department of dermatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chenguang Zhao</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianchang Qian</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ouchen Wang</Name>
        <Affiliation>Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaohua Zhang</Name>
        <Affiliation>Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, China. Electronic address: zhangxiaohua925@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Guang Liang</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China. Electronic address: wzmcliangguang@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inflammatory mediators resulting from transglutaminase 2 expressed in mast cells contribute to the development of Parkinson's disease in a mouse model.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30195017</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30403-4</DOI>
    <KeywordList>
      <Keywords>Dopaminergic (DA) neurons</Keywords>
      <Keywords>Inflammatory mediators</Keywords>
      <Keywords>Mast cells</Keywords>
      <Keywords>Parkinson's disease</Keywords>
      <Keywords>Substantia nigra</Keywords>
      <Keywords>Transglutaminase 2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gwan Ui Hong</Name>
        <Affiliation>Department of Pharmacology, SBRI, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Whan Cho</Name>
        <Affiliation>Department of Neurology, SBRI, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Soo Youl Kim</Name>
        <Affiliation>Cancer Cell and Molecular Biology Branch, Division of Cancer Biology, Research Institute, National Cancer Center, Goyang, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Joo Ho Shin</Name>
        <Affiliation>Department of Pharmacology, SBRI, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jai Youl Ro</Name>
        <Affiliation>Department of Pharmacology, SBRI, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea. Electronic address: jyro426@skku.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>GSK-3 inhibition through GLP-1R allosteric activation mediates the neurogenesis promoting effect of P7C3 after cerebral ischemic/reperfusional injury in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30189238</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30399-5</DOI>
    <KeywordList>
      <Keywords>Aminopropyl carbazole</Keywords>
      <Keywords>GLP-1R</Keywords>
      <Keywords>GSK-3</Keywords>
      <Keywords>Neurogenesis</Keywords>
      <Keywords>β-Catenin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yea Hwey Wang</Name>
        <Affiliation>National Taipei University of Nursing and Health Sciences, Taipei City, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Kuo Tong Liou</Name>
        <Affiliation>National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei City, Taiwan; Department of Medicine, Mackay Medical College, New Taipei City, Taiwan; Department of Chinese Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei City, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Keng Chang Tsai</Name>
        <Affiliation>National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei City, Taiwan; Ph.D. Program for Medical Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei City, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Kang Liu</Name>
        <Affiliation>National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei City, Taiwan; Ph.D. Program for the Clinical Drug Discovery from Botanical Herbs, College of Pharmacy, Taipei Medical University, Taipei City, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Li Ming Yang</Name>
        <Affiliation>National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei City, Taiwan; School of Pharmacy, Taipei Medical University, Taipei City, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chang Ming Chern</Name>
        <Affiliation>Division of Neurovascular Disease, Neurological Institute, Taipei Veterans General Hospital, Taiwan; Taipei Municipal Gan-Dau Hospital, Taiwan; Institute of Brain Science, School of Medicine, National Yang-Ming University, Taipei City, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuh Chiang Shen</Name>
        <Affiliation>National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei City, Taiwan; National Taipei University of Nursing and Health Sciences, Taipei City, Taiwan; Ph.D. Program for the Clinical Drug Discovery from Botanical Herbs, College of Pharmacy, Taipei Medical University, Taipei City, Taiwan. Electronic address: yuhcs@nricm.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inhibition of chlorine-induced airway fibrosis by budesonide.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30189237</pubmedLink>
    <GrantList>
      <Grant>U01 ES022564</Grant>
      <Grant>P20 GM103436</Grant>
      <Grant>T32 ES011564</Grant>
      <Grant>P30 GM106396</Grant>
      <Grant>U01 ES015673</Grant>
    </GrantList>
    <Year>2019</Year>
    <DOI>S0041-008X(18)30400-9</DOI>
    <KeywordList>
      <Keywords>Airway fibrosis</Keywords>
      <Keywords>Chemical threat agent</Keywords>
      <Keywords>Chlorine</Keywords>
      <Keywords>Corticosteroid</Keywords>
      <Keywords>Inflammation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sadiatu Musah</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, School of Public Health and Information Sciences, University of Louisville, Louisville, KY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Chen</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, School of Public Health and Information Sciences, University of Louisville, Louisville, KY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Connie Schlueter</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, School of Public Health and Information Sciences, University of Louisville, Louisville, KY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>David M. Humphrey</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, School of Public Health and Information Sciences, University of Louisville, Louisville, KY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Kendall Stocke</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, School of Public Health and Information Sciences, University of Louisville, Louisville, KY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mona I. Hoyle</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, School of Public Health and Information Sciences, University of Louisville, Louisville, KY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Gary W. Hoyle</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, School of Public Health and Information Sciences, University of Louisville, Louisville, KY, United States. Electronic address: Gary.Hoyle@louisville.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Environmental exposure to perchlorate: A review of toxicology and human health.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30184474</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30401-0</DOI>
    <KeywordList>
      <Keywords>Environment</Keywords>
      <Keywords>Goitrogen</Keywords>
      <Keywords>Perchlorate</Keywords>
      <Keywords>Thyroid</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Richard C. Pleus</Name>
        <Affiliation>Intertox, Inc., 600 Stewart Street, Suite 1101 Seattle, WA 98101, United States. Electronic address: rcpleus@intertox.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa M. Corey</Name>
        <Affiliation>Intertox, Inc., 600 Stewart Street, Suite 1101 Seattle, WA 98101, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A novel anti-cancer role of β-apopicropodophyllin against non-small cell lung cancer cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30170025</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30389-2</DOI>
    <KeywordList>
      <Keywords>Anti-cancer drug</Keywords>
      <Keywords>Drug repositioning</Keywords>
      <Keywords>Non-small cell lung cancer cells</Keywords>
      <Keywords>Podophyllotoxin derivatives</Keywords>
      <Keywords>β-apopicropodophyllin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ju Yeon Kim</Name>
        <Affiliation>Division of Radiation Biomedical Research, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea; Division of Life Sciences, Korea University, Seoul 02841, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jeong Hyun Cho</Name>
        <Affiliation>Division of Radiation Biomedical Research, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jong Ryoo Choi</Name>
        <Affiliation>J&amp;C Sciences Co., Ltd., KAIST Moonji Campus F712, 193 Moonji-ro, Yusung-Gu, Daejeon 305-732, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyun Jin Shin</Name>
        <Affiliation>Division of Radiation Biomedical Research, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Young Song</Name>
        <Affiliation>Division of Radiation Biomedical Research, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sang Gu Hwang</Name>
        <Affiliation>Division of Radiation Biomedical Research, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Duck Um</Name>
        <Affiliation>Division of Radiation Biomedical Research, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Young Do Yoo</Name>
        <Affiliation>Laboratory of Molecular Cell Biology, Graduate School of Medicine, Korea University College of Medicine, Korea University, Seoul 02841, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Joon Kim</Name>
        <Affiliation>Division of Life Sciences, Korea University, Seoul 02841, Republic of Korea. Electronic address: joonkim@korea.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Jong Kuk Park</Name>
        <Affiliation>Division of Radiation Biomedical Research, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea. Electronic address: jkpark@kirams.re.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nrf2 in alcoholic liver disease.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30165058</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30386-7</DOI>
    <KeywordList>
      <Keywords>Alcoholic liver disease</Keywords>
      <Keywords>Ethanol</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>Oxidative stress</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jing Sun</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingqi Fu</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China. Electronic address: jqfu@cmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Li</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chengjie Chen</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Huihui Wang</Name>
        <Affiliation>Group of Chronic Disease and Environmental Genomics, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongyong Hou</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanyuan Xu</Name>
        <Affiliation>Group of Chronic Disease and Environmental Genomics, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingbo Pi</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China. Electronic address: jbpi@cmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Integration of sperm DNA damage assessment into OECD test guidelines for genotoxicity testing using the MutaMouse model.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30165057</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30388-0</DOI>
    <KeywordList>
      <Keywords>BMD modelling</Keywords>
      <Keywords>DNA damage</Keywords>
      <Keywords>LacZ assay</Keywords>
      <Keywords>Micronucleus assay</Keywords>
      <Keywords>Sperm</Keywords>
      <Keywords>Triethylenemelamine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Clotilde Maurice</Name>
        <Affiliation>Environmental Health Science and Research Bureau, Health Canada, Tunney's Pasture, 0803A, Ottawa, ON K1A 0K9, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Jason M. O'Brien</Name>
        <Affiliation>Ecotoxicology and Wildlife Health Division, Environment and Climate Change Canada, Ottawa, ON K1A 0H3, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Carole L. Yauk</Name>
        <Affiliation>Environmental Health Science and Research Bureau, Health Canada, Tunney's Pasture, 0803A, Ottawa, ON K1A 0K9, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Francesco Marchetti</Name>
        <Affiliation>Environmental Health Science and Research Bureau, Health Canada, Tunney's Pasture, 0803A, Ottawa, ON K1A 0K9, Canada. Electronic address: francesco.marchetti@canada.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Arsenite methyltransferase (AS3MT) polymorphisms and arsenic methylation in children in rural Bangladesh.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30153448</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30387-9</DOI>
    <KeywordList>
      <Keywords>AS3MT</Keywords>
      <Keywords>Arsenic</Keywords>
      <Keywords>Children</Keywords>
      <Keywords>Metabolism</Keywords>
      <Keywords>Methylation</Keywords>
      <Keywords>Polymorphism</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jessica De Loma</Name>
        <Affiliation>Institute of Environmental Medicine, Unit of Metals and Health, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Helena Skröder</Name>
        <Affiliation>Institute of Environmental Medicine, Unit of Metals and Health, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Rubhana Raqib</Name>
        <Affiliation>International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.</Affiliation>
      </Author>
      <Author>
        <Name>Marie Vahter</Name>
        <Affiliation>Institute of Environmental Medicine, Unit of Metals and Health, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Karin Broberg</Name>
        <Affiliation>Institute of Environmental Medicine, Unit of Metals and Health, Karolinska Institutet, Stockholm, Sweden. Electronic address: karin.broberg@ki.se.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Diosbulbin B induced G</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30145177</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30383-1</DOI>
    <KeywordList>
      <Keywords>CDK1</Keywords>
      <Keywords>Cell Cycle Arrest</Keywords>
      <Keywords>DB</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>miRNA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rui Yang</Name>
        <Affiliation>The MOE Key Laboratory for Standardization of Chinese Medicines, Shanghai Key Laboratory of Compound Chinese Medicines and The SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; Center for Drug Safety Evaluation and Research, Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201203, China; Guangming Traditional Chinese Medicine Hospital, Pudong New Area, Shanghai 201399, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mengjuan Wei</Name>
        <Affiliation>The MOE Key Laboratory for Standardization of Chinese Medicines, Shanghai Key Laboratory of Compound Chinese Medicines and The SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fan Yang</Name>
        <Affiliation>The MOE Key Laboratory for Standardization of Chinese Medicines, Shanghai Key Laboratory of Compound Chinese Medicines and The SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; Center for Drug Safety Evaluation and Research, Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuchen Sheng</Name>
        <Affiliation>Center for Drug Safety Evaluation and Research, Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai 201203, China. Electronic address: ycsheng@shutcm.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Lili Ji</Name>
        <Affiliation>The MOE Key Laboratory for Standardization of Chinese Medicines, Shanghai Key Laboratory of Compound Chinese Medicines and The SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Electronic address: jilili@shutcm.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>OSHA and elongate mineral particles.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30145176</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30384-3</DOI>
    <AuthorList>
      <Author>
        <Name>Daniel T. Crane</Name>
        <Affiliation>United States Department of Labor, Occupational Safety and Health Administration, Salt Lake Technical Center, Sandy, UT, USA. Electronic address: crane.dan@dol.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>BjSP, a novel serine protease from Bothrops jararaca snake venom that degrades fibrinogen without forming fibrin clots.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30145175</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30385-5</DOI>
    <KeywordList>
      <Keywords>Bothrops jararaca</Keywords>
      <Keywords>Coagulation</Keywords>
      <Keywords>Fibrinogen</Keywords>
      <Keywords>Serine protease</Keywords>
      <Keywords>Snake venom</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sante E. I. Carone</Name>
        <Affiliation>Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Danilo L. Menaldo</Name>
        <Affiliation>Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Marco A. Sartim</Name>
        <Affiliation>Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Carolina P. Bernardes</Name>
        <Affiliation>Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Renato C. Caetano</Name>
        <Affiliation>Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ronivaldo R. da Silva</Name>
        <Affiliation>Departamento de Ciências Farmacêuticas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil; Instituto de Biociências, Letras e Ciências Exatas, Universidade Estadual Paulista (UNESP), São José do Rio Preto, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Hamilton Cabral</Name>
        <Affiliation>Departamento de Ciências Farmacêuticas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Benedito Barraviera</Name>
        <Affiliation>Centro de Estudos de Venenos e Animais Peçonhentos (CEVAP), Universidade Estadual Paulista (UNESP), Botucatu, SP, Brazil; Faculdade de Medicina de Botucatu, Universidade Estadual Paulista (UNESP), Botucatu, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Rui S. Ferreira Junior</Name>
        <Affiliation>Centro de Estudos de Venenos e Animais Peçonhentos (CEVAP), Universidade Estadual Paulista (UNESP), Botucatu, SP, Brazil; Faculdade de Medicina de Botucatu, Universidade Estadual Paulista (UNESP), Botucatu, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Suely V. Sampaio</Name>
        <Affiliation>Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil. Electronic address: suvilela@usp.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>PFOS-induced excitotoxicity is dependent on Ca</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30144469</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30382-X</DOI>
    <KeywordList>
      <Keywords>Cerebellar granule neurons</Keywords>
      <Keywords>Cytosolic Ca(2+)</Keywords>
      <Keywords>Excitotoxicity</Keywords>
      <Keywords>Fura-2</Keywords>
      <Keywords>N-methyl-d-aspartate receptor</Keywords>
      <Keywords>Perfluorooctanesulfonic acid</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hanne Friis Berntsen</Name>
        <Affiliation>Department of Production Animal Clinical Sciences, NMBU-School of Veterinary Science, P.O. Box 8146 Dep, N-0033 Oslo, Norway; Department of Administration, Lab Animal Unit, National Institute of Occupational Health, P.O. Box 8149 Dep, N-0033 Oslo, Norway. Electronic address: hanne.friis.berntsen@nmbu.no.</Affiliation>
      </Author>
      <Author>
        <Name>Cesilie Granum Bjørklund</Name>
        <Affiliation>Department of Production Animal Clinical Sciences, NMBU-School of Veterinary Science, P.O. Box 8146 Dep, N-0033 Oslo, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Rønnaug Strandabø</Name>
        <Affiliation>Department of Biosciences, University of Oslo, Oslo, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Trude Marie Haug</Name>
        <Affiliation>Department of Oral Biology, University of Oslo, Oslo, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Angel Moldes-Anaya</Name>
        <Affiliation>R&amp;D section, PET-center, University Hospital of North Norway (UNN), Tromsø, Norway; Neurobiology Research Group, Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Judit Fuentes-Lazaro</Name>
        <Affiliation>Department of Pharmaceutical Biosciences, University of Oslo, Oslo, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Steven Verhaegen</Name>
        <Affiliation>Department of Production Animal Clinical Sciences, NMBU-School of Veterinary Science, P.O. Box 8146 Dep, N-0033 Oslo, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Ragnhild Elisabeth Paulsen</Name>
        <Affiliation>Department of Pharmaceutical Biosciences, University of Oslo, Oslo, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>R. Andrew Tasker</Name>
        <Affiliation>Department of Biomedical Sciences, University of Prince Edward Island, 550 University Avenue, Charlottetown PEI, C1A4P3, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Erik Ropstad</Name>
        <Affiliation>Department of Production Animal Clinical Sciences, NMBU-School of Veterinary Science, P.O. Box 8146 Dep, N-0033 Oslo, Norway.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute and 28-day sub-acute intravenous toxicity studies of 1'-S-1'-acetoxychavicol acetate in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30138658</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30381-8</DOI>
    <KeywordList>
      <Keywords>1’-S-1′-acetoxychavicol acetate</Keywords>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Alpinia conchigera</Keywords>
      <Keywords>Rats</Keywords>
      <Keywords>Sub-acute toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yasir Osman Ali Abdalla</Name>
        <Affiliation>Institute of Biological Sciences (Genetics and Molecular Biology), Faculty of Science, University Malaya, 50603 Kuala Lumpur, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Shaik Nyamathulla</Name>
        <Affiliation>Department of Pharmacy, Faculty of Medicine, University Malaya, 50603 Kuala Lumpur, Malaysia; Centre for Natural Products and Drug Discovery (CENAR), Faculty of Science, University Malaya, 50603 Kuala Lumpur, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Noorasyikin Shamsuddin</Name>
        <Affiliation>Department of Pharmacy, Faculty of Medicine, University Malaya, 50603 Kuala Lumpur, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Norhafiza M. Arshad</Name>
        <Affiliation>Institute of Biological Sciences (Genetics and Molecular Biology), Faculty of Science, University Malaya, 50603 Kuala Lumpur, Malaysia; Centre for Research in Biotechnology for Agriculture (CEBAR), University Malaya, 50603 Kuala Lumpur, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Kein Seong Mun</Name>
        <Affiliation>Department of Pathology, Faculty of Medicine, University Malaya, 50603 Kuala Lumpur, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Khalijah Awang</Name>
        <Affiliation>Department of Chemistry, Faculty of Science, University Malaya, 50603 Kuala Lumpur, Malaysia; Centre for Natural Products and Drug Discovery (CENAR), Faculty of Science, University Malaya, 50603 Kuala Lumpur, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Noor Hasima Nagoor</Name>
        <Affiliation>Institute of Biological Sciences (Genetics and Molecular Biology), Faculty of Science, University Malaya, 50603 Kuala Lumpur, Malaysia; Centre for Research in Biotechnology for Agriculture (CEBAR), University Malaya, 50603 Kuala Lumpur, Malaysia. Electronic address: hasima@um.edu.my.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>COX-2/EP2-EP4/β-catenin signaling regulates patulin-induced intestinal cell proliferation and inflammation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30138657</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30378-8</DOI>
    <KeywordList>
      <Keywords>Cell proliferation</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Intestinal toxicity</Keywords>
      <Keywords>Mycotoxin</Keywords>
      <Keywords>Patulin</Keywords>
      <Keywords>Prostaglandin E2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Neha Singh</Name>
        <Affiliation>Food Toxicology Division, Food, Drug, and Chemical Toxicology Group, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India.; Academy of Scientific and Innovative Research (AcSIR), CSIR-Indian Institute of Toxicology Research Campus, (CSIR-IITR), Lucknow 226001, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Megha Bansal</Name>
        <Affiliation>Food Toxicology Division, Food, Drug, and Chemical Toxicology Group, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India.; Academy of Scientific and Innovative Research (AcSIR), CSIR-Indian Institute of Toxicology Research Campus, (CSIR-IITR), Lucknow 226001, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Saurabh Pal</Name>
        <Affiliation>Food Toxicology Division, Food, Drug, and Chemical Toxicology Group, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India.; Academy of Scientific and Innovative Research (AcSIR), CSIR-Indian Institute of Toxicology Research Campus, (CSIR-IITR), Lucknow 226001, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Shamshad Alam</Name>
        <Affiliation>Food Toxicology Division, Food, Drug, and Chemical Toxicology Group, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Pankaj Jagdale</Name>
        <Affiliation>Animal House Facility, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India.; Department of Zoology, University of Lucknow, Lucknow 226007, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Anjaneya Ayanur</Name>
        <Affiliation>Animal House Facility, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Kausar Mahmood Ansari</Name>
        <Affiliation>Food Toxicology Division, Food, Drug, and Chemical Toxicology Group, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhawan, 31, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India.. Electronic address: kmansari@iitr.res.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Antimetastatic effect of the pharmacological inhibition of serine/arginine-rich protein kinases (SRPK) in murine melanoma.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30138656</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30379-X</DOI>
    <KeywordList>
      <Keywords>Melanoma</Keywords>
      <Keywords>Metastasis</Keywords>
      <Keywords>Protein kinases</Keywords>
      <Keywords>SRVIC compounds</Keywords>
      <Keywords>Serine/Arginine-rich</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gabriela Alves Moreira</Name>
        <Affiliation>Universidade Federal de Viçosa, Departamento de Bioquímica e Biologia Molecular, Viçosa, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Graziela Domingues de Almeida Lima</Name>
        <Affiliation>Universidade Federal de Viçosa, Departamento de Biologia Geral, Viçosa, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Raoni Pais Siqueira</Name>
        <Affiliation>Universidade Federal de Viçosa, Departamento de Bioquímica e Biologia Molecular, Viçosa, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Marcus Vinícius de Andrade Barros</Name>
        <Affiliation>Universidade Federal de Viçosa, Departamento de Química, Viçosa, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Abraham Landry Mahuvi Adjanohoun</Name>
        <Affiliation>Universidade Federal de Minas Gerais, Departamento de Bioquímica e Imunologia, Belo Horizonte, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Viviane Corrêa Santos</Name>
        <Affiliation>Universidade Federal de Minas Gerais, Departamento de Bioquímica e Imunologia, Belo Horizonte, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Éverton de Almeida Alves Barbosa</Name>
        <Affiliation>Universidade Federal de Viçosa, Departamento de Bioquímica e Biologia Molecular, Viçosa, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Robson Kriiger Loterio</Name>
        <Affiliation>Universidade Federal de Viçosa, Departamento de Bioquímica e Biologia Molecular, Viçosa, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Janine Cerqueira de Paiva</Name>
        <Affiliation>Universidade Federal de Viçosa, Departamento de Bioquímica e Biologia Molecular, Viçosa, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Victor Hugo Sousa Gonçalves</Name>
        <Affiliation>Universidade Federal de Viçosa, Departamento de Bioquímica e Biologia Molecular, Viçosa, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Lívia Cristina de Souza Viol</Name>
        <Affiliation>Universidade Federal de Viçosa, Departamento de Química, Viçosa, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Eduardo de Almeida Marques-da-Silva</Name>
        <Affiliation>Universidade Federal de Viçosa, Departamento de Biologia Geral, Viçosa, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Abelardo Silva Júnior</Name>
        <Affiliation>Universidade Federal de Viçosa, Departamento de Veterinária, Viçosa, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Márcia Rogéria Almeida</Name>
        <Affiliation>Universidade Federal de Viçosa, Departamento de Bioquímica e Biologia Molecular, Viçosa, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Juliana Lopes Rangel Fietto</Name>
        <Affiliation>Universidade Federal de Viçosa, Departamento de Bioquímica e Biologia Molecular, Viçosa, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Mariana Machado-Neves</Name>
        <Affiliation>Universidade Federal de Viçosa, Departamento de Biologia Geral, Viçosa, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Rafaela Salgado Ferreira</Name>
        <Affiliation>Universidade Federal de Minas Gerais, Departamento de Bioquímica e Imunologia, Belo Horizonte, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Róbson Ricardo Teixeira</Name>
        <Affiliation>Universidade Federal de Viçosa, Departamento de Química, Viçosa, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Gustavo Costa Bressan</Name>
        <Affiliation>Universidade Federal de Viçosa, Departamento de Bioquímica e Biologia Molecular, Viçosa, MG, Brazil. Electronic address: gustavo.bressan@ufv.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Zearalenone exposure elevated the expression of tumorigenesis genes in mouse ovarian granulosa cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30138655</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30380-6</DOI>
    <KeywordList>
      <Keywords>Granulosa cells</Keywords>
      <Keywords>RNA-seq</Keywords>
      <Keywords>Tumorigenesis</Keywords>
      <Keywords>Zearalenone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rui Qian Zhang</Name>
        <Affiliation>College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, China; College of Life Sciences, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Feng Sun</Name>
        <Affiliation>College of Life Sciences, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Ying Wu</Name>
        <Affiliation>Center for Reproductive Medicine, Qingdao Women's and Children's Hospital, Qingdao University, Qingdao 266034, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shun Feng Cheng</Name>
        <Affiliation>College of Life Sciences, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guo Liang Zhang</Name>
        <Affiliation>College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiu Yue Zhai</Name>
        <Affiliation>College of Life Sciences, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xue Lian Liu</Name>
        <Affiliation>College of Life Sciences, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Zhao</Name>
        <Affiliation>College of Life Sciences, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Shen</Name>
        <Affiliation>College of Life Sciences, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lan Li</Name>
        <Affiliation>College of Life Sciences, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China. Electronic address: lilan9600@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Measurement of elongate mineral particles: What we should measure and how do we do it?</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30134140</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30376-4</DOI>
    <KeywordList>
      <Keywords>Amphibole</Keywords>
      <Keywords>Asbestos</Keywords>
      <Keywords>Chrysotile</Keywords>
      <Keywords>Elongate mineral particle</Keywords>
      <Keywords>Fiber</Keywords>
      <Keywords>Mesothelioma</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Eric J. Chatfield</Name>
        <Affiliation>Chatfield Technical Consulting Limited, 2071 Dickson Road, Mississauga, L5B 1Y8, Ontario, Canada. Electronic address: echatfield@ejchatfield.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Sodium arsenite exposure inhibits histone acetyltransferase p300 for attenuating H3K27ac at enhancers in mouse embryonic fibroblast cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30130555</pubmedLink>
    <GrantList>
      <Grant>R01 ES025761</Grant>
      <Grant>R21 ES028351</Grant>
      <Grant>U01 ES026721</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30377-6</DOI>
    <KeywordList>
      <Keywords>Cancers</Keywords>
      <Keywords>Enhancers</Keywords>
      <Keywords>H3K27ac</Keywords>
      <Keywords>Histone acetyltransferase p300</Keywords>
      <Keywords>Sodium arsenite</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yan Zhu</Name>
        <Affiliation>Laboratory of Human Environmental Epigenome, Department of Environmental Health &amp; Engineering, Bloomberg School of Public Health, Johns Hopkins University, 615 N. Wolfe St., Baltimore, MD 21205, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yanqiang Li</Name>
        <Affiliation>Laboratory of Human Environmental Epigenome, Department of Environmental Health &amp; Engineering, Bloomberg School of Public Health, Johns Hopkins University, 615 N. Wolfe St., Baltimore, MD 21205, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Dan Lou</Name>
        <Affiliation>Laboratory of Human Environmental Epigenome, Department of Environmental Health &amp; Engineering, Bloomberg School of Public Health, Johns Hopkins University, 615 N. Wolfe St., Baltimore, MD 21205, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Gao</Name>
        <Affiliation>Laboratory of Human Environmental Epigenome, Department of Environmental Health &amp; Engineering, Bloomberg School of Public Health, Johns Hopkins University, 615 N. Wolfe St., Baltimore, MD 21205, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Yu</Name>
        <Affiliation>Laboratory of Human Environmental Epigenome, Department of Environmental Health &amp; Engineering, Bloomberg School of Public Health, Johns Hopkins University, 615 N. Wolfe St., Baltimore, MD 21205, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Dehui Kong</Name>
        <Affiliation>Laboratory of Human Environmental Epigenome, Department of Environmental Health &amp; Engineering, Bloomberg School of Public Health, Johns Hopkins University, 615 N. Wolfe St., Baltimore, MD 21205, USA; Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, College of Life Sciences, Hubei University, 368 Youyi Avenue, Wuchang District, Wuhan, Hubei Province 430062, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiang Zhang</Name>
        <Affiliation>Laboratory of Human Environmental Epigenome, Department of Environmental Health &amp; Engineering, Bloomberg School of Public Health, Johns Hopkins University, 615 N. Wolfe St., Baltimore, MD 21205, USA; Department of Occupational and Environmental Health, School of Public Health, Tianjin Medical University, No. 22 Qixiangtai Road, Tianjin 300070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yankai Jia</Name>
        <Affiliation>GENEWIZ Suzhou, 218 Xinghu Road, Suzhou Industrial Park, Suzhou 215123, China. Electronic address: yankai.jia@genewiz.com.</Affiliation>
      </Author>
      <Author>
        <Name>Haimou Zhang</Name>
        <Affiliation>Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, College of Life Sciences, Hubei University, 368 Youyi Avenue, Wuchang District, Wuhan, Hubei Province 430062, China. Electronic address: haimou@hubu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Zhibin Wang</Name>
        <Affiliation>Laboratory of Human Environmental Epigenome, Department of Environmental Health &amp; Engineering, Bloomberg School of Public Health, Johns Hopkins University, 615 N. Wolfe St., Baltimore, MD 21205, USA; Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, College of Life Sciences, Hubei University, 368 Youyi Avenue, Wuchang District, Wuhan, Hubei Province 430062, China; Fengxian Central Hospital, 9588 Nanfeng Hwy, Fengxian District, Shanghai 201406, China. Electronic address: zwang47@jhu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Affecting NF-κB cell signaling pathway in chronic lymphocytic leukemia by dendrimers-based nanoparticles.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30125597</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30374-0</DOI>
    <KeywordList>
      <Keywords>Chronic lymphocytic leukemia (CLL)</Keywords>
      <Keywords>Gene expression</Keywords>
      <Keywords>Glycodendrimer, NF-κB</Keywords>
      <Keywords>PPI dendrimer</Keywords>
      <Keywords>Signaling pathway</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ida Franiak-Pietryga</Name>
        <Affiliation>Department of Clinical and Laboratory Genetics, Medical University of Lodz, 251 Pomorska St., 92-213 Lodz, Poland; Department of Ophthalmology, University of California San Diego, 9500 Gillman Dr, La Jolla, CA 92093-0718, United States; Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, 62 Pabianicka St., 93-513 Lodz, Poland; GeneaMed LTD, 16/18/904 Kopcinskiego St., 90-232 Lodz, Poland. Electronic address: franiak.ida@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kinga Ostrowska</Name>
        <Affiliation>Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, 62 Pabianicka St., 93-513 Lodz, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Henryk Maciejewski</Name>
        <Affiliation>Department of Computer Engineering, Wroclaw University of Technology, 11/17 Janiszewskiego St., 50-372 Wroclaw, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Barbara Ziemba</Name>
        <Affiliation>Department of Clinical and Laboratory Genetics, Medical University of Lodz, 251 Pomorska St., 92-213 Lodz, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Dietmar Appelhans</Name>
        <Affiliation>Leibniz Institute of Polymer Research Dresden, Hohe Str. 6, D-01069 Dresden, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Brigitte Voit</Name>
        <Affiliation>Leibniz Institute of Polymer Research Dresden, Hohe Str. 6, D-01069 Dresden, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Magdalena Jander</Name>
        <Affiliation>GeneaMed LTD, 16/18/904 Kopcinskiego St., 90-232 Lodz, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Jacek Treliński</Name>
        <Affiliation>Department of Hematology, Medical University of Lodz, Copernicus Memorial Hospital, 62 Pabianicka St., 93-513 Lodz, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Bryszewska</Name>
        <Affiliation>Department of General Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, 141/143 Pomorska St., 90-236 Lodz, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Maciej Borowiec</Name>
        <Affiliation>Department of Clinical and Laboratory Genetics, Medical University of Lodz, 251 Pomorska St., 92-213 Lodz, Poland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Taurine-magnesium coordination compound, a potential anti-arrhythmic complex, improves aconitine-induced arrhythmias through regulation of multiple ion channels.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30125596</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30375-2</DOI>
    <KeywordList>
      <Keywords>Aconitine</Keywords>
      <Keywords>Arrhythmia</Keywords>
      <Keywords>Bay K8644</Keywords>
      <Keywords>Taurine–Magnesium coordination compound</Keywords>
      <Keywords>Veratridine</Keywords>
      <Keywords>Whole-cell patch-clamp technique</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jianshi Lou</Name>
        <Affiliation>Department of Pharmacology, Tianjin Medical University, Tianjin, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Wu</Name>
        <Affiliation>Department of Pharmacology, Tianjin Medical University, Tianjin, PR China; Mudanjiang Medical University, Mudanjiang, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lingfang Wang</Name>
        <Affiliation>Institute of Translational Medicine, Nanchang University, Nanchang, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lin Zhao</Name>
        <Affiliation>International College, Tianjin Medical University, Tianjin, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Li</Name>
        <Affiliation>Department of Pharmacology, Tianjin Medical University, Tianjin, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Kang</Name>
        <Affiliation>Department of Pharmacology, Tianjin Medical University, Tianjin, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ke Wen</Name>
        <Affiliation>Department of Pharmacology, Tianjin Medical University, Tianjin, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongqiang Yin</Name>
        <Affiliation>Department of Pharmacology, Tianjin Medical University, Tianjin, PR China. Electronic address: yinyongqiang@tijmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Binge ethanol exposure induces endoplasmic reticulum stress in the brain of adult mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30114398</pubmedLink>
    <GrantList>
      <Grant>I01 BX001721</Grant>
      <Grant>R01 AA015407</Grant>
      <Grant>R01 AA017226</Grant>
      <Grant>T32 DK007778</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30373-9</DOI>
    <KeywordList>
      <Keywords>Alcohol use isorder</Keywords>
      <Keywords>Brain damage</Keywords>
      <Keywords>Endoplasmic reticulum tress</Keywords>
      <Keywords>Neurodegeneration</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>mTOR signaling</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yongchao Wang</Name>
        <Affiliation>Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40536, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Wang</Name>
        <Affiliation>Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40536, United States; Center for Health Services Research, University of Kentucky College of Medicine, Lexington, KY 40536, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Li</Name>
        <Affiliation>Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40536, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mei Xu</Name>
        <Affiliation>Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40536, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jacqueline Frank</Name>
        <Affiliation>Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40536, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jia Luo</Name>
        <Affiliation>Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40536, United States. Electronic address: jialuo888@uky.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>PIKfyve inhibitor cytotoxicity requires AKT suppression and excessive cytoplasmic vacuolation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30098992</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30358-2</DOI>
    <KeywordList>
      <Keywords>AKT</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>MK-2206</Keywords>
      <Keywords>PIKfyve</Keywords>
      <Keywords>Ppilimod</Keywords>
      <Keywords>YM201636</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ognian C. Ikonomov</Name>
        <Affiliation>Department of Physiology, Wayne State University School of Medicine, Detroit, MI 48201, USA. Electronic address: oikonomo@med.wayne.edu.</Affiliation>
      </Author>
      <Author>
        <Name>George Altankov</Name>
        <Affiliation>Institute for Bioengineering of Catalonia (IBBC), Barcelona, Spain; ICREA (Institució Catalana de Recerca i Estudis Avançats), Barcelona, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Diego Sbrissa</Name>
        <Affiliation>Department of Physiology, Wayne State University School of Medicine, Detroit, MI 48201, USA. Electronic address: dsbrissa@med.wayne.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Assia Shisheva</Name>
        <Affiliation>Department of Physiology, Wayne State University School of Medicine, Detroit, MI 48201, USA. Electronic address: ashishev@med.wayne.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Impact of silver, gold, and iron oxide nanoparticles on cellular response to tumor necrosis factor.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30096344</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30361-2</DOI>
    <KeywordList>
      <Keywords>A549</Keywords>
      <Keywords>Cellular Signaling</Keywords>
      <Keywords>Gold Nanoparticles</Keywords>
      <Keywords>HepG2</Keywords>
      <Keywords>Silver Nanoparticles</Keywords>
      <Keywords>Superparamagnetic Iron Oxide Nanoparticles</Keywords>
      <Keywords>Tumor Necrosis Factor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kamil Brzóska</Name>
        <Affiliation>Institute of Nuclear Chemistry and Technology, Centre for Radiobiology and Biological Dosimetry, Dorodna 16, 03-195 Warsaw, Poland. Electronic address: k.brzoska@ichtj.waw.pl.</Affiliation>
      </Author>
      <Author>
        <Name>Iwona Grądzka</Name>
        <Affiliation>Institute of Nuclear Chemistry and Technology, Centre for Radiobiology and Biological Dosimetry, Dorodna 16, 03-195 Warsaw, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Marcin Kruszewski</Name>
        <Affiliation>Institute of Nuclear Chemistry and Technology, Centre for Radiobiology and Biological Dosimetry, Dorodna 16, 03-195 Warsaw, Poland; University of Information Technology and Management, Department of Medical Biology and Translational Research, Sucharskiego 2, 35-225 Rzeszów, Poland; Institute of Rural Health, Department of Molecular Biology and Translational Research, Jaczewskiego 2, 20-090 Lublin, Poland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>New Bis copper complex ((Z) -4 - ((4-chlorophenyl) amino) -4-oxobut-2-enoyl) oxy): Cytotoxicity in 4T1 cells and their toxicogenic potential in Swiss mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30092250</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30360-0</DOI>
    <KeywordList>
      <Keywords>Antitumor Activity</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Breast Cancer</Keywords>
      <Keywords>Cell Cycle</Keywords>
      <Keywords>Copper(II) Complexes</Keywords>
      <Keywords>DNA Damage</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Edwin José Torres de Oliveira</Name>
        <Affiliation>Centro de Estudos em Células Tronco, Terapia Celular e Genética Toxicológica - CeTroGen, Hospital Universitário Maria Aparecida Pedrossian, Empresa Brasileira de Serviços Hospitalares - EBSERH, Campo Grande, Mato Grosso do Sul, Brazil; Programa de Pós-graduação em Genética e Biologia Molecular, Centro de Ciências Biológicas - CCB, Departamento de Biologia Geral, Universidade Estadual de Londrina - UEL, Londrina, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Lucas Roberto Pessatto</Name>
        <Affiliation>Centro de Estudos em Células Tronco, Terapia Celular e Genética Toxicológica - CeTroGen, Hospital Universitário Maria Aparecida Pedrossian, Empresa Brasileira de Serviços Hospitalares - EBSERH, Campo Grande, Mato Grosso do Sul, Brazil; Programa de Pós-graduação em Genética e Biologia Molecular, Centro de Ciências Biológicas - CCB, Departamento de Biologia Geral, Universidade Estadual de Londrina - UEL, Londrina, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Raquel Oliveira Nascimento de Freitas</Name>
        <Affiliation>Laboratório de Síntese e Modificação Molecular, Faculdade de Ciências Exatas e Tecnologia - FACET, Universidade Federal da Grande Dourados - UFGD, Dourados, Mato Grosso do Sul 79804-970, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Bruno Ivo Pelizaro</Name>
        <Affiliation>Centro de Estudos em Células Tronco, Terapia Celular e Genética Toxicológica - CeTroGen, Hospital Universitário Maria Aparecida Pedrossian, Empresa Brasileira de Serviços Hospitalares - EBSERH, Campo Grande, Mato Grosso do Sul, Brazil; Programa de Mestrado em Farmácia, Faculdade de Ciências Farmacêuticas, Alimentos e Nutrição - FACFAN, Universidade Federal de Mato Grosso do Sul - UFMS, Campo Grande, Mato Grosso do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Paula Maluf Rabacow</Name>
        <Affiliation>Centro de Estudos em Células Tronco, Terapia Celular e Genética Toxicológica - CeTroGen, Hospital Universitário Maria Aparecida Pedrossian, Empresa Brasileira de Serviços Hospitalares - EBSERH, Campo Grande, Mato Grosso do Sul, Brazil; Faculdade de Medicina Dr. Hélio Mandetta, Programa de Pós-graduação em Saúde e Desenvolvimento na Região Centro-Oeste, Campo Grande, Mato Grosso do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Juliana Miron Vani</Name>
        <Affiliation>Centro de Estudos em Células Tronco, Terapia Celular e Genética Toxicológica - CeTroGen, Hospital Universitário Maria Aparecida Pedrossian, Empresa Brasileira de Serviços Hospitalares - EBSERH, Campo Grande, Mato Grosso do Sul, Brazil; Faculdade de Medicina Dr. Hélio Mandetta, Programa de Pós-graduação em Saúde e Desenvolvimento na Região Centro-Oeste, Campo Grande, Mato Grosso do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Antônio Carlos Duenhas Monreal</Name>
        <Affiliation>Centro de Estudos em Células Tronco, Terapia Celular e Genética Toxicológica - CeTroGen, Hospital Universitário Maria Aparecida Pedrossian, Empresa Brasileira de Serviços Hospitalares - EBSERH, Campo Grande, Mato Grosso do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Mário Sérgio Mantovani</Name>
        <Affiliation>Programa de Pós-graduação em Genética e Biologia Molecular, Centro de Ciências Biológicas - CCB, Departamento de Biologia Geral, Universidade Estadual de Londrina - UEL, Londrina, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ricardo Bentes de Azevedo</Name>
        <Affiliation>Departamento de Genética e Morfologia, Instituto de Ciências Biológicas - IB, Universidade de Brasília - UNB, Brasília, Distrito Federal, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Andréia Conceição Milan Brochado Antoniolli-Silva</Name>
        <Affiliation>Centro de Estudos em Células Tronco, Terapia Celular e Genética Toxicológica - CeTroGen, Hospital Universitário Maria Aparecida Pedrossian, Empresa Brasileira de Serviços Hospitalares - EBSERH, Campo Grande, Mato Grosso do Sul, Brazil; Faculdade de Medicina Dr. Hélio Mandetta, Programa de Pós-graduação em Saúde e Desenvolvimento na Região Centro-Oeste, Campo Grande, Mato Grosso do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Roberto da Silva Gomes</Name>
        <Affiliation>Laboratório de Síntese e Modificação Molecular, Faculdade de Ciências Exatas e Tecnologia - FACET, Universidade Federal da Grande Dourados - UFGD, Dourados, Mato Grosso do Sul 79804-970, Brazil. Electronic address: robertogomes@ufgd.edu.br.</Affiliation>
      </Author>
      <Author>
        <Name>Rodrigo Juliano Oliveira</Name>
        <Affiliation>Centro de Estudos em Células Tronco, Terapia Celular e Genética Toxicológica - CeTroGen, Hospital Universitário Maria Aparecida Pedrossian, Empresa Brasileira de Serviços Hospitalares - EBSERH, Campo Grande, Mato Grosso do Sul, Brazil; Programa de Pós-graduação em Genética e Biologia Molecular, Centro de Ciências Biológicas - CCB, Departamento de Biologia Geral, Universidade Estadual de Londrina - UEL, Londrina, Brazil.; Programa de Mestrado em Farmácia, Faculdade de Ciências Farmacêuticas, Alimentos e Nutrição - FACFAN, Universidade Federal de Mato Grosso do Sul - UFMS, Campo Grande, Mato Grosso do Sul, Brazil; Faculdade de Medicina Dr. Hélio Mandetta, Programa de Pós-graduação em Saúde e Desenvolvimento na Região Centro-Oeste, Campo Grande, Mato Grosso do Sul, Brazil. Electronic address: rodrigo.oliveira@ufms.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Alantolactone induces apoptosis and improves chemosensitivity of pancreatic cancer cells by impairment of autophagy-lysosome pathway via targeting TFEB.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30086361</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30359-4</DOI>
    <KeywordList>
      <Keywords>Alantolactone</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Autophagy</Keywords>
      <Keywords>Lysosome</Keywords>
      <Keywords>Pancreatic cancer</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ruizhi He</Name>
        <Affiliation>Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiuhui Shi</Name>
        <Affiliation>Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Min Zhou</Name>
        <Affiliation>Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Zhao</Name>
        <Affiliation>Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shutao Pan</Name>
        <Affiliation>Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunle Zhao</Name>
        <Affiliation>Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xingjun Guo</Name>
        <Affiliation>Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Min Wang</Name>
        <Affiliation>Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Li</Name>
        <Affiliation>Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, PR China. Electronic address: kuai_1985@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Renyi Qin</Name>
        <Affiliation>Department of Biliary-Pancreatic Surgery, Affiliated Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, PR China. Electronic address: ryqin@tjh.tjmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Activation of ornithine decarboxylase protects against methylmercury toxicity by increasing putrescine.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30081057</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30357-0</DOI>
    <KeywordList>
      <Keywords>Methylmercury</Keywords>
      <Keywords>Ornithine Decarboxylase</Keywords>
      <Keywords>Putrescine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Masayuki Sato</Name>
        <Affiliation>Laboratory of Molecular and Biochemical Toxicology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takashi Toyama</Name>
        <Affiliation>Laboratory of Molecular and Biochemical Toxicology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Yong Lee</Name>
        <Affiliation>Laboratory of Molecular and Biochemical Toxicology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, Japan; Laboratory of Pharmaceutical Health Sciences, School of Pharmacy, Aichi Gakuin University, 1-100 Kusumoto-cho, Chikusa-ku, Nagoya 464-8650, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Nobuhiko Miura</Name>
        <Affiliation>Division of Health Effects Research, Japan National Institute of Occupational Safety and Health, 6-21-1 Nagao, Tama-ku, Kawasaki 214-8585, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Akira Naganuma</Name>
        <Affiliation>Laboratory of Molecular and Biochemical Toxicology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Gi Wook Hwang</Name>
        <Affiliation>Laboratory of Molecular and Biochemical Toxicology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, Japan. Electronic address: gwhwang@m.tohoku.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A comparison of asbestos fiber potency and elongate mineral particle (EMP) potency for mesothelioma in humans.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30077661</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30314-4</DOI>
    <KeywordList>
      <Keywords>Asbestos</Keywords>
      <Keywords>Elongate mineral particles</Keywords>
      <Keywords>Potency</Keywords>
      <Keywords>Taconite</Keywords>
      <Keywords>Talc</Keywords>
      <Keywords>Vermiculite</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David H. Garabrant</Name>
        <Affiliation>Epidstat Institute, 2100 Commonwealth Blvd., Suite 203, Ann Arbor, MI, United States. Electronic address: dhg3@comcast.net.</Affiliation>
      </Author>
      <Author>
        <Name>Susan T. Pastula</Name>
        <Affiliation>Epidstat Institute, 2100 Commonwealth Blvd., Suite 203, Ann Arbor, MI, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Polyphyllin I modulates MALAT1/STAT3 signaling to induce apoptosis in gefitinib-resistant non-small cell lung cancer.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30076870</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30356-9</DOI>
    <KeywordList>
      <Keywords>Gefitinib-resistance</Keywords>
      <Keywords>MALAT1</Keywords>
      <Keywords>NSCLC</Keywords>
      <Keywords>Polyphyllin</Keywords>
      <Keywords>STAT3</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qi Yang</Name>
        <Affiliation>Department of Respiration, The First Hospital of Jiaxing (The First Affiliated Hospital of Jiaxing University), Jiaxing, Zhejiang 314000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenyu Chen</Name>
        <Affiliation>Department of Respiration, The First Hospital of Jiaxing (The First Affiliated Hospital of Jiaxing University), Jiaxing, Zhejiang 314000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yufeng Xu</Name>
        <Affiliation>Department of Oncology, The First Hospital of Jiaxing (The First Affiliated Hospital of Jiaxing University), Jiaxing, Zhejiang 314000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaodong Lv</Name>
        <Affiliation>Department of Respiration, The First Hospital of Jiaxing (The First Affiliated Hospital of Jiaxing University), Jiaxing, Zhejiang 314000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Zhang</Name>
        <Affiliation>Department of Respiration, The First Hospital of Jiaxing (The First Affiliated Hospital of Jiaxing University), Jiaxing, Zhejiang 314000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hao Jiang</Name>
        <Affiliation>Department of Oncology, Zhejiang Hospital, Hangzhou, Zhejiang 310013, PR China. Electronic address: zjhoncol@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Maternal serum arsenic level during pregnancy is positively associated with adverse pregnant outcomes in a Chinese population.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30075163</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30355-7</DOI>
    <KeywordList>
      <Keywords>Adverse pregnant outcomes</Keywords>
      <Keywords>Arsenic</Keywords>
      <Keywords>Birth cohort study</Keywords>
      <Keywords>Low birth weight (LBW)</Keywords>
      <Keywords>Preterm delivery</Keywords>
      <Keywords>Small for gestational age (SGA)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hua Wang</Name>
        <Affiliation>Department of Toxicology, Anhui Medical University, China; Anhui Provincial Key Laboratory of Population Health &amp; Aristogenics, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Li</Name>
        <Affiliation>Department of Toxicology, Anhui Medical University, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiang Zhang</Name>
        <Affiliation>Department of Toxicology, Anhui Medical University, China.</Affiliation>
      </Author>
      <Author>
        <Name>Peng Zhu</Name>
        <Affiliation>Anhui Provincial Key Laboratory of Population Health &amp; Aristogenics, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jia Hu Hao</Name>
        <Affiliation>Anhui Provincial Key Laboratory of Population Health &amp; Aristogenics, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fang Biao Tao</Name>
        <Affiliation>Anhui Provincial Key Laboratory of Population Health &amp; Aristogenics, China. Electronic address: fbtao@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>De Xiang Xu</Name>
        <Affiliation>Department of Toxicology, Anhui Medical University, China. Electronic address: xudex@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Reversal of Sp1 transactivation and TGFβ1/SMAD1 signaling by H</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30055191</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30343-0</DOI>
    <KeywordList>
      <Keywords>Cystathionine gamma-lyase</Keywords>
      <Keywords>Fibroblast Activation</Keywords>
      <Keywords>H(2)S</Keywords>
      <Keywords>Nickel</Keywords>
      <Keywords>TGFβ1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mélanie Racine</Name>
        <Affiliation>Department of Chemistry and Biochemistry, Canada; Cardiovascular and Metabolic Research Unit, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Fu</Name>
        <Affiliation>Cardiovascular and Metabolic Research Unit, Canada; School of Human Kinetics, Canada; Department of Biology, Laurentian University, Sudbury, Canada; Health Science North Research Institute, Sudbury, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Tian Shuang</Name>
        <Affiliation>Cardiovascular and Metabolic Research Unit, Canada; School of Human Kinetics, Canada; Department of Biology, Laurentian University, Sudbury, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Yanjie Zhang</Name>
        <Affiliation>Department of Chemistry and Biochemistry, Canada; Cardiovascular and Metabolic Research Unit, Canada; School of Life Science, Shanxi University, Taiyuan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanxi Pei</Name>
        <Affiliation>School of Life Science, Shanxi University, Taiyuan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lingyun Wu</Name>
        <Affiliation>Cardiovascular and Metabolic Research Unit, Canada; School of Human Kinetics, Canada; Health Science North Research Institute, Sudbury, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Wang</Name>
        <Affiliation>Cardiovascular and Metabolic Research Unit, Canada; Department of Biology, Laurentian University, Sudbury, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Guangdong Yang</Name>
        <Affiliation>Department of Chemistry and Biochemistry, Canada; Cardiovascular and Metabolic Research Unit, Canada. Electronic address: gyang2@laurentian.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The cardenolide ouabain suppresses coronaviral replication via augmenting a Na</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30053394</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30342-9</DOI>
    <KeywordList>
      <Keywords>Cardenolide</Keywords>
      <Keywords>Coronavirus</Keywords>
      <Keywords>Na(+)/K(+)-ATPase</Keywords>
      <Keywords>Ouabain</Keywords>
      <Keywords>PDK1</Keywords>
      <Keywords>PI3K</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cheng Wei Yang</Name>
        <Affiliation>Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli 35053, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Hsin Yu Chang</Name>
        <Affiliation>Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli 35053, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Yue Zhi Lee</Name>
        <Affiliation>Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli 35053, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Hsing Yu Hsu</Name>
        <Affiliation>Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli 35053, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Shiow Ju Lee</Name>
        <Affiliation>Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli 35053, Taiwan, ROC. Electronic address: slee@nhri.org.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Adverse outcome pathway-driven identification of rat liver tumorigens in short-term assays.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30048669</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30337-5</DOI>
    <KeywordList>
      <Keywords>Adverse outcome pathway</Keywords>
      <Keywords>Aryl hydrocarbon receptor</Keywords>
      <Keywords>Clinical chemistry</Keywords>
      <Keywords>Constitutive activated receptor</Keywords>
      <Keywords>Estrogen receptor</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Key events</Keywords>
      <Keywords>Liver cancer</Keywords>
      <Keywords>Liver weight</Keywords>
      <Keywords>Molecular initiating events</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Peroxisome proliferator-activated receptor alpha</Keywords>
      <Keywords>ToxPi</Keywords>
      <Keywords>Transcript profiling</Keywords>
      <Keywords>p53</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>John Rooney</Name>
        <Affiliation>Oak Ridge Institute for Science and Education (ORISE) fellow at the National Health and Environmental Effects Research Laboratory (NHEERL), Office of Research and Development, U.S. Environmental Protection Agency (EPA), Research Triangle Park, NC, United States; Integrated Systems Toxicology Division, NHEERL, U.S. EPA, Research Triangle Park, NC, United States. Electronic address: John.Rooney@qiagen.com.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Hill</Name>
        <Affiliation>Oak Ridge Institute for Science and Education (ORISE) fellow at the National Health and Environmental Effects Research Laboratory (NHEERL), Office of Research and Development, U.S. Environmental Protection Agency (EPA), Research Triangle Park, NC, United States; Integrated Systems Toxicology Division, NHEERL, U.S. EPA, Research Triangle Park, NC, United States. Electronic address: hill.thomas@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Chunhua Qin</Name>
        <Affiliation>Merck and Co., Inc., West Point, PA, United States. Electronic address: chunhua.qin@merck.com.</Affiliation>
      </Author>
      <Author>
        <Name>Frank D. Sistare</Name>
        <Affiliation>Merck and Co., Inc., West Point, PA, United States. Electronic address: frank.sistare@merck.com.</Affiliation>
      </Author>
      <Author>
        <Name>J. Christopher Corton</Name>
        <Affiliation>Integrated Systems Toxicology Division, NHEERL, U.S. EPA, Research Triangle Park, NC, United States. Electronic address: corton.chris@epa.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma. Toxicology and Applied Pharmacology 332 (2017) 1-7.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30048668</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30336-3</DOI>
    <AuthorList>
      <Author>
        <Name>Yu Mei Hsueh</Name>
        <Affiliation>Department of Family Medicine, Taipei Medical University Hospital, Taipei, Taiwan; Department of Public Health, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Chin Lin</Name>
        <Affiliation>Department of Family Medicine, Shung Ho Hospital, Taipei Medical University, Taipei, Taiwan; Department of Health Examination, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan; Department of Family Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Jen Chen</Name>
        <Affiliation>School of Public Health, College of Public Health, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Yuan Huang</Name>
        <Affiliation>Department of Urology, National Taiwan University Hospital, College of Medicine National Taiwan University, Taipei, Taiwan; Department of Urology, National Taiwan University Hospital, Hsin Chu Branch, Hsin Chu, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Horng Sheng Shiue</Name>
        <Affiliation>Department of Chinese Medicine, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taoyuan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yeong Shiau Pu</Name>
        <Affiliation>Department of Urology, National Taiwan University Hospital, College of Medicine National Taiwan University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chi Hung Chen</Name>
        <Affiliation>School of Public Health, College of Public Health, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chien Tien Su</Name>
        <Affiliation>Department of Family Medicine, Taipei Medical University Hospital, Taipei, Taiwan; School of Public Health, College of Public Health, Taipei Medical University, Taipei, Taiwan. Electronic address: ctsu@tmu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>RNA sequence analysis of inducible pluripotent stem cell-derived cardiomyocytes reveals altered expression of DNA damage and cell cycle genes in response to doxorubicin.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30031762</pubmedLink>
    <GrantList>
      <Grant>P30 CA016672</Grant>
      <Grant>R25 CA057730</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30333-8</DOI>
    <KeywordList>
      <Keywords>Doxorubicin</Keywords>
      <Keywords>RNA sequence</Keywords>
      <Keywords>iPSC-Cardiomyocytes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Monica E. Reyes</Name>
        <Affiliation>Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jianzhong Ma</Name>
        <Affiliation>Human Genetics Center, Department of Epidemiology, Human Genetics, and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Megan L. Grove</Name>
        <Affiliation>Human Genetics Center, Department of Epidemiology, Human Genetics, and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joann L. Ater</Name>
        <Affiliation>Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alanna C. Morrison</Name>
        <Affiliation>Human Genetics Center, Department of Epidemiology, Human Genetics, and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle A. T. Hildebrandt</Name>
        <Affiliation>Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: mhildebr@mdanderson.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to 'Characterization of heme oxygenase and biliverdin reductase gene expression in zebrafish (Danio rerio): Basal expression and response to pro-oxidant exposures' [Toxicol. Appl. Pharmacol. 311 (2016) 74-87].</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30031761</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30335-1</DOI>
    <AuthorList>
      <Author>
        <Name>Andrew Holowiecki</Name>
        <Affiliation>Department of Biological Sciences, University of Alabama, Tuscaloosa, AL 35487, USA; Molecular Cardiovascular Biology Division and Heart Institute, Cincinnati Children's Research Foundation, Cincinnati, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Britton O'Shields</Name>
        <Affiliation>Department of Biological Sciences, University of Alabama, Tuscaloosa, AL 35487, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew J. Jenny</Name>
        <Affiliation>Department of Biological Sciences, University of Alabama, Tuscaloosa, AL 35487, USA. Electronic address: mjjenny@ua.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Zebrafish (Danio rerio) model as an early stage screening tool to study the biodistribution and toxicity profile of doxorubicin-loaded mixed micelles.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30031011</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30332-6</DOI>
    <KeywordList>
      <Keywords>Danio rerio</Keywords>
      <Keywords>Doxorubicin</Keywords>
      <Keywords>Mixed micelles</Keywords>
      <Keywords>Nanotoxicity</Keywords>
      <Keywords>Wild-type zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>María Natalia Calienni</Name>
        <Affiliation>Laboratory of Biomembranes - GBEyB (IMBICE, CCT-La Plata, CONICET), Departamento de Ciencia y Tecnología, National University of Quilmes, Bernal, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Maximiliano Cagel</Name>
        <Affiliation>Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Cátedra de Tecnología Farmacéutica I., Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Jorge Montanari</Name>
        <Affiliation>Laboratory of Biomembranes - GBEyB (IMBICE, CCT-La Plata, CONICET), Departamento de Ciencia y Tecnología, National University of Quilmes, Bernal, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Marcela A. Moretton</Name>
        <Affiliation>Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Cátedra de Tecnología Farmacéutica I., Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Jimena Prieto</Name>
        <Affiliation>Laboratory of Biomembranes - GBEyB (IMBICE, CCT-La Plata, CONICET), Departamento de Ciencia y Tecnología, National University of Quilmes, Bernal, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Diego A. Chiappetta</Name>
        <Affiliation>Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Cátedra de Tecnología Farmacéutica I., Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Silvia Del Valle Alonso</Name>
        <Affiliation>Laboratory of Biomembranes - GBEyB (IMBICE, CCT-La Plata, CONICET), Departamento de Ciencia y Tecnología, National University of Quilmes, Bernal, Argentina. Electronic address: salonso@unq.edu.ar.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Suppression of ferroportin expression by cadmium stimulates proliferation, EMT, and migration in triple-negative breast cancer cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30030096</pubmedLink>
    <GrantList>
      <Grant>P20 GM103430</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30330-2</DOI>
    <KeywordList>
      <Keywords>Breast cancer</Keywords>
      <Keywords>Cadmium</Keywords>
      <Keywords>EMT</Keywords>
      <Keywords>Ferroportin</Keywords>
      <Keywords>Iron</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhongguo Shan</Name>
        <Affiliation>Center for Molecular Toxicology, Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zhengxi Wei</Name>
        <Affiliation>Center for Molecular Toxicology, Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zahir A. Shaikh</Name>
        <Affiliation>Center for Molecular Toxicology, Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA. Electronic address: zshaikh@uri.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mechanistic in vitro studies: What they have told us about carcinogenic properties of elongated mineral particles (EMPs).</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30030095</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30331-4</DOI>
    <KeywordList>
      <Keywords>Asbestos</Keywords>
      <Keywords>Erionite</Keywords>
      <Keywords>Lung cancers</Keywords>
      <Keywords>Mesothelioma</Keywords>
      <Keywords>Nanotubes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Brooke T. Mossman</Name>
        <Affiliation>Department of Pathology and Laboratory Medicine, University of Vermont College of Medicine, 89 Beaumont Avenue, Given C222, Burlington, VT 05405, USA. Electronic address: Brooke.Mossman@med.uvm.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Editorial: Developmental neurotoxicity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30030094</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30329-6</DOI>
    <AuthorList>
      <Author>
        <Name>Anna Bal-Price</Name>
        <Affiliation>European Commission Joint Research Centre, Directorate F - Health, Consumers and Reference Materials, Unit F3: Chemicals Safety and Alternative Methods, Via E. Fermi, 2749. TP126, I-21027 Ispra, VA, Italy. Electronic address: anna.price@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Ellen Fritsche</Name>
        <Affiliation>IUF - Leibniz Research Institute for Environmental Medicine, Auf'm Hennekamp 50, 40225 Düsseldorf, Germany. Electronic address: ellen.fritsche@uni-duessseldorf.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparative study of anti-VEGF Ranibizumab and Interleukin-6 receptor antagonist Tocilizumab in Adjuvant-induced Arthritis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30025850</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30327-2</DOI>
    <KeywordList>
      <Keywords>Adjuvant induced arthritis</Keywords>
      <Keywords>Immune Response</Keywords>
      <Keywords>Ranibizumab</Keywords>
      <Keywords>Tocilizumab</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Amany El Shahawy Abdel-Maged</Name>
        <Affiliation>National Organization for Research and Control of Biologicals (NORCB), Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Amany M. Gad</Name>
        <Affiliation>Department of Pharmacology, National Organization for Drug Control and Research (NODCAR), Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Amal Kamal Abdel-Aziz</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Mohammad M. Aboulwafa</Name>
        <Affiliation>Department of Microbiology and Immunology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Samar S. Azab</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt. Electronic address: samar_saad_azab@pharma.asu.edu.eg.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Risk of Alzheimer's disease with metal concentrations in whole blood and urine: A case-control study using propensity score matching.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30025849</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30328-4</DOI>
    <KeywordList>
      <Keywords>Alzheimer's diseases</Keywords>
      <Keywords>Arsenic methylation capacity</Keywords>
      <Keywords>Heavy metals</Keywords>
      <Keywords>Propensity score matching</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yu Wan Yang</Name>
        <Affiliation>Department of Neurology, China Medical University and Hospital, Taichung, Taiwan; School of Medicine, College of Medicine, China Medical University and Hospital, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Saou Hsing Liou</Name>
        <Affiliation>Division of Environmental Health and Occupational Medicine, National Health Research Institutes, Zhunan, Miaoli County, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Mei Hsueh</Name>
        <Affiliation>Department of Family Medicine, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Wun Sin Lyu</Name>
        <Affiliation>Department of Health Risk Management, College of Public Health, China Medical University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chiu Shong Liu</Name>
        <Affiliation>Department of Family Medicine, China Medical University Hospital, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Huei Ju Liu</Name>
        <Affiliation>Division of Environmental Health and Occupational Medicine, National Health Research Institutes, Zhunan, Miaoli County, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Mu Chi Chung</Name>
        <Affiliation>Division of Nephrology, Department of Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Peir Haur Hung</Name>
        <Affiliation>Department of Internal Medicine, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi, Taiwan; Department of Applied Life Science and Health, Chia Nan University of Pharmacy and Science, Tainan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chi Jung Chung</Name>
        <Affiliation>Department of Health Risk Management, College of Public Health, China Medical University, Taichung, Taiwan; Department of Medical Research, China Medical University Hospital, Taichung, Taiwan. Electronic address: cjchung@mail.cmu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Naringenin protects against oxido-inflammatory aberrations and altered tryptophan metabolism in olfactory bulbectomized-mice model of depression.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30017640</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30321-1</DOI>
    <KeywordList>
      <Keywords>Depression</Keywords>
      <Keywords>Kynurenine</Keywords>
      <Keywords>Naringenin</Keywords>
      <Keywords>Olfactory Bulbectomy</Keywords>
      <Keywords>Serotonin</Keywords>
      <Keywords>Tryptophan</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yashika Bansal</Name>
        <Affiliation>Pharmacology Research Laboratory, University Institute of Pharmaceutical Sciences, UGC-Centre of Advanced Study, Panjab University, Chandigarh 160 014, India.</Affiliation>
      </Author>
      <Author>
        <Name>Raghunath Singh</Name>
        <Affiliation>Pharmacology Research Laboratory, University Institute of Pharmaceutical Sciences, UGC-Centre of Advanced Study, Panjab University, Chandigarh 160 014, India.</Affiliation>
      </Author>
      <Author>
        <Name>Priyanka Saroj</Name>
        <Affiliation>Pharmacology Research Laboratory, University Institute of Pharmaceutical Sciences, UGC-Centre of Advanced Study, Panjab University, Chandigarh 160 014, India.</Affiliation>
      </Author>
      <Author>
        <Name>Rupinder Kaur Sodhi</Name>
        <Affiliation>Pharmacology Research Laboratory, University Institute of Pharmaceutical Sciences, UGC-Centre of Advanced Study, Panjab University, Chandigarh 160 014, India.</Affiliation>
      </Author>
      <Author>
        <Name>Anurag Kuhad</Name>
        <Affiliation>Pharmacology Research Laboratory, University Institute of Pharmaceutical Sciences, UGC-Centre of Advanced Study, Panjab University, Chandigarh 160 014, India. Electronic address: anurag.kuhad@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Bisphenol A induced male germ cell apoptosis via IFNβ-XAF1-XIAP pathway in adult mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30017639</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30320-X</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Bisphenol A</Keywords>
      <Keywords>Interferon-beta</Keywords>
      <Keywords>Male reproductive toxicity</Keywords>
      <Keywords>X-linked inhibitor of apoptosis protein</Keywords>
      <Keywords>X-linked inhibitor of apoptosis-associated Factor 1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiao Jiang</Name>
        <Affiliation>College of Preventive Medicine, Institute of Toxicology, Army Medical University, 30 Gaotanyan Street, Shapingba District, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Yin</Name>
        <Affiliation>College of Preventive Medicine, Institute of Toxicology, Army Medical University, 30 Gaotanyan Street, Shapingba District, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ning Zhang</Name>
        <Affiliation>College of Preventive Medicine, Institute of Toxicology, Army Medical University, 30 Gaotanyan Street, Shapingba District, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fei Han</Name>
        <Affiliation>College of Preventive Medicine, Institute of Toxicology, Army Medical University, 30 Gaotanyan Street, Shapingba District, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Bin Liu</Name>
        <Affiliation>College of Preventive Medicine, Institute of Toxicology, Army Medical University, 30 Gaotanyan Street, Shapingba District, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xi Zhang</Name>
        <Affiliation>College of Preventive Medicine, Institute of Toxicology, Army Medical University, 30 Gaotanyan Street, Shapingba District, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Qiang Chen</Name>
        <Affiliation>College of Preventive Medicine, Institute of Toxicology, Army Medical University, 30 Gaotanyan Street, Shapingba District, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jia Cao</Name>
        <Affiliation>College of Preventive Medicine, Institute of Toxicology, Army Medical University, 30 Gaotanyan Street, Shapingba District, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Yi Liu</Name>
        <Affiliation>College of Preventive Medicine, Institute of Toxicology, Army Medical University, 30 Gaotanyan Street, Shapingba District, Chongqing 400038, China. Electronic address: jinyiliutmmu@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Involvement of estrogen receptor α in pro-pruritic and pro-inflammatory responses in a mouse model of allergic dermatitis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30017638</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30319-3</DOI>
    <KeywordList>
      <Keywords>Allergic dermatitis</Keywords>
      <Keywords>Estrogen receptor α</Keywords>
      <Keywords>IL-33</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Itch</Keywords>
      <Keywords>Keratinocyte</Keywords>
      <Keywords>TSLP</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yuko Watanabe</Name>
        <Affiliation>The Institute of Environmental Toxicology, 4321, Uchimoriya-machi, Joso-shi, Ibaraki, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Emi Makino</Name>
        <Affiliation>The Institute of Environmental Toxicology, 4321, Uchimoriya-machi, Joso-shi, Ibaraki, Japan. Electronic address: makino@iet.or.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Risako Tajiki-Nishino</Name>
        <Affiliation>The Institute of Environmental Toxicology, 4321, Uchimoriya-machi, Joso-shi, Ibaraki, Japan. Electronic address: tajiki@iet.or.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Aya Koyama</Name>
        <Affiliation>The Institute of Environmental Toxicology, 4321, Uchimoriya-machi, Joso-shi, Ibaraki, Japan. Electronic address: koyama@iet.or.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Hitoshi Tajima</Name>
        <Affiliation>The Institute of Environmental Toxicology, 4321, Uchimoriya-machi, Joso-shi, Ibaraki, Japan. Electronic address: tajima@iet.or.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Makoto Ishimota</Name>
        <Affiliation>The Institute of Environmental Toxicology, 4321, Uchimoriya-machi, Joso-shi, Ibaraki, Japan. Electronic address: ishimota@iet.or.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Tomoki Fukuyama</Name>
        <Affiliation>The Institute of Environmental Toxicology, 4321, Uchimoriya-machi, Joso-shi, Ibaraki, Japan. Electronic address: fukuyama@iet.or.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Short- and long-term gene expression profiles induced by inhaled TiO</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30012374</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30326-0</DOI>
    <KeywordList>
      <Keywords>Gene expression profile</Keywords>
      <Keywords>Lung inflammation</Keywords>
      <Keywords>Short- and long-term response</Keywords>
      <Keywords>Titanium dioxide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Laëtitia Chézeau</Name>
        <Affiliation>Institut National de Recherche et de Sécurité, Rue du Morvan, CS 60027, F-54519 Vandœuvre, Cedex, France; EA 3452 CITHEFOR, Université de Lorraine, BP 80403, 54001 Nancy Cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Sylvie Sébillaud</Name>
        <Affiliation>Institut National de Recherche et de Sécurité, Rue du Morvan, CS 60027, F-54519 Vandœuvre, Cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Ramia Safar</Name>
        <Affiliation>EA 3452 CITHEFOR, Université de Lorraine, BP 80403, 54001 Nancy Cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Carole Seidel</Name>
        <Affiliation>Institut National de Recherche et de Sécurité, Rue du Morvan, CS 60027, F-54519 Vandœuvre, Cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Doulaye Dembélé</Name>
        <Affiliation>Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS UMR 7104 - Inserm U 964, Université de Strasbourg, BP 10142, F-67404 Illkirch, Cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Mylène Lorcin</Name>
        <Affiliation>Institut National de Recherche et de Sécurité, Rue du Morvan, CS 60027, F-54519 Vandœuvre, Cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Cristina Langlais</Name>
        <Affiliation>Institut National de Recherche et de Sécurité, Rue du Morvan, CS 60027, F-54519 Vandœuvre, Cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Stéphane Grossmann</Name>
        <Affiliation>Institut National de Recherche et de Sécurité, Rue du Morvan, CS 60027, F-54519 Vandœuvre, Cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Hervé Nunge</Name>
        <Affiliation>Institut National de Recherche et de Sécurité, Rue du Morvan, CS 60027, F-54519 Vandœuvre, Cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Sylvie Michaux</Name>
        <Affiliation>Institut National de Recherche et de Sécurité, Rue du Morvan, CS 60027, F-54519 Vandœuvre, Cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Hélène Dubois-Pot-Schneider</Name>
        <Affiliation>CNRS, UMR 7565, SRSMC, Université de Lorraine, F-54506 Vandœuvre-lès-Nancy, France.</Affiliation>
      </Author>
      <Author>
        <Name>Bertrand Rihn</Name>
        <Affiliation>Institut Jean-Lamour, UMR 7198 CNRS, Université de Lorraine, F-54506 Vandœuvre-lès-Nancy, Cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Olivier Joubert</Name>
        <Affiliation>Institut Jean-Lamour, UMR 7198 CNRS, Université de Lorraine, F-54506 Vandœuvre-lès-Nancy, Cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Stéphane Binet</Name>
        <Affiliation>Institut National de Recherche et de Sécurité, Rue du Morvan, CS 60027, F-54519 Vandœuvre, Cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Frédéric Cosnier</Name>
        <Affiliation>Institut National de Recherche et de Sécurité, Rue du Morvan, CS 60027, F-54519 Vandœuvre, Cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Laurent Gaté</Name>
        <Affiliation>Institut National de Recherche et de Sécurité, Rue du Morvan, CS 60027, F-54519 Vandœuvre, Cedex, France. Electronic address: laurent.gate@inrs.fr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Triptolide induces p53-dependent cardiotoxicity through mitochondrial membrane permeabilization in cardiomyocytes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30009776</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30322-3</DOI>
    <KeywordList>
      <Keywords>Bax</Keywords>
      <Keywords>Cardiotoxicity</Keywords>
      <Keywords>Mitochondrial membrane permeabilization</Keywords>
      <Keywords>Triptolide</Keywords>
      <Keywords>p53</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yue Xi</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenwen Wang</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Wang</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Pan</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yisen Cheng</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Feihai Shen</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, PR China. Electronic address: shenfh3@mail.sysu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Zhiying Huang</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, PR China. Electronic address: hzhiying@mail.sysu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Proteasome mediated degradation of CDC25C and Cyclin B1 in Demethoxycurcumin treated human glioma U87 MG cells to trigger G2/M cell cycle arrest.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30009775</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30325-9</DOI>
    <KeywordList>
      <Keywords>CDC25C</Keywords>
      <Keywords>CDK1/CDC2</Keywords>
      <Keywords>Cyclin B1</Keywords>
      <Keywords>DMC</Keywords>
      <Keywords>G2/M Arrest</Keywords>
      <Keywords>GBM</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Neetika Lal</Name>
        <Affiliation>Neuropharmaceutical Chemistry Laboratory, Dr. B. R. Ambedkar Centre for Biomedical Research, North Campus, University of Delhi, Delhi 110007, India.</Affiliation>
      </Author>
      <Author>
        <Name>Vishal Nemaysh</Name>
        <Affiliation>Neuropharmaceutical Chemistry Laboratory, Dr. B. R. Ambedkar Centre for Biomedical Research, North Campus, University of Delhi, Delhi 110007, India.</Affiliation>
      </Author>
      <Author>
        <Name>Pratibha Mehta Luthra</Name>
        <Affiliation>Neuropharmaceutical Chemistry Laboratory, Dr. B. R. Ambedkar Centre for Biomedical Research, North Campus, University of Delhi, Delhi 110007, India. Electronic address: pmluthra@acbr.du.ac.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Microbiome-related metabolite changes in gut tissue, cecum content and feces of rats treated with antibiotics.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30008377</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30291-6</DOI>
    <KeywordList>
      <Keywords>Antibiotics</Keywords>
      <Keywords>Gut content and tissue</Keywords>
      <Keywords>Gut microbiome</Keywords>
      <Keywords>Metabolite profiling</Keywords>
      <Keywords>Metabolomics</Keywords>
      <Keywords>Repeated dose oral toxicity study</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>C. Behr</Name>
        <Affiliation>BASF, SE, 67056 Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>S. Sperber</Name>
        <Affiliation>BASF, SE, 67056 Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>X. Jiang</Name>
        <Affiliation>BASF, SE, 67056 Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>V. Strauss</Name>
        <Affiliation>BASF, SE, 67056 Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>H. Kamp</Name>
        <Affiliation>BASF, SE, 67056 Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>T. Walk</Name>
        <Affiliation>Metanomics GmbH, 10589 Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>M. Herold</Name>
        <Affiliation>Metanomics GmbH, 10589 Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>K. Beekmann</Name>
        <Affiliation>Division of Toxicology, Wageningen University, 6700 EA Wageningen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>I. M. C. M. Rietjens</Name>
        <Affiliation>Division of Toxicology, Wageningen University, 6700 EA Wageningen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>B. van Ravenzwaay</Name>
        <Affiliation>BASF, SE, 67056 Ludwigshafen, Germany. Electronic address: bennard.ravenzwaay@basf.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Stabilization of the hypoxia-inducible transcription Factor-1 alpha (HIF-1α) in thiamine deficiency is mediated by pyruvate accumulation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30008376</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30315-6</DOI>
    <KeywordList>
      <Keywords>Astrocytes</Keywords>
      <Keywords>Deficiency</Keywords>
      <Keywords>HIF-1α</Keywords>
      <Keywords>Hypoxia</Keywords>
      <Keywords>Pyruvate</Keywords>
      <Keywords>Thiamine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kristy Zera</Name>
        <Affiliation>Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens 30602, Georgia.</Affiliation>
      </Author>
      <Author>
        <Name>Jason Zastre</Name>
        <Affiliation>Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens 30602, Georgia. Electronic address: jzastre@uga.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Monoclonal antibody targeting of fibroblast growth factor receptor 1c causes cardiac valvulopathy in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30008375</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30309-0</DOI>
    <KeywordList>
      <Keywords>Fibroblast Growth Factors</Keywords>
      <Keywords>Heart</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Valves</Keywords>
      <Keywords>Valvulopathy</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nicholas Buss</Name>
        <Affiliation>Biologics Safety Assessment, MedImmune, Gaithersburg, MD 20878, USA. Electronic address: nbuss@regenxbio.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Martin Lapointe</Name>
        <Affiliation>Biologics Safety Assessment, MedImmune, Cambridge, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Lolke de Haan</Name>
        <Affiliation>Biologics Safety Assessment, MedImmune, Cambridge, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Sally Price</Name>
        <Affiliation>BioHub, Alderley Park, Cheshire, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Ahnmark</Name>
        <Affiliation>Bioscience Diabetes, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Lorraine Irving</Name>
        <Affiliation>Department of Antibody Discovery and Protein Engineering, MedImmune, Cambridge, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Buchanan</Name>
        <Affiliation>Department of Antibody Discovery and Protein Engineering, MedImmune, Cambridge, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Feenagh Keyes</Name>
        <Affiliation>Department of Antibody Discovery and Protein Engineering, MedImmune, Cambridge, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Pia Davidsson</Name>
        <Affiliation>Translational Sciences, Cardiovascular, Renal and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Rakesh Dixit</Name>
        <Affiliation>Biologics Safety Assessment, MedImmune, Gaithersburg, MD 20878, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Lindén</Name>
        <Affiliation>Bioscience Diabetes, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In vitro and ex vivo anti-fibrotic effects of LY2109761, a small molecule inhibitor against TGF-β.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30008374</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30312-0</DOI>
    <KeywordList>
      <Keywords>Ex vivo</Keywords>
      <Keywords>Fibrosis</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>LY2109761</Keywords>
      <Keywords>TGF-β</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Theerut Luangmonkong</Name>
        <Affiliation>Department of Pharmacology, Faculty of Pharmacy, Mahidol University, Thailand; Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Su Suriguga</Name>
        <Affiliation>Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Adhyatmika Adhyatmika</Name>
        <Affiliation>Department of Pharmacokinetics, Toxicology and Targeting, University of Groningen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Amirah Adlia</Name>
        <Affiliation>Department of Pharmacokinetics, Toxicology and Targeting, University of Groningen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Dorenda Oosterhuis</Name>
        <Affiliation>Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Chuthamanee Suthisisang</Name>
        <Affiliation>Department of Pharmacology, Faculty of Pharmacy, Mahidol University, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Koert P. de Jong</Name>
        <Affiliation>Department of Hepato-Pancreato-Biliary Surgery and Liver Transplantation, University Medical Center Groningen, University of Groningen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Henricus A. M. Mutsaers</Name>
        <Affiliation>Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, The Netherlands; Department of Clinical Medicine, Aarhus University, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Olinga</Name>
        <Affiliation>Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, The Netherlands. Electronic address: p.olinga@rug.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Monoubiquitinated γ-H2AX: Abundant product and specific biomarker for non-apoptotic DNA double-strand breaks.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/30006243</pubmedLink>
    <GrantList>
      <Grant>R01 ES008786</Grant>
      <Grant>R01 ES028072</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30318-1</DOI>
    <KeywordList>
      <Keywords>DNA damage</Keywords>
      <Keywords>DNA double-strand break</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Histone H2AX</Keywords>
      <Keywords>RNF168</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michal W. Luczak</Name>
        <Affiliation>Department of Pathology and Laboratory Medicine, Brown University, Providence, RI 02912, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anatoly Zhitkovich</Name>
        <Affiliation>Department of Pathology and Laboratory Medicine, Brown University, Providence, RI 02912, USA. Electronic address: anatoly_zhitkovich@brown.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Embryoid body test with morphological and molecular endpoints implicates potential developmental toxicity of trans-resveratrol.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29990529</pubmedLink>
    <GrantList>
      <Grant>P20 GM103457</Grant>
      <Grant>R03 HD088970</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30316-8</DOI>
    <KeywordList>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Dietary supplement</Keywords>
      <Keywords>In vitro assay</Keywords>
      <Keywords>Morphogenesis</Keywords>
      <Keywords>Resveratrol</Keywords>
      <Keywords>Stem cell</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Iris Q. Kim</Name>
        <Affiliation>Developmental and Reproductive Biology Graduate Program, Institute for Biogenesis Research, University of Hawaii John A. Burns School of Medicine, Honolulu, HI 96813, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yusuke Marikawa</Name>
        <Affiliation>Developmental and Reproductive Biology Graduate Program, Institute for Biogenesis Research, University of Hawaii John A. Burns School of Medicine, Honolulu, HI 96813, USA. Electronic address: marikawa@hawaii.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Novel formononetin-7-sal ester ameliorates pulmonary fibrosis via MEF2c signaling pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29990528</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30317-X</DOI>
    <KeywordList>
      <Keywords>Anti-pulmonary fibrosis</Keywords>
      <Keywords>Formononetin-7-sal ester</Keywords>
      <Keywords>MEF2c</Keywords>
      <Keywords>TGF-β1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xueying Zhao</Name>
        <Affiliation>Department of Clinical Nursing, Affiliated Hospital to Binzhou Medical University, Binzhou 256602, China; Department of Cellular and Genetic Medicine, School of Pharmaceutical Sciences, Binzhou Medical University, Yantai 264003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guiwu Qu</Name>
        <Affiliation>Department of Cellular and Genetic Medicine, School of Pharmaceutical Sciences, Binzhou Medical University, Yantai 264003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chenguang Song</Name>
        <Affiliation>Department of Respiratory Medicine, Zouping Chinese Medicine Hospital, Binzhou 256602, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rongrong Li</Name>
        <Affiliation>Department of Respiratory Medicine, Affiliated Hospital to Binzhou Medical University, Binzhou 256602, China.</Affiliation>
      </Author>
      <Author>
        <Name>Weili Liu</Name>
        <Affiliation>Department of Respiratory Medicine, Affiliated Hospital to Binzhou Medical University, Binzhou 256602, China.</Affiliation>
      </Author>
      <Author>
        <Name>Changjun Lv</Name>
        <Affiliation>Department of Respiratory Medicine, Affiliated Hospital to Binzhou Medical University, Binzhou 256602, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaodong Song</Name>
        <Affiliation>Department of Cellular and Genetic Medicine, School of Pharmaceutical Sciences, Binzhou Medical University, Yantai 264003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinjin Zhang</Name>
        <Affiliation>Department of Cellular and Genetic Medicine, School of Pharmaceutical Sciences, Binzhou Medical University, Yantai 264003, China. Electronic address: jjinzhang@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Minge Li</Name>
        <Affiliation>Department of Clinical Nursing, Affiliated Hospital to Binzhou Medical University, Binzhou 256602, China. Electronic address: byfylme@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to 'Embryotoxic and pharmacologic potency ranking of six azoles in the rat whole embryo culture by morphological and transcriptomic analysis' [Toxicol. Appl. Pharmacol., 322 (2017) 15-26].</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29980297</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30263-1</DOI>
    <AuthorList>
      <Author>
        <Name>Myrto Dimopoulou</Name>
        <Affiliation>Division of Toxicology, Wageningen University, The Netherlands; National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands. Electronic address: myrto.dimopoulou@wur.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Aart Verhoef</Name>
        <Affiliation>National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Jeroen Pennings</Name>
        <Affiliation>National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Bennard van Ravenzwaay</Name>
        <Affiliation>Division of Toxicology, Wageningen University, The Netherlands; BASF SE, Experimental Toxicology and Ecology, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Ivonne M. C. M. Rietjens</Name>
        <Affiliation>Division of Toxicology, Wageningen University, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Aldert H. Piersma</Name>
        <Affiliation>National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands; Institute for Risk Assessment sciences, Utrecht University, Utrecht, The Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Protective roles of NRF2 signaling pathway in cobalt chloride-induced hypoxic cytotoxicity in human HaCaT keratinocytes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29966676</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30307-7</DOI>
    <KeywordList>
      <Keywords>Antioxidant response</Keywords>
      <Keywords>Cobalt chloride</Keywords>
      <Keywords>Hypoxia</Keywords>
      <Keywords>KEAP1</Keywords>
      <Keywords>Keratinocytes</Keywords>
      <Keywords>NFE2L2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bei Yang</Name>
        <Affiliation>Department of Forensic Pathology, China Medical University School of Forensic Medicine, Shenyang 110122, China; Department of Histology and Embryology, College of Basic Medical Science, China Medical University, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hao Cheng</Name>
        <Affiliation>Department of Forensic Pathology, China Medical University School of Forensic Medicine, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Linlin Wang</Name>
        <Affiliation>Department of Forensic Pathology, China Medical University School of Forensic Medicine, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingqi Fu</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guohua Zhang</Name>
        <Affiliation>Department of Forensic Pathology, China Medical University School of Forensic Medicine, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dawei Guan</Name>
        <Affiliation>Department of Forensic Pathology, China Medical University School of Forensic Medicine, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ruiqun Qi</Name>
        <Affiliation>Department of Dermatology, No.1 Hospital of China Medical University, Key Laboratory of Immunodermatology, Ministry of Health and Ministry of Education, Shenyang 110001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xinghua Gao</Name>
        <Affiliation>Department of Dermatology, No.1 Hospital of China Medical University, Key Laboratory of Immunodermatology, Ministry of Health and Ministry of Education, Shenyang 110001, China. Electronic address: gaobarry@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Zhao</Name>
        <Affiliation>Department of Forensic Pathology, China Medical University School of Forensic Medicine, Shenyang 110122, China. Electronic address: rzhao@cmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Melatonin improves cardiac and mitochondrial function during doxorubicin-induced cardiotoxicity: A possible role for peroxisome proliferator-activated receptor gamma coactivator 1-alpha and sirtuin activity?</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29966675</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30305-3</DOI>
    <KeywordList>
      <Keywords>Cardiac function</Keywords>
      <Keywords>Doxorubicin-induced cardiotoxicity</Keywords>
      <Keywords>Melatonin</Keywords>
      <Keywords>Mitochondrial function</Keywords>
      <Keywords>PGC1-α and sirtuins</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jenelle Govender</Name>
        <Affiliation>Department of Physiological Sciences, Stellenbosch University, Stellenbosch 7600, South Africa. Electronic address: yjgovender@sun.ac.za.</Affiliation>
      </Author>
      <Author>
        <Name>Ben Loos</Name>
        <Affiliation>Department of Physiological Sciences, Stellenbosch University, Stellenbosch 7600, South Africa.</Affiliation>
      </Author>
      <Author>
        <Name>Erna Marais</Name>
        <Affiliation>Department of Medical Physiology, Faculty of Medicine, Stellenbosch University, Tygerberg Campus, 7505, South Africa.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Mart Engelbrecht</Name>
        <Affiliation>Department of Physiological Sciences, Stellenbosch University, Stellenbosch 7600, South Africa.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mapping dynamic histone modification patterns during arsenic-induced malignant transformation of human bladder cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29966674</pubmedLink>
    <GrantList>
      <Grant>R01 ES022629</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30306-5</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Cell Malignant Transformation</Keywords>
      <Keywords>Histone Acetylation and Methylation</Keywords>
      <Keywords>LC-MS/MS Based Histone Modification Analysis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yichen Ge</Name>
        <Affiliation>Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, The State University of New York, Buffalo, NY 14214, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jinqiu Zhu</Name>
        <Affiliation>Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, The State University of New York, Buffalo, NY 14214, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xue Wang</Name>
        <Affiliation>Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, The State University of New York, Buffalo, NY 14214, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nina Zheng</Name>
        <Affiliation>Department of Pharmacology and Toxicology, School of Biomedical Sciences, The State University of New York, Buffalo, NY 14214, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chengjian Tu</Name>
        <Affiliation>Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, The State University of New York, Buffalo, NY 14214, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Qu</Name>
        <Affiliation>Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, The State University of New York, Buffalo, NY 14214, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xuefeng Ren</Name>
        <Affiliation>Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, The State University of New York, Buffalo, NY 14214, USA; Department of Pharmacology and Toxicology, School of Biomedical Sciences, The State University of New York, Buffalo, NY 14214, USA. Electronic address: xuefengr@buffalo.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Expression of cytochrome P450 epoxygenases and soluble epoxide hydrolase is regulated by hypolipidemic drugs in dose-dependent manner.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29960002</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30292-8</DOI>
    <KeywordList>
      <Keywords>CYP epoxygenases</Keywords>
      <Keywords>Fibrates</Keywords>
      <Keywords>Peroxisome proliferator-activated receptor alpha</Keywords>
      <Keywords>Proliferation</Keywords>
      <Keywords>Protein expression</Keywords>
      <Keywords>Soluble epoxide hydrolase</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Katerina Cizkova</Name>
        <Affiliation>Department of Histology and Embryology, Faculty of Medicine and Dentistry, Palacky University, 779 00 Olomouc, Czech Republic; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 779 00 Olomouc, Czech Republic. Electronic address: katerina.cizkova@upol.cz.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Flavonoids interfere with NLRP3 inflammasome activation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29960001</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30288-6</DOI>
    <KeywordList>
      <Keywords>Flavonoid</Keywords>
      <Keywords>Monosodium urate crystal</Keywords>
      <Keywords>NLRP3 inflammasome</Keywords>
      <Keywords>Pyk2</Keywords>
      <Keywords>Syk</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hyun Lim</Name>
        <Affiliation>College of Pharmacy, Kangwon National University, Chuncheon 24341, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dong Suk Min</Name>
        <Affiliation>College of Pharmacy, Kangwon National University, Chuncheon 24341, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Haeil Park</Name>
        <Affiliation>College of Pharmacy, Kangwon National University, Chuncheon 24341, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyun Pyo Kim</Name>
        <Affiliation>College of Pharmacy, Kangwon National University, Chuncheon 24341, Republic of Korea. Electronic address: hpkim@kangwon.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The asbestos-carbon nanotube analogy: An update.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29960000</pubmedLink>
    <GrantList>
      <Grant>P42 ES013660</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30294-1</DOI>
    <KeywordList>
      <Keywords>Asbestos fibers</Keywords>
      <Keywords>Carbon nanotubes</Keywords>
      <Keywords>Fiber pathogenicity paradigm</Keywords>
      <Keywords>High aspect ratio nanomaterials</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Agnes B. Kane</Name>
        <Affiliation>Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, United States; Institute for Molecular and Nanoscale Innovation, Providence, RI, United States. Electronic address: agnes_kane@brown.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Robert H. Hurt</Name>
        <Affiliation>School of Engineering, Brown University, Providence, RI, United States; Institute for Molecular and Nanoscale Innovation, Providence, RI, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Huajian Gao</Name>
        <Affiliation>School of Engineering, Brown University, Providence, RI, United States; Institute for Molecular and Nanoscale Innovation, Providence, RI, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Measuring EMPs in the lung what can be measured in the lung: Asbestiform minerals and cleavage fragments.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29959999</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30293-X</DOI>
    <KeywordList>
      <Keywords>Asbestiform</Keywords>
      <Keywords>Cleavage</Keywords>
      <Keywords>EMP's</Keywords>
      <Keywords>Fragments</Keywords>
      <Keywords>Lung</Keywords>
      <Keywords>Minerals</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Victor L. Roggli</Name>
        <Affiliation>Department of Pathology, Duke University Medical Center, M255 Davison Bldg. Durham, NC 27710, United States. Electronic address: victor.roggli@duke.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Energy drink and alcohol combination leads to kidney and liver alterations in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29959998</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30290-4</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Alcohol</Keywords>
      <Keywords>Energy drinks</Keywords>
      <Keywords>Nephrotoxicity</Keywords>
      <Keywords>Oxidative stress</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marina Tuerlinckx Costa-Valle</Name>
        <Affiliation>Programa de Pós-Graduação em Ciências Biológicas: Neurociências, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul (UFRGS), Rua Sarmento Leite, 500/209, 90046-900 Porto Alegre, Rio Grande do Sul, Brazil; Laboratório de Farmacologia e Toxicologia de Produtos Naturais, Departamento de Farmacologia, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul (UFRGS), Rua Sarmento Leite, 500/309, 90050-170 Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Bruna Ducatti Tonieto</Name>
        <Affiliation>Laboratório de Farmacologia e Toxicologia de Produtos Naturais, Departamento de Farmacologia, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul (UFRGS), Rua Sarmento Leite, 500/309, 90050-170 Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Louise Altknecht</Name>
        <Affiliation>Laboratório de Toxicologia (LATOX), Departamento de Análises, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul (UFRGS), Av. Ipiranga 2752/605B, 90610-000 Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Camila D. Cunha</Name>
        <Affiliation>Laboratório de Toxicologia (LATOX), Departamento de Análises, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul (UFRGS), Av. Ipiranga 2752/605B, 90610-000 Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Nuryan Fão</Name>
        <Affiliation>Laboratório de Toxicologia (LATOX), Departamento de Análises, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul (UFRGS), Av. Ipiranga 2752/605B, 90610-000 Porto Alegre, Rio Grande do Sul, Brazil; Programa de Pós-Graduação em Ciências Farmacêuticas (PPGCF), Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul (UFRGS), Av. Ipiranga 2752/1° andar, 90610-000 Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Larissa V. Cestonaro</Name>
        <Affiliation>Laboratório de Toxicologia (LATOX), Departamento de Análises, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul (UFRGS), Av. Ipiranga 2752/605B, 90610-000 Porto Alegre, Rio Grande do Sul, Brazil; Programa de Pós-Graduação em Ciências Farmacêuticas (PPGCF), Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul (UFRGS), Av. Ipiranga 2752/1° andar, 90610-000 Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Gabriela Göethel</Name>
        <Affiliation>Laboratório de Toxicologia (LATOX), Departamento de Análises, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul (UFRGS), Av. Ipiranga 2752/605B, 90610-000 Porto Alegre, Rio Grande do Sul, Brazil; Programa de Pós-Graduação em Ciências Farmacêuticas (PPGCF), Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul (UFRGS), Av. Ipiranga 2752/1° andar, 90610-000 Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Solange C. Garcia</Name>
        <Affiliation>Laboratório de Toxicologia (LATOX), Departamento de Análises, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul (UFRGS), Av. Ipiranga 2752/605B, 90610-000 Porto Alegre, Rio Grande do Sul, Brazil; Programa de Pós-Graduação em Ciências Farmacêuticas (PPGCF), Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul (UFRGS), Av. Ipiranga 2752/1° andar, 90610-000 Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Mirna Bainy Leal</Name>
        <Affiliation>Programa de Pós-Graduação em Ciências Biológicas: Neurociências, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul (UFRGS), Rua Sarmento Leite, 500/209, 90046-900 Porto Alegre, Rio Grande do Sul, Brazil; Laboratório de Farmacologia e Toxicologia de Produtos Naturais, Departamento de Farmacologia, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul (UFRGS), Rua Sarmento Leite, 500/309, 90050-170 Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Eliane Dallegrave</Name>
        <Affiliation>Departamento de Farmacociências, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Rua Sarmento Leite, 245, 90050-170 Porto Alegre, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Marcelo Dutra Arbo</Name>
        <Affiliation>Laboratório de Toxicologia (LATOX), Departamento de Análises, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul (UFRGS), Av. Ipiranga 2752/605B, 90610-000 Porto Alegre, Rio Grande do Sul, Brazil; Programa de Pós-Graduação em Ciências Farmacêuticas (PPGCF), Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul (UFRGS), Av. Ipiranga 2752/1° andar, 90610-000 Porto Alegre, Rio Grande do Sul, Brazil. Electronic address: marcelo.arbo@ufrgs.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nanomaterial exposure and sterile inflammatory reactions.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29959027</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30287-4</DOI>
    <KeywordList>
      <Keywords>Adenosine signaling</Keywords>
      <Keywords>Damage molecular patterns</Keywords>
      <Keywords>High-mobility group box-1 (HMGB-1)</Keywords>
      <Keywords>Inflammasome</Keywords>
      <Keywords>Nanomaterials</Keywords>
      <Keywords>Sterile inflammation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Veruscka Leso</Name>
        <Affiliation>Department of Public Health, Section of Occupational Medicine, University of Naples Federico II, Via S. Pansini 5, 80131, Naples, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Luca Fontana</Name>
        <Affiliation>Department of Occupational and Environmental Medicine, Epidemiology and Hygiene, Italian Workers' Compensation Authority (INAIL), Via di Fontana Candida 1, 00040 Monte Porzio Catone (Rome), Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Ivo Iavicoli</Name>
        <Affiliation>Department of Public Health, Section of Occupational Medicine, University of Naples Federico II, Via S. Pansini 5, 80131, Naples, Italy. Electronic address: ivo.iavicoli@unina.it.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicokinetics and tolerance of a high energy material 3,4,5-trinitropyrazole (TNP) in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29959026</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30289-8</DOI>
    <KeywordList>
      <Keywords>3,4,5-Trinitropyrazole</Keywords>
      <Keywords>Explosives molecules</Keywords>
      <Keywords>High energy materials (HEM)</Keywords>
      <Keywords>Metabolism</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Pyrazoles</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Laetitia Guyot</Name>
        <Affiliation>Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Laboratoire de biochimie-toxicologie, F-69495 Pierre Bénite, France; EMR 3738, Université Lyon 1, Faculté de Médecin Lyon-Sud-Charles Mérieux, F-69921 Oullins, France.</Affiliation>
      </Author>
      <Author>
        <Name>Myléne Honorat</Name>
        <Affiliation>Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Laboratoire de biochimie-toxicologie, F-69495 Pierre Bénite, France.</Affiliation>
      </Author>
      <Author>
        <Name>Guy Jacob</Name>
        <Affiliation>Airbus Safran Launchers, Centre de Recherches du Bouchet, 9 Rue Lavoisier, 91710 Vert le Petit, France.</Affiliation>
      </Author>
      <Author>
        <Name>Claire Bardel</Name>
        <Affiliation>Hospices Civils de Lyon, Department of biostatistics, Lyon, France.</Affiliation>
      </Author>
      <Author>
        <Name>Michel Tod</Name>
        <Affiliation>EMR 3738, Université Lyon 1, Faculté de Médecin Lyon-Sud-Charles Mérieux, F-69921 Oullins, France.</Affiliation>
      </Author>
      <Author>
        <Name>Alain Puisieux</Name>
        <Affiliation>UMR INSERM U1052/CNRS 5286, Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, 69373 Lyon, France.</Affiliation>
      </Author>
      <Author>
        <Name>Jérôme Guitton</Name>
        <Affiliation>Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Laboratoire de biochimie-toxicologie, F-69495 Pierre Bénite, France; EMR 3738, Université Lyon 1, Faculté de Médecin Lyon-Sud-Charles Mérieux, F-69921 Oullins, France; Université Lyon 1, ISPBL, Faculté de pharmacie, Laboratoire de Toxicologie, 69373 Lyon, France. Electronic address: jerome.guitton@chu-lyon.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Léa Payen</Name>
        <Affiliation>Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Laboratoire de biochimie-toxicologie, F-69495 Pierre Bénite, France; UMR INSERM U1052/CNRS 5286, Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, 69373 Lyon, France; Université Lyon 1, ISPBL, Faculté de pharmacie, Laboratoire de Toxicologie, 69373 Lyon, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Vitamin D treatment abrogates the inflammatory response in paraquat-induced lung fibrosis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29944852</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30286-2</DOI>
    <KeywordList>
      <Keywords>Collagen Production</Keywords>
      <Keywords>Cytokines</Keywords>
      <Keywords>Lung fibrosis</Keywords>
      <Keywords>Metalloproteinases</Keywords>
      <Keywords>Paraquat intoxication</Keywords>
      <Keywords>Tracheal responsiveness</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Adriana Schapochnik</Name>
        <Affiliation>Post Graduate Program in Biophotonics Applied to Health Sciences, University Nove de Julho (UNINOVE), São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Marcia Rodrigues da Silva</Name>
        <Affiliation>Post Graduate Program in Biophotonics Applied to Health Sciences, University Nove de Julho (UNINOVE), São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Mayara Peres Leal</Name>
        <Affiliation>Post Graduate Program in Biophotonics Applied to Health Sciences, University Nove de Julho (UNINOVE), São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Janete Esteves</Name>
        <Affiliation>Post Graduate Program in Biophotonics Applied to Health Sciences, University Nove de Julho (UNINOVE), São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Cristina Bichels Hebeda</Name>
        <Affiliation>Department of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Silvana Sandri</Name>
        <Affiliation>Department of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Daniela de Fátima Teixeira da Silva</Name>
        <Affiliation>Post Graduate Program in Biophotonics Applied to Health Sciences, University Nove de Julho (UNINOVE), São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Sandra Helena Poliseli Farsky</Name>
        <Affiliation>Department of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Rodrigo Labat Marcos</Name>
        <Affiliation>Post Graduate Program in Biophotonics Applied to Health Sciences, University Nove de Julho (UNINOVE), São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Adriana Lino-Dos-Santos-Franco</Name>
        <Affiliation>Post Graduate Program in Biophotonics Applied to Health Sciences, University Nove de Julho (UNINOVE), São Paulo, Brazil. Electronic address: alsantosfranco@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toluene diisocyanate exposure and autotaxin-lysophosphatidic acid signalling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29940203</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30285-0</DOI>
    <KeywordList>
      <Keywords>Autotaxin</Keywords>
      <Keywords>Genetic Susceptibility</Keywords>
      <Keywords>Interleukin 1β</Keywords>
      <Keywords>Isocyanate</Keywords>
      <Keywords>Lysophosphatidic Acid</Keywords>
      <Keywords>Purinergic Receptors</Keywords>
      <Keywords>Respiratory Sensitizer</Keywords>
      <Keywords>Toluene Diisocyanate</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Julia M. Broström</Name>
        <Affiliation>Division of Occupational and Environmental Medicine, Lund University, SE 221 85 Lund, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Aram Ghalali</Name>
        <Affiliation>Institute of Environmental Medicine, Karolinska Institutet, Box 210, SE171 77 Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Huiyuan Zheng</Name>
        <Affiliation>Institute of Environmental Medicine, Karolinska Institutet, Box 210, SE171 77 Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Johan Högberg</Name>
        <Affiliation>Institute of Environmental Medicine, Karolinska Institutet, Box 210, SE171 77 Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Ulla Stenius</Name>
        <Affiliation>Institute of Environmental Medicine, Karolinska Institutet, Box 210, SE171 77 Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Margareta Littorin</Name>
        <Affiliation>Division of Occupational and Environmental Medicine, Lund University, SE 221 85 Lund, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Håkan Tinnerberg</Name>
        <Affiliation>Division of Occupational and Environmental Medicine, Lund University, SE 221 85 Lund, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Karin Broberg</Name>
        <Affiliation>Division of Occupational and Environmental Medicine, Lund University, SE 221 85 Lund, Sweden; Institute of Environmental Medicine, Karolinska Institutet, Box 210, SE171 77 Stockholm, Sweden. Electronic address: karin.broberg@ki.se.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Identification and analysis of ambient EMPs.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29935283</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30284-9</DOI>
    <KeywordList>
      <Keywords>Amphibole</Keywords>
      <Keywords>Analysis</Keywords>
      <Keywords>Asbestos</Keywords>
      <Keywords>Elongate mineral particle</Keywords>
      <Keywords>Serpentine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Drew R. Van Orden</Name>
        <Affiliation>RJ Lee Group, Inc, 350 Hochberg Road, Monroeville, PA 15146, USA. Electronic address: drew@rjlg.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A novel benzamide derivative protects ligature-induced alveolar bone erosion by inhibiting NFATc1-mediated osteoclastogenesis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29935282</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30283-7</DOI>
    <KeywordList>
      <Keywords>Alveolar bone loss</Keywords>
      <Keywords>Benzamide</Keywords>
      <Keywords>Bone resorption</Keywords>
      <Keywords>OCLI-070</Keywords>
      <Keywords>Osteoclast</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hye Jung Ihn</Name>
        <Affiliation>Institute for Hard Tissue and Bio-tooth Regeneration, Kyungpook National University, Daegu 41940, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Taeho Lee</Name>
        <Affiliation>College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 41566, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Doohyun Lee</Name>
        <Affiliation>College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 41566, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ju Ang Kim</Name>
        <Affiliation>Department of Oral Pathology and Regenerative Medicine, School of Dentistry, IHBR, Kyungpook National University, Daegu 41940, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kiryeong Kim</Name>
        <Affiliation>Department of Oral Pathology and Regenerative Medicine, School of Dentistry, IHBR, Kyungpook National University, Daegu 41940, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Soomin Lim</Name>
        <Affiliation>Department of Oral Pathology and Regenerative Medicine, School of Dentistry, IHBR, Kyungpook National University, Daegu 41940, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Young Kim</Name>
        <Affiliation>Department of Biochemistry, School of Dentistry, IHBR, Kyungpook National University, Daegu 41940, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Youngkyun Lee</Name>
        <Affiliation>Department of Biochemistry, School of Dentistry, IHBR, Kyungpook National University, Daegu 41940, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sang Hyun Kim</Name>
        <Affiliation>Department of Pharmacology, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyun Shik Lee</Name>
        <Affiliation>School of Life Sciences, Kyungpook National University, Daegu 41566, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hong In Shin</Name>
        <Affiliation>Department of Oral Pathology and Regenerative Medicine, School of Dentistry, IHBR, Kyungpook National University, Daegu 41940, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eui Kyun Park</Name>
        <Affiliation>Department of Oral Pathology and Regenerative Medicine, School of Dentistry, IHBR, Kyungpook National University, Daegu 41940, Republic of Korea. Electronic address: epark@knu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Expression of cytokines and chemokines in mouse skin treated with sulfur mustard.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29935281</pubmedLink>
    <GrantList>
      <Grant>P30 ES005022</Grant>
      <Grant>T32 ES007148</Grant>
      <Grant>U54 AR055073</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30266-7</DOI>
    <KeywordList>
      <Keywords>Dermal toxicity</Keywords>
      <Keywords>Immuno-multiplex assays</Keywords>
      <Keywords>Inflammatory cells infiltration</Keywords>
      <Keywords>Inflammatory mediators</Keywords>
      <Keywords>Sulfur mustard</Keywords>
      <Keywords>Vesicants</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yoke Chen Chang</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA. Electronic address: chang@eohsi.rutgers.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Melannie Soriano</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rita A. Hahn</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert P. Casillas</Name>
        <Affiliation>MRIGlobal, Kansas City, Missouri, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marion K. Gordon</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey D. Laskin</Name>
        <Affiliation>Department of Environmental and Occupational Health, School of Public Health, Rutgers University, Piscataway, New Jersey, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Donald R. Gerecke</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Thiopurine-induced toxicity is associated with dysfunction variant of the human molybdenum cofactor sulfurase gene (xanthinuria type II).</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29935280</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30281-3</DOI>
    <KeywordList>
      <Keywords>Azathioprine</Keywords>
      <Keywords>Human molybdenum cofactor sulfurase</Keywords>
      <Keywords>Hypouricemia</Keywords>
      <Keywords>Thiopurine-induced toxicity</Keywords>
      <Keywords>Xanthinuria</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Blanka Stiburkova</Name>
        <Affiliation>Institute of Rheumatology, Prague, Czech Republic; Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University, General University Hospital in Prague, Prague, Czech Republic. Electronic address: stiburkova@revma.cz.</Affiliation>
      </Author>
      <Author>
        <Name>Katerina Pavelcova</Name>
        <Affiliation>Institute of Rheumatology, Prague, Czech Republic; Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Lenka Petru</Name>
        <Affiliation>Institute of Rheumatology, Prague, Czech Republic; Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Jakub Krijt</Name>
        <Affiliation>Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University, General University Hospital in Prague, Prague, Czech Republic.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Broad spectrum proteomics analysis of the inferior colliculus following acute hydrogen sulfide exposure.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29932956</pubmedLink>
    <GrantList>
      <Grant>R21 NS089487</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30257-6</DOI>
    <KeywordList>
      <Keywords>Hydrogen sulfide</Keywords>
      <Keywords>Neurodegeneration</Keywords>
      <Keywords>Neurotoxicity</Keywords>
      <Keywords>Proteomic analysis</Keywords>
      <Keywords>Proteomic profiling</Keywords>
      <Keywords>TMT labeled LC-MS/MS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dong Suk Kim</Name>
        <Affiliation>Veterinary Diagnostic &amp; Production Animal Medicine, Iowa State University, Ames, IA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Poojya Anantharam</Name>
        <Affiliation>Veterinary Diagnostic &amp; Production Animal Medicine, Iowa State University, Ames, IA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Hoffmann</Name>
        <Affiliation>Henry M Jackson Foundation on contract 711HPW/USAFSAM/FHOF, Wright Patterson Air Force Base, Dayton, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mitchell L. Meade</Name>
        <Affiliation>711HPW/RHDJ, Wright Patterson Air Force Base, Dayton, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nadja Grobe</Name>
        <Affiliation>711HPW/RHDJ, Wright Patterson Air Force Base, Dayton, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffery M. Gearhart</Name>
        <Affiliation>Henry M Jackson Foundation on contract 711HPW/USAFSAM/FHOF, Wright Patterson Air Force Base, Dayton, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Elizabeth M. Whitley</Name>
        <Affiliation>Pathogenesis, LLC, Gainesville, FL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Belinda Mahama</Name>
        <Affiliation>Veterinary Diagnostic &amp; Production Animal Medicine, Iowa State University, Ames, IA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wilson K. Rumbeiha</Name>
        <Affiliation>Veterinary Diagnostic &amp; Production Animal Medicine, Iowa State University, Ames, IA, USA. Electronic address: rumbeiha@iastate.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Biological mechanisms of non-linear dose-response for respirable mineral fibers.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29932955</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30282-5</DOI>
    <KeywordList>
      <Keywords>Asbestos</Keywords>
      <Keywords>Dose-response</Keywords>
      <Keywords>Elongated mineral particles</Keywords>
      <Keywords>NLRP3 Inflammasome</Keywords>
      <Keywords>Nonlinear</Keywords>
      <Keywords>Threshold</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Louis Anthony Tony Cox</Name>
        <Affiliation>Cox Associates and University of Colorado, United States. Electronic address: tcoxdenver@aol.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Liquiritigenin and liquiritin alleviated MCT-induced HSOS by activating Nrf2 antioxidative defense system.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29908794</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30272-2</DOI>
    <KeywordList>
      <Keywords>HSOS</Keywords>
      <Keywords>Liquiritigenin</Keywords>
      <Keywords>Liquiritin</Keywords>
      <Keywords>Monocrotaline</Keywords>
      <Keywords>Nrf2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhenlin Huang</Name>
        <Affiliation>The MOE Key Laboratory for Standardization of Chinese Medicines, Shanghai Key Laboratory of Compound Chinese Medicines and The SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuchen Sheng</Name>
        <Affiliation>Center for Drug Safety Evaluation and Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Minwei Chen</Name>
        <Affiliation>The MOE Key Laboratory for Standardization of Chinese Medicines, Shanghai Key Laboratory of Compound Chinese Medicines and The SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhanxia Hao</Name>
        <Affiliation>The MOE Key Laboratory for Standardization of Chinese Medicines, Shanghai Key Laboratory of Compound Chinese Medicines and The SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Feifei Hu</Name>
        <Affiliation>Center for Drug Safety Evaluation and Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lili Ji</Name>
        <Affiliation>The MOE Key Laboratory for Standardization of Chinese Medicines, Shanghai Key Laboratory of Compound Chinese Medicines and The SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Electronic address: jilili@shutcm.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "MWCNTs of different physicochemical properties cause similar inflammatory responses, but differences in transcriptional and histological markers of fibrosis in mouse lungs" [Toxicol. Appl. Pharmacol., 284 (2015) 16-32].</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29908758</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30264-3</DOI>
    <AuthorList>
      <Author>
        <Name>Sarah S. Poulsen</Name>
        <Affiliation>National Research Centre for the Working Environment, Copenhagen DK-2100, Denmark; Department of Science, Systems and Models, Roskilde University, DK-4000 Roskilde, Denmark. Electronic address: spo@nrcwe.dk.</Affiliation>
      </Author>
      <Author>
        <Name>Anne T. Saber</Name>
        <Affiliation>National Research Centre for the Working Environment, Copenhagen DK-2100, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Williams</Name>
        <Affiliation>Environmental and Radiation Health Sciences Directorate, Health Canada, Ottawa, Ontario K1A 0K9, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Ole Andersen</Name>
        <Affiliation>Department of Science, Systems and Models, Roskilde University, DK-4000 Roskilde, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Carsten Købler</Name>
        <Affiliation>Department of Micro- and Nanotechnology, Technical University of Denmark, DK-2800 Kgs. Lyngby, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Rambabu Atluri</Name>
        <Affiliation>Nanologica AB, SE-114 28 Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Maria E. Pozzebon</Name>
        <Affiliation>Veneto Nanotech SCpA, ECSIN - European Centre for the Sustainable Impact of Nanotechnology, I-45100 Rovigo, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Stefano P. Mucelli</Name>
        <Affiliation>Veneto Nanotech SCpA, ECSIN - European Centre for the Sustainable Impact of Nanotechnology, I-45100 Rovigo, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Monica Simion</Name>
        <Affiliation>Laboratory of Nanobiotechnology, National Institute for Research and Development in Microtechnologies, 077190 Bucharest, Romania.</Affiliation>
      </Author>
      <Author>
        <Name>David Rickerby</Name>
        <Affiliation>European Commission Joint Research Centre, Institute for Environment and Sustainability, I-21027 Ispra, VA, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Alicja Mortensen</Name>
        <Affiliation>National Food Institute, Technical University of Denmark, Søborg, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Petra Jackson</Name>
        <Affiliation>National Research Centre for the Working Environment, Copenhagen DK-2100, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Zdenka O. Kyjovska</Name>
        <Affiliation>National Research Centre for the Working Environment, Copenhagen DK-2100, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Kristian Mølhave</Name>
        <Affiliation>Department of Micro- and Nanotechnology, Technical University of Denmark, DK-2800 Kgs. Lyngby, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Nicklas R. Jacobsen</Name>
        <Affiliation>National Research Centre for the Working Environment, Copenhagen DK-2100, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Keld A. Jensen</Name>
        <Affiliation>National Research Centre for the Working Environment, Copenhagen DK-2100, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Carole L. Yauk</Name>
        <Affiliation>Environmental and Radiation Health Sciences Directorate, Health Canada, Ottawa, Ontario K1A 0K9, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Håkan Wallin</Name>
        <Affiliation>National Research Centre for the Working Environment, Copenhagen DK-2100, Denmark; Department of Public Health, University of Copenhagen, DK-1014 Copenhagen K, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Sabina Halappanavar</Name>
        <Affiliation>Environmental and Radiation Health Sciences Directorate, Health Canada, Ottawa, Ontario K1A 0K9, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Ulla Vogel</Name>
        <Affiliation>National Research Centre for the Working Environment, Copenhagen DK-2100, Denmark; Department of Micro- and Nanotechnology, Technical University of Denmark, DK-2800 Kgs. Lyngby, Denmark.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Refractory ceramic fibers: Fiber characteristics, potential health effects and clinical observations.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29908246</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30269-2</DOI>
    <AuthorList>
      <Author>
        <Name>Mark J. Utell</Name>
        <Affiliation>University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, United States. Electronic address: mark_utell@urmc.rochester.edu.</Affiliation>
      </Author>
      <Author>
        <Name>L. Daniel Maxim</Name>
        <Affiliation>Principal, Everest Consulting, 295 Princeton-Hightstown Road Box 222, West Windsor, NJ 08550, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In vitro interaction and biocompatibility of titanate nanotubes with microglial cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29908245</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30271-0</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Lysosomal integrity</Keywords>
      <Keywords>Microglial activation</Keywords>
      <Keywords>Mitochondrial hyperpolarisation</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
      <Keywords>Titanate nanotubes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>S. Sruthi</Name>
        <Affiliation>Toxicology Division, Biomedical Technology Wing, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram 695 012, Kerala, India; Nanosciences Department, Laboratoire Interdisciplinaire Carnot de Bourgogne, UMR 6303, CNRS/Université Bourgogne Franche-Comté, 9 av. A. Savary BP 47 870, 21 078 Dijon, France.</Affiliation>
      </Author>
      <Author>
        <Name>A. Loiseau</Name>
        <Affiliation>Nanosciences Department, Laboratoire Interdisciplinaire Carnot de Bourgogne, UMR 6303, CNRS/Université Bourgogne Franche-Comté, 9 av. A. Savary BP 47 870, 21 078 Dijon, France.</Affiliation>
      </Author>
      <Author>
        <Name>J. Boudon</Name>
        <Affiliation>Nanosciences Department, Laboratoire Interdisciplinaire Carnot de Bourgogne, UMR 6303, CNRS/Université Bourgogne Franche-Comté, 9 av. A. Savary BP 47 870, 21 078 Dijon, France.</Affiliation>
      </Author>
      <Author>
        <Name>F. Sallem</Name>
        <Affiliation>Nanosciences Department, Laboratoire Interdisciplinaire Carnot de Bourgogne, UMR 6303, CNRS/Université Bourgogne Franche-Comté, 9 av. A. Savary BP 47 870, 21 078 Dijon, France.</Affiliation>
      </Author>
      <Author>
        <Name>L. Maurizi</Name>
        <Affiliation>Nanosciences Department, Laboratoire Interdisciplinaire Carnot de Bourgogne, UMR 6303, CNRS/Université Bourgogne Franche-Comté, 9 av. A. Savary BP 47 870, 21 078 Dijon, France.</Affiliation>
      </Author>
      <Author>
        <Name>P. V. Mohanan</Name>
        <Affiliation>Toxicology Division, Biomedical Technology Wing, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram 695 012, Kerala, India.</Affiliation>
      </Author>
      <Author>
        <Name>G. Lizard</Name>
        <Affiliation>Faculté des Sciences Gabriel, Laboratoire Bio-PeroxIL, EA7270, Université Bourgogne Franche-Comté/Inserm, 6 Bd Gabriel, 21 000 Dijon, France. Electronic address: Gerard.Lizard@u-bourgogne.fr.</Affiliation>
      </Author>
      <Author>
        <Name>N. Millot</Name>
        <Affiliation>Nanosciences Department, Laboratoire Interdisciplinaire Carnot de Bourgogne, UMR 6303, CNRS/Université Bourgogne Franche-Comté, 9 av. A. Savary BP 47 870, 21 078 Dijon, France. Electronic address: Nadine.Millot@u-bourgogne.fr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Prompt treatment with uridine triacetate improves survival and reduces toxicity due to fluorouracil and capecitabine overdose or dihydropyrimidine dehydrogenase deficiency.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29908244</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30270-9</DOI>
    <KeywordList>
      <Keywords>Capecitabine</Keywords>
      <Keywords>DPD</Keywords>
      <Keywords>Fluorouracil</Keywords>
      <Keywords>Overdose</Keywords>
      <Keywords>Uridine triacetate</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rolando A. G. Garcia</Name>
        <Affiliation>Discovery Research, Wellstat Therapeutics, Rockville, MD, United States. Electronic address: rgarcia@wellstattherapeutics.com.</Affiliation>
      </Author>
      <Author>
        <Name>Joel A. Saydoff</Name>
        <Affiliation>Currently at the National Institute of Neurological Disorders and Stroke, Bethesda, MD 20892, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Michael K. Bamat</Name>
        <Affiliation>Research and Development, Wellstat Therapeutics, Rockville, MD, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Reid W. von Borstel</Name>
        <Affiliation>Discovery Research, Wellstat Therapeutics, Rockville, MD, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Protective roles of fenofibrate against cisplatin-induced ototoxicity by the rescue of peroxisomal and mitochondrial dysfunction.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29908243</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30268-0</DOI>
    <KeywordList>
      <Keywords>Cisplatin</Keywords>
      <Keywords>Fenofibrate</Keywords>
      <Keywords>NADPH Oxidase Isoforms</Keywords>
      <Keywords>Ototoxicity</Keywords>
      <Keywords>PPAR-α</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Se Jin Kim</Name>
        <Affiliation>Lab of Peroxisomes &amp; Lipid Metabolism, Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Channy Park</Name>
        <Affiliation>Lab of Peroxisomes &amp; Lipid Metabolism, Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Joon No Lee</Name>
        <Affiliation>Lab of Peroxisomes &amp; Lipid Metabolism, Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Raekil Park</Name>
        <Affiliation>Lab of Peroxisomes &amp; Lipid Metabolism, Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea. Electronic address: rkpark@gist.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dihydronortanshinone, a natural product, alleviates LPS-induced inflammatory response through NF-κB, mitochondrial ROS, and MAPK pathways.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29906494</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30265-5</DOI>
    <KeywordList>
      <Keywords>Dihydronortanshinone</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>LPS</Keywords>
      <Keywords>Macrophage</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiaxia Wu</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongwei Gao</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Hou</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Yu</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Sun</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Wang</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoyan Chen</Name>
        <Affiliation>Department of Pathophysiology, Zunyi Medical College, Zunyi, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yulin Feng</Name>
        <Affiliation>State Key Laboratory of Innovative Drug and Efficient Energy-Saving Pharmaceutical Equipment, Jiangxi University of Traditional Chinese Medicine, Nanchang 330004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiong Ming Xu</Name>
        <Affiliation>Department of Pharmacognosy, College of Pharmaceutical Science, Soochow University, Suzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiuping Chen</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China. Electronic address: xpchen@umac.mo.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The tamoxifen derivative ridaifen-B is a high affinity selective CB</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29906493</pubmedLink>
    <GrantList>
      <Grant>R01 DA039143</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30267-9</DOI>
    <KeywordList>
      <Keywords>Antagonist</Keywords>
      <Keywords>Cannabinoid receptors</Keywords>
      <Keywords>Drug action</Keywords>
      <Keywords>G-protein coupled receptors</Keywords>
      <Keywords>Inverse agonist</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lirit N. Franks</Name>
        <Affiliation>Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Benjamin M. Ford</Name>
        <Affiliation>Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Toshifumi Fujiwara</Name>
        <Affiliation>Department of Internal Medicine, Endocrinology Division, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Haibo Zhao</Name>
        <Affiliation>Department of Internal Medicine, Endocrinology Division, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA. Electronic address: hzhao@uams.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Paul L. Prather</Name>
        <Affiliation>Department of Pharmacology and Toxicology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA. Electronic address: pratherpaull@uams.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Roles of ROS, Nrf2, and autophagy in cadmium-carcinogenesis and its prevention by sulforaphane.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29885333</pubmedLink>
    <GrantList>
      <Grant>P30 ES026529</Grant>
      <Grant>R01 ES025515</Grant>
      <Grant>R01 ES028984</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30259-X</DOI>
    <KeywordList>
      <Keywords>Autophagy deficiency</Keywords>
      <Keywords>Cadmium</Keywords>
      <Keywords>Carcinogenesis</Keywords>
      <Keywords>Sulforaphane</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yuting Wang</Name>
        <Affiliation>Department of Pulmonology, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310052, People's Republic of China; Center for Research on Environmental Disease, College of Medicine, University of Kentucky, 1095 VA Drive, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ardhendu Kumar Mandal</Name>
        <Affiliation>Center for Research on Environmental Disease, College of Medicine, University of Kentucky, 1095 VA Drive, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Young Ok Son</Name>
        <Affiliation>Center for Research on Environmental Disease, College of Medicine, University of Kentucky, 1095 VA Drive, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Poyil Pratheeshkumar</Name>
        <Affiliation>Center for Research on Environmental Disease, College of Medicine, University of Kentucky, 1095 VA Drive, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James T. F. Wise</Name>
        <Affiliation>Center for Research on Environmental Disease, College of Medicine, University of Kentucky, 1095 VA Drive, Lexington, KY 40536, USA; Division of Nutritional Sciences, Department of Pharmacology and Nutritional Sciences, College of Medicine, University of Kentucky, Lexington, KY 40536-0305,USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lei Wang</Name>
        <Affiliation>Center for Research on Environmental Disease, College of Medicine, University of Kentucky, 1095 VA Drive, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zhuo Zhang</Name>
        <Affiliation>Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, 1095 VA Drive, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xianglin Shi</Name>
        <Affiliation>Center for Research on Environmental Disease, College of Medicine, University of Kentucky, 1095 VA Drive, Lexington, KY 40536, USA. Electronic address: xianglin.shi@uky.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Zhimin Chen</Name>
        <Affiliation>Department of Pulmonology, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310052, People's Republic of China. Electronic address: zmchen@zju.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pesticides and cardiotoxicity. Where do we stand?</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29885332</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30260-6</DOI>
    <KeywordList>
      <Keywords>CLP Regulation</Keywords>
      <Keywords>Cardiotoxicity</Keywords>
      <Keywords>Heart</Keywords>
      <Keywords>Myocardial infarction</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Pesticides</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nikolaos Georgiadis</Name>
        <Affiliation>European Food Safety Authority, Via Carlo Magno 1A, 43126 Parma, Italy; Department of Biochemistry- Biotechnology, School of Health Sciences, University of Thessaly, Viopolis, Larissa 41500, Greece.</Affiliation>
      </Author>
      <Author>
        <Name>Konstantinos Tsarouhas</Name>
        <Affiliation>Department of Cardiology, University Hospital of Larissa, Mezourlo, Larissa 41110, Greece.</Affiliation>
      </Author>
      <Author>
        <Name>Christina Tsitsimpikou</Name>
        <Affiliation>Generalr Chemical State Laboratory of Greece, 16 An. Tsocha Str., 11521 Athens, Greece.</Affiliation>
      </Author>
      <Author>
        <Name>Alexandros Vardavas</Name>
        <Affiliation>Laboratory of Toxicology, Medical School, University of Crete, Voutes, Heraklion, 71003 Crete, Greece.</Affiliation>
      </Author>
      <Author>
        <Name>Ramin Rezaee</Name>
        <Affiliation>Clinical Research Unit, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Ioannis Germanakis</Name>
        <Affiliation>Paediatric Cardiology Unit, Department of Paediatrics, University Hospital Voutes, Heraklion, 71409 Crete, Greece.</Affiliation>
      </Author>
      <Author>
        <Name>Aristides Tsatsakis</Name>
        <Affiliation>Laboratory of Toxicology, Medical School, University of Crete, Voutes, Heraklion, 71003 Crete, Greece.</Affiliation>
      </Author>
      <Author>
        <Name>Dimitrios Stagos</Name>
        <Affiliation>Department of Biochemistry- Biotechnology, School of Health Sciences, University of Thessaly, Viopolis, Larissa 41500, Greece.</Affiliation>
      </Author>
      <Author>
        <Name>Demetrios Kouretas</Name>
        <Affiliation>Department of Biochemistry- Biotechnology, School of Health Sciences, University of Thessaly, Viopolis, Larissa 41500, Greece. Electronic address: dkouret@uth.gr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Sex differences in effects of gestational polychlorinated biphenyl exposure on hypothalamic neuroimmune and neuromodulator systems in neonatal rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29879404</pubmedLink>
    <GrantList>
      <Grant>F32 ES023291</Grant>
      <Grant>R01 ES020662</Grant>
      <Grant>R01 ES023254</Grant>
      <Grant>T32 ES007247</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30258-8</DOI>
    <KeywordList>
      <Keywords>Cytokine</Keywords>
      <Keywords>Dopamine</Keywords>
      <Keywords>Endocrine disrupting chemicals</Keywords>
      <Keywords>Estrogen receptor beta</Keywords>
      <Keywords>Lipopolysaccharide</Keywords>
      <Keywords>Sex difference</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Margaret R. Bell</Name>
        <Affiliation>Department of Biological Sciences and Department of Health Sciences, DePaul University, Chicago, IL 60614, United States. Electronic address: margaret.bell@depaul.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Ariel Dryden</Name>
        <Affiliation>Franklin College, Franklin, IN 46131, United States. Electronic address: ariel.dryden@franklincollege.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Ryan Will</Name>
        <Affiliation>Department of Psychology, The University of Texas at Austin, Austin, TX 78712, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea C. Gore</Name>
        <Affiliation>Division of Pharmacology and Toxicology, College of Pharmacy, Institute for Cellular and Molecular Biology, and Institute for Neuroscience, The University of Texas at Austin, Austin, TX 78712, United States. Electronic address: andrea.gore@austin.utexas.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological study of a new doxorubicin-loaded pH-sensitive liposome: A preclinical approach.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29864484</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30256-4</DOI>
    <KeywordList>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Cardiotoxicity</Keywords>
      <Keywords>Doxorubicin</Keywords>
      <Keywords>Electrocardiogram</Keywords>
      <Keywords>pH-sensitive liposomes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Juliana de Oliveira Silva</Name>
        <Affiliation>Departamento de Produtos Farmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Sued Eustáquio Mendes Miranda</Name>
        <Affiliation>Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Elaine Amaral Leite</Name>
        <Affiliation>Departamento de Produtos Farmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Adriano de Paula Sabino</Name>
        <Affiliation>Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Karina Braga Gomes Borges</Name>
        <Affiliation>Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Valbert Nascimento Cardoso</Name>
        <Affiliation>Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Geovanni Dantas Cassali</Name>
        <Affiliation>Departamento de Patologia Geral, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Grabe Guimarães</Name>
        <Affiliation>Departamento de Farmácia, Escola de Farmácia, Universidade Federal de Ouro Preto, Ouro Preto, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Mônica Cristina Oliveira</Name>
        <Affiliation>Departamento de Produtos Farmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>André Luis Branco de Barros</Name>
        <Affiliation>Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil. Electronic address: albb@ufmg.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Neuroprotective effect of linagliptin against cuprizone-induced demyelination and behavioural dysfunction in mice: A pivotal role of AMPK/SIRT1 and JAK2/STAT3/NF-κB signalling pathway modulation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29864483</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30246-1</DOI>
    <KeywordList>
      <Keywords>AMPK</Keywords>
      <Keywords>Cuprizone</Keywords>
      <Keywords>Demyelination</Keywords>
      <Keywords>Linagliptin</Keywords>
      <Keywords>Multiple sclerosis</Keywords>
      <Keywords>SIRT1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Eman M. Elbaz</Name>
        <Affiliation>Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Mahmoud A. Senousy</Name>
        <Affiliation>Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Dalia M. El-Tanbouly</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Rabab H. Sayed</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt. Electronic address: rabab.sayed@pharma.cu.edu.eg.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The mineralogy and epidemiology of cosmetic talc.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29859223</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30247-3</DOI>
    <AuthorList>
      <Author>
        <Name>Christy A. Barlow</Name>
        <Affiliation>GZA GeoEnvironmental, Inc, 4450 Arapahoe Avenue, Suite 100, Boulder, CO 80303, USA. Electronic address: christy.barlow@gza.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gary M. Marsh</Name>
        <Affiliation>Cardno ChemRisk, 20 Stanwix St, Suite 505, Pittsburgh, PA 15222, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stacey Benson</Name>
        <Affiliation>Cardno ChemRisk, 20 Stanwix St, Suite 505, Pittsburgh, PA 15222, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brent L. Finley</Name>
        <Affiliation>Cardno ChemRisk, 231 Front St/244 Water Street, Suite 212, Brooklyn, NY 11201, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The effect of occupational chronic lead exposure on the complete blood count and the levels of selected hematopoietic cytokines.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29857081</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30245-X</DOI>
    <KeywordList>
      <Keywords>Blood morphology</Keywords>
      <Keywords>Cytokines</Keywords>
      <Keywords>IL-7</Keywords>
      <Keywords>Lead poisoning</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Artur Chwalba</Name>
        <Affiliation>Department of Pharmacology, School of Medicine with the Division of Dentistry, Medical University of Silesia, ul. Jordana 19, 41-808 Zabrze, Poland. Electronic address: artur.adam.chwalba@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Beata Maksym</Name>
        <Affiliation>Department of Pharmacology, School of Medicine with the Division of Dentistry, Medical University of Silesia, ul. Jordana 19, 41-808 Zabrze, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Michał Dobrakowski</Name>
        <Affiliation>Department of Biochemistry, School of Medicine with the Division of Dentistry, Medical University of Silesia, ul. Jordana 19, 41-808 Zabrze, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Sławomir Kasperczyk</Name>
        <Affiliation>Department of Biochemistry, School of Medicine with the Division of Dentistry, Medical University of Silesia, ul. Jordana 19, 41-808 Zabrze, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Natalia Pawlas</Name>
        <Affiliation>Department of Pharmacology, School of Medicine with the Division of Dentistry, Medical University of Silesia, ul. Jordana 19, 41-808 Zabrze, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Ewa Birkner</Name>
        <Affiliation>Department of Biochemistry, School of Medicine with the Division of Dentistry, Medical University of Silesia, ul. Jordana 19, 41-808 Zabrze, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Aleksandra Kasperczyk</Name>
        <Affiliation>Department of Biochemistry, School of Medicine with the Division of Dentistry, Medical University of Silesia, ul. Jordana 19, 41-808 Zabrze, Poland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Incorporation of the glutathione conjugation pathway in an updated physiologically-based pharmacokinetic model for perchloroethylene in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29857080</pubmedLink>
    <GrantList>
      <Grant>F32 ES026005</Grant>
      <Grant>P42 ES005948</Grant>
      <Grant>P42 ES027704</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30243-6</DOI>
    <KeywordList>
      <Keywords>Bayesian analysis</Keywords>
      <Keywords>Glutathione conjugation</Keywords>
      <Keywords>Oxidative metabolism</Keywords>
      <Keywords>Physiologically based pharmacokinetic (PBPK) model</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Tetrachloroethylene</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chimeddulam Dalaijamts</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, Texas A&amp;M University, College Station, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph A. Cichocki</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, Texas A&amp;M University, College Station, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Syuan Luo</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, Texas A&amp;M University, College Station, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ivan Rusyn</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, Texas A&amp;M University, College Station, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Weihsueh A. Chiu</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, Texas A&amp;M University, College Station, TX, USA. Electronic address: WChiu@cvm.tamu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Raddeanin A, a natural triterpenoid saponin compound, exerts anticancer effect on human osteosarcoma via the ROS/JNK and NF-κB signal pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29847772</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30236-9</DOI>
    <KeywordList>
      <Keywords>Human osteosarcoma</Keywords>
      <Keywords>Migration</Keywords>
      <Keywords>NF-κB</Keywords>
      <Keywords>ROS/JNK</Keywords>
      <Keywords>Raddeanin A</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bo Ma</Name>
        <Affiliation>School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 210009, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianwei Zhu</Name>
        <Affiliation>School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 210009, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Ang Zhao</Name>
        <Affiliation>School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 210009, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Zhang</Name>
        <Affiliation>School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 210009, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Wang</Name>
        <Affiliation>School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 210009, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Hang Zhang</Name>
        <Affiliation>School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 210009, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Lifang Zhang</Name>
        <Affiliation>College of Pharmaceutical and Life Sciences, Jiujiang University, Jiujiang 332000, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Zhang</Name>
        <Affiliation>School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing 210009, People's Republic of China. Electronic address: zhangqi@njtech.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The modifying effect of kidney function on the association of cadmium exposure with blood pressure and cardiovascular mortality: NHANES 1999-2010.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29842852</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30244-8</DOI>
    <KeywordList>
      <Keywords>Blood pressure</Keywords>
      <Keywords>Cadmium</Keywords>
      <Keywords>Cardiovascular mortality</Keywords>
      <Keywords>NHANES</Keywords>
      <Keywords>Renal function</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yi Gao</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Shanxi Medical University, Taiyuan, Shanxi 030001, China; Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37203, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xiangzhu Zhu</Name>
        <Affiliation>Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37203, USA; Vanderbilt Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Martha J. Shrubsole</Name>
        <Affiliation>Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37203, USA; Vanderbilt Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lei Fan</Name>
        <Affiliation>Department of Oncology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhaolin Xia</Name>
        <Affiliation>Department of Occupational health and Toxicology, School of Public Health, Fudan University, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Raymond C. Harris</Name>
        <Affiliation>Division of Nephrology, Department of Medicine, Vanderbilt University, Nashville, TN 37232, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lifang Hou</Name>
        <Affiliation>Institute for Public Health and Medicine, Northwestern University, Chicago, IL 60611, USA; Environmental Department, School of Public Health, Shanxi Medical University, Taiyuan, Shanxi 030001, China. Electronic address: l-hou@northwestern.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Dai</Name>
        <Affiliation>Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37203, USA; Vanderbilt Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. Electronic address: qi.dai@vanderbilt.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Does qualitative examination of Elongated Mineral Particles (EMP) recovered from human and animal lungs provide reliable information on their carcinogenic and other effects?</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29807038</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30222-9</DOI>
    <AuthorList>
      <Author>
        <Name>Bruce W. Case</Name>
        <Affiliation>Department of Epidemiology, Biostatistics and Occupational Health, and Associate Member, McGill School of Environment, McGill University, Montreal, Canada. Electronic address: bruce.case@mcgill.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Behavioral, cellular and molecular maladaptations covary with exposure to pyridostigmine bromide in a rat model of gulf war illness pain.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29803855</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30234-5</DOI>
    <KeywordList>
      <Keywords>Chronic Pain</Keywords>
      <Keywords>Gulf War Illness</Keywords>
      <Keywords>Muscarinic</Keywords>
      <Keywords>Na(v)1.9</Keywords>
      <Keywords>Pyridostigmine</Keywords>
      <Keywords>TRPA1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>B. Y. Cooper</Name>
        <Affiliation>Division of Neuroscience, Dept. of Oral and Maxillofacial Surgery, Box 100416, JHMHC, University of Florida College of Dentistry, Gainesville, FL 32610, USA. Electronic address: bcooper@dental.ufl.edu.</Affiliation>
      </Author>
      <Author>
        <Name>L. D. Flunker</Name>
        <Affiliation>Division of Neuroscience, Dept. of Oral and Maxillofacial Surgery, Box 100416, JHMHC, University of Florida College of Dentistry, Gainesville, FL 32610, USA. Electronic address: lflunker@dental.ufl.edu.</Affiliation>
      </Author>
      <Author>
        <Name>R. D. Johnson</Name>
        <Affiliation>Dept. of Physiological Sciences, University of Florida College of Veterinary Science, Gainesville, FL 32610, USA. Electronic address: rdjohnso@ufl.edu.</Affiliation>
      </Author>
      <Author>
        <Name>T. J. Nutter</Name>
        <Affiliation>Division of Neuroscience, Dept. of Oral and Maxillofacial Surgery, Box 100416, JHMHC, University of Florida College of Dentistry, Gainesville, FL 32610, USA. Electronic address: tnutter@dental.ufl.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>cAMP/PKA/EGR1 signaling mediates the molecular mechanism of ethanol-induced inhibition of placental 11β-HSD2 expression.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29802914</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30240-0</DOI>
    <KeywordList>
      <Keywords>11β-Hydroxysteroid dehydrogenase type 2</Keywords>
      <Keywords>Early growth response factor 1</Keywords>
      <Keywords>Glucocorticoids</Keywords>
      <Keywords>Placenta</Keywords>
      <Keywords>Prenatal ethanol exposure</Keywords>
      <Keywords>cAMP/PKA pathway</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Luting Yu</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Zhou</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guohui Zhang</Name>
        <Affiliation>Department of Obstetrics and Gynecology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Huang</Name>
        <Affiliation>Department of Obstetrics and Gynecology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Linguo Pei</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Feng Lv</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanzhen Zhang</Name>
        <Affiliation>Hubei Provincial Key Laboratory of Developmentally Originated Diseases, Wuhan 430071, China; Department of Obstetrics and Gynecology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Zhang</Name>
        <Affiliation>Hubei Provincial Key Laboratory of Developmentally Originated Diseases, Wuhan 430071, China; Department of Obstetrics and Gynecology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Wang</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, Wuhan 430071, China; Department of Obstetrics and Gynecology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China. Electronic address: wanghui19@whu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of acute and chronic methamphetamine administration on cynomolgus monkey hippocampus structure and cellular transcriptome.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29802913</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30242-4</DOI>
    <KeywordList>
      <Keywords>Hippocampal structure alteration</Keywords>
      <Keywords>Methamphetamine</Keywords>
      <Keywords>Nonhuman primate</Keywords>
      <Keywords>Profilin 2</Keywords>
      <Keywords>Transcriptome profiling</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mi Ran Choi</Name>
        <Affiliation>Department of Psychiatry, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Won Chun</Name>
        <Affiliation>Department of Psychiatry, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Su Min Kwak</Name>
        <Affiliation>Department of Psychiatry, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sol Hee Bang</Name>
        <Affiliation>Department of Psychiatry, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yeung Bae Jin</Name>
        <Affiliation>National Primate Research Center (NPRC), Korea Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Youngjeon Lee</Name>
        <Affiliation>National Primate Research Center (NPRC), Korea Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Han Na Kim</Name>
        <Affiliation>National Primate Research Center (NPRC), Korea Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyu Tae Chang</Name>
        <Affiliation>National Primate Research Center (NPRC), Korea Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju, Republic of Korea; Department of Functional Genomics, University of Science and Technology, Daejeon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Young Gyu Chai</Name>
        <Affiliation>Department of Molecular and Life Sciences, Hanyang University, Ansan, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sang Rae Lee</Name>
        <Affiliation>National Primate Research Center (NPRC), Korea Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju, Republic of Korea; Department of Functional Genomics, University of Science and Technology, Daejeon, Republic of Korea. Electronic address: srlee@kribb.re.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Dai Jin Kim</Name>
        <Affiliation>Department of Psychiatry, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Republic of Korea. Electronic address: kdj922@catholic.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Caffeic acid prevents UVB radiation induced photocarcinogenesis through regulation of PTEN signaling in human dermal fibroblasts and mouse skin.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29802912</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30241-2</DOI>
    <KeywordList>
      <Keywords>Caffeic acid</Keywords>
      <Keywords>Nucleotide excision repair</Keywords>
      <Keywords>Photocarcinogenesis</Keywords>
      <Keywords>UV radiation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Agilan Balupillai</Name>
        <Affiliation>Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar 608002, Tamil Nadu, India.</Affiliation>
      </Author>
      <Author>
        <Name>Rajendra Prasad Nagarajan</Name>
        <Affiliation>Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar 608002, Tamil Nadu, India. Electronic address: drprasadnr@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Karthikeyan Ramasamy</Name>
        <Affiliation>Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar 608002, Tamil Nadu, India.</Affiliation>
      </Author>
      <Author>
        <Name>Kanimozhi Govindasamy</Name>
        <Affiliation>Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar 608002, Tamil Nadu, India.</Affiliation>
      </Author>
      <Author>
        <Name>Ganesan Muthusamy</Name>
        <Affiliation>Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar 608002, Tamil Nadu, India.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of kidney injury biomarkers in an adult Mexican population environmentally exposed to fluoride and low arsenic levels.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29800643</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30238-2</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Biomarkers</Keywords>
      <Keywords>Fluoride</Keywords>
      <Keywords>Human Biomonitoring</Keywords>
      <Keywords>Kidney Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Monica I. Jiménez-Córdova</Name>
        <Affiliation>Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Mariana Cárdenas-González</Name>
        <Affiliation>Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Guadalupe Aguilar-Madrid</Name>
        <Affiliation>Unidad de Investigación y Salud en el Trabajo, Instituto Mexicano del Seguro Social, Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Luz C. Sanchez-Peña</Name>
        <Affiliation>Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Ángel Barrera-Hernández</Name>
        <Affiliation>Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Iván A. Domínguez-Guerrero</Name>
        <Affiliation>Facultad de Ciencias Químicas, Universidad Autónoma de Chihuahua, Chihuahua, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Carmen González-Horta</Name>
        <Affiliation>Facultad de Ciencias Químicas, Universidad Autónoma de Chihuahua, Chihuahua, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Olivier C. Barbier</Name>
        <Affiliation>Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Luz M. Del Razo</Name>
        <Affiliation>Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Ciudad de México, Mexico. Electronic address: ldelrazo@cinvestav.mx.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The roles of bone morphogenetic protein 2 in perfluorooctanoic acid induced developmental cardiotoxicity and l-carnitine mediated protection.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29800642</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30239-4</DOI>
    <KeywordList>
      <Keywords>Bone morphogenetic protein 2</Keywords>
      <Keywords>Developmental cardiotoxicity</Keywords>
      <Keywords>Perfluorooctanoic acid</Keywords>
      <Keywords>in ovo gene silencing</Keywords>
      <Keywords>l-carnitine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Na Lv</Name>
        <Affiliation>Department of Pharmacology, School of Pharmacy, Qingdao University, China.</Affiliation>
      </Author>
      <Author>
        <Name>Meng Zhao</Name>
        <Affiliation>Qingdao University Medical College, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yantao Han</Name>
        <Affiliation>Qingdao University Medical College, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lianhua Cui</Name>
        <Affiliation>Qingdao University Institution of Public Health, China.</Affiliation>
      </Author>
      <Author>
        <Name>Weizhen Zhong</Name>
        <Affiliation>Qingdao University Medical College, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunbo Wang</Name>
        <Affiliation>Qingdao University Medical College, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qixiao Jiang</Name>
        <Affiliation>Department of Pharmacology, School of Pharmacy, Qingdao University, China. Electronic address: jiangq@qdu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Isoalantolactone induces apoptosis through reactive oxygen species-dependent upregulation of death receptor 5 in human esophageal cancer cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29800641</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30237-0</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Death receptor 5</Keywords>
      <Keywords>Esophageal cancer</Keywords>
      <Keywords>Isoalantolactone</Keywords>
      <Keywords>ROS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhengyang Lu</Name>
        <Affiliation>Department of General Surgery, The Second Hospital of Jilin University, Changchun 130041, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Guangxin Zhang</Name>
        <Affiliation>Thoracic Surgery, The Second Hospital of Jilin University, Changchun 130041, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yifan Zhang</Name>
        <Affiliation>Breast surgery, The Second Hospital of Jilin University, Changchun 130041, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Peiyan Hua</Name>
        <Affiliation>Thoracic Surgery, The Second Hospital of Jilin University, Changchun 130041, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Meidan Fang</Name>
        <Affiliation>Thoracic Surgery, The Second Hospital of Jilin University, Changchun 130041, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Meiliang Wu</Name>
        <Affiliation>Breast surgery, The Second Hospital of Jilin University, Changchun 130041, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Tongjun Liu</Name>
        <Affiliation>Department of General Surgery, The Second Hospital of Jilin University, Changchun 130041, PR China. Electronic address: tongjunliu@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Glutathione deficiency sensitizes cultured embryonic mouse ovaries to benzo[a]pyrene-induced germ cell apoptosis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29800640</pubmedLink>
    <GrantList>
      <Grant>R01 ES020454</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30235-7</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Benzo[a]pyrene</Keywords>
      <Keywords>Embryonic ovary</Keywords>
      <Keywords>Germ cells</Keywords>
      <Keywords>Glutamate cysteine ligase modifier subunit</Keywords>
      <Keywords>Glutathione</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jinhwan Lim</Name>
        <Affiliation>Department of Medicine, University of California Irvine, Irvine, CA 92617, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ulrike Luderer</Name>
        <Affiliation>Department of Medicine, University of California Irvine, Irvine, CA 92617, United States; Department of Developmental and Cell Biology, University of California Irvine, Irvine, CA 92617, United States; Program in Public Health, University of California Irvine, Irvine, CA 92617, United States. Electronic address: uluderer@uci.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>TRAIL attenuates sulforaphane-mediated Nrf2 and sustains ROS generation, leading to apoptosis of TRAIL-resistant human bladder cancer cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29792947</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30233-3</DOI>
    <KeywordList>
      <Keywords>Nuclear factor erythroid 2-related factor 2 (Nrf2)</Keywords>
      <Keywords>Reactive oxygen species (ROS)</Keywords>
      <Keywords>Sulforaphane (SFN)</Keywords>
      <Keywords>Tumor necrosis factor-related apoptosis inducing ligand (TRAIL)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cheng Yun Jin</Name>
        <Affiliation>School of Pharmaceutical Science, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ilandarage Menu Neelaka Molagoda</Name>
        <Affiliation>Department of Marine Life Sciences, Jeju National University, Jeju 63243, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Wisurumuni Arachchilage Hasitha Maduranga Karunarathne</Name>
        <Affiliation>Department of Marine Life Sciences, Jeju National University, Jeju 63243, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sang Hyuck Kang</Name>
        <Affiliation>Department of Marine Life Sciences, Jeju National University, Jeju 63243, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Cheol Park</Name>
        <Affiliation>Department of Molecular Biology, College of Natural Sciences and Human Ecology, Dongeui University, Busan 67340, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Gi Young Kim</Name>
        <Affiliation>Department of Marine Life Sciences, Jeju National University, Jeju 63243, Republic of Korea. Electronic address: immunkim@jejunu.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Yung Hyun Choi</Name>
        <Affiliation>Department of Biochemistry, College of Oriental Medicine, Dong-Eui University, Busan 47227, Republic of Korea. Electronic address: choiyh@deu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Investigation of nonalcoholic fatty liver disease-induced drug metabolism by comparative global toxicoproteomics.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29792946</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30232-1</DOI>
    <KeywordList>
      <Keywords>Cytochrome P450</Keywords>
      <Keywords>Drug metabolism</Keywords>
      <Keywords>Methionine-choline deficient diet</Keywords>
      <Keywords>Nonalcoholic fatty liver disease</Keywords>
      <Keywords>Tandem mass tags-based toxicoproteomics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ann Yae Na</Name>
        <Affiliation>BK21 Plus KNU Multi-Omics based Creative Drug Research Team, College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 41566, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jung Jae Jo</Name>
        <Affiliation>BK21 Plus KNU Multi-Omics based Creative Drug Research Team, College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 41566, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Oh Kwang Kwon</Name>
        <Affiliation>BK21 Plus KNU Multi-Omics based Creative Drug Research Team, College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 41566, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Riya Shrestha</Name>
        <Affiliation>BK21 Plus KNU Multi-Omics based Creative Drug Research Team, College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 41566, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Pil Joung Cho</Name>
        <Affiliation>BK21 Plus KNU Multi-Omics based Creative Drug Research Team, College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 41566, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyu Min Kim</Name>
        <Affiliation>College of Pharmacy, Chosun University, Gwangju 61452, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sung Hwan Ki</Name>
        <Affiliation>College of Pharmacy, Chosun University, Gwangju 61452, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Tae Hee Lee</Name>
        <Affiliation>Toxicological Research Center, Hoseo University, Asan 31499, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Tae Won Jeon</Name>
        <Affiliation>CRI Global Institute of Toxicology, Suwon 16614, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Tae Cheon Jeong</Name>
        <Affiliation>College of Pharmacy, Yeungnam University, Gyeongsan, 38541, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sangkyu Lee</Name>
        <Affiliation>BK21 Plus KNU Multi-Omics based Creative Drug Research Team, College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 41566, Republic of Korea. Electronic address: sangkyu@knu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cross-linking by epichlorohydrin and diepoxybutane correlates with cytotoxicity and leads to apoptosis in human leukemia (HL-60) cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29792945</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30231-X</DOI>
    <KeywordList>
      <Keywords>Alkylating agents</Keywords>
      <Keywords>Comet assay</Keywords>
      <Keywords>DNA-protein cross-links</Keywords>
      <Keywords>Interstrand cross-links</Keywords>
      <Keywords>Nitrogen mustard</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Phuong M. Le</Name>
        <Affiliation>Department of Chemistry, Colby College, Waterville, ME 04901, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Vanesa L. Silvestri</Name>
        <Affiliation>Department of Chemistry, Colby College, Waterville, ME 04901, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Samuel C. Redstone</Name>
        <Affiliation>Department of Chemistry, Colby College, Waterville, ME 04901, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jordanne B. Dunn</Name>
        <Affiliation>Department of Chemistry, Colby College, Waterville, ME 04901, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Julie T. Millard</Name>
        <Affiliation>Department of Chemistry, Colby College, Waterville, ME 04901, United States. Electronic address: jtmillar@colby.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Membrane cholesterol delays cellular apoptosis induced by ginsenoside Rh2, a steroid saponin.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29782965</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30219-9</DOI>
    <KeywordList>
      <Keywords>Akt</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Cholesterol</Keywords>
      <Keywords>Ginsenoside</Keywords>
      <Keywords>Membrane</Keywords>
      <Keywords>Saponin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sandrine L. Verstraeten</Name>
        <Affiliation>Louvain Drug Research Institute (LDRI), Cellular &amp; Molecular Pharmacology Unit (FACM), Université catholique de Louvain (UCL), Brussels 1200, Belgium; de Duve Institute (DDUV), Cell Biology Unit (CELL), Université catholique de Louvain (UCL), Brussels 1200, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Marie Albert</Name>
        <Affiliation>Louvain Drug Research Institute (LDRI), Cellular &amp; Molecular Pharmacology Unit (FACM), Université catholique de Louvain (UCL), Brussels 1200, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Adrien Paquot</Name>
        <Affiliation>Louvain Drug Research Institute (LDRI), Bioanalysis and Pharmacology of Bioactive Lipids Research Group (BPBL), Université catholique de Louvain (UCL), Brussels 1200, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Giulio G. Muccioli</Name>
        <Affiliation>Louvain Drug Research Institute (LDRI), Bioanalysis and Pharmacology of Bioactive Lipids Research Group (BPBL), Université catholique de Louvain (UCL), Brussels 1200, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Donatienne Tyteca</Name>
        <Affiliation>de Duve Institute (DDUV), Cell Biology Unit (CELL), Université catholique de Louvain (UCL), Brussels 1200, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Marie Paule Mingeot-Leclercq</Name>
        <Affiliation>Louvain Drug Research Institute (LDRI), Cellular &amp; Molecular Pharmacology Unit (FACM), Université catholique de Louvain (UCL), Brussels 1200, Belgium. Electronic address: marie-paule.mingeot@uclouvain.be.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An in vitro approach for prioritization and evaluation of chemical effects on glucocorticoid receptor mediated adipogenesis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29782964</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30221-7</DOI>
    <KeywordList>
      <Keywords>Adipogenesis</Keywords>
      <Keywords>Chemical prioritization</Keywords>
      <Keywords>Glucocorticoid receptor</Keywords>
      <Keywords>IVIVE</Keywords>
      <Keywords>Obesogen</Keywords>
      <Keywords>ToxCast</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jessica K. Hartman</Name>
        <Affiliation>ScitoVation, 6 Davis Drive, PO Box 12878, Research Triangle Park, NC 27709, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Tyler Beames</Name>
        <Affiliation>ScitoVation, 6 Davis Drive, PO Box 12878, Research Triangle Park, NC 27709, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Bethany Parks</Name>
        <Affiliation>ScitoVation, 6 Davis Drive, PO Box 12878, Research Triangle Park, NC 27709, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Doheny</Name>
        <Affiliation>ScitoVation, 6 Davis Drive, PO Box 12878, Research Triangle Park, NC 27709, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Gina Song</Name>
        <Affiliation>ScitoVation, 6 Davis Drive, PO Box 12878, Research Triangle Park, NC 27709, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Alina Efremenko</Name>
        <Affiliation>ScitoVation, 6 Davis Drive, PO Box 12878, Research Triangle Park, NC 27709, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Miyoung Yoon</Name>
        <Affiliation>ScitoVation, 6 Davis Drive, PO Box 12878, Research Triangle Park, NC 27709, United States; ToxStrategies, Inc, 1249 Kildaire Farm Road #134, Cary, NC 27511, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Briana Foley</Name>
        <Affiliation>ScitoVation, 6 Davis Drive, PO Box 12878, Research Triangle Park, NC 27709, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Chad Deisenroth</Name>
        <Affiliation>ScitoVation, 6 Davis Drive, PO Box 12878, Research Triangle Park, NC 27709, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Patrick D. McMullen</Name>
        <Affiliation>ScitoVation, 6 Davis Drive, PO Box 12878, Research Triangle Park, NC 27709, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Rebecca A. Clewell</Name>
        <Affiliation>ScitoVation, 6 Davis Drive, PO Box 12878, Research Triangle Park, NC 27709, United States; ToxStrategies, Inc, 1249 Kildaire Farm Road #134, Cary, NC 27511, United States. Electronic address: correspondingauthor@scitovation.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>BET-inhibition by JQ1 alleviates streptozotocin-induced diabetic cardiomyopathy.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29782963</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30229-1</DOI>
    <KeywordList>
      <Keywords>Bromodomain and extra-terminal proteins</Keywords>
      <Keywords>Caveolin-1</Keywords>
      <Keywords>Diabetic cardiomyopathy</Keywords>
      <Keywords>TGF-β1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Miao Guo</Name>
        <Affiliation>Department of Geriatrics, Linyi People's Hospital, Linyi, Shandong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Xia Wang</Name>
        <Affiliation>Department of Geriatrics, Linyi Jiaotong Hospital, Linyi, Shandong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Jun Chen</Name>
        <Affiliation>Department of Oncology, Linyi People's Hospital, Linyi, Shandong, China. Electronic address: wen_junchen@sina.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Monosodium glutamate induced nociception and oxidative stress dependent on time of administration, age of rats and susceptibility of spinal cord and brain regions.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29782962</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30230-8</DOI>
    <KeywordList>
      <Keywords>Brain regions</Keywords>
      <Keywords>Monosodium glutamate</Keywords>
      <Keywords>Nociception</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Spinal cord</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Suzan Gonçalves Rosa</Name>
        <Affiliation>Laboratório de Síntese, Reatividade e Avaliação Farmacológica e Toxicológica de Organocalcogênios, Departamento de Bioquímica e Biologia Molecular, Centro de Ciências Naturais e Exatas, Universidade Federal de Santa Maria, CEP 97105-900 Santa Maria, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Pietro Maria Chagas</Name>
        <Affiliation>Laboratório de Síntese, Reatividade e Avaliação Farmacológica e Toxicológica de Organocalcogênios, Departamento de Bioquímica e Biologia Molecular, Centro de Ciências Naturais e Exatas, Universidade Federal de Santa Maria, CEP 97105-900 Santa Maria, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Paula Pesarico</Name>
        <Affiliation>Laboratório de Síntese, Reatividade e Avaliação Farmacológica e Toxicológica de Organocalcogênios, Departamento de Bioquímica e Biologia Molecular, Centro de Ciências Naturais e Exatas, Universidade Federal de Santa Maria, CEP 97105-900 Santa Maria, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Cristina Wayne Nogueira</Name>
        <Affiliation>Laboratório de Síntese, Reatividade e Avaliação Farmacológica e Toxicológica de Organocalcogênios, Departamento de Bioquímica e Biologia Molecular, Centro de Ciências Naturais e Exatas, Universidade Federal de Santa Maria, CEP 97105-900 Santa Maria, Rio Grande do Sul, Brazil. Electronic address: criswn@ufsm.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Antipsychotic-induced disorders: Reported cases and prospective study on muscle biomarkers after high exposure to haloperidol.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29778398</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30220-5</DOI>
    <KeywordList>
      <Keywords>Biomarkers</Keywords>
      <Keywords>CK</Keywords>
      <Keywords>Haloperidol</Keywords>
      <Keywords>LDH</Keywords>
      <Keywords>Muscle</Keywords>
      <Keywords>Selenium</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Abderrezak Khelfi</Name>
        <Affiliation>Department of Toxicology, Bab-El-Oued Hospital, Avenue Mohamed Lamine Debaghine, 16009 Algiers, Algeria; National Center of Toxicology, Avenue petit Staouali Delly Brahim, 16062 Algiers, Algeria. Electronic address: khelfi_ar@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Mohammed Azzouz</Name>
        <Affiliation>Department of Biology and Toxicology, Ait-Idir Hospital, Avenue Abderrezak Hahad Casbah, 16017 Algiers, Algeria.</Affiliation>
      </Author>
      <Author>
        <Name>Rania Abtroun</Name>
        <Affiliation>Department of Toxicology, Bab-El-Oued Hospital, Avenue Mohamed Lamine Debaghine, 16009 Algiers, Algeria.</Affiliation>
      </Author>
      <Author>
        <Name>Mohammed Reggabi</Name>
        <Affiliation>Department of Biology and Toxicology, Ait-Idir Hospital, Avenue Abderrezak Hahad Casbah, 16017 Algiers, Algeria.</Affiliation>
      </Author>
      <Author>
        <Name>Berkahoum Alamir</Name>
        <Affiliation>Department of Toxicology, Bab-El-Oued Hospital, Avenue Mohamed Lamine Debaghine, 16009 Algiers, Algeria; National Center of Toxicology, Avenue petit Staouali Delly Brahim, 16062 Algiers, Algeria.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Antinociceptive effect of tadalafil in various pain models: Involvement of opioid receptors and nitric oxide cyclic GMP pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29777732</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30218-7</DOI>
    <KeywordList>
      <Keywords>Analgesic</Keywords>
      <Keywords>Nitric oxide</Keywords>
      <Keywords>Nociception</Keywords>
      <Keywords>Phosphodiesterase inhibitor</Keywords>
      <Keywords>Tadalafil</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mohammed M. Mehanna</Name>
        <Affiliation>Department of Pharmaceutical Technology, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon; Department of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt. Electronic address: mmhanna@bau.edu.lb.</Affiliation>
      </Author>
      <Author>
        <Name>Souraya Domiati</Name>
        <Affiliation>Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon.</Affiliation>
      </Author>
      <Author>
        <Name>Hania Nakkash Chmaisse</Name>
        <Affiliation>Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon.</Affiliation>
      </Author>
      <Author>
        <Name>Ahmed El Mallah</Name>
        <Affiliation>Department of Pharmacology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Expression and function of TLR4- induced B1R bradykinin receptor on cardiac fibroblasts.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29775649</pubmedLink>
    <GrantList>
      <Grant>PG/11/80/29135</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30210-2</DOI>
    <KeywordList>
      <Keywords>Cardiac Fibroblast</Keywords>
      <Keywords>Collagen</Keywords>
      <Keywords>Kinin Receptors</Keywords>
      <Keywords>NO</Keywords>
      <Keywords>PGI2</Keywords>
      <Keywords>TLR4</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Claudia Muñoz-Rodríguez</Name>
        <Affiliation>Laboratory of Molecular Pharmacology, Department of Pharmacological &amp; Toxicological Chemistry, Faculty of Chemical and Pharmaceutical Sciences; University of Chile, Santiago, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Samuel Fernández</Name>
        <Affiliation>Laboratory of Molecular Pharmacology, Department of Pharmacological &amp; Toxicological Chemistry, Faculty of Chemical and Pharmaceutical Sciences; University of Chile, Santiago, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>José Miguel Osorio</Name>
        <Affiliation>Laboratory of Molecular Pharmacology, Department of Pharmacological &amp; Toxicological Chemistry, Faculty of Chemical and Pharmaceutical Sciences; University of Chile, Santiago, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Francisco Olivares</Name>
        <Affiliation>Laboratory of Molecular Pharmacology, Department of Pharmacological &amp; Toxicological Chemistry, Faculty of Chemical and Pharmaceutical Sciences; University of Chile, Santiago, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Renatto Anfossi</Name>
        <Affiliation>Laboratory of Molecular Pharmacology, Department of Pharmacological &amp; Toxicological Chemistry, Faculty of Chemical and Pharmaceutical Sciences; University of Chile, Santiago, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Samir Bolivar</Name>
        <Affiliation>Laboratory of Molecular Pharmacology, Department of Pharmacological &amp; Toxicological Chemistry, Faculty of Chemical and Pharmaceutical Sciences; University of Chile, Santiago, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Claudio Humeres</Name>
        <Affiliation>Laboratory of Molecular Pharmacology, Department of Pharmacological &amp; Toxicological Chemistry, Faculty of Chemical and Pharmaceutical Sciences; University of Chile, Santiago, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Pía Boza</Name>
        <Affiliation>Laboratory of Molecular Pharmacology, Department of Pharmacological &amp; Toxicological Chemistry, Faculty of Chemical and Pharmaceutical Sciences; University of Chile, Santiago, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Raúl Vivar</Name>
        <Affiliation>Laboratory of Molecular Pharmacology, Department of Pharmacological &amp; Toxicological Chemistry, Faculty of Chemical and Pharmaceutical Sciences; University of Chile, Santiago, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Viviana Pardo-Jimenez</Name>
        <Affiliation>Laboratory of Molecular Pharmacology, Department of Pharmacological &amp; Toxicological Chemistry, Faculty of Chemical and Pharmaceutical Sciences; University of Chile, Santiago, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Karen E. Hemmings</Name>
        <Affiliation>Discovery and Translational Science Department, Leeds Institute of Cardiovascular &amp; Metabolic Medicine, School of Medicine, University of Leeds, Leeds LS2 9JT, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Neil A. Turner</Name>
        <Affiliation>Discovery and Translational Science Department, Leeds Institute of Cardiovascular &amp; Metabolic Medicine, School of Medicine, University of Leeds, Leeds LS2 9JT, United Kingdom. Electronic address: n.a.turner@leeds.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Guillermo Díaz-Araya</Name>
        <Affiliation>Laboratory of Molecular Pharmacology, Department of Pharmacological &amp; Toxicological Chemistry, Faculty of Chemical and Pharmaceutical Sciences; University of Chile, Santiago, Chile; Advanced Center of Chronic Diseases (ACCDiS), Faculty of Chemical and Pharmaceutical Sciences; University of Chile, Santiago, Chile. Electronic address: gadiaz@ciq.uchile.cl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Towards a quantitative model to predict the toxicity/pathogenicity potential of mineral fibers.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29775648</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30211-4</DOI>
    <KeywordList>
      <Keywords>Crystal structure</Keywords>
      <Keywords>Lung cancer</Keywords>
      <Keywords>Mineral fibers</Keywords>
      <Keywords>Pathogenicity</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alessandro F. Gualtieri</Name>
        <Affiliation>Chemical and Earth Sciences Department, The University of Modena and Reggio Emilia, Modena, Italy. Electronic address: alessandro.gualtieri@unimore.it.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inhibition of COX-2/mPGES-1 and 5-LOX in macrophages by leonurine ameliorates monosodium urate crystal-induced inflammation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29763636</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30209-6</DOI>
    <KeywordList>
      <Keywords>COX-2/mPGES-1/5-LOX</Keywords>
      <Keywords>Gouty arthritis</Keywords>
      <Keywords>Leonurine</Keywords>
      <Keywords>Macrophage</Keywords>
      <Keywords>NLRP3 inflammasome</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yanzhuo Liu</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chenfan Duan</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Honglei Chen</Name>
        <Affiliation>Department of Pathology and Pathophysiology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chenlong Wang</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoxiao Liu</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China; Hubei Key Laboratory of Medical Information Analysis and Tumor Diagnosis &amp; Treatment, South-central University For Nationalities, Wuhan 430074, China.</Affiliation>
      </Author>
      <Author>
        <Name>Miao Qiu</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Honglin Tang</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Feng Zhang</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoyang Zhou</Name>
        <Affiliation>Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Yang</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China. Electronic address: yangjingliu2013@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Differentiation of sow and mouse ovarian granulosa cells exposed to zearalenone in vitro using RNA-seq gene expression.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29758222</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30202-3</DOI>
    <KeywordList>
      <Keywords>Gene expression</Keywords>
      <Keywords>Granulosa cells</Keywords>
      <Keywords>Mouse</Keywords>
      <Keywords>Porcine</Keywords>
      <Keywords>RNA-seq</Keywords>
      <Keywords>ZEA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Guo Liang Zhang</Name>
        <Affiliation>College of Life Sciences, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Lin Song</Name>
        <Affiliation>Central Laboratory, Qingdao Agricultural University, Qingdao, Shandong 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Zhou</Name>
        <Affiliation>Center for Reproductive Medicine, Qingdao Women's and Children's Hospital, Qingdao University, Qingdao 266034, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Qian Zhang</Name>
        <Affiliation>College of Life Sciences, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shun Feng Cheng</Name>
        <Affiliation>College of Life Sciences, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Feng Sun</Name>
        <Affiliation>College of Life Sciences, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guo Qing Qin</Name>
        <Affiliation>Institute of Research &amp; Development, Yongda Food, Hebi 458030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Shen</Name>
        <Affiliation>College of Life Sciences, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lan Li</Name>
        <Affiliation>College of Life Sciences, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China. Electronic address: lilan9600@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Disposition and metabolism of the bisphenol analogue, bisphenol S, in Harlan Sprague Dawley rats and B6C3F1/N mice and in vitro in hepatocytes from rats, mice, and humans.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29753715</pubmedLink>
    <GrantList>
      <Grant>N01ES75563</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30207-2</DOI>
    <KeywordList>
      <Keywords>Absorption</Keywords>
      <Keywords>Bisphenol S</Keywords>
      <Keywords>Distribution</Keywords>
      <Keywords>Excretion</Keywords>
      <Keywords>Metabolism</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Suramya Waidyanatha</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA. Electronic address: waidyanathas@niehs.nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Sherry R. Black</Name>
        <Affiliation>RTI International, Discovery Sciences, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rodney W. Snyder</Name>
        <Affiliation>RTI International, Discovery Sciences, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yun Lan Yueh</Name>
        <Affiliation>RTI International, Discovery Sciences, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Vicki Sutherland</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Purvi R. Patel</Name>
        <Affiliation>RTI International, Discovery Sciences, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Scott L. Watson</Name>
        <Affiliation>RTI International, Discovery Sciences, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy R. Fennell</Name>
        <Affiliation>RTI International, Discovery Sciences, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Course-, dose-, and stage-dependent toxic effects of prenatal dexamethasone exposure on long bone development in fetal mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29753006</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30204-7</DOI>
    <KeywordList>
      <Keywords>Bone development</Keywords>
      <Keywords>Course</Keywords>
      <Keywords>Dexamethasone</Keywords>
      <Keywords>Dose</Keywords>
      <Keywords>Prenatal Exposure</Keywords>
      <Keywords>Stage</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ze Chen</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, No.185 Donghu Road, Wuhan, Hubei Province 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Zhao</Name>
        <Affiliation>Department of Physiology, Basic Medical School of Wuhan University, No.185 Donghu Road, Wuhan, Hubei Province 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yunzepeng Li</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, No.185 Donghu Road, Wuhan, Hubei Province 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Zhang</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, No.185 Donghu Road, Wuhan, Hubei Province 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zaihui Nie</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, No.185 Donghu Road, Wuhan, Hubei Province 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiang Cheng</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, No.185 Donghu Road, Wuhan, Hubei Province 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xianrong Zhang</Name>
        <Affiliation>Department of Orthopaedics and Traumatology, Nanfang Hospital, Southern Medical University, No.1838, North of Guangzhou Avenue, Guangzhou, Guangdong Province 510515, China; Guangdong Provincial Key Laboratory of Bone and Cartilage Regenerative Medicine, Nanfang Hospital, Southern Medical University, No.1838, North of Guangzhou Avenue, Guangzhou, Guangdong Province 510515, China. Electronic address: xianrongzh@smu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Wang</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, No.185 Donghu Road, Wuhan, Hubei Province 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan University, No.185 Donghu Road, Wuhan, Hubei Province 430071, China. Electronic address: wanghui19@whu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A transcriptome comparison of time-matched developing human, mouse and rat neural progenitor cells reveals human uniqueness.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29753005</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30208-4</DOI>
    <KeywordList>
      <Keywords>Alternative method</Keywords>
      <Keywords>Brain development</Keywords>
      <Keywords>DNT</Keywords>
      <Keywords>Developmental neurotoxicity</Keywords>
      <Keywords>Neurosphere</Keywords>
      <Keywords>Species differences</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Stefan Masjosthusmann</Name>
        <Affiliation>IUF - Leibniz Research Institute for Environmental Medicine, Auf'm Hennekamp 50, 40225 Duesseldorf, NRW, Germany. Electronic address: Stefan.Masjosthusmann@iuf-duesseldorf.de.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Becker</Name>
        <Affiliation>IUF - Leibniz Research Institute for Environmental Medicine, Auf'm Hennekamp 50, 40225 Duesseldorf, NRW, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Barbara Petzuch</Name>
        <Affiliation>IUF - Leibniz Research Institute for Environmental Medicine, Auf'm Hennekamp 50, 40225 Duesseldorf, NRW, Germany. Electronic address: barbara.petzuch@mnet-mail.de.</Affiliation>
      </Author>
      <Author>
        <Name>Jördis Klose</Name>
        <Affiliation>IUF - Leibniz Research Institute for Environmental Medicine, Auf'm Hennekamp 50, 40225 Duesseldorf, NRW, Germany. Electronic address: Joerdis.Klose@IUF-Duesseldorf.de.</Affiliation>
      </Author>
      <Author>
        <Name>Clara Siebert</Name>
        <Affiliation>IUF - Leibniz Research Institute for Environmental Medicine, Auf'm Hennekamp 50, 40225 Duesseldorf, NRW, Germany. Electronic address: clara@hocke-siebert.de.</Affiliation>
      </Author>
      <Author>
        <Name>Rene Deenen</Name>
        <Affiliation>Biological and Medical Research Centre (BMFZ), Medical Faculty, Heinrich-Heine-University, Universitätsstraße 1, 40225 Duesseldorf, NRW, Germany. Electronic address: Rene.deenen@thermofisher.com.</Affiliation>
      </Author>
      <Author>
        <Name>Marta Barenys</Name>
        <Affiliation>IUF - Leibniz Research Institute for Environmental Medicine, Auf'm Hennekamp 50, 40225 Duesseldorf, NRW, Germany. Electronic address: mbarenys@ub.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Jenny Baumann</Name>
        <Affiliation>IUF - Leibniz Research Institute for Environmental Medicine, Auf'm Hennekamp 50, 40225 Duesseldorf, NRW, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Katharina Dach</Name>
        <Affiliation>IUF - Leibniz Research Institute for Environmental Medicine, Auf'm Hennekamp 50, 40225 Duesseldorf, NRW, Germany; Department of Molecular Biosciences, University of California-Davis School of Veterinary Medicine, Davis, CA 95616, United States. Electronic address: kdach@ucdavis.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Julia Tigges</Name>
        <Affiliation>IUF - Leibniz Research Institute for Environmental Medicine, Auf'm Hennekamp 50, 40225 Duesseldorf, NRW, Germany. Electronic address: Julia.Tigges@IUF-Duesseldorf.de.</Affiliation>
      </Author>
      <Author>
        <Name>Ulrike Hübenthal</Name>
        <Affiliation>IUF - Leibniz Research Institute for Environmental Medicine, Auf'm Hennekamp 50, 40225 Duesseldorf, NRW, Germany. Electronic address: Ulrike.Huebenthal@IUF-Duesseldorf.de.</Affiliation>
      </Author>
      <Author>
        <Name>Karl Köhrer</Name>
        <Affiliation>Biological and Medical Research Centre (BMFZ), Medical Faculty, Heinrich-Heine-University, Universitätsstraße 1, 40225 Duesseldorf, NRW, Germany. Electronic address: koehrer@uni-duesseldorf.de.</Affiliation>
      </Author>
      <Author>
        <Name>Ellen Fritsche</Name>
        <Affiliation>IUF - Leibniz Research Institute for Environmental Medicine, Auf'm Hennekamp 50, 40225 Duesseldorf, NRW, Germany; Medical Faculty, Heinrich-Heine-University, Universitätsstraße 1, 40225 Duesseldorf, NRW, Germany. Electronic address: ellen.fritsche@iuf-duesseldorf.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Aggregate exposure of the adult French population to pyrethroids.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29753004</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30206-0</DOI>
    <KeywordList>
      <Keywords>Aggregate exposure</Keywords>
      <Keywords>Air and dust</Keywords>
      <Keywords>DCCA</Keywords>
      <Keywords>Diet</Keywords>
      <Keywords>PBPK model</Keywords>
      <Keywords>Permethrin</Keywords>
      <Keywords>Pyrethroid</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Keyvin Darney</Name>
        <Affiliation>Risk Assessment Department, French Agency for Food, Environmental and Occupational Health &amp; Safety (ANSES), 14 rue Pierre et Marie Curie, Maisons-Alfort F-94701, France. Electronic address: keyvin.darney@anses.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Laurent Bodin</Name>
        <Affiliation>Risk Assessment Department, French Agency for Food, Environmental and Occupational Health &amp; Safety (ANSES), 14 rue Pierre et Marie Curie, Maisons-Alfort F-94701, France. Electronic address: laurent.bodin@anses.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Michèle Bouchard</Name>
        <Affiliation>Department of Environmental and Occupational Health, Chair in Toxicological Risk Assessment and Management, Institute of Research in Public Health, University of Montreal, Roger-Gaudry Building, U424, P.O. Box 6128, Main Station, Montreal, Quebec H3C 3J7, Canada. Electronic address: michele.bouchard@umontreal.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Jonathan Côté</Name>
        <Affiliation>Department of Environmental and Occupational Health, Chair in Toxicological Risk Assessment and Management, Institute of Research in Public Health, University of Montreal, Roger-Gaudry Building, U424, P.O. Box 6128, Main Station, Montreal, Quebec H3C 3J7, Canada. Electronic address: jonathan.cote.3@umontreal.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Luc Volatier</Name>
        <Affiliation>Risk Assessment Department, French Agency for Food, Environmental and Occupational Health &amp; Safety (ANSES), 14 rue Pierre et Marie Curie, Maisons-Alfort F-94701, France. Electronic address: jean-luc.volatier@anses.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Virginie Desvignes</Name>
        <Affiliation>Risk Assessment Department, French Agency for Food, Environmental and Occupational Health &amp; Safety (ANSES), 14 rue Pierre et Marie Curie, Maisons-Alfort F-94701, France. Electronic address: virginie.desvignes@anses.fr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Increased butyrate priming in the gut stalls microbiome associated-gastrointestinal inflammation and hepatic metabolic reprogramming in a mouse model of Gulf War Illness.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29751049</pubmedLink>
    <GrantList>
      <Grant>R01 AI129788</Grant>
      <Grant>I01 BX001357</Grant>
      <Grant>R01 MH094755</Grant>
      <Grant>R01 ES019313</Grant>
      <Grant>P20 GM103641</Grant>
      <Grant>P01 AT003961</Grant>
      <Grant>R01 AT006888</Grant>
      <Grant>R01 AI123947</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30205-9</DOI>
    <KeywordList>
      <Keywords>Claudin-2</Keywords>
      <Keywords>Cytokines</Keywords>
      <Keywords>Gut dysbiosis</Keywords>
      <Keywords>Permethrin</Keywords>
      <Keywords>Pyridostigmine bromide</Keywords>
      <Keywords>TLR4</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ratanesh Kumar Seth</Name>
        <Affiliation>Environmental Health and Disease Laboratory, Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Diana Kimono</Name>
        <Affiliation>Environmental Health and Disease Laboratory, Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Firas Alhasson</Name>
        <Affiliation>Environmental Health and Disease Laboratory, Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sutapa Sarkar</Name>
        <Affiliation>Environmental Health and Disease Laboratory, Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Muayad Albadrani</Name>
        <Affiliation>Environmental Health and Disease Laboratory, Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen K. Lasley</Name>
        <Affiliation>Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine, Peoria, IL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ronnie Horner</Name>
        <Affiliation>Department of Health Services Policy and Management, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia Janulewicz</Name>
        <Affiliation>Department of Environmental Health, Boston University School of Public Health, Boston University, Boston, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mitzi Nagarkatti</Name>
        <Affiliation>Department of Pathology Microbiology and Immunology, USC School of Medicine, University of South Carolina, Columbia, SC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Prakash Nagarkatti</Name>
        <Affiliation>Department of Pathology Microbiology and Immunology, USC School of Medicine, University of South Carolina, Columbia, SC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kimberly Sullivan</Name>
        <Affiliation>Department of Environmental Health, Boston University School of Public Health, Boston University, Boston, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Saurabh Chatterjee</Name>
        <Affiliation>Environmental Health and Disease Laboratory, Department of Environmental Health Sciences, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA. Electronic address: Schatt@mailbox.sc.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Predicting EMP hazard: Lessons from studies with inhaled fibrous and non-fibrous nano- and micro-particles.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29751048</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30203-5</DOI>
    <KeywordList>
      <Keywords>Inhalation</Keywords>
      <Keywords>Nano and micro particles</Keywords>
      <Keywords>Persistence</Keywords>
      <Keywords>Physico-chemical properties</Keywords>
      <Keywords>Risk-ranking</Keywords>
      <Keywords>Solubility</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Günter Oberdörster</Name>
        <Affiliation>University of Rochester, United States. Electronic address: gunter_oberdorster@urmc.rochester.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Uschi Graham</Name>
        <Affiliation>University of Kentucky, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dosimetry of inhaled elongate mineral particles in the respiratory tract: The impact of shape factor.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29738812</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30194-7</DOI>
    <KeywordList>
      <Keywords>Asbestos</Keywords>
      <Keywords>Dosimetry modeling</Keywords>
      <Keywords>Elongate mineral particles (EMPs)</Keywords>
      <Keywords>Fibers</Keywords>
      <Keywords>High aspect ratio</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>Nanotubes</Keywords>
      <Keywords>Respiratory</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bahman Asgharian</Name>
        <Affiliation>Applied Research Associates, Raleigh, NC, United States. Electronic address: basgharian@ara.com.</Affiliation>
      </Author>
      <Author>
        <Name>T. Price Owen</Name>
        <Affiliation>Applied Research Associates, Arlington, VA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Eileen D. Kuempel</Name>
        <Affiliation>National Institute for Occupational Safety and Health, Cincinnati, OH, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Annie M. Jarabek</Name>
        <Affiliation>U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Investigation of belinostat-induced genomic instability by molecular cytogenetic analysis and pathway-focused gene expression profiling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29733868</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30201-1</DOI>
    <KeywordList>
      <Keywords>Belinostat</Keywords>
      <Keywords>Carcinogenesis</Keywords>
      <Keywords>DNA repair genes</Keywords>
      <Keywords>Genomic instability</Keywords>
      <Keywords>Histone deacetylase inhibitors</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>S. M. Attia</Name>
        <Affiliation>Pharmacology &amp; Toxicology Department, Faculty of Pharmacy, King Saud University, P.O. 2457, Riyadh 11451, Saudi Arabia; Pharmacology &amp; Toxicology Department, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt. Electronic address: attiasm@ksu.edu.sa.</Affiliation>
      </Author>
      <Author>
        <Name>M. A. Al-Hamamah</Name>
        <Affiliation>Pharmacology &amp; Toxicology Department, Faculty of Pharmacy, King Saud University, P.O. 2457, Riyadh 11451, Saudi Arabia.</Affiliation>
      </Author>
      <Author>
        <Name>M. R. Alotaibi</Name>
        <Affiliation>Pharmacology &amp; Toxicology Department, Faculty of Pharmacy, King Saud University, P.O. 2457, Riyadh 11451, Saudi Arabia.</Affiliation>
      </Author>
      <Author>
        <Name>G. I. Harisa</Name>
        <Affiliation>Kayyali Chair for Pharmaceutical Industry, Faculty of Pharmacy, King Saud University, Riyadh, Saudi Arabia.</Affiliation>
      </Author>
      <Author>
        <Name>M. M. Attia</Name>
        <Affiliation>Plant Protection Department, College of Agriculture, Damanhour University, Damanhour, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>S. F. Ahmad</Name>
        <Affiliation>Pharmacology &amp; Toxicology Department, Faculty of Pharmacy, King Saud University, P.O. 2457, Riyadh 11451, Saudi Arabia.</Affiliation>
      </Author>
      <Author>
        <Name>M. A. Ansari</Name>
        <Affiliation>Pharmacology &amp; Toxicology Department, Faculty of Pharmacy, King Saud University, P.O. 2457, Riyadh 11451, Saudi Arabia.</Affiliation>
      </Author>
      <Author>
        <Name>A. Nadeem</Name>
        <Affiliation>Pharmacology &amp; Toxicology Department, Faculty of Pharmacy, King Saud University, P.O. 2457, Riyadh 11451, Saudi Arabia.</Affiliation>
      </Author>
      <Author>
        <Name>S. A. Bakheet</Name>
        <Affiliation>Pharmacology &amp; Toxicology Department, Faculty of Pharmacy, King Saud University, P.O. 2457, Riyadh 11451, Saudi Arabia.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Sodium tanshinone IIA sulfonate promotes endothelial integrity via regulating VE-cadherin dynamics and RhoA/ROCK-mediated cellular contractility and prevents atorvastatin-induced intracerebral hemorrhage in zebrafish.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29730311</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30191-1</DOI>
    <KeywordList>
      <Keywords>Atorvastatin</Keywords>
      <Keywords>Hemorrhagic stroke</Keywords>
      <Keywords>ROCK</Keywords>
      <Keywords>Salvia miltiorrhiza</Keywords>
      <Keywords>Sodium tanshinone IIA sulfonate</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhong Yan Zhou</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China; Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bin Huang</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shang Li</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Hui Huang</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Yi Tang</Name>
        <Affiliation>Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yiu Wa Kwan</Name>
        <Affiliation>School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Pui Man Hoi</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China. Electronic address: maghoi@umac.mo.</Affiliation>
      </Author>
      <Author>
        <Name>Simon Ming Yuen Lee</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China. Electronic address: simonlee@umac.mo.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Analysis and identification of elongated mineral particles in road coated aggregates.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29730310</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30171-6</DOI>
    <KeywordList>
      <Keywords>Actinolite</Keywords>
      <Keywords>Asbestiform</Keywords>
      <Keywords>Cleavage fragment</Keywords>
      <Keywords>Elongated mineral particule</Keywords>
      <Keywords>Naturally occuring asbestos</Keywords>
      <Keywords>Road coated aggregate</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Erell Leocat</Name>
        <Affiliation>Asbestos Testing Unit - Eichrom Laboratories, Ker Lann Campus, Maryse Bastie Street, Bruz 35170, France. Electronic address: leocat.erell@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Christophe Rielland</Name>
        <Affiliation>Asbestos Testing Unit - Eichrom Laboratories, Ker Lann Campus, Maryse Bastie Street, Bruz 35170, France.</Affiliation>
      </Author>
      <Author>
        <Name>Patrice Letessier</Name>
        <Affiliation>Asbestos Testing Unit - Eichrom Laboratories, Ker Lann Campus, Maryse Bastie Street, Bruz 35170, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Salvianolic acid A alleviates chronic ethanol-induced liver injury via promotion of β-catenin nuclear accumulation by restoring SIRT1 in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29729281</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30190-X</DOI>
    <KeywordList>
      <Keywords>Alcoholic Liver Disease</Keywords>
      <Keywords>SIRT1</Keywords>
      <Keywords>Salvianolic Acid A</Keywords>
      <Keywords>β-Catenin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xue Shi</Name>
        <Affiliation>Department of Pharmacology, Dalian Medical University, Dalian 116044, China; Department of Pharmacy, First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Zhao</Name>
        <Affiliation>Department of Pharmacology, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunchun Ding</Name>
        <Affiliation>Department of Pharmacology, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhecheng Wang</Name>
        <Affiliation>Department of Pharmacology, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Anlong Ji</Name>
        <Affiliation>Department of General Surgery, Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenlu Li</Name>
        <Affiliation>Department of General Surgery, Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dongcheng Feng</Name>
        <Affiliation>Department of General Surgery, Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Li</Name>
        <Affiliation>Department of General Surgery, Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dongyan Gao</Name>
        <Affiliation>Department of Pharmacology, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Junjun Zhou</Name>
        <Affiliation>Department of Pharmacology, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaofeng Tian</Name>
        <Affiliation>Department of General Surgery, Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jihong Yao</Name>
        <Affiliation>Department of Pharmacology, Dalian Medical University, Dalian 116044, China. Electronic address: yaojihong65@hotmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Adiponectin gene polymorphisms and obesity increase the susceptibility to arsenic-related renal cell carcinoma.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29723618</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30188-1</DOI>
    <KeywordList>
      <Keywords>ADIPOQ</Keywords>
      <Keywords>Arsenic</Keywords>
      <Keywords>Obesity</Keywords>
      <Keywords>Polymorphism</Keywords>
      <Keywords>Renal Cell Carcinoma</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yu Mei Hsueh</Name>
        <Affiliation>Department of Family Medicine, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan; Department of Public Health, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Jen Chen</Name>
        <Affiliation>Department of Biostatistics and Epidemiology, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA; School of Public Health, College of Public Health, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Chin Lin</Name>
        <Affiliation>Department of Family Medicine, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan; Department of Health Examination, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan; Division of Family Medicine, School of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Yuan Huang</Name>
        <Affiliation>Department of Urology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan; Department of Urology, National Taiwan University Hospital, Hsin Chu Branch, Hsin Chu, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Horng Sheng Shiue</Name>
        <Affiliation>Department of Chinese Medicine, Chang Gung Memorial Hospital and Chang Gung University, College of Medicine, Taoyuan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Shu Mei Yang</Name>
        <Affiliation>School of Public Health, College of Public Health, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Pui Lam Ao</Name>
        <Affiliation>School of Public Health, College of Public Health, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yeong Shiau Pu</Name>
        <Affiliation>Department of Health Examination, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chien Tien Su</Name>
        <Affiliation>School of Public Health, College of Public Health, Taipei Medical University, Taipei, Taiwan; Department of Family Medicine, Taipei Medical University Hospital, Taipei, Taiwan. Electronic address: ctsu@tmu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Feraheme® suppresses immune function of human T lymphocytes through mitochondrial damage and mitoROS production.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29715466</pubmedLink>
    <GrantList>
      <Grant>HHSN261200800001E</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30172-8</DOI>
    <KeywordList>
      <Keywords>Immunosuppression</Keywords>
      <Keywords>Immunotoxicity</Keywords>
      <Keywords>Iron oxide</Keywords>
      <Keywords>Nanoparticles</Keywords>
      <Keywords>T Cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ankit Shah</Name>
        <Affiliation>Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Cassandra I. Mankus</Name>
        <Affiliation>Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alison M. Vermilya</Name>
        <Affiliation>Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ferri Soheilian</Name>
        <Affiliation>Electron Microscopy Laboratory, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey D. Clogston</Name>
        <Affiliation>Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marina A. Dobrovolskaia</Name>
        <Affiliation>Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA. Electronic address: marina@mail.nih.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Glyphosate affects the secretion of regulators of uterine contractions in cows while it does not directly impair the motoric function of myometrium in vitro.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29705296</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30175-3</DOI>
    <KeywordList>
      <Keywords>Cow</Keywords>
      <Keywords>Glyphosate</Keywords>
      <Keywords>Herbicide</Keywords>
      <Keywords>Ovary</Keywords>
      <Keywords>Roundup</Keywords>
      <Keywords>Uterus</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michael Hubert Wrobel</Name>
        <Affiliation>Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Tuwima Street 10, 10-748 Olsztyn, Poland. Electronic address: m.wrobel@pan.olsztyn.pl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the dose-response and fate in the lung and pleura of chrysotile-containing brake dust compared to chrysotile or crocidolite asbestos in a 28-day quantitative inhalation toxicology study.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29705295</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30177-7</DOI>
    <AuthorList>
      <Author>
        <Name>D. M. Bernstein</Name>
        <Affiliation>Consultant in Toxicology, Geneva, Switzerland. Electronic address: davidb@itox.ch.</Affiliation>
      </Author>
      <Author>
        <Name>B. Toth</Name>
        <Affiliation>CiToxLab, Szabadságpuszta, Hungary.</Affiliation>
      </Author>
      <Author>
        <Name>R. A. Rogers</Name>
        <Affiliation>Rogers Imaging, Needham, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>R. Sepulveda</Name>
        <Affiliation>Rogers Imaging, Needham, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>P. Kunzendorf</Name>
        <Affiliation>GSA Gesellschaft für Schadstoffanalytik mbH, Ratingen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>J. I. Phillips</Name>
        <Affiliation>National Institute for Occupational Health, National Health Laboratory Service, Johannesburg South Africa and Department of Biomedical Technology, University of Johannesburg, Johannesburg, South Africa.</Affiliation>
      </Author>
      <Author>
        <Name>H. Ernst</Name>
        <Affiliation>Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Standardized methods for preparation and bi-variate length &amp; diameter counting/sizing of aerosol and tissue digestion fiber samples.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29705294</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30170-4</DOI>
    <AuthorList>
      <Author>
        <Name>David M. Bernstein</Name>
        <Affiliation>Consultant in Toxicology, 1208 Geneva, Switzerland. Electronic address: davidb@itox.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Kunzendorf</Name>
        <Affiliation>GSA Gesellschaft für Schadstoffanalytik mbH, D-40880 Ratingen, Germany. Electronic address: peter.kunzendorf@gsa-ratingen.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cytotoxicity of radiocontrast dyes in human umbilical cord mesenchymal stem cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29705293</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30176-5</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Iohexol</Keywords>
      <Keywords>Iopamidol</Keywords>
      <Keywords>Mesenchymal stem cells</Keywords>
      <Keywords>Radiocontrast dyes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Christina McKee</Name>
        <Affiliation>Department of Biological Sciences, Oakland University, Rochester, MI 48309, USA; OU-WB Institute for Stem Cell and Regenerative Medicine, Oakland University, Rochester, MI 48309, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Naimisha Beeravolu</Name>
        <Affiliation>Department of Biological Sciences, Oakland University, Rochester, MI 48309, USA; OU-WB Institute for Stem Cell and Regenerative Medicine, Oakland University, Rochester, MI 48309, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Shreeya Bakshi</Name>
        <Affiliation>Department of Biological Sciences, Oakland University, Rochester, MI 48309, USA; OU-WB Institute for Stem Cell and Regenerative Medicine, Oakland University, Rochester, MI 48309, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bryan Thibodeau</Name>
        <Affiliation>Beaumont Health System, Royal Oak, MI 48073, USA.</Affiliation>
      </Author>
      <Author>
        <Name>George Wilson</Name>
        <Affiliation>OU-WB Institute for Stem Cell and Regenerative Medicine, Oakland University, Rochester, MI 48309, USA; Beaumont Health System, Royal Oak, MI 48073, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mick Perez-Cruet</Name>
        <Affiliation>OU-WB Institute for Stem Cell and Regenerative Medicine, Oakland University, Rochester, MI 48309, USA; Beaumont Health System, Royal Oak, MI 48073, USA.</Affiliation>
      </Author>
      <Author>
        <Name>G. Rasul Chaudhry</Name>
        <Affiliation>Department of Biological Sciences, Oakland University, Rochester, MI 48309, USA; OU-WB Institute for Stem Cell and Regenerative Medicine, Oakland University, Rochester, MI 48309, USA. Electronic address: chaudhry@oakland.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>DRm217 attenuates myocardial ischemia-reperfusion injury via stabilizing plasma membrane Na</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29702141</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30174-1</DOI>
    <KeywordList>
      <Keywords>DRm217</Keywords>
      <Keywords>Ischemia-reperfusion (IR)</Keywords>
      <Keywords>Myocardial cells</Keywords>
      <Keywords>Na(+)-K(+)-ATPase</Keywords>
      <Keywords>ROS</Keywords>
      <Keywords>Src</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiaofei Yan</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an 710061, Shaanxi, China; Key Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education, Xi'an, Shaanxi, China. Electronic address: yanxiaofei@xjtu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Meng Xun</Name>
        <Affiliation>Department of Immunology and Microbiology, Health Science Center, Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Litao Wu</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an 710061, Shaanxi, China; Key Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education, Xi'an, Shaanxi, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaojuan Du</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an 710061, Shaanxi, China; Key Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education, Xi'an, Shaanxi, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fujun Zhang</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an 710061, Shaanxi, China; Key Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education, Xi'an, Shaanxi, China.</Affiliation>
      </Author>
      <Author>
        <Name>J. Zheng</Name>
        <Affiliation>Hospital of Nephrology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Uranyl acetate induced DNA single strand breaks and AP sites in Chinese hamster ovary cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29698738</pubmedLink>
    <GrantList>
      <Grant>P30 ES006694</Grant>
      <Grant>R15 ES019703</Grant>
      <Grant>P42 ES004940</Grant>
      <Grant>U54 CA096281</Grant>
      <Grant>U54 CA096320</Grant>
      <Grant>F31 ES014971</Grant>
      <Grant>U54 CA143924</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30166-2</DOI>
    <KeywordList>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>DNA Damage</Keywords>
      <Keywords>Depleted Uranium</Keywords>
      <Keywords>Uranyl Acetate</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Monica Yellowhair</Name>
        <Affiliation>Department of Pharmacology and Toxicology, The University of Arizona, Tucson, AZ 85724, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle R. Romanotto</Name>
        <Affiliation>Department of Chemistry and Biochemistry, Northern Arizona University, Flagstaff, AZ 86011, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Diane M. Stearns</Name>
        <Affiliation>Department of Chemistry and Biochemistry, Northern Arizona University, Flagstaff, AZ 86011, United States.</Affiliation>
      </Author>
      <Author>
        <Name>R. Clark Lantz</Name>
        <Affiliation>Department of Cellular and Molecular Medicine, Southwest Environmental Health Sciences Center, The University of Arizona, Tucson, AZ 85724, United States. Electronic address: lantz@email.arizona.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dichlorophenyl piperazines, including a recently-approved atypical antipsychotic, are potent inhibitors of DHCR7, the last enzyme in cholesterol biosynthesis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29698737</pubmedLink>
    <GrantList>
      <Grant>R01 ES024133</Grant>
      <Grant>R01 HD064727</Grant>
      <Grant>R01 MH110636</Grant>
      <Grant>U54 HD083211</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30173-X</DOI>
    <KeywordList>
      <Keywords>Antipyschotics</Keywords>
      <Keywords>Cholesterol biosynthesis</Keywords>
      <Keywords>Neurodevelopment</Keywords>
      <Keywords>Teratogen</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Thiago C. Genaro-Mattos</Name>
        <Affiliation>Department of Chemistry, Vanderbilt Institute of Chemical Biology, Nashville, TN, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Keri A. Tallman</Name>
        <Affiliation>Department of Chemistry, Vanderbilt Institute of Chemical Biology, Nashville, TN, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Luke B. Allen</Name>
        <Affiliation>Department of Pediatrics and Biochemistry, Molecular Biology, UNMC, Omaha, NE 68198, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Allison Anderson</Name>
        <Affiliation>Munroe-Meyer Institute for Genetics and Rehabilitation, Omaha, NE 68198, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Karoly Mirnics</Name>
        <Affiliation>Munroe-Meyer Institute for Genetics and Rehabilitation, Omaha, NE 68198, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Zeljka Korade</Name>
        <Affiliation>Department of Pediatrics and Biochemistry, Molecular Biology, UNMC, Omaha, NE 68198, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ned A. Porter</Name>
        <Affiliation>Department of Chemistry, Vanderbilt Institute of Chemical Biology, Nashville, TN, United States; Vanderbilt Kennedy Center for Research on Human Development, Nashville, TN, United States. Electronic address: n.porter@vanderbilt.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pharmacologic inhibition of S1P attenuates ATF6 expression, causes ER stress and contributes to apoptotic cell death.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29689241</pubmedLink>
    <GrantList>
      <Grant>74477</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30158-3</DOI>
    <KeywordList>
      <Keywords>ATF6</Keywords>
      <Keywords>ER stress</Keywords>
      <Keywords>PF-429242</Keywords>
      <Keywords>S1P inhibition</Keywords>
      <Keywords>SREBP</Keywords>
      <Keywords>UPR inhibition</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Paul Lebeau</Name>
        <Affiliation>Department of Medicine, Division of Nephrology, McMaster University, St. Joseph's Healthcare Hamilton, Hamilton Centre for Kidney Research, Hamilton, Ontario L8N 4A6, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Hyun Byun</Name>
        <Affiliation>Department of Medicine, Division of Nephrology, McMaster University, St. Joseph's Healthcare Hamilton, Hamilton Centre for Kidney Research, Hamilton, Ontario L8N 4A6, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Tamana Yousof</Name>
        <Affiliation>Department of Medicine, Division of Nephrology, McMaster University, St. Joseph's Healthcare Hamilton, Hamilton Centre for Kidney Research, Hamilton, Ontario L8N 4A6, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Richard C. Austin</Name>
        <Affiliation>Department of Medicine, Division of Nephrology, McMaster University, St. Joseph's Healthcare Hamilton, Hamilton Centre for Kidney Research, Hamilton, Ontario L8N 4A6, Canada. Electronic address: austinr@taari.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Streptozotocin toxicity in vitro depends on maturity of neurons.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29684395</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30169-8</DOI>
    <KeywordList>
      <Keywords>Calcium</Keywords>
      <Keywords>Cultured immature neurons</Keywords>
      <Keywords>Neurodegeneration</Keywords>
      <Keywords>Streptozotocin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nickolay K. Isaev</Name>
        <Affiliation>M.V. Lomonosov Moscow State University, A.N. Belozersky Institute of Physico-Chemical Biology, Biological Faculty, Leninskiye gory, 1, b. 40, 119991 Moscow, Russia; Research Center of Neurology, Volokolamskoe Shosse 80, 125367 Moscow, Russia. Electronic address: isaev@genebee.msu.ru.</Affiliation>
      </Author>
      <Author>
        <Name>Elisaveta E. Genrikhs</Name>
        <Affiliation>Research Center of Neurology, Volokolamskoe Shosse 80, 125367 Moscow, Russia.</Affiliation>
      </Author>
      <Author>
        <Name>Dmitriy N. Voronkov</Name>
        <Affiliation>Research Center of Neurology, Volokolamskoe Shosse 80, 125367 Moscow, Russia.</Affiliation>
      </Author>
      <Author>
        <Name>Marina R. Kapkaeva</Name>
        <Affiliation>Research Center of Neurology, Volokolamskoe Shosse 80, 125367 Moscow, Russia.</Affiliation>
      </Author>
      <Author>
        <Name>Elena V. Stelmashook</Name>
        <Affiliation>Research Center of Neurology, Volokolamskoe Shosse 80, 125367 Moscow, Russia.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) attenuates silicotic fibrosis by suppressing apoptosis of alveolar type II epithelial cells via mediation of endoplasmic reticulum stress.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29684394</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30167-4</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Endoplasmic reticulum stress</Keywords>
      <Keywords>N-acetyl-seryl-aspartyl-lysyl-proline</Keywords>
      <Keywords>Silicosis</Keywords>
      <Keywords>Type II alveolar epithelial cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lijuan Zhang</Name>
        <Affiliation>Basic Medical College, Hebei Medical University, Shijiazhuang, Hebei 050017, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dingjie Xu</Name>
        <Affiliation>Traditional Chinese Medicine College, North China University of Science and Technology, Tangshan, Hebei 063210, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qian Li</Name>
        <Affiliation>Medical Research Center, North China University of Science and Technology, Tangshan, Hebei 063210, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Yang</Name>
        <Affiliation>Department of educational affairs, North China University of Science and Technology, Tangshan, Hebei 063210, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Xu</Name>
        <Affiliation>Medical Research Center, North China University of Science and Technology, Tangshan, Hebei 063210, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhongqiu Wei</Name>
        <Affiliation>Basic Medical College, North China University of Science and Technology, Tangshan, Hebei 063210, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ruimin Wang</Name>
        <Affiliation>Medical Research Center, North China University of Science and Technology, Tangshan, Hebei 063210, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenli Zhang</Name>
        <Affiliation>Medical Research Center, North China University of Science and Technology, Tangshan, Hebei 063210, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Liu</Name>
        <Affiliation>Basic Medical College, North China University of Science and Technology, Tangshan, Hebei 063210, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yucong Geng</Name>
        <Affiliation>Medical Research Center, North China University of Science and Technology, Tangshan, Hebei 063210, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shifeng Li</Name>
        <Affiliation>Medical Research Center, North China University of Science and Technology, Tangshan, Hebei 063210, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xuemin Gao</Name>
        <Affiliation>Medical Research Center, North China University of Science and Technology, Tangshan, Hebei 063210, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fang Yang</Name>
        <Affiliation>Basic Medical College, Hebei Medical University, Shijiazhuang, Hebei 050017, China; Medical Research Center, North China University of Science and Technology, Tangshan, Hebei 063210, China. Electronic address: fangyang@ncst.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Silicosis decreases bone mineral density in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29680408</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30168-6</DOI>
    <KeywordList>
      <Keywords>Bone mineral density</Keywords>
      <Keywords>Osteoclast</Keywords>
      <Keywords>Osteoporosis</Keywords>
      <Keywords>Silicosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhang Hui</Name>
        <Affiliation>Medical Research Center, North China University of Science and Technology, Tangshan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Dingjie</Name>
        <Affiliation>College of Traditional Chinese Medicine, North China University of Science and Technology, Tangshan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Yuan</Name>
        <Affiliation>Pathology Department, Beijing Tiantan Hospital, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Zhongqiu</Name>
        <Affiliation>Medical Research Center, North China University of Science and Technology, Tangshan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mao Na</Name>
        <Affiliation>Medical Research Center, North China University of Science and Technology, Tangshan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bei Mingjian</Name>
        <Affiliation>Center for Translational Medicine, Jane and Leonard Korman Respiratory Institute, Thomas Jefferson University, Philadelphia, PA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Gou Yu</Name>
        <Affiliation>Center for Translational Medicine, Jane and Leonard Korman Respiratory Institute, Thomas Jefferson University, Philadelphia, PA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Liu Guangyuan</Name>
        <Affiliation>Center for Translational Medicine, Jane and Leonard Korman Respiratory Institute, Thomas Jefferson University, Philadelphia, PA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Gao Xuemin</Name>
        <Affiliation>Medical Research Center, North China University of Science and Technology, Tangshan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Shifeng</Name>
        <Affiliation>Medical Research Center, North China University of Science and Technology, Tangshan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Geng Yucong</Name>
        <Affiliation>Medical Research Center, North China University of Science and Technology, Tangshan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Fang</Name>
        <Affiliation>Medical Research Center, North China University of Science and Technology, Tangshan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ross Summer</Name>
        <Affiliation>Center for Translational Medicine, Jane and Leonard Korman Respiratory Institute, Thomas Jefferson University, Philadelphia, PA, United States. Electronic address: ross.summer@jefferson.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Hong</Name>
        <Affiliation>Medical Research Center, North China University of Science and Technology, Tangshan, China. Electronic address: Hong.Xu2@jefferson.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>N-acetylcysteine transforms necrosis into apoptosis and affords tailored protection from cisplatin cytotoxicity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29679655</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30146-7</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Cisplatin</Keywords>
      <Keywords>N-acetylcysteine</Keywords>
      <Keywords>Necrosis</Keywords>
      <Keywords>Nephroprotectant</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sandra M. Sancho-Martínez</Name>
        <Affiliation>Institute of Biomedical Research of Salamanca (IBSAL), Spain; Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain; Group of Translational Research on Renal and Cardiovascular Diseases (TRECARD), Salamanca, Spain; Group of Biomedical Research in Critical Care Medicine (BioCritic), Valladolid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Prieto-García</Name>
        <Affiliation>Institute of Biomedical Research of Salamanca (IBSAL), Spain; Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain; Group of Translational Research on Renal and Cardiovascular Diseases (TRECARD), Salamanca, Spain; Group of Biomedical Research in Critical Care Medicine (BioCritic), Valladolid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Marta Prieto</Name>
        <Affiliation>Institute of Biomedical Research of Salamanca (IBSAL), Spain; Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain; Group of Translational Research on Renal and Cardiovascular Diseases (TRECARD), Salamanca, Spain; Group of Biomedical Research in Critical Care Medicine (BioCritic), Valladolid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Isabel Fuentes-Calvo</Name>
        <Affiliation>Institute of Biomedical Research of Salamanca (IBSAL), Spain; Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain; Group of Translational Research on Renal and Cardiovascular Diseases (TRECARD), Salamanca, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>José M. López-Novoa</Name>
        <Affiliation>Institute of Biomedical Research of Salamanca (IBSAL), Spain; Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Ana I. Morales</Name>
        <Affiliation>Institute of Biomedical Research of Salamanca (IBSAL), Spain; Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain; Group of Translational Research on Renal and Cardiovascular Diseases (TRECARD), Salamanca, Spain; Group of Biomedical Research in Critical Care Medicine (BioCritic), Valladolid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Carlos Martínez-Salgado</Name>
        <Affiliation>Institute of Biomedical Research of Salamanca (IBSAL), Spain; Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain; Instituto de Estudios de Ciencias de la Salud de Castilla y León, Soria, Spain; Group of Translational Research on Renal and Cardiovascular Diseases (TRECARD), Salamanca, Spain; Group of Biomedical Research in Critical Care Medicine (BioCritic), Valladolid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Francisco J. López-Hernández</Name>
        <Affiliation>Institute of Biomedical Research of Salamanca (IBSAL), Spain; Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain; Instituto de Estudios de Ciencias de la Salud de Castilla y León, Soria, Spain; Group of Translational Research on Renal and Cardiovascular Diseases (TRECARD), Salamanca, Spain; Group of Biomedical Research in Critical Care Medicine (BioCritic), Valladolid, Spain. Electronic address: flopezher@usal.es.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The vanillin derivative 6-bromine-5-hydroxy-4-methoxybenzaldehyde induces aberrant mitotic progression and enhances radio-sensitivity accompanying suppression the expression of PLK1 in esophageal squamous cell carcinoma.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29679654</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30165-0</DOI>
    <KeywordList>
      <Keywords>BVAN08</Keywords>
      <Keywords>Microtubule assembly</Keywords>
      <Keywords>Mitotic catastrophe</Keywords>
      <Keywords>PLK1</Keywords>
      <Keywords>Radio-sensitivity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Meng Meng Gu</Name>
        <Affiliation>State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Medical College of Soochow University, Suzhou 215123, PR China; Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Li</Name>
        <Affiliation>State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Medical College of Soochow University, Suzhou 215123, PR China; Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Dexuan Gao</Name>
        <Affiliation>Department of Urology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lang Huan Liu</Name>
        <Affiliation>School of Public Heath, Central South University, Changsha 410078, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yue Lang</Name>
        <Affiliation>State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Medical College of Soochow University, Suzhou 215123, PR China; Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Si Ming Yang</Name>
        <Affiliation>State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Medical College of Soochow University, Suzhou 215123, PR China; Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongling Ou</Name>
        <Affiliation>Department of Clinical Laboratory, The General Hospital of the PLA Rocket Force, Beijing 100088, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Huang</Name>
        <Affiliation>School of Public Heath, Central South University, Changsha 410078, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Kun Zhou</Name>
        <Affiliation>State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Medical College of Soochow University, Suzhou 215123, PR China; Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, PR China; Department of Radiation Toxicology and Oncology, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing 100850, PR China. Electronic address: zhoupk@bmi.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Zeng Fu Shang</Name>
        <Affiliation>State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Medical College of Soochow University, Suzhou 215123, PR China; Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, PR China. Electronic address: zengfu.shang@suda.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of selective serotonin-reuptake inhibitors (SSRIs) on human villous trophoblasts syncytialization.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29679653</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30153-4</DOI>
    <KeywordList>
      <Keywords>Antidepressant</Keywords>
      <Keywords>Cell Cycle</Keywords>
      <Keywords>Fusion</Keywords>
      <Keywords>Human Placenta</Keywords>
      <Keywords>Pregnancy</Keywords>
      <Keywords>Proliferation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hélène Clabault</Name>
        <Affiliation>INRS-Institut Armand-Frappier, 531 blvd des Prairies, Laval, QC, H7V 1B7, Canada; BioMed Research Centre, Université du Québec à Montréal, Montréal, QC H3C 3P8, Canada; Center for Interdisciplinary Research on Well-Being, Health, Society and Environment, Université du Québec à Montréal, Montréal, QC H3C 3P8, Canada. Electronic address: helene.clabault@iaf.inrs.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Denis Flipo</Name>
        <Affiliation>BioMed Research Centre, Université du Québec à Montréal, Montréal, QC H3C 3P8, Canada; Département des Sciences Biologiques, Université du Québec à Montréal, Montréal, QC H3C 3P8, Canada. Electronic address: flipo.denis@uqam.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Guibourdenche</Name>
        <Affiliation>INSERM, UMR-S1139, Faculté de Pharmacie de Paris, Université Paris Descartes, Sorbonne Paris Cité, Paris F-75006, France; Service d'hormonologie Centre Hospitalier, Universitaire Cochin Broca Hôtel Dieu, Assistance Publique-Hôpital de Paris, Paris F-75014, France. Electronic address: jguibourdenche@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Thierry Fournier</Name>
        <Affiliation>INSERM, UMR-S1139, Faculté de Pharmacie de Paris, Université Paris Descartes, Sorbonne Paris Cité, Paris F-75006, France; Fondation PremUp, Paris F-75006, France. Electronic address: thierry.fournier@parisdescartes.fr.</Affiliation>
      </Author>
      <Author>
        <Name>J. Thomas Sanderson</Name>
        <Affiliation>INRS-Institut Armand-Frappier, 531 blvd des Prairies, Laval, QC, H7V 1B7, Canada. Electronic address: thomas.sanderson@iaf.irns.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Cathy Vaillancourt</Name>
        <Affiliation>INRS-Institut Armand-Frappier, 531 blvd des Prairies, Laval, QC, H7V 1B7, Canada; BioMed Research Centre, Université du Québec à Montréal, Montréal, QC H3C 3P8, Canada; Center for Interdisciplinary Research on Well-Being, Health, Society and Environment, Université du Québec à Montréal, Montréal, QC H3C 3P8, Canada. Electronic address: cathy.vaillancourt@iaf.inrs.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of phenidone (DuCLOX-2/5 inhibitor) against N-methyl-N-nitrosourea induced mammary gland carcinoma in albino rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29679652</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30154-6</DOI>
    <KeywordList>
      <Keywords>Cyclooxygenase</Keywords>
      <Keywords>DuCLOX-2/5</Keywords>
      <Keywords>Lipoxygenase</Keywords>
      <Keywords>Mammary gland</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Phenidone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Swetlana Gautam</Name>
        <Affiliation>Department of Pharmaceutical Sciences, School of Biosciences and Biotechnology, Babasaheb Bhimrao Ambedkar University (A Central University), Lucknow, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Soniya Rani</Name>
        <Affiliation>Department of Pharmaceutical Sciences, School of Biosciences and Biotechnology, Babasaheb Bhimrao Ambedkar University (A Central University), Lucknow, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sara A. Aldossary</Name>
        <Affiliation>Department of Pharmaceutical Sciences, King Faisal University, Al-Ahsa, KSA, Saudi Arabia.</Affiliation>
      </Author>
      <Author>
        <Name>Abdulaziz S. Saeedan</Name>
        <Affiliation>Department of Pharmacology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, KSA, Saudi Arabia.</Affiliation>
      </Author>
      <Author>
        <Name>Mohd Nazam Ansari</Name>
        <Affiliation>Department of Pharmacology, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, KSA, Saudi Arabia.</Affiliation>
      </Author>
      <Author>
        <Name>Gaurav Kaithwas</Name>
        <Affiliation>Department of Pharmaceutical Sciences, School of Biosciences and Biotechnology, Babasaheb Bhimrao Ambedkar University (A Central University), Lucknow, Uttar Pradesh, India. Electronic address: gauravpharm@hotmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Using primary organotypic mouse midbrain cultures to examine developmental neurotoxicity of silver nanoparticles across two genetic strains.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29678449</pubmedLink>
    <GrantList>
      <Grant>U19 ES019545</Grant>
      <Grant>P30 ES007033</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30151-0</DOI>
    <KeywordList>
      <Keywords>Developmental neurotoxicity</Keywords>
      <Keywords>Dosimetry</Keywords>
      <Keywords>Genes x environment</Keywords>
      <Keywords>In vitro nanotoxicology</Keywords>
      <Keywords>Micromass</Keywords>
      <Keywords>Silver nanoparticles</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Brittany A. Weldon</Name>
        <Affiliation>Institute for Risk Analysis and Risk Communication, University of Washington, Seattle, WA, USA; Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Julie Juyoung Park</Name>
        <Affiliation>Institute for Risk Analysis and Risk Communication, University of Washington, Seattle, WA, USA; Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sungwoo Hong</Name>
        <Affiliation>Institute for Risk Analysis and Risk Communication, University of Washington, Seattle, WA, USA; Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tomomi Workman</Name>
        <Affiliation>Institute for Risk Analysis and Risk Communication, University of Washington, Seattle, WA, USA; Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Russell Dills</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Hyun Lee</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>William C. Griffith</Name>
        <Affiliation>Institute for Risk Analysis and Risk Communication, University of Washington, Seattle, WA, USA; Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Terrance J. Kavanagh</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Elaine M. Faustman</Name>
        <Affiliation>Institute for Risk Analysis and Risk Communication, University of Washington, Seattle, WA, USA; Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, USA. Electronic address: faustman@u.washington.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Detection of nanocarrier potentiation on drug induced phospholipidosis in cultured cells and primary hepatocyte spheroids by high content imaging and analysis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29678448</pubmedLink>
    <GrantList>
      <Grant>Z01 HG200319-05</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30152-2</DOI>
    <KeywordList>
      <Keywords>High content screening</Keywords>
      <Keywords>Nanocarrier</Keywords>
      <Keywords>Phospholipidosis</Keywords>
      <Keywords>Primary hepatocyte</Keywords>
      <Keywords>Spheroid</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xihui Zhang</Name>
        <Affiliation>School for Radiological and Interdisciplinary Sciences (RAD-X), State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China; School of Biology and Basic Medical Sciences, Soochow University, Suzhou 215123, China.</Affiliation>
      </Author>
      <Author>
        <Name>Liecheng Yang</Name>
        <Affiliation>School for Radiological and Interdisciplinary Sciences (RAD-X), State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China; School of Biology and Basic Medical Sciences, Soochow University, Suzhou 215123, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongming Liu</Name>
        <Affiliation>School for Radiological and Interdisciplinary Sciences (RAD-X), State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China; School of Biology and Basic Medical Sciences, Soochow University, Suzhou 215123, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhentao Song</Name>
        <Affiliation>State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jian Zhao</Name>
        <Affiliation>State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dandan Chen</Name>
        <Affiliation>School for Radiological and Interdisciplinary Sciences (RAD-X), State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huan Yu</Name>
        <Affiliation>School for Radiological and Interdisciplinary Sciences (RAD-X), State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ruibin Li</Name>
        <Affiliation>School for Radiological and Interdisciplinary Sciences (RAD-X), State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yangyun Wang</Name>
        <Affiliation>School for Radiological and Interdisciplinary Sciences (RAD-X), State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kai Yang</Name>
        <Affiliation>School for Radiological and Interdisciplinary Sciences (RAD-X), State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Chen</Name>
        <Affiliation>State Key Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai 200050, China.</Affiliation>
      </Author>
      <Author>
        <Name>Menghang Xia</Name>
        <Affiliation>National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Leshuai W. Zhang</Name>
        <Affiliation>School for Radiological and Interdisciplinary Sciences (RAD-X), State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou 215123, China. Electronic address: zhangls@suda.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Crystalline silica alters Sulfatase-1 expression in rat lungs which influences hyper-proliferative and fibrogenic effects in human lung epithelial cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29673857</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30147-9</DOI>
    <KeywordList>
      <Keywords>Crystalline-silica</Keywords>
      <Keywords>Epithelium</Keywords>
      <Keywords>HSPG</Keywords>
      <Keywords>Lung</Keywords>
      <Keywords>Silicosis</Keywords>
      <Keywords>Sulfatase-1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Timothy N. Perkins</Name>
        <Affiliation>Department of Respiratory Medicine, Maastricht University, Medical Centre, Maastricht, The Netherlands; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. Electronic address: tnp16@pitt.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Paul M. Peeters</Name>
        <Affiliation>Department of Respiratory Medicine, Maastricht University, Medical Centre, Maastricht, The Netherlands; IUF, Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany. Electronic address: p.peeters@maastrichtuniversity.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Catrin Albrecht</Name>
        <Affiliation>IUF, Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany. Electronic address: catrin.albrecht@uni-duesseldorf.de.</Affiliation>
      </Author>
      <Author>
        <Name>Roel P. F. Schins</Name>
        <Affiliation>IUF, Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany. Electronic address: Roel.Schins@uni-duesseldorf.de.</Affiliation>
      </Author>
      <Author>
        <Name>Mieke A. Dentener</Name>
        <Affiliation>Department of Respiratory Medicine, Maastricht University, Medical Centre, Maastricht, The Netherlands. Electronic address: m.dentener@maastrichtuniversity.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Brooke T. Mossman</Name>
        <Affiliation>Department of Pathology, University of Vermont College of Medicine, Burlington, VT, USA. Electronic address: brooke.mossman@med.uvm.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Emiel F. M. Wouters</Name>
        <Affiliation>Department of Respiratory Medicine, Maastricht University, Medical Centre, Maastricht, The Netherlands. Electronic address: e.wouters@mumc.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Niki L. Reynaert</Name>
        <Affiliation>Department of Respiratory Medicine, Maastricht University, Medical Centre, Maastricht, The Netherlands. Electronic address: n.reynaert@maastrichtuniversity.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>2,3,7,8-Tetrachlorodibenzo-p-dioxin dose-dependently increases bone mass and decreases marrow adiposity in juvenile mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29673856</pubmedLink>
    <GrantList>
      <Grant>P42 ES004911</Grant>
      <Grant>T32 GM092715</Grant>
      <Grant>DFS-140386</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30148-0</DOI>
    <KeywordList>
      <Keywords>AhR</Keywords>
      <Keywords>Bone</Keywords>
      <Keywords>TCDD</Keywords>
      <Keywords>Transmembrane glycoprotein NMB</Keywords>
      <Keywords>Vitamin D</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kelly A. Fader</Name>
        <Affiliation>Department of Biochemistry &amp; Molecular Biology, Michigan State University, East Lansing, MI 48824, United States; Institute for Integrative Toxicology, Michigan State University, East Lansing, MI 48824, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Rance Nault</Name>
        <Affiliation>Department of Biochemistry &amp; Molecular Biology, Michigan State University, East Lansing, MI 48824, United States; Institute for Integrative Toxicology, Michigan State University, East Lansing, MI 48824, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Sandi Raehtz</Name>
        <Affiliation>Department of Physiology, Michigan State University, East Lansing, MI 48824, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Laura R. McCabe</Name>
        <Affiliation>Department of Physiology, Michigan State University, East Lansing, MI 48824, United States; Department of Radiology, Michigan State University, East Lansing, MI 48824, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy R. Zacharewski</Name>
        <Affiliation>Department of Biochemistry &amp; Molecular Biology, Michigan State University, East Lansing, MI 48824, United States; Institute for Integrative Toxicology, Michigan State University, East Lansing, MI 48824, United States. Electronic address: tzachare@msu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Prenatal nicotine exposure intergenerationally programs imperfect articular cartilage via histone deacetylation through maternal lineage.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29660438</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30104-2</DOI>
    <KeywordList>
      <Keywords>Articular cartilage</Keywords>
      <Keywords>Histone deacetylation modification</Keywords>
      <Keywords>Intergenerational transmission</Keywords>
      <Keywords>Nicotine prenatal exposure</Keywords>
      <Keywords>Transforming growth factor β</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhe Xie</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, 185 Donghu Road, Wuchang District, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhe Zhao</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Yang</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, 185 Donghu Road, Wuchang District, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Linguo Pei</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hanwen Luo</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qubo Ni</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, 185 Donghu Road, Wuchang District, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bin Li</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongjian Qi</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, 185 Donghu Road, Wuchang District, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kai Tie</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, 185 Donghu Road, Wuchang District, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jacques Magdalou</Name>
        <Affiliation>UMR 7561CNRS, Université de Lorraine, Faculté de Médicine, Vandoeuvre-lès-Nancy, France.</Affiliation>
      </Author>
      <Author>
        <Name>Liaobin Chen</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, 185 Donghu Road, Wuchang District, Wuhan 430071, China. Electronic address: lbchen@whu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Wang</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, 185 Donghu Road, Wuchang District, Wuhan 430071, China. Electronic address: wanghui19@whu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Deoxycholylglycine, a conjugated secondary bile acid, reduces vascular tone by attenuating Ca</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29660437</pubmedLink>
    <GrantList>
      <Grant>R01 EY022416</Grant>
      <Grant>K08 DK081479</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30145-5</DOI>
    <KeywordList>
      <Keywords>Bile acids</Keywords>
      <Keywords>Cirrhosis</Keywords>
      <Keywords>Deoxycholylglycine (DCG)</Keywords>
      <Keywords>Rho kinase</Keywords>
      <Keywords>Vascular dysfunction</Keywords>
      <Keywords>Vascular tone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ravirajsinh N. Jadeja</Name>
        <Affiliation>Digestive Health Center, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Menaka C. Thounaojam</Name>
        <Affiliation>Department of Ophthalmology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Manuela Bartoli</Name>
        <Affiliation>Department of Ophthalmology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sandeep Khurana</Name>
        <Affiliation>Digestive Health Center, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA. Electronic address: skhurana@geisinger.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In vitro study of doxorubicin-induced oxidative stress in spermatogonia and immature Sertoli cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29660436</pubmedLink>
    <GrantList />
    <Year>2018</Year>
    <DOI>S0041-008X(18)30149-2</DOI>
    <KeywordList>
      <Keywords>Antioxidants</Keywords>
      <Keywords>Doxorubicin</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Sertoli cells</Keywords>
      <Keywords>Spermatogonia</Keywords>
      <Keywords>Testis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Amélie R. Tremblay</Name>
        <Affiliation>INRS-Institut Armand-Frappier, 531 boulevard des Prairies, Laval H7V 1B7, Quebec, Canada. Electronic address: amelie.tremblay@iaf.inrs.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Geraldine Delbes</Name>
        <Affiliation>INRS-Institut Armand-Frappier, 531 boulevard des Prairies, Laval H7V 1B7, Quebec, Canada. Electronic address: geraldine.delbes@iaf.inrs.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29660435</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30150-9</DOI>
    <KeywordList>
      <Keywords>Cholestasis</Keywords>
      <Keywords>Farnesoid X receptor (FXR)</Keywords>
      <Keywords>Liver inflammation</Keywords>
      <Keywords>Liver repair</Keywords>
      <Keywords>Transporters</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiaoguang Gao</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ting Fu</Name>
        <Affiliation>Pharmacy Department of Affiliated Zhongshan Hospital of Dalian University, Dalian, China.</Affiliation>
      </Author>
      <Author>
        <Name>Changyuan Wang</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian 116044, China; Key Laboratory of Pharmacokinetics and Transport of Liaoning Province, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chenqing Ning</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kexin Liu</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian 116044, China; Key Laboratory of Pharmacokinetics and Transport of Liaoning Province, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhihao Liu</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian 116044, China; Key Laboratory of Pharmacokinetics and Transport of Liaoning Province, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huijun Sun</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian 116044, China; Key Laboratory of Pharmacokinetics and Transport of Liaoning Province, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaodong Ma</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian 116044, China; Key Laboratory of Pharmacokinetics and Transport of Liaoning Province, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaokui Huo</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaobo Yang</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian 116044, China; Key Laboratory of Pharmacokinetics and Transport of Liaoning Province, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Zou</Name>
        <Affiliation>Pharmacy Department of Affiliated Zhongshan Hospital of Dalian University, Dalian, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiang Meng</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian 116044, China; Key Laboratory of Pharmacokinetics and Transport of Liaoning Province, Dalian Medical University, Dalian 116044, China. Electronic address: qiangmeng@dlmedu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mesothelioma and other lung disease in taconite miners; the uncertain role of non-asbestiform EMP.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29653125</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30142-X</DOI>
    <KeywordList>
      <Keywords>Case-Control Study</Keywords>
      <Keywords>Epidemiology</Keywords>
      <Keywords>Mesothelioma</Keywords>
      <Keywords>Mortality</Keywords>
      <Keywords>Odds Ratio</Keywords>
      <Keywords>Taconite</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jeffrey H. Mandel</Name>
        <Affiliation>Division of Environmental Health Sciences, University of Minnesota School of Public Health, 420 Delaware Street, S.E., Box 807 Mayo, Minneapolis, MN 55455, USA. Electronic address: mand0125@umn.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Nnaemeka U. Odo</Name>
        <Affiliation>United Health Group, Henderson, NV 89052, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29653124</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30144-3</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Cancer chemotherapy</Keywords>
      <Keywords>Cardiotoxicity</Keywords>
      <Keywords>Doxorubicin</Keywords>
      <Keywords>Mitochondria</Keywords>
      <Keywords>Pyruvate Dehydrogenase (PDH)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Teresa Cunha-Oliveira</Name>
        <Affiliation>CNC, Center for Neuroscience and Cell Biology, University of Coimbra, UC-Biotech Building, Biocant Park, Cantanhede, Portugal. Electronic address: teresa.oliveira@uc-biotech.pt.</Affiliation>
      </Author>
      <Author>
        <Name>Luciana L. Ferreira</Name>
        <Affiliation>CNC, Center for Neuroscience and Cell Biology, University of Coimbra, UC-Biotech Building, Biocant Park, Cantanhede, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Raquel Coelho</Name>
        <Affiliation>CNC, Center for Neuroscience and Cell Biology, University of Coimbra, UC-Biotech Building, Biocant Park, Cantanhede, Portugal; Institute for Interdisciplinary Research (I.I.I.), University of Coimbra, 3030-789 Coimbra, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Cláudia M. Deus</Name>
        <Affiliation>CNC, Center for Neuroscience and Cell Biology, University of Coimbra, UC-Biotech Building, Biocant Park, Cantanhede, Portugal; Institute for Interdisciplinary Research (I.I.I.), University of Coimbra, 3030-789 Coimbra, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Paulo J. Oliveira</Name>
        <Affiliation>CNC, Center for Neuroscience and Cell Biology, University of Coimbra, UC-Biotech Building, Biocant Park, Cantanhede, Portugal; Institute for Interdisciplinary Research (I.I.I.), University of Coimbra, 3030-789 Coimbra, Portugal.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The wakefulness promoting drug Modafinil causes adenosine receptor-mediated upregulation of receptor activator of nuclear factor κB ligand in osteoblasts: Negative impact of the drug on peak bone accrual in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29649498</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30140-6</DOI>
    <KeywordList>
      <Keywords>Cognition enhancer</Keywords>
      <Keywords>Peak bone mass</Keywords>
      <Keywords>RANKL</Keywords>
      <Keywords>Skeletal toxicity</Keywords>
      <Keywords>cAMP</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shyamsundar Pal China</Name>
        <Affiliation>Division of Endocrinology, Center for Research in Anabolic Skeletal Target in Health and Illness (ASTHI), Central Drug Research Institute (CDRI), Council of Scientific and Industrial Research (CSIR), Lucknow 226031, India; AcSIR, CSIR-Central Drug Research Institute Campus, Lucknow 226031, India.</Affiliation>
      </Author>
      <Author>
        <Name>Subhashis Pal</Name>
        <Affiliation>Division of Endocrinology, Center for Research in Anabolic Skeletal Target in Health and Illness (ASTHI), Central Drug Research Institute (CDRI), Council of Scientific and Industrial Research (CSIR), Lucknow 226031, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sourav Chattopadhyay</Name>
        <Affiliation>AcSIR, CSIR-Central Drug Research Institute Campus, Lucknow 226031, India; Division of Biochemistry, CSIR-CDRI, Lucknow 226031, India.</Affiliation>
      </Author>
      <Author>
        <Name>Konica Porwal</Name>
        <Affiliation>Division of Endocrinology, Center for Research in Anabolic Skeletal Target in Health and Illness (ASTHI), Central Drug Research Institute (CDRI), Council of Scientific and Industrial Research (CSIR), Lucknow 226031, India.</Affiliation>
      </Author>
      <Author>
        <Name>Monika Mittal</Name>
        <Affiliation>Division of Endocrinology, Center for Research in Anabolic Skeletal Target in Health and Illness (ASTHI), Central Drug Research Institute (CDRI), Council of Scientific and Industrial Research (CSIR), Lucknow 226031, India; AcSIR, CSIR-Central Drug Research Institute Campus, Lucknow 226031, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sabyasachi Sanyal</Name>
        <Affiliation>AcSIR, CSIR-Central Drug Research Institute Campus, Lucknow 226031, India; Division of Biochemistry, CSIR-CDRI, Lucknow 226031, India.</Affiliation>
      </Author>
      <Author>
        <Name>Naibedya Chattopadhyay</Name>
        <Affiliation>Division of Endocrinology, Center for Research in Anabolic Skeletal Target in Health and Illness (ASTHI), Central Drug Research Institute (CDRI), Council of Scientific and Industrial Research (CSIR), Lucknow 226031, India; AcSIR, CSIR-Central Drug Research Institute Campus, Lucknow 226031, India. Electronic address: n_chattopadhyay@cdri.res.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chronic low-dose exposure of nonylphenol alters energy homeostasis in the reproductive system of female rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29641977</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30141-8</DOI>
    <KeywordList>
      <Keywords>CPTI/AMPK/mTOR/PPAR-γ</Keywords>
      <Keywords>Chronic low-dose exposure</Keywords>
      <Keywords>Energy homeostasis</Keywords>
      <Keywords>Metabonomics</Keywords>
      <Keywords>Nonylphenol</Keywords>
      <Keywords>Reproductive toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qian Nan Di</Name>
        <Affiliation>Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Xin Cao</Name>
        <Affiliation>Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Run Xu</Name>
        <Affiliation>Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lingeng Lu</Name>
        <Affiliation>Department of Chronic Disease Epidemiology, Yale School of Public Health, School of Medicine, Yale University, 60 College Street, New Haven, CT 06520-8034, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Qian Xu</Name>
        <Affiliation>Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, China. Electronic address: q_xu68@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Bin Wang</Name>
        <Affiliation>Laboratory Animal Center, Southeast University, Nanjing 210009, China. Electronic address: xb_w@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Hazard assessment of three haloacetic acids, as byproducts of water disinfection, in human urothelial cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29634955</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30138-8</DOI>
    <KeywordList>
      <Keywords>Bromoacetic acid</Keywords>
      <Keywords>Cell transformation</Keywords>
      <Keywords>Chloroacetic acid</Keywords>
      <Keywords>Haloacetic acids</Keywords>
      <Keywords>Iodoacetic acid</Keywords>
      <Keywords>T24 cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alicia Marsà</Name>
        <Affiliation>Grup de Mutagènesi, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Constanza Cortés</Name>
        <Affiliation>Grup de Mutagènesi, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Alba Hernández</Name>
        <Affiliation>Grup de Mutagènesi, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain; CIBER Epidemiología y Salud Pública, ISCIII, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Ricard Marcos</Name>
        <Affiliation>Grup de Mutagènesi, Departament de Genètica i de Microbiologia, Facultat de Biociències, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain; CIBER Epidemiología y Salud Pública, ISCIII, Spain. Electronic address: ricard.marcos@uab.es.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Systematic developmental neurotoxicity assessment of a representative PAH Superfund mixture using zebrafish.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29630969</pubmedLink>
    <GrantList>
      <Grant>P30 ES000210</Grant>
      <Grant>P42 ES016465</Grant>
      <Grant>T32 ES007060</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30121-2</DOI>
    <KeywordList>
      <Keywords>Aryl hydrocarbon receptor</Keywords>
      <Keywords>Behavior</Keywords>
      <Keywords>Biomarker</Keywords>
      <Keywords>Cytochrome P4501A</Keywords>
      <Keywords>Passive sampling</Keywords>
      <Keywords>Polycyclic aromatic hydrocarbons</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mitra C. Geier</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, Oregon State University, ALS 1007, Corvallis, OR 97331, United States.</Affiliation>
      </Author>
      <Author>
        <Name>D. James Minick</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, Oregon State University, ALS 1007, Corvallis, OR 97331, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa Truong</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, Oregon State University, ALS 1007, Corvallis, OR 97331, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Susan Tilton</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, Oregon State University, ALS 1007, Corvallis, OR 97331, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Paritosh Pande</Name>
        <Affiliation>Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99352, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Kim A. Anderson</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, Oregon State University, ALS 1007, Corvallis, OR 97331, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Justin Teeguardan</Name>
        <Affiliation>Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99352, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Robert L. Tanguay</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, Oregon State University, ALS 1007, Corvallis, OR 97331, United States. Electronic address: Robert.Tanguay@oregonstate.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Antimicrobial agent triclosan disrupts mitochondrial structure, revealed by super-resolution microscopy, and inhibits mast cell signaling via calcium modulation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29630968</pubmedLink>
    <GrantList>
      <Grant>P20 GM103423</Grant>
      <Grant>R15 ES024593</Grant>
      <Grant>R15 GM094713</Grant>
      <Grant>R15 GM116002</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30139-X</DOI>
    <KeywordList>
      <Keywords>Ca(2+)</Keywords>
      <Keywords>Degranulation</Keywords>
      <Keywords>Fluorescence photoactivation localization microscopy (FPALM)</Keywords>
      <Keywords>Keratinocyte</Keywords>
      <Keywords>Mast cell</Keywords>
      <Keywords>Membrane potential</Keywords>
      <Keywords>Microtubules</Keywords>
      <Keywords>Mitochondria</Keywords>
      <Keywords>NIH-3T3</Keywords>
      <Keywords>RBL-2H3</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
      <Keywords>Super-resolution microscopy</Keywords>
      <Keywords>Triclosan</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lisa M. Weatherly</Name>
        <Affiliation>Graduate School of Biomedical Science and Engineering, University of Maine, Orono, ME, USA; Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew J. Nelson</Name>
        <Affiliation>Department of Physics and Astronomy, University of Maine, Orono, ME, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Juyoung Shim</Name>
        <Affiliation>Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Abigail M. Riitano</Name>
        <Affiliation>Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Erik D. Gerson</Name>
        <Affiliation>Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew J. Hart</Name>
        <Affiliation>Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jaime de Juan-Sanz</Name>
        <Affiliation>Department of Biochemistry, Weill Cornell Medicine, New York, NY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy A. Ryan</Name>
        <Affiliation>Department of Biochemistry, Weill Cornell Medicine, New York, NY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Roger Sher</Name>
        <Affiliation>Department of Neurobiology and Behavior, Stony Brook University, Stony Brook, NY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Samuel T. Hess</Name>
        <Affiliation>Graduate School of Biomedical Science and Engineering, University of Maine, Orono, ME, USA; Department of Physics and Astronomy, University of Maine, Orono, ME, USA. Electronic address: Samuel.hess@maine.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Julie A. Gosse</Name>
        <Affiliation>Graduate School of Biomedical Science and Engineering, University of Maine, Orono, ME, USA; Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME, USA. Electronic address: Julie.gosse@maine.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>TRPA1 mediates the cardiac effects of acrolein through parasympathetic dominance but also sympathetic modulation in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29627347</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
      <Grant>T32 ES007126</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30113-3</DOI>
    <KeywordList>
      <Keywords>Acrolein</Keywords>
      <Keywords>Arrhythmia</Keywords>
      <Keywords>Autonomic nervous system</Keywords>
      <Keywords>Cardiac</Keywords>
      <Keywords>Heart rate variability</Keywords>
      <Keywords>Whole body plethysmography</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nicole Kurhanewicz</Name>
        <Affiliation>Curriciulm in Toxicology, School of Medicine, University of North Carolina, Chapel Hill, NC 27599, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Allen Ledbetter</Name>
        <Affiliation>Environmental Public Health Division, National Health and Environmental Effects Research Laboratory, US Environmental Protection Agency, Research Triangle Park, NC 27711, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Aimen Farraj</Name>
        <Affiliation>Environmental Public Health Division, National Health and Environmental Effects Research Laboratory, US Environmental Protection Agency, Research Triangle Park, NC 27711, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mehdi Hazari</Name>
        <Affiliation>Environmental Public Health Division, National Health and Environmental Effects Research Laboratory, US Environmental Protection Agency, Research Triangle Park, NC 27711, United States. Electronic address: hazari.mehdi@epa.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Berberine induced modulation of PHLPP2-Akt-MST1 kinase signaling is coupled with mitochondrial impairment and hepatoma cell death.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29626488</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30131-5</DOI>
    <KeywordList>
      <Keywords>Akt</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Berberine</Keywords>
      <Keywords>Bim</Keywords>
      <Keywords>Mst1</Keywords>
      <Keywords>PHLPP2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sugandh Saxena</Name>
        <Affiliation>Herbal Research Laboratory, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhawan 31, Mahatma Gandhi Marg, Lucknow 226001, India; Academy of Scientific and Innovative Research, CSIR-IITR, Lucknow, India.</Affiliation>
      </Author>
      <Author>
        <Name>Shatrunajay Shukla</Name>
        <Affiliation>Herbal Research Laboratory, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhawan 31, Mahatma Gandhi Marg, Lucknow 226001, India.</Affiliation>
      </Author>
      <Author>
        <Name>Poonam Kakkar</Name>
        <Affiliation>Herbal Research Laboratory, CSIR-Indian Institute of Toxicology Research (CSIR-IITR), Vishvigyan Bhawan 31, Mahatma Gandhi Marg, Lucknow 226001, India; Academy of Scientific and Innovative Research, CSIR-IITR, Lucknow, India. Electronic address: pkakkar@iitr.res.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Testing for developmental neurotoxicity using a battery of in vitro assays for key cellular events in neurodevelopment.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29626487</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30135-2</DOI>
    <KeywordList>
      <Keywords>Assay suite</Keywords>
      <Keywords>Concentration-response</Keywords>
      <Keywords>Developmental neurotoxicity</Keywords>
      <Keywords>High content imaging</Keywords>
      <Keywords>In vitro models</Keywords>
      <Keywords>Toxicity screening</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joshua A. Harrill</Name>
        <Affiliation>National Center for Computational Toxicology, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, USA. Electronic address: harrill.joshua@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Theresa Freudenrich</Name>
        <Affiliation>National Health and Environmental Effects Research Laboratory, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kathleen Wallace</Name>
        <Affiliation>National Health and Environmental Effects Research Laboratory, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kenneth Ball</Name>
        <Affiliation>National Health and Environmental Effects Research Laboratory, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, USA; Oak Ridge Institute for Science and Education, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy J. Shafer</Name>
        <Affiliation>National Health and Environmental Effects Research Laboratory, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>William R. Mundy</Name>
        <Affiliation>National Health and Environmental Effects Research Laboratory, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Substituents at the C3' and C3'N positions are critical for taxanes to overcome acquired resistance of cancer cells to paclitaxel.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29625142</pubmedLink>
    <GrantList>
      <Grant>R01 CA103314</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30136-4</DOI>
    <KeywordList>
      <Keywords>ABCB1 transporter</Keywords>
      <Keywords>Acquired resistance to paclitaxel</Keywords>
      <Keywords>Breast cancer cells</Keywords>
      <Keywords>Molecular docking</Keywords>
      <Keywords>Taxane derivates</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michael Jelínek</Name>
        <Affiliation>Department of Cell and Molecular Biology, Third Faculty of Medicine, Charles University, Ruská 87, 110 00 Prague, Czech Republic. Electronic address: michael.j@email.cz.</Affiliation>
      </Author>
      <Author>
        <Name>Kamila Balušíková</Name>
        <Affiliation>Department of Cell and Molecular Biology, Third Faculty of Medicine, Charles University, Ruská 87, 110 00 Prague, Czech Republic. Electronic address: kamilabalusikova@seznam.cz.</Affiliation>
      </Author>
      <Author>
        <Name>Petr Daniel</Name>
        <Affiliation>Department of Cell and Molecular Biology, Third Faculty of Medicine, Charles University, Ruská 87, 110 00 Prague, Czech Republic. Electronic address: petr85daniel@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Vlasta Němcová-Fürstová</Name>
        <Affiliation>Department of Cell and Molecular Biology, Third Faculty of Medicine, Charles University, Ruská 87, 110 00 Prague, Czech Republic. Electronic address: vlasta.furstova@lf3.cuni.cz.</Affiliation>
      </Author>
      <Author>
        <Name>Palani Kirubakaran</Name>
        <Affiliation>Institute of Organic Chemistry and Biochemistry, Czech Academy of Science, Flemingovo náměstí 542/2, 166 10 Prague, Czech Republic. Electronic address: kirubakaran.palani@uochb.cas.cz.</Affiliation>
      </Author>
      <Author>
        <Name>Martin Jaček</Name>
        <Affiliation>Department of Hygiene, Epidemiology and Preventive Medicine, Third Faculty of Medicine, Charles University, Ruská 87, 110 00 Prague, Czech Republic. Electronic address: martin.jacek@volny.cz.</Affiliation>
      </Author>
      <Author>
        <Name>Longfei Wei</Name>
        <Affiliation>Department of Chemistry, Institute of Chemical Biology and Drug Discovery, State University of New York at Stony Brook, Stony Brook, NY 11794-3400, USA. Electronic address: longfei.wei@stonybrook.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Wang</Name>
        <Affiliation>Department of Chemistry, Institute of Chemical Biology and Drug Discovery, State University of New York at Stony Brook, Stony Brook, NY 11794-3400, USA. Electronic address: xin.wang@stonybrook.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Jiří Vondrášek</Name>
        <Affiliation>Institute of Organic Chemistry and Biochemistry, Czech Academy of Science, Flemingovo náměstí 542/2, 166 10 Prague, Czech Republic. Electronic address: jiri.vondrasek@uochb.cas.cz.</Affiliation>
      </Author>
      <Author>
        <Name>Iwao Ojima</Name>
        <Affiliation>Department of Chemistry, Institute of Chemical Biology and Drug Discovery, State University of New York at Stony Brook, Stony Brook, NY 11794-3400, USA. Electronic address: iwao.ojima@stonybrook.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Jan Kovář</Name>
        <Affiliation>Department of Cell and Molecular Biology, Third Faculty of Medicine, Charles University, Ruská 87, 110 00 Prague, Czech Republic. Electronic address: jan.kovar@lf3.cuni.cz.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Arsenic-gene interactions and beta-cell function in the Strong Heart Family Study.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29621497</pubmedLink>
    <GrantList>
      <Grant>U01 HL041642</Grant>
      <Grant>U01 HL041654</Grant>
      <Grant>R01 ES025216</Grant>
      <Grant>UL1 TR001409</Grant>
      <Grant>U01 HL041652</Grant>
      <Grant>P42 ES010349</Grant>
      <Grant>R01 HL109315</Grant>
      <Grant>L60 MD008216</Grant>
      <Grant>R01 HL109319</Grant>
      <Grant>R01 HL109284</Grant>
      <Grant>U01 HL065521</Grant>
      <Grant>T32 ES007141</Grant>
      <Grant>P30 ES019776</Grant>
      <Grant>R01 HL109282</Grant>
      <Grant>U01 HL065520</Grant>
      <Grant>R01 ES021367</Grant>
      <Grant>R01 HL109301</Grant>
      <Grant>P30 ES009089</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30134-0</DOI>
    <KeywordList>
      <Keywords>Arsenicals</Keywords>
      <Keywords>Diabetes</Keywords>
      <Keywords>Environmental Epidemiology</Keywords>
      <Keywords>Genetic Epidemiology</Keywords>
      <Keywords>Pancreas</Keywords>
      <Keywords>Susceptibility</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Poojitha Balakrishnan</Name>
        <Affiliation>Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, NY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Navas-Acien</Name>
        <Affiliation>Department of Environmental Health Sciences, Columbia University Mailman School of Public Health, New York, NY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Karin Haack</Name>
        <Affiliation>Texas Biomedical Research Institute, San Antonio, TX, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Dhananjay Vaidya</Name>
        <Affiliation>Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, United States; Clinical and Translational Research, Johns Hopkins School of Medicine, Baltimore, MD, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jason G. Umans</Name>
        <Affiliation>MedStar Health Research Institute, Hyattsville, MD, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Lyle G. Best</Name>
        <Affiliation>Missouri Breaks Industries Research, Inc., Eagle Butte, SD, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Walter Goessler</Name>
        <Affiliation>Institute of Chemistry, University of Graz, Graz, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin A. Francesconi</Name>
        <Affiliation>Institute of Chemistry, University of Graz, Graz, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>Nora Franceschini</Name>
        <Affiliation>Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Kari E. North</Name>
        <Affiliation>Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Shelley A. Cole</Name>
        <Affiliation>Texas Biomedical Research Institute, San Antonio, TX, United States.</Affiliation>
      </Author>
      <Author>
        <Name>V. Saroja Voruganti</Name>
        <Affiliation>Department of Nutrition and UNC Nutrition Research Institute, University of North Carolina at Chapel Hill, Kannapolis, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew O. Gribble</Name>
        <Affiliation>Department of Environmental Health, Emory University Rollins School of Public Health, Atlanta, GA, United States; Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA, United States. Electronic address: matt.gribble@emory.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Fluoride induces apoptosis via inhibiting SIRT1 activity to activate mitochondrial p53 pathway in human neuroblastoma SH-SY5Y cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29609003</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30122-4</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Fluoride</Keywords>
      <Keywords>Neurotoxicity</Keywords>
      <Keywords>SIRT1</Keywords>
      <Keywords>p53</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wei Tu</Name>
        <Affiliation>Department of Occupational and Environmental Health, Key Laboratory of Environment and Health, Ministry of Education, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Qian Zhang</Name>
        <Affiliation>Department of Occupational and Environmental Health, Key Laboratory of Environment and Health, Ministry of Education, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yin Liu</Name>
        <Affiliation>Department of Occupational and Environmental Health, Key Laboratory of Environment and Health, Ministry of Education, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lianyong Han</Name>
        <Affiliation>Department of Occupational and Environmental Health, Key Laboratory of Environment and Health, Ministry of Education, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Qin Wang</Name>
        <Affiliation>Department of Occupational and Environmental Health, Key Laboratory of Environment and Health, Ministry of Education, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Panpan Chen</Name>
        <Affiliation>Department of Occupational and Environmental Health, Key Laboratory of Environment and Health, Ministry of Education, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shun Zhang</Name>
        <Affiliation>Department of Occupational and Environmental Health, Key Laboratory of Environment and Health, Ministry of Education, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Aiguo Wang</Name>
        <Affiliation>Department of Occupational and Environmental Health, Key Laboratory of Environment and Health, Ministry of Education, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xue Zhou</Name>
        <Affiliation>Department of Occupational and Environmental Health, Key Laboratory of Environment and Health, Ministry of Education, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, PR China. Electronic address: xue.zhou@hust.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Angiotensin II facilitates neointimal formation by increasing vascular smooth muscle cell migration: Involvement of APE/Ref-1-mediated overexpression of sphingosine-1-phosphate receptor 1.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29609002</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30124-8</DOI>
    <KeywordList>
      <Keywords>APE/Ref-1</Keywords>
      <Keywords>Angiotensin II</Keywords>
      <Keywords>Sphingosine-1-phosphate receptor (S1PR)</Keywords>
      <Keywords>Vascular neointima</Keywords>
      <Keywords>Vascular smooth muscle cell (VSMC)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dong Youb Lee</Name>
        <Affiliation>Department of Medicine, School of Medicine, Konkuk University, Seoul 05029, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyung Jong Won</Name>
        <Affiliation>Department of Medicine, School of Medicine, Konkuk University, Seoul 05029, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kang Pa Lee</Name>
        <Affiliation>Department of Medicine, School of Medicine, Konkuk University, Seoul 05029, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Hyo Jung</Name>
        <Affiliation>Department of Medicine, School of Medicine, Konkuk University, Seoul 05029, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Suji Baek</Name>
        <Affiliation>Department of Medicine, School of Medicine, Konkuk University, Seoul 05029, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyun Woo Chung</Name>
        <Affiliation>Department of Medicine, School of Medicine, Konkuk University, Seoul 05029, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Wahn Soo Choi</Name>
        <Affiliation>Department of Medicine, School of Medicine, Konkuk University, Seoul 05029, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hwan Myung Lee</Name>
        <Affiliation>Department of Cosmetic Science, College of Life and Health, Hoseo University, Asan 336-795, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Byeong Han Lee</Name>
        <Affiliation>Laboratory Animal Center, Osong Medical Innovation Foundation, 123 Osongsaengmyeong-ro, Chungbuk 28160, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Byeong Hwa Jeon</Name>
        <Affiliation>Department of Physiology, School of Medicine, Chungnam National University, Daejeon 301-131, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Bokyung Kim</Name>
        <Affiliation>Department of Medicine, School of Medicine, Konkuk University, Seoul 05029, Republic of Korea. Electronic address: bkkim2@kku.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological assessment of PEGylated single-walled carbon nanotubes in early developing zebrafish.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29609001</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30123-6</DOI>
    <KeywordList>
      <Keywords>Carbon nanomaterials</Keywords>
      <Keywords>Danio rerio</Keywords>
      <Keywords>Embriotoxicity</Keywords>
      <Keywords>Nanotoxicology</Keywords>
      <Keywords>Polyethylene glycol</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marcos F. Cordeiro</Name>
        <Affiliation>Programa de Pós Graduação em Ciências Fisiológicas (PPGCF), Universidade Federal do Rio Grande (FURG), Rio Grande, RS, Brazil. Electronic address: mfcordeiro@furg.br.</Affiliation>
      </Author>
      <Author>
        <Name>Felipe A. Girardi</Name>
        <Affiliation>Programa de Residência Multiprofissional em Atenção ao Câncer, Universidade de Passo Fundo (UPF), Passo Fundo, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Carla O. F. Gonçalves</Name>
        <Affiliation>Centro de Desenvolvimento de Tecnologia Nuclear (CDTN), Belo Horizonte, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Carolina S. Peixoto</Name>
        <Affiliation>Programa de Pós Graduação em Ciências Fisiológicas (PPGCF), Universidade Federal do Rio Grande (FURG), Rio Grande, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Lidiane Dal Bosco</Name>
        <Affiliation>Universidade Federal do Pampa (UNIPAMPA), Uruguaiana, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Sangram K. Sahoo</Name>
        <Affiliation>Departamento de Física, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Adelina P. Santos</Name>
        <Affiliation>Centro de Desenvolvimento de Tecnologia Nuclear (CDTN), Belo Horizonte, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Cristiano Fantini</Name>
        <Affiliation>Departamento de Física, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Gisele Eva Bruch</Name>
        <Affiliation>Programa de Pós Graduação em Ciências Fisiológicas (PPGCF), Universidade Federal do Rio Grande (FURG), Rio Grande, RS, Brazil; Programa de Pós Graduação em Ciências Biológicas: Fisiologia e Farmacologia, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Paula Horn</Name>
        <Affiliation>Programa de Pós Graduação em Ciências Fisiológicas (PPGCF), Universidade Federal do Rio Grande (FURG), Rio Grande, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Daniela M. Barros</Name>
        <Affiliation>Programa de Pós Graduação em Ciências Fisiológicas (PPGCF), Universidade Federal do Rio Grande (FURG), Rio Grande, RS, Brazil. Electronic address: barrosdm@yahoo.com.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cardiac safety evaluation in zebrafish and in silico ADME prediction of cephalosporins with an aminothiazoyl ring at the C-7 position.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29596928</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30108-X</DOI>
    <KeywordList>
      <Keywords>Biomarkers</Keywords>
      <Keywords>Cardiac toxicity</Keywords>
      <Keywords>Embryo</Keywords>
      <Keywords>Predictive toxicology</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ying Han</Name>
        <Affiliation>Division of Antibiotics, National Institutes for Food and Drug Control, Beijing 102629, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Chen</Name>
        <Affiliation>Department of Pharmacology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100050, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingpu Zhang</Name>
        <Affiliation>Department of Pharmacology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100050, China. Electronic address: zhangjingpu@imb.pumc.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Changqin Hu</Name>
        <Affiliation>Division of Antibiotics, National Institutes for Food and Drug Control, Beijing 102629, China. Electronic address: hucq@nifdc.org.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Gene expression profiling of human bronchial epithelial cells exposed to fine particulate matter (PM</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29596927</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30110-8</DOI>
    <KeywordList>
      <Keywords>Biomass combustion</Keywords>
      <Keywords>Gene ontology analysis</Keywords>
      <Keywords>Human bronchial epithelial cells</Keywords>
      <Keywords>Particulate matter</Keywords>
      <Keywords>Pathway analysis</Keywords>
      <Keywords>Transcriptome</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Désirée Popadić</Name>
        <Affiliation>Institute of Pharmaceutical Sciences, Department of Pharmaceutical Biology and Biotechnology, Albert-Ludwigs-University Freiburg, Freiburg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Katharina Heßelbach</Name>
        <Affiliation>Institute of Pharmaceutical Sciences, Department of Pharmaceutical Biology and Biotechnology, Albert-Ludwigs-University Freiburg, Freiburg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Sigrid Richter-Brockmann</Name>
        <Affiliation>Institute of Geology and Palaeontology - Applied Geology, University of Muenster, Muenster, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Gwang Jin Kim</Name>
        <Affiliation>Institute of Pharmaceutical Sciences, Department of Pharmaceutical Bioinformatics, Albert-Ludwigs-University Freiburg, Freiburg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Stephan Flemming</Name>
        <Affiliation>Institute of Pharmaceutical Sciences, Department of Pharmaceutical Bioinformatics, Albert-Ludwigs-University Freiburg, Freiburg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Wolfgang Schmidt-Heck</Name>
        <Affiliation>Leibniz Institute for Natural Product Research and Infection Biology - Hans-Knöll-Institute (HKI), Jena, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Häupl</Name>
        <Affiliation>Department of Rheumatology and Clinical Immunology, Charité University Hospital Berlin, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Marc Bonin</Name>
        <Affiliation>Department of Rheumatology and Clinical Immunology, Charité University Hospital Berlin, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Regina Dornhof</Name>
        <Affiliation>Institute of Pharmaceutical Sciences, Department of Pharmaceutical Biology and Biotechnology, Albert-Ludwigs-University Freiburg, Freiburg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Christine Achten</Name>
        <Affiliation>Institute of Geology and Palaeontology - Applied Geology, University of Muenster, Muenster, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Stefan Günther</Name>
        <Affiliation>Institute of Pharmaceutical Sciences, Department of Pharmaceutical Bioinformatics, Albert-Ludwigs-University Freiburg, Freiburg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Matjaz Humar</Name>
        <Affiliation>Institute of Pharmaceutical Sciences, Department of Pharmaceutical Biology and Biotechnology, Albert-Ludwigs-University Freiburg, Freiburg, Germany. Electronic address: matjaz.humar@pharmazie.uni-freiburg.de.</Affiliation>
      </Author>
      <Author>
        <Name>Irmgard Merfort</Name>
        <Affiliation>Institute of Pharmaceutical Sciences, Department of Pharmaceutical Biology and Biotechnology, Albert-Ludwigs-University Freiburg, Freiburg, Germany; Spemann Graduate School of Biology and Medicine (SGBM), Albert-Ludwigs University Freiburg, Freiburg, Germany. Electronic address: irmgard.merfort@pharmazie.uni-freiburg.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of prenatal exposure to triclosan on the liver transcriptome in chicken embryos.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29596926</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30112-1</DOI>
    <KeywordList>
      <Keywords>Adverse outcome pathway</Keywords>
      <Keywords>Chicken embryo</Keywords>
      <Keywords>Tarsus length</Keywords>
      <Keywords>Transcriptome</Keywords>
      <Keywords>Triclosan</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jiahua Guo</Name>
        <Affiliation>Center for Marine Environmental Studies, Ehime University, Bunkyo-cho 2-5, Matsuyama, Ehime Prefecture, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shohei Ito</Name>
        <Affiliation>Center for Marine Environmental Studies, Ehime University, Bunkyo-cho 2-5, Matsuyama, Ehime Prefecture, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hoa Thanh Nguyen</Name>
        <Affiliation>Center for Marine Environmental Studies, Ehime University, Bunkyo-cho 2-5, Matsuyama, Ehime Prefecture, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kimika Yamamoto</Name>
        <Affiliation>Center for Marine Environmental Studies, Ehime University, Bunkyo-cho 2-5, Matsuyama, Ehime Prefecture, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Rumi Tanoue</Name>
        <Affiliation>Center for Marine Environmental Studies, Ehime University, Bunkyo-cho 2-5, Matsuyama, Ehime Prefecture, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tatsuya Kunisue</Name>
        <Affiliation>Center for Marine Environmental Studies, Ehime University, Bunkyo-cho 2-5, Matsuyama, Ehime Prefecture, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hisato Iwata</Name>
        <Affiliation>Center for Marine Environmental Studies, Ehime University, Bunkyo-cho 2-5, Matsuyama, Ehime Prefecture, Japan. Electronic address: iwata.hisato.mz@ehime-u.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Association of pesticide exposure with human congenital abnormalities.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29596925</pubmedLink>
    <GrantList>
      <Grant>T32 DK007529</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30111-X</DOI>
    <KeywordList>
      <Keywords>Congenital abnormalities</Keywords>
      <Keywords>Ecotoxicology</Keywords>
      <Keywords>Human</Keywords>
      <Keywords>Musculoskeletal abnormalities</Keywords>
      <Keywords>Neural tube defects</Keywords>
      <Keywords>Pesticides</Keywords>
      <Keywords>Urogenital abnormalities</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Charikleia Kalliora</Name>
        <Affiliation>Medical School, University of Crete, Heraklion, Crete, Greece; Department of Pharmacology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Charalampos Mamoulakis</Name>
        <Affiliation>Department of Urology, University General Hospital of Heraklion, University of Crete, Medical School, Heraklion, Crete, Greece. Electronic address: mamoulak@uoc.gr.</Affiliation>
      </Author>
      <Author>
        <Name>Eleni Vasilopoulos</Name>
        <Affiliation>Department of Biology, Temple University, Philadelphia, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>George A. Stamatiades</Name>
        <Affiliation>Division of Endocrinology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lydia Kalafati</Name>
        <Affiliation>Department of Biology, University of Crete, Greece.</Affiliation>
      </Author>
      <Author>
        <Name>Roza Barouni</Name>
        <Affiliation>Department of Biology, University of Athens, Greece.</Affiliation>
      </Author>
      <Author>
        <Name>Triantafyllia Karakousi</Name>
        <Affiliation>Department of Biology, University of Crete, Greece.</Affiliation>
      </Author>
      <Author>
        <Name>Mohammad Abdollahi</Name>
        <Affiliation>Department of Toxicology &amp; Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Aristidis Tsatsakis</Name>
        <Affiliation>Department of Toxicology &amp; Forensic Science, Medical School, University of Crete, Voutes Campus, Heraklion 71003, Greece.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Do in vitro assays in rat primary neurons predict drug-induced seizure liability in humans?</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29596924</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30114-5</DOI>
    <KeywordList>
      <Keywords>Drug-induced seizures</Keywords>
      <Keywords>MEA</Keywords>
      <Keywords>Primary neurons</Keywords>
      <Keywords>Safety pharmacology</Keywords>
      <Keywords>in vitro</Keywords>
      <Keywords>in vivo</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>M. Kreir</Name>
        <Affiliation>Preclinical Development and Safety, Discovery Sciences, Janssen Research and Development, Janssen Pharmaceutica NV, Beerse, Belgium. Electronic address: mkreir@its.jnj.com.</Affiliation>
      </Author>
      <Author>
        <Name>B. Van Deuren</Name>
        <Affiliation>Preclinical Development and Safety, Discovery Sciences, Janssen Research and Development, Janssen Pharmaceutica NV, Beerse, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>S. Versweyveld</Name>
        <Affiliation>Neuroscience Discovery, Janssen Research and Development, Division of Janssen Pharmaceutica NV, Beerse, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>A. De Bondt</Name>
        <Affiliation>Computational Sciences, Discovery Sciences, Janssen Research and Development, Janssen Pharmaceutica NV, Beerse, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>I. Van den Wyngaert</Name>
        <Affiliation>Computational Sciences, Discovery Sciences, Janssen Research and Development, Janssen Pharmaceutica NV, Beerse, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>H. Van der Linde</Name>
        <Affiliation>Preclinical Development and Safety, Discovery Sciences, Janssen Research and Development, Janssen Pharmaceutica NV, Beerse, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>H. R. Lu</Name>
        <Affiliation>Preclinical Development and Safety, Discovery Sciences, Janssen Research and Development, Janssen Pharmaceutica NV, Beerse, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>G. Teuns</Name>
        <Affiliation>Preclinical Development and Safety, Discovery Sciences, Janssen Research and Development, Janssen Pharmaceutica NV, Beerse, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>D. J. Gallacher</Name>
        <Affiliation>Preclinical Development and Safety, Discovery Sciences, Janssen Research and Development, Janssen Pharmaceutica NV, Beerse, Belgium.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of continuous bisphenol A exposure from early gestation on 90 day old rat testes function and sperm molecular profiles: A CLARITY-BPA consortium study.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29596923</pubmedLink>
    <GrantList>
      <Grant>T32 ES007272</Grant>
      <Grant>U01 ES020913</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30107-8</DOI>
    <AuthorList>
      <Author>
        <Name>Edward Dere</Name>
        <Affiliation>Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, United States; Division of Urology, Rhode Island Hospital, Providence, RI, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Linnea M. Anderson</Name>
        <Affiliation>Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Susan M. Huse</Name>
        <Affiliation>Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel J. Spade</Name>
        <Affiliation>Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Elizabeth McDonnell-Clark</Name>
        <Affiliation>Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Samantha J. Madnick</Name>
        <Affiliation>Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Susan J. Hall</Name>
        <Affiliation>Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Luísa Camacho</Name>
        <Affiliation>Division of Biochemical Toxicology, National Center for Toxicological Research, Jefferson, AR, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Sherry M. Lewis</Name>
        <Affiliation>Office of Scientific Coordination, National Center for Toxicological Research, Jefferson, AR, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle M. Vanlandingham</Name>
        <Affiliation>Division of Biochemical Toxicology, National Center for Toxicological Research, Jefferson, AR, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Kim Boekelheide</Name>
        <Affiliation>Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, United States. Electronic address: kim_boekelheide@brown.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>TAT-mediated intracellular delivery of carboxypeptidase G2 protects against methotrexate-induced cell death in HepG2 cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29574210</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30109-1</DOI>
    <KeywordList>
      <Keywords>Carboxypeptidase G2</Keywords>
      <Keywords>Cell penetrating peptide</Keywords>
      <Keywords>HepG2 cells</Keywords>
      <Keywords>Methotrexate</Keywords>
      <Keywords>Protein transduction</Keywords>
      <Keywords>Transactivator transduction domain</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Issa Sadeghian</Name>
        <Affiliation>Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Bahman Khalvati</Name>
        <Affiliation>Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Younes Ghasemi</Name>
        <Affiliation>Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran; Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Shiva Hemmati</Name>
        <Affiliation>Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran; Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Electronic address: hemmatish@sums.ac.ir.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Curcumin plays neuroprotective roles against traumatic brain injury partly via Nrf2 signaling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29571711</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30106-6</DOI>
    <KeywordList>
      <Keywords>Antioxidant response</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Curcumin</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>NF-E2-related factor (Nrf2)</Keywords>
      <Keywords>Traumatic brain injury (TBI)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wenwen Dong</Name>
        <Affiliation>Department of Forensic Pathology, China Medical University School of Forensic Medicine, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bei Yang</Name>
        <Affiliation>Department of Histology and Embryology, College of Basic Medical Sciences, China Medical University, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Linlin Wang</Name>
        <Affiliation>Department of Forensic Pathology, China Medical University School of Forensic Medicine, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bingxuan Li</Name>
        <Affiliation>Department of Forensic Pathology, China Medical University School of Forensic Medicine, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiangshen Guo</Name>
        <Affiliation>Department of Forensic Pathology, China Medical University School of Forensic Medicine, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Miao Zhang</Name>
        <Affiliation>Department of Forensic Pathology, China Medical University School of Forensic Medicine, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenfei Jiang</Name>
        <Affiliation>Department of Forensic Pathology, China Medical University School of Forensic Medicine, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingqi Fu</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical Univeristy, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingbo Pi</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical Univeristy, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dawei Guan</Name>
        <Affiliation>Department of Forensic Pathology, China Medical University School of Forensic Medicine, Shenyang 110122, China. Electronic address: dwguan@cmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Zhao</Name>
        <Affiliation>Department of Forensic Pathology, China Medical University School of Forensic Medicine, Shenyang 110122, China. Electronic address: rzhao@cmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6) are associated with long term tramadol treatment-induced oxidative damage and hepatotoxicity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29555325</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30105-4</DOI>
    <KeywordList>
      <Keywords>CYP2D6 alleles</Keywords>
      <Keywords>Hepatotoxicity grade</Keywords>
      <Keywords>O-desmethyltramadol (M1)</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Tramadol</Keywords>
      <Keywords>α-GST</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Manar Hamed Arafa</Name>
        <Affiliation>Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Zagazig University, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Hebatallah Husseini Atteia</Name>
        <Affiliation>Department of Biochemistry, Faculty of Pharmacy, Zagazig University, Egypt. Electronic address: hebahosany@yahoo.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The antipsychotics sulpiride induces fatty liver in rats via phosphorylation of insulin receptor substrate-1 at Serine 307-mediated adipose tissue insulin resistance.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29551354</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30069-3</DOI>
    <KeywordList>
      <Keywords>Adipose tissue</Keywords>
      <Keywords>Antipsychotics</Keywords>
      <Keywords>Fatty acid</Keywords>
      <Keywords>Fatty liver</Keywords>
      <Keywords>Insulin resistance</Keywords>
      <Keywords>Sulpiride</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xia Zhou</Name>
        <Affiliation>Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Liying Ren</Name>
        <Affiliation>Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhiling Yu</Name>
        <Affiliation>School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoqian Huang</Name>
        <Affiliation>Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuhao Li</Name>
        <Affiliation>Endocrinology and Metabolism Group, Sydney Institute of Health Sciences/Sydney Institute of Traditional Chinese Medicine, NSW 2000, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Chunxia Wang</Name>
        <Affiliation>Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China. Electronic address: wangcx@smu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Lipid profiling as an effective approach for identifying biomarkers/adverse events associated with pediatric anesthesia.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29550513</pubmedLink>
    <GrantList>
      <Grant>R01 GM105724</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30101-7</DOI>
    <KeywordList>
      <Keywords>Anesthetic-induced</Keywords>
      <Keywords>Biomarker</Keywords>
      <Keywords>Development</Keywords>
      <Keywords>Lipidomics</Keywords>
      <Keywords>Neurotoxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cheng Wang</Name>
        <Affiliation>Division of Neurotoxicology, National Center for Toxicological Research/Food and Drug Administration, Jefferson, AR 72079, USA. Electronic address: cheng.wang@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Xianlin Han</Name>
        <Affiliation>Center for Metabolic Origins of Disease, Sanford Burnham Prebys Medical Discovery Institute at Lake Nona, Orlando, FL 32827, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Fang Liu</Name>
        <Affiliation>Division of Neurotoxicology, National Center for Toxicological Research/Food and Drug Administration, Jefferson, AR 72079, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tucker A. Patterson</Name>
        <Affiliation>National Center for Toxicological Research/Food and Drug Administration, Jefferson, AR 72079, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph P. Hanig</Name>
        <Affiliation>Center for Drug Evaluation and Research/Food and Drug Administration, Silver Spring, MD 20993, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Merle G. Paule</Name>
        <Affiliation>Division of Neurotoxicology, National Center for Toxicological Research/Food and Drug Administration, Jefferson, AR 72079, USA.</Affiliation>
      </Author>
      <Author>
        <Name>William Slikker</Name>
        <Affiliation>National Center for Toxicological Research/Food and Drug Administration, Jefferson, AR 72079, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>C. elegans as a model in developmental neurotoxicology.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29550512</pubmedLink>
    <GrantList>
      <Grant>R01 ES007331</Grant>
      <Grant>R01 ES010563</Grant>
      <Grant>R01 ES020852</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30100-5</DOI>
    <KeywordList>
      <Keywords>C. elegans</Keywords>
      <Keywords>Manganese</Keywords>
      <Keywords>Mercury</Keywords>
      <Keywords>Neurodevelopment</Keywords>
      <Keywords>Neurotoxicity</Keywords>
      <Keywords>Pesticides</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joanna A. Ruszkiewicz</Name>
        <Affiliation>Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York, United States. Electronic address: joanna.ruszkiewicz@einstein.yu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Adi Pinkas</Name>
        <Affiliation>Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mahfuzur R. Miah</Name>
        <Affiliation>Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York, United States. Electronic address: mahfuzur.miah@phd.einstein.yu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Rebecca L. Weitz</Name>
        <Affiliation>Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Michael J. A. Lawes</Name>
        <Affiliation>Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ayodele J. Akinyemi</Name>
        <Affiliation>Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York, United States; Department of Biochemistry, Afe Babalola University, Ado-Ekiti, Ekiti State, Nigeria. Electronic address: ayodele.akinyemi@einstein.yu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Omamuyovwi M. Ijomone</Name>
        <Affiliation>Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York, United States; Department of Anatomy, School of Health and Health Technology, Federal University of Technology Akure (FUTA), Nigeria. Electronic address: omamuyovwi.ijomone@einstein.edu.yu.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Aschner</Name>
        <Affiliation>Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York, United States. Electronic address: michael.aschner@einstein.yu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Early life exposure to air pollution particulate matter (PM) as risk factor for attention deficit/hyperactivity disorder (ADHD): Need for novel strategies for mechanisms and causalities.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29550511</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30099-1</DOI>
    <KeywordList>
      <Keywords>Brain organoids</Keywords>
      <Keywords>Chicken embryo model</Keywords>
      <Keywords>Developmental neurotoxicity</Keywords>
      <Keywords>Human induced pluripotent stem cells</Keywords>
      <Keywords>In silico</Keywords>
      <Keywords>Physiologically-based pharmaco kinetic (PBPK)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Oddvar Myhre</Name>
        <Affiliation>Department of Toxicology and Risk Assessment, Norwegian Institute of Public Health, Oslo, Norway. Electronic address: Oddvar.Myhre@fhi.no.</Affiliation>
      </Author>
      <Author>
        <Name>Marit Låg</Name>
        <Affiliation>Department of Air pollution and Noise, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Gro D. Villanger</Name>
        <Affiliation>Department of Child Health and Development, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Bente Oftedal</Name>
        <Affiliation>Department of Air pollution and Noise, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Johan Øvrevik</Name>
        <Affiliation>Department of Air pollution and Noise, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Jørn A. Holme</Name>
        <Affiliation>Department of Air pollution and Noise, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Heidi Aase</Name>
        <Affiliation>Department of Child Health and Development, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Ragnhild E. Paulsen</Name>
        <Affiliation>Department of Pharmaceutical Biosciences, School of Pharmacy, University of Oslo, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Bal-Price</Name>
        <Affiliation>European Commission, Joint Research Centre, Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Hubert Dirven</Name>
        <Affiliation>Department of Toxicology and Risk Assessment, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Design and validation of an ontology-driven animal-free testing strategy for developmental neurotoxicity testing.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29544899</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30091-7</DOI>
    <KeywordList>
      <Keywords>3Rs</Keywords>
      <Keywords>Brain development</Keywords>
      <Keywords>Developmental neurotoxicity</Keywords>
      <Keywords>Ontology</Keywords>
      <Keywords>Validation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ellen V. S. Hessel</Name>
        <Affiliation>Center for Health Protection, National Institute for Public Health and The Environment (RIVM), P.O. Box 1, 3720BA Bilthoven, The Netherlands. Electronic address: ellen.hessel@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Yvonne C. M. Staal</Name>
        <Affiliation>Center for Health Protection, National Institute for Public Health and The Environment (RIVM), P.O. Box 1, 3720BA Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Aldert H. Piersma</Name>
        <Affiliation>Center for Health Protection, National Institute for Public Health and The Environment (RIVM), P.O. Box 1, 3720BA Bilthoven, The Netherlands; Institute for Risk Assessment Sciences (IRAS), Utrecht University, Utrecht, The Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A better approach to in vivo developmental neurotoxicity assessment: Alignment of rodent testing with effects seen in children after neurotoxic exposures.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29544898</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30090-5</DOI>
    <KeywordList>
      <Keywords>Acoustic startle</Keywords>
      <Keywords>Conditioned fear</Keywords>
      <Keywords>Developmental neurotoxicity</Keywords>
      <Keywords>Egocentric learning</Keywords>
      <Keywords>Motor activity</Keywords>
      <Keywords>Object recognition</Keywords>
      <Keywords>Regulatory studies</Keywords>
      <Keywords>Spatial learning</Keywords>
      <Keywords>Working memory</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Charles V. Vorhees</Name>
        <Affiliation>Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA; Division of Neurology, Cincinnati Children's Research Foundation, Cincinnati, OH 45229, USA. Electronic address: Charles.vorhees@cchmc.org.</Affiliation>
      </Author>
      <Author>
        <Name>Jenna N. Sprowles</Name>
        <Affiliation>Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA; Division of Neurology, Cincinnati Children's Research Foundation, Cincinnati, OH 45229, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Samantha L. Regan</Name>
        <Affiliation>Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA; Division of Neurology, Cincinnati Children's Research Foundation, Cincinnati, OH 45229, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael T. Williams</Name>
        <Affiliation>Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA; Division of Neurology, Cincinnati Children's Research Foundation, Cincinnati, OH 45229, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Epigenetic modulation of Nrf2 and Ogg1 gene expression in testicular germ cells by methyl parathion exposure.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29540303</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30088-7</DOI>
    <KeywordList>
      <Keywords>DNA methylation</Keywords>
      <Keywords>Epigenetics</Keywords>
      <Keywords>Gene expression</Keywords>
      <Keywords>Methyl parathion</Keywords>
      <Keywords>Oxidation</Keywords>
      <Keywords>Sperm cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>D. Hernandez-Cortes</Name>
        <Affiliation>Department of Toxicology, Cinvestav, Mexico City 07360, Mexico. Electronic address: danielhc@email.arizona.edu.</Affiliation>
      </Author>
      <Author>
        <Name>I. Alvarado-Cruz</Name>
        <Affiliation>Department of Toxicology, Cinvestav, Mexico City 07360, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>M. J. Solís-Heredia</Name>
        <Affiliation>Department of Toxicology, Cinvestav, Mexico City 07360, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>B. Quintanilla-Vega</Name>
        <Affiliation>Department of Toxicology, Cinvestav, Mexico City 07360, Mexico. Electronic address: mquintan@cinvestav.mx.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Tumor-promoting cyanotoxin microcystin-LR does not induce procarcinogenic events in adult human liver stem cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29534881</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30089-9</DOI>
    <KeywordList>
      <Keywords>Adult liver stem cells</Keywords>
      <Keywords>HL1-hT1</Keywords>
      <Keywords>Liver tumor-promotion</Keywords>
      <Keywords>Microcystin-LR</Keywords>
      <Keywords>Multidrug resistance proteins</Keywords>
      <Keywords>OATP</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jan Raska</Name>
        <Affiliation>Masaryk University, Faculty of Science, RECETOX - Research Centre for Toxic Compounds in the Environment, Kamenice 753/5, 625 00 Brno, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Lucie Ctverackova</Name>
        <Affiliation>Masaryk University, Faculty of Science, RECETOX - Research Centre for Toxic Compounds in the Environment, Kamenice 753/5, 625 00 Brno, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Aneta Dydowiczova</Name>
        <Affiliation>Masaryk University, Faculty of Science, RECETOX - Research Centre for Toxic Compounds in the Environment, Kamenice 753/5, 625 00 Brno, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Iva Sovadinova</Name>
        <Affiliation>Masaryk University, Faculty of Science, RECETOX - Research Centre for Toxic Compounds in the Environment, Kamenice 753/5, 625 00 Brno, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Ludek Blaha</Name>
        <Affiliation>Masaryk University, Faculty of Science, RECETOX - Research Centre for Toxic Compounds in the Environment, Kamenice 753/5, 625 00 Brno, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Pavel Babica</Name>
        <Affiliation>Masaryk University, Faculty of Science, RECETOX - Research Centre for Toxic Compounds in the Environment, Kamenice 753/5, 625 00 Brno, Czech Republic. Electronic address: babica@recetox.muni.cz.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The dual role of mitochondrial superoxide in arsenite toxicity: Signaling at the boundary between apoptotic commitment and cytoprotection.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29526526</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30086-3</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Arsenite</Keywords>
      <Keywords>Mitochondrial permeability transition</Keywords>
      <Keywords>Mitochondrial superoxide</Keywords>
      <Keywords>Nrf2, GSH</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mara Fiorani</Name>
        <Affiliation>Dipartimento di Scienze Biomolecolari, Università degli Studi di Urbino "Carlo Bo", 61029 Urbino, Italy. Electronic address: mara.fiorani@uniurb.it.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Guidarelli</Name>
        <Affiliation>Dipartimento di Scienze Biomolecolari, Università degli Studi di Urbino "Carlo Bo", 61029 Urbino, Italy. Electronic address: andrea.guidarelli@uniurb.it.</Affiliation>
      </Author>
      <Author>
        <Name>Valentina Capellacci</Name>
        <Affiliation>Dipartimento di Scienze Biomolecolari, Università degli Studi di Urbino "Carlo Bo", 61029 Urbino, Italy. Electronic address: valentina.capellacci@uniurb.it.</Affiliation>
      </Author>
      <Author>
        <Name>Liana Cerioni</Name>
        <Affiliation>Dipartimento di Scienze Biomolecolari, Università degli Studi di Urbino "Carlo Bo", 61029 Urbino, Italy. Electronic address: liana.cerioni@uniurb.it.</Affiliation>
      </Author>
      <Author>
        <Name>Rita Crinelli</Name>
        <Affiliation>Dipartimento di Scienze Biomolecolari, Università degli Studi di Urbino "Carlo Bo", 61029 Urbino, Italy. Electronic address: rita.crinelli@uniurb.it.</Affiliation>
      </Author>
      <Author>
        <Name>Orazio Cantoni</Name>
        <Affiliation>Dipartimento di Scienze Biomolecolari, Università degli Studi di Urbino "Carlo Bo", 61029 Urbino, Italy. Electronic address: orazio.cantoni@uniurb.it.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Analysis of 3',5'-dichloro-2,3,4-trihydroxy-2-methylbutylanilide (DTMBA) as a new potential biomarker of exposure to vinclozolin in urine.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29526525</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30087-5</DOI>
    <KeywordList>
      <Keywords>Anti-androgenic</Keywords>
      <Keywords>Biomarkers</Keywords>
      <Keywords>DTMBA</Keywords>
      <Keywords>Endocrine disruptors</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Urine elimination</Keywords>
      <Keywords>Vinclozolin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marycarmen Cruz-Hurtado</Name>
        <Affiliation>Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav-IPN), Av. IPN No. 2508, Col. San Pedro Zacatenco, Ciudad de México, CP 07360, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Ma de Lourdes López-González</Name>
        <Affiliation>Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav-IPN), Av. IPN No. 2508, Col. San Pedro Zacatenco, Ciudad de México, CP 07360, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Derly Constanza Escobar-Wilches</Name>
        <Affiliation>Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav-IPN), Av. IPN No. 2508, Col. San Pedro Zacatenco, Ciudad de México, CP 07360, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Adolfo Sierra-Santoyo</Name>
        <Affiliation>Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav-IPN), Av. IPN No. 2508, Col. San Pedro Zacatenco, Ciudad de México, CP 07360, Mexico. Electronic address: asierra@cinvestav.mx.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pharmacological inhibition of SUMO-1 with ginkgolic acid alleviates cardiac fibrosis induced by myocardial infarction in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29524504</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30084-X</DOI>
    <KeywordList>
      <Keywords>Cardiac fibrosis</Keywords>
      <Keywords>Ginkgolic acid</Keywords>
      <Keywords>PML</Keywords>
      <Keywords>Pin1</Keywords>
      <Keywords>SUMO-1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Fang Qiu</Name>
        <Affiliation>Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang 150081, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Changjiang Dong</Name>
        <Affiliation>Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang 150081, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanxin Liu</Name>
        <Affiliation>Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang 150081, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoqi Shao</Name>
        <Affiliation>Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang 150081, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Di Huang</Name>
        <Affiliation>Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang 150081, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanna Han</Name>
        <Affiliation>Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang 150081, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Bing Wang</Name>
        <Affiliation>Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang 150081, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanli Liu</Name>
        <Affiliation>Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang 150081, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Rong Huo</Name>
        <Affiliation>Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang 150081, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Petro Paulo</Name>
        <Affiliation>Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang 150081, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhi Ren Zhang</Name>
        <Affiliation>Department of Cardiology and Clinic Pharmacy, Harbin Medical University Cancer Hospital, Institute of Metabolic Disease, Heilongjiang Academy of Medical Science, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Dan Zhao</Name>
        <Affiliation>Departments of Clinical Pharmacy and Cardiology, The 2nd Affiliated Hospital, Harbin Medical University, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, Harbin, PR China. Electronic address: zhaodan7719@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Feng Chu</Name>
        <Affiliation>Department of Pharmacology (the State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang 150081, PR China. Electronic address: cwf76928@aliyun.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Autophagy as a compensation mechanism participates in ethanol-induced fetal adrenal dysfunction in female rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29524503</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30085-1</DOI>
    <KeywordList>
      <Keywords>Adrenal steroidogenesis</Keywords>
      <Keywords>Fetal adrenal development</Keywords>
      <Keywords>Hypothalamic-pituitary-adrenal axis</Keywords>
      <Keywords>Intrauterine growth retardation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hegui Huang</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China; Department of Pharmacy, Wuhan No. 1 Hospital, Wuhan 430022, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lian Liu</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Li</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunyan Zhu</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoyu Xie</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Ao</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Disorder, Wuhan 430071, China. Electronic address: yingao@whu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Wang</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Disorder, Wuhan 430071, China. Electronic address: wanghui19@whu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Combined treatment with benzo[a]pyrene and 1α,25-dihydroxyvitamin D</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29524502</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30081-4</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Benzo[a]pyrene</Keywords>
      <Keywords>Macrophages</Keywords>
      <Keywords>Plasminogen activator inhibitor 1</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
      <Keywords>Vitamin D</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Masaru Nakagawa</Name>
        <Affiliation>Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shigeyuki Uno</Name>
        <Affiliation>Division of Biochemistry, Department of Biomedical Sciences, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Noriyoshi Iriyama</Name>
        <Affiliation>Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Manabu Matsunawa</Name>
        <Affiliation>Division of Biochemistry, Department of Biomedical Sciences, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Makoto Makishima</Name>
        <Affiliation>Division of Biochemistry, Department of Biomedical Sciences, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan. Electronic address: makishima.makoto@nihon-u.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Takeuchi</Name>
        <Affiliation>Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Isao Tsuboi</Name>
        <Affiliation>Division of Anatomical Science, Department of Functional Morphology, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yoshihiro Hatta</Name>
        <Affiliation>Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Masami Takei</Name>
        <Affiliation>Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Development of the Adverse Outcome Pathway (AOP): Chronic binding of antagonist to N-methyl-d-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities of children.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29524501</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30070-X</DOI>
    <KeywordList>
      <Keywords>Adverse Outcome Pathway</Keywords>
      <Keywords>Developmental Neurotoxicity</Keywords>
      <Keywords>Regulatory Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Magdalini Sachana</Name>
        <Affiliation>European Commission, Joint Research Centre, Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Alexandra Rolaki</Name>
        <Affiliation>European Commission, Joint Research Centre, Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Bal-Price</Name>
        <Affiliation>European Commission, Joint Research Centre, Ispra, Italy. Electronic address: anna.price@ec.europa.eu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Differences in statin associated neuroprotection corresponds with either decreased production of IL-1β or TNF-α in an in vitro model of neuroinflammation-induced neurodegeneration.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29522792</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30083-8</DOI>
    <KeywordList>
      <Keywords>HAPI</Keywords>
      <Keywords>Neuroinflammation</Keywords>
      <Keywords>Neuroprotection</Keywords>
      <Keywords>Neurotoxicity</Keywords>
      <Keywords>SH-SY5Y</Keywords>
      <Keywords>Statin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>A. J. McFarland</Name>
        <Affiliation>School of Pharmacy and Pharmacology, Griffith University, Queensland 4222, Australia; Quality Use of Medicines Network, Queensland, Australia; Menzies Health Institute Queensland, Griffith University, Queensland, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>A. K. Davey</Name>
        <Affiliation>School of Pharmacy and Pharmacology, Griffith University, Queensland 4222, Australia; Quality Use of Medicines Network, Queensland, Australia; Menzies Health Institute Queensland, Griffith University, Queensland, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>C. M. McDermott</Name>
        <Affiliation>Faculty of Health Sciences and Medicine, Bond University, Queensland 4226, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>G. D. Grant</Name>
        <Affiliation>School of Pharmacy and Pharmacology, Griffith University, Queensland 4222, Australia; Quality Use of Medicines Network, Queensland, Australia; Menzies Health Institute Queensland, Griffith University, Queensland, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>J. Lewohl</Name>
        <Affiliation>Menzies Health Institute Queensland, Griffith University, Queensland, Australia; School of Medical Science, Griffith University, Queensland 4222, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>S. Anoopkumar-Dukie</Name>
        <Affiliation>School of Pharmacy and Pharmacology, Griffith University, Queensland 4222, Australia; Quality Use of Medicines Network, Queensland, Australia; Menzies Health Institute Queensland, Griffith University, Queensland, Australia. Electronic address: s.dukie@griffith.edu.au.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Electrophysiological determination of phosphodiesterase-6 inhibitor inhibition constants in intact mouse retina.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29518412</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30080-2</DOI>
    <KeywordList>
      <Keywords>Ex vivo electroretinography</Keywords>
      <Keywords>Inhibition constant</Keywords>
      <Keywords>Inhibitor</Keywords>
      <Keywords>Phosphodiesterase-6</Keywords>
      <Keywords>Photoreceptors</Keywords>
      <Keywords>Retina</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Teemu T. Turunen</Name>
        <Affiliation>Department of Neuroscience and Biomedical Engineering, Aalto University School of Science, P.O. Box 12200, FI-00076 Aalto, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>Ari Koskelainen</Name>
        <Affiliation>Department of Neuroscience and Biomedical Engineering, Aalto University School of Science, P.O. Box 12200, FI-00076 Aalto, Finland. Electronic address: ari.koskelainen@aalto.fi.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Efficacy and tolerability of AFPep, a cyclic peptide with anti-breast cancer properties.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29518411</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30082-6</DOI>
    <KeywordList>
      <Keywords>Breast cancer</Keywords>
      <Keywords>Efficacy</Keywords>
      <Keywords>Hepatocellular carcinoma</Keywords>
      <Keywords>Prevention</Keywords>
      <Keywords>Therapeutics</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wasila Mansouri</Name>
        <Affiliation>Department of Molecular and Cellular Physiology, Albany Medical College, Albany, NY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Samuel B. Fordyce</Name>
        <Affiliation>Department of Molecular and Cellular Physiology, Albany Medical College, Albany, NY, United States; Rensselaer Polytechnic Institute, Rensselaer, NY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew Wu</Name>
        <Affiliation>Department of Molecular and Cellular Physiology, Albany Medical College, Albany, NY, United States; Union College, Schenectady, NY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>David Jones</Name>
        <Affiliation>Department of Pathology, Albany Medical Center Hospital, Albany, NY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Douglas Cohn</Name>
        <Affiliation>Animal Resource Facility, Albany Medical College, Albany, NY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Qishan Lin</Name>
        <Affiliation>Center for Functional Genomics, University at Albany, Rensselaer, NY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Feustel</Name>
        <Affiliation>Deparment of Neuroscience and Experimental Therapeutics, Albany Medical College, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Tanuj Sharma</Name>
        <Affiliation>Department of Molecular and Cellular Physiology, Albany Medical College, Albany, NY, United States; Rensselaer Polytechnic Institute, Rensselaer, NY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>James A. Bennett</Name>
        <Affiliation>Department of Immunology and Microbial Disease, Albany Medical College, Albany, NY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas T. Andersen</Name>
        <Affiliation>Department of Molecular and Cellular Physiology, Albany Medical College, Albany, NY, United States. Electronic address: anderst@mail.amc.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Demethoxycurcumin mediated targeting of MnSOD leading to activation of apoptotic pathway and inhibition of Akt/NF-κB survival signalling in human glioma U87 MG cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29510157</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30066-8</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>DMC</Keywords>
      <Keywords>GBM</Keywords>
      <Keywords>MnSOD</Keywords>
      <Keywords>Superoxide anion radical</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rakesh Kumar</Name>
        <Affiliation>Neuropharmaceutical Chemistry Laboratory, Dr. B. R. Ambedkar Centre for Biomedical Research, University of Delhi, North Campus, Delhi 110007, India.</Affiliation>
      </Author>
      <Author>
        <Name>Neetika Lal</Name>
        <Affiliation>Neuropharmaceutical Chemistry Laboratory, Dr. B. R. Ambedkar Centre for Biomedical Research, University of Delhi, North Campus, Delhi 110007, India.</Affiliation>
      </Author>
      <Author>
        <Name>Vishal Nemaysh</Name>
        <Affiliation>Neuropharmaceutical Chemistry Laboratory, Dr. B. R. Ambedkar Centre for Biomedical Research, University of Delhi, North Campus, Delhi 110007, India.</Affiliation>
      </Author>
      <Author>
        <Name>Pratibha Mehta Luthra</Name>
        <Affiliation>Neuropharmaceutical Chemistry Laboratory, Dr. B. R. Ambedkar Centre for Biomedical Research, University of Delhi, North Campus, Delhi 110007, India. Electronic address: pmluthra@acbr.du.ac.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Epithelial-mesenchymal transition in breast epithelial cells treated with cadmium and the role of Snail.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29501589</pubmedLink>
    <GrantList>
      <Grant>P20 GM103430</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30068-1</DOI>
    <KeywordList>
      <Keywords>Breast cancer</Keywords>
      <Keywords>Cadmium</Keywords>
      <Keywords>Epithelial-mesenchymal transition</Keywords>
      <Keywords>MCF10A cells</Keywords>
      <Keywords>MDA-MB-231 cells</Keywords>
      <Keywords>Snail</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhengxi Wei</Name>
        <Affiliation>Center for Molecular Toxicology, Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zhongguo Shan</Name>
        <Affiliation>Center for Molecular Toxicology, Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zahir A. Shaikh</Name>
        <Affiliation>Center for Molecular Toxicology, Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA. Electronic address: zshaikh@uri.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Convergence of hepcidin deficiency, systemic iron overloading, heme accumulation, and REV-ERBα/β activation in aryl hydrocarbon receptor-elicited hepatotoxicity" [Toxicol. Appl. Pharmacol. 321 (2017) 1-17].</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29501526</pubmedLink>
    <GrantList>
      <Grant>P42 ES004911</Grant>
      <Grant>T32 GM092715</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30071-1</DOI>
    <AuthorList>
      <Author>
        <Name>K. A. Fader</Name>
        <Affiliation>Department of Biochemistry &amp; Molecular Biology, Michigan State University, East Lansing, MI 48824, United States; Institute for Integrative Toxicology, Michigan State University, East Lansing, MI 48824, United States.</Affiliation>
      </Author>
      <Author>
        <Name>R. Nault</Name>
        <Affiliation>Department of Biochemistry &amp; Molecular Biology, Michigan State University, East Lansing, MI 48824, United States; Institute for Integrative Toxicology, Michigan State University, East Lansing, MI 48824, United States.</Affiliation>
      </Author>
      <Author>
        <Name>M. P. Kirby</Name>
        <Affiliation>Department of Biochemistry &amp; Molecular Biology, Michigan State University, East Lansing, MI 48824, United States.</Affiliation>
      </Author>
      <Author>
        <Name>G. Markous</Name>
        <Affiliation>Department of Biochemistry &amp; Molecular Biology, Michigan State University, East Lansing, MI 48824, United States.</Affiliation>
      </Author>
      <Author>
        <Name>J. Matthews</Name>
        <Affiliation>Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo 0316, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>T. R. Zacharewski</Name>
        <Affiliation>Department of Biochemistry &amp; Molecular Biology, Michigan State University, East Lansing, MI 48824, United States; Institute for Integrative Toxicology, Michigan State University, East Lansing, MI 48824, United States. Electronic address: tzachare@msu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Biosensing estrogenic endocrine disruptors in human blood and urine: A RAPID cell-free protein synthesis approach.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29499249</pubmedLink>
    <GrantList>
      <Grant>R21 ES016630</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30062-0</DOI>
    <KeywordList>
      <Keywords>Biosensor</Keywords>
      <Keywords>CFPS</Keywords>
      <Keywords>Endocrine disruptor</Keywords>
      <Keywords>Hormone receptor</Keywords>
      <Keywords>RNAse inhibitor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Amin S. M. Salehi</Name>
        <Affiliation>Department of Chemical Engineering, Brigham Young University, Provo, UT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Ook Yang</Name>
        <Affiliation>Department of Chemical Engineering, Brigham Young University, Provo, UT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Conner C. Earl</Name>
        <Affiliation>Department of Chemical Engineering, Brigham Young University, Provo, UT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Miriam J. Shakalli Tang</Name>
        <Affiliation>Department of Chemical and Biomolecular Engineering, Ohio State University, Columbus, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. Porter Hunt</Name>
        <Affiliation>Department of Chemical Engineering, Brigham Young University, Provo, UT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mark T. Smith</Name>
        <Affiliation>Department of Chemical Engineering, Brigham Young University, Provo, UT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David W. Wood</Name>
        <Affiliation>Department of Chemical and Biomolecular Engineering, Ohio State University, Columbus, OH, USA. Electronic address: wood.750@osu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Bradley C. Bundy</Name>
        <Affiliation>Department of Chemical Engineering, Brigham Young University, Provo, UT, USA. Electronic address: bundy@byu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Methylmercury interferes with glucocorticoid receptor: Potential role in the mediation of developmental neurotoxicity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29499248</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30067-X</DOI>
    <KeywordList>
      <Keywords>Alternative methods</Keywords>
      <Keywords>Developmental neurotoxicity</Keywords>
      <Keywords>Endocrine disruptor</Keywords>
      <Keywords>Glucocorticoid receptor</Keywords>
      <Keywords>Methylmercury</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>S. Spulber</Name>
        <Affiliation>Karolinska Institutet, Department of Neuroscience, Stockholm, Sweden. Electronic address: stefan.spulber@ki.se.</Affiliation>
      </Author>
      <Author>
        <Name>M. Raciti</Name>
        <Affiliation>Karolinska Institutet, Department of Neuroscience, Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>B. Dulko-Smith</Name>
        <Affiliation>Umeå University, Faculty of Science and Technology, Department of Chemistry, Umeå, Sweden; University of Texas at Arlington, Department of Chemistry and Biochemistry, Arlington, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>D. Lupu</Name>
        <Affiliation>Swetox, Karolinska Institutet, Unit of Toxicology Science, Södertälje, Sweden; "Iuliu Hatieganu" University of Medicine and Pharmacy, Department of Toxicology, Cluj-Napoca, Romania.</Affiliation>
      </Author>
      <Author>
        <Name>J. Rüegg</Name>
        <Affiliation>Swetox, Karolinska Institutet, Unit of Toxicology Science, Södertälje, Sweden; Karolinska Institutet, Department of Clinical Neuroscience, Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>K. Nam</Name>
        <Affiliation>Umeå University, Faculty of Science and Technology, Department of Chemistry, Umeå, Sweden; University of Texas at Arlington, Department of Chemistry and Biochemistry, Arlington, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>S. Ceccatelli</Name>
        <Affiliation>Karolinska Institutet, Department of Neuroscience, Stockholm, Sweden.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Multidimensional chemobehavior analysis of flavonoids and neuroactive compounds in zebrafish.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29499247</pubmedLink>
    <GrantList>
      <Grant>K99 ES025280</Grant>
      <Grant>P30 ES000210</Grant>
      <Grant>P42 ES016465</Grant>
      <Grant>T32 ES007060</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30065-6</DOI>
    <KeywordList>
      <Keywords>Behavior</Keywords>
      <Keywords>Flavonoids</Keywords>
      <Keywords>GABA receptor</Keywords>
      <Keywords>Locomotion</Keywords>
      <Keywords>Neurotoxicity</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sean M. Bugel</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, Environmental Health Sciences Center, Sinnhuber Aquatic Research Laboratory, Oregon State University, Corvallis, OR 97333, United States. Electronic address: Sean.Bugel@oregonstate.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Robert L. Tanguay</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, Environmental Health Sciences Center, Sinnhuber Aquatic Research Laboratory, Oregon State University, Corvallis, OR 97333, United States. Electronic address: Robert.Tanguay@oregonstate.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dihydrotanshinone I, a natural product, ameliorates DSS-induced experimental ulcerative colitis in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29496522</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30064-4</DOI>
    <KeywordList>
      <Keywords>15,16-Dihydrotanshinone I</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Necroptosis</Keywords>
      <Keywords>Ulcerative colitis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yanling Guo</Name>
        <Affiliation>Key Lab for Pharmacology of Ministry of Education, Department of Pharmacology, Zunyi Medical College, Zunyi, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaxia Wu</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao.</Affiliation>
      </Author>
      <Author>
        <Name>Qin Wu</Name>
        <Affiliation>Key Lab for Pharmacology of Ministry of Education, Department of Pharmacology, Zunyi Medical College, Zunyi, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanfu Lu</Name>
        <Affiliation>Key Lab for Pharmacology of Ministry of Education, Department of Pharmacology, Zunyi Medical College, Zunyi, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingshan Shi</Name>
        <Affiliation>Key Lab for Pharmacology of Ministry of Education, Department of Pharmacology, Zunyi Medical College, Zunyi, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiuping Chen</Name>
        <Affiliation>Key Lab for Pharmacology of Ministry of Education, Department of Pharmacology, Zunyi Medical College, Zunyi, China; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao. Electronic address: xpchen@umac.mo.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>nAChRs-ERK1/2-Egr-1 signaling participates in the developmental toxicity of nicotine by epigenetically down-regulating placental 11β-HSD2.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29486207</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30063-2</DOI>
    <KeywordList>
      <Keywords>11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2)</Keywords>
      <Keywords>Early growth response-1 (Egr-1)</Keywords>
      <Keywords>Epigenetics</Keywords>
      <Keywords>Glucocorticoid</Keywords>
      <Keywords>Placenta</Keywords>
      <Keywords>Prenatal nicotine exposure</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jin Zhou</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fulin Liu</Name>
        <Affiliation>Department of Gynaecology, Renmin Hospital of Wuhan University, Wuhan 430060, China.</Affiliation>
      </Author>
      <Author>
        <Name>Luting Yu</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dan Xu</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bin Li</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guohui Zhang</Name>
        <Affiliation>Department of Gynecology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Huang</Name>
        <Affiliation>Department of Gynecology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Li</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanzhen Zhang</Name>
        <Affiliation>Department of Gynecology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Zhang</Name>
        <Affiliation>Department of Gynecology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, Wuhan 430071, China. Electronic address: zw6676@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Wang</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, Wuhan 430071, China. Electronic address: wanghui19@whu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Ghrelin protects against depleted uranium-induced bone damage by increasing osteoprotegerin/RANKL ratio.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29477364</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30061-9</DOI>
    <KeywordList>
      <Keywords>Depleted uranium</Keywords>
      <Keywords>Ghrelin</Keywords>
      <Keywords>Osteoblast</Keywords>
      <Keywords>Osteoprotegerin</Keywords>
      <Keywords>RANKL</Keywords>
      <Keywords>p38-MAPK</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yuhui Hao</Name>
        <Affiliation>State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Combined Injury, Chongqing Engineering Research Center for Nanomedicine, College of Preventive Medicine, Third Military Medical University, No. 30 Gaotanyan Street, Shapingba District, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Gao</Name>
        <Affiliation>Department of Orthopaedics, Xinqiao Hospital, Third Military Medical University, Chongqing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Binghui Lu</Name>
        <Affiliation>State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Combined Injury, Chongqing Engineering Research Center for Nanomedicine, College of Preventive Medicine, Third Military Medical University, No. 30 Gaotanyan Street, Shapingba District, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yonghong Ran</Name>
        <Affiliation>State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Combined Injury, Chongqing Engineering Research Center for Nanomedicine, College of Preventive Medicine, Third Military Medical University, No. 30 Gaotanyan Street, Shapingba District, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhangyou Yang</Name>
        <Affiliation>State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Combined Injury, Chongqing Engineering Research Center for Nanomedicine, College of Preventive Medicine, Third Military Medical University, No. 30 Gaotanyan Street, Shapingba District, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Liu</Name>
        <Affiliation>State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Combined Injury, Chongqing Engineering Research Center for Nanomedicine, College of Preventive Medicine, Third Military Medical University, No. 30 Gaotanyan Street, Shapingba District, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rong Li</Name>
        <Affiliation>State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Combined Injury, Chongqing Engineering Research Center for Nanomedicine, College of Preventive Medicine, Third Military Medical University, No. 30 Gaotanyan Street, Shapingba District, Chongqing 400038, China. Electronic address: yuhui_hao@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methods.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29476865</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30054-1</DOI>
    <KeywordList>
      <Keywords>Adverse outcome pathways</Keywords>
      <Keywords>Developmental neurotoxicity</Keywords>
      <Keywords>Human in vitro test systems</Keywords>
      <Keywords>Integrated Approaches to Testing and Assessment</Keywords>
      <Keywords>Regulatory purposes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anna Bal-Price</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Ispra, Italy. Electronic address: anna.price@ec.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Francesca Pistollato</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Magdalini Sachana</Name>
        <Affiliation>Organisation for Economic Co-operation and Development (OECD), 2 rue André Pascal, 75775 Paris, Cedex 16, France.</Affiliation>
      </Author>
      <Author>
        <Name>Stephanie K. Bopp</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Sharon Munn</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Ispra, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Worth</Name>
        <Affiliation>European Commission, Joint Research Centre (JRC), Ispra, Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A systems biology approach to predictive developmental neurotoxicity of a larvicide used in the prevention of Zika virus transmission.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29476864</pubmedLink>
    <GrantList>
      <Grant>R01 ES021477</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30060-7</DOI>
    <KeywordList>
      <Keywords>Computational biology</Keywords>
      <Keywords>Developmental neurotoxicity</Keywords>
      <Keywords>Pesticide</Keywords>
      <Keywords>Predictive toxicology</Keywords>
      <Keywords>Pyriproxyfen</Keywords>
      <Keywords>Systems biology</Keywords>
      <Keywords>Toxicity testing</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Karine Audouze</Name>
        <Affiliation>INSERM UMR-S 973, 75013 Paris, France; University of Paris Diderot, 75013 Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>Olivier Taboureau</Name>
        <Affiliation>INSERM UMR-S 973, 75013 Paris, France; University of Paris Diderot, 75013 Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>Philippe Grandjean</Name>
        <Affiliation>Harvard T.H. Chan School of Public Health, Boston, MA, USA; University of Southern Denmark, Odense, Denmark. Electronic address: pgrand@hsph.harvard.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Time course of polyhexamethyleneguanidine phosphate-induced lung inflammation and fibrosis in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29476863</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30059-0</DOI>
    <KeywordList>
      <Keywords>Fibrosis</Keywords>
      <Keywords>Inflammasome</Keywords>
      <Keywords>Polyhexamethyleneguanidine phosphate</Keywords>
      <Keywords>Pulmonary inflammation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jeongah Song</Name>
        <Affiliation>Systems Toxicology Center, Predictive Toxicology Department, Korea Institute of Toxicology, Daejeon 305-343, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Woojin Kim</Name>
        <Affiliation>Pathology Analytical Research Center, Korea Institute of Toxicology, Daejeon 305-343, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Bum Kim</Name>
        <Affiliation>Pathology Analytical Research Center, Korea Institute of Toxicology, Daejeon 305-343, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Bumseok Kim</Name>
        <Affiliation>Biosafety Research Institute and Laboratory of Pathology (BK21 Plus Program), College of Veterinary Medicine, Chonbuk National University, Iksan, Republic of Korea. Electronic address: bskims@jbnu.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Kyuhong Lee</Name>
        <Affiliation>Inhalation Toxicology Research Center, Korea Institute of Toxicology, Jeonbuk 580-185, Republic of Korea; Human and Environment Toxicology, University of Science and Technology, Daejeon 305-350, Republic of Korea. Electronic address: khlee@kitox.re.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Erratum to "Gene expression profiles modulated by the human carcinogen aristolochic acid I in human cancer cells and their dependence on TP53" [Toxicol. Appl. Pharmacol. 232(1) (2008) 86-98].</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29471084</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30056-5</DOI>
    <AuthorList>
      <Author>
        <Name>Maria L. Simões</Name>
        <Affiliation>Section of Molecular Carcinogenesis, Institute of Cancer Research, Brookes Lawley Building, Cotswold Road, Sutton, Surrey SM2 5NG, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Sarah L. Hockley</Name>
        <Affiliation>Section of Molecular Carcinogenesis, Institute of Cancer Research, Brookes Lawley Building, Cotswold Road, Sutton, Surrey SM2 5NG, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Tanja Schwerdtle</Name>
        <Affiliation>Institute of Food Chemistry and Food Toxicology, Technical University of Berlin, TIB 4/3-1, Gustav-Meyer-Allee 25, D-13355 Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Gonçalo Gamboa da Costa</Name>
        <Affiliation>Section of Molecular Carcinogenesis, Institute of Cancer Research, Brookes Lawley Building, Cotswold Road, Sutton, Surrey SM2 5NG, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Heinz H. Schmeiser</Name>
        <Affiliation>Division of Molecular Toxicology, German Cancer Research Center, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>David H. Phillips</Name>
        <Affiliation>Section of Molecular Carcinogenesis, Institute of Cancer Research, Brookes Lawley Building, Cotswold Road, Sutton, Surrey SM2 5NG, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Volker M. Arlt</Name>
        <Affiliation>Section of Molecular Carcinogenesis, Institute of Cancer Research, Brookes Lawley Building, Cotswold Road, Sutton, Surrey SM2 5NG, UK. Electronic address: volker.arlt@kcl.ac.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Imaging the penetration and distribution of zinc and zinc species after topical application of zinc pyrithione to human skin.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29471083</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30058-9</DOI>
    <KeywordList>
      <Keywords>Cell toxicity</Keywords>
      <Keywords>Human skin</Keywords>
      <Keywords>Skin delivery</Keywords>
      <Keywords>Skin penetration</Keywords>
      <Keywords>X-ray fluorescence</Keywords>
      <Keywords>Zinc</Keywords>
      <Keywords>Zinc pyrithione</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Amy M. Holmes</Name>
        <Affiliation>The University of South Australia, School of Pharmacy and Medical Sciences, Adelaide, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Ivan Kempson</Name>
        <Affiliation>The University of South Australia, Future Industries Institute, Adelaide, Australia. Electronic address: ivan.kempson@unisa.edu.au.</Affiliation>
      </Author>
      <Author>
        <Name>Tyron Turnbull</Name>
        <Affiliation>The University of South Australia, Future Industries Institute, Adelaide, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>David Paterson</Name>
        <Affiliation>Australian Synchrotron, Clayton, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Michael S. Roberts</Name>
        <Affiliation>The University of South Australia, School of Pharmacy and Medical Sciences, Adelaide, Australia; The University of Queensland, Therapeutics Research Centre, Brisbane, Australia. Electronic address: Michael.Roberts@unisa.edu.au.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pharmacokinetic and pharmacodynamic evaluation of 5-methoxy-2-aminoindane (MEAI): A new binge-mitigating agent.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29458138</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30053-X</DOI>
    <KeywordList>
      <Keywords>Aminoindane</Keywords>
      <Keywords>MEAI</Keywords>
      <Keywords>Nonlinear</Keywords>
      <Keywords>Pharmacodynamics</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jakob A. Shimshoni</Name>
        <Affiliation>Department of Food Quality &amp; Safety, Institute for Postharvest and Food Sciences, Agricultural Research Organization, Volcani Center, Rishon Letzion 7528809, Israel. Electronic address: jakobs@volcani.agri.gov.il.</Affiliation>
      </Author>
      <Author>
        <Name>Eyal Sobol</Name>
        <Affiliation>Department of Food Quality &amp; Safety, Institute for Postharvest and Food Sciences, Agricultural Research Organization, Volcani Center, Rishon Letzion 7528809, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Ezekiel Golan</Name>
        <Affiliation>BSC BV Company, Veemarkt 61, Amsterdam, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Yulius Ben Ari</Name>
        <Affiliation>Faculty of Agriculture, The Interdepartmental Equipment Facility, The Hebrew University, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Orit Gal</Name>
        <Affiliation>Faculty of Agriculture, The Interdepartmental Equipment Facility, The Hebrew University, Israel.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Bisphenol A alters oocyte maturation by prematurely closing gap junctions in the cumulus cell-oocyte complex.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29458137</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30057-7</DOI>
    <KeywordList>
      <Keywords>Bisphenol A</Keywords>
      <Keywords>Connexin</Keywords>
      <Keywords>Cumulus cell-oocyte complex</Keywords>
      <Keywords>Gap junction intercellular communication</Keywords>
      <Keywords>Oocyte maturation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Deyanira Guadalupe Acuña-Hernández</Name>
        <Affiliation>Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav), IPN 2508, Col. San Pedro Zacatenco, México City 07360, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Arreola-Mendoza</Name>
        <Affiliation>Departamento de Biociencias e Ingenieria CIIEMAD, del Instituto Politécnico Nacional, México City, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Ramsés Santacruz-Márquez</Name>
        <Affiliation>Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav), IPN 2508, Col. San Pedro Zacatenco, México City 07360, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Sihomara Patricia García-Zepeda</Name>
        <Affiliation>Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav), IPN 2508, Col. San Pedro Zacatenco, México City 07360, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Lyda Yuliana Parra-Forero</Name>
        <Affiliation>Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav), IPN 2508, Col. San Pedro Zacatenco, México City 07360, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Jesús Alberto Olivares-Reyes</Name>
        <Affiliation>Departamento de Bioquímica, Cinvestav, IPN 2508, Col. San Pedro Zacatenco, México City 07360, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Isabel Hernández-Ochoa</Name>
        <Affiliation>Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav), IPN 2508, Col. San Pedro Zacatenco, México City 07360, Mexico. Electronic address: mihernandez@cinvestav.mx.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Activation of NLRX1-mediated autophagy accelerates the ototoxic potential of cisplatin in auditory cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29454061</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30052-8</DOI>
    <KeywordList>
      <Keywords>Auditory cells</Keywords>
      <Keywords>Autophagy</Keywords>
      <Keywords>Cisplatin</Keywords>
      <Keywords>NLRX1</Keywords>
      <Keywords>Ototoxity</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Haiyan Yin</Name>
        <Affiliation>Department of Otolaryngology-Head and Neck Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, PR China; Department of Pathology and Pathophysiology, Shandong University, Cheeloo College Of Medicine, Jinan 250012, PR China; Shandong Provincial Key Laboratory of Otology, Jinan, 250021, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Qianqian Yang</Name>
        <Affiliation>Department of Otolaryngology-Head and Neck Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, PR China; Department of Pathology and Pathophysiology, Shandong University, Cheeloo College Of Medicine, Jinan 250012, PR China; Shandong Provincial Key Laboratory of Otology, Jinan, 250021, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhixin Cao</Name>
        <Affiliation>Department of Pathology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, 250021, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongrui Li</Name>
        <Affiliation>Department of Otolaryngology-Head and Neck Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, PR China; Shandong Provincial Key Laboratory of Otology, Jinan, 250021, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhaoyan Yu</Name>
        <Affiliation>Department of Otolaryngology-Head and Neck Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, PR China; Shandong Provincial Key Laboratory of Otology, Jinan, 250021, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Guodong Zhang</Name>
        <Affiliation>Department of Otolaryngology-Head and Neck Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, PR China; Shandong Provincial Key Laboratory of Otology, Jinan, 250021, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Gaoying Sun</Name>
        <Affiliation>Department of Otolaryngology-Head and Neck Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, PR China; Shandong Provincial Key Laboratory of Otology, Jinan, 250021, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Rongjun Man</Name>
        <Affiliation>Department of Otolaryngology-Head and Neck Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, PR China; Shandong Provincial Key Laboratory of Otology, Jinan, 250021, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Haibo Wang</Name>
        <Affiliation>Department of Otolaryngology-Head and Neck Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, PR China; Shandong Provincial Key Laboratory of Otology, Jinan, 250021, PR China. Electronic address: whboto11@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jianfeng Li</Name>
        <Affiliation>Department of Otolaryngology-Head and Neck Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250021, PR China; Shandong Provincial Key Laboratory of Otology, Jinan, 250021, PR China. Electronic address: ljf_sdph@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>AOP-DB: A database resource for the exploration of Adverse Outcome Pathways through integrated association networks.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29454060</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30051-6</DOI>
    <KeywordList>
      <Keywords>Adverse Outcome Pathways (AOPs)</Keywords>
      <Keywords>Association networks</Keywords>
      <Keywords>Data integration</Keywords>
      <Keywords>Data mining</Keywords>
      <Keywords>Database</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Maureen E. Pittman</Name>
        <Affiliation>Oak Ridge Associated Universities, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen W. Edwards</Name>
        <Affiliation>US Environmental Protection Agency, Office of Research and Development (ORD), National Health and Environmental Effects Laboratory, Integrated Systems Toxicology Division, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Cataia Ives</Name>
        <Affiliation>Oak Ridge Associated Universities, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Holly M. Mortensen</Name>
        <Affiliation>US Environmental Protection Agency, Office of Research and Development (ORD), National Health and Environmental Effects Laboratory, Research Cores Unit, Research Triangle Park, NC 27709, USA. Electronic address: mortensen.holly@epa.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Towards a regulatory use of alternative developmental neurotoxicity testing (DNT).</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29454059</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30041-3</DOI>
    <KeywordList>
      <Keywords>DNT</Keywords>
      <Keywords>IATA</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>Regulatory</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Andrea Terron</Name>
        <Affiliation>European Food Safety Authority, Italy. Electronic address: andrea.terron@efsa.europa.eu.</Affiliation>
      </Author>
      <Author>
        <Name>Susanne Hougaard Bennekou</Name>
        <Affiliation>Danish Environmental Protection Agency, Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Aryl hydrocarbon receptor (AhR) mediated short-term effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on bile acid homeostasis in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29452137</pubmedLink>
    <GrantList>
      <Grant>F32 DK092069</Grant>
      <Grant>R01 ES009649</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30044-9</DOI>
    <KeywordList>
      <Keywords>Aryl hydrocarbon receptor</Keywords>
      <Keywords>Bile acids</Keywords>
      <Keywords>Biliary excretion</Keywords>
      <Keywords>Cyp8b1</Keywords>
      <Keywords>TCDD</Keywords>
      <Keywords>Taurodeoxycholic acid</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Iván L. Csanaky</Name>
        <Affiliation>Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Division of Gastroenterology, Children's Mercy Hospital, Kansas City, MO 64108; USA; Department of Pediatrics, University of Kansas Medical Center, Kansas City, KS 66160, USA. Electronic address: ilcsanaky@cmh.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew J. Lickteig</Name>
        <Affiliation>Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Curtis D. Klaassen</Name>
        <Affiliation>Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USA. Electronic address: curtisklaassenphd@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29447839</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30043-7</DOI>
    <KeywordList>
      <Keywords>Developmental neurotoxicity</Keywords>
      <Keywords>In vitro testing</Keywords>
      <Keywords>Regulatory purposes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ellen Fritsche</Name>
        <Affiliation>IUF - Leibniz Research Institute for Environmental Medicine, Duesseldorf, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Philippe Grandjean</Name>
        <Affiliation>University of Southern Denmark, Harvard T.H. Chan School of Public Health, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin M. Crofton</Name>
        <Affiliation>Neurotoxicologist, Durham, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Aschner</Name>
        <Affiliation>Albert Einstein College of Medicine Bronx, New York, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alan Goldberg</Name>
        <Affiliation>Bloomberg School of Public Health, Founding Director (Emeritus) of Center for Alternatives to Animal Testing (CAAT), Johns Hopkins University, Baltimore, USA; Global Food Ethics, Johns Hopkins University, Baltimore, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tuula Heinonen</Name>
        <Affiliation>Finnish Centre for Alternative Methods (FICAM), University of Tampere, Tampere, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>Ellen V. S. Hessel</Name>
        <Affiliation>National Institute for Public Health and the Environment, RIVM Center for Health Protection, Bilthoven, Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Helena T. Hogberg</Name>
        <Affiliation>Centre for Alternatives to Animal Testing (CAAT), Johns Hopkins University, Baltimore, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Susanne Hougaard Bennekou</Name>
        <Affiliation>The Danish Environmental Protection Agency (EPA), Copenhagen, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Pamela J. Lein</Name>
        <Affiliation>Department of Molecular Biosciences, School of Veterinary Medicine, University of California Davis, Davis, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marcel Leist</Name>
        <Affiliation>CAAT - Centre for Alternatives to Animal Testing, University of Konstanz, Konstanz, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>William R. Mundy</Name>
        <Affiliation>Neurotoxicologist, Durham, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Martin Paparella</Name>
        <Affiliation>Austrian National Coordinator of Testing Methods, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>Aldert H. Piersma</Name>
        <Affiliation>RIVM Center for Health Protection, Bilthoven and Institute for Risk Assessment Sciences, Utrecht University, Utrecht, Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Magdalini Sachana</Name>
        <Affiliation>Organisation for Economic Co-operation and Development (OECD), Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>Gabriele Schmuck</Name>
        <Affiliation>Bayer, Wuppertal, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Roland Solecki</Name>
        <Affiliation>Federal Institute for Risk Assessment (BfR), Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Terron</Name>
        <Affiliation>European Food Safety Authority (EFSA), Parma, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Florianne Monnet-Tschudi</Name>
        <Affiliation>Department of Physiology, University of Lausanne and SCAHT, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Martin F. Wilks</Name>
        <Affiliation>SCAHT - Swiss Centre for Applied Human Toxicology, University of Basel, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Hilda Witters</Name>
        <Affiliation>VITO, Flemish Institute for Technological Research, Unit Environmental Risk and Health, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Marie Gabrielle Zurich</Name>
        <Affiliation>Department of Physiology, University of Lausanne and SCAHT, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Bal-Price</Name>
        <Affiliation>European Commission -DG Joint Research Centre (JRC), Ispra, Italy. Electronic address: anna.price@ec.europa.eu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Rotenone exerts developmental neurotoxicity in a human brain spheroid model.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29428530</pubmedLink>
    <GrantList>
      <Grant>U18 TR000547</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30042-5</DOI>
    <KeywordList>
      <Keywords>DNT</Keywords>
      <Keywords>Developmental neurotoxicity</Keywords>
      <Keywords>In Vitro</Keywords>
      <Keywords>Organoids</Keywords>
      <Keywords>Rotenone</Keywords>
      <Keywords>Spheroids</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David Pamies</Name>
        <Affiliation>Center for Alternative to Animal Testing (CAAT), Johns Hopkins University, 615 North Wolfe Street, Baltimore, MD 21205, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Katharina Block</Name>
        <Affiliation>Center for Alternative to Animal Testing (CAAT), Johns Hopkins University, 615 North Wolfe Street, Baltimore, MD 21205, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Pierre Lau</Name>
        <Affiliation>European Commission, Joint Research Centre, European Reference Laboratory - European Centre for the Validation of Alternative Methods (EURL ECVAM), Via Enrico Fermi 2749, Ispra, VA 21027, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Gribaldo</Name>
        <Affiliation>European Commission, Joint Research Centre, European Reference Laboratory - European Centre for the Validation of Alternative Methods (EURL ECVAM), Via Enrico Fermi 2749, Ispra, VA 21027, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Carlos A. Pardo</Name>
        <Affiliation>Department of Neurology, Johns Hopkins University, 600 N Wolfe Street, Baltimore, MD 21287, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Paula Barreras</Name>
        <Affiliation>Department of Neurology, Johns Hopkins University, 600 N Wolfe Street, Baltimore, MD 21287, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lena Smirnova</Name>
        <Affiliation>Center for Alternative to Animal Testing (CAAT), Johns Hopkins University, 615 North Wolfe Street, Baltimore, MD 21205, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Daphne Wiersma</Name>
        <Affiliation>Center for Alternative to Animal Testing (CAAT), Johns Hopkins University, 615 North Wolfe Street, Baltimore, MD 21205, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Liang Zhao</Name>
        <Affiliation>Center for Alternative to Animal Testing (CAAT), Johns Hopkins University, 615 North Wolfe Street, Baltimore, MD 21205, USA; Bloomberg-Kimmel Institute for Cancer Immunotherapy, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, 650 Orleans Street, CRB1, Rm 464, Baltimore, MD 21287, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Georgina Harris</Name>
        <Affiliation>Center for Alternative to Animal Testing (CAAT), Johns Hopkins University, 615 North Wolfe Street, Baltimore, MD 21205, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Hartung</Name>
        <Affiliation>Center for Alternative to Animal Testing (CAAT), Johns Hopkins University, 615 North Wolfe Street, Baltimore, MD 21205, USA; University of Konstanz, CAAT-Europe, Universitätsstr. 10, Konstanz 78464, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Helena T. Hogberg</Name>
        <Affiliation>Center for Alternative to Animal Testing (CAAT), Johns Hopkins University, 615 North Wolfe Street, Baltimore, MD 21205, USA. Electronic address: hhogberg2@jhu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Orally administered berberine ameliorates bleomycin-induced pulmonary fibrosis in mice through promoting activation of PPAR-γ and subsequent expression of HGF in colons.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29408570</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30040-1</DOI>
    <KeywordList>
      <Keywords>Berberine</Keywords>
      <Keywords>Gut</Keywords>
      <Keywords>HGF</Keywords>
      <Keywords>PPAR-γ</Keywords>
      <Keywords>Pulmonary fibrosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chunge Guan</Name>
        <Affiliation>Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Simiao Qiao</Name>
        <Affiliation>Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Lv</Name>
        <Affiliation>Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Na Cao</Name>
        <Affiliation>Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kai Wang</Name>
        <Affiliation>Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yue Dai</Name>
        <Affiliation>Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China. Electronic address: 1019880912@cpu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Zhifeng Wei</Name>
        <Affiliation>Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China. Electronic address: 1020132346@cpu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cadmium disrupts signaling of the hypoxia-inducible (HIF) and transforming growth factor (TGF-β) pathways in placental JEG-3 trophoblast cells via reactive oxygen species.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29408318</pubmedLink>
    <GrantList>
      <Grant>P42 ES005948</Grant>
      <Grant>R01 ES019315</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30017-6</DOI>
    <KeywordList>
      <Keywords>Cadmium</Keywords>
      <Keywords>Gene expression</Keywords>
      <Keywords>Growth factor</Keywords>
      <Keywords>Hypoxia</Keywords>
      <Keywords>Placentation</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Oluwadamilare A. Adebambo</Name>
        <Affiliation>Department of Biological Sciences, North Carolina State University, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Damian Shea</Name>
        <Affiliation>Department of Biological Sciences, North Carolina State University, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rebecca C. Fry</Name>
        <Affiliation>Department of Environmental Science and Engineering, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, USA. Electronic address: rfry@unc.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>H6, a novel hederagenin derivative, reverses multidrug resistance in vitro and in vivo.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29408042</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30022-X</DOI>
    <KeywordList>
      <Keywords>H6</Keywords>
      <Keywords>Molecular docking</Keywords>
      <Keywords>Multidrug resistance</Keywords>
      <Keywords>P-glycoprotein</Keywords>
      <Keywords>α-Hederagenin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yanting Yang</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, China.</Affiliation>
      </Author>
      <Author>
        <Name>Daokun Guan</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lei Lei</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, China; State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100050, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Lu</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, China; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jia Qi Liu</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, China.</Affiliation>
      </Author>
      <Author>
        <Name>Gangqiang Yang</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunhong Yan</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, China; Department of Biochemistry and Molecular Biology, Medical College of Georgia, Georgia Regents University, Augusta 30602, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rong Zhai</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingwei Tian</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Bi</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, China. Electronic address: 13361368686@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Fenghua Fu</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, China. Electronic address: fufh@ytu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Hongbo Wang</Name>
        <Affiliation>School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai, 264005, China. Electronic address: hongbowang@ytu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Low-level arsenic causes proteotoxic stress and not oxidative stress.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29408041</pubmedLink>
    <GrantList>
      <Grant>P30 CA023074</Grant>
      <Grant>R01 ES023758</Grant>
      <Grant>P30 ES006694</Grant>
      <Grant>P42 ES004940</Grant>
      <Grant>R01 DK109555</Grant>
      <Grant>R01 ES026845</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30021-8</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Autophagy inhibitor</Keywords>
      <Keywords>ER stress</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Proteostasis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Matthew Dodson</Name>
        <Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Montserrat Rojo de la Vega</Name>
        <Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bryan Harder</Name>
        <Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Raul Castro-Portuguez</Name>
        <Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Silvia D. Rodrigues</Name>
        <Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Pak Kin Wong</Name>
        <Affiliation>Department of Biomedical Engineering, The Pennsylvania State University, University Park, PA 16802, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Eli Chapman</Name>
        <Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Donna D. Zhang</Name>
        <Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA; Arizona Cancer Center, University of Arizona, Tucson, AZ 85724, USA. Electronic address: dzhang@pharmacy.arizona.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Different effects of ursodeoxycholic acid on intrahepatic cholestasis in acute and recovery stages induced by alpha-naphthylisothiocyanate in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29407775</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30026-7</DOI>
    <KeywordList>
      <Keywords>Alpha-naphthylisothiocyanate</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Intrahepatic cholestasis</Keywords>
      <Keywords>Ursodeoxycholic acid</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Linlin Zhang</Name>
        <Affiliation>Shuguang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine, No. 528 Zhangheng Road, Shanghai 201203, People's Republic of China; Laboratory of Clinical Pharmacokinetics, Shuguang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine, No. 528 Zhangheng Road, Shanghai 201203, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Huizong Su</Name>
        <Affiliation>Shuguang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine, No. 528 Zhangheng Road, Shanghai 201203, People's Republic of China; Laboratory of Clinical Pharmacokinetics, Shuguang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine, No. 528 Zhangheng Road, Shanghai 201203, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yue Li</Name>
        <Affiliation>Shuguang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine, No. 528 Zhangheng Road, Shanghai 201203, People's Republic of China; Laboratory of Clinical Pharmacokinetics, Shuguang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine, No. 528 Zhangheng Road, Shanghai 201203, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yujuan Fan</Name>
        <Affiliation>Shuguang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine, No. 528 Zhangheng Road, Shanghai 201203, People's Republic of China; Laboratory of Clinical Pharmacokinetics, Shuguang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine, No. 528 Zhangheng Road, Shanghai 201203, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Qian Wang</Name>
        <Affiliation>Shuguang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine, No. 528 Zhangheng Road, Shanghai 201203, People's Republic of China; Laboratory of Clinical Pharmacokinetics, Shuguang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine, No. 528 Zhangheng Road, Shanghai 201203, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Jian Jiang</Name>
        <Affiliation>Shuguang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine, No. 528 Zhangheng Road, Shanghai 201203, People's Republic of China; Laboratory of Clinical Pharmacokinetics, Shuguang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine, No. 528 Zhangheng Road, Shanghai 201203, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yiyang Hu</Name>
        <Affiliation>Shuguang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine, No. 528 Zhangheng Road, Shanghai 201203, People's Republic of China; Laboratory of Clinical Pharmacokinetics, Shuguang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine, No. 528 Zhangheng Road, Shanghai 201203, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Gaofeng Chen</Name>
        <Affiliation>Shuguang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine, No. 528 Zhangheng Road, Shanghai 201203, People's Republic of China; Laboratory of Clinical Pharmacokinetics, Shuguang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine, No. 528 Zhangheng Road, Shanghai 201203, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Tan</Name>
        <Affiliation>Shuguang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine, No. 528 Zhangheng Road, Shanghai 201203, People's Republic of China; Laboratory of Clinical Pharmacokinetics, Shuguang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine, No. 528 Zhangheng Road, Shanghai 201203, People's Republic of China. Electronic address: tbolt@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Furong Qiu</Name>
        <Affiliation>Shuguang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine, No. 528 Zhangheng Road, Shanghai 201203, People's Republic of China; Laboratory of Clinical Pharmacokinetics, Shuguang Hospital Affiliated with Shanghai University of Traditional Chinese Medicine, No. 528 Zhangheng Road, Shanghai 201203, People's Republic of China. Electronic address: Furong_qiu@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Relevance to investigate different stages of pregnancy to highlight toxic effects of nanoparticles: The example of silica.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29407774</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30033-4</DOI>
    <KeywordList>
      <Keywords>Fetus</Keywords>
      <Keywords>Nanoparticles</Keywords>
      <Keywords>Placenta</Keywords>
      <Keywords>Pregnancy</Keywords>
      <Keywords>Silica</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Antonio Pietroiusti</Name>
        <Affiliation>Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, Rome 00133, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Lucia Vecchione</Name>
        <Affiliation>Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, Rome 00133, Italy; Department of Physics, University of Calabria, Via P. Bucci, Cubo 31 C, Arcavacata di Rende, CS 87036, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Ada Malvindi</Name>
        <Affiliation>Nanobiointeractions &amp; Nanodiagnostics, Center for Biomolecular Nanotechnologies@UniLe, Istituto Italiano di Tecnologia, Via Barsanti, Arnesano, Lecce 73010, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Cinzia Aru</Name>
        <Affiliation>Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, Rome 00133, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Micol Massimiani</Name>
        <Affiliation>Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, Rome 00133, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Antonella Camaioni</Name>
        <Affiliation>Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, Rome 00133, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Magrini</Name>
        <Affiliation>Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, Rome 00133, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Roberta Bernardini</Name>
        <Affiliation>Animal Technology Station, University of Rome "Tor Vergata", Via Montpellier 1, Rome 00133, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Stefania Sabella</Name>
        <Affiliation>Italian Institute of Technology, D3_Pharma Chemistry, Via Morego, Genova, GE 16146, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Pier Paolo Pompa</Name>
        <Affiliation>Nanobiointeractions &amp; Nanodiagnostics, Center for Biomolecular Nanotechnologies@UniLe, Istituto Italiano di Tecnologia, Via Barsanti, Arnesano, Lecce 73010, Italy; Nanobiointeractions &amp; Nanodiagnostics, Istituto Italiano di Tecnologia, Via Morego, 30, Genova 16163, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Luisa Campagnolo</Name>
        <Affiliation>Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, Rome 00133, Italy. Electronic address: campagno@med.uniroma2.it.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Preclinical evaluation of the mono-PEGylated recombinant human interleukin-11 in cynomolgus monkeys.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29407773</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30023-1</DOI>
    <KeywordList>
      <Keywords>IL-11</Keywords>
      <Keywords>Interleukin</Keywords>
      <Keywords>Monkeys</Keywords>
      <Keywords>PEGylated</Keywords>
      <Keywords>Preclinical</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kuo Ming Yu</Name>
        <Affiliation>Nansha Biologics (Hong Kong) Ltd., Unit 608-613, IC Development Centre, No. 6 Science Park West Avenue, Hong Kong Science Park, Shatin, Hong Kong, China; Department of Applied Biology &amp; Chemical Technology, The Hong Kong Polytechnic University, 11 Yuk Choi Road, Hung Hom, Kowloon, Hong Kong. Electronic address: kyu@nansha-biologics.com.</Affiliation>
      </Author>
      <Author>
        <Name>Johnson Yiu Nam Lau</Name>
        <Affiliation>Nansha Biologics (Hong Kong) Ltd., Unit 608-613, IC Development Centre, No. 6 Science Park West Avenue, Hong Kong Science Park, Shatin, Hong Kong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Manson Fok</Name>
        <Affiliation>Nansha Biologics (Hong Kong) Ltd., Unit 608-613, IC Development Centre, No. 6 Science Park West Avenue, Hong Kong Science Park, Shatin, Hong Kong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuk Keung Yeung</Name>
        <Affiliation>Nansha Biologics (Hong Kong) Ltd., Unit 608-613, IC Development Centre, No. 6 Science Park West Avenue, Hong Kong Science Park, Shatin, Hong Kong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Siu Ping Fok</Name>
        <Affiliation>Nansha Biologics (Hong Kong) Ltd., Unit 608-613, IC Development Centre, No. 6 Science Park West Avenue, Hong Kong Science Park, Shatin, Hong Kong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Suxing Zhang</Name>
        <Affiliation>KG Pharma Limited, Wuhua Road, Zhangcha Subdistrict, Foshan 528000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Peizhen Ye</Name>
        <Affiliation>KG Pharma Limited, Wuhua Road, Zhangcha Subdistrict, Foshan 528000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kezhi Zhang</Name>
        <Affiliation>KG Pharma Limited, Wuhua Road, Zhangcha Subdistrict, Foshan 528000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaobo Li</Name>
        <Affiliation>New South Center for Safety Evaluation of Drugs, 436, Chentai Road, Baiyun District, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Li</Name>
        <Affiliation>New South Center for Safety Evaluation of Drugs, 436, Chentai Road, Baiyun District, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qin Xu</Name>
        <Affiliation>New South Center for Safety Evaluation of Drugs, 436, Chentai Road, Baiyun District, Guangzhou, China; Institute of Tropical Medicine, Guangzhou University of Chinese Medicine, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wing Tak Wong</Name>
        <Affiliation>Department of Applied Biology &amp; Chemical Technology, The Hong Kong Polytechnic University, 11 Yuk Choi Road, Hung Hom, Kowloon, Hong Kong.</Affiliation>
      </Author>
      <Author>
        <Name>Qui Lim Choo</Name>
        <Affiliation>Nansha Biologics (Hong Kong) Ltd., Unit 608-613, IC Development Centre, No. 6 Science Park West Avenue, Hong Kong Science Park, Shatin, Hong Kong, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety assessment of starch-based personal care products: Nanocapsules and pickering emulsions.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29407772</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30025-5</DOI>
    <KeywordList>
      <Keywords>Biological effects</Keywords>
      <Keywords>Cosmetics</Keywords>
      <Keywords>Excipients</Keywords>
      <Keywords>Safety assessment</Keywords>
      <Keywords>Starch vehicles</Keywords>
      <Keywords>Topical application</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>J. Marto</Name>
        <Affiliation>Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>P. Pinto</Name>
        <Affiliation>Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Portugal; PhD Trials, Rua das Murtas, n°1B, 1° - 1700-309, Lisboa, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>M. Fitas</Name>
        <Affiliation>PhD Trials, Rua das Murtas, n°1B, 1° - 1700-309, Lisboa, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>L. M. Gonçalves</Name>
        <Affiliation>Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>A. J. Almeida</Name>
        <Affiliation>Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>H. M. Ribeiro</Name>
        <Affiliation>Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Portugal. Electronic address: hribeiro@campus.ul.pt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Triptolide induces mitochondria-mediated apoptosis of Burkitt's lymphoma cell via deacetylation of GSK-3β by increased SIRT3 expression.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29407771</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30018-8</DOI>
    <KeywordList>
      <Keywords>Burkitt's lymphoma</Keywords>
      <Keywords>GSK-3β</Keywords>
      <Keywords>SIRT3</Keywords>
      <Keywords>Triptolide</Keywords>
      <Keywords>apoptosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jiamin Kong</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Wang</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Ren</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yujing Yan</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yisen Cheng</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhiying Huang</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, PR China. Electronic address: hzhiying@mail.sysu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Feihai Shen</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, PR China. Electronic address: shenfh3@mail.sysu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Investigating mitochondrial dysfunction in human lung cells exposed to redox-active PM components.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29407367</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
      <Grant>T32 ES007126</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30031-0</DOI>
    <KeywordList>
      <Keywords>Air pollution</Keywords>
      <Keywords>Bioenergetics</Keywords>
      <Keywords>Extracellular flux</Keywords>
      <Keywords>Mitochondria</Keywords>
      <Keywords>Quinones</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Katelyn S. Lavrich</Name>
        <Affiliation>Curriculum in Toxicology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Electronic address: klavrich@email.unc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Elizabeth M. Corteselli</Name>
        <Affiliation>Department of Environmental Sciences and Engineering, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Electronic address: emc252@live.unc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Phillip A. Wages</Name>
        <Affiliation>Curriculum in Toxicology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Electronic address: p.wages@vanderbilt.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Philip A. Bromberg</Name>
        <Affiliation>Center for Environmental Medicine, Asthma, and Lung Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Electronic address: philip_bromberg@med.unc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Steven O. Simmons</Name>
        <Affiliation>National Center for Computational Toxicology, U.S. Environmental Protection Agency, Research Triangle Park, NC 27709, USA. Electronic address: Simmons.Steve@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Eugene A. Gibbs-Flournoy</Name>
        <Affiliation>Oak Ridge Institute for Science and Education, Oak Ridge, TN 37830, USA. Electronic address: Gibbs-Flournoy.Eugene@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>James M. Samet</Name>
        <Affiliation>Environmental Public Health Division, National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, Chapel Hill, NC 27599, USA. Electronic address: samet.james@epa.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Low, but not high, dose triptolide controls neuroinflammation and improves behavioral deficits in toxic model of multiple sclerosis by dampening of NF-κB activation and acceleration of intrinsic myelin repair.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29407366</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30030-9</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Cuprizone</Keywords>
      <Keywords>Demyelination</Keywords>
      <Keywords>Multiple sclerosis</Keywords>
      <Keywords>Neuroinflammation</Keywords>
      <Keywords>Triptolide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nima Sanadgol</Name>
        <Affiliation>Department of Biology, Faculty of Sciences, University of Zabol, Zabol, Iran; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Fereshteh Golab</Name>
        <Affiliation>Cellular and Molecular Research Center, Iran University of Medical Science, Tehran, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Ali Mostafaie</Name>
        <Affiliation>Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Mehdi Mehdizadeh</Name>
        <Affiliation>Cellular and Molecular Research Center, Iran University of Medical Science, Tehran, Iran; Faculty of Advanced Technologies in Medicine, Department of Anatomical Sciences, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Roghayeh Khalseh</Name>
        <Affiliation>Department of Chemical Engineering, Babol Noshirvani University of Technology, Babol, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Morteza Mahmoudi</Name>
        <Affiliation>Department of Nanotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran; Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mohammad Abdollahi</Name>
        <Affiliation>Toxicology and Diseases Group, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Gelareh Vakilzadeh</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Ghorban Taghizadeh</Name>
        <Affiliation>Department of Occupational Therapy, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran; Rehabilitation Research Center, School of Rehabilitation Sciences, Iran University of Medical Sciences, Tehran, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Mohammad Sharifzadeh</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: msharifzadeh@sina.tums.ac.ir.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>p-Cresyl sulfate decreases peripheral B cells in mice with adenine-induced renal dysfunction.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29407365</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30032-2</DOI>
    <KeywordList>
      <Keywords>Bone marrow</Keywords>
      <Keywords>Cell cycle</Keywords>
      <Keywords>Chronic kidney disease</Keywords>
      <Keywords>STAT5</Keywords>
      <Keywords>Uremic toxin</Keywords>
      <Keywords>p-Cresol</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Takahiro Shiba</Name>
        <Affiliation>Yakult Central Institute, 5-11 Izumi, Kunitachi-Shi, Tokyo 186-8650, Japan. Electronic address: takahiro-shiba@yakult.co.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Ikuyo Makino</Name>
        <Affiliation>Yakult Central Institute, 5-11 Izumi, Kunitachi-Shi, Tokyo 186-8650, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takashi Sasaki</Name>
        <Affiliation>Yakult Central Institute, 5-11 Izumi, Kunitachi-Shi, Tokyo 186-8650, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuji Fukuhara</Name>
        <Affiliation>Yakult Central Institute, 5-11 Izumi, Kunitachi-Shi, Tokyo 186-8650, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Koji Kawakami</Name>
        <Affiliation>Yakult Central Institute, 5-11 Izumi, Kunitachi-Shi, Tokyo 186-8650, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Ikuo Kato</Name>
        <Affiliation>Yakult Central Institute, 5-11 Izumi, Kunitachi-Shi, Tokyo 186-8650, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Toshihide Kobayashi</Name>
        <Affiliation>Yakult Central Institute, 5-11 Izumi, Kunitachi-Shi, Tokyo 186-8650, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Defining toxicological tipping points in neuronal network development.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29397954</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30024-3</DOI>
    <KeywordList>
      <Keywords>In vitro</Keywords>
      <Keywords>Network development</Keywords>
      <Keywords>Screening</Keywords>
      <Keywords>Tipping point</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Christopher L. Frank</Name>
        <Affiliation>Integrated Systems Toxicology Division, National Health and Environmental Effects Research Laboratory, EPA, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jasmine P. Brown</Name>
        <Affiliation>Integrated Systems Toxicology Division, National Health and Environmental Effects Research Laboratory, EPA, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kathleen Wallace</Name>
        <Affiliation>Integrated Systems Toxicology Division, National Health and Environmental Effects Research Laboratory, EPA, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John F. Wambaugh</Name>
        <Affiliation>National Center for Computational Toxicology, EPA, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Imran Shah</Name>
        <Affiliation>National Center for Computational Toxicology, EPA, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy J. Shafer</Name>
        <Affiliation>Integrated Systems Toxicology Division, National Health and Environmental Effects Research Laboratory, EPA, Research Triangle Park, NC, USA. Electronic address: Shafer.tim@epa.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Atorvastatin and insulin equally mitigate brain pathology in diabetic rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29391240</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30028-0</DOI>
    <KeywordList>
      <Keywords>Amyloid beta</Keywords>
      <Keywords>Atorvastatin</Keywords>
      <Keywords>Brain apoptosis</Keywords>
      <Keywords>Brain mitochondrial function</Keywords>
      <Keywords>Diabetes mellitus type 1</Keywords>
      <Keywords>Insulin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wasana Pratchayasakul</Name>
        <Affiliation>Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand; Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>La Ongdao Thongnak</Name>
        <Affiliation>Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Kenneth Chattipakorn</Name>
        <Affiliation>Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Anusorn Lungaphin</Name>
        <Affiliation>Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Anchalee Pongchaidecha</Name>
        <Affiliation>Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Pattarapong Satjaritanun</Name>
        <Affiliation>Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Thidarat Jaiwongkam</Name>
        <Affiliation>Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Sasiwan Kerdphoo</Name>
        <Affiliation>Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Siriporn C. Chattipakorn</Name>
        <Affiliation>Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand; Department of Oral Biology and Diagnostic Sciences, Faculty of Dentistry, Chiang Mai University, Chiang Mai 50200, Thailand. Electronic address: siriporn.c@cmu.ac.th.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Ozone modifies the metabolic and endocrine response to glucose: Reproduction of effects with the stress hormone corticosterone.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29391239</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30027-9</DOI>
    <KeywordList>
      <Keywords>Air pollution</Keywords>
      <Keywords>Endocrine</Keywords>
      <Keywords>Glucose tolerance test</Keywords>
      <Keywords>Metabolic</Keywords>
      <Keywords>Ozone</Keywords>
      <Keywords>Stress hormone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Errol M. Thomson</Name>
        <Affiliation>Environmental Health Science and Research Bureau, Health Canada, Ottawa K1A 0K9, Canada. Electronic address: errol.thomson@canada.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Shinjini Pilon</Name>
        <Affiliation>Environmental Health Science and Research Bureau, Health Canada, Ottawa K1A 0K9, Canada. Electronic address: shinjini.pilon@canada.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Josée Guénette</Name>
        <Affiliation>Environmental Health Science and Research Bureau, Health Canada, Ottawa K1A 0K9, Canada. Electronic address: josee.guenette@canada.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Williams</Name>
        <Affiliation>Environmental Health Science and Research Bureau, Health Canada, Ottawa K1A 0K9, Canada. Electronic address: andrew.williams@canada.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Alison C. Holloway</Name>
        <Affiliation>Department of Obstetrics and Gynecology, McMaster University, Hamilton, Ontario L8N 3Z5, Canada. Electronic address: hollow@mcmaster.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Upregulation of histone-lysine methyltransferases plays a causal role in hexavalent chromium-induced cancer stem cell-like property and cell transformation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29391238</pubmedLink>
    <GrantList>
      <Grant>P30 ES026529</Grant>
      <Grant>R01 ES026151</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30029-2</DOI>
    <KeywordList>
      <Keywords>Cancer stem cell-like cell</Keywords>
      <Keywords>Carcinogenesis</Keywords>
      <Keywords>Cell transformation</Keywords>
      <Keywords>Epigenetics</Keywords>
      <Keywords>Hexavalent chromium</Keywords>
      <Keywords>Histone methyltransferase</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhishan Wang</Name>
        <Affiliation>Center for Research on Environmental Disease, University of Kentucky College of Medicine, Lexington, KY, USA; Department of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jianjun Wu</Name>
        <Affiliation>Center for Research on Environmental Disease, University of Kentucky College of Medicine, Lexington, KY, USA; Institute for Chemical Carcinogenesis, State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou, Guangdong, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Brock Humphries</Name>
        <Affiliation>Department of Radiology, University of Michigan, Ann Arbor, MI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kazuya Kondo</Name>
        <Affiliation>Department of Oncological Medical Services, Graduate School of Biomedical Sciences, Tokushima University Graduate School, Tokushima city, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yiguo Jiang</Name>
        <Affiliation>Institute for Chemical Carcinogenesis, State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou, Guangdong, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xianglin Shi</Name>
        <Affiliation>Center for Research on Environmental Disease, University of Kentucky College of Medicine, Lexington, KY, USA; Department of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chengfeng Yang</Name>
        <Affiliation>Center for Research on Environmental Disease, University of Kentucky College of Medicine, Lexington, KY, USA; Department of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, KY, USA. Electronic address: Chengfeng.yang@uky.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Combined effects of simultaneous exposure to six phthalates and emulsifier glycerol monosterate on male reproductive system in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29366639</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30020-6</DOI>
    <KeywordList>
      <Keywords>Combined effects</Keywords>
      <Keywords>Glycerin monostearate</Keywords>
      <Keywords>Long-term low-dose exposure</Keywords>
      <Keywords>Metabonomics</Keywords>
      <Keywords>Phthalates</Keywords>
      <Keywords>Reproductive toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hai Tao Gao</Name>
        <Affiliation>Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Run Xu</Name>
        <Affiliation>Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Xin Cao</Name>
        <Affiliation>Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qian Nan Di</Name>
        <Affiliation>Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Xian Li</Name>
        <Affiliation>Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lingeng Lu</Name>
        <Affiliation>Department of Chronic Disease Epidemiology, Yale School of Public Health, School of Medicine, Yale University, 60 College Street, New Haven, CT 06520-8034, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Qian Xu</Name>
        <Affiliation>Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing 210009, China; Suzhou Key Laboratory of Environment and Biosafety, Suzhou 215123, China. Electronic address: q_xu68@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Shu Qin Yu</Name>
        <Affiliation>Jiangsu Key Laboratory for Supramolecular Medicinal Material and Applications, College of Life Sciences, Nanjing Normal University, Nanjing 210046, China; Jiangsu Province Key Laboratory for Molecular and Medicinal Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing 210046, China. Electronic address: yushuqin@njnu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>3,4-diaminopyridine reverses paralysis in botulinum neurotoxin-intoxicated diaphragms through two functionally distinct mechanisms.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29366638</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30019-X</DOI>
    <KeywordList>
      <Keywords>3,4-Diaminopyridine</Keywords>
      <Keywords>Botulinum neurotoxin</Keywords>
      <Keywords>Endplate recordings</Keywords>
      <Keywords>Isometric muscle contractions</Keywords>
      <Keywords>Neurotransmission</Keywords>
      <Keywords>Release probability</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Aaron B. Bradford</Name>
        <Affiliation>Department of Neuroscience, United States Army Medical Research Institute of Chemical Defense, 2900 Ricketts Point Road, Gunpowder, MD 21010, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James B. Machamer</Name>
        <Affiliation>Department of Neuroscience, United States Army Medical Research Institute of Chemical Defense, 2900 Ricketts Point Road, Gunpowder, MD 21010, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Trisha M. Russo</Name>
        <Affiliation>Department of Neuroscience, United States Army Medical Research Institute of Chemical Defense, 2900 Ricketts Point Road, Gunpowder, MD 21010, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Patrick M. McNutt</Name>
        <Affiliation>Department of Neuroscience, United States Army Medical Research Institute of Chemical Defense, 2900 Ricketts Point Road, Gunpowder, MD 21010, USA. Electronic address: patrick.m.mcnutt2.civ@mail.mil.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Kuwanon G attenuates atherosclerosis by upregulation of LXRα-ABCA1/ABCG1 and inhibition of NFκB activity in macrophages.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29355567</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30007-3</DOI>
    <KeywordList>
      <Keywords>Atherosclerosis</Keywords>
      <Keywords>Foam cell formation</Keywords>
      <Keywords>Inflammatory</Keywords>
      <Keywords>Kuwanon G</Keywords>
      <Keywords>Macrophages</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiao Xiao Liu</Name>
        <Affiliation>Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, China; Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Wen Zhang</Name>
        <Affiliation>Department of Natural Medicine &amp; Institute of Materia Medica, School of Pharmacy, Fourth Military Medical University, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kai Wang</Name>
        <Affiliation>Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xue Ying Wang</Name>
        <Affiliation>Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Long Ma</Name>
        <Affiliation>Department of Neurosurgery, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Cao</Name>
        <Affiliation>Shaanxi Key Laboratory of Natural Products &amp; Chemical Biology, School of Chemistry &amp; Pharmacy, Northwest A&amp;F University, Yangling, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dan Mo</Name>
        <Affiliation>Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Sun</Name>
        <Affiliation>Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, China; Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Qiang Li</Name>
        <Affiliation>Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, China; Key Laboratory of Gastrointestinal Pharmacology of Chinese Materia Medica of the State Administration of Traditional Chinese Medicine, Xi'an, China. Electronic address: xxqqli@fmmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pinocembrin from Penthorum chinense Pursh suppresses hepatic stellate cells activation through a unified SIRT3-TGF-β-Smad signaling pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29352975</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30009-7</DOI>
    <KeywordList>
      <Keywords>Hepatic stellate cells</Keywords>
      <Keywords>Liver fibrosis</Keywords>
      <Keywords>Penthorum chinense Pursh</Keywords>
      <Keywords>Pinocembrin</Keywords>
      <Keywords>Silent mating type information regulation 2 homolog 3</Keywords>
      <Keywords>Sma- and Mad-related proteins</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Fayang Zhou</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.</Affiliation>
      </Author>
      <Author>
        <Name>Anqi Wang</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dan Li</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yitao Wang</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ligen Lin</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China. Electronic address: ligenl@umac.mo.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>IGF1/MAPK/ERK signaling pathway-mediated programming alterations of adrenal cortex cell proliferation by prenatal caffeine exposure in male offspring rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29343424</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30008-5</DOI>
    <KeywordList>
      <Keywords>Adrenal cell proliferation</Keywords>
      <Keywords>Glucocorticoid</Keywords>
      <Keywords>Insulin-like growth factor 1</Keywords>
      <Keywords>Mitogen-activated protein kinase/extracellular signal-regulated kinase</Keywords>
      <Keywords>Prenatal caffeine exposure</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Guanghui Chen</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Yuan</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fangfang Duan</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanyan Liu</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinzhi Zhang</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zheng He</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hegui Huang</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunjiang He</Name>
        <Affiliation>Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Wang</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan 430071, China. Electronic address: wanghui19@whu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A rapid and sensitive fluorometric method for determination of aldehyde oxidase activity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29329804</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30006-1</DOI>
    <KeywordList>
      <Keywords>Aquatic species</Keywords>
      <Keywords>Biotransformation</Keywords>
      <Keywords>Cytosol</Keywords>
      <Keywords>Fluorometric assay</Keywords>
      <Keywords>Molybdenum oxidases</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nancy Apenova</Name>
        <Affiliation>Toxicology Centre, University of Saskatchewan, 44 Campus Drive, Saskatoon, Saskatchewan S7N 5B3, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Peng</Name>
        <Affiliation>Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, Ontario M5S 3H6, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Markus Hecker</Name>
        <Affiliation>Toxicology Centre, University of Saskatchewan, 44 Campus Drive, Saskatoon, Saskatchewan S7N 5B3, Canada; School of Environment and Sustainability, University of Saskatchewan, 44 Campus Drive, Saskatoon, Saskatchewan S7N 5B3, Canada. Electronic address: markus.hecker@usask.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Markus Brinkmann</Name>
        <Affiliation>Toxicology Centre, University of Saskatchewan, 44 Campus Drive, Saskatoon, Saskatchewan S7N 5B3, Canada; School of Environment and Sustainability, University of Saskatchewan, 44 Campus Drive, Saskatoon, Saskatchewan S7N 5B3, Canada. Electronic address: markus.brinkmann@usask.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Photo(geno)toxicity changes associated with hydroxylation of the aromatic chromophores during diclofenac metabolism.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29325823</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30005-X</DOI>
    <KeywordList>
      <Keywords>Comet assay</Keywords>
      <Keywords>DNA repair capability</Keywords>
      <Keywords>Metabolites</Keywords>
      <Keywords>Photosensitized DNA damage</Keywords>
      <Keywords>Phototoxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Guillermo Garcia-Lainez</Name>
        <Affiliation>Instituto de Investigación Sanitaria (IIS) La Fe, Hospital Universitari i Politècnic La Fe, Avenida de Fernando Abril Martorell 106, 46026 Valencia, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Ana M. Martínez-Reig</Name>
        <Affiliation>Instituto de Investigación Sanitaria (IIS) La Fe, Hospital Universitari i Politècnic La Fe, Avenida de Fernando Abril Martorell 106, 46026 Valencia, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Limones-Herrero</Name>
        <Affiliation>Instituto de Tecnología Química UPV-CSIC, Departamento de Química, Universitat Politècnica de València, Camino de Vera s/n, 46022 Valencia, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>M. Consuelo Jiménez</Name>
        <Affiliation>Instituto de Tecnología Química UPV-CSIC, Departamento de Química, Universitat Politècnica de València, Camino de Vera s/n, 46022 Valencia, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Miguel A. Miranda</Name>
        <Affiliation>Instituto de Tecnología Química UPV-CSIC, Departamento de Química, Universitat Politècnica de València, Camino de Vera s/n, 46022 Valencia, Spain. Electronic address: mmiranda@qim.upv.es.</Affiliation>
      </Author>
      <Author>
        <Name>Inmaculada Andreu</Name>
        <Affiliation>Instituto de Investigación Sanitaria (IIS) La Fe, Hospital Universitari i Politècnic La Fe, Avenida de Fernando Abril Martorell 106, 46026 Valencia, Spain; Instituto de Tecnología Química UPV-CSIC, Departamento de Química, Universitat Politècnica de València, Camino de Vera s/n, 46022 Valencia, Spain. Electronic address: iandreur@qim.upv.es.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicity and cardiac effects of acute exposure to tryptophan metabolites on the kynurenine pathway in early developing zebrafish (Danio rerio) embryos.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29317240</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30004-8</DOI>
    <KeywordList>
      <Keywords>Anthranilic acid</Keywords>
      <Keywords>Cinnabarinic acid</Keywords>
      <Keywords>Kynurenic acid</Keywords>
      <Keywords>Nicotinic acid</Keywords>
      <Keywords>Picolinic acid</Keywords>
      <Keywords>Xanthurenic acid</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michal Majewski</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Medicine, UWM, Olsztyn, Poland. Electronic address: michal.majewski@uwm.edu.pl.</Affiliation>
      </Author>
      <Author>
        <Name>Natalia Kasica</Name>
        <Affiliation>Department of Animal Anatomy, Faculty of Veterinary Medicine, UWM, Olsztyn, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Jakimiuk</Name>
        <Affiliation>Department of Pathophysiology, Forensic Veterinary and Administration, Faculty of Veterinary Medicine, UWM, Olsztyn, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Piotr Podlasz</Name>
        <Affiliation>Department of Pathophysiology, Forensic Veterinary and Administration, Faculty of Veterinary Medicine, UWM, Olsztyn, Poland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Protective effect of mitochondrial-targeted antioxidant MitoQ against iron ion </ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29317239</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30003-6</DOI>
    <KeywordList>
      <Keywords>(56)Fe ion radiation</Keywords>
      <Keywords>MitoQ</Keywords>
      <Keywords>Mitochondria</Keywords>
      <Keywords>Oxidative stress</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lu Gan</Name>
        <Affiliation>Department of Radiation Medicine, Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou 730000, PR China; Key Laboratory of Heavy Ion Radiation Biology and Medicine, Chinese Academy of Sciences, Lanzhou 730000, PR China; University of Chinese Academy of Sciences, Beijing 100039, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenhua Wang</Name>
        <Affiliation>Center of Mitochondria and Healthy Aging, School of Life Sciences, Yantai University, Yantai 264000, PR China. Electronic address: zhenhuawang@tom.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Si</Name>
        <Affiliation>Department of Radiation Medicine, Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou 730000, PR China; Key Laboratory of Heavy Ion Radiation Biology and Medicine, Chinese Academy of Sciences, Lanzhou 730000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Rong Zhou</Name>
        <Affiliation>Department of Radiation Medicine, Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou 730000, PR China; Key Laboratory of Heavy Ion Radiation Biology and Medicine, Chinese Academy of Sciences, Lanzhou 730000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Sun</Name>
        <Affiliation>Department of Radiation Medicine, Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou 730000, PR China; Key Laboratory of Heavy Ion Radiation Biology and Medicine, Chinese Academy of Sciences, Lanzhou 730000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Liu</Name>
        <Affiliation>Department of Radiation Medicine, Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou 730000, PR China; Key Laboratory of Heavy Ion Radiation Biology and Medicine, Chinese Academy of Sciences, Lanzhou 730000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yancheng Ye</Name>
        <Affiliation>Gansu Wuwei Tumor Hospital, Department of Science and Technology, Wuwei 733000, Gansu, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanshan Zhang</Name>
        <Affiliation>Gansu Wuwei Tumor Hospital, Department of Science and Technology, Wuwei 733000, Gansu, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhiyuan Liu</Name>
        <Affiliation>Gansu Key Laboratory of Environmental Friendly Composites and Biomass Utilization, College of Chemical Engineering, Northwest University for Nationalities, Lanzhou 730030, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Zhang</Name>
        <Affiliation>Department of Radiation Medicine, Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou 730000, PR China; Key Laboratory of Heavy Ion Radiation Biology and Medicine, Chinese Academy of Sciences, Lanzhou 730000, PR China; Gansu Wuwei Tumor Hospital, Department of Science and Technology, Wuwei 733000, Gansu, PR China. Electronic address: zhangh@impcas.ac.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicity and related mechanisms of dihydroartemisinin on porcine oocyte maturation in vitro.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29309768</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30002-4</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Calcium</Keywords>
      <Keywords>Dihydroartemisinin (DHA)</Keywords>
      <Keywords>In vitro maturation</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Porcine oocyte</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yan Luo</Name>
        <Affiliation>State Key Laboratory for Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing 100193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Man Ju Che</Name>
        <Affiliation>National Demonstration Center for Experimental Biological Sciences Education, College of Biological Sciences, China Agricultural University, Beijing 100193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cong Liu</Name>
        <Affiliation>School of life science, Wuchang University of Technology, Wuhan 430223, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hua Ge Liu</Name>
        <Affiliation>State Key Laboratory for Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing 100193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiang Wei Fu</Name>
        <Affiliation>Key Laboratory of Animal Genetics, Breeding and Reproduction, Ministry of Agriculture and National Engineering Laboratory for Animal Breeding, College of Animal Science and Technology, China Agricultural University, Beijing 100193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yun Peng Hou</Name>
        <Affiliation>State Key Laboratory for Agrobiotechnology, College of Biological Sciences, China Agricultural University, Beijing 100193, China. Electronic address: hou@cau.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Neurotoxic effect of oxaliplatin: Comparison with its oxalate-free analogue cis-[PtII(1R,2R-DACH)(3-acetoxy-1,1-cyclobutanedicarboxylato)] (LLC-1402) in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29307816</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(18)30001-2</DOI>
    <KeywordList>
      <Keywords>Analogue</Keywords>
      <Keywords>Neuropathy</Keywords>
      <Keywords>Oxalate</Keywords>
      <Keywords>Oxaliplatin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anamaria Falcão Pereira</Name>
        <Affiliation>Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceará, 60430-270 Fortaleza, CE, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Francisco Fábio Bezerra de Oliveira</Name>
        <Affiliation>Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceará, 60430-270 Fortaleza, CE, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Bruno Wesley de Freitas Alves</Name>
        <Affiliation>Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceará, 60430-270 Fortaleza, CE, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Karoline Luanne Santos de Menezes</Name>
        <Affiliation>Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceará, 60430-270 Fortaleza, CE, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Aline Kelly Viana de Mesquita</Name>
        <Affiliation>Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceará, 60430-270 Fortaleza, CE, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Mario Roberto Pontes Lisboa</Name>
        <Affiliation>Department of Morphology, Faculty of Medicine, Federal University of Ceará, 60430-170 Fortaleza, CE, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Kalina Kelma Oliveira de Sousa</Name>
        <Affiliation>Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceará, 60430-140, Fortaleza, CE, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Mariana Lima Vale</Name>
        <Affiliation>Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceará, 60430-270 Fortaleza, CE, Brazil; Department of Morphology, Faculty of Medicine, Federal University of Ceará, 60430-170 Fortaleza, CE, Brazil. Electronic address: mariana.vale@pq.cnpq.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Astragaloside IV protects blood-brain barrier integrity from LPS-induced disruption via activating Nrf2 antioxidant signaling pathway in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29294303</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30506-9</DOI>
    <KeywordList>
      <Keywords>Astragaloside IV</Keywords>
      <Keywords>Blood-brain barrier</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>ROS</Keywords>
      <Keywords>Tight junction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hongli Li</Name>
        <Affiliation>Shanghai Key Laboratory of Compound Chinese Medicines, The Ministry of Education (MOE), Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Wang</Name>
        <Affiliation>Shanghai Key Laboratory of Compound Chinese Medicines, The Ministry of Education (MOE), Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fei Huang</Name>
        <Affiliation>Shanghai Key Laboratory of Compound Chinese Medicines, The Ministry of Education (MOE), Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinmei Jin</Name>
        <Affiliation>Shanghai Key Laboratory of Compound Chinese Medicines, The Ministry of Education (MOE), Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Wu</Name>
        <Affiliation>Shanghai Key Laboratory of Compound Chinese Medicines, The Ministry of Education (MOE), Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Beibei Zhang</Name>
        <Affiliation>Shanghai Key Laboratory of Compound Chinese Medicines, The Ministry of Education (MOE), Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhifei Wang</Name>
        <Affiliation>Shanghai Key Laboratory of Compound Chinese Medicines, The Ministry of Education (MOE), Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hailian Shi</Name>
        <Affiliation>Shanghai Key Laboratory of Compound Chinese Medicines, The Ministry of Education (MOE), Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Electronic address: shihailian2003@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaojun Wu</Name>
        <Affiliation>Shanghai Key Laboratory of Compound Chinese Medicines, The Ministry of Education (MOE), Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Electronic address: xiaojunwu320@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The potential benefit of combined versus monotherapy of coenzyme Q10 and fluoxetine on depressive-like behaviors and intermediates coupled to Gsk-3β in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29291430</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30499-4</DOI>
    <KeywordList>
      <Keywords>Brain derived neurotrophic factor</Keywords>
      <Keywords>Co-enzyme Q10</Keywords>
      <Keywords>Depressive-like behavior</Keywords>
      <Keywords>Fluoxetine</Keywords>
      <Keywords>Glycogen synthase kinase-3β</Keywords>
      <Keywords>cAMP response element binding protein</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sally A. Abuelezz</Name>
        <Affiliation>Pharmacology Department, Faculty of Medicine, Ain-Shams University, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Nevien Hendawy</Name>
        <Affiliation>Pharmacology Department, Faculty of Medicine, Ain-Shams University, Cairo, Egypt. Electronic address: drnevien_hendawi@med.asu.edu.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Yosra Magdy</Name>
        <Affiliation>Pharmacology Department, Faculty of Medicine, Ain-Shams University, Cairo, Egypt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A multi-omics analysis reveals metabolic reprogramming in THP-1 cells upon treatment with the contact allergen DNCB.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29289672</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30497-0</DOI>
    <KeywordList>
      <Keywords>Allergic contact dermatitis</Keywords>
      <Keywords>Metabolic reprogramming</Keywords>
      <Keywords>Metabolomics</Keywords>
      <Keywords>Proteomics</Keywords>
      <Keywords>Sensitization</Keywords>
      <Keywords>THP-1 cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Franz Mussotter</Name>
        <Affiliation>German Federal Institute for Risk Assessment (BfR), Department of Chemical and Product Safety, Berlin, Germany. Electronic address: franz.mussotter@bfr.bund.de.</Affiliation>
      </Author>
      <Author>
        <Name>Sarah Potratz</Name>
        <Affiliation>German Federal Institute for Risk Assessment (BfR), Department of Chemical and Product Safety, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Jan Budczies</Name>
        <Affiliation>Institute of Pathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany; German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Luch</Name>
        <Affiliation>German Federal Institute for Risk Assessment (BfR), Department of Chemical and Product Safety, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Haase</Name>
        <Affiliation>German Federal Institute for Risk Assessment (BfR), Department of Chemical and Product Safety, Berlin, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Melatonin protects mouse spermatogonial stem cells against hexavalent chromium-induced apoptosis and epigenetic histone modification.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29289671</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30498-2</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Cr(VI)</Keywords>
      <Keywords>Epigenetic</Keywords>
      <Keywords>Melatonin</Keywords>
      <Keywords>Mouse</Keywords>
      <Keywords>SSCs</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yinghua Lv</Name>
        <Affiliation>College of Animal Science and Technology, Northwest A&amp;F University, Shaanxi 712100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Pengfei Zhang</Name>
        <Affiliation>College of Animal Science and Technology, Northwest A&amp;F University, Shaanxi 712100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiayin Guo</Name>
        <Affiliation>College of Animal Science and Technology, Northwest A&amp;F University, Shaanxi 712100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhendong Zhu</Name>
        <Affiliation>College of Animal Science and Technology, Northwest A&amp;F University, Shaanxi 712100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xueliang Li</Name>
        <Affiliation>College of Animal Science and Technology, Northwest A&amp;F University, Shaanxi 712100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dazhong Xu</Name>
        <Affiliation>Department of Pathology, New York Medical College School of Medicine, 15 Dana Road, Valhalla, NY 10959, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wenxian Zeng</Name>
        <Affiliation>College of Animal Science and Technology, Northwest A&amp;F University, Shaanxi 712100, China. Electronic address: zengwenxian2015@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Neuroprotective activity of macamides on manganese-induced mitochondrial disruption in U-87 MG glioblastoma cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29288688</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30495-7</DOI>
    <KeywordList>
      <Keywords>Anandamide</Keywords>
      <Keywords>Cannabinoids</Keywords>
      <Keywords>Macamides</Keywords>
      <Keywords>Mitochondria</Keywords>
      <Keywords>Mitochondrial dysfunction</Keywords>
      <Keywords>PPARγ</Keywords>
      <Keywords>ROS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kuljeet S. Gugnani</Name>
        <Affiliation>Department of Pharmaceutical Sciences, MCPHS University, 179 Longwood Avenue, Boston, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nguyen Vu</Name>
        <Affiliation>School of Pharmacy, MCPHS University, 179 Longwood Avenue, Boston, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alejandro N. Rondón-Ortiz</Name>
        <Affiliation>Department of Pharmaceutical Sciences, MCPHS University, 179 Longwood Avenue, Boston, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Böhlke</Name>
        <Affiliation>Department of Pharmaceutical Sciences, MCPHS University, 179 Longwood Avenue, Boston, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy J. Maher</Name>
        <Affiliation>Department of Pharmaceutical Sciences, MCPHS University, 179 Longwood Avenue, Boston, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alejandro J. Pino-Figueroa</Name>
        <Affiliation>Department of Pharmaceutical Sciences, MCPHS University, 179 Longwood Avenue, Boston, MA, USA. Electronic address: alejandro.pino-figueroa@mcphs.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Distinctive effects of licarin A on lipolysis mediated by PKA and on formation of brown adipocytes from C3H10T1/2 mesenchymal stem cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29288687</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30496-9</DOI>
    <KeywordList>
      <Keywords>Browning</Keywords>
      <Keywords>C3H10T1/2</Keywords>
      <Keywords>Licarin A</Keywords>
      <Keywords>Lipolysis</Keywords>
      <Keywords>Protein kinase A</Keywords>
      <Keywords>Ucp1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dahyeon Yoon</Name>
        <Affiliation>Institute of Tissue Regeneration, College of Medicine, Soonchunhyang University, Republic of Korea; Department of Microbiology, College of Medicine, Soonchunhyang University, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Khan Mohammad Imran</Name>
        <Affiliation>Institute of Tissue Regeneration, College of Medicine, Soonchunhyang University, Republic of Korea; Department of Microbiology, College of Medicine, Soonchunhyang University, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Sik Kim</Name>
        <Affiliation>Institute of Tissue Regeneration, College of Medicine, Soonchunhyang University, Republic of Korea; Department of Microbiology, College of Medicine, Soonchunhyang University, Republic of Korea. Electronic address: yongsikkim@sch.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Stage-specific metabolic features of differentiating neurons: Implications for toxicant sensitivity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29278688</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30494-5</DOI>
    <KeywordList>
      <Keywords>(13)C labeling experiment</Keywords>
      <Keywords>Developmental neurotoxicity</Keywords>
      <Keywords>Energy metabolism</Keywords>
      <Keywords>Metabolic flux</Keywords>
      <Keywords>Metabolomics</Keywords>
      <Keywords>Oxygen consumption</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Johannes Delp</Name>
        <Affiliation>In Vitro Toxicology and Biomedicine, Dept Inaugurated by the Doerenkamp-Zbinden Foundation, University of Konstanz, 78457 Konstanz, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Simon Gutbier</Name>
        <Affiliation>In Vitro Toxicology and Biomedicine, Dept Inaugurated by the Doerenkamp-Zbinden Foundation, University of Konstanz, 78457 Konstanz, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Martin Cerff</Name>
        <Affiliation>Institute of Bio- and Geosciences, IBG-1: Biotechnology, Forschungszentrum Jülich GmbH, Jülich 52425, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Christin Zasada</Name>
        <Affiliation>Max-Delbrück-Center of Molecular Medicine in the Helmholtz Association, Berlin 13125, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Sebastian Niedenführ</Name>
        <Affiliation>Institute of Bio- and Geosciences, IBG-1: Biotechnology, Forschungszentrum Jülich GmbH, Jülich 52425, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Liang Zhao</Name>
        <Affiliation>Johns Hopkins University, Bloomberg School of Public Health, Center for Alternatives to Animal Testing (CAAT), Baltimore, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lena Smirnova</Name>
        <Affiliation>Johns Hopkins University, Bloomberg School of Public Health, Center for Alternatives to Animal Testing (CAAT), Baltimore, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Hartung</Name>
        <Affiliation>Johns Hopkins University, Bloomberg School of Public Health, Center for Alternatives to Animal Testing (CAAT), Baltimore, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hanna Borlinghaus</Name>
        <Affiliation>Department of Computer and Information Science, University of Konstanz, Konstanz, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Falk Schreiber</Name>
        <Affiliation>Department of Computer and Information Science, University of Konstanz, Konstanz, Germany; Faculty of Information Technology, Monash University, Melbourne, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Jörg Bergemann</Name>
        <Affiliation>Department of Life Sciences, Albstadt-Sigmaringen University of Applied Sciences, Sigmaringen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Jochem Gätgens</Name>
        <Affiliation>Institute of Bio- and Geosciences, IBG-1: Biotechnology, Forschungszentrum Jülich GmbH, Jülich 52425, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Martin Beyss</Name>
        <Affiliation>Institute of Bio- and Geosciences, IBG-1: Biotechnology, Forschungszentrum Jülich GmbH, Jülich 52425, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Salah Azzouzi</Name>
        <Affiliation>Institute of Bio- and Geosciences, IBG-1: Biotechnology, Forschungszentrum Jülich GmbH, Jülich 52425, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Tanja Waldmann</Name>
        <Affiliation>In Vitro Toxicology and Biomedicine, Dept Inaugurated by the Doerenkamp-Zbinden Foundation, University of Konstanz, 78457 Konstanz, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Stefan Kempa</Name>
        <Affiliation>Max-Delbrück-Center of Molecular Medicine in the Helmholtz Association, Berlin 13125, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Katharina Nöh</Name>
        <Affiliation>Institute of Bio- and Geosciences, IBG-1: Biotechnology, Forschungszentrum Jülich GmbH, Jülich 52425, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Marcel Leist</Name>
        <Affiliation>In Vitro Toxicology and Biomedicine, Dept Inaugurated by the Doerenkamp-Zbinden Foundation, University of Konstanz, 78457 Konstanz, Germany; CAAT-Europe, University of Konstanz, Konstanz 78457, Germany. Electronic address: marcel.leist@uni-konstanz.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Disruption of liver development and coagulation pathway by ochratoxin A in embryonic zebrafish.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29274910</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30493-3</DOI>
    <AuthorList>
      <Author>
        <Name>Ting Shuan Wu</Name>
        <Affiliation>Graduate Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Ting Lin</Name>
        <Affiliation>Graduate Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Tzu Huang</Name>
        <Affiliation>Graduate Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ya Chih Cheng</Name>
        <Affiliation>Graduate Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Feng Yih Yu</Name>
        <Affiliation>Department of Biomedical Sciences, Chung Shan Medical University, Taichung, Taiwan; Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan. Electronic address: fengyu@csmu.edu.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Biing Hui Liu</Name>
        <Affiliation>Graduate Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan. Electronic address: biingliu@ntu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Ochratoxin A exposure decreased sperm motility via the AMPK and PTEN signaling pathways.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29274354</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30492-1</DOI>
    <KeywordList>
      <Keywords>AMPK/PTEN</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Ochratoxin A</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Sperm motility</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tian Yu Zhang</Name>
        <Affiliation>College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Ying Wu</Name>
        <Affiliation>Center for Reproductive Medicine, Qingdao Women's and Children's Hospital, Qingdao University, Qingdao 266034, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Zhao</Name>
        <Affiliation>College of Life Sciences, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chun Shuang Xu</Name>
        <Affiliation>Center for Reproductive Medicine, Qingdao Women's and Children's Hospital, Qingdao University, Qingdao 266034, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Dong Zhang</Name>
        <Affiliation>College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Ge</Name>
        <Affiliation>College of Life Sciences, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Liu</Name>
        <Affiliation>Core Laboratories of Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhong Yi Sun</Name>
        <Affiliation>Department of Urology, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing 400042, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shu Hua Zou</Name>
        <Affiliation>Center for Reproductive Medicine, Qingdao Women's and Children's Hospital, Qingdao University, Qingdao 266034, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Shen</Name>
        <Affiliation>College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, China; College of Life Sciences, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China. Electronic address: wshen@qau.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Carnosic acid prevents COL1A2 transcription through the reduction of Smad3 acetylation via the AMPKα1/SIRT1 pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29253500</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30491-X</DOI>
    <KeywordList>
      <Keywords>AMPKα1/SIRT1 pathway</Keywords>
      <Keywords>COL1A2</Keywords>
      <Keywords>Carnosic acid</Keywords>
      <Keywords>Liver fibrosis</Keywords>
      <Keywords>Smad3 acetylation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yan Zhao</Name>
        <Affiliation>Department of Pharmacology, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xue Shi</Name>
        <Affiliation>Department of Pharmacology, Dalian Medical University, Dalian 116044, China; Department of Pharmacy, First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunchun Ding</Name>
        <Affiliation>Department of Pharmacology, Dalian Medical University, Dalian 116044, China; Department of Pharmacy, Gansu Provincial Hospital, Lanzhou, 730000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dongcheng Feng</Name>
        <Affiliation>Department of General Surgery, Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Li</Name>
        <Affiliation>Department of General Surgery, Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Hu</Name>
        <Affiliation>Department of Pharmacology, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Wang</Name>
        <Affiliation>Department of Pharmacology, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dongyan Gao</Name>
        <Affiliation>Department of Pharmacology, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaofeng Tian</Name>
        <Affiliation>Department of General Surgery, Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jihong Yao</Name>
        <Affiliation>Department of Pharmacology, Dalian Medical University, Dalian 116044, China. Electronic address: yaojihong65@dmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Leptin suppresses microRNA-122 promoter activity by phosphorylation of foxO1 in hepatic stellate cell contributing to leptin promotion of mouse liver fibrosis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29248466</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30488-X</DOI>
    <KeywordList>
      <Keywords>Forkhead box protein O1</Keywords>
      <Keywords>Hepatic stellate cell</Keywords>
      <Keywords>Leptin</Keywords>
      <Keywords>Liver fibrosis</Keywords>
      <Keywords>microRNA-122</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qing Cao</Name>
        <Affiliation>Department of Biochemistry &amp; Molecular Biology, Medical College, Nantong University, Qi Xiou Road 19, Nantong 226001, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaofei Zhu</Name>
        <Affiliation>Department of Biochemistry &amp; Molecular Biology, Medical College, Nantong University, Qi Xiou Road 19, Nantong 226001, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xuguang Zhai</Name>
        <Affiliation>Department of Biochemistry &amp; Molecular Biology, Medical College, Nantong University, Qi Xiou Road 19, Nantong 226001, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Ji</Name>
        <Affiliation>Department of Pharmacology, School of Pharmacy, Nantong University, Qi Xiou Road 19, Nantong 226001, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fangyun Cheng</Name>
        <Affiliation>Department of Biochemistry &amp; Molecular Biology, Medical College, Nantong University, Qi Xiou Road 19, Nantong 226001, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yiqi Zhu</Name>
        <Affiliation>Department of Biochemistry &amp; Molecular Biology, Medical College, Nantong University, Qi Xiou Road 19, Nantong 226001, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Pengfei Yu</Name>
        <Affiliation>Department of Biochemistry &amp; Molecular Biology, Medical College, Nantong University, Qi Xiou Road 19, Nantong 226001, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yajun Zhou</Name>
        <Affiliation>Department of Biochemistry &amp; Molecular Biology, Medical College, Nantong University, Qi Xiou Road 19, Nantong 226001, Jiangsu, China. Electronic address: zhouyajun@ntu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Disposition of β-N-methylamino-l-alanine (L-BMAA), a neurotoxin, in rodents following a single or repeated oral exposure.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29248465</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30489-1</DOI>
    <KeywordList>
      <Keywords>Disposition</Keywords>
      <Keywords>L-BMAA (β-N-methylamino-l-alanine)</Keywords>
      <Keywords>Protein binding</Keywords>
      <Keywords>Proteomics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Suramya Waidyanatha</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States. Electronic address: waidyanathas@niehs.nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Kristen Ryan</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>J. Michael Sanders</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jacob D. McDonald</Name>
        <Affiliation>Lovelace Respiratory Research Institute, Albuquerque, NM, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher J. Wegerski</Name>
        <Affiliation>Lovelace Respiratory Research Institute, Albuquerque, NM, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Melanie Doyle-Eisle</Name>
        <Affiliation>Lovelace Respiratory Research Institute, Albuquerque, NM, United States.</Affiliation>
      </Author>
      <Author>
        <Name>C. Edwin Garner</Name>
        <Affiliation>Lovelace Respiratory Research Institute, Albuquerque, NM, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Decanoic acid suppresses proliferation and invasiveness of human trophoblast cells by disrupting mitochondrial function.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29248464</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30490-8</DOI>
    <KeywordList>
      <Keywords>Decanoic acid</Keywords>
      <Keywords>Invasion</Keywords>
      <Keywords>Mitochondria</Keywords>
      <Keywords>Proliferation</Keywords>
      <Keywords>Trophoblast</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Changwon Yang</Name>
        <Affiliation>Institute of Animal Molecular Biotechnology, Korea University, Seoul 02841, Republic of Korea; Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Whasun Lim</Name>
        <Affiliation>Department of Biomedical Sciences, Catholic Kwandong University, Gangneung 25601, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Fuller W. Bazer</Name>
        <Affiliation>Center for Animal Biotechnology and Genomics, Texas A&amp;M University, College Station, TX 77843-2471, USA; Department of Animal Science, Texas A&amp;M University, College Station, TX 77843-2471, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gwonhwa Song</Name>
        <Affiliation>Institute of Animal Molecular Biotechnology, Korea University, Seoul 02841, Republic of Korea; Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea. Electronic address: ghsong@korea.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Adrenergic and glucocorticoid receptor antagonists reduce ozone-induced lung injury and inflammation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29247675</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
      <Grant>T32 ES007126</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30487-8</DOI>
    <KeywordList>
      <Keywords>Adrenergic receptor antagonist</Keywords>
      <Keywords>Glucocorticoid receptor antagonist</Keywords>
      <Keywords>Lung inflammation</Keywords>
      <Keywords>Lung injury</Keywords>
      <Keywords>Ozone</Keywords>
      <Keywords>Stress response</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Andres R. Henriquez</Name>
        <Affiliation>Curriculum in Toxicology, University of North Carolina-Chapel Hill, Chapel Hill, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Samantha J. Snow</Name>
        <Affiliation>Environmental Public Health Division, National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mette C. Schladweiler</Name>
        <Affiliation>Environmental Public Health Division, National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Colette N. Miller</Name>
        <Affiliation>Environmental Public Health Division, National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Janice A. Dye</Name>
        <Affiliation>Environmental Public Health Division, National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Allen D. Ledbetter</Name>
        <Affiliation>Environmental Public Health Division, National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Judy E. Richards</Name>
        <Affiliation>Environmental Public Health Division, National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin Mauge-Lewis</Name>
        <Affiliation>Curriculum in Toxicology, University of North Carolina-Chapel Hill, Chapel Hill, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Marie A. McGee</Name>
        <Affiliation>Oak Ridge Institute for Science and Education, Oak Ridge, TN, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Urmila P. Kodavanti</Name>
        <Affiliation>Environmental Public Health Division, National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States. Electronic address: kodavanti.urmila@epa.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Valproic acid disrupts the oscillatory expression of core circadian rhythm transcription factors.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29229235</pubmedLink>
    <GrantList>
      <Grant>P30 ES006694</Grant>
      <Grant>T32 ES007091</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30478-7</DOI>
    <KeywordList>
      <Keywords>Circadian rhythm</Keywords>
      <Keywords>Glucocorticoids</Keywords>
      <Keywords>Histone deacetylase inhibitor</Keywords>
      <Keywords>Transcription</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chanel A. Griggs</Name>
        <Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Scott W. Malm</Name>
        <Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Rosa Jaime-Frias</Name>
        <Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Catharine L. Smith</Name>
        <Affiliation>Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, AZ 85721, United States. Electronic address: csmith@pharmacy.arizona.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Trans-resveratrol mitigates type 1 diabetes-induced oxidative DNA damage and accumulation of advanced glycation end products in glomeruli and tubules of rat kidneys.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29229234</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30470-2</DOI>
    <KeywordList>
      <Keywords>AGE-RAGE axis</Keywords>
      <Keywords>Antioxidants</Keywords>
      <Keywords>Diabetic nephropathy</Keywords>
      <Keywords>Mesangial fibrosis</Keywords>
      <Keywords>Renal histopathology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Heba Al-Hussaini</Name>
        <Affiliation>Department of Anatomy, Faculty of Medicine, Kuwait University, Kuwait.</Affiliation>
      </Author>
      <Author>
        <Name>Narayana Kilarkaje</Name>
        <Affiliation>Department of Anatomy, Faculty of Medicine, Kuwait University, Kuwait. Electronic address: knarayana@hsc.edu.kw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Total particulate matter from cigarette smoke disrupts vascular development in zebrafish brain (Danio rerio).</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29221954</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30476-3</DOI>
    <KeywordList>
      <Keywords>Brain vascular development</Keywords>
      <Keywords>Cardiovascular toxicity</Keywords>
      <Keywords>Cigarette smoke</Keywords>
      <Keywords>Total particulate matter (TPM)</Keywords>
      <Keywords>Wnt signaling (CHIR99021)</Keywords>
      <Keywords>Zebrafish development</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Andrey Massarsky</Name>
        <Affiliation>Nicholas School of the Environment, Duke University, Durham, NC 27708, USA. Electronic address: andrey.massarsky@duke.edu.</Affiliation>
      </Author>
      <Author>
        <Name>G. L. Prasad</Name>
        <Affiliation>RAI Services Company, Winston-Salem, NC 27101, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard T. Di Giulio</Name>
        <Affiliation>Nicholas School of the Environment, Duke University, Durham, NC 27708, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Antitumor action of 3-bromopyruvate implicates reorganized tumor growth regulatory components of tumor milieu, cell cycle arrest and induction of mitochondria-dependent tumor cell death.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29221953</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30477-5</DOI>
    <KeywordList>
      <Keywords>3-Bromopyruvate</Keywords>
      <Keywords>Tumor metabolism</Keywords>
      <Keywords>Tumor milieu</Keywords>
      <Keywords>Tumor progression</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Saveg Yadav</Name>
        <Affiliation>School of Biotechnology, Institute of Science, Banaras Hindu University, Varanasi 221005, India.</Affiliation>
      </Author>
      <Author>
        <Name>Praveen Kumar Kujur</Name>
        <Affiliation>Cancer Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India.</Affiliation>
      </Author>
      <Author>
        <Name>Shrish Kumar Pandey</Name>
        <Affiliation>School of Biotechnology, Institute of Science, Banaras Hindu University, Varanasi 221005, India.</Affiliation>
      </Author>
      <Author>
        <Name>Yugal Goel</Name>
        <Affiliation>School of Biotechnology, Institute of Science, Banaras Hindu University, Varanasi 221005, India.</Affiliation>
      </Author>
      <Author>
        <Name>Babu Nandan Maurya</Name>
        <Affiliation>Department of Radiodiagnosis and Imaging, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, India.</Affiliation>
      </Author>
      <Author>
        <Name>Ashish Verma</Name>
        <Affiliation>Department of Radiodiagnosis and Imaging, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, India.</Affiliation>
      </Author>
      <Author>
        <Name>Ajay Kumar</Name>
        <Affiliation>Department of Zoology, Institute of Science, Banaras Hindu University, Varanasi 221005, India.</Affiliation>
      </Author>
      <Author>
        <Name>Rana Pratap Singh</Name>
        <Affiliation>Cancer Biology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sukh Mahendra Singh</Name>
        <Affiliation>School of Biotechnology, Institute of Science, Banaras Hindu University, Varanasi 221005, India. Electronic address: sukhmahendrasingh@yahoo.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Genistein and daidzein treatments differently affect uterine homeostasis in the ovary-intact middle-aged rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29217487</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30474-X</DOI>
    <KeywordList>
      <Keywords>Isoflavones</Keywords>
      <Keywords>Middle-aged rats</Keywords>
      <Keywords>Ovary-intact</Keywords>
      <Keywords>Proliferation</Keywords>
      <Keywords>Steroid receptors</Keywords>
      <Keywords>Uterine function</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ivana Jarić</Name>
        <Affiliation>Department of Citology, Institute for Biological Research "Siniša Stanković", University of Belgrade, Belgrade, Serbia. Electronic address: ivana84.ibiss@tesla.rcub.bg.ac.rs.</Affiliation>
      </Author>
      <Author>
        <Name>Jasmina Živanović</Name>
        <Affiliation>Department of Citology, Institute for Biological Research "Siniša Stanković", University of Belgrade, Belgrade, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Marko Miler</Name>
        <Affiliation>Department of Citology, Institute for Biological Research "Siniša Stanković", University of Belgrade, Belgrade, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Vladimir Ajdžanović</Name>
        <Affiliation>Department of Citology, Institute for Biological Research "Siniša Stanković", University of Belgrade, Belgrade, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Duško Blagojević</Name>
        <Affiliation>Department of Physiology, Institute for Biological Research "Siniša Stanković", University of Belgrade, Belgrade, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Nataša Ristić</Name>
        <Affiliation>Department of Citology, Institute for Biological Research "Siniša Stanković", University of Belgrade, Belgrade, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Verica Milošević</Name>
        <Affiliation>Department of Citology, Institute for Biological Research "Siniša Stanković", University of Belgrade, Belgrade, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Nataša Nestorović</Name>
        <Affiliation>Department of Citology, Institute for Biological Research "Siniša Stanković", University of Belgrade, Belgrade, Serbia.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Aberrant promoter methylation in genes related to hematopoietic malignancy in workers exposed to a VOC mixture.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29217486</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30475-1</DOI>
    <KeywordList>
      <Keywords>Ethylbenzene</Keywords>
      <Keywords>Hematopoietic cancer</Keywords>
      <Keywords>Promoter methylation</Keywords>
      <Keywords>TOP2A</Keywords>
      <Keywords>Toluene</Keywords>
      <Keywords>VOC mixtures</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Octavio Jiménez-Garza</Name>
        <Affiliation>Health Sciences Division, University of Guanajuato, León, Campus. Blvd. Puente del Mienio 1001, Fracción del Predio San Carlos, C.P. 37670 León Guanajuato, Mexico. Electronic address: ojimenezgarza@ugto.mx.</Affiliation>
      </Author>
      <Author>
        <Name>Liqiong Guo</Name>
        <Affiliation>Department of Occupational &amp; Environmental Health, Tianjin Medical University, No.22 Qixiangtai Road, Heping District, Tianjin 300070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hyang Min Byun</Name>
        <Affiliation>Human Nutrition Research Centre, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne NE4 5PL, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Mariella Carrieri</Name>
        <Affiliation>Department of Cardiologic, Thoracic and Vascular Science, University of Padova, Via Giustiniani, 2, 35128 Padova, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Giovanni Battista Bartolucci</Name>
        <Affiliation>Department of Cardiologic, Thoracic and Vascular Science, University of Padova, Via Giustiniani, 2, 35128 Padova, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Briscia Socorro Barrón-Vivanco</Name>
        <Affiliation>The Laboratory of Environmental Toxicology and Pollution, Autonomous University of Nayarit, Av de la Cultura Amado Nervo S/N, CP 36000 Tepic, Nayarit, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea A. Baccarelli</Name>
        <Affiliation>The Laboratory of Human Environmental Epigenetics, Harvard T.H. Chan School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Flumioxazin metabolism in pregnant animals and cell-based protoporphyrinogen IX oxidase (PPO) inhibition assay of fetal metabolites in various animal species to elucidate the mechanism of the rat-specific developmental toxicity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29198728</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30473-8</DOI>
    <KeywordList>
      <Keywords>Flumioxazin</Keywords>
      <Keywords>Placental transfer</Keywords>
      <Keywords>Protoporphyrinogen oxidase (PPO)</Keywords>
      <Keywords>Species differences</Keywords>
      <Keywords>Sumisoya</Keywords>
      <Keywords>Teratogenicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jun Abe</Name>
        <Affiliation>Environmental Health Science Laboratory, Sumitomo Chemical Co., Ltd., 1-98, 3-Chome, Kasugade-Naka, Konohana-Ku, Osaka 554-8558, Japan. Electronic address: abej@sc.sumitomo-chem.co.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Naohiko Isobe</Name>
        <Affiliation>Environmental Health Science Laboratory, Sumitomo Chemical Co., Ltd., 1-98, 3-Chome, Kasugade-Naka, Konohana-Ku, Osaka 554-8558, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kazuki Mikata</Name>
        <Affiliation>Environmental Health Science Laboratory, Sumitomo Chemical Co., Ltd., 1-98, 3-Chome, Kasugade-Naka, Konohana-Ku, Osaka 554-8558, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hirohisa Nagahori</Name>
        <Affiliation>Environmental Health Science Laboratory, Sumitomo Chemical Co., Ltd., 1-98, 3-Chome, Kasugade-Naka, Konohana-Ku, Osaka 554-8558, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yoshikazu Naito</Name>
        <Affiliation>Environmental Health Science Laboratory, Sumitomo Chemical Co., Ltd., 1-98, 3-Chome, Kasugade-Naka, Konohana-Ku, Osaka 554-8558, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hideo Saji</Name>
        <Affiliation>Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29, Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Masahiro Ono</Name>
        <Affiliation>Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29, Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Satoshi Kawamura</Name>
        <Affiliation>Environmental Health Science Laboratory, Sumitomo Chemical Co., Ltd., 1-98, 3-Chome, Kasugade-Naka, Konohana-Ku, Osaka 554-8558, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of pirfenidone in acute and sub-chronic liver fibrosis, and an initiation-promotion cancer model in the mouse.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29197520</pubmedLink>
    <GrantList>
      <Grant>U01 AA021908</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30469-6</DOI>
    <KeywordList>
      <Keywords>Carbon tetrachloride</Keywords>
      <Keywords>Carcinogenesis</Keywords>
      <Keywords>Liver fibrosis</Keywords>
      <Keywords>Pirfenidone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Oleksii Seniutkin</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&amp;M University, College Station, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Shinji Furuya</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&amp;M University, College Station, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Syuan Luo</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&amp;M University, College Station, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph A. Cichocki</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&amp;M University, College Station, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hisataka Fukushima</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&amp;M University, College Station, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yuki Kato</Name>
        <Affiliation>Pharmaceutical Research Division, Shionogi &amp; Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka 561-0825, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hiromi Sugimoto</Name>
        <Affiliation>Pharmaceutical Research Division, Shionogi &amp; Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka 561-0825, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tomoko Matsumoto</Name>
        <Affiliation>Analysis Support Department, Shionogi Techno Advance Research Co., Ltd., 3-1-1, Futaba-cho, Toyonaka, Osaka 561-0825, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takeki Uehara</Name>
        <Affiliation>Project Management Department, Shionogi &amp; Co., Ltd., 12F Hankyu Terminal Bldg., 1-4, Shibata 1-chome, Kita-ku, Osaka 530-0012, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Ivan Rusyn</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&amp;M University, College Station, TX, USA. Electronic address: irusyn@cvm.tamu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Intestinal exposure to PCB 153 induces inflammation via the ATM/NEMO pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29197519</pubmedLink>
    <GrantList>
      <Grant>F30 ES026797</Grant>
      <Grant>R01 DK099076</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30472-6</DOI>
    <KeywordList>
      <Keywords>ATM</Keywords>
      <Keywords>Intestinal inflammation</Keywords>
      <Keywords>NF-κB</Keywords>
      <Keywords>Nemo</Keywords>
      <Keywords>PCB 153</Keywords>
      <Keywords>Polychlorinated biphenyl</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Matthew C. Phillips</Name>
        <Affiliation>Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rishu Dheer</Name>
        <Affiliation>Division of Gastroenterology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rebeca Santaolalla</Name>
        <Affiliation>Division of Gastroenterology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Julie M. Davies</Name>
        <Affiliation>Division of Gastroenterology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Burgueño</Name>
        <Affiliation>Division of Gastroenterology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jessica K. Lang</Name>
        <Affiliation>Division of Gastroenterology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michal Toborek</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, FL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Maria T. Abreu</Name>
        <Affiliation>Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL, USA; Division of Gastroenterology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA. Electronic address: Mabreu1@med.miami.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The effect of association between inefficient arsenic methylation capacity and demographic characteristics on the risk of skin lesions.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29197518</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30471-4</DOI>
    <KeywordList>
      <Keywords>Arsenicosis</Keywords>
      <Keywords>Hyperpigmentation</Keywords>
      <Keywords>Keratosis</Keywords>
      <Keywords>Methylation capacity</Keywords>
      <Keywords>Monomethylarsonic acid (MMA)</Keywords>
      <Keywords>Skin lesions</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hifza Rasheed</Name>
        <Affiliation>water@leeds, School of Geography, University of Leeds, Leeds LS2 s9JT, United Kingdom. Electronic address: gyhj@leeds.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Paul Kay</Name>
        <Affiliation>water@leeds, School of Geography, University of Leeds, Leeds LS2 s9JT, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Rebecca Slack</Name>
        <Affiliation>water@leeds, School of Geography, University of Leeds, Leeds LS2 s9JT, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Yun Yun Gong</Name>
        <Affiliation>School of Food Science and Nutrition, University of Leeds, Leeds LS2 9JT, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Asiatic acid ameliorates hepatic ischemia/reperfusion injury in rats via mitochondria-targeted protective mechanism.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29196105</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30468-4</DOI>
    <KeywordList>
      <Keywords>Asiatic acid</Keywords>
      <Keywords>Hepatic ischemia/reperfusion injury</Keywords>
      <Keywords>Mitochondrial anoxia/reoxygenation</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yapeng Lu</Name>
        <Affiliation>Institute of Nautical Medicine, Nantong University, Nantong 226019, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huiwen Kan</Name>
        <Affiliation>Institute of Nautical Medicine, Nantong University, Nantong 226019, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Wang</Name>
        <Affiliation>Institute of Nautical Medicine, Nantong University, Nantong 226019, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dan Wang</Name>
        <Affiliation>Institute of Nautical Medicine, Nantong University, Nantong 226019, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xueting Wang</Name>
        <Affiliation>Institute of Nautical Medicine, Nantong University, Nantong 226019, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Gao</Name>
        <Affiliation>School of Medicine, Jiangsu University, Zhenjiang 212013, China. Electronic address: jinggao@ujs.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Li Zhu</Name>
        <Affiliation>Institute of Nautical Medicine, Nantong University, Nantong 226019, China; Co-innovation Center of Neuroregeneration, Nantong University, Nantong 226019, China. Electronic address: zhulizhou@ntu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Fullerene (C60) particle size implications in neurotoxicity following infusion into the hippocampi of Wistar rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29191454</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30467-2</DOI>
    <KeywordList>
      <Keywords>Buckminsterfullerene</Keywords>
      <Keywords>Hippocampus</Keywords>
      <Keywords>Learning</Keywords>
      <Keywords>Memory</Keywords>
      <Keywords>Nanotechnology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ândrea Barbosa Kraemer</Name>
        <Affiliation>Programa de Pós-Graduação em Ciências Fisiológicas, Universidade Federal do Rio Grande - FURG, Rio Grande, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Gustavo Morrone Parfitt</Name>
        <Affiliation>Programa de Pós-Graduação em Ciências Fisiológicas, Universidade Federal do Rio Grande - FURG, Rio Grande, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Daiane da Silva Acosta</Name>
        <Affiliation>Programa de Pós-Graduação em Ciências Fisiológicas, Universidade Federal do Rio Grande - FURG, Rio Grande, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Gisele Eva Bruch</Name>
        <Affiliation>Programa de Pós-Graduação em Ciências Fisiológicas, Universidade Federal do Rio Grande - FURG, Rio Grande, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Marcos Freitas Cordeiro</Name>
        <Affiliation>Programa de Pós-Graduação em Ciências Fisiológicas, Universidade Federal do Rio Grande - FURG, Rio Grande, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Luis Fernando Marins</Name>
        <Affiliation>Programa de Pós-Graduação em Ciências Fisiológicas, Universidade Federal do Rio Grande - FURG, Rio Grande, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Juliane Ventura-Lima</Name>
        <Affiliation>Programa de Pós-Graduação em Ciências Fisiológicas, Universidade Federal do Rio Grande - FURG, Rio Grande, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>José Maria Monserrat</Name>
        <Affiliation>Programa de Pós-Graduação em Ciências Fisiológicas, Universidade Federal do Rio Grande - FURG, Rio Grande, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Daniela Martí Barros</Name>
        <Affiliation>Programa de Pós-Graduação em Ciências Fisiológicas, Universidade Federal do Rio Grande - FURG, Rio Grande, RS, Brazil. Electronic address: barrosdm@yahoo.com.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Phosphodiesterase 4B plays a role in benzophenone-3-induced phototoxicity in normal human keratinocytes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29183759</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30466-0</DOI>
    <KeywordList>
      <Keywords>Benzophenone-3</Keywords>
      <Keywords>Normal human keratinocytes</Keywords>
      <Keywords>Phosphodiesterase 4B</Keywords>
      <Keywords>Phototoxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hyoung June Kim</Name>
        <Affiliation>Basic Research and Innovation Division, AmorePacific Corporation R&amp;D Center, Yongin, Gyeounggi-do 17074, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eunyoung Lee</Name>
        <Affiliation>College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea; Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Moonyoung Lee</Name>
        <Affiliation>College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea; Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sungjin Ahn</Name>
        <Affiliation>College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea; Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jungmin Kim</Name>
        <Affiliation>College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea; Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jingjing Liu</Name>
        <Affiliation>College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea; Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sun Hee Jin</Name>
        <Affiliation>College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea; Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jaehyoun Ha</Name>
        <Affiliation>Toxicology Division, IEC Korea, Suwon 17074, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Il Hong Bae</Name>
        <Affiliation>Basic Research and Innovation Division, AmorePacific Corporation R&amp;D Center, Yongin, Gyeounggi-do 17074, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Tae Ryong Lee</Name>
        <Affiliation>Basic Research and Innovation Division, AmorePacific Corporation R&amp;D Center, Yongin, Gyeounggi-do 17074, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Minsoo Noh</Name>
        <Affiliation>College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea; Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea. Electronic address: minsoonoh@snu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inhibition of estrogen receptor reduces connexin 43 expression in breast cancers.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29180066</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30465-9</DOI>
    <KeywordList>
      <Keywords>Cell migration</Keywords>
      <Keywords>Connexin</Keywords>
      <Keywords>ER-positive breast cancer</Keywords>
      <Keywords>Estrogen receptor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cheng Fang Tsai</Name>
        <Affiliation>Department of Biotechnology, Asia University, No.500 Lioufeng Road, Taichung 41354, Taiwan. Electronic address: tsaicf@asia.edu.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Kai Cheng</Name>
        <Affiliation>Division of Neurosurgery, China Medical University Hospital, No.2 Yuh-Der Road, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Dah Yuu Lu</Name>
        <Affiliation>Department of Pharmacology, School of Medicine, China Medical University, No.91 Hsueh-Shih Road, Taichung 40402, Taiwan; Department of Photonics and Communication Engineering, Asia University, No.500 Lioufeng Road, Taichung 41354, Taiwan. Electronic address: dahyuu@mail.cmu.edu.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Shu Lin Wang</Name>
        <Affiliation>Institute of New Drug Development, China Medical University, No.91 Hsueh-Shih Road, Taichung 40402, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chen Ni Chang</Name>
        <Affiliation>Department of Biological Science and Technology, China Medical University, No.91 Hsueh-Shih Road, Taichung 40402, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Pei Chun Chang</Name>
        <Affiliation>Department of Bioinformatics and Medical Engineering, Asia University, No.500 Lioufeng Road, Taichung 41354, Taiwan. Electronic address: pcchang@asia.edu.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Lan Yeh</Name>
        <Affiliation>Institute of New Drug Development, China Medical University, No.91 Hsueh-Shih Road, Taichung 40402, Taiwan. Electronic address: wlyeh@mail.cmu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>β-Naphthoflavone treatment attenuates neonatal hyperoxic lung injury in wild type and Cyp1a2-knockout mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29180065</pubmedLink>
    <GrantList>
      <Grant>K08 HL127103</Grant>
      <Grant>R01 HL129794</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30462-3</DOI>
    <KeywordList>
      <Keywords>Beta-naphthoflavone</Keywords>
      <Keywords>Bronchoplumonary dysplasia</Keywords>
      <Keywords>CYP1A2</Keywords>
      <Keywords>Hyperoxia</Keywords>
      <Keywords>Neonate</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Krithika Lingappan</Name>
        <Affiliation>Department of Pediatrics, Section of Neonatology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Paramahamsa Maturu</Name>
        <Affiliation>Department of Pediatrics, Section of Neonatology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yanhong Wei Liang</Name>
        <Affiliation>Department of Pediatrics, Section of Neonatology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Weiwu Jiang</Name>
        <Affiliation>Department of Pediatrics, Section of Neonatology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lihua Wang</Name>
        <Affiliation>Department of Pediatrics, Section of Neonatology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bhagavatula Moorthy</Name>
        <Affiliation>Department of Pediatrics, Section of Neonatology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xanthi I. Couroucli</Name>
        <Affiliation>Department of Pediatrics, Section of Neonatology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA. Electronic address: xanthic@bcm.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Exposure to bisphenol S alters the expression of microRNA in male zebrafish.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29180064</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30464-7</DOI>
    <KeywordList>
      <Keywords>Bisphenol S</Keywords>
      <Keywords>MicroRNA</Keywords>
      <Keywords>Microarray</Keywords>
      <Keywords>Reproduction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jiyun Lee</Name>
        <Affiliation>Department of Environmental Health, Graduate School at Yongin University, Yongin, Gyeonggi 17092, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Younglim Kho</Name>
        <Affiliation>Department of Health, Environment and Safety, Eulji University, Seongnam, Gyeonggi 13135, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Pan Gyi Kim</Name>
        <Affiliation>Department of Environmental Health, Graduate School at Yongin University, Yongin, Gyeonggi 17092, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyunghee Ji</Name>
        <Affiliation>Department of Environmental Health, Graduate School at Yongin University, Yongin, Gyeonggi 17092, Republic of Korea. Electronic address: kyungheeji@yongin.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Ecliptal, a promising natural lead isolated from Eclipta alba modulates adipocyte function and ameliorates metabolic syndrome.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29175456</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30461-1</DOI>
    <KeywordList>
      <Keywords>3T3-L1 adipocyte</Keywords>
      <Keywords>Anti-adipogenic</Keywords>
      <Keywords>Dyslipidemia</Keywords>
      <Keywords>Insulin sensitivity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Abhishek Gupta</Name>
        <Affiliation>Division of Pharmacology, CSIR-Central Drug Research Institute, Lucknow 226031, India.</Affiliation>
      </Author>
      <Author>
        <Name>Ashok Kumar</Name>
        <Affiliation>Division of Medicinal and Process Chemistry, CSIR-Central Drug Research Institute, Lucknow 226031, India.</Affiliation>
      </Author>
      <Author>
        <Name>Durgesh Kumar</Name>
        <Affiliation>Division of Pharmacology, CSIR-Central Drug Research Institute, Lucknow 226031, India; Academy of Scientific and Innovative Research, New Delhi 110025, India.</Affiliation>
      </Author>
      <Author>
        <Name>Rohit Singh</Name>
        <Affiliation>Division of Medicinal and Process Chemistry, CSIR-Central Drug Research Institute, Lucknow 226031, India; Academy of Scientific and Innovative Research, New Delhi 110025, India.</Affiliation>
      </Author>
      <Author>
        <Name>Kripa Shankar</Name>
        <Affiliation>Division of Pharmacology, CSIR-Central Drug Research Institute, Lucknow 226031, India.</Affiliation>
      </Author>
      <Author>
        <Name>Salil Varshney</Name>
        <Affiliation>Division of Pharmacology, CSIR-Central Drug Research Institute, Lucknow 226031, India; Academy of Scientific and Innovative Research, New Delhi 110025, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sujith Rajan</Name>
        <Affiliation>Division of Pharmacology, CSIR-Central Drug Research Institute, Lucknow 226031, India; Academy of Scientific and Innovative Research, New Delhi 110025, India.</Affiliation>
      </Author>
      <Author>
        <Name>Ankita Srivastava</Name>
        <Affiliation>Division of Pharmacology, CSIR-Central Drug Research Institute, Lucknow 226031, India; Academy of Scientific and Innovative Research, New Delhi 110025, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sanchita Gupta</Name>
        <Affiliation>Division of Pharmacology, CSIR-Central Drug Research Institute, Lucknow 226031, India; Academy of Scientific and Innovative Research, New Delhi 110025, India.</Affiliation>
      </Author>
      <Author>
        <Name>T. Narender</Name>
        <Affiliation>Division of Medicinal and Process Chemistry, CSIR-Central Drug Research Institute, Lucknow 226031, India. Electronic address: t_narendra@cdri.res.in.</Affiliation>
      </Author>
      <Author>
        <Name>Anil Nilkanth Gaikwad</Name>
        <Affiliation>Division of Pharmacology, CSIR-Central Drug Research Institute, Lucknow 226031, India. Electronic address: anil_gaikwad@cdri.res.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Anxiolytic- and antidepressant-like effects of Silymarin compared to diazepam and fluoxetine in a mouse model of mild traumatic brain injury.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29175455</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30457-X</DOI>
    <KeywordList>
      <Keywords>Anxiety</Keywords>
      <Keywords>Depression</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Silymarin</Keywords>
      <Keywords>Traumatic brain injury</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Morteza Kosari-Nasab</Name>
        <Affiliation>Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Ghaffar Shokouhi</Name>
        <Affiliation>Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Neurosurgery, Tabriz University of Medical Sciences, Tabriz, Iran; Neuroscience Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: shokouhigh@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Amir Ghorbanihaghjo</Name>
        <Affiliation>Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Mehran Mesgari Abbasi</Name>
        <Affiliation>Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Ali Akbar Salari</Name>
        <Affiliation>Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Salari Institute of Cognitive and Behavioral Disorders (SICBD), Alborz, Iran. Electronic address: aa.salari@yahoo.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Selective inhibition of CTCF binding by iAs directs TET-mediated reprogramming of 5-hydroxymethylation patterns in iAs-transformed cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29175454</pubmedLink>
    <GrantList>
      <Grant>P30 CA177558</Grant>
      <Grant>R01 ES024478</Grant>
      <Grant>T32 CA165990</Grant>
      <Grant>R25 ES027684</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30460-X</DOI>
    <KeywordList>
      <Keywords>5hmC</Keywords>
      <Keywords>EMT</Keywords>
      <Keywords>Epigenetics</Keywords>
      <Keywords>Inorganic arsenic</Keywords>
      <Keywords>RRHP</Keywords>
      <Keywords>TET</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Matthew Rea</Name>
        <Affiliation>Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tyler Gripshover</Name>
        <Affiliation>Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY 40536, USA; Eastern Kentucky University, Richmond, KY 40475, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yvonne Fondufe-Mittendorf</Name>
        <Affiliation>Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY 40536, USA. Electronic address: y.fondufe-mittendorf@uky.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Activation of PPARα decreases bile acids in livers of female mice while maintaining bile flow and biliary bile acid excretion.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29175453</pubmedLink>
    <GrantList>
      <Grant>F32 DK092069</Grant>
      <Grant>R01 ES009649</Grant>
      <Grant>R01 ES025708</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30459-3</DOI>
    <KeywordList>
      <Keywords>Bile acids</Keywords>
      <Keywords>Biliary excretion</Keywords>
      <Keywords>Gender difference</Keywords>
      <Keywords>PPARα</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Youcai Zhang</Name>
        <Affiliation>School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, PR China. Electronic address: youcai.zhang@tju.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew J. Lickteig</Name>
        <Affiliation>Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas 66160,USA.</Affiliation>
      </Author>
      <Author>
        <Name>Iván L. Csanaky</Name>
        <Affiliation>Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Division of Gastroenterology, Children's Mercy Hospital &amp; Clinics, Kansas City, MO 64108; USA; Department of Pediatrics, University of Kansas Medical Center, Kansas City, Kansas 66160, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Curtis D. Klaassen</Name>
        <Affiliation>Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas 66160,USA. Electronic address: curtisklaassenphd@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluating the evidence for non-monotonic dose-response relationships: A systematic literature review and (re-)analysis of in vivo toxicity data in the area of food safety.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29174429</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30463-5</DOI>
    <KeywordList>
      <Keywords>Dose-response analysis</Keywords>
      <Keywords>NMDR</Keywords>
      <Keywords>Non-monotonic dose-response relationship</Keywords>
      <Keywords>Systematic Review</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>C. Varret</Name>
        <Affiliation>ANSES, Risk Assessment Department, Maisons-Alfort, France.</Affiliation>
      </Author>
      <Author>
        <Name>A. Beronius</Name>
        <Affiliation>Institute of Environmental Medicine (IMM), Karolinska Institutet, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>L. Bodin</Name>
        <Affiliation>ANSES, Risk Assessment Department, Maisons-Alfort, France.</Affiliation>
      </Author>
      <Author>
        <Name>B. G. H. Bokkers</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>P. E. Boon</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>M. Burger</Name>
        <Affiliation>Agency for Health and Food Safety GmbH (AGES), Austria.</Affiliation>
      </Author>
      <Author>
        <Name>L. De Wit-Bos</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>A. Fischer</Name>
        <Affiliation>Agency for Health and Food Safety GmbH (AGES), Austria.</Affiliation>
      </Author>
      <Author>
        <Name>A. Hanberg</Name>
        <Affiliation>Institute of Environmental Medicine (IMM), Karolinska Institutet, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>S. Litens-Karlsson</Name>
        <Affiliation>Institute of Environmental Medicine (IMM), Karolinska Institutet, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>W. Slob</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>G. Wolterink</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>J. Zilliacus</Name>
        <Affiliation>Institute of Environmental Medicine (IMM), Karolinska Institutet, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>C. Beausoleil</Name>
        <Affiliation>ANSES, Risk Assessment Department, Maisons-Alfort, France.</Affiliation>
      </Author>
      <Author>
        <Name>C. Rousselle</Name>
        <Affiliation>ANSES, Risk Assessment Department, Maisons-Alfort, France. Electronic address: Christophe.rousselle@anses.fr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pb</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29170096</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30458-1</DOI>
    <KeywordList>
      <Keywords>Ca(2+)</Keywords>
      <Keywords>Pb(2+)</Keywords>
      <Keywords>Radioligand binding assays</Keywords>
      <Keywords>RyRs</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qiyue Jia</Name>
        <Affiliation>Department of Occupational Health and Toxicology, School of Public Health, Nanchang University, BaYi Road 461, Nanchang, Jiangxi Province 330006, PR China; Jiangxi Provincial Key Laboratory of Preventive Medicine, Nanchang University, BaYi Road 461, Nanchang, Jiangxi Province 330006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Guihua Du</Name>
        <Affiliation>Department of Occupational Health and Toxicology, School of Public Health, Nanchang University, BaYi Road 461, Nanchang, Jiangxi Province 330006, PR China; Jiangxi Provincial Key Laboratory of Preventive Medicine, Nanchang University, BaYi Road 461, Nanchang, Jiangxi Province 330006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Li</Name>
        <Affiliation>Center of Biological Experimental Teaching, School of Life Sciences, Nanchang University, University Avenue 999, Nanchang, Jiangxi Province 330031, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhiping Wang</Name>
        <Affiliation>Department of Occupational Health and Toxicology, School of Public Health, Nanchang University, BaYi Road 461, Nanchang, Jiangxi Province 330006, PR China; Jiangxi Provincial Key Laboratory of Preventive Medicine, Nanchang University, BaYi Road 461, Nanchang, Jiangxi Province 330006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Xie</Name>
        <Affiliation>Department of Occupational Health and Toxicology, School of Public Health, Nanchang University, BaYi Road 461, Nanchang, Jiangxi Province 330006, PR China; Jiangxi Provincial Key Laboratory of Preventive Medicine, Nanchang University, BaYi Road 461, Nanchang, Jiangxi Province 330006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Junwang Gu</Name>
        <Affiliation>Department of Occupational Health and Toxicology, School of Public Health, Nanchang University, BaYi Road 461, Nanchang, Jiangxi Province 330006, PR China; Jiangxi Provincial Key Laboratory of Preventive Medicine, Nanchang University, BaYi Road 461, Nanchang, Jiangxi Province 330006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Guangming Yin</Name>
        <Affiliation>Department of Occupational Health and Toxicology, School of Public Health, Nanchang University, BaYi Road 461, Nanchang, Jiangxi Province 330006, PR China; Jiangxi Provincial Key Laboratory of Preventive Medicine, Nanchang University, BaYi Road 461, Nanchang, Jiangxi Province 330006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuyun Zhang</Name>
        <Affiliation>Department of Occupational Health and Toxicology, School of Public Health, Nanchang University, BaYi Road 461, Nanchang, Jiangxi Province 330006, PR China; Jiangxi Provincial Key Laboratory of Preventive Medicine, Nanchang University, BaYi Road 461, Nanchang, Jiangxi Province 330006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanyan Gao</Name>
        <Affiliation>Department of Occupational Health and Toxicology, School of Public Health, Nanchang University, BaYi Road 461, Nanchang, Jiangxi Province 330006, PR China; Jiangxi Provincial Key Laboratory of Preventive Medicine, Nanchang University, BaYi Road 461, Nanchang, Jiangxi Province 330006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Fankun Zhou</Name>
        <Affiliation>Department of Occupational Health and Toxicology, School of Public Health, Nanchang University, BaYi Road 461, Nanchang, Jiangxi Province 330006, PR China; Jiangxi Provincial Key Laboratory of Preventive Medicine, Nanchang University, BaYi Road 461, Nanchang, Jiangxi Province 330006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chang Feng</Name>
        <Affiliation>Department of Occupational Health and Toxicology, School of Public Health, Nanchang University, BaYi Road 461, Nanchang, Jiangxi Province 330006, PR China; Jiangxi Provincial Key Laboratory of Preventive Medicine, Nanchang University, BaYi Road 461, Nanchang, Jiangxi Province 330006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Guangqin Fan</Name>
        <Affiliation>Department of Occupational Health and Toxicology, School of Public Health, Nanchang University, BaYi Road 461, Nanchang, Jiangxi Province 330006, PR China; Jiangxi Provincial Key Laboratory of Preventive Medicine, Nanchang University, BaYi Road 461, Nanchang, Jiangxi Province 330006, PR China. Electronic address: fanguangqin@ncu.edu.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Capsaicin reduces genotoxicity, colonic cell proliferation and preneoplastic lesions induced by 1,2-dimethylhydrazine in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29155087</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30445-3</DOI>
    <KeywordList>
      <Keywords>Capsaicin</Keywords>
      <Keywords>Chemoprevention</Keywords>
      <Keywords>Colon Cancer</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Brunno Felipe Ramos Caetano</Name>
        <Affiliation>Department of Pathology, Medical School, São Paulo State University (UNESP), Botucatu, 18618-687, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Mariana Baptista Tablas</Name>
        <Affiliation>Department of Morphology, Institute of Biosciences, São Paulo State University (UNESP), Botucatu, 18618-689, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Natália Elias Ferreira Pereira</Name>
        <Affiliation>Department of Morphology, Institute of Biosciences, São Paulo State University (UNESP), Botucatu, 18618-689, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Nelci Antunes de Moura</Name>
        <Affiliation>Department of Morphology, Institute of Biosciences, São Paulo State University (UNESP), Botucatu, 18618-689, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Robson Francisco Carvalho</Name>
        <Affiliation>Department of Morphology, Institute of Biosciences, São Paulo State University (UNESP), Botucatu, 18618-689, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Aparecida Marchesan Rodrigues</Name>
        <Affiliation>Department of Pathology, Medical School, São Paulo State University (UNESP), Botucatu, 18618-687, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Luis Fernando Barbisan</Name>
        <Affiliation>Department of Morphology, Institute of Biosciences, São Paulo State University (UNESP), Botucatu, 18618-689, Brazil. Electronic address: barbisan@ibb.unesp.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Systemic exposure of vinpocetine in pregnant Sprague Dawley rats following repeated oral exposure: An investigation of fetal transfer.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29155086</pubmedLink>
    <GrantList>
      <Grant>HHSN273201400027C</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30456-8</DOI>
    <AuthorList>
      <Author>
        <Name>Suramya Waidyanatha</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States. Electronic address: waidyanathas@niehs.nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Heather Toy</Name>
        <Affiliation>Battelle Memorial Institute, Columbus, OH, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Natalie South</Name>
        <Affiliation>Battelle Memorial Institute, Columbus, OH, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Seth Gibbs</Name>
        <Affiliation>Battelle Memorial Institute, Columbus, OH, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Esra Mutlu</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Brian Burback</Name>
        <Affiliation>Battelle Memorial Institute, Columbus, OH, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Barry S. McIntyre</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Natasha Catlin</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Age dependent in vitro metabolism of bifenthrin in rat and human hepatic microsomes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29146463</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30447-7</DOI>
    <KeywordList>
      <Keywords>Bifenthrin</Keywords>
      <Keywords>Intrinsic hepatic clearance</Keywords>
      <Keywords>K(m)</Keywords>
      <Keywords>Liver microsomes</Keywords>
      <Keywords>V(max)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gopinath C. Nallani</Name>
        <Affiliation>Global Regulatory Sciences, FMC Agricultural Solutions, 701 Princeton South Corporate Center, Ewing, NJ 08628, USA. Electronic address: Gopinath.Nallani@fmc.com.</Affiliation>
      </Author>
      <Author>
        <Name>Appavu Chandrasekaran</Name>
        <Affiliation>Global Regulatory Sciences, FMC Agricultural Solutions, 701 Princeton South Corporate Center, Ewing, NJ 08628, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kelem Kassahun</Name>
        <Affiliation>Drug Metabolism and Pharmacokinetics, Frontage Laboratories, 700 Pennsylvania Dr, Exton, PA 19341, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Li Shen</Name>
        <Affiliation>Drug Metabolism and Pharmacokinetics, Frontage Laboratories, 700 Pennsylvania Dr, Exton, PA 19341, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Shaaban F. ElNaggar</Name>
        <Affiliation>Global Regulatory Sciences, FMC Agricultural Solutions, 701 Princeton South Corporate Center, Ewing, NJ 08628, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zhiwei Liu</Name>
        <Affiliation>Global Regulatory Sciences, FMC Agricultural Solutions, 701 Princeton South Corporate Center, Ewing, NJ 08628, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Individual serum bile acid profiling in rats aids in human risk assessment of drug-induced liver injury due to BSEP inhibition.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29146462</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30444-1</DOI>
    <KeywordList>
      <Keywords>Bile acids</Keywords>
      <Keywords>Biomarkers</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Steven Cepa</Name>
        <Affiliation>Abbvie, 1 North Waukegan Road, North Chicago, IL 60064, United States.</Affiliation>
      </Author>
      <Author>
        <Name>David Potter</Name>
        <Affiliation>Pfizer, Drug Safety R&amp;D, Eastern Point Road, Groton, CT 06340, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa Wong</Name>
        <Affiliation>Genentech Safety Assessment, Drug Metabolism, Pharmacokinetics, and Pharmaceutical Sciences, 1 DNA Way, South San Francisco, CA 94080, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Leah Schutt</Name>
        <Affiliation>Genentech Safety Assessment, Drug Metabolism, Pharmacokinetics, and Pharmaceutical Sciences, 1 DNA Way, South San Francisco, CA 94080, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jacqueline Tarrant</Name>
        <Affiliation>Gilead Sciences, Biomarker Sciences, 333 Lakeside Drive, Foster City, CA 94404, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jodie Pang</Name>
        <Affiliation>Genentech Safety Assessment, Drug Metabolism, Pharmacokinetics, and Pharmaceutical Sciences, 1 DNA Way, South San Francisco, CA 94080, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaolin Zhang</Name>
        <Affiliation>Genentech Safety Assessment, Drug Metabolism, Pharmacokinetics, and Pharmaceutical Sciences, 1 DNA Way, South San Francisco, CA 94080, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Roxanne Andaya</Name>
        <Affiliation>Genentech Safety Assessment, Drug Metabolism, Pharmacokinetics, and Pharmaceutical Sciences, 1 DNA Way, South San Francisco, CA 94080, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Laurent Salphati</Name>
        <Affiliation>Genentech Safety Assessment, Drug Metabolism, Pharmacokinetics, and Pharmaceutical Sciences, 1 DNA Way, South San Francisco, CA 94080, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Yingqing Ran</Name>
        <Affiliation>Genentech Safety Assessment, Drug Metabolism, Pharmacokinetics, and Pharmaceutical Sciences, 1 DNA Way, South San Francisco, CA 94080, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Le An</Name>
        <Affiliation>Genentech Safety Assessment, Drug Metabolism, Pharmacokinetics, and Pharmaceutical Sciences, 1 DNA Way, South San Francisco, CA 94080, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ryan Morgan</Name>
        <Affiliation>Amgen, 1 Amgen Center Drive, Thousand Oaks, CA 91320, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jonathan Maher</Name>
        <Affiliation>Genentech Safety Assessment, Drug Metabolism, Pharmacokinetics, and Pharmaceutical Sciences, 1 DNA Way, South San Francisco, CA 94080, United States. Electronic address: maher.jonathan@gene.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Resveratrol supports and alpha-naphthoflavone disrupts growth of human ovarian follicles in an in vitro tissue culture model.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29146461</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30446-5</DOI>
    <KeywordList>
      <Keywords>Alpha-naphthoflavone</Keywords>
      <Keywords>Follicle growth</Keywords>
      <Keywords>Formylindolocarbazole</Keywords>
      <Keywords>Human ovary</Keywords>
      <Keywords>Resveratrol</Keywords>
      <Keywords>Steroidogenesis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jie Hao</Name>
        <Affiliation>Reproductive Medicine Center, Department of Obstetrics and Gynecology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Astrud R. Tuck</Name>
        <Affiliation>Swetox, Karolinska Institutet, Unit of Toxicological Sciences, Forskargatan 20, SE-15136 Södertälje, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Marcus O. D. Sjödin</Name>
        <Affiliation>Swetox, Karolinska Institutet, Unit of Toxicological Sciences, Forskargatan 20, SE-15136 Södertälje, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Johan Lindberg</Name>
        <Affiliation>Swetox, Karolinska Institutet, Unit of Toxicological Sciences, Forskargatan 20, SE-15136 Södertälje, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Sand</Name>
        <Affiliation>Karolinska Institutet, Department of Women's and Children's Health, Karolinska University Hospital, SE-17176 Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Boel Niklasson</Name>
        <Affiliation>Karolinska Institutet, Department of Clinical Sciences, Intervention and Technology, Unit of Obstetrics and Gynecology, K57 Karolinska University Hospital Huddinge, SE-14186 Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Argyraki</Name>
        <Affiliation>Karolinska Institutet, Department of Clinical Sciences, Intervention and Technology, Unit of Obstetrics and Gynecology, K57 Karolinska University Hospital Huddinge, SE-14186 Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Outi Hovatta</Name>
        <Affiliation>Karolinska Institutet, Department of Clinical Sciences, Intervention and Technology, Unit of Obstetrics and Gynecology, K57 Karolinska University Hospital Huddinge, SE-14186 Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Pauliina Damdimopoulou</Name>
        <Affiliation>Swetox, Karolinska Institutet, Unit of Toxicological Sciences, Forskargatan 20, SE-15136 Södertälje, Sweden; Karolinska Institutet, Department of Clinical Sciences, Intervention and Technology, Unit of Obstetrics and Gynecology, K57 Karolinska University Hospital Huddinge, SE-14186 Stockholm, Sweden. Electronic address: Pauliina.Damdimopoulou@ki.se.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Deferiprone inhibits iron overload-induced tissue factor bearing endothelial microparticle generation by inhibition oxidative stress induced mitochondrial injury, and apoptosis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29132816</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30442-8</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Endothelial microparticles</Keywords>
      <Keywords>Iron</Keywords>
      <Keywords>L1</Keywords>
      <Keywords>Mitochondria</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Tissue factor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shing Chan</Name>
        <Affiliation>Department of Paediatrics and Adolescent Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region.</Affiliation>
      </Author>
      <Author>
        <Name>Qizhou Lian</Name>
        <Affiliation>Department of Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region; School of Biomedical Sciences, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region.</Affiliation>
      </Author>
      <Author>
        <Name>Mei Pian Chen</Name>
        <Affiliation>Department of Paediatrics and Adolescent Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region.</Affiliation>
      </Author>
      <Author>
        <Name>Dan Jiang</Name>
        <Affiliation>Department of Ophthalmology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region.</Affiliation>
      </Author>
      <Author>
        <Name>Jolie T. K. Ho</Name>
        <Affiliation>Department of Paediatrics and Adolescent Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region.</Affiliation>
      </Author>
      <Author>
        <Name>Yiu Fai Cheung</Name>
        <Affiliation>Department of Paediatrics and Adolescent Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region.</Affiliation>
      </Author>
      <Author>
        <Name>Godfrey Chi Fung Chan</Name>
        <Affiliation>Department of Paediatrics and Adolescent Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region. Electronic address: gcfchan@hku.hk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Trichloroethylene metabolite S-(1,2-dichlorovinyl)-l-cysteine induces lipid peroxidation-associated apoptosis via the intrinsic and extrinsic apoptosis pathways in a first-trimester placental cell line.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29129777</pubmedLink>
    <GrantList>
      <Grant>P30 ES017885</Grant>
      <Grant>P42 ES017198</Grant>
      <Grant>T32 ES007062</Grant>
    </GrantList>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30443-X</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Extravillous trophoblasts</Keywords>
      <Keywords>Lipid peroxidation</Keywords>
      <Keywords>Placenta</Keywords>
      <Keywords>S-(1,2-dichlorovinyl)-l-cysteine [DCVC]</Keywords>
      <Keywords>Trichloroethylene [TCE]</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Elana R. Elkin</Name>
        <Affiliation>Department of Environmental Health Sciences, University of Michigan, 1415 Washington Heights, Ann Arbor, MI 48109-2029, USA. Electronic address: elkinela@umich.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Sean M. Harris</Name>
        <Affiliation>Department of Environmental Health Sciences, University of Michigan, 1415 Washington Heights, Ann Arbor, MI 48109-2029, USA. Electronic address: harrsemi@umich.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Rita Loch-Caruso</Name>
        <Affiliation>Department of Environmental Health Sciences, University of Michigan, 1415 Washington Heights, Ann Arbor, MI 48109-2029, USA. Electronic address: rlc@umich.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An anti-inflammatory chalcone derivative prevents heart and kidney from hyperlipidemia-induced injuries by attenuating inflammation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29128402</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30440-4</DOI>
    <KeywordList>
      <Keywords>Cardiomyopathy</Keywords>
      <Keywords>Chalcone derivative</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Nephropathy</Keywords>
      <Keywords>Obesity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiong Chen</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China; Department of Endocrinology, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Weihui Yu</Name>
        <Affiliation>Department of Endocrinology, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Weixin Li</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hailing Zhang</Name>
        <Affiliation>Department of Endocrinology, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Weijian Huang</Name>
        <Affiliation>Department of Cardiology, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingying Wang</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Weiwei Zhu</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qilu Fang</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Chen</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China; College of Life Sciences, Huzhou University, Huzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaokun Li</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China. Electronic address: proflxk@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Guang Liang</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China. Electronic address: liangguang@wmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>H</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29128401</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30441-6</DOI>
    <KeywordList>
      <Keywords>Cystathionine gamma-lyase</Keywords>
      <Keywords>Endothelial cells</Keywords>
      <Keywords>H(2)S</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>LPS</Keywords>
      <Keywords>NFκB</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Caitlyn Bourque</Name>
        <Affiliation>Department of Chemistry and Biochemistry, Laurentian University, Sudbury, Canada; Cardiovascular and Metabolic Research Unit, Laurentian University, Sudbury, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Yanjie Zhang</Name>
        <Affiliation>Cardiovascular and Metabolic Research Unit, Laurentian University, Sudbury, Canada; School of Life Science, Shanxi University, Taiyuan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Fu</Name>
        <Affiliation>Cardiovascular and Metabolic Research Unit, Laurentian University, Sudbury, Canada; School of Human Kinetics, Laurentian University, Sudbury, Canada; Department of Biology, Laurentian University, Sudbury, Canada; Health Science North Research Institute, Sudbury, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Mélanie Racine</Name>
        <Affiliation>Department of Chemistry and Biochemistry, Laurentian University, Sudbury, Canada; Cardiovascular and Metabolic Research Unit, Laurentian University, Sudbury, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Adam Greasley</Name>
        <Affiliation>Department of Chemistry and Biochemistry, Laurentian University, Sudbury, Canada; Cardiovascular and Metabolic Research Unit, Laurentian University, Sudbury, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Yanxi Pei</Name>
        <Affiliation>School of Life Science, Shanxi University, Taiyuan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lingyun Wu</Name>
        <Affiliation>Cardiovascular and Metabolic Research Unit, Laurentian University, Sudbury, Canada; School of Human Kinetics, Laurentian University, Sudbury, Canada; Health Science North Research Institute, Sudbury, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Wang</Name>
        <Affiliation>Cardiovascular and Metabolic Research Unit, Laurentian University, Sudbury, Canada; Department of Biology, Laurentian University, Sudbury, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Guangdong Yang</Name>
        <Affiliation>Department of Chemistry and Biochemistry, Laurentian University, Sudbury, Canada; Cardiovascular and Metabolic Research Unit, Laurentian University, Sudbury, Canada. Electronic address: gyang2@laurentian.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Temporal cytokine and lymphoid responses to an inhaled TLR7 antedrug agonist in the cynomolgus monkey demonstrates potential safety and tolerability of this approach.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29122671</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30432-5</DOI>
    <KeywordList>
      <Keywords>AZD8848</Keywords>
      <Keywords>Antedrug</Keywords>
      <Keywords>Asthma</Keywords>
      <Keywords>Cynomolgus</Keywords>
      <Keywords>Safety assessment</Keywords>
      <Keywords>TLR7</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>John Bell</Name>
        <Affiliation>Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Mike Dymond</Name>
        <Affiliation>Plus-Project Ltd, Alderley Park, Cheshire, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Biffen</Name>
        <Affiliation>Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen Delaney</Name>
        <Affiliation>Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>David Keeling</Name>
        <Affiliation>Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Zhang</Name>
        <Affiliation>Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Robinson</Name>
        <Affiliation>Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom. Electronic address: Ian.robinson@astrazeneca.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of opioid and nonopioid analgesics on canine wheal formation and cultured human mast cell degranulation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29111148</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30425-8</DOI>
    <KeywordList>
      <Keywords>A</Keywords>
      <Keywords>Abbreviations</Keywords>
      <Keywords>Analgesics</Keywords>
      <Keywords>Area</Keywords>
      <Keywords>Calcium Channel</Keywords>
      <Keywords>Degranulation</Keywords>
      <Keywords>ID</Keywords>
      <Keywords>IL</Keywords>
      <Keywords>IM</Keywords>
      <Keywords>IT</Keywords>
      <Keywords>IV</Keywords>
      <Keywords>MCs</Keywords>
      <Keywords>Mas-related, gen-like receptors</Keywords>
      <Keywords>MrgX</Keywords>
      <Keywords>NMDA</Keywords>
      <Keywords>NMDA Antagonist</Keywords>
      <Keywords>Opiates</Keywords>
      <Keywords>PAR</Keywords>
      <Keywords>PBS</Keywords>
      <Keywords>hMC</Keywords>
      <Keywords>human mast cells</Keywords>
      <Keywords>interleukin</Keywords>
      <Keywords>intradermal</Keywords>
      <Keywords>intramuscular</Keywords>
      <Keywords>intrathecal</Keywords>
      <Keywords>intravenous</Keywords>
      <Keywords>n-methyl d-aspartate</Keywords>
      <Keywords>phosphate buffered saline</Keywords>
      <Keywords>proteinase activated receptors</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Eric Schmidt-Rondon</Name>
        <Affiliation>Department of Anesthesiology, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093, United States. Electronic address: itacron@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenping Wang</Name>
        <Affiliation>Department of Dermatology, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093, United States. Electronic address: z7wang@ucsd.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Shelle A. Malkmus</Name>
        <Affiliation>Department of Anesthesiology, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093, United States. Electronic address: smalkmus@ucsd.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Di Nardo</Name>
        <Affiliation>Department of Dermatology, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093, United States. Electronic address: adinardo@ucsd.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Keith Hildebrand</Name>
        <Affiliation>Medtronic, Inc., Neuromodulation, 7000 Central Avenue NE, RCE470, Minneapolis, MN 55432, United States. Electronic address: keith.hildebrand@medtronic.com.</Affiliation>
      </Author>
      <Author>
        <Name>Linda Page</Name>
        <Affiliation>Medtronic, Inc., Neuromodulation, 7000 Central Avenue NE, RCE470, Minneapolis, MN 55432, United States. Electronic address: linda.page@medtronic.com.</Affiliation>
      </Author>
      <Author>
        <Name>Tony L. Yaksh</Name>
        <Affiliation>Department of Anesthesiology, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093, United States. Electronic address: tyaksh@ucsd.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of Nrf2 deficiency on arsenic metabolism in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29108910</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30431-3</DOI>
    <KeywordList>
      <Keywords>Antioxidant response</Keywords>
      <Keywords>Arsenic metabolism</Keywords>
      <Keywords>Nrf2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Huihui Wang</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiayu Zhu</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Li</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongfang Li</Name>
        <Affiliation>Research Center of Environment and Non-Communicable Disease, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hang Lv</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanyuan Xu</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guifan Sun</Name>
        <Affiliation>Research Center of Environment and Non-Communicable Disease, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingbo Pi</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang 110122, China. Electronic address: jbpi@cmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chronic treatment with caffeine and its withdrawal modify the antidepressant-like activity of selective serotonin reuptake inhibitors in the forced swim and tail suspension tests in mice. Effects on Comt, Slc6a15 and Adora1 gene expression.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29107002</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30428-3</DOI>
    <KeywordList>
      <Keywords>Adora1</Keywords>
      <Keywords>Caffeine</Keywords>
      <Keywords>Depression</Keywords>
      <Keywords>Mice</Keywords>
      <Keywords>SSRI</Keywords>
      <Keywords>Slc6a15</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Aleksandra Szopa</Name>
        <Affiliation>Chair and Department of Applied Pharmacy, Medical University of Lublin, Lublin, Poland. Electronic address: aleksandra.szopa@umlub.pl.</Affiliation>
      </Author>
      <Author>
        <Name>Urszula Doboszewska</Name>
        <Affiliation>Department of Animal Physiology, Faculty of Biology and Biotechnology, Maria Curie-Skłodowska University, Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Mariola Herbet</Name>
        <Affiliation>Chair and Department of Toxicology, Medical University of Lublin, Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Sylwia Wośko</Name>
        <Affiliation>Chair and Department of Applied Pharmacy, Medical University of Lublin, Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Elżbieta Wyska</Name>
        <Affiliation>Department of Pharmacokinetics and Physical Pharmacy, Jagiellonian University Medical College, Kraków, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Katarzyna Świąder</Name>
        <Affiliation>Chair and Department of Applied Pharmacy, Medical University of Lublin, Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Serefko</Name>
        <Affiliation>Chair and Department of Applied Pharmacy, Medical University of Lublin, Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Agnieszka Korga</Name>
        <Affiliation>Chair and Department of Toxicology, Medical University of Lublin, Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Aleksandra Wlaź</Name>
        <Affiliation>Department of Pathophysiology, Medical University of Lublin, Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Andrzej Wróbel</Name>
        <Affiliation>Second Department of Gynecology, Medical University of Lublin, Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Marta Ostrowska</Name>
        <Affiliation>Chair and Department of Toxicology, Medical University of Lublin, Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Joanna Terlecka</Name>
        <Affiliation>Chair and Department of Applied Pharmacy, Medical University of Lublin, Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Adam Kanadys</Name>
        <Affiliation>Chair and Department of Toxicology, Medical University of Lublin, Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Ewa Poleszak</Name>
        <Affiliation>Chair and Department of Applied Pharmacy, Medical University of Lublin, Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Jarosław Dudka</Name>
        <Affiliation>Chair and Department of Toxicology, Medical University of Lublin, Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Piotr Wlaź</Name>
        <Affiliation>Department of Animal Physiology, Faculty of Biology and Biotechnology, Maria Curie-Skłodowska University, Lublin, Poland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Application of gene specific mRNA level determinations in individual cells using flow cytometry-based PrimeFlow™ in immunotoxicology.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29107001</pubmedLink>
    <GrantList>
      <Grant>P42 ES004911</Grant>
      <Grant>R01 DA007908</Grant>
      <Grant>R01 ES002520</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30427-1</DOI>
    <KeywordList>
      <Keywords>B cells</Keywords>
      <Keywords>Flow cytometry</Keywords>
      <Keywords>Immunotoxicology</Keywords>
      <Keywords>Plasmacytoid dendritic cells</Keywords>
      <Keywords>PrimeFlow™</Keywords>
      <Keywords>mRNA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joseph Henriquez</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI 48824, USA; Institute for Integrative Toxicology, Michigan State University, East Lansing, MI 48824, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jiajun Zhou</Name>
        <Affiliation>Department of Microbiology and Molecular Genetics, Michigan State University, East Lansing, MI 48824, USA; Institute for Integrative Toxicology, Michigan State University, East Lansing, MI 48824, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jinpeng Li</Name>
        <Affiliation>Department of Genetics,Michigan State University, East Lansing, MI 48824, USA; Institute for Integrative Toxicology, Michigan State University, East Lansing, MI 48824, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Crawford</Name>
        <Affiliation>Department of Microbiology and Molecular Genetics, Michigan State University, East Lansing, MI 48824, USA; Institute for Integrative Toxicology, Michigan State University, East Lansing, MI 48824, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Norbert Kaminski</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI 48824, USA; Department of Microbiology and Molecular Genetics, Michigan State University, East Lansing, MI 48824, USA; Institute for Integrative Toxicology, Michigan State University, East Lansing, MI 48824, USA. Electronic address: kamins11@msu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Oxytocin inhibits ox-LDL-induced adhesion of monocytic THP-1 cells to human brain microvascular endothelial cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29104011</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30430-1</DOI>
    <KeywordList>
      <Keywords>Cerebrovascular diseases</Keywords>
      <Keywords>Ox-LDL</Keywords>
      <Keywords>Oxytocin</Keywords>
      <Keywords>VCAM-1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shuyan Liu</Name>
        <Affiliation>Department of neurology, Danyang People's Hospital of Jiangsu Province, Danyang, Jiangsu 212300, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shengying Pan</Name>
        <Affiliation>Department of neurology, Danyang People's Hospital of Jiangsu Province, Danyang, Jiangsu 212300, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Tan</Name>
        <Affiliation>Department of neurology, Danyang People's Hospital of Jiangsu Province, Danyang, Jiangsu 212300, China.</Affiliation>
      </Author>
      <Author>
        <Name>Weina Zhao</Name>
        <Affiliation>Department of neurology, Hongqi Hospital Affiliated to Mudanjiang Medical university, Mudanjiang, Heilongjiang 157000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fengguo Liu</Name>
        <Affiliation>Department of neurology, Danyang People's Hospital of Jiangsu Province, Danyang, Jiangsu 212300, China; Department of neurology, Hongqi Hospital Affiliated to Mudanjiang Medical university, Mudanjiang, Heilongjiang 157000, China. Electronic address: liufg088@yeah.net.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of acute exposure to chlorpyrifos on cholinergic and non-cholinergic targets in normal and high-fat fed male C57BL/6J mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29097212</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30429-5</DOI>
    <KeywordList>
      <Keywords>Acetylcholinesterase</Keywords>
      <Keywords>Carboxylesterase</Keywords>
      <Keywords>Chlorpyrifos</Keywords>
      <Keywords>Endocannabinoid</Keywords>
      <Keywords>High-fat diet</Keywords>
      <Keywords>Organophosphate</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sandeep Kondakala</Name>
        <Affiliation>Mississippi State University College of Veterinary Medicine, Department of Basic Sciences, MS 39762, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jung Hwa Lee</Name>
        <Affiliation>Mississippi State University College of Veterinary Medicine, Department of Basic Sciences, MS 39762, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew K. Ross</Name>
        <Affiliation>Mississippi State University College of Veterinary Medicine, Department of Basic Sciences, MS 39762, United States.</Affiliation>
      </Author>
      <Author>
        <Name>George E. Howell</Name>
        <Affiliation>Mississippi State University College of Veterinary Medicine, Department of Basic Sciences, MS 39762, United States. Electronic address: geh3@msstate.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>ABC-transporter blockage mediated by xanthotoxin and bergapten is the major pathway for chemosensitization of multidrug-resistant cancer cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29079042</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30426-X</DOI>
    <KeywordList>
      <Keywords>ATP-binding cassettes</Keywords>
      <Keywords>Bergapten</Keywords>
      <Keywords>Efflux kinetic</Keywords>
      <Keywords>Furanocoumarin</Keywords>
      <Keywords>Multidrug resistance</Keywords>
      <Keywords>Xanthotoxin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Seyed Abbas Mirzaei</Name>
        <Affiliation>Cancer Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Neda Gholamian Dehkordi</Name>
        <Affiliation>Cancer Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Mahsa Ghamghami</Name>
        <Affiliation>Department of Pharmaceutical Biotechnology, School of Pharmacy, Zanjan University of Medical Sciences, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Amir Hossein Amiri</Name>
        <Affiliation>Cancer Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Elaheh Dalir Abdolahinia</Name>
        <Affiliation>Department of Pharmaceutical Biotechnology, School of Pharmacy, Zanjan University of Medical Sciences, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Fatemeh Elahian</Name>
        <Affiliation>Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran. Electronic address: elahian@skums.ac.ir.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Xanthatin triggers Chk1-mediated DNA damage response and destabilizes Cdc25C via lysosomal degradation in lung cancer cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29074359</pubmedLink>
    <GrantList />
    <Year>2017</Year>
    <DOI>S0041-008X(17)30423-4</DOI>
    <KeywordList>
      <Keywords>Cdc25C</Keywords>
      <Keywords>Chk1</Keywords>
      <Keywords>DNA damage response</Keywords>
      <Keywords>Lysosomal proteolysis</Keywords>
      <Keywords>Xanthatin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Li Tao</Name>
        <Affiliation>Department of Pharmacy, College of Medicine, Yangzhou University, Yangzhou, Jiangsu 225001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuzhu Cao</Name>
        <Affiliation>Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhonghong Wei</Name>
        <Affiliation>Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Jia</Name>
        <Affiliation>Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Suyun Yu</Name>
        <Affiliation>Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinqiu Zhong</Name>
        <Affiliation>Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ainyun Wang</Name>
        <Affiliation>Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, China.</Affiliation>
      </Author>
      <Author>
        <Name>James R. Woodgett</Name>
        <Affiliation>Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario M5G 1X5, Canada; Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5G 1X5, Canada. Electronic address: woodgett@lunenfeld.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Yin Lu</Name>
        <Affiliation>Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, China. Electronic address: luyingreen@njucm.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inhibitory effect of silver nanoparticles on proliferation of estrogen-dependent MCF-7/BUS human breast cancer cells induced by butyl paraben or di-n-butyl phthalate.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29074358</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30422-2</DOI>
    <KeywordList>
      <Keywords>Aluminum</Keywords>
      <Keywords>Breast cancer cells</Keywords>
      <Keywords>Estrogenic activity</Keywords>
      <Keywords>Paraben</Keywords>
      <Keywords>Phthalate</Keywords>
      <Keywords>Silver nanoparticles</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joanna Roszak</Name>
        <Affiliation>Department of Toxicology and Carcinogenesis, Nofer Institute of Occupational Medicine, 8 St Teresy St., 91-348 Łódź, Poland. Electronic address: joanna.roszak@imp.lodz.pl.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Smok-Pieniążek</Name>
        <Affiliation>Department of Toxicology and Carcinogenesis, Nofer Institute of Occupational Medicine, 8 St Teresy St., 91-348 Łódź, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Katarzyna Domeradzka-Gajda</Name>
        <Affiliation>Department of Toxicology and Carcinogenesis, Nofer Institute of Occupational Medicine, 8 St Teresy St., 91-348 Łódź, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Jarosław Grobelny</Name>
        <Affiliation>Department of Materials Technology and Chemistry, Faculty of Chemistry, University of Łódź, 163 Pomorska St, 90-236 Łódź, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Emilia Tomaszewska</Name>
        <Affiliation>Department of Materials Technology and Chemistry, Faculty of Chemistry, University of Łódź, 163 Pomorska St, 90-236 Łódź, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Katarzyna Ranoszek-Soliwoda</Name>
        <Affiliation>Department of Materials Technology and Chemistry, Faculty of Chemistry, University of Łódź, 163 Pomorska St, 90-236 Łódź, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Grzegorz Celichowski</Name>
        <Affiliation>Department of Materials Technology and Chemistry, Faculty of Chemistry, University of Łódź, 163 Pomorska St, 90-236 Łódź, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Maciej Stępnik</Name>
        <Affiliation>Department of Toxicology and Carcinogenesis, Nofer Institute of Occupational Medicine, 8 St Teresy St., 91-348 Łódź, Poland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Tetramethylpyrazine suppresses angiotensin II-induced soluble epoxide hydrolase expression in coronary endothelium via anti-ER stress mechanism.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29066182</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30424-6</DOI>
    <KeywordList>
      <Keywords>Endoplasmic reticulum stress</Keywords>
      <Keywords>Endothelial function</Keywords>
      <Keywords>Soluble epoxide hydrolase</Keywords>
      <Keywords>Tetramethylpyrazine</Keywords>
      <Keywords>Vasorelaxing factors</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shiu Kwong Mak</Name>
        <Affiliation>Division of Cardiology, Department of Medicine and Therapeutics, Institute of Vascular Medicine, Li Ka Shing Institute of Health Sciences, Institute of Innovative Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong.</Affiliation>
      </Author>
      <Author>
        <Name>Cheuk Man Yu</Name>
        <Affiliation>Division of Cardiology, Department of Medicine and Therapeutics, Institute of Vascular Medicine, Li Ka Shing Institute of Health Sciences, Institute of Innovative Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Tao Sun</Name>
        <Affiliation>Division of Cardiology, Department of Medicine and Therapeutics, Institute of Vascular Medicine, Li Ka Shing Institute of Health Sciences, Institute of Innovative Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong.</Affiliation>
      </Author>
      <Author>
        <Name>Guo Wei He</Name>
        <Affiliation>TEDA International Cardiovascular Hospital, Chinese Academy of Medical Sciences, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Cheng Liu</Name>
        <Affiliation>TEDA International Cardiovascular Hospital, Chinese Academy of Medical Sciences, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qin Yang</Name>
        <Affiliation>Division of Cardiology, Department of Medicine and Therapeutics, Institute of Vascular Medicine, Li Ka Shing Institute of Health Sciences, Institute of Innovative Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong; TEDA International Cardiovascular Hospital, Chinese Academy of Medical Sciences, Tianjin, China. Electronic address: qyanghk@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Natural modulators of nonalcoholic fatty liver disease: Mode of action analysis and in silico ADME-Tox prediction.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29056366</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30421-0</DOI>
    <KeywordList>
      <Keywords>ADME-Tox</Keywords>
      <Keywords>In silico prediction</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>NAFLD</Keywords>
      <Keywords>Natural compounds</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Merilin Al Sharif</Name>
        <Affiliation>Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, Acad. G. Bonchev Str., bl. 105, 1113 Sofia, Bulgaria. Electronic address: merilin.al@biomed.bas.bg.</Affiliation>
      </Author>
      <Author>
        <Name>Petko Alov</Name>
        <Affiliation>Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, Acad. G. Bonchev Str., bl. 105, 1113 Sofia, Bulgaria. Electronic address: petko@biophys.bas.bg.</Affiliation>
      </Author>
      <Author>
        <Name>Vessela Vitcheva</Name>
        <Affiliation>Faculty of Pharmacy, Medical University of Sofia, Dunav 2 Str., 1000 Sofia, Bulgaria. Electronic address: vesselavitcheva@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Antonia Diukendjieva</Name>
        <Affiliation>Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, Acad. G. Bonchev Str., bl. 105, 1113 Sofia, Bulgaria. Electronic address: antonia.diukendjieva@biomed.bas.bg.</Affiliation>
      </Author>
      <Author>
        <Name>Mattia Mori</Name>
        <Affiliation>Center for Life Nano Science@Sapienza, Istituto Italiano di Tecnologia, Regina Elena 291 Str., 00161 Rome, Italy. Electronic address: m.mattia79@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Bruno Botta</Name>
        <Affiliation>Department of Chemistry and Technology of Drugs, Sapienza University of Rome, P.le A. Moro 5, 00185 Rome, Italy. Electronic address: bruno.botta@uniroma1.it.</Affiliation>
      </Author>
      <Author>
        <Name>Ivanka Tsakovska</Name>
        <Affiliation>Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, Acad. G. Bonchev Str., bl. 105, 1113 Sofia, Bulgaria. Electronic address: ITsakovska@biomed.bas.bg.</Affiliation>
      </Author>
      <Author>
        <Name>Ilza Pajeva</Name>
        <Affiliation>Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, Acad. G. Bonchev Str., bl. 105, 1113 Sofia, Bulgaria. Electronic address: pajeva@biomed.bas.bg.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The anthelminthic drug praziquantel is a selective agonist of the sensory transient receptor potential melastatin type 8 channel.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29054683</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30420-9</DOI>
    <KeywordList>
      <Keywords>Calcium imaging</Keywords>
      <Keywords>Dorsal root ganglion</Keywords>
      <Keywords>Praziquantel</Keywords>
      <Keywords>Schisostoma mansoni</Keywords>
      <Keywords>Transient Receptor Potential</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ramona Madalina Babes</Name>
        <Affiliation>Department of Anatomy, Physiology and Biophysics, Faculty of Biology, University of Bucharest, Romania; Department of Biophysics, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.</Affiliation>
      </Author>
      <Author>
        <Name>Tudor Selescu</Name>
        <Affiliation>Department of Anatomy, Physiology and Biophysics, Faculty of Biology, University of Bucharest, Romania.</Affiliation>
      </Author>
      <Author>
        <Name>Dan Domocos</Name>
        <Affiliation>Department of Anatomy, Physiology and Biophysics, Faculty of Biology, University of Bucharest, Romania.</Affiliation>
      </Author>
      <Author>
        <Name>Alexandru Babes</Name>
        <Affiliation>Department of Anatomy, Physiology and Biophysics, Faculty of Biology, University of Bucharest, Romania. Electronic address: alex@biologie.kappa.ro.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Liposomalization of oxaliplatin induces skin accumulation of it, but negligible skin toxicity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29054682</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30414-3</DOI>
    <KeywordList>
      <Keywords>Doxorubicin</Keywords>
      <Keywords>Hand-foot syndrome</Keywords>
      <Keywords>Oxaliplatin</Keywords>
      <Keywords>PEGylated liposome</Keywords>
      <Keywords>Skin toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kentaro Nishida</Name>
        <Affiliation>Department of Environmental Biochemistry, Kyoto Pharmaceutical University, 5 Nakauchi-cho, Misasagi, Yamashina-ku, Kyoto 607-8414, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Misaki Kashiwagi</Name>
        <Affiliation>Department of Environmental Biochemistry, Kyoto Pharmaceutical University, 5 Nakauchi-cho, Misasagi, Yamashina-ku, Kyoto 607-8414, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shunsuke Shiba</Name>
        <Affiliation>Department of Environmental Biochemistry, Kyoto Pharmaceutical University, 5 Nakauchi-cho, Misasagi, Yamashina-ku, Kyoto 607-8414, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kiwamu Muroki</Name>
        <Affiliation>Department of Environmental Biochemistry, Kyoto Pharmaceutical University, 5 Nakauchi-cho, Misasagi, Yamashina-ku, Kyoto 607-8414, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Akihiro Ohishi</Name>
        <Affiliation>Department of Environmental Biochemistry, Kyoto Pharmaceutical University, 5 Nakauchi-cho, Misasagi, Yamashina-ku, Kyoto 607-8414, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yusuke Doi</Name>
        <Affiliation>Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University, 1-78-1, Sho-machi, Tokushima 770-8505, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hidenori Ando</Name>
        <Affiliation>Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University, 1-78-1, Sho-machi, Tokushima 770-8505, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tatsuhiro Ishida</Name>
        <Affiliation>Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University, 1-78-1, Sho-machi, Tokushima 770-8505, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kazuki Nagasawa</Name>
        <Affiliation>Department of Environmental Biochemistry, Kyoto Pharmaceutical University, 5 Nakauchi-cho, Misasagi, Yamashina-ku, Kyoto 607-8414, Japan. Electronic address: nagasawa@mb.kyoto-phu.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Role of histone acetylation in activation of nuclear factor erythroid 2-related factor 2/heme oxygenase 1 pathway by manganese chloride.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29054681</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30419-2</DOI>
    <KeywordList>
      <Keywords>Heme oxygenase-1(HO-1)</Keywords>
      <Keywords>Histone acetylation</Keywords>
      <Keywords>Manganese chloride</Keywords>
      <Keywords>NF-E2-related factor 2 (Nrf2)</Keywords>
      <Keywords>Neurotoxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhipeng Zhang</Name>
        <Affiliation>Fujian Provincial Key Laboratory of Environmental Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou 350122, China; Fujian Provincial Center for Adverse Drug Reaction Monitoring, Fujian Provincial Food and Drug Administration, Fuzhou 350001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenkun Guo</Name>
        <Affiliation>Fujian Provincial Key Laboratory of Environmental Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou 350122, China; The Key Laboratory of Environment and Health, School of Public Health, Fujian Medical University, Fuzhou 350122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanting Zhan</Name>
        <Affiliation>Fujian Provincial Key Laboratory of Environmental Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou 350122, China; Deapartment of Mannagement, Fujian Health College, Fuzhou 350101, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huangyuan Li</Name>
        <Affiliation>Fujian Provincial Key Laboratory of Environmental Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou 350122, China; Department of Preventive Medicine, School of Public Health, Fujian Medical University, Fuzhou 350122, China. Electronic address: fmulhy@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Siying Wu</Name>
        <Affiliation>Fujian Provincial Key Laboratory of Environmental Factors and Cancer, School of Public Health, Fujian Medical University, Fuzhou 350122, China; Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, Fuzhou 350122, China. Electronic address: fmuwsy@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Phosphorylation of protein phosphatase 2A facilitated an early stage of chemical carcinogenesis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29054680</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30418-0</DOI>
    <KeywordList>
      <Keywords>Cell proliferation</Keywords>
      <Keywords>DNA adduct</Keywords>
      <Keywords>Estragole</Keywords>
      <Keywords>Gene mutation</Keywords>
      <Keywords>PP2A</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yuji Ishii</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Ken Kuroda</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kohei Matsushita</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuh Yokoo</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shinji Takasu</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Aki Kijima</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takehiko Nohmi</Name>
        <Affiliation>Division of Genetics and Mutagenesis, National Institute of Health Science, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kumiko Ogawa</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takashi Umemura</Name>
        <Affiliation>Division of Pathology, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan; Faculty of Animal Science Technology, Yamazaki Gakuen University, 4-7-2 Minami-osawa, Hachioji, Tokyo 192-0364, Japan. Electronic address: umemura@nihs.go.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Perspectives on using a multiplex human kidney safety biomarker panel to detect cisplatin-induced tubular toxicity in male and female Cynomolgus monkeys.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29051111</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30417-9</DOI>
    <KeywordList>
      <Keywords>Biomarkers</Keywords>
      <Keywords>Cisplatin</Keywords>
      <Keywords>Cynomolgus monkey</Keywords>
      <Keywords>Drug-induced kidney injury</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yafei Chen</Name>
        <Affiliation>Mechanistic &amp; Investigative Toxicology, Preclinical Development &amp; Safety, Janssen Research &amp; Development, L.L.C., San Diego, CA 92121, USA; Global Safety Assessment, AstraZeneca Research &amp; Development, Waltham, MA 02451, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. Dale Thurman</Name>
        <Affiliation>Global Safety Assessment, AstraZeneca Research &amp; Development, Waltham, MA 02451, USA; Global Pathology Services, 140 Indian Hannah Road, West Chester, PA 19382, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lewis B. Kinter</Name>
        <Affiliation>Global Safety Assessment, AstraZeneca Research &amp; Development, Waltham, MA 02451, USA; Green Lawn Professional Scientific Consulting, P.O. Box 765, Unionville, PA 19375, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Russell Bialecki</Name>
        <Affiliation>Global Safety Assessment, AstraZeneca Research &amp; Development, Waltham, MA 02451, USA; Stine-Haskell Research Center, DuPont Crop Protection, Newark, DE 19711, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. Eric McDuffie</Name>
        <Affiliation>Mechanistic &amp; Investigative Toxicology, Preclinical Development &amp; Safety, Janssen Research &amp; Development, L.L.C., San Diego, CA 92121, USA. Electronic address: jmcduffi@its.jnj.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A novel stilbene-like compound that inhibits melanoma growth by regulating melanocyte differentiation and proliferation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29042215</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30416-7</DOI>
    <KeywordList>
      <Keywords>A11</Keywords>
      <Keywords>Akt</Keywords>
      <Keywords>MAPK</Keywords>
      <Keywords>Melanocyte differentiation</Keywords>
      <Keywords>Melanoma</Keywords>
      <Keywords>mitf</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Noah A. Stueven</Name>
        <Affiliation>Biology Department, University of Wisconsin-River Falls, River Falls, WI 54022, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Nicholas M. Schlaeger</Name>
        <Affiliation>Biology Department, University of Wisconsin-River Falls, River Falls, WI 54022, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Aaron P. Monte</Name>
        <Affiliation>Department of Chemistry and Biochemistry, University of Wisconsin-La Crosse, La Crosse, WI 54601, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Sheng Ping L. Hwang</Name>
        <Affiliation>Institute of Cellular and Organismic Biology, Academia Sinica, Taipei 115, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Cheng Chen Huang</Name>
        <Affiliation>Biology Department, University of Wisconsin-River Falls, River Falls, WI 54022, United States. Electronic address: cheng-chen.huang@uwrf.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Synthetic cannabinoid AM2201 induces seizures: Involvement of cannabinoid CB</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29042214</pubmedLink>
    <Year>2018</Year>
    <DOI>S0041-008X(17)30415-5</DOI>
    <KeywordList>
      <Keywords>AM2201</Keywords>
      <Keywords>Glutamate</Keywords>
      <Keywords>Intoxication</Keywords>
      <Keywords>Seizure</Keywords>
      <Keywords>Synthetic Cannabinoid</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Masahiko Funada</Name>
        <Affiliation>Department of Drug Dependence Research, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-higashi, Kodaira, Tokyo 187-8553, Japan. Electronic address: mfunada@ncnp.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Mika Takebayashi-Ohsawa</Name>
        <Affiliation>Department of Drug Dependence Research, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-higashi, Kodaira, Tokyo 187-8553, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of triclosan on hormones and reproductive axis in female Yellow River carp (Cyprinus carpio): Potential mechanisms underlying estrogen effect.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29032082</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30413-1</DOI>
    <KeywordList>
      <Keywords>Aromatase</Keywords>
      <Keywords>Female Yellow River carp</Keywords>
      <Keywords>HPG axis</Keywords>
      <Keywords>Sex steroid</Keywords>
      <Keywords>Triclosan</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Fan Wang</Name>
        <Affiliation>School of Biological Science, Luoyang Normal University, Luoyang 471022, China; Cold Water Fish Breeding Engineering Technology Research Center of Henan Province, Luoyang 471022, China. Electronic address: wangfan7677@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xiangmeng Guo</Name>
        <Affiliation>School of Biological Science, Luoyang Normal University, Luoyang 471022, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wanguang Chen</Name>
        <Affiliation>School of Biological Science, Luoyang Normal University, Luoyang 471022, China; Cold Water Fish Breeding Engineering Technology Research Center of Henan Province, Luoyang 471022, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yaowen Sun</Name>
        <Affiliation>College of Animal Science &amp; Technology, Henan University of Science and Technology, Luoyang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chaojie Fan</Name>
        <Affiliation>College of Animal Science &amp; Technology, Henan University of Science and Technology, Luoyang, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>6-Hydroxy-3-O-methyl-kaempferol 6-O-glucopyranoside potentiates the anti-proliferative effect of interferon α/β by promoting activation of the JAK/STAT signaling by inhibiting SOCS3 in hepatocellular carcinoma cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/29031523</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30405-2</DOI>
    <KeywordList>
      <Keywords>Interferon</Keywords>
      <Keywords>JAK/STAT</Keywords>
      <Keywords>Kaempferol glucopyranoside</Keywords>
      <Keywords>SOCS3</Keywords>
      <Keywords>Saussurea stella</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Orawan Wonganan</Name>
        <Affiliation>Key Laboratory of Natural Medicine and Clinical Translation, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China; University of Chinese Academy of Sciences, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Jiao He</Name>
        <Affiliation>Key Laboratory of Natural Medicine and Clinical Translation, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China; Department of Antibiotic Research &amp; Re-evaluation, Key Laboratory of Sichuan Province, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu 610052, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Fei Shen</Name>
        <Affiliation>Key Laboratory of Natural Medicine and Clinical Translation, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kanjana Wongkrajang</Name>
        <Affiliation>Key Laboratory of Natural Medicine and Clinical Translation, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China; Department of Chemistry, Faculty of Science and Technology, Pibulsongkram Rajabhat University, Phitsanulok, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Apichart Suksamrarn</Name>
        <Affiliation>Department of Chemistry and Center for Innovation in Chemistry, Faculty of Science, Ramkhamhaeng University, Bangkok 10240, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Guo Lin Zhang</Name>
        <Affiliation>Key Laboratory of Natural Medicine and Clinical Translation, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China. Electronic address: zhanggl@cib.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Fei Wang</Name>
        <Affiliation>Key Laboratory of Natural Medicine and Clinical Translation, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China. Electronic address: wangfei@cib.ac.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nanotoxicological and teratogenic effects: A linkage between dendrimer surface charge and zebrafish developmental stages.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28993268</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30404-0</DOI>
    <KeywordList>
      <Keywords>Dendrimer</Keywords>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Nanotoxicology</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Maria Natalia Calienni</Name>
        <Affiliation>Laboratorio de Biomembranas - GBEyB (IMBICE, CCT-La Plata, CONICET), Departamento de Ciencia y Tecnología, Universidad Nacional de Quilmes, Bernal B1876BXD, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Daniela Agustina Feas</Name>
        <Affiliation>Laboratorio de Biomembranas - GBEyB (IMBICE, CCT-La Plata, CONICET), Departamento de Ciencia y Tecnología, Universidad Nacional de Quilmes, Bernal B1876BXD, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Daniela Edith Igartúa</Name>
        <Affiliation>Laboratorio de Biomembranas - GBEyB (IMBICE, CCT-La Plata, CONICET), Departamento de Ciencia y Tecnología, Universidad Nacional de Quilmes, Bernal B1876BXD, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Nadia Silvia Chiaramoni</Name>
        <Affiliation>Laboratorio de Biomembranas - GBEyB (IMBICE, CCT-La Plata, CONICET), Departamento de Ciencia y Tecnología, Universidad Nacional de Quilmes, Bernal B1876BXD, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Silvia Del Valle Alonso</Name>
        <Affiliation>Laboratorio de Biomembranas - GBEyB (IMBICE, CCT-La Plata, CONICET), Departamento de Ciencia y Tecnología, Universidad Nacional de Quilmes, Bernal B1876BXD, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Jimena Prieto</Name>
        <Affiliation>Laboratorio de Biomembranas - GBEyB (IMBICE, CCT-La Plata, CONICET), Departamento de Ciencia y Tecnología, Universidad Nacional de Quilmes, Bernal B1876BXD, Argentina. Electronic address: jprieto@unq.edu.ar.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Arginine methyltransferase inhibitor 1 inhibits gastric cancer by downregulating eIF4E and targeting PRMT5.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28987382</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30402-7</DOI>
    <KeywordList>
      <Keywords>Arginine methyltransferase inhibitor 1 (AMI-1)</Keywords>
      <Keywords>Gastric cancer</Keywords>
      <Keywords>Histonemethylation</Keywords>
      <Keywords>Protein arginine methyltransferase 5 (PRMT5)</Keywords>
      <Keywords>eIF4E</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Baolai Zhang</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Key Lab of Preclinical Study for New Drugs of Gansu Province, Lanzhou, PR China. Electronic address: zhangbl@lzu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Su Zhang</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Key Lab of Preclinical Study for New Drugs of Gansu Province, Lanzhou, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lijuan Zhu</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Key Lab of Preclinical Study for New Drugs of Gansu Province, Lanzhou, PR China; Department of Pharmacology, Gansu University of Chinese Medicine, Lanzhou, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xue Chen</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Key Lab of Preclinical Study for New Drugs of Gansu Province, Lanzhou, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yunfeng Zhao</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Key Lab of Preclinical Study for New Drugs of Gansu Province, Lanzhou, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Chao</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Key Lab of Preclinical Study for New Drugs of Gansu Province, Lanzhou, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Juanping Zhou</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Key Lab of Preclinical Study for New Drugs of Gansu Province, Lanzhou, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xing Wang</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Key Lab of Preclinical Study for New Drugs of Gansu Province, Lanzhou, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xinyang Zhang</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Key Lab of Preclinical Study for New Drugs of Gansu Province, Lanzhou, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Nengqian Ma</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Lanzhou University, Key Lab of Preclinical Study for New Drugs of Gansu Province, Lanzhou, PR China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Altered gene expression profiles in the lungs of benzo[a]pyrene-exposed mice in the presence of lipopolysaccharide-induced pulmonary inflammation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28987381</pubmedLink>
    <GrantList />
    <Year>2017</Year>
    <DOI>S0041-008X(17)30401-5</DOI>
    <KeywordList>
      <Keywords>Benzo[a]pyrene (B[a]P)</Keywords>
      <Keywords>Lipopolysaccharide (LPS)</Keywords>
      <Keywords>Mouse lung</Keywords>
      <Keywords>RNA microarray</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Q. Shi</Name>
        <Affiliation>Department of Toxicology &amp; Pharmacology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, PO Box 616, 6200, MD, Maastricht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>R. R. Fijten</Name>
        <Affiliation>Department of Toxicology &amp; Pharmacology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, PO Box 616, 6200, MD, Maastricht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>D. Spina</Name>
        <Affiliation>Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, King's College London, 150 Stamford Street, London SE1 9NH, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Y. Riffo Vasquez</Name>
        <Affiliation>Sackler Institute of Pulmonary Pharmacology, Institute of Pharmaceutical Science, King's College London, 150 Stamford Street, London SE1 9NH, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>V. M. Arlt</Name>
        <Affiliation>Analytical and Environmental Sciences Division, MRC-PHE Centre for Environmental &amp; Health, King's College London, 150 Stamford Street, London SE1 9NH, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>R. W. Godschalk</Name>
        <Affiliation>Department of Toxicology &amp; Pharmacology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, PO Box 616, 6200, MD, Maastricht, The Netherlands. Electronic address: R.Godschalk@maastrichtuniversity.nl.</Affiliation>
      </Author>
      <Author>
        <Name>F. J. Van Schooten</Name>
        <Affiliation>Department of Toxicology &amp; Pharmacology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, PO Box 616, 6200, MD, Maastricht, The Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The disturbed redox-balance in pulmonary fibrosis is modulated by the plant flavonoid quercetin.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28987380</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30403-9</DOI>
    <KeywordList>
      <Keywords>Antioxidants</Keywords>
      <Keywords>Idiopathic pulmonary fibrosis (IPF)</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Interstitial lung diseases (ILD)</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Quercetin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>C. Veith</Name>
        <Affiliation>Department of Pharmacology and Toxicology, NUTRIM School of Nutrition &amp; Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands. Electronic address: c.veith@maastrichtuniversity.nl.</Affiliation>
      </Author>
      <Author>
        <Name>M. Drent</Name>
        <Affiliation>Department of Pharmacology and Toxicology, NUTRIM School of Nutrition &amp; Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands; ILD Center of Excellence, St. Antonius Hospital, Koekoekslaan 1, 3435 CM Nieuwegein, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>A. Bast</Name>
        <Affiliation>Department of Pharmacology and Toxicology, NUTRIM School of Nutrition &amp; Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>F. J. van Schooten</Name>
        <Affiliation>Department of Pharmacology and Toxicology, NUTRIM School of Nutrition &amp; Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands. Electronic address: f.vanschooten@maastrichtuniversity.nl.</Affiliation>
      </Author>
      <Author>
        <Name>A. W. Boots</Name>
        <Affiliation>Department of Pharmacology and Toxicology, NUTRIM School of Nutrition &amp; Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Melatonin as an angiogenesis inhibitor to combat cancer: Mechanistic evidence.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28974455</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30400-3</DOI>
    <KeywordList>
      <Keywords>Angiogenesis</Keywords>
      <Keywords>HIF-1α</Keywords>
      <Keywords>Melatonin</Keywords>
      <Keywords>VEGF</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nasser Hashemi Goradel</Name>
        <Affiliation>Young Researchers and Elite Club, Ardabil Branch, Islamic Azad University, Ardabil, Iran; Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Mohammad Hossein Asghari</Name>
        <Affiliation>Department of Pharmacology, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Milad Moloudizargari</Name>
        <Affiliation>Student Research Committee, Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Babak Negahdari</Name>
        <Affiliation>Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Hamed Haghi-Aminjan</Name>
        <Affiliation>Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Mohammad Abdollahi</Name>
        <Affiliation>Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran; Toxicology and Diseases Group, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: Mohammad.Abdollahi@UToronto.Ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Sildenafil protects against bile duct ligation induced hepatic fibrosis in rats: Potential role for silent information regulator 1 (SIRT1).</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28974454</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30393-9</DOI>
    <KeywordList>
      <Keywords>Hepatic fibrosis</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>SIRT1</Keywords>
      <Keywords>Sildenafil</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dalia M. Abd El Motteleb</Name>
        <Affiliation>Clinical Pharmacology Department, Faculty of Medicine, Zagazig University, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Islam A. A. E. H. Ibrahim</Name>
        <Affiliation>Pharmacology and Toxicology Department, Faculty of Pharmacy, Zagazig University, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Shimaa M. Elshazly</Name>
        <Affiliation>Pharmacology and Toxicology Department, Faculty of Pharmacy, Zagazig University, Egypt. Electronic address: smelshazly@zu.edu.eg.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Gut satiety hormones cholecystokinin and glucagon-like Peptide-1</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28964791</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30392-7</DOI>
    <KeywordList>
      <Keywords>Cholecystokinin</Keywords>
      <Keywords>Diacetoxyscirpenol</Keywords>
      <Keywords>Glucagon-like peptide-1(7-36) amide</Keywords>
      <Keywords>HT-2 toxin</Keywords>
      <Keywords>Neosolaniol</Keywords>
      <Keywords>T-2 toxin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jie Zhang</Name>
        <Affiliation>College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shengli Liu</Name>
        <Affiliation>Shandong Lonct Enzymes Co., Ltd., Linyi 276000, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hua Zhang</Name>
        <Affiliation>College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanyuan Li</Name>
        <Affiliation>College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenda Wu</Name>
        <Affiliation>College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, PR China. Electronic address: wuwenda@njau.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Haibin Zhang</Name>
        <Affiliation>College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, PR China. Electronic address: haibinzh@njau.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessing molecular initiating events (MIEs), key events (KEs) and modulating factors (MFs) for styrene responses in mouse lungs using whole genome gene expression profiling following 1-day and multi-week exposures.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28951217</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30387-3</DOI>
    <KeywordList>
      <Keywords>Adaptation and modulating factors</Keywords>
      <Keywords>MIEs</Keywords>
      <Keywords>Molecular initiating events</Keywords>
      <Keywords>Mouse lung tumors</Keywords>
      <Keywords>Nr4 family gene downregulation</Keywords>
      <Keywords>Styrene inhalation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Melvin E. Andersen</Name>
        <Affiliation>ScitoVation LLC, Six Davis Drive, PO Box 12878, Research Triangle Park, NC 27709, United States.</Affiliation>
      </Author>
      <Author>
        <Name>George Cruzan</Name>
        <Affiliation>ToxWorks, 1153 Roadstown Road, Bridgeton, NJ 08302, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Michael B. Black</Name>
        <Affiliation>ScitoVation LLC, Six Davis Drive, PO Box 12878, Research Triangle Park, NC 27709, United States. Electronic address: mblack@scitovation.com.</Affiliation>
      </Author>
      <Author>
        <Name>Salil N. Pendse</Name>
        <Affiliation>ScitoVation LLC, Six Davis Drive, PO Box 12878, Research Triangle Park, NC 27709, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Darol Dodd</Name>
        <Affiliation>Charles River, 640 N. Elizabeth St., Spencerville, OH 45887, United States.</Affiliation>
      </Author>
      <Author>
        <Name>James S. Bus</Name>
        <Affiliation>Exponent Inc., 5806 Woodberry Drive, Midland, MI 48640, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Satinder S. Sarang</Name>
        <Affiliation>Shell International, 910 Louisiana Street, Houston, TX 77002, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Marcy I. Banton</Name>
        <Affiliation>Lyondell Chemical Company, Houston, TX 77010, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Robbie Waites</Name>
        <Affiliation>SABIC Innovative Plastics US LLC, Mount Vernon, IN 47620, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Patrick D. McMullen</Name>
        <Affiliation>ScitoVation LLC, Six Davis Drive, PO Box 12878, Research Triangle Park, NC 27709, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Perfluorooctanoic acid exposure disturbs glucose metabolism in mouse liver.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28947262</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30391-5</DOI>
    <KeywordList>
      <Keywords>Blood glucose</Keywords>
      <Keywords>Metabolism</Keywords>
      <Keywords>Perfluorooctanoic acid</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Fei Zheng</Name>
        <Affiliation>Key Laboratory of Animal Ecology and Conservation Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, PR China; Shanxi Key Laboratory of Ecological Animal Science and Environmental Medicine, Shanxi Agricultural University, Taigu 030801, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Nan Sheng</Name>
        <Affiliation>Key Laboratory of Animal Ecology and Conservation Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongxia Zhang</Name>
        <Affiliation>Key Laboratory of Animal Ecology and Conservation Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shengmin Yan</Name>
        <Affiliation>Key Laboratory of Animal Ecology and Conservation Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianhai Zhang</Name>
        <Affiliation>Shanxi Key Laboratory of Ecological Animal Science and Environmental Medicine, Shanxi Agricultural University, Taigu 030801, PR China. Electronic address: jianhaiz@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jianshe Wang</Name>
        <Affiliation>Key Laboratory of Animal Ecology and Conservation Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, PR China. Electronic address: jianshewang@ioz.ac.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cytogenetic effects of Jacareubin from Calophyllum brasiliense on human peripheral blood mononucleated cells in vitro and on mouse polychromatic erythrocytes in vivo.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28943391</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30390-3</DOI>
    <KeywordList>
      <Keywords>Aneuploidy</Keywords>
      <Keywords>Calophyllum</Keywords>
      <Keywords>DNA damage</Keywords>
      <Keywords>Micronucleus</Keywords>
      <Keywords>PBMC</Keywords>
      <Keywords>Xanthones</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>W. R. García-Niño</Name>
        <Affiliation>Department of Toxicology, Centre for Research and Advanced Studies of the National Polytechnic Institute (CINVESTAV-IPN), Av. IPN 2508, San Pedro Zacatenco, GA Madero, Ciudad de México, CP 07360, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>E. Estrada-Muñiz</Name>
        <Affiliation>Department of Toxicology, Centre for Research and Advanced Studies of the National Polytechnic Institute (CINVESTAV-IPN), Av. IPN 2508, San Pedro Zacatenco, GA Madero, Ciudad de México, CP 07360, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>M. Valverde</Name>
        <Affiliation>Department of Genomic Medicine and Environmental Toxicology, Biomedical Research Institute, National University of Mexico (UNAM), Ciudad de México, CP 04510, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>R. Reyes-Chilpa</Name>
        <Affiliation>Department of Natural Products, Chemistry Institute, National University of Mexico (UNAM), Ciudad de México, CP 04510, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>L. Vega</Name>
        <Affiliation>Department of Toxicology, Centre for Research and Advanced Studies of the National Polytechnic Institute (CINVESTAV-IPN), Av. IPN 2508, San Pedro Zacatenco, GA Madero, Ciudad de México, CP 07360, Mexico. Electronic address: lvega@cinvestav.mx.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Leptomycin B reduces primary and acquired resistance of gefitinib in lung cancer cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28942004</pubmedLink>
    <GrantList>
      <Grant>R15 ES026789</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30389-7</DOI>
    <KeywordList>
      <Keywords>Acquired resistance</Keywords>
      <Keywords>CRM1</Keywords>
      <Keywords>EGFR</Keywords>
      <Keywords>EMT</Keywords>
      <Keywords>KRAS mutation</Keywords>
      <Keywords>NSCLC</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhongwei Liu</Name>
        <Affiliation>Department of Environmental Toxicology, The Institute of Environmental and Human Health, Texas Tech University, Lubbock, TX, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Weimin Gao</Name>
        <Affiliation>Department of Environmental Toxicology, The Institute of Environmental and Human Health, Texas Tech University, Lubbock, TX, United States. Electronic address: weimin.gao@ttu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inhalation exposure to three-dimensional printer emissions stimulates acute hypertension and microvascular dysfunction.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28942003</pubmedLink>
    <GrantList>
      <Grant>R01 ES015022</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30388-5</DOI>
    <KeywordList>
      <Keywords>Endothelium</Keywords>
      <Keywords>Hypertension</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>Microcirculation</Keywords>
      <Keywords>Ultrafine particle</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>A. B. Stefaniak</Name>
        <Affiliation>Toxicology Working Group, West Virginia University School of Medicine, Morgantown, WV, USA; National Institute for Occupational Safety and Health, Morgantown, WV, USA.</Affiliation>
      </Author>
      <Author>
        <Name>R. F. LeBouf</Name>
        <Affiliation>National Institute for Occupational Safety and Health, Morgantown, WV, USA.</Affiliation>
      </Author>
      <Author>
        <Name>M. G. Duling</Name>
        <Affiliation>National Institute for Occupational Safety and Health, Morgantown, WV, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. Yi</Name>
        <Affiliation>Department of Physiology, Pharmacology and Neuroscience, West Virginia University School of Medicine, Morgantown, WV, USA; National Institute for Occupational Safety and Health, Morgantown, WV, USA.</Affiliation>
      </Author>
      <Author>
        <Name>A. B. Abukabda</Name>
        <Affiliation>Department of Physiology, Pharmacology and Neuroscience, West Virginia University School of Medicine, Morgantown, WV, USA; Toxicology Working Group, West Virginia University School of Medicine, Morgantown, WV, USA.</Affiliation>
      </Author>
      <Author>
        <Name>C. R. McBride</Name>
        <Affiliation>Department of Physiology, Pharmacology and Neuroscience, West Virginia University School of Medicine, Morgantown, WV, USA; Toxicology Working Group, West Virginia University School of Medicine, Morgantown, WV, USA.</Affiliation>
      </Author>
      <Author>
        <Name>T. R. Nurkiewicz</Name>
        <Affiliation>Department of Physiology, Pharmacology and Neuroscience, West Virginia University School of Medicine, Morgantown, WV, USA; Toxicology Working Group, West Virginia University School of Medicine, Morgantown, WV, USA; National Institute for Occupational Safety and Health, Morgantown, WV, USA. Electronic address: tnurkiewicz@hsc.wvu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Long-enduring primary hepatocyte-based co-cultures improve prediction of hepatotoxicity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28942002</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30385-X</DOI>
    <KeywordList>
      <Keywords>Co-culture</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>DILI</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Eric I. Novik</Name>
        <Affiliation>Hμrel Corporation, North Brunswick, NJ 08902, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jacquelyn Dwyer</Name>
        <Affiliation>Preclinical Safety, Sanofi, Framingham, MA 01701, United States.</Affiliation>
      </Author>
      <Author>
        <Name>James K. Morelli</Name>
        <Affiliation>Preclinical Safety, Sanofi, Framingham, MA 01701, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Amit Parekh</Name>
        <Affiliation>Hμrel Corporation, North Brunswick, NJ 08902, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Cheul Cho</Name>
        <Affiliation>Hμrel Corporation, North Brunswick, NJ 08902, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Eitan Pludwinski</Name>
        <Affiliation>Hμrel Corporation, North Brunswick, NJ 08902, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Anil Shrirao</Name>
        <Affiliation>Hμrel Corporation, North Brunswick, NJ 08902, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Robert M. Freedman</Name>
        <Affiliation>Hμrel Corporation, North Brunswick, NJ 08902, United States.</Affiliation>
      </Author>
      <Author>
        <Name>James S. MacDonald</Name>
        <Affiliation>Chrysalis Pharma Partners, LLC, Chester, NJ 07930, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Zaid Jayyosi</Name>
        <Affiliation>Preclinical Safety, Sanofi, Framingham, MA 01701, United States. Electronic address: zaid.jayyosi@sanofi.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>DMARD use is associated with a higher risk of dementia in patients with rheumatoid arthritis: A propensity score-matched case-control study.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28927738</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30386-1</DOI>
    <KeywordList>
      <Keywords>Biological disease-modifying antirheumatic drugs</Keywords>
      <Keywords>Conventional synthetic disease-modifying antirheumatic drugs</Keywords>
      <Keywords>Dementia</Keywords>
      <Keywords>Rheumatoid arthritis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ming Hsien Chou</Name>
        <Affiliation>Department of Public Health, China Medical University, Taichung, Taiwan; Department of Physical Medicine and Rehabilitation, Taichung Armed Forces General Hospital, Taichung, Taiwan; Department of Physical Medicine and Rehabilitation, Tri-Service General Hospital, Taipei, Taiwan; Section of Physical Medicine and Rehabilitation, School of Medicine, National Defense Medical Center, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Jong Yi Wang</Name>
        <Affiliation>Department of Public Health, China Medical University, Taichung, Taiwan; Department of Health Services Administration, China Medical University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Cheng Li Lin</Name>
        <Affiliation>Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Sheng Chung</Name>
        <Affiliation>Department of Health Services Administration, China Medical University, Taichung, Taiwan; Department of Internal Medicine, Taichung Hospital, Ministry of Health and Welfare, Taichung, Taiwan; Department of Healthcare Administration, Central Taiwan University of Science and Technology, Taichung, Taiwan. Electronic address: chung.w53@msa.hinet.net.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A dioxin-like compound induces hyperplasia and branching morphogenesis in mouse mammary gland, through alterations in TGF-β1 and aryl hydrocarbon receptor signaling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28923513</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30384-8</DOI>
    <KeywordList>
      <Keywords>Aryl Hydrocarbon Receptor</Keywords>
      <Keywords>Endocrine Disruptor</Keywords>
      <Keywords>Hexachlorobenzene</Keywords>
      <Keywords>Mouse Mammary Gland</Keywords>
      <Keywords>Transforming Growth Factor β1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Noelia Miret</Name>
        <Affiliation>Universidad de Buenos Aires, Facultad de Medicina, Departamento de Bioquímica Humana, Laboratorio de Efectos Biológicos de Contaminantes Ambientales, Paraguay 2155, 5° piso, CP1121, Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Eva Rico-Leo</Name>
        <Affiliation>Universidad de Extremadura, Facultad de Ciencias, Departamento de Bioquímica y Biología Molecular y Genética, Laboratorio de Biología Molecular del Cáncer, Avenida de Elvas s/n, CP06080 Badajoz, Spain. Electronic address: evaricoleo@unex.es.</Affiliation>
      </Author>
      <Author>
        <Name>Carolina Pontillo</Name>
        <Affiliation>Universidad de Buenos Aires, Facultad de Medicina, Departamento de Bioquímica Humana, Laboratorio de Efectos Biológicos de Contaminantes Ambientales, Paraguay 2155, 5° piso, CP1121, Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Elsa Zotta</Name>
        <Affiliation>Universidad de Buenos Aires, Facultad de Medicina, Departamento de Ciencias Fisiológicas, Sección Patología, Laboratorio de Fisiopatogenia, Paraguay 2155, 7° piso, CP1121, Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Pedro Fernández-Salguero</Name>
        <Affiliation>Universidad de Extremadura, Facultad de Ciencias, Departamento de Bioquímica y Biología Molecular y Genética, Laboratorio de Biología Molecular del Cáncer, Avenida de Elvas s/n, CP06080 Badajoz, Spain. Electronic address: pmfersal@unex.es.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Randi</Name>
        <Affiliation>Universidad de Buenos Aires, Facultad de Medicina, Departamento de Bioquímica Humana, Laboratorio de Efectos Biológicos de Contaminantes Ambientales, Paraguay 2155, 5° piso, CP1121, Buenos Aires, Argentina. Electronic address: arandi@fmed.uba.ar.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>HZ-6d targeted HERC5 to regulate p53 ISGylation in human hepatocellular carcinoma.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28919514</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30383-6</DOI>
    <KeywordList>
      <Keywords>Disubstituted quinazoline derivative</Keywords>
      <Keywords>HERC5</Keywords>
      <Keywords>Hepatocellular carcinoma</Keywords>
      <Keywords>p53 ISGylation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yang Wang</Name>
        <Affiliation>School of Pharmacy, Anhui Medical University, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University, Anhui Medical University, Hefei 230032, China; The Key Laboratory of major autoimmune disease, School of Pharmacy, Anhui Medical University, Hefei, Anhui Province 230032,China; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Anhui Medical University, Hefei, 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Ding</Name>
        <Affiliation>School of Pharmacy, Anhui Medical University, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University, Anhui Medical University, Hefei 230032, China; The Key Laboratory of major autoimmune disease, School of Pharmacy, Anhui Medical University, Hefei, Anhui Province 230032,China; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Anhui Medical University, Hefei, 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tao Xu</Name>
        <Affiliation>School of Pharmacy, Anhui Medical University, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University, Anhui Medical University, Hefei 230032, China; The Key Laboratory of major autoimmune disease, School of Pharmacy, Anhui Medical University, Hefei, Anhui Province 230032,China; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Anhui Medical University, Hefei, 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chang Yao Li</Name>
        <Affiliation>School of Pharmacy, Anhui Medical University, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University, Anhui Medical University, Hefei 230032, China; The Key Laboratory of major autoimmune disease, School of Pharmacy, Anhui Medical University, Hefei, Anhui Province 230032,China; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Anhui Medical University, Hefei, 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dan Dan Zhou</Name>
        <Affiliation>School of Pharmacy, Anhui Medical University, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University, Anhui Medical University, Hefei 230032, China; The Key Laboratory of major autoimmune disease, School of Pharmacy, Anhui Medical University, Hefei, Anhui Province 230032,China; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Anhui Medical University, Hefei, 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lei Zhang</Name>
        <Affiliation>School of Pharmacy, Anhui Medical University, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University, Anhui Medical University, Hefei 230032, China; The Key Laboratory of major autoimmune disease, School of Pharmacy, Anhui Medical University, Hefei, Anhui Province 230032,China; The Key Laboratory of Anti-inflammatory and Immune Medicines, Ministry of Education, Anhui Medical University, Hefei, 230032, China. Electronic address: zhanglei-1@ahmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>MK-801, but not naloxone, attenuates high-dose dextromethorphan-induced convulsive behavior: Possible involvement of the GluN2B receptor.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28916251</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30382-4</DOI>
    <KeywordList>
      <Keywords>Dextromethorphan</Keywords>
      <Keywords>Hippocampus</Keywords>
      <Keywords>N-methyl-d-aspartate receptor subunit GluN2B</Keywords>
      <Keywords>Neurotoxicity</Keywords>
      <Keywords>Seizure</Keywords>
      <Keywords>Supra-antitussive dose</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hai Quyen Tran</Name>
        <Affiliation>Neuropsychopharmacology and Toxicology Program, College of Pharmacy, Kangwon National University, Chunchon 24341, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yoon Hee Chung</Name>
        <Affiliation>Department of Anatomy, College of Medicine, Chung-Ang University, Seoul 06974, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Joo Shin</Name>
        <Affiliation>Neuropsychopharmacology and Toxicology Program, College of Pharmacy, Kangwon National University, Chunchon 24341, Republic of Korea. Electronic address: shinej@kangwon.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>The Vinh Tran</Name>
        <Affiliation>Neuropsychopharmacology and Toxicology Program, College of Pharmacy, Kangwon National University, Chunchon 24341, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Hoon Jeong</Name>
        <Affiliation>Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul 06974, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Choon Gon Jang</Name>
        <Affiliation>Department of Pharmacology, School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Yeol Nah</Name>
        <Affiliation>Ginsentology Research Laboratory, Department of Physiology, College of Veterinary Medicine, Konkuk University, Seoul 05029, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kiyofumi Yamada</Name>
        <Affiliation>Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Toshitaka Nabeshima</Name>
        <Affiliation>Advanced Diagnostic System Research Laboratory, Fujita Health University Graduate School of Health Science, Aichi 470-1192, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hyoung Chun Kim</Name>
        <Affiliation>Neuropsychopharmacology and Toxicology Program, College of Pharmacy, Kangwon National University, Chunchon 24341, Republic of Korea. Electronic address: kimhc@kangwon.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Novel oxolane derivative DMTD mitigates high glucose-induced erythrocyte apoptosis by regulating oxidative stress.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28911973</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30380-0</DOI>
    <KeywordList>
      <Keywords>DMTD</Keywords>
      <Keywords>Diabetes mellitus</Keywords>
      <Keywords>Eryptosis</Keywords>
      <Keywords>Glycated hemoglobin</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>PS externalization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Swamy Jagadish</Name>
        <Affiliation>Department of Studies in Biochemistry, University of Mysore, Manasagangotri, Mysuru 570 006, India; Department of Studies in Chemistry, University of Mysore, Manasagangotri, Mysuru 570 006, India.</Affiliation>
      </Author>
      <Author>
        <Name>Mahadevappa Hemshekhar</Name>
        <Affiliation>Department of Studies in Biochemistry, University of Mysore, Manasagangotri, Mysuru 570 006, India.</Affiliation>
      </Author>
      <Author>
        <Name>Somanathapura K. NaveenKumar</Name>
        <Affiliation>Department of Studies in Biochemistry, University of Mysore, Manasagangotri, Mysuru 570 006, India.</Affiliation>
      </Author>
      <Author>
        <Name>Kothanahally S. Sharath Kumar</Name>
        <Affiliation>Department of Studies in Chemistry, University of Mysore, Manasagangotri, Mysuru 570 006, India.</Affiliation>
      </Author>
      <Author>
        <Name>Mahalingam S. Sundaram</Name>
        <Affiliation>Department of Studies in Biochemistry, University of Mysore, Manasagangotri, Mysuru 570 006, India.</Affiliation>
      </Author>
      <Author>
        <Name> Basappa</Name>
        <Affiliation>Department of Studies in Organic Chemistry, University of Mysore, Manasagangotri, Mysuru 570 006, India.</Affiliation>
      </Author>
      <Author>
        <Name>Kesturu S. Girish</Name>
        <Affiliation>Department of Studies in Biochemistry, University of Mysore, Manasagangotri, Mysuru 570 006, India; Department of Studies and Research in Biochemistry, Tumkur University, Tumakuru 572 103, India. Electronic address: ksgbaboo@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kanchugarakoppal S. Rangappa</Name>
        <Affiliation>Department of Studies in Chemistry, University of Mysore, Manasagangotri, Mysuru 570 006, India; Institute of Excellence, Vijnana Bhavan, University of Mysore, Manasagangotri, Mysuru 570 006, India. Electronic address: rangappaks@chemistry.uni-mysore.ac.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Sex-specific effects of developmental lead exposure on the immune-neuroendocrine network.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28911972</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30381-2</DOI>
    <AuthorList>
      <Author>
        <Name>Jane Kasten-Jolly</Name>
        <Affiliation>Wadsworth Center, New York State Department of Health University at Albany School of Public Health, Albany, NY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>David A. Lawrence</Name>
        <Affiliation>Wadsworth Center, New York State Department of Health University at Albany School of Public Health, Albany, NY, United States; Department of Environmental Health Sciences, University at Albany School of Public Health, Albany, NY, United States. Electronic address: david.lawrence@health.ny.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Downregulation of UBE2E2 in rat liver cells after hepatocarcinogen treatment facilitates cell proliferation and slowing down of DNA damage response in GST-P-expressing preneoplastic lesions.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28899750</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30377-0</DOI>
    <KeywordList>
      <Keywords>Carcinogenesis</Keywords>
      <Keywords>Glutathione S-transferase placental form (GST-P)</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Thioacetamide (TAA)</Keywords>
      <Keywords>Ubiquitin-conjugating enzyme E2E 2 (UBE2E2)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sayaka Mizukami</Name>
        <Affiliation>Laboratory of Veterinary Pathology, Division of Animal Life Science, Institute of Agriculture, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shi, Tokyo 183-8509, Japan; Pathogenetic Veterinary Science, United Graduate School of Veterinary Sciences, Gifu University, 1-1 Yanagido, Gifu-shi, Gifu 501-1193, Japan. Electronic address: smizuka@cc.tuat.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Yousuke Watanabe</Name>
        <Affiliation>Laboratory of Veterinary Pathology, Division of Animal Life Science, Institute of Agriculture, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shi, Tokyo 183-8509, Japan; Pathogenetic Veterinary Science, United Graduate School of Veterinary Sciences, Gifu University, 1-1 Yanagido, Gifu-shi, Gifu 501-1193, Japan. Electronic address: ywatana@cc.tuat.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Yukie Saegusa</Name>
        <Affiliation>Environment Health and Safety Division, Environment Directorate, OECD, 2, rue André Pascal, 75775 Paris, Cedex 16, France. Electronic address: Yukie.SAEGUSA@oecd.org.</Affiliation>
      </Author>
      <Author>
        <Name>Kota Nakajima</Name>
        <Affiliation>Laboratory of Veterinary Pathology, Division of Animal Life Science, Institute of Agriculture, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shi, Tokyo 183-8509, Japan; Pathogenetic Veterinary Science, United Graduate School of Veterinary Sciences, Gifu University, 1-1 Yanagido, Gifu-shi, Gifu 501-1193, Japan. Electronic address: knakaji@m2.tuat.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Yuko Ito</Name>
        <Affiliation>Laboratory of Veterinary Pathology, Division of Animal Life Science, Institute of Agriculture, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shi, Tokyo 183-8509, Japan; Pathogenetic Veterinary Science, United Graduate School of Veterinary Sciences, Gifu University, 1-1 Yanagido, Gifu-shi, Gifu 501-1193, Japan. Electronic address: yitoh@m2.tuat.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Yasunori Masubuchi</Name>
        <Affiliation>Laboratory of Veterinary Pathology, Division of Animal Life Science, Institute of Agriculture, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shi, Tokyo 183-8509, Japan; Pathogenetic Veterinary Science, United Graduate School of Veterinary Sciences, Gifu University, 1-1 Yanagido, Gifu-shi, Gifu 501-1193, Japan. Electronic address: y-masubuchi@m2.tuat.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Toshinori Yoshida</Name>
        <Affiliation>Laboratory of Veterinary Pathology, Division of Animal Life Science, Institute of Agriculture, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shi, Tokyo 183-8509, Japan. Electronic address: yoshida7@cc.tuat.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Makoto Shibutani</Name>
        <Affiliation>Laboratory of Veterinary Pathology, Division of Animal Life Science, Institute of Agriculture, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shi, Tokyo 183-8509, Japan; Institute of Global Innovation Research, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shi, Tokyo 183-8509, Japan. Electronic address: mshibuta@cc.tuat.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>CYP4A/CYP2C modulation of the interaction of calcium channel blockers with cyclosporine on EDHF-mediated renal vasodilations in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28899749</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30379-4</DOI>
    <KeywordList>
      <Keywords>Blood pressure</Keywords>
      <Keywords>Calcium channel blockers</Keywords>
      <Keywords>Cyclosporine</Keywords>
      <Keywords>Cytochrome P450</Keywords>
      <Keywords>Endothelium-derived hyperpolarizing factor</Keywords>
      <Keywords>Renal vasodilations</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Safaa H. Hammoud</Name>
        <Affiliation>Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Beirut Arab University, Lebanon.</Affiliation>
      </Author>
      <Author>
        <Name>Amal G. Omar</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Assaad A. Eid</Name>
        <Affiliation>Department of Anatomy, Cell Biology and Physiology, Faculty of Medicine, American University of Beirut, Lebanon. Electronic address: ae49@aub.edu.lb.</Affiliation>
      </Author>
      <Author>
        <Name>Mahmoud M. El-Mas</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Egypt. Electronic address: mahelm@hotmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Current nonclinical testing paradigm enables safe entry to First-In-Human clinical trials: The IQ consortium nonclinical to clinical translational database.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28893587</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30378-2</DOI>
    <KeywordList>
      <Keywords>Animal testing</Keywords>
      <Keywords>Clinical</Keywords>
      <Keywords>Concordance</Keywords>
      <Keywords>Nonclinical</Keywords>
      <Keywords>Safety</Keywords>
      <Keywords>Translational</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Thomas M. Monticello</Name>
        <Affiliation>Comparative Biology and Safety Sciences, Amgen, Thousand Oaks, CA 91320, USA. Electronic address: tmontice@amgen.com.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas W. Jones</Name>
        <Affiliation>Eli Lilly and Company, Indianapolis, IN 46285, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Donna M. Dambach</Name>
        <Affiliation>Safety Assessment, Genentech, South San Francisco, CA 92056, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David M. Potter</Name>
        <Affiliation>Drug Safety Research and Development, Pfizer, Groton, CT 06340, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael W. Bolt</Name>
        <Affiliation>Drug Safety Research and Development, Pfizer, Cambridge, MA 02139, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Maggie Liu</Name>
        <Affiliation>IQ Consortium, Washington, DC 20005, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Douglas A. Keller</Name>
        <Affiliation>Preclinical Safety, Sanofi, Bridgewater, NJ 08807, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy K. Hart</Name>
        <Affiliation>GlaxoSmithKline, King of Prussia, PA 19406, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Vivek J. Kadambi</Name>
        <Affiliation>Nonclinical Development Sciences, Blueprint Medicines, Cambridge, MA 02139, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of diisononyl phthalate on osteopenia in intact mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28893586</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30355-1</DOI>
    <KeywordList>
      <Keywords>Bone loss</Keywords>
      <Keywords>Diisononyl phthalate</Keywords>
      <Keywords>Endocrine disrupting chemical</Keywords>
      <Keywords>Environmental pollutant</Keywords>
      <Keywords>Osteoporosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yun Ho Hwang</Name>
        <Affiliation>College of Pharmacy, Sunchon National University, 255 Jungangno, Suncheon, 540-950, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Young Jin Son</Name>
        <Affiliation>College of Pharmacy, Sunchon National University, 255 Jungangno, Suncheon, 540-950, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Man Jeong Paik</Name>
        <Affiliation>College of Pharmacy, Sunchon National University, 255 Jungangno, Suncheon, 540-950, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sung Tae Yee</Name>
        <Affiliation>College of Pharmacy, Sunchon National University, 255 Jungangno, Suncheon, 540-950, Republic of Korea; Suncheon Research Center for Natural Medicines, Suncheon, Republic of Korea. Electronic address: sungtae@sunchon.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Impaired autophagic flux and p62-mediated EMT are involved in arsenite-induced transformation of L-02 cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28888487</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30370-8</DOI>
    <KeywordList>
      <Keywords>Arsenite</Keywords>
      <Keywords>Autophagic flux</Keywords>
      <Keywords>EMT</Keywords>
      <Keywords>Transformation</Keywords>
      <Keywords>p62</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xinlu Liu</Name>
        <Affiliation>Institute of Toxicology, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Min Ling</Name>
        <Affiliation>Jiangsu Center for Disease Control and Prevention, Nanjing 210009, Jiangsu, People's Republic China.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Chen</Name>
        <Affiliation>Institute of Toxicology, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Fei Luo</Name>
        <Affiliation>Institute of Toxicology, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Yang</Name>
        <Affiliation>School of Public Health, Institute for Chemical Carcinogenesis, Guangzhou Medical University, Guangzhou 510182, Guangdong, People's Republic China.</Affiliation>
      </Author>
      <Author>
        <Name>Dapeng Wang</Name>
        <Affiliation>The Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, School of Public Health, Guizhou Medical University, Guiyang 550025, Guizhou, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiong Chen</Name>
        <Affiliation>The Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, School of Public Health, Guizhou Medical University, Guiyang 550025, Guizhou, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Xu</Name>
        <Affiliation>Institute of Toxicology, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Junchao Xue</Name>
        <Affiliation>Institute of Toxicology, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Qianlei Yang</Name>
        <Affiliation>Institute of Toxicology, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Lu</Name>
        <Affiliation>Institute of Toxicology, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiachun Lu</Name>
        <Affiliation>School of Public Health, Institute for Chemical Carcinogenesis, Guangzhou Medical University, Guangzhou 510182, Guangdong, People's Republic China.</Affiliation>
      </Author>
      <Author>
        <Name>Qian Bian</Name>
        <Affiliation>Jiangsu Center for Disease Control and Prevention, Nanjing 210009, Jiangsu, People's Republic China.</Affiliation>
      </Author>
      <Author>
        <Name>Aihua Zhang</Name>
        <Affiliation>The Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, School of Public Health, Guizhou Medical University, Guiyang 550025, Guizhou, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Qizhan Liu</Name>
        <Affiliation>Institute of Toxicology, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China. Electronic address: qzliu@njmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Prostacyclin mimetics afford protection against lipopolysaccharide/d-galactosamine-induced acute liver injury in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28887131</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30369-1</DOI>
    <KeywordList>
      <Keywords>Acute liver failure</Keywords>
      <Keywords>Hepatoprotection</Keywords>
      <Keywords>IP receptor</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
      <Keywords>Signal transducers and activators of transcription</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hiroki Misawa</Name>
        <Affiliation>Department of Molecular and Medical Pharmacology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan; Department of Japanese Oriental Medicine, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Wakana Ohashi</Name>
        <Affiliation>Department of Molecular and Medical Pharmacology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kengo Tomita</Name>
        <Affiliation>Department of Molecular and Medical Pharmacology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kohshi Hattori</Name>
        <Affiliation>Department of Anesthesiology and Pain Relief Center, The University of Tokyo Hospital, Tokyo, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yutaka Shimada</Name>
        <Affiliation>Department of Japanese Oriental Medicine, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuichi Hattori</Name>
        <Affiliation>Department of Molecular and Medical Pharmacology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan. Electronic address: yhattori@med.u-toyama.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Gender-specific impairment of in vitro sinoatrial node chronotropic responses and of myocardial ischemia tolerance in rats exposed prenatally to betamethasone.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28887130</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30368-X</DOI>
    <KeywordList>
      <Keywords>Adenosine</Keywords>
      <Keywords>Betamethasone</Keywords>
      <Keywords>Fetal programming</Keywords>
      <Keywords>Infarct</Keywords>
      <Keywords>Ischemia</Keywords>
      <Keywords>Sinoatrial node</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>L. R. A. Kiguti</Name>
        <Affiliation>Department of Pharmacology, São Paulo State University (UNESP), Institute of Biosciences, Campus of Botucatu, Distrito de Rubião Junior s/n°, 18618-689 Botucatu, SP, Brazil. Electronic address: luizkiguti@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>C. S. Borges</Name>
        <Affiliation>Department of Morphology, São Paulo State University (UNESP), Institute of Biosciences, Campus of Botucatu, Distrito de Rubião Junior s/n°, 18618-689 Botucatu, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>A. Mueller</Name>
        <Affiliation>Department of Pharmacology, São Paulo State University (UNESP), Institute of Biosciences, Campus of Botucatu, Distrito de Rubião Junior s/n°, 18618-689 Botucatu, SP, Brazil; Instituto de Ciências da Saúde, Federal University of Mato Grosso, Sinop, MT, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>K. P. Silva</Name>
        <Affiliation>Department of Pharmacology, São Paulo State University (UNESP), Institute of Biosciences, Campus of Botucatu, Distrito de Rubião Junior s/n°, 18618-689 Botucatu, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>C. M. Polo</Name>
        <Affiliation>Department of Physiology, São Paulo State University (UNESP), Institute of Biosciences, Campus of Botucatu, Distrito de Rubião Junior s/n°, 18618-689 Botucatu, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>J. L. Rosa</Name>
        <Affiliation>Department of Morphology, São Paulo State University (UNESP), Institute of Biosciences, Campus of Botucatu, Distrito de Rubião Junior s/n°, 18618-689 Botucatu, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>P. V. Silva</Name>
        <Affiliation>Department of Morphology, São Paulo State University (UNESP), Institute of Biosciences, Campus of Botucatu, Distrito de Rubião Junior s/n°, 18618-689 Botucatu, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>G. Missassi</Name>
        <Affiliation>Department of Morphology, São Paulo State University (UNESP), Institute of Biosciences, Campus of Botucatu, Distrito de Rubião Junior s/n°, 18618-689 Botucatu, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>L. Valencise</Name>
        <Affiliation>Department of Morphology, São Paulo State University (UNESP), Institute of Biosciences, Campus of Botucatu, Distrito de Rubião Junior s/n°, 18618-689 Botucatu, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>W. G. Kempinas</Name>
        <Affiliation>Department of Morphology, São Paulo State University (UNESP), Institute of Biosciences, Campus of Botucatu, Distrito de Rubião Junior s/n°, 18618-689 Botucatu, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>A. S. Pupo</Name>
        <Affiliation>Department of Pharmacology, São Paulo State University (UNESP), Institute of Biosciences, Campus of Botucatu, Distrito de Rubião Junior s/n°, 18618-689 Botucatu, SP, Brazil.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Zinc chloride rapidly stimulates efflux transporters in renal proximal tubules of killifish (Fundulus heteroclitus).</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28882485</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30367-8</DOI>
    <KeywordList>
      <Keywords>Drug efflux</Keywords>
      <Keywords>Multidrug resistance-related protein 2 (Mrp2)</Keywords>
      <Keywords>Renal proximal tubules</Keywords>
      <Keywords>Signaling pathways</Keywords>
      <Keywords>Transport regulation</Keywords>
      <Keywords>ZnCl(2)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alexander Zaremba</Name>
        <Affiliation>Institute of Pharmacy and Molecular Biotechnology, University of Heidelberg, 69120 Heidelberg, Germany; Mount Desert Island Biological Laboratory, Salisbury Cove, ME 04672, United States.</Affiliation>
      </Author>
      <Author>
        <Name>David S. Miller</Name>
        <Affiliation>Mount Desert Island Biological Laboratory, Salisbury Cove, ME 04672, United States; Laboratory of Toxicology and Pharmacology, NIH/National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Gert Fricker</Name>
        <Affiliation>Institute of Pharmacy and Molecular Biotechnology, University of Heidelberg, 69120 Heidelberg, Germany; Mount Desert Island Biological Laboratory, Salisbury Cove, ME 04672, United States. Electronic address: gert.fricker@uni-hd.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A two-step model of TiO</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28870656</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30352-6</DOI>
    <KeywordList>
      <Keywords>Cell cycle</Keywords>
      <Keywords>Cell-response model</Keywords>
      <Keywords>Nanotoxicology</Keywords>
      <Keywords>PBPK model</Keywords>
      <Keywords>TiO(2) nanoparticles</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>T. Laomettachit</Name>
        <Affiliation>Bioinformatics and Systems Biology Program, School of Bioresources and Technology, King Mongkut's University of Technology Thonburi, Bangkok 10150, Thailand; Theoretical and Computational Physics (TCP) Group, King Mongkut's University of Technology Thonburi, Bangkok 10150, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>I. K. Puri</Name>
        <Affiliation>Department of Mechanical Engineering, McMaster University, Hamilton, ON L8S 4L7, Canada; School of Biomedical Engineering, McMaster University, Hamilton, ON L8S 4L7, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>M. Liangruksa</Name>
        <Affiliation>National Nanotechnology Center (NANOTEC), National Science and Technology Development Agency, 111 Thailand Science Park, Phahonyothin Road, Khlong Nueng, Khlong Luang, Pathum Thani 12120, Thailand. Electronic address: monrudee@nanotec.or.th.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparative health effects in mice of Libby amphibole asbestos and a fibrous amphibole from Arizona.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28870655</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30366-6</DOI>
    <KeywordList>
      <Keywords>Amphibole</Keywords>
      <Keywords>Asbestos</Keywords>
      <Keywords>Autoantibodies</Keywords>
      <Keywords>Lung fibrosis</Keywords>
      <Keywords>Pleural fibrosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jean C. Pfau</Name>
        <Affiliation>Department of Microbiology and Immunology, Montana State University, Bozeman, MT 59717, USA. Electronic address: jean.pfau@montana.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Brenda Buck</Name>
        <Affiliation>Department of Geoscience, University of Nevada Las Vegas, Las Vegas, NV 89154, USA. Electronic address: buckb@unlv.nevada.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Rodney V. Metcalf</Name>
        <Affiliation>Department of Geoscience, University of Nevada Las Vegas, Las Vegas, NV 89154, USA. Electronic address: metcalfr@unlv.nevada.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Zoie Kaupish</Name>
        <Affiliation>Department of Microbiology and Immunology, Montana State University, Bozeman, MT 59717, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Caleb Stair</Name>
        <Affiliation>Department of Microbiology and Immunology, Montana State University, Bozeman, MT 59717, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Rodriguez</Name>
        <Affiliation>Department of Microbiology and Immunology, Montana State University, Bozeman, MT 59717, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Deborah E. Keil</Name>
        <Affiliation>Department of Microbiology and Immunology, Montana State University, Bozeman, MT 59717, USA. Electronic address: Deborah.keil@montana.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Neuromuscular paralysis by the basic phospholipase A</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28867438</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30365-4</DOI>
    <KeywordList>
      <Keywords>Crotalinea Snake Venom</Keywords>
      <Keywords>Crotalus durissus terrificus</Keywords>
      <Keywords>Neuromuscular transmission</Keywords>
      <Keywords>Phospholipase A(2)</Keywords>
      <Keywords>Real-time transmitter exocytosis</Keywords>
      <Keywords>[(3)H]-Acetylcholine Release</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Walter L. G. Cavalcante</Name>
        <Affiliation>Departamento de Farmacologia, Instituto de Ciências Biológicas, UFMG, Av. Antônio Carlos, 6627 Belo Horizonte, Brazil; Laboratório de Farmacologia e Neurobiologia, Instituto de Ciências Biomédicas Abel Salazar - Universidade do Porto (ICBAS-UP), R. Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal; Departamento de Física e Biofísica, Instituto de Biociências, UNESP, Distrito de Rubião Jr., Botucatu, 18618-970, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>José B. Noronha-Matos</Name>
        <Affiliation>Laboratório de Farmacologia e Neurobiologia, Instituto de Ciências Biomédicas Abel Salazar - Universidade do Porto (ICBAS-UP), R. Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal; Center for Drug Discovery and Innovative Medicines (MedInUP), Instituto de Ciências Biomédicas Abel Salazar - Universidade do Porto (ICBAS-UP), R. Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Maria A. Timóteo</Name>
        <Affiliation>Laboratório de Farmacologia e Neurobiologia, Instituto de Ciências Biomédicas Abel Salazar - Universidade do Porto (ICBAS-UP), R. Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal; Center for Drug Discovery and Innovative Medicines (MedInUP), Instituto de Ciências Biomédicas Abel Salazar - Universidade do Porto (ICBAS-UP), R. Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Marcos R. M. Fontes</Name>
        <Affiliation>Departamento de Física e Biofísica, Instituto de Biociências, UNESP, Distrito de Rubião Jr., Botucatu, 18618-970, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Márcia Gallacci</Name>
        <Affiliation>Departamento de Farmacologia, Instituto de Biociências, UNESP, Distrito de Rubião Jr., Botucatu, 18618-970, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Paulo Correia-de-Sá</Name>
        <Affiliation>Laboratório de Farmacologia e Neurobiologia, Instituto de Ciências Biomédicas Abel Salazar - Universidade do Porto (ICBAS-UP), R. Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal; Center for Drug Discovery and Innovative Medicines (MedInUP), Instituto de Ciências Biomédicas Abel Salazar - Universidade do Porto (ICBAS-UP), R. Jorge Viterbo Ferreira, 228, 4050-313 Porto, Portugal. Electronic address: farmacol@icbas.up.pt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Quinacrine induces the apoptosis of human leukemia U937 cells through FOXP3/miR-183/β-TrCP/SP1 axis-mediated BAX upregulation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28867437</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30353-8</DOI>
    <KeywordList>
      <Keywords>BAX upregulation</Keywords>
      <Keywords>ERK</Keywords>
      <Keywords>FOXP3/miR-183/β-TrCP/SP1 axis</Keywords>
      <Keywords>Quinacrine</Keywords>
      <Keywords>p38 MAPK</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chia Hui Huang</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Chin Lee</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Jung Chen</Name>
        <Affiliation>Department of Fragrance and Cosmetic Science, Kaohsiung Medical University, Kaohsiung 807, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Liang Jun Wang</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Jun Shi</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Long Sen Chang</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan; Department of Biotechnology, Kaohsiung Medical University, Kaohsiung 807, Taiwan. Electronic address: lschang@mail.nsysu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of diosmetin on nine cytochrome P450 isoforms, UGTs and three drug transporters in vitro.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28867436</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30364-2</DOI>
    <KeywordList>
      <Keywords>Cytochrome P450</Keywords>
      <Keywords>Diosmetin</Keywords>
      <Keywords>Drug-drug interactions</Keywords>
      <Keywords>Hepatic uptake transporters</Keywords>
      <Keywords>UDP-glucuronyltransferases</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jun Jun Chen</Name>
        <Affiliation>Department of Pharmacy, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, 600 Yi Shan Road, Shanghai 200233, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Xian Zhang</Name>
        <Affiliation>Department of Pharmacy, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, 600 Yi Shan Road, Shanghai 200233, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiang Qi Zhang</Name>
        <Affiliation>Department of Pharmacy, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, 600 Yi Shan Road, Shanghai 200233, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mei Juan Qi</Name>
        <Affiliation>College of Food Science and Technology, Shanghai Ocean University, 999 Hucheng Huan Road, Shanghai 201306, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mei Zhi Shi</Name>
        <Affiliation>Department of Pharmacy, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, 600 Yi Shan Road, Shanghai 200233, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiao Yang</Name>
        <Affiliation>Department of Pharmacy, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, 600 Yi Shan Road, Shanghai 200233, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ke Zhi Zhang</Name>
        <Affiliation>State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University, 220 Handan Road, Shanghai 200433, China; KG Pharma Limited, Floor 2, Building 3, No. 5-13 Wuhua Road, Chancheng, Foshan 528000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cheng Guo</Name>
        <Affiliation>Department of Pharmacy, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, 600 Yi Shan Road, Shanghai 200233, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Long Han</Name>
        <Affiliation>Department of Pharmacy, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, 600 Yi Shan Road, Shanghai 200233, China. Electronic address: yonglongh@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A cell impedance-based real-time in vitro assay to assess the toxicity of amphotericin B formulations.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28865757</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30356-3</DOI>
    <KeywordList>
      <Keywords>Cell impedance</Keywords>
      <Keywords>Gene expression</Keywords>
      <Keywords>In vitro assay</Keywords>
      <Keywords>Liposomal amphotericin B</Keywords>
      <Keywords>Proinflammatory cytokines</Keywords>
      <Keywords>Real-time</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jean Menotti</Name>
        <Affiliation>Institut Pasteur, CNRS, Molecular Mycology unit, URA3012 Paris, France; Laboratory of Parasitology-Mycology, Saint-Louis Lariboisière Fernand Widal hospitals, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; Paris-Diderot, Sorbonne Paris Cité University, Paris, France; Laboratory of Parasitology-Mycology, Croix-Rousse Hospital, Hospices Civils de Lyon, Université Claude Bernard - Lyon 1, Lyon, France. Electronic address: jean.menotti@univ-lyon1.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Alexandre Alanio</Name>
        <Affiliation>Institut Pasteur, CNRS, Molecular Mycology unit, URA3012 Paris, France; Laboratory of Parasitology-Mycology, Saint-Louis Lariboisière Fernand Widal hospitals, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; Paris-Diderot, Sorbonne Paris Cité University, Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>Aude Sturny-Leclère</Name>
        <Affiliation>Institut Pasteur, CNRS, Molecular Mycology unit, URA3012 Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>Sandrine Vitry</Name>
        <Affiliation>Viral Neuroimmunology unit, CNRS UMR 3569, Pasteur Institute, Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>Félix Sauvage</Name>
        <Affiliation>CNRS UMR8612, Faculty of Pharmacy, Univ. Paris-Sud, Châtenay-Malabry, France.</Affiliation>
      </Author>
      <Author>
        <Name>Gillian Barratt</Name>
        <Affiliation>CNRS UMR8612, Faculty of Pharmacy, Univ. Paris-Sud, Châtenay-Malabry, France.</Affiliation>
      </Author>
      <Author>
        <Name>Stéphane Bretagne</Name>
        <Affiliation>Institut Pasteur, CNRS, Molecular Mycology unit, URA3012 Paris, France; Laboratory of Parasitology-Mycology, Saint-Louis Lariboisière Fernand Widal hospitals, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; Paris-Diderot, Sorbonne Paris Cité University, Paris, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Diethylcarbamazine: A potential treatment drug for pulmonary hypertension?</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28851623</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30354-X</DOI>
    <KeywordList>
      <Keywords>Diethylcarbamazine</Keywords>
      <Keywords>Hypertension</Keywords>
      <Keywords>Monocrotaline</Keywords>
      <Keywords>Pulmonary apoptosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Edlene Lima Ribeiro</Name>
        <Affiliation>Laboratory of Ultrastructure, Aggeu Magalhães Research Center - CPqAM, Pernambuco, Brazil; Federal University of Pernambuco, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ingrid Tavares Fragoso</Name>
        <Affiliation>Laboratory of Ultrastructure, Aggeu Magalhães Research Center - CPqAM, Pernambuco, Brazil; Federal University of Pernambuco, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Fabiana Oliveira Dos Santos Gomes</Name>
        <Affiliation>Laboratory of Ultrastructure, Aggeu Magalhães Research Center - CPqAM, Pernambuco, Brazil; Federal University of Pernambuco, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Amanda Costa Oliveira</Name>
        <Affiliation>Laboratory of Ultrastructure, Aggeu Magalhães Research Center - CPqAM, Pernambuco, Brazil; Federal University of Pernambuco, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Amanda Karoline Soares E. Silva</Name>
        <Affiliation>Laboratory of Ultrastructure, Aggeu Magalhães Research Center - CPqAM, Pernambuco, Brazil; Federal University of Pernambuco, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Patrícia Martins E. Silva</Name>
        <Affiliation>Laboratory of Inflammation, FIOCRUZ, Rio de Janeiro, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Bianca Torres Ciambarella</Name>
        <Affiliation>Laboratory of Inflammation, FIOCRUZ, Rio de Janeiro, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Isalira Peroba Rezende Ramos</Name>
        <Affiliation>National Center Structural Biology and Bio-imaging, Carlos Chagas Filho Biophysics Institute, Department of Radiology, University Hospital Clementino Fraga Filho, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Christina Alves Peixoto</Name>
        <Affiliation>Laboratory of Ultrastructure, Aggeu Magalhães Research Center - CPqAM, Pernambuco, Brazil. Electronic address: cpeixoto@cpqam.fiocruz.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nano-sized titanium dioxide toxicity in rat prostate and testis: Possible ameliorative effect of morin.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28844848</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30351-4</DOI>
    <KeywordList>
      <Keywords>Morin</Keywords>
      <Keywords>Nano-sized titanium dioxide</Keywords>
      <Keywords>Prostate</Keywords>
      <Keywords>Spermatogenesis</Keywords>
      <Keywords>Steroidogenesis</Keywords>
      <Keywords>Testis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nancy N. Shahin</Name>
        <Affiliation>Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt. Electronic address: nancy.shahin@pharma.cu.edu.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Maha M. Mohamed</Name>
        <Affiliation>Department of Home Economics, Faculty of Women for Arts, Science and Education, Ain Shams University, Cairo, Egypt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chronic alcohol consumption regulates the expression of poly immunoglobulin receptor (pIgR) and secretory IgA in the gut.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28843478</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30350-2</DOI>
    <KeywordList>
      <Keywords>Chronic alcohol consumption</Keywords>
      <Keywords>Cytokines</Keywords>
      <Keywords>Dendritic cells</Keywords>
      <Keywords>IgA</Keywords>
      <Keywords>Macrophages</Keywords>
      <Keywords>Poly-immunoglobulin receptor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>María C. López</Name>
        <Affiliation>Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, 120 New Scotland Ave., Albany, NY 12208, USA. Electronic address: maria.lopez@health.ny.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Central administration of tert-butylhydroquinone attenuates hypertension via regulating Nrf2 signaling in the hypothalamic paraventricular nucleus of hypertensive rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28842207</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30349-6</DOI>
    <KeywordList>
      <Keywords>Hypertension</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Paraventricular nucleus</Keywords>
      <Keywords>Tert-butylhydroquinone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Juan Bai</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Jing Yu</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education, Xi'an 710061, China. Electronic address: yuxiaojing@mail.xjtu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Kai Li Liu</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fang Fang Wang</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Gui Xia Jing</Name>
        <Affiliation>Department of Anesthesiology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Bao Li</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Zhang</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chan Juan Huo</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiang Li</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Li Gao</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Qi</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Ming Kang</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Key Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education, Xi'an 710061, China. Electronic address: ykang@mail.xjtu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effect of low-dose zearalenone exposure on reproductive capacity of male mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28837831</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30348-4</DOI>
    <KeywordList>
      <Keywords>Semen quality</Keywords>
      <Keywords>Spermatogenesis</Keywords>
      <Keywords>Zearalenone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jian Pang</Name>
        <Affiliation>Department of Urology, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing 400042, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qingsong Zhou</Name>
        <Affiliation>Department of Urology, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing 400042, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaofeng Sun</Name>
        <Affiliation>Institute of Reproductive Sciences, College of Life Sciences, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lan Li</Name>
        <Affiliation>Institute of Reproductive Sciences, College of Life Sciences, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Zhou</Name>
        <Affiliation>Department of Urology, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing 400042, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fanchun Zeng</Name>
        <Affiliation>Department of Urology, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing 400042, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Zhao</Name>
        <Affiliation>Institute of Reproductive Sciences, College of Life Sciences, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Shen</Name>
        <Affiliation>Institute of Reproductive Sciences, College of Life Sciences, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhongyi Sun</Name>
        <Affiliation>Department of Urology, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing 400042, China. Electronic address: sunzhongyi1001@hotmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicity evaluation of two polyoxotungstates with anti-acetylcholinesterase activity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28830837</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30347-2</DOI>
    <KeywordList>
      <Keywords>Acetylcholinesterase</Keywords>
      <Keywords>Biochemical parameters</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Histopathological analysis</Keywords>
      <Keywords>Polyoxometalates</Keywords>
      <Keywords>Renal function</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mirjana B. Čolović</Name>
        <Affiliation>Department of Physical Chemistry, "Vinča" Institute of Nuclear Sciences, University of Belgrade, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Branislava Medić</Name>
        <Affiliation>Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Mila Ćetković</Name>
        <Affiliation>Institute of Histology and Embryology, Faculty of Medicine, University of Belgrade, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Tamara Kravić Stevović</Name>
        <Affiliation>Institute of Histology and Embryology, Faculty of Medicine, University of Belgrade, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Marko Stojanović</Name>
        <Affiliation>Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Wassim W. Ayass</Name>
        <Affiliation>Department of Life Sciences and Chemistry, Jacobs University, Bremen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Ali S. Mougharbel</Name>
        <Affiliation>Department of Life Sciences and Chemistry, Jacobs University, Bremen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Miroslav Radenković</Name>
        <Affiliation>Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Milica Prostran</Name>
        <Affiliation>Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, Serbia.</Affiliation>
      </Author>
      <Author>
        <Name>Ulrich Kortz</Name>
        <Affiliation>Department of Life Sciences and Chemistry, Jacobs University, Bremen, Germany. Electronic address: u.kortz@jacobs-university.de.</Affiliation>
      </Author>
      <Author>
        <Name>Danijela Z. Krstić</Name>
        <Affiliation>Institute of Medical Chemistry, Faculty of Medicine, University of Belgrade, Serbia. Electronic address: danijela.krstic@med.bg.ac.rs.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Autoimmune potential of perchloroethylene: Role of lipid-derived aldehydes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28818516</pubmedLink>
    <GrantList>
      <Grant>R21 ES023106</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30345-9</DOI>
    <KeywordList>
      <Keywords>Autoantibody</Keywords>
      <Keywords>Autoimmunity</Keywords>
      <Keywords>Lipid-derived aldehydes</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Perchloroethylene</Keywords>
      <Keywords>Th17 cell</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gangduo Wang</Name>
        <Affiliation>Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jianling Wang</Name>
        <Affiliation>Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation>
      </Author>
      <Author>
        <Name>G. A. Shakeel Ansari</Name>
        <Affiliation>Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation>
      </Author>
      <Author>
        <Name>M. Firoze Khan</Name>
        <Affiliation>Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA. Electronic address: mfkhan@utmb.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Integrative analysis of hepatic microRNA and mRNA to identify potential biological pathways associated with monocrotaline-induced liver injury in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28818515</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30344-7</DOI>
    <KeywordList>
      <Keywords>Integrative analysis</Keywords>
      <Keywords>Liver injury</Keywords>
      <Keywords>Monocrotaline</Keywords>
      <Keywords>Phagosome</Keywords>
      <Keywords>mRNA</Keywords>
      <Keywords>miRNA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhenlin Huang</Name>
        <Affiliation>Shanghai Key Laboratory for Complex Prescription, MOE Key Laboratory for Standardization of Chinese Medicines, and SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Minwei Chen</Name>
        <Affiliation>Shanghai Key Laboratory for Complex Prescription, MOE Key Laboratory for Standardization of Chinese Medicines, and SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiaqi Zhang</Name>
        <Affiliation>Shanghai Key Laboratory for Complex Prescription, MOE Key Laboratory for Standardization of Chinese Medicines, and SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuchen Sheng</Name>
        <Affiliation>Center for Drug Safety Evaluation and Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lili Ji</Name>
        <Affiliation>Shanghai Key Laboratory for Complex Prescription, MOE Key Laboratory for Standardization of Chinese Medicines, and SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Electronic address: jilili@shutcm.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of low-dose irradiation on mice with Escherichia coli-induced sepsis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28818514</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30343-5</DOI>
    <KeywordList>
      <Keywords>Antioxidant</Keywords>
      <Keywords>Immune response</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Low-dose irradiation</Keywords>
      <Keywords>Sepsis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kyung Hee Song</Name>
        <Affiliation>Division of Applied Radiation Bioscience, Korea Institute of Radiological &amp; Medical Sciences, 75 Nowon-ro, Nowon-gu, Seoul 01812, Republic of Korea; Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul 03760, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Youn Jung</Name>
        <Affiliation>Division of Applied Radiation Bioscience, Korea Institute of Radiological &amp; Medical Sciences, 75 Nowon-ro, Nowon-gu, Seoul 01812, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seong Ho Kho</Name>
        <Affiliation>Division of Applied Radiation Bioscience, Korea Institute of Radiological &amp; Medical Sciences, 75 Nowon-ro, Nowon-gu, Seoul 01812, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sang Gu Hwang</Name>
        <Affiliation>Division of Applied Radiation Bioscience, Korea Institute of Radiological &amp; Medical Sciences, 75 Nowon-ro, Nowon-gu, Seoul 01812, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hunjoo Ha</Name>
        <Affiliation>Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul 03760, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seon Young Nam</Name>
        <Affiliation>Low-Dose Radiation Research Team, Radiation Health Institute, Korea Hydro &amp; Nuclear Power Co., Ltd., Seoul 01450, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Young Song</Name>
        <Affiliation>Division of Applied Radiation Bioscience, Korea Institute of Radiological &amp; Medical Sciences, 75 Nowon-ro, Nowon-gu, Seoul 01812, Republic of Korea. Electronic address: immu@kirams.re.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28807765</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30340-X</DOI>
    <KeywordList>
      <Keywords>Cognitive function</Keywords>
      <Keywords>Dapagliflozin</Keywords>
      <Keywords>Mitochondrial function</Keywords>
      <Keywords>Obese-insulin resistance</Keywords>
      <Keywords>Synaptic plasticity</Keywords>
      <Keywords>Vildagliptin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Piangkwan Sa-Nguanmoo</Name>
        <Affiliation>Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Pongpan Tanajak</Name>
        <Affiliation>Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Sasiwan Kerdphoo</Name>
        <Affiliation>Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Thidarat Jaiwongkam</Name>
        <Affiliation>Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Wasana Pratchayasakul</Name>
        <Affiliation>Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Nipon Chattipakorn</Name>
        <Affiliation>Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Siriporn C. Chattipakorn</Name>
        <Affiliation>Neurophysiology Unit, Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai, Thailand; Department of Oral Biology and Diagnostic Sciences, Faculty of Dentistry, Chiang Mai University, Chiang Mai, Thailand. Electronic address: scchattipakorn@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Staphylococcal enterotoxin C2 mutant drives T lymphocyte activation through PI3K/mTOR and NF-ĸB signaling pathways.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28807764</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30342-3</DOI>
    <KeywordList>
      <Keywords>IL-2</Keywords>
      <Keywords>NF-ĸB</Keywords>
      <Keywords>PI3K</Keywords>
      <Keywords>Proliferation</Keywords>
      <Keywords>Staphylococcal enterotoxin C2</Keywords>
      <Keywords>mTOR</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xuanhe Fu</Name>
        <Affiliation>School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, 103 WenHua Road, Shenyang 110016, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Mingkai Xu</Name>
        <Affiliation>Institute of Applied Ecology, Chinese Academy of Sciences, 72 WenHua Road, Shenyang 110016, PR China. Electronic address: mkxu@iae.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Songyuan Yao</Name>
        <Affiliation>Institute of Applied Ecology, Chinese Academy of Sciences, 72 WenHua Road, Shenyang 110016, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Huiwen Zhang</Name>
        <Affiliation>Institute of Applied Ecology, Chinese Academy of Sciences, 72 WenHua Road, Shenyang 110016, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chenggang Zhang</Name>
        <Affiliation>Institute of Applied Ecology, Chinese Academy of Sciences, 72 WenHua Road, Shenyang 110016, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinghai Zhang</Name>
        <Affiliation>School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, 103 WenHua Road, Shenyang 110016, PR China. Electronic address: jinghaizhang@foxmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of 2,2',4,4'-tetrabromodiphenyl ether on neurobehavior and memory change and bcl-2, c-fos, grin1b and lingo1b gene expression in male zebrafish (Danio rerio).</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28807763</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30341-1</DOI>
    <KeywordList>
      <Keywords>Maze learning</Keywords>
      <Keywords>Memory testing</Keywords>
      <Keywords>Neurobehavioral changes</Keywords>
      <Keywords>Neurotoxicity</Keywords>
      <Keywords>PBDEs</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shukai Zheng</Name>
        <Affiliation>Department of Preventive Medicine, Shantou University Medical College, Shantou 515041, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Caixia Liu</Name>
        <Affiliation>Department of Preventive Medicine, Shantou University Medical College, Shantou 515041, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanhong Huang</Name>
        <Affiliation>Mental Health Center, Shantou University Medical College, North Taishan Road, Shantou, Guangdong Province 515065, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mian Bao</Name>
        <Affiliation>Department of Preventive Medicine, Shantou University Medical College, Shantou 515041, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanni Huang</Name>
        <Affiliation>Department of Preventive Medicine, Shantou University Medical College, Shantou 515041, Guangdong, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kusheng Wu</Name>
        <Affiliation>Department of Preventive Medicine, Shantou University Medical College, Shantou 515041, Guangdong, China. Electronic address: kswu@stu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>DHEA increases epithelial markers and decreases mesenchymal proteins in breast cancer cells and reduces xenograft growth.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28803991</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30338-1</DOI>
    <KeywordList>
      <Keywords>Anti-tumor activity</Keywords>
      <Keywords>Breast cancer</Keywords>
      <Keywords>Dehydroepiandrosterone</Keywords>
      <Keywords>EMT</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zaira Colín-Val</Name>
        <Affiliation>Departamento de Fisiología, Instituto Nacional de Cardiología "Ignacio Chávez", Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Viridiana Yazmín González-Puertos</Name>
        <Affiliation>Laboratorio de Bioenergética y Envejecimiento Celular, Departamento de Ciencias Biológicas y de la Salud, UAM-Iztapalapa, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Criselda Mendoza-Milla</Name>
        <Affiliation>Laboratorio de Biología Celular, Departamento de Fibrosis Pulmonar, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Erika Olivia Gómez</Name>
        <Affiliation>Universidad Autónoma de la Ciudad de México, Colegio de Ciencias y Humanidades, Plantel San Lorenzo Tezonco, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Claudia Huesca-Gómez</Name>
        <Affiliation>Departamento de Fisiología, Instituto Nacional de Cardiología "Ignacio Chávez", Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Rebeca López-Marure</Name>
        <Affiliation>Departamento de Fisiología, Instituto Nacional de Cardiología "Ignacio Chávez", Ciudad de México, Mexico. Electronic address: rebeca.lopez@cardiologia.org.mx.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>High doses of baicalin induces kidney injury and fibrosis through regulating TGF-β/Smad signaling pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28803990</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30339-3</DOI>
    <KeywordList>
      <Keywords>Baicalin</Keywords>
      <Keywords>Fibrosis</Keywords>
      <Keywords>Kidney injury</Keywords>
      <Keywords>TGF-β/Smad signaling pathway</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yi Cai</Name>
        <Affiliation>Center of Pharmaceutical Research and Development, Guangzhou Medical University, Guangdong 511436, PR China; The Fifth Affiliated Hospital, Guangzhou Medical University. Guangzhou, Guangdong 511436, PR China. Electronic address: 2012990019@gzhmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Wanqing Ma</Name>
        <Affiliation>Center of Pharmaceutical Research and Development, Guangzhou Medical University, Guangdong 511436, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yichuan Xiao</Name>
        <Affiliation>Department of Pharmacology, Guangzhou Medical University, Guangzhou, Guangdong 511436, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Wu</Name>
        <Affiliation>Center of Pharmaceutical Research and Development, Guangzhou Medical University, Guangdong 511436, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaobing Li</Name>
        <Affiliation>Center of Pharmaceutical Research and Development, Guangzhou Medical University, Guangdong 511436, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Fengrong Liu</Name>
        <Affiliation>Center of Pharmaceutical Research and Development, Guangzhou Medical University, Guangdong 511436, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianhua Qiu</Name>
        <Affiliation>Center of Pharmaceutical Research and Development, Guangzhou Medical University, Guangdong 511436, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Genshui Zhang</Name>
        <Affiliation>Department of Pharmacology, Guangzhou Medical University, Guangzhou, Guangdong 511436, PR China. Electronic address: zhanggs99@sohu.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>MAPK/JNK1 activation protects cells against cadmium-induced autophagic cell death via differential regulation of catalase and heme oxygenase-1 in oral cancer cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28782507</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30325-3</DOI>
    <KeywordList>
      <Keywords>Autophagy</Keywords>
      <Keywords>Cadmium</Keywords>
      <Keywords>Catalase</Keywords>
      <Keywords>Heme oxygenase-1</Keywords>
      <Keywords>JNK</Keywords>
      <Keywords>Oral cancer cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Keum Young So</Name>
        <Affiliation>Department of Anesthesiology and Pain Medicine, Chosun University, 309 Pilmundaero, Dong-gu, Gwangju 61452, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sang Hun Kim</Name>
        <Affiliation>Department of Anesthesiology and Pain Medicine, Chosun University, 309 Pilmundaero, Dong-gu, Gwangju 61452, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ki Tae Jung</Name>
        <Affiliation>Department of Anesthesiology and Pain Medicine, Chosun University, 309 Pilmundaero, Dong-gu, Gwangju 61452, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyun Young Lee</Name>
        <Affiliation>Department of Anesthesiology and Pain Medicine, Chosun University, 309 Pilmundaero, Dong-gu, Gwangju 61452, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seon Hee Oh</Name>
        <Affiliation>School of Medicine, Chosun University, 309 Pilmundaero, Dong-gu, Gwangju 61452, Republic of Korea. Electronic address: seonh@chosun.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Species-specific effects of neuregulin-1β (cimaglermin alfa) on glucose handling in animal models and humans with heart failure.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28780372</pubmedLink>
    <GrantList>
      <Grant>P20 HL101425</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30326-5</DOI>
    <KeywordList>
      <Keywords>Animal models</Keywords>
      <Keywords>Glucose handling</Keywords>
      <Keywords>Humans</Keywords>
      <Keywords>Neuregulins</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhihong Huang</Name>
        <Affiliation>Acorda Therapeutics, Inc., 420 Saw Mill River Rd, Ardsley, NY 10502, USA. Electronic address: huang5994@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Douglas B. Sawyer</Name>
        <Affiliation>Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, 2220 Pierce Avenue, Nashville, TN 37232, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Erika L. Troy</Name>
        <Affiliation>Acorda Therapeutics, Inc., 420 Saw Mill River Rd, Ardsley, NY 10502, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Corissa McEwen</Name>
        <Affiliation>Acorda Therapeutics, Inc., 420 Saw Mill River Rd, Ardsley, NY 10502, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John H. Cleator</Name>
        <Affiliation>Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, 2220 Pierce Avenue, Nashville, TN 37232, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Abigail Murphy</Name>
        <Affiliation>Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, 2220 Pierce Avenue, Nashville, TN 37232, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anthony O. Caggiano</Name>
        <Affiliation>Acorda Therapeutics, Inc., 420 Saw Mill River Rd, Ardsley, NY 10502, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Eisen</Name>
        <Affiliation>Acorda Therapeutics, Inc., 420 Saw Mill River Rd, Ardsley, NY 10502, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tom J. Parry</Name>
        <Affiliation>Acorda Therapeutics, Inc., 420 Saw Mill River Rd, Ardsley, NY 10502, USA. Electronic address: tomparry@temple.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In vitro to in vivo extrapolation of effective dosimetry in developmental toxicity testing: Application of a generic PBK modelling approach.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28760446</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30318-6</DOI>
    <KeywordList>
      <Keywords>EST assays</Keywords>
      <Keywords>Generic PBK-model</Keywords>
      <Keywords>Glycol ethers</Keywords>
      <Keywords>Phthalates</Keywords>
      <Keywords>QIVIVE</Keywords>
      <Keywords>Triazoles</Keywords>
      <Keywords>WEC</Keywords>
      <Keywords>ZET</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Styliani Fragki</Name>
        <Affiliation>Center for Health Protection, RIVM, National Institute for Public Health and the Environment, P.O. Box 1, 3720 BA Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Aldert H. Piersma</Name>
        <Affiliation>Center for Health Protection, RIVM, National Institute for Public Health and the Environment, P.O. Box 1, 3720 BA Bilthoven, The Netherlands; Institute for Risk Assessment Sciences, Utrecht University, P.O. Box 80178, 3508 TD Utrecht, The Netherlands. Electronic address: aldert.piersma@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Emiel Rorije</Name>
        <Affiliation>Center for Health Protection, RIVM, National Institute for Public Health and the Environment, P.O. Box 1, 3720 BA Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Marco J. Zeilmaker</Name>
        <Affiliation>Center for Health Protection, RIVM, National Institute for Public Health and the Environment, P.O. Box 1, 3720 BA Bilthoven, The Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>High serum lead concentration in the first trimester is associated with an elevated risk of small-for-gestational-age infants.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28755861</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30317-4</DOI>
    <KeywordList>
      <Keywords>Birth cohort study</Keywords>
      <Keywords>Infants</Keywords>
      <Keywords>Lead</Keywords>
      <Keywords>Serum</Keywords>
      <Keywords>Small-for-gestational-age</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hua Wang</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Anhui Medical University, Hefei, China; Anhui Provincial Key Laboratory of Population Health &amp; Aristogenics, Anhui Medical University, Hefei, China; Laboratory of Environmental Toxicology, Anhui Medical University, Hefei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Li</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Anhui Medical University, Hefei, China; Laboratory of Environmental Toxicology, Anhui Medical University, Hefei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jia Hu Hao</Name>
        <Affiliation>Anhui Provincial Key Laboratory of Population Health &amp; Aristogenics, Anhui Medical University, Hefei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Hua Chen</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Anhui Medical University, Hefei, China; Anhui Provincial Key Laboratory of Population Health &amp; Aristogenics, Anhui Medical University, Hefei, China; Laboratory of Environmental Toxicology, Anhui Medical University, Hefei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Liu</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Anhui Medical University, Hefei, China; Laboratory of Environmental Toxicology, Anhui Medical University, Hefei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhen Yu</Name>
        <Affiliation>Anhui Provincial Key Laboratory of Population Health &amp; Aristogenics, Anhui Medical University, Hefei, China; Laboratory of Environmental Toxicology, Anhui Medical University, Hefei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lin Fu</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Anhui Medical University, Hefei, China; Anhui Provincial Key Laboratory of Population Health &amp; Aristogenics, Anhui Medical University, Hefei, China; Laboratory of Environmental Toxicology, Anhui Medical University, Hefei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fang Biao Tao</Name>
        <Affiliation>Anhui Provincial Key Laboratory of Population Health &amp; Aristogenics, Anhui Medical University, Hefei, China. Electronic address: fbtao@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>De Xiang Xu</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Anhui Medical University, Hefei, China; Anhui Provincial Key Laboratory of Population Health &amp; Aristogenics, Anhui Medical University, Hefei, China; Laboratory of Environmental Toxicology, Anhui Medical University, Hefei, China. Electronic address: xudex@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dynamic and accurate assessment of acetaminophen-induced hepatotoxicity by integrated photoacoustic imaging and mechanistic biomarkers in vivo.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28755860</pubmedLink>
    <GrantList>
      <Grant>MR/K026739/1</Grant>
      <Grant>MR/L012707/1</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30316-2</DOI>
    <KeywordList>
      <Keywords>Acetaminophen</Keywords>
      <Keywords>Biomarker</Keywords>
      <Keywords>Drug-induced liver injury</Keywords>
      <Keywords>HMGB1</Keywords>
      <Keywords>MSOT</Keywords>
      <Keywords>miR-122</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nathalie Brillant</Name>
        <Affiliation>Department of Molecular &amp; Clinical Pharmacology, MRC Centre for Drug Safety Science, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Mohamed Elmasry</Name>
        <Affiliation>Department of Molecular &amp; Clinical Pharmacology, MRC Centre for Drug Safety Science, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Neal C. Burton</Name>
        <Affiliation>iThera Medical, Munich, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Josep Monne Rodriguez</Name>
        <Affiliation>Department of Veterinary Pathology, Institute of Veterinary Science, University of Liverpool, Liverpool, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Jack W. Sharkey</Name>
        <Affiliation>Department of Cellular &amp; Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen Fenwick</Name>
        <Affiliation>General Surgery, Aintree University Hospital, Liverpool, Merseyside, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Harish Poptani</Name>
        <Affiliation>Department of Cellular &amp; Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Neil R. Kitteringham</Name>
        <Affiliation>Department of Molecular &amp; Clinical Pharmacology, MRC Centre for Drug Safety Science, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher E. Goldring</Name>
        <Affiliation>Department of Molecular &amp; Clinical Pharmacology, MRC Centre for Drug Safety Science, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Anja Kipar</Name>
        <Affiliation>Institute of Global Health, University of Liverpool, Liverpool, UK; Institute of Veterinary Pathology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>B. Kevin Park</Name>
        <Affiliation>Department of Molecular &amp; Clinical Pharmacology, MRC Centre for Drug Safety Science, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel J. Antoine</Name>
        <Affiliation>Department of Molecular &amp; Clinical Pharmacology, MRC Centre for Drug Safety Science, Institute of Translational Medicine, University of Liverpool, Liverpool, UK. Electronic address: d.antoine@liverpool.ac.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inactivation of the orphan nuclear receptor NR4A1 contributes to apoptosis induction by fangchinoline in pancreatic cancer cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28754437</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30314-9</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>ER stress</Keywords>
      <Keywords>Fangchinoline</Keywords>
      <Keywords>NR4A1</Keywords>
      <Keywords>Pancreatic cancer</Keywords>
      <Keywords>Sp1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hyo Seon Lee</Name>
        <Affiliation>Department of Food Science and Technology, Keimyung University, Daegu 42601, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen Safe</Name>
        <Affiliation>Department of Veterinary Physiology and Pharmacology, Texas A&amp;M University, College Station, TX 77843-4466, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Syng Ook Lee</Name>
        <Affiliation>Department of Food Science and Technology, Keimyung University, Daegu 42601, Republic of Korea; The center for Traditional Microorganism Resource (TMR), Keimyung University, Daegu 42601, Republic of Korea. Electronic address: synglee@kmu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The use of a unique co-culture model of fetoplacental steroidogenesis as a screening tool for endocrine disruptors: The effects of neonicotinoids on aromatase activity and hormone production.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28750898</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30315-0</DOI>
    <KeywordList>
      <Keywords>Aromatase</Keywords>
      <Keywords>Co-culture</Keywords>
      <Keywords>Estriol</Keywords>
      <Keywords>Fetoplacental unit</Keywords>
      <Keywords>Nonicotinoids</Keywords>
      <Keywords>Steroid 16α-hydroxylase (CYP3A7)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Elyse Caron-Beaudoin</Name>
        <Affiliation>INRS - Institut Armand-Frappier, Laval, QC H7V 1B7, Canada; Center for Interdisciplinary Research on Well-Being, Health, Society and Environment (CINBIOSE), Université du Québec à Montréal, Montreal, QC H3C 3P8, Canada. Electronic address: elyse.caron-beaudoin@iaf.inrs.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Rachel Viau</Name>
        <Affiliation>INRS - Institut Armand-Frappier, Laval, QC H7V 1B7, Canada. Electronic address: rachel.viau@iaf.inrs.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Andrée Anne Hudon-Thibeault</Name>
        <Affiliation>INRS - Institut Armand-Frappier, Laval, QC H7V 1B7, Canada; BioMed Research Center, Université du Québec à Montréal, Montreal, QC H3C 3P8, Canada; Center for Interdisciplinary Research on Well-Being, Health, Society and Environment (CINBIOSE), Université du Québec à Montréal, Montreal, QC H3C 3P8, Canada. Electronic address: andree-anne.hudon.thibeault@iaf.inrs.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Cathy Vaillancourt</Name>
        <Affiliation>INRS - Institut Armand-Frappier, Laval, QC H7V 1B7, Canada; BioMed Research Center, Université du Québec à Montréal, Montreal, QC H3C 3P8, Canada; Center for Interdisciplinary Research on Well-Being, Health, Society and Environment (CINBIOSE), Université du Québec à Montréal, Montreal, QC H3C 3P8, Canada. Electronic address: cathy.vaillancourt@iaf.inrs.ca.</Affiliation>
      </Author>
      <Author>
        <Name>J. Thomas Sanderson</Name>
        <Affiliation>INRS - Institut Armand-Frappier, Laval, QC H7V 1B7, Canada. Electronic address: thomas.sanderson@iaf.inrs.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Suppression of IgE-mediated mast cell activation and mouse anaphylaxis via inhibition of Syk activation by 8-formyl-7-hydroxy-4-methylcoumarin, 4μ8C.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28736076</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30312-5</DOI>
    <KeywordList>
      <Keywords>4μ8C</Keywords>
      <Keywords>8-Formyl-7-hydroxy-4-methylcoumarin</Keywords>
      <Keywords>Allergy</Keywords>
      <Keywords>Anaphylaxis</Keywords>
      <Keywords>Fyn</Keywords>
      <Keywords>Lyn</Keywords>
      <Keywords>Mast cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Seung Taek Nam</Name>
        <Affiliation>Department of Immunology, College of Medicine, Konkuk University, Chungju 27478, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Young Hwan Park</Name>
        <Affiliation>Department of Immunology, College of Medicine, Konkuk University, Chungju 27478, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyun Woo Kim</Name>
        <Affiliation>Department of Immunology, College of Medicine, Konkuk University, Chungju 27478, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyuk Soon Kim</Name>
        <Affiliation>Department of Immunology, College of Medicine, Konkuk University, Chungju 27478, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dajeong Lee</Name>
        <Affiliation>Department of Immunology, College of Medicine, Konkuk University, Chungju 27478, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Min Bum Lee</Name>
        <Affiliation>Department of Immunology, College of Medicine, Konkuk University, Chungju 27478, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Young Mi Kim</Name>
        <Affiliation>College of Pharmacy, Duksung Women's University, Seoul 01369, Republic of Korea. Electronic address: kym123@duksung.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Wahn Soo Choi</Name>
        <Affiliation>Department of Immunology, College of Medicine, Konkuk University, Chungju 27478, Republic of Korea. Electronic address: wahnchoi@kku.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Sex-specific differences in the modulation of Growth Differentiation Factor 15 (GDF15) by hyperoxia in vivo and in vitro: Role of Hif-1α.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28734801</pubmedLink>
    <GrantList>
      <Grant>K08 HL127103</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30313-7</DOI>
    <KeywordList>
      <Keywords>Bronchopulmonary dysplasia</Keywords>
      <Keywords>GDF15</Keywords>
      <Keywords>HIF-1alpha</Keywords>
      <Keywords>Hyperoxia</Keywords>
      <Keywords>Sex-specific</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yuhao Zhang</Name>
        <Affiliation>Department of Pediatrics, Section of Neonatology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Weiwu Jiang</Name>
        <Affiliation>Department of Pediatrics, Section of Neonatology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lihua Wang</Name>
        <Affiliation>Department of Pediatrics, Section of Neonatology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Krithika Lingappan</Name>
        <Affiliation>Department of Pediatrics, Section of Neonatology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA. Electronic address: lingappa@bcm.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>UPLC-Q-TOF/MS-based urine and plasma metabonomics study on the ameliorative effects of aspirin eugenol ester in hyperlipidemia rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28733207</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30310-1</DOI>
    <KeywordList>
      <Keywords>Aspirin eugenol ester</Keywords>
      <Keywords>Blood lipids</Keywords>
      <Keywords>Hyperlipidemia</Keywords>
      <Keywords>Metabonomics</Keywords>
      <Keywords>Rat</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ning Ma</Name>
        <Affiliation>Key Lab of New Animal Drug Project of Gansu Province, Key Lab of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Science of Chinese Academy of Agricultural Sciences, Lanzhou 730050, P.R. China.</Affiliation>
      </Author>
      <Author>
        <Name>Isam Karam</Name>
        <Affiliation>Key Lab of New Animal Drug Project of Gansu Province, Key Lab of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Science of Chinese Academy of Agricultural Sciences, Lanzhou 730050, P.R. China.</Affiliation>
      </Author>
      <Author>
        <Name>Xi Wang Liu</Name>
        <Affiliation>Key Lab of New Animal Drug Project of Gansu Province, Key Lab of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Science of Chinese Academy of Agricultural Sciences, Lanzhou 730050, P.R. China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Jun Kong</Name>
        <Affiliation>Key Lab of New Animal Drug Project of Gansu Province, Key Lab of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Science of Chinese Academy of Agricultural Sciences, Lanzhou 730050, P.R. China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhe Qin</Name>
        <Affiliation>Key Lab of New Animal Drug Project of Gansu Province, Key Lab of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Science of Chinese Academy of Agricultural Sciences, Lanzhou 730050, P.R. China.</Affiliation>
      </Author>
      <Author>
        <Name>Shi Hong Li</Name>
        <Affiliation>Key Lab of New Animal Drug Project of Gansu Province, Key Lab of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Science of Chinese Academy of Agricultural Sciences, Lanzhou 730050, P.R. China.</Affiliation>
      </Author>
      <Author>
        <Name>Zeng Hua Jiao</Name>
        <Affiliation>Key Lab of New Animal Drug Project of Gansu Province, Key Lab of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Science of Chinese Academy of Agricultural Sciences, Lanzhou 730050, P.R. China.</Affiliation>
      </Author>
      <Author>
        <Name>Peng Cheng Dong</Name>
        <Affiliation>Key Lab of New Animal Drug Project of Gansu Province, Key Lab of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Science of Chinese Academy of Agricultural Sciences, Lanzhou 730050, P.R. China.</Affiliation>
      </Author>
      <Author>
        <Name>Ya Jun Yang</Name>
        <Affiliation>Key Lab of New Animal Drug Project of Gansu Province, Key Lab of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Science of Chinese Academy of Agricultural Sciences, Lanzhou 730050, P.R. China. Electronic address: yangyue10224@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jian Yong Li</Name>
        <Affiliation>Key Lab of New Animal Drug Project of Gansu Province, Key Lab of Veterinary Pharmaceutical Development, Ministry of Agriculture, Lanzhou Institute of Husbandry and Pharmaceutical Science of Chinese Academy of Agricultural Sciences, Lanzhou 730050, P.R. China. Electronic address: lijy1971@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Omics-based identification of the combined effects of idiosyncratic drugs and inflammatory cytokines on the development of drug-induced liver injury.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28733206</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30311-3</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Ceramide</Keywords>
      <Keywords>Drug-induced liver injury</Keywords>
      <Keywords>ER stress</Keywords>
      <Keywords>Microarray</Keywords>
      <Keywords>Toxicogenomics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>J. Jiang</Name>
        <Affiliation>Department of Toxicogenomics, GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands. Electronic address: j.jiang@maastrichtuniversity.nl.</Affiliation>
      </Author>
      <Author>
        <Name>K. Mathijs</Name>
        <Affiliation>Department of Toxicogenomics, GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>L. Timmermans</Name>
        <Affiliation>Department of Toxicogenomics, GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>S. M. Claessen</Name>
        <Affiliation>Department of Toxicogenomics, GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>A. Hecka</Name>
        <Affiliation>DSM Resolve, Geleen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>J. Weusten</Name>
        <Affiliation>DSM Resolve, Geleen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>R. Peters</Name>
        <Affiliation>Van 't Hoff Institute for Molecular Science (HIMS), Universiteit van Amsterdam, Amsterdam, The Netherlands; DSM Coating Resins, Waalwijk, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>J. H. van Delft</Name>
        <Affiliation>Department of Toxicogenomics, GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>J. C. S. Kleinjans</Name>
        <Affiliation>Department of Toxicogenomics, GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>D. G. J. Jennen</Name>
        <Affiliation>Department of Toxicogenomics, GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>T. M. de Kok</Name>
        <Affiliation>Department of Toxicogenomics, GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>(+)-Dehydrofukinone modulates membrane potential and delays seizure onset by GABAa receptor-mediated mechanism in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28733205</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30307-1</DOI>
    <KeywordList>
      <Keywords>Anticonvulsant</Keywords>
      <Keywords>Calcium</Keywords>
      <Keywords>Essential oil</Keywords>
      <Keywords>Natural products</Keywords>
      <Keywords>Nectandra grandiflora</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Quelen Iane Garlet</Name>
        <Affiliation>Post-Graduation Program in Pharmacology, Federal University of Santa Maria, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Luana da Costa Pires</Name>
        <Affiliation>Post-Graduation Program in Pharmacology, Federal University of Santa Maria, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Hautrive Milanesi</Name>
        <Affiliation>Post-Graduation Program in Pharmacology, Federal University of Santa Maria, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Joseane Righes Marafiga</Name>
        <Affiliation>Post-Graduation Program in Pharmacology, Federal University of Santa Maria, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Bernardo Baldisserotto</Name>
        <Affiliation>Post-Graduation Program in Pharmacology, Federal University of Santa Maria, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Carlos Fernando Mello</Name>
        <Affiliation>Post-Graduation Program in Pharmacology, Federal University of Santa Maria, Santa Maria, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Berta Maria Heinzmann</Name>
        <Affiliation>Post-Graduation Program in Pharmacology, Federal University of Santa Maria, Santa Maria, RS, Brazil. Electronic address: berta@smail.ufsm.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28733204</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30309-5</DOI>
    <KeywordList>
      <Keywords>8-OHdG</Keywords>
      <Keywords>Arsenic</Keywords>
      <Keywords>Polymorphism</Keywords>
      <Keywords>Renal cell carcinoma</Keywords>
      <Keywords>XRCC1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yu Mei Hsueh</Name>
        <Affiliation>Department of Family Medicine, Taipei Medical University Hospital, Taipei, Taiwan; Department of Public Health, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Chin Lin</Name>
        <Affiliation>Department of Family Medicine, Shung Ho Hospital, Taipei Medical University, Taipei, Taiwan; Department of Health Examination, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan; Division of Family Medicine, School of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Jen Chen</Name>
        <Affiliation>School of Public Health, College of Public Health, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Yuan Huang</Name>
        <Affiliation>Department of Urology, National Taiwan University Hospital, College of Medicine National Taiwan University, Taipei, Taiwan; Department of Urology, National Taiwan University Hospital, Hsin Chu Branch, Hsin Chu, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Horng Sheng Shiue</Name>
        <Affiliation>Department of Chinese Medicine, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taoyuan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yeong Shiau Pu</Name>
        <Affiliation>Department of Urology, National Taiwan University Hospital, College of Medicine National Taiwan University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chi Hung Chen</Name>
        <Affiliation>School of Public Health, College of Public Health, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chien Tien Su</Name>
        <Affiliation>Department of Family Medicine, Taipei Medical University Hospital, Taipei, Taiwan; School of Public Health, College of Public Health, Taipei Medical University, Taipei, Taiwan. Electronic address: ctsu@tmu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In silico pharmacogenetic approach: The natalizumab case study.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28733203</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30308-3</DOI>
    <KeywordList>
      <Keywords>HINT score</Keywords>
      <Keywords>Molecular dynamics simulation (MD)</Keywords>
      <Keywords>Multiple sclerosis</Keywords>
      <Keywords>Natalizumab</Keywords>
      <Keywords>Pharmacogenetics</Keywords>
      <Keywords>Single nucleotide polymorphism (SNP)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Francesca Cavaliere</Name>
        <Affiliation>Human Microbial, Geno-toxicology, and Plant Lab, Department of Chemistry, Life Sciences and Environmental Sustainability, Parco Area delle Scienze 11/A, 43124 Parma, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Enrico Montanari</Name>
        <Affiliation>Polo Neurologico Interaziendale, ASL Parma, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Emerson</Name>
        <Affiliation>Supercomputing Applications and Innovation Dept (SCAI), CINECA, Via Magnanelli, 6/3 40033 Casalecchio di Reno (BO), Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Annamaria Buschini</Name>
        <Affiliation>Human Microbial, Geno-toxicology, and Plant Lab, Department of Chemistry, Life Sciences and Environmental Sustainability, Parco Area delle Scienze 11/A, 43124 Parma, Italy. Electronic address: annamaria.buschini@unipr.it.</Affiliation>
      </Author>
      <Author>
        <Name>Pietro Cozzini</Name>
        <Affiliation>Molecular Modeling Lab, Food and Drug Department, University of Parma, Parco Area delle Scienze 17/A, 43124 Parma, Italy. Electronic address: pietro.cozzini@unipr.it.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Expression of CYP4V2 in human THP1 macrophages and its transcriptional regulation by peroxisome proliferator-activated receptor gamma.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28729181</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30306-X</DOI>
    <KeywordList>
      <Keywords>CYP</Keywords>
      <Keywords>CYP4V2</Keywords>
      <Keywords>Fatty acid metabolism</Keywords>
      <Keywords>Macrophage</Keywords>
      <Keywords>PPAR gamma</Keywords>
      <Keywords>THP1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Myeongjin Yi</Name>
        <Affiliation>Department of Pharmacology and Pharmacogenomics Research Center, Inje University College of Medicine, Inje University, Busan, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Gook Shin</Name>
        <Affiliation>Department of Pharmacology and Pharmacogenomics Research Center, Inje University College of Medicine, Inje University, Busan, South Korea; Department of Clinical Pharmacology, Inje University Busan Paik Hospital, Inje University College of Medicine, Inje University, Busan, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Su Jun Lee</Name>
        <Affiliation>Department of Pharmacology and Pharmacogenomics Research Center, Inje University College of Medicine, Inje University, Busan, South Korea. Electronic address: 2sujun@inje.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nanoquinacrine caused apoptosis in oral cancer stem cells by disrupting the interaction between GLI1 and β catenin through activation of GSK3β.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28720477</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30304-6</DOI>
    <KeywordList>
      <Keywords>CSC</Keywords>
      <Keywords>GSK3β</Keywords>
      <Keywords>Hedgehog</Keywords>
      <Keywords>Oral cancer stem cells</Keywords>
      <Keywords>Quinacrine</Keywords>
      <Keywords>WNT</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anmada Nayak</Name>
        <Affiliation>Cancer Biology Division, KIIT School of Biotechnology, KIIT University, Campus-11, Patia, Bhubaneswar, Odisha 751024, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sumit Siddharth</Name>
        <Affiliation>Cancer Biology Division, KIIT School of Biotechnology, KIIT University, Campus-11, Patia, Bhubaneswar, Odisha 751024, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sarita Das</Name>
        <Affiliation>Cancer Biology Division, KIIT School of Biotechnology, KIIT University, Campus-11, Patia, Bhubaneswar, Odisha 751024, India.</Affiliation>
      </Author>
      <Author>
        <Name>Deepika Nayak</Name>
        <Affiliation>Cancer Biology Division, KIIT School of Biotechnology, KIIT University, Campus-11, Patia, Bhubaneswar, Odisha 751024, India.</Affiliation>
      </Author>
      <Author>
        <Name>Chinmayee Sethy</Name>
        <Affiliation>Cancer Biology Division, KIIT School of Biotechnology, KIIT University, Campus-11, Patia, Bhubaneswar, Odisha 751024, India.</Affiliation>
      </Author>
      <Author>
        <Name>Chanakya Nath Kundu</Name>
        <Affiliation>Cancer Biology Division, KIIT School of Biotechnology, KIIT University, Campus-11, Patia, Bhubaneswar, Odisha 751024, India. Electronic address: cnkundu@kiitbiotech.ac.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A novel topoisomerase 2a inhibitor, cryptotanshinone, suppresses the growth of PC3 cells without apparent cytotoxicity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28716507</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30305-8</DOI>
    <KeywordList>
      <Keywords>Chemotherapeutic agent</Keywords>
      <Keywords>Cleavable complex</Keywords>
      <Keywords>Cryptotanshinone</Keywords>
      <Keywords>Human prostate cancer</Keywords>
      <Keywords>Topoisomerase</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Eun Ju Kim</Name>
        <Affiliation>Division of Radiation Effect, Korea Institute of Radiological &amp; Medical Sciences, Seoul 01812, Republic of Korea; Health Services Management, KH School of Management, Kyung Hee University, Seoul 02453, Republic of Korea. Electronic address: ejkim@kirams.re.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Sun Young Kim</Name>
        <Affiliation>Division of Radiation Effect, Korea Institute of Radiological &amp; Medical Sciences, Seoul 01812, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sang Man Kim</Name>
        <Affiliation>Health Services Management, KH School of Management, Kyung Hee University, Seoul 02453, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Minyoung Lee</Name>
        <Affiliation>Division of Radiation Effect, Korea Institute of Radiological &amp; Medical Sciences, Seoul 01812, Republic of Korea. Electronic address: mylee@kirams.re.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Novel Hsp90 inhibitor platycodin D disrupts Hsp90/Cdc37 complex and enhances the anticancer effect of mTOR inhibitor.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28711525</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30303-4</DOI>
    <KeywordList>
      <Keywords>Cdc37</Keywords>
      <Keywords>EGFR</Keywords>
      <Keywords>Everolimus</Keywords>
      <Keywords>Hsp90</Keywords>
      <Keywords>IGF1R</Keywords>
      <Keywords>Platycodin D</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ting Li</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Chen</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Yang Dai</Name>
        <Affiliation>College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bin Wei</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qin Jie Weng</Name>
        <Affiliation>College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiuping Chen</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.</Affiliation>
      </Author>
      <Author>
        <Name>De Fang Ouyang</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ru Yan</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhang Jian Huang</Name>
        <Affiliation>State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hu Lin Jiang</Name>
        <Affiliation>State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Zhu</Name>
        <Affiliation>College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Jian Lu</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China. Electronic address: jinjianlu@umac.mo.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Induction of ABCG2/BCRP restricts the distribution of zidovudine to the fetal brain in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28705594</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30285-5</DOI>
    <KeywordList>
      <Keywords>ABCG2</Keywords>
      <Keywords>Bioavailability</Keywords>
      <Keywords>Fetal brain</Keywords>
      <Keywords>HIV</Keywords>
      <Keywords>Placenta</Keywords>
      <Keywords>Zidovudine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>María Fernanda Filia</Name>
        <Affiliation>Instituto de Investigaciones Farmacológicas (ININFA UBA-CONICET), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956 5°, 1113 Ciudad Autónoma de Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Timoteo Marchini</Name>
        <Affiliation>CONICET, Instituto de Bioquímica y Medicina Molecular (IBIMOL), Facultad de Farmacia y Bioquímica, Cátedra de Química General e Inorgánica, Universidad de Buenos Aires, Junín 956 2°, 1113 Ciudad Autónoma de Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Mauricio Minoia</Name>
        <Affiliation>Instituto de Investigaciones Farmacológicas (ININFA UBA-CONICET), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956 5°, 1113 Ciudad Autónoma de Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Martín Ignacio Roma</Name>
        <Affiliation>Instituto de Investigaciones Farmacológicas (ININFA UBA-CONICET), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956 5°, 1113 Ciudad Autónoma de Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Fernanda Teresa De Fino</Name>
        <Affiliation>Instituto de Investigaciones Farmacológicas (ININFA UBA-CONICET), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956 5°, 1113 Ciudad Autónoma de Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Modesto Carlos Rubio</Name>
        <Affiliation>Instituto de Investigaciones Farmacológicas (ININFA UBA-CONICET), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956 5°, 1113 Ciudad Autónoma de Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Guillermo J. Copello</Name>
        <Affiliation>Cátedra de Química Analítica Instrumental e Instituto de Química y Metabolismo del Fármaco (IQUIMEFA UBA-CONICET), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956 3°, 1113 Ciudad Autónoma de Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Pablo A. Evelson</Name>
        <Affiliation>CONICET, Instituto de Bioquímica y Medicina Molecular (IBIMOL), Facultad de Farmacia y Bioquímica, Cátedra de Química General e Inorgánica, Universidad de Buenos Aires, Junín 956 2°, 1113 Ciudad Autónoma de Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Roxana Noemí Peroni</Name>
        <Affiliation>Instituto de Investigaciones Farmacológicas (ININFA UBA-CONICET), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Junín 956 5°, 1113 Ciudad Autónoma de Buenos Aires, Argentina. Electronic address: rperoni@ffyb.uba.ar.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparison of phenotypic and global gene expression changes in Xenopus tropicalis embryos induced by agonists of RAR and RXR.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28689802</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30284-3</DOI>
    <KeywordList>
      <Keywords>Gene expression</Keywords>
      <Keywords>Malformation</Keywords>
      <Keywords>Retinoic acid</Keywords>
      <Keywords>Retinoic acid receptor (RAR)</Keywords>
      <Keywords>Retinoid X receptor (RXR)</Keywords>
      <Keywords>Xenopus tropicalis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jingmin Zhu</Name>
        <Affiliation>State Key Laboratory of Estuarine and Coastal Research, East China Normal University, Shanghai 200062, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lingling Hu</Name>
        <Affiliation>State Key Laboratory of Estuarine and Coastal Research, East China Normal University, Shanghai 200062, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lingyun Li</Name>
        <Affiliation>State Key Laboratory of Estuarine and Coastal Research, East China Normal University, Shanghai 200062, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Huang</Name>
        <Affiliation>Institute of Cellular and Developmental Biology, College of Life Sciences, Zhejiang University, Hangzhou, Zhejiang, China. Electronic address: xh220@zju.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Huahong Shi</Name>
        <Affiliation>State Key Laboratory of Estuarine and Coastal Research, East China Normal University, Shanghai 200062, China. Electronic address: hhshi@des.ecnu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Single-cell RNA sequencing reveals an altered gene expression pattern as a result of CRISPR/cas9-mediated deletion of Gene 33/Mig6 and chronic exposure to hexavalent chromium in human lung epithelial cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28688920</pubmedLink>
    <GrantList>
      <Grant>R21 ES023862</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30283-1</DOI>
    <KeywordList>
      <Keywords>Carcinogenesis</Keywords>
      <Keywords>Chromium</Keywords>
      <Keywords>Gene 33/Mig6</Keywords>
      <Keywords>Lung</Keywords>
      <Keywords>RNA-seq</Keywords>
      <Keywords>Single cell</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Soyoung Park</Name>
        <Affiliation>Department of Pathology, School of Medicine, New York Medical College, Valhalla, NY 10595, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaowen Zhang</Name>
        <Affiliation>Department of Pathology, School of Medicine, New York Medical College, Valhalla, NY 10595, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Cen Li</Name>
        <Affiliation>Department of Pathology, School of Medicine, New York Medical College, Valhalla, NY 10595, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Changhong Yin</Name>
        <Affiliation>Department of Pathology, School of Medicine, New York Medical College, Valhalla, NY 10595, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jiangwei Li</Name>
        <Affiliation>Department of Pathology, School of Medicine, New York Medical College, Valhalla, NY 10595, United States.</Affiliation>
      </Author>
      <Author>
        <Name>John T. Fallon</Name>
        <Affiliation>Department of Pathology, School of Medicine, New York Medical College, Valhalla, NY 10595, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Weihua Huang</Name>
        <Affiliation>Department of Pathology, School of Medicine, New York Medical College, Valhalla, NY 10595, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Dazhong Xu</Name>
        <Affiliation>Department of Pathology, School of Medicine, New York Medical College, Valhalla, NY 10595, United States. Electronic address: Dazhong_xu@nymc.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of the mutagenic potential of hexavalent chromium in the duodenum of big blue® rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28687238</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30282-X</DOI>
    <KeywordList>
      <Keywords>Big Blue® transgenic rat</Keywords>
      <Keywords>Duodenum</Keywords>
      <Keywords>Hexavalent chromium [Cr(VI)]</Keywords>
      <Keywords>Mode of action (MOA)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chad M. Thompson</Name>
        <Affiliation>ToxStrategies, Inc., Katy, TX, United States. Electronic address: cthompson@toxstrategies.com.</Affiliation>
      </Author>
      <Author>
        <Name>Robert R. Young</Name>
        <Affiliation>BioReliance, Rockville, MD, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Harshini Dinesdurage</Name>
        <Affiliation>BioReliance, Rockville, MD, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mina Suh</Name>
        <Affiliation>ToxStrategies, Inc., Mission Viejo, CA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mark A. Harris</Name>
        <Affiliation>ToxStrategies, Inc., Katy, TX, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Annette C. Rohr</Name>
        <Affiliation>Electric Power Research Institute, Palo Alto, CA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Deborah M. Proctor</Name>
        <Affiliation>ToxStrategies, Inc., Mission Viejo, CA, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Physiologically based pharmacokinetic modeling of human exposure to perfluorooctanoic acid suggests historical non drinking-water exposures are important for predicting current serum concentrations.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28684146</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30281-8</DOI>
    <KeywordList>
      <Keywords>Human</Keywords>
      <Keywords>Monte Carlo</Keywords>
      <Keywords>PBPK</Keywords>
      <Keywords>PFOA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rachel Rogers Worley</Name>
        <Affiliation>Division of Community Health Investigations, Agency for Toxic Substances and Disease Registry, Atlanta, GA, USA; Interdisciplinary Toxicology Program, University of Georgia, Athens, GA, USA. Electronic address: RWorley@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoxia Yang</Name>
        <Affiliation>National Center for Toxicological Research, Food and Drug Administration, Jefferson, AR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey Fisher</Name>
        <Affiliation>Interdisciplinary Toxicology Program, University of Georgia, Athens, GA, USA; National Center for Toxicological Research, Food and Drug Administration, Jefferson, AR, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The effect of fibroblast growth factor 15 deficiency on the development of high fat diet induced non-alcoholic steatohepatitis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28673684</pubmedLink>
    <GrantList>
      <Grant>T32 ES007148</Grant>
      <Grant>P30 ES005022</Grant>
      <Grant>R01 GM104037</Grant>
      <Grant>R56 DK090036</Grant>
      <Grant>R01 DK081343</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30279-X</DOI>
    <KeywordList>
      <Keywords>Bile acids</Keywords>
      <Keywords>Fibroblast growth factor 15</Keywords>
      <Keywords>Fibrosis</Keywords>
      <Keywords>Metabolic syndrome</Keywords>
      <Keywords>Non-alcoholic steatohepatitis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>J. D. Schumacher</Name>
        <Affiliation>Department of Pharmacology and Toxicology, School of Pharmacy, EOHSI, Rutgers University, Piscataway, NJ 08854, United States.</Affiliation>
      </Author>
      <Author>
        <Name>B. Kong</Name>
        <Affiliation>Department of Pharmacology and Toxicology, School of Pharmacy, EOHSI, Rutgers University, Piscataway, NJ 08854, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Y. Pan</Name>
        <Affiliation>Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>L. Zhan</Name>
        <Affiliation>Rutgers Cancer Institute of New Jersey, New Brunswick, NJ 08903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>R. Sun</Name>
        <Affiliation>Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>J. Aa</Name>
        <Affiliation>Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>D. Rizzolo</Name>
        <Affiliation>Department of Pharmacology and Toxicology, School of Pharmacy, EOHSI, Rutgers University, Piscataway, NJ 08854, United States.</Affiliation>
      </Author>
      <Author>
        <Name>J. R. Richardson</Name>
        <Affiliation>Department of Pharmacology and Toxicology, School of Pharmacy, EOHSI, Rutgers University, Piscataway, NJ 08854, United States.</Affiliation>
      </Author>
      <Author>
        <Name>A. Chen</Name>
        <Affiliation>Department of Pathology, St. Louis University, St. Louis, MO 63104, United States.</Affiliation>
      </Author>
      <Author>
        <Name>M. Goedken</Name>
        <Affiliation>Department of Pharmacology and Toxicology, School of Pharmacy, EOHSI, Rutgers University, Piscataway, NJ 08854, United States.</Affiliation>
      </Author>
      <Author>
        <Name>L. M. Aleksunes</Name>
        <Affiliation>Department of Pharmacology and Toxicology, School of Pharmacy, EOHSI, Rutgers University, Piscataway, NJ 08854, United States.</Affiliation>
      </Author>
      <Author>
        <Name>D. L. Laskin</Name>
        <Affiliation>Department of Pharmacology and Toxicology, School of Pharmacy, EOHSI, Rutgers University, Piscataway, NJ 08854, United States.</Affiliation>
      </Author>
      <Author>
        <Name>G. L. Guo</Name>
        <Affiliation>Department of Pharmacology and Toxicology, School of Pharmacy, EOHSI, Rutgers University, Piscataway, NJ 08854, United States. Electronic address: guo@eohsi.rutgers.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Single-walled carbon nanotubes (SWCNTs) inhibit heat shock protein 90 (HSP90) signaling in human lung fibroblasts and keratinocytes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28673683</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30280-6</DOI>
    <KeywordList>
      <Keywords>Carbon nanotube</Keywords>
      <Keywords>HSP90</Keywords>
      <Keywords>Nanomaterials</Keywords>
      <Keywords>Nanotoxicity</Keywords>
      <Keywords>Single-walled</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Li Chu Ong</Name>
        <Affiliation>Center for Cancer and Stem Cell Research, International Medical University, Bukit Jalil, 57000 Kuala Lumpur, Malaysia; School of Postgraduate Studies, International Medical University, Bukit Jalil, 57000 Kuala Lumpur, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Yuen Fen Tan</Name>
        <Affiliation>Center for Cancer and Stem Cell Research, International Medical University, Bukit Jalil, 57000 Kuala Lumpur, Malaysia; School of Postgraduate Studies, International Medical University, Bukit Jalil, 57000 Kuala Lumpur, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Boon Shing Tan</Name>
        <Affiliation>Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Felicia Fei Lei Chung</Name>
        <Affiliation>Center for Cancer and Stem Cell Research, International Medical University, Bukit Jalil, 57000 Kuala Lumpur, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Soon Keng Cheong</Name>
        <Affiliation>Faculty of Medicine and Health Sciences, University Tunku Abdul Rahman, Bandar Sungai Long, Selangor, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Chee Onn Leong</Name>
        <Affiliation>Center for Cancer and Stem Cell Research, International Medical University, Bukit Jalil, 57000 Kuala Lumpur, Malaysia; School of Pharmacy, International Medical University, Bukit Jalil, 57000 Kuala Lumpur, Malaysia. Electronic address: cheeonn_leong@imu.edu.my.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Low level exposure to inorganic mercury interferes with B cell receptor signaling in transitional type 1 B cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28668464</pubmedLink>
    <GrantList>
      <Grant>P30 ES020957</Grant>
      <Grant>R21 ES024476</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30278-8</DOI>
    <KeywordList>
      <Keywords>Autoimmunity</Keywords>
      <Keywords>B cell receptor (BCR)</Keywords>
      <Keywords>Mercury</Keywords>
      <Keywords>Transitional type 1 (T1) B cell</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>R. Gill</Name>
        <Affiliation>Department of Immunology, Microbiology and Biochemistry, Wayne State University, Detroit, MI, United States.</Affiliation>
      </Author>
      <Author>
        <Name>M. J. McCabe</Name>
        <Affiliation>Department of Environmental Medicine, University of Rochester, Rochester, NY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>A. J. Rosenspire</Name>
        <Affiliation>Department of Immunology, Microbiology and Biochemistry, Wayne State University, Detroit, MI, United States; Center for Urban Responses to Environmental Stressors (CURES), Wayne State University, Detroit, MI, United States. Electronic address: arosenspire@wayne.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Molecular evidence of offspring liver dysfunction after maternal exposure to zinc oxide nanoparticles.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28648595</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30277-6</DOI>
    <KeywordList>
      <Keywords>Gene expression</Keywords>
      <Keywords>Liver dysfunction</Keywords>
      <Keywords>Offspring</Keywords>
      <Keywords>Protein level</Keywords>
      <Keywords>ZnO nanoparticles</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yanan Hao</Name>
        <Affiliation>College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Liu</Name>
        <Affiliation>Core Laboratories of Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanni Feng</Name>
        <Affiliation>College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuai Yu</Name>
        <Affiliation>College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Weidong Zhang</Name>
        <Affiliation>College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lan Li</Name>
        <Affiliation>College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lingjiang Min</Name>
        <Affiliation>College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongfu Zhang</Name>
        <Affiliation>State Key Laboratory of Animal Nutrition, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing 100193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Shen</Name>
        <Affiliation>College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Zhao</Name>
        <Affiliation>College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, China; State Key Laboratory of Animal Nutrition, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing 100193, China. Electronic address: yzhao@msu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Derivatives of alkyl gallate triphenylphosphonium exhibit antitumor activity in a syngeneic murine model of mammary adenocarcinoma.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28647477</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30274-0</DOI>
    <KeywordList>
      <Keywords>Alkyl gallate triphenylphosphonium derivatives</Keywords>
      <Keywords>Delocalized lipophilic cation</Keywords>
      <Keywords>Doxycycline</Keywords>
      <Keywords>Syngeneic murine model of breast cancer</Keywords>
      <Keywords>Uncoupling of mitochondrial function</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Liliana Peredo-Silva</Name>
        <Affiliation>Clinical and Molecular Pharmacology Program, Institute of Biomedical Sciences (ICBM), Faculty of Medicine, University of Chile, Av. Independencia 1027, Santiago 8380453, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Sebastián Fuentes-Retamal</Name>
        <Affiliation>Clinical and Molecular Pharmacology Program, Institute of Biomedical Sciences (ICBM), Faculty of Medicine, University of Chile, Av. Independencia 1027, Santiago 8380453, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Cristian Sandoval-Acuña</Name>
        <Affiliation>Institute of Biotechnology, Czech Academy of Sciences, Průmyslová 595, Vestec, 25250, Prague, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Mario Pavani</Name>
        <Affiliation>Clinical and Molecular Pharmacology Program, Institute of Biomedical Sciences (ICBM), Faculty of Medicine, University of Chile, Av. Independencia 1027, Santiago 8380453, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Juan D. Maya</Name>
        <Affiliation>Clinical and Molecular Pharmacology Program, Institute of Biomedical Sciences (ICBM), Faculty of Medicine, University of Chile, Av. Independencia 1027, Santiago 8380453, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Vicente Castro-Castillo</Name>
        <Affiliation>Department of Organic and Physical Chemistry, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santos Dumont 964, Santiago 8380494, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Matías Madrid-Rojas</Name>
        <Affiliation>Department of Chemistry, Faculty of Basic Sciences, Metropolitan University of Educational Sciences, Av. José Pedro Alessandri 774, Santiago 7760197, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Solange Rebolledo</Name>
        <Affiliation>Department of Chemistry, Faculty of Basic Sciences, Metropolitan University of Educational Sciences, Av. José Pedro Alessandri 774, Santiago 7760197, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Ulrike Kemmerling</Name>
        <Affiliation>Program of Anatomy and Developmental Biology, Institute of Biomedical Sciences (ICBM), Faculty of Medicine, University of Chile, Av. Independencia 1027, Santiago 8380453, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Eduardo Parra</Name>
        <Affiliation>School of Medicine, Faculty of Health Sciences, University of Tarapacá, Av. General Velásquez 1775, Arica 1000007, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Jorge Ferreira</Name>
        <Affiliation>Clinical and Molecular Pharmacology Program, Institute of Biomedical Sciences (ICBM), Faculty of Medicine, University of Chile, Av. Independencia 1027, Santiago 8380453, Chile. Electronic address: jferreir@med.uchile.cl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Substance P promotes hepatic stellate cell proliferation and activation via the TGF-β1/Smad-3 signaling pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28647476</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30276-4</DOI>
    <KeywordList>
      <Keywords>HSCs</Keywords>
      <Keywords>Liver fibrosis</Keywords>
      <Keywords>SMAD-3</Keywords>
      <Keywords>Substance P</Keywords>
      <Keywords>TGF-β1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lei Peng</Name>
        <Affiliation>Department of Hepatology and Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong Province 250012, PR China; Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06510, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoqing Jia</Name>
        <Affiliation>Department of Hepatology and Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong Province 250012, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianjian Zhao</Name>
        <Affiliation>Department of Hepatology and Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong Province 250012, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ruibing Cui</Name>
        <Affiliation>Department of Hepatology and Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong Province 250012, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Yan</Name>
        <Affiliation>Department of Hepatology and Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong Province 250012, PR China. Electronic address: ymylh@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Maternal exposure to a mixture of persistent organic pollutants (POPs) affects testis histology, epididymal sperm count and induces sperm DNA fragmentation in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28645691</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30275-2</DOI>
    <KeywordList>
      <Keywords>Persistent organic pollutants (POPs) mixture</Keywords>
      <Keywords>Reproductive toxicity</Keywords>
      <Keywords>Sperm chromatin structure assay (SCSA)</Keywords>
      <Keywords>Sperm count</Keywords>
      <Keywords>Testis histology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Abdolrahman Khezri</Name>
        <Affiliation>Department of Basic Science and Aquatic Medicine, Faculty of Veterinary Medicine, Norwegian University of Life Science, Pb. 8146 Dep, 0033 Oslo, Norway. Electronic address: Abdolrahman.Khezri@nmbu.no.</Affiliation>
      </Author>
      <Author>
        <Name>Birgitte Lindeman</Name>
        <Affiliation>Department of Toxicology and Risk, Norwegian Institute of Public Health, Pb 4404, 0403 Oslo, Norway. Electronic address: Birgitte.Lindeman@fhi.no.</Affiliation>
      </Author>
      <Author>
        <Name>Anette K. Krogenæs</Name>
        <Affiliation>Department of Production Animal Clinical Science, Faculty of Veterinary Medicine, Norwegian University of Life Science, Pb. 8146 Dep, 0033 Oslo, Norway. Electronic address: Anette.Krogenaes@nmbu.no.</Affiliation>
      </Author>
      <Author>
        <Name>Hanne F. Berntsen</Name>
        <Affiliation>Norwegian National Institute of Occupational Health, Pb. 8149 Dep, 0033 Oslo, Norway. Electronic address: Hanne.Berntsen@stami.no.</Affiliation>
      </Author>
      <Author>
        <Name>Karin E. Zimmer</Name>
        <Affiliation>Department of Basic Science and Aquatic Medicine, Faculty of Veterinary Medicine, Norwegian University of Life Science, Pb. 8146 Dep, 0033 Oslo, Norway. Electronic address: Karin.Zimmer@nmbu.no.</Affiliation>
      </Author>
      <Author>
        <Name>Erik Ropstad</Name>
        <Affiliation>Department of Production Animal Clinical Science, Faculty of Veterinary Medicine, Norwegian University of Life Science, Pb. 8146 Dep, 0033 Oslo, Norway. Electronic address: Erik.Ropstad@nmbu.no.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Modulation of the heart's electrical properties by the anticonvulsant drug retigabine.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28641963</pubmedLink>
    <GrantList>
      <Grant>P 23060</Grant>
      <Grant>W 1205</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30273-9</DOI>
    <KeywordList>
      <Keywords>Cardiac arrhythmia</Keywords>
      <Keywords>Cardiomyocytes</Keywords>
      <Keywords>Ion channels</Keywords>
      <Keywords>QT interval</Keywords>
      <Keywords>Retigabine</Keywords>
      <Keywords>Sympathetic ganglionic neurons</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lena Rubi</Name>
        <Affiliation>Center for Physiology and Pharmacology, Department of Neurophysiology and Pharmacology, Medical University of Vienna, Vienna, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Kovar</Name>
        <Affiliation>Center for Physiology and Pharmacology, Department of Neurophysiology and Pharmacology, Medical University of Vienna, Vienna, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>Eva Zebedin-Brandl</Name>
        <Affiliation>Center for Physiology and Pharmacology, Department of Neurophysiology and Pharmacology, Medical University of Vienna, Vienna, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>Xaver Koenig</Name>
        <Affiliation>Center for Physiology and Pharmacology, Department of Neurophysiology and Pharmacology, Medical University of Vienna, Vienna, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>Manuel Dominguez-Rodriguez</Name>
        <Affiliation>Center for Physiology and Pharmacology, Department of Neurophysiology and Pharmacology, Medical University of Vienna, Vienna, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>Hannes Todt</Name>
        <Affiliation>Center for Physiology and Pharmacology, Department of Neurophysiology and Pharmacology, Medical University of Vienna, Vienna, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>Helmut Kubista</Name>
        <Affiliation>Center for Physiology and Pharmacology, Department of Neurophysiology and Pharmacology, Medical University of Vienna, Vienna, Austria.</Affiliation>
      </Author>
      <Author>
        <Name>Stefan Boehm</Name>
        <Affiliation>Center for Physiology and Pharmacology, Department of Neurophysiology and Pharmacology, Medical University of Vienna, Vienna, Austria. Electronic address: stefan.boehm@meduniwien.ac.at.</Affiliation>
      </Author>
      <Author>
        <Name>Karlheinz Hilber</Name>
        <Affiliation>Center for Physiology and Pharmacology, Department of Neurophysiology and Pharmacology, Medical University of Vienna, Vienna, Austria. Electronic address: karlheinz.hilber@meduniwien.ac.at.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Arsenic alters transcriptional responses to Pseudomonas aeruginosa infection and decreases antimicrobial defense of human airway epithelial cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28625800</pubmedLink>
    <GrantList>
      <Grant>F32 ES025082</Grant>
      <Grant>P42 ES007373</Grant>
      <Grant>P30 CA023108</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30266-1</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Immunity</Keywords>
      <Keywords>Lung</Keywords>
      <Keywords>Lysozyme</Keywords>
      <Keywords>RNA-Seq</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Britton C. Goodale</Name>
        <Affiliation>Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, United States. Electronic address: britton.goodale@dartmouth.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Erica J. Rayack</Name>
        <Affiliation>Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Bruce A. Stanton</Name>
        <Affiliation>Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, NH 03755, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Distribution, lipid-bilayer affinity and kinetics of the metabolic effects of dinoseb in the liver.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28624444</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30269-7</DOI>
    <KeywordList>
      <Keywords>Hepatic metabolism</Keywords>
      <Keywords>Hepatic perfusion</Keywords>
      <Keywords>Herbicides</Keywords>
      <Keywords>Isolated mitochondria</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gabriela Bueno Franco Salla</Name>
        <Affiliation>Department of Biochemistry, University of Maringá, 87020900 Maringá, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Lívia Bracht</Name>
        <Affiliation>Department of Biochemistry, University of Maringá, 87020900 Maringá, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Anacharis Babeto de Sá-Nakanishi</Name>
        <Affiliation>Department of Biochemistry, University of Maringá, 87020900 Maringá, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Angela Valderrama Parizotto</Name>
        <Affiliation>Department of Biochemistry, University of Maringá, 87020900 Maringá, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Fabrício Bracht</Name>
        <Affiliation>Department of Biochemistry, University of Maringá, 87020900 Maringá, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Rosane Marina Peralta</Name>
        <Affiliation>Department of Biochemistry, University of Maringá, 87020900 Maringá, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Adelar Bracht</Name>
        <Affiliation>Department of Biochemistry, University of Maringá, 87020900 Maringá, Brazil. Electronic address: adebracht@uol.com.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inhibitory effect of trans-caryophyllene (TC) on leukocyte-endothelial attachment.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28624443</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30272-7</DOI>
    <KeywordList>
      <Keywords>IFN regulatory factor-1 (IRF-1)</Keywords>
      <Keywords>Type 2 cannabinoid receptor (CB2R)</Keywords>
      <Keywords>Vascular cell adhesion molecule-1 (VCAM-1)</Keywords>
      <Keywords>Vascular inflammation</Keywords>
      <Keywords>trans-Caryophyllene</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhen Zhang</Name>
        <Affiliation>Department of Pediatric ICU, The First Affiliated Hospital of Jilin University, Changchun 130021, Jilin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunfeng Yang</Name>
        <Affiliation>Department of Pediatric ICU, The First Affiliated Hospital of Jilin University, Changchun 130021, Jilin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xinlun Dai</Name>
        <Affiliation>Clinical Medical College, The First Affiliated Hospital of Jilin University, Changchun 130021, Jilin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Ao</Name>
        <Affiliation>Department of Pediatric ICU, The First Affiliated Hospital of Jilin University, Changchun 130021, Jilin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yumei Li</Name>
        <Affiliation>Department of Pediatric ICU, The First Affiliated Hospital of Jilin University, Changchun 130021, Jilin, China. Electronic address: yumei2888@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Loss of fructose-1,6-bisphosphatase induces glycolysis and promotes apoptosis resistance of cancer stem-like cells: an important role in hexavalent chromium-induced carcinogenesis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28624442</pubmedLink>
    <GrantList>
      <Grant>P30 CA177558</Grant>
      <Grant>R01 ES021771</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30270-3</DOI>
    <KeywordList>
      <Keywords>Cancer stem cells</Keywords>
      <Keywords>Cr(VI)</Keywords>
      <Keywords>Fructose-1,6-bisphosphatase</Keywords>
      <Keywords>Metabolism</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
      <Keywords>Tumorigenesis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jin Dai</Name>
        <Affiliation>Department of Toxicology and Cancer Biology, 1095 Veterans Drive, University of Kentucky, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yanli Ji</Name>
        <Affiliation>Department of Toxicology and Cancer Biology, 1095 Veterans Drive, University of Kentucky, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Wang</Name>
        <Affiliation>Department of Toxicology and Cancer Biology, 1095 Veterans Drive, University of Kentucky, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Donghern Kim</Name>
        <Affiliation>Department of Toxicology and Cancer Biology, 1095 Veterans Drive, University of Kentucky, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Leonard Yenwong Fai</Name>
        <Affiliation>Department of Toxicology and Cancer Biology, 1095 Veterans Drive, University of Kentucky, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lei Wang</Name>
        <Affiliation>Center for Research on Environmental Diseases, 1095 Veterans Drive, University of Kentucky, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jia Luo</Name>
        <Affiliation>Department of Pharmacology and Nutritional Sciences, 1095 Veterans Drive, University of Kentucky, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zhuo Zhang</Name>
        <Affiliation>Department of Toxicology and Cancer Biology, 1095 Veterans Drive, University of Kentucky, Lexington, KY 40536, USA. Electronic address: zhuo.zhang@uky.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Hsp90 inhibitor geldanamycin attenuates the cytotoxicity of sunitinib in cardiomyocytes via inhibition of the autophagy pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28624441</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30271-5</DOI>
    <KeywordList>
      <Keywords>Autophagy</Keywords>
      <Keywords>Cardiotoxicity</Keywords>
      <Keywords>Hsp90 inhibitor</Keywords>
      <Keywords>Human induced pluripotent stem cell</Keywords>
      <Keywords>Sunitinib</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Takayuki Kimura</Name>
        <Affiliation>Tsukuba Research Laboratories, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan; Department of Genomics-Based Drug Discovery, Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan. Electronic address: t4-kimura@hhc.eisai.co.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Mai Uesugi</Name>
        <Affiliation>Tsukuba Research Laboratories, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kazuma Takase</Name>
        <Affiliation>Tsukuba Research Laboratories, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Norimasa Miyamoto</Name>
        <Affiliation>Tsukuba Research Laboratories, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan; Department of Genomics-Based Drug Discovery, Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kohei Sawada</Name>
        <Affiliation>Tsukuba Research Laboratories, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635, Japan; Department of Genomics-Based Drug Discovery, Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Behavioral screening of the LOPAC</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28623180</pubmedLink>
    <GrantList>
      <Grant>T32 ES018827</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30267-3</DOI>
    <KeywordList>
      <Keywords>Behavior</Keywords>
      <Keywords>High-content screening</Keywords>
      <Keywords>LOPAC(1280)</Keywords>
      <Keywords>Spontaneous activity</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sara M. Vliet</Name>
        <Affiliation>Environmental Toxicology Graduate Program, University of California, Riverside, CA, USA; Department of Environmental Sciences, University of California, Riverside, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Trina C. Ho</Name>
        <Affiliation>Department of Environmental Sciences, University of California, Riverside, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David C. Volz</Name>
        <Affiliation>Department of Environmental Sciences, University of California, Riverside, CA, USA. Electronic address: david.volz@ucr.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Modulation of TGF-β/Smad and ERK signaling pathways mediates the anti-fibrotic effect of mirtazapine in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28623179</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30268-5</DOI>
    <KeywordList>
      <Keywords>5-HT</Keywords>
      <Keywords>5-HT2A receptor</Keywords>
      <Keywords>Extracellular signal regulated kinase 1 and 2</Keywords>
      <Keywords>Mirtazapine</Keywords>
      <Keywords>Smad</Keywords>
      <Keywords>Transforming growth factor-β1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dalia M. El-Tanbouly</Name>
        <Affiliation>Pharmacology and Toxicology Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Walaa Wadie</Name>
        <Affiliation>Pharmacology and Toxicology Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Rabab H. Sayed</Name>
        <Affiliation>Pharmacology and Toxicology Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt. Electronic address: rabab.sayed@pharma.cu.edu.eg.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Adrenal-derived stress hormones modulate ozone-induced lung injury and inflammation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28623178</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
      <Grant>T32 ES007126</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30265-X</DOI>
    <KeywordList>
      <Keywords>Adrenalectomy</Keywords>
      <Keywords>Lung</Keywords>
      <Keywords>Ozone</Keywords>
      <Keywords>RNAseq</Keywords>
      <Keywords>Stress hormones</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Andres Henriquez</Name>
        <Affiliation>Curriculum in Toxicology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>John House</Name>
        <Affiliation>Bioinformatics Research Center, North Carolina State University, Raleigh, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Desinia B. Miller</Name>
        <Affiliation>Curriculum in Toxicology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Samantha J. Snow</Name>
        <Affiliation>Environmental Public Health Division, National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Fisher</Name>
        <Affiliation>Research Cores Unit, National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Hongzu Ren</Name>
        <Affiliation>Research Cores Unit, National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mette C. Schladweiler</Name>
        <Affiliation>Environmental Public Health Division, National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Allen D. Ledbetter</Name>
        <Affiliation>Environmental Public Health Division, National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Fred Wright</Name>
        <Affiliation>Bioinformatics Research Center, North Carolina State University, Raleigh, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Urmila P. Kodavanti</Name>
        <Affiliation>Environmental Public Health Division, National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States. Electronic address: kodavanti.urmila@epa.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Zingerone reduces HMGB1-mediated septic responses and improves survival in septic mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28610995</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30262-4</DOI>
    <KeywordList>
      <Keywords>Endothelium</Keywords>
      <Keywords>HMGB1</Keywords>
      <Keywords>Sepsis</Keywords>
      <Keywords>Zingerone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wonhwa Lee</Name>
        <Affiliation>College of Pharmacy, CMRI, Research Institute of Pharmaceutical Sciences, BK21 Plus KNU Multi-Omics based Creative Drug Research Team, Kyungpook National University, Daegu 41566, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sae Kwang Ku</Name>
        <Affiliation>Department of Anatomy and Histology, College of Korean Medicine, Daegu Haany University, Gyeongsan 38610, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jong Sup Bae</Name>
        <Affiliation>College of Pharmacy, CMRI, Research Institute of Pharmaceutical Sciences, BK21 Plus KNU Multi-Omics based Creative Drug Research Team, Kyungpook National University, Daegu 41566, Republic of Korea. Electronic address: baejs@knu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Manganese-induced sex-specific gut microbiome perturbations in C57BL/6 mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28610994</pubmedLink>
    <GrantList>
      <Grant>P30 ES010126</Grant>
      <Grant>R01 ES024950</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30264-8</DOI>
    <KeywordList>
      <Keywords>Gut microbiome</Keywords>
      <Keywords>Gut-brain axis</Keywords>
      <Keywords>Manganese exposure</Keywords>
      <Keywords>Metabolome</Keywords>
      <Keywords>Metagenomics</Keywords>
      <Keywords>Sex-specific toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Liang Chi</Name>
        <Affiliation>Department of Environmental Sciences and Engineering, University of North Carolina at Chapel Hill, 27599, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Bei Gao</Name>
        <Affiliation>Department of Environmental Health Science, University of Georgia, Athens, GA 30602, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoming Bian</Name>
        <Affiliation>Department of Environmental Health Science, University of Georgia, Athens, GA 30602, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Pengcheng Tu</Name>
        <Affiliation>Department of Environmental Sciences and Engineering, University of North Carolina at Chapel Hill, 27599, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Hongyu Ru</Name>
        <Affiliation>Department of Population Health and Pathobiology, North Carolina State University, Raleigh, NC 27607, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Kun Lu</Name>
        <Affiliation>Department of Environmental Sciences and Engineering, University of North Carolina at Chapel Hill, 27599, United States. Electronic address: kunlu@unc.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of a co-micronized composite containing palmitoylethanolamide and polydatin in an experimental model of benign prostatic hyperplasia.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28610993</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30261-2</DOI>
    <KeywordList>
      <Keywords>Benign prostatic hyperplasia</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Palmitoylethanolamide</Keywords>
      <Keywords>Polydatin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marika Cordaro</Name>
        <Affiliation>Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D'Alcontres 31, 98166 Messina, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Daniela Impellizzeri</Name>
        <Affiliation>Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D'Alcontres 31, 98166 Messina, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Rosalba Siracusa</Name>
        <Affiliation>Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D'Alcontres 31, 98166 Messina, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Enrico Gugliandolo</Name>
        <Affiliation>Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D'Alcontres 31, 98166 Messina, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Roberta Fusco</Name>
        <Affiliation>Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D'Alcontres 31, 98166 Messina, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Antonino Inferrera</Name>
        <Affiliation>Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", AUO "Gaetano Martino", Via Consolare Valeria 1, 98125 Messina, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Emanuela Esposito</Name>
        <Affiliation>Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D'Alcontres 31, 98166 Messina, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Rosanna Di Paola</Name>
        <Affiliation>Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D'Alcontres 31, 98166 Messina, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Salvatore Cuzzocrea</Name>
        <Affiliation>Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno D'Alcontres 31, 98166 Messina, Italy; Department of Pharmacological and Physiological Science, Saint Louis University School of Medicine, 1402 South Grand Blvd, St Louis, MO 63104, USA. Electronic address: salvator@unime.it.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Anti-liver cancer activity in vitro and in vivo induced by 2-pyridyl 2,3-thiazole derivatives.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28610992</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30259-4</DOI>
    <KeywordList>
      <Keywords>2-Pyridyl 2,3-thiazoles</Keywords>
      <Keywords>Antitumor</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>HepG2</Keywords>
      <Keywords>Liver Cancer</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Thiago David Dos Santos Silva</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Health Sciences Center, Federal University of Pernambuco, 50740-520 Recife, PE, Brazil; Department of Physiology and Pharmacology, Federal University of Pernambuco, 50670-901 Recife, PE, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Larissa Mendes Bomfim</Name>
        <Affiliation>Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), 40296-710 Salvador, Bahia, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Carolina Borges da Cruz Rodrigues</Name>
        <Affiliation>Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), 40296-710 Salvador, Bahia, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Rosane Borges Dias</Name>
        <Affiliation>Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), 40296-710 Salvador, Bahia, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Caroline Brandi Schlaepfer Sales</Name>
        <Affiliation>Department of Biomorphology, Institute of Health Sciences, Federal University of Bahia, 40110-902 Salvador, Bahia, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Clarissa Araújo Gurgel Rocha</Name>
        <Affiliation>Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), 40296-710 Salvador, Bahia, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Milena Botelho Pereira Soares</Name>
        <Affiliation>Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), 40296-710 Salvador, Bahia, Brazil.; Center of Biotechnology and Cell therapy, Hospital São Rafael, 41253-190 Salvador, Bahia, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Pereira Bezerra</Name>
        <Affiliation>Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), 40296-710 Salvador, Bahia, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Marcos Veríssimo de Oliveira Cardoso</Name>
        <Affiliation>Collegiate of Nutrition, University of Pernambuco, 56328-903 Petrolina, PE, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Cristina Lima Leite</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Health Sciences Center, Federal University of Pernambuco, 50740-520 Recife, PE, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Gardenia Carmen Gadelha Militão</Name>
        <Affiliation>Department of Physiology and Pharmacology, Federal University of Pernambuco, 50670-901 Recife, PE, Brazil. Electronic address: gcgadelha@yahoo.com.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Antitumor effectiveness of a combined therapy with a new cucurbitacin B derivative and paclitaxel on a human lung cancer xenograft model.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28610991</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30263-6</DOI>
    <KeywordList>
      <Keywords>Antitumor effect</Keywords>
      <Keywords>Cucurbitacins</Keywords>
      <Keywords>Lung cancer</Keywords>
      <Keywords>Paclitaxel</Keywords>
      <Keywords>Scintigraphic images</Keywords>
      <Keywords>Xenograft lung tumor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lucas Lourenço Marostica</Name>
        <Affiliation>Departamento de Ciências Farmacêuticas, Centro de Ciências da Saúde, Universidade Federal de Santa Catarina, Campus Trindade, CEP 88040-900 Florianópolis, Santa Catarina, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>André Luís Branco de Barros</Name>
        <Affiliation>Departamento de Produtos Farmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Campus Pampulha, CEP 31270-901 Belo Horizonte, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Juliana Oliveira</Name>
        <Affiliation>Departamento de Produtos Farmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Campus Pampulha, CEP 31270-901 Belo Horizonte, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Breno Souza Salgado</Name>
        <Affiliation>Departamento de Patologia, Centro de Ciências da Saúde, Universidade Federal do Espírito Santo, Campus Maruípe, CEP 29075-910 Vitória, Espírito Santo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Geovanni Dantas Cassali</Name>
        <Affiliation>Departamento de Patologia Geral, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Campus Pampulha, CEP 31270-901 Belo Horizonte, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Elaine Amaral Leite</Name>
        <Affiliation>Departamento de Produtos Farmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Campus Pampulha, CEP 31270-901 Belo Horizonte, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Valbert Nascimento Cardoso</Name>
        <Affiliation>Departamento de Produtos Farmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Campus Pampulha, CEP 31270-901 Belo Horizonte, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Karen Luise Lang</Name>
        <Affiliation>Departamento de Ciências Farmacêuticas, Centro de Ciências da Saúde, Universidade Federal de Santa Catarina, Campus Trindade, CEP 88040-900 Florianópolis, Santa Catarina, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Miguel Soriano Balparda Caro</Name>
        <Affiliation>Departamento de Química, Centro de Ciências Físicas e Matemáticas, Universidade Federal de Santa Catarina, Campus Trindade, CEP 88040-900 Florianópolis, SC, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Fernando Javier Durán</Name>
        <Affiliation>UMYMFOR-CONICET, Departamento de Química Orgánica, Universidad de Buenos Aires, Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Eloir Paulo Schenkel</Name>
        <Affiliation>Departamento de Ciências Farmacêuticas, Centro de Ciências da Saúde, Universidade Federal de Santa Catarina, Campus Trindade, CEP 88040-900 Florianópolis, Santa Catarina, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Mônica Cristina de Oliveira</Name>
        <Affiliation>Departamento de Produtos Farmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Campus Pampulha, CEP 31270-901 Belo Horizonte, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Cláudia Maria Oliveira Simões</Name>
        <Affiliation>Departamento de Ciências Farmacêuticas, Centro de Ciências da Saúde, Universidade Federal de Santa Catarina, Campus Trindade, CEP 88040-900 Florianópolis, Santa Catarina, Brazil. Electronic address: claudia.simoes@ufsc.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Radiation exposure from depleted uranium: The radiation bystander effect.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28602947</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30260-0</DOI>
    <AuthorList>
      <Author>
        <Name>Alexandra C. Miller</Name>
        <Affiliation>Science Research Department, Armed Forces Radiobiology Research Institute, Radiology and Radiation Sciences Department, Uniformed Services University of the Health Sciences, Bethesda, MD 20889, United States; Center for Radiological Research, Columbia University Medical Center, Columbia University, New York, NY 10022, United States; New York University, School of Medicine, 550 First Avenue, New York, NY 10016, United States. Electronic address: alexandra.miller@usuhs.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Rafael Rivas</Name>
        <Affiliation>Science Research Department, Armed Forces Radiobiology Research Institute, Radiology and Radiation Sciences Department, Uniformed Services University of the Health Sciences, Bethesda, MD 20889, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Leonard Tesoro</Name>
        <Affiliation>Science Research Department, Armed Forces Radiobiology Research Institute, Radiology and Radiation Sciences Department, Uniformed Services University of the Health Sciences, Bethesda, MD 20889, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Gregor Kovalenko</Name>
        <Affiliation>New York University, School of Medicine, 550 First Avenue, New York, NY 10016, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Nikola Kovaric</Name>
        <Affiliation>New York University, School of Medicine, 550 First Avenue, New York, NY 10016, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Pavlovic</Name>
        <Affiliation>New York University, School of Medicine, 550 First Avenue, New York, NY 10016, United States.</Affiliation>
      </Author>
      <Author>
        <Name>David Brenner</Name>
        <Affiliation>Center for Radiological Research, Columbia University Medical Center, Columbia University, New York, NY 10022, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Characterization of xenobiotic metabolizing enzymes of a reconstructed human epidermal model from adult hair follicles.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28601433</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30258-2</DOI>
    <KeywordList>
      <Keywords>Cutaneous metabolism</Keywords>
      <Keywords>Functional activity</Keywords>
      <Keywords>Gene expression</Keywords>
      <Keywords>Hair follicle</Keywords>
      <Keywords>Reconstructed human epidermis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Daniel Bacqueville</Name>
        <Affiliation>Pierre Fabre Dermo-cosmétique, Service Pharmacologie Division 2 et Pharmacocinétique Cutané, Département Pharmacologie, Centre R&amp;D Pierre Fabre, 3 avenue Hubert Curien, Toulouse, France. Electronic address: daniel.bacqueville@pierre-fabre.com.</Affiliation>
      </Author>
      <Author>
        <Name>Carine Jacques</Name>
        <Affiliation>Pierre Fabre Dermo-cosmétique, Service Pharmacologie Division 2 et Pharmacocinétique Cutané, Département Pharmacologie, Centre R&amp;D Pierre Fabre, 3 avenue Hubert Curien, Toulouse, France.</Affiliation>
      </Author>
      <Author>
        <Name>Laure Duprat</Name>
        <Affiliation>Pierre Fabre Dermo-cosmétique, Service Pharmacologie Division 2 et Pharmacocinétique Cutané, Département Pharmacologie, Centre R&amp;D Pierre Fabre, 3 avenue Hubert Curien, Toulouse, France.</Affiliation>
      </Author>
      <Author>
        <Name>Emilien L. Jamin</Name>
        <Affiliation>Toxalim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, Toulouse, France.</Affiliation>
      </Author>
      <Author>
        <Name>Beatrice Guiraud</Name>
        <Affiliation>Pierre Fabre Dermo-cosmétique, Service Pharmacologie Division 2 et Pharmacocinétique Cutané, Département Pharmacologie, Centre R&amp;D Pierre Fabre, 3 avenue Hubert Curien, Toulouse, France.</Affiliation>
      </Author>
      <Author>
        <Name>Elisabeth Perdu</Name>
        <Affiliation>Toxalim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, Toulouse, France.</Affiliation>
      </Author>
      <Author>
        <Name>Sandrine Bessou-Touya</Name>
        <Affiliation>Pierre Fabre Dermo-cosmétique, Service Pharmacologie Division 2 et Pharmacocinétique Cutané, Département Pharmacologie, Centre R&amp;D Pierre Fabre, 3 avenue Hubert Curien, Toulouse, France.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Zalko</Name>
        <Affiliation>Toxalim (Research Centre in Food Toxicology), Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, Toulouse, France.</Affiliation>
      </Author>
      <Author>
        <Name>Hélène Duplan</Name>
        <Affiliation>Pierre Fabre Dermo-cosmétique, Service Pharmacologie Division 2 et Pharmacocinétique Cutané, Département Pharmacologie, Centre R&amp;D Pierre Fabre, 3 avenue Hubert Curien, Toulouse, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Curcumin inhibits adipogenesis induced by benzyl butyl phthalate in 3T3-L1 cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28595985</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30252-1</DOI>
    <KeywordList>
      <Keywords>3T3-L1 cell</Keywords>
      <Keywords>Adipocyte differentiation</Keywords>
      <Keywords>Benzyl butyl phthalate</Keywords>
      <Keywords>Curcumin</Keywords>
      <Keywords>Tumor necrosis factor-α</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Satoru Sakuma</Name>
        <Affiliation>Laboratory of Physiological Chemistry, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan. Electronic address: sakuma@gly.oups.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Maki Sumida</Name>
        <Affiliation>Laboratory of Physiological Chemistry, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yukiko Endoh</Name>
        <Affiliation>Laboratory of Physiological Chemistry, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Ayaka Kurita</Name>
        <Affiliation>Laboratory of Physiological Chemistry, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Ayana Yamaguchi</Name>
        <Affiliation>Laboratory of Physiological Chemistry, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tomoki Watanabe</Name>
        <Affiliation>Laboratory of Physiological Chemistry, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tetsuya Kohda</Name>
        <Affiliation>Laboratory of Physiological Chemistry, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yui Tsukiyama</Name>
        <Affiliation>Laboratory of Physiological Chemistry, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yohko Fujimoto</Name>
        <Affiliation>Laboratory of Physiological Chemistry, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan. Electronic address: fujimoto@gly.oups.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cell cycle pathway dysregulation in human keratinocytes during chronic exposure to low arsenite.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28595984</pubmedLink>
    <GrantList>
      <Grant>P20 GM103436</Grant>
      <Grant>P30 GM106396</Grant>
      <Grant>R21 ES023627</Grant>
      <Grant>T35 ES014559</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30257-0</DOI>
    <KeywordList>
      <Keywords>Arsenic-induced skin cancer</Keywords>
      <Keywords>Carcinogenesis</Keywords>
      <Keywords>Cell cycle</Keywords>
      <Keywords>Chronic exposure</Keywords>
      <Keywords>Transformation</Keywords>
      <Keywords>mRNA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Laila Al-Eryani</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Sabine Waigel</Name>
        <Affiliation>Department of Medicine, University of Louisville, Louisville, KY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Venkatakrishna Jala</Name>
        <Affiliation>Department of Microbiology and Immunology, University of Louisville, Louisville, KY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Samantha F. Jenkins</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>J. Christopher States</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY, United States. Electronic address: jcstates@louisville.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Human renal tubular cells contain CD24/CD133 progenitor cell populations: Implications for tubular regeneration after toxicant induced damage using cadmium as a model.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28587817</pubmedLink>
    <GrantList>
      <Grant>P20 GM103442</Grant>
      <Grant>P20 GM113123</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30255-7</DOI>
    <KeywordList>
      <Keywords>CD24/CD133</Keywords>
      <Keywords>Cadmium</Keywords>
      <Keywords>Kidney</Keywords>
      <Keywords>RPTEC/TERT1</Keywords>
      <Keywords>Stem cells</Keywords>
      <Keywords>Tubular cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Swojani Shrestha</Name>
        <Affiliation>Department of Pathology, University of North Dakota, School of Medicine and Health Sciences, 1301 N. Columbia Road, Stop 9037, Grand Forks, ND 58202, United States. Electronic address: swojani.shrestha@und.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Seema Somji</Name>
        <Affiliation>Department of Pathology, University of North Dakota, School of Medicine and Health Sciences, 1301 N. Columbia Road, Stop 9037, Grand Forks, ND 58202, United States. Electronic address: seema.somji@med.und.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Donald A. Sens</Name>
        <Affiliation>Department of Pathology, University of North Dakota, School of Medicine and Health Sciences, 1301 N. Columbia Road, Stop 9037, Grand Forks, ND 58202, United States. Electronic address: donald.sens@med.und.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Slusser-Nore</Name>
        <Affiliation>Department of Pathology, University of North Dakota, School of Medicine and Health Sciences, 1301 N. Columbia Road, Stop 9037, Grand Forks, ND 58202, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Divyen H. Patel</Name>
        <Affiliation>Genome Explorations, Division of Compass Lab Services, 654 Jefferson Avenue, Memphis, TN 38105, United States. Electronic address: dpatel@COMPASSLABSERVICES.COM.</Affiliation>
      </Author>
      <Author>
        <Name>Evan Savage</Name>
        <Affiliation>Genome Explorations, Division of Compass Lab Services, 654 Jefferson Avenue, Memphis, TN 38105, United States. Electronic address: esavage@COMPASSLABSERVICES.COM.</Affiliation>
      </Author>
      <Author>
        <Name>Scott H. Garrett</Name>
        <Affiliation>Department of Pathology, University of North Dakota, School of Medicine and Health Sciences, 1301 N. Columbia Road, Stop 9037, Grand Forks, ND 58202, United States. Electronic address: scott.garrett@med.und.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Transgenerational inheritance of neurobehavioral and physiological deficits from developmental exposure to benzo[a]pyrene in zebrafish.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28583304</pubmedLink>
    <GrantList>
      <Grant>P30 ES000210</Grant>
      <Grant>P30 ES025128</Grant>
      <Grant>P42 ES016465</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30239-9</DOI>
    <KeywordList>
      <Keywords>Aryl hydrocarbon receptor</Keywords>
      <Keywords>Benzo[a]pyrene</Keywords>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Neurobehavioral</Keywords>
      <Keywords>Physiological deficits</Keywords>
      <Keywords>Transgenerational</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Andrea L. Knecht</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, The Sinnhuber Aquatic Research Laboratory, Environmental Health Sciences Center, Oregon State University, Corvallis, OR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa Truong</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, The Sinnhuber Aquatic Research Laboratory, Environmental Health Sciences Center, Oregon State University, Corvallis, OR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Skylar W. Marvel</Name>
        <Affiliation>Department of Biological Sciences, Bioinformatics Research Center, Center for Human Health and the Environment, North Carolina State University, Raleigh, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David M. Reif</Name>
        <Affiliation>Department of Biological Sciences, Bioinformatics Research Center, Center for Human Health and the Environment, North Carolina State University, Raleigh, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Abraham Garcia</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, The Sinnhuber Aquatic Research Laboratory, Environmental Health Sciences Center, Oregon State University, Corvallis, OR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Catherine Lu</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, The Sinnhuber Aquatic Research Laboratory, Environmental Health Sciences Center, Oregon State University, Corvallis, OR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael T. Simonich</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, The Sinnhuber Aquatic Research Laboratory, Environmental Health Sciences Center, Oregon State University, Corvallis, OR, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Justin G. Teeguarden</Name>
        <Affiliation>Health Effects and Exposure Science, Pacific Northwest National Laboratory, Richland, WA 99352, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert L. Tanguay</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, The Sinnhuber Aquatic Research Laboratory, Environmental Health Sciences Center, Oregon State University, Corvallis, OR, USA. Electronic address: Robert.Tanguay@oregonstate.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Biological implications of selenium in adolescent rats exposed to binge drinking: Oxidative, immunologic and apoptotic balance.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28579252</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30253-3</DOI>
    <KeywordList>
      <Keywords>Adolescence</Keywords>
      <Keywords>Binge drinking</Keywords>
      <Keywords>Caspasa-3</Keywords>
      <Keywords>NfkB</Keywords>
      <Keywords>Selenium supplementation</Keywords>
      <Keywords>Selenoproteins</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>M. Luisa Ojeda</Name>
        <Affiliation>Department of Physiology, Faculty of Pharmacy, Seville University, 41012 Seville, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Olimpia Carreras</Name>
        <Affiliation>Department of Physiology, Faculty of Pharmacy, Seville University, 41012 Seville, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Paula Sobrino</Name>
        <Affiliation>Department of Physiology, Faculty of Pharmacy, Seville University, 41012 Seville, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>M. Luisa Murillo</Name>
        <Affiliation>Department of Physiology, Faculty of Pharmacy, Seville University, 41012 Seville, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Fátima Nogales</Name>
        <Affiliation>Department of Physiology, Faculty of Pharmacy, Seville University, 41012 Seville, Spain. Electronic address: fnogales@us.es.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Perinatal exposure to organohalogen pollutants decreases vasopressin content and its mRNA expression in magnocellular neuroendocrine cells activated by osmotic stress in adult rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28579251</pubmedLink>
    <GrantList>
      <Grant>EPA999999</Grant>
      <Grant>EPA999999</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30254-5</DOI>
    <KeywordList>
      <Keywords>Neuroendocrine disruption</Keywords>
      <Keywords>PBDEs</Keywords>
      <Keywords>PCBs</Keywords>
      <Keywords>Salt loading</Keywords>
      <Keywords>Vasopressin</Keywords>
      <Keywords>cFOS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Samuel Mucio-Ramírez</Name>
        <Affiliation>Departamento de Neuromorfología Funcional, Dirección de Investigaciones en Neurociencias, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Calz. México Xochimilco No. 101, Col. San Lorenzo Huipulco, México D.F. C.P. 14370, México. Electronic address: mucios@imp.edu.mx.</Affiliation>
      </Author>
      <Author>
        <Name>Eduardo Sánchez-Islas</Name>
        <Affiliation>Departamento de Neuromorfología Funcional, Dirección de Investigaciones en Neurociencias, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Calz. México Xochimilco No. 101, Col. San Lorenzo Huipulco, México D.F. C.P. 14370, México. Electronic address: edaxy@imp.edu.mx.</Affiliation>
      </Author>
      <Author>
        <Name>Edith Sánchez-Jaramillo</Name>
        <Affiliation>Laboratorio de Neuroendocrinología Molecular, Dirección de Investigaciones en Neurociencias, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Calz. México Xochimilco No. 101, Col. San Lorenzo Huipulco. México D.F. C.P. 14370, México. Electronic address: esanchez@imp.edu.mx.</Affiliation>
      </Author>
      <Author>
        <Name>Margarita Currás-Collazo</Name>
        <Affiliation>Department of Cell Biology and Neuroscience, University of California, Riverside, CA 92521, USA. Electronic address: margarita.curras@ucr.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Victor R. Juárez-González</Name>
        <Affiliation>Medicina Molecular y Bioprocesos, Instituto de Biotecnología, UNAM, Av. Universidad #2001, Col. Chamilpa, C.P. 62210 Cuernavaca, Morelos, México. Electronic address: rivelino@ibt.unam.mx.</Affiliation>
      </Author>
      <Author>
        <Name>Mhar Y. Álvarez-González</Name>
        <Affiliation>Departamento de Neuromorfología Funcional, Dirección de Investigaciones en Neurociencias, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Calz. México Xochimilco No. 101, Col. San Lorenzo Huipulco, México D.F. C.P. 14370, México. Electronic address: mhar123@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>L. E. Orser</Name>
        <Affiliation>Department of Cell Biology and Neuroscience, University of California, Riverside, CA 92521, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Borin Hou</Name>
        <Affiliation>Department of Cell Biology and Neuroscience, University of California, Riverside, CA 92521, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Francisco Pellicer</Name>
        <Affiliation>Laboratorio de Fisiología Integrativa, Dirección de Investigaciones en Neurociencias, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz. Calz. México Xochimilco No. 101, Col. San Lorenzo Huipulco, México D.F. C.P. 14370, México. Electronic address: pellicer@imp.edu.mx.</Affiliation>
      </Author>
      <Author>
        <Name>Prasada Rao S. Kodavanti</Name>
        <Affiliation>Neurotoxicology Branch, Toxicity Assessment Division, NHEERL/ORD, US Environmental Protection Agency, Research Triangle Park, NC 27711, USA. Electronic address: Kodavanti.Prasada@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Martha León-Olea</Name>
        <Affiliation>Departamento de Neuromorfología Funcional, Dirección de Investigaciones en Neurociencias, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Calz. México Xochimilco No. 101, Col. San Lorenzo Huipulco, México D.F. C.P. 14370, México. Electronic address: marthalo@imp.edu.mx.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>DNA methylation of extracellular matrix remodeling genes in children exposed to arsenic.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28579250</pubmedLink>
    <GrantList>
      <Grant>P30 ES006694</Grant>
      <Grant>P42 ES004940</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30256-9</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Children</Keywords>
      <Keywords>DNA methylation</Keywords>
      <Keywords>MMP9</Keywords>
      <Keywords>RAGE</Keywords>
      <Keywords>TIMP1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tania Gonzalez-Cortes</Name>
        <Affiliation>Department of Environmental Health, Biomedical Research Center, School of Medicine, University of Coahuila, Torreon, Coahuila, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>Rogelio Recio-Vega</Name>
        <Affiliation>Department of Environmental Health, Biomedical Research Center, School of Medicine, University of Coahuila, Torreon, Coahuila, Mexico. Electronic address: rogeliorecio@uadec.edu.mx.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Clark Lantz</Name>
        <Affiliation>Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ, United States; Southwest Environmental Health Science Center, University of Arizona, Tucson, AZ, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Binh T. Chau</Name>
        <Affiliation>Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Bisphenol A impairs the memory function and glutamatergic homeostasis in a sex-dependent manner in mice: Beneficial effects of diphenyl diselenide.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28572023</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30241-7</DOI>
    <KeywordList>
      <Keywords>Bisphenol A</Keywords>
      <Keywords>Glutamatergic system</Keywords>
      <Keywords>Memory</Keywords>
      <Keywords>Organoseleniun</Keywords>
      <Keywords>Sex</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Natália S. Jardim</Name>
        <Affiliation>Laboratório de Síntese, Reatividade e Avaliação Farmacológica e Toxicológica de Organocalcogênios, Centro de Ciências Naturais e Exatas, Universidade Federal de Santa Maria, Santa Maria CEP 97105-900, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Glaúbia Sartori</Name>
        <Affiliation>Laboratório de Síntese, Reatividade e Avaliação Farmacológica e Toxicológica de Organocalcogênios, Centro de Ciências Naturais e Exatas, Universidade Federal de Santa Maria, Santa Maria CEP 97105-900, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Marcel H. M. Sari</Name>
        <Affiliation>Laboratório de Síntese, Reatividade e Avaliação Farmacológica e Toxicológica de Organocalcogênios, Centro de Ciências Naturais e Exatas, Universidade Federal de Santa Maria, Santa Maria CEP 97105-900, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Sabrina G. Müller</Name>
        <Affiliation>Laboratório de Síntese, Reatividade e Avaliação Farmacológica e Toxicológica de Organocalcogênios, Centro de Ciências Naturais e Exatas, Universidade Federal de Santa Maria, Santa Maria CEP 97105-900, RS, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Cristina W. Nogueira</Name>
        <Affiliation>Laboratório de Síntese, Reatividade e Avaliação Farmacológica e Toxicológica de Organocalcogênios, Centro de Ciências Naturais e Exatas, Universidade Federal de Santa Maria, Santa Maria CEP 97105-900, RS, Brazil. Electronic address: criswn@ufsm.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Galangin ameliorates cisplatin-induced nephrotoxicity by attenuating oxidative stress, inflammation and cell death in mice through inhibition of ERK and NF-kappaB signaling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28558962</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30240-5</DOI>
    <KeywordList>
      <Keywords>Cisplatin nephrotoxicity</Keywords>
      <Keywords>ERK</Keywords>
      <Keywords>Galangin</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>NF-κB</Keywords>
      <Keywords>Oxidative stress</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yu Ching Huang</Name>
        <Affiliation>Department of Bioindustry Technology, Da-Yeh University, Taiwan, Republic of China; Department of Neurology, Taoyuan General Hospital, Ministry of Health and Welfare, Executive Yuan, Taiwan, Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Shiun Tsai</Name>
        <Affiliation>Department of Bioindustry Technology, Da-Yeh University, Taiwan, Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Pei Chi Hsieh</Name>
        <Affiliation>Department of Biomedical Sciences, Chung Shan Medical University, Taiwan, Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Jheng Hong Shih</Name>
        <Affiliation>Department of Biomedical Sciences, Chung Shan Medical University, Taiwan, Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Tsu Shing Wang</Name>
        <Affiliation>Department of Biomedical Sciences, Chung Shan Medical University, Taiwan, Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Chun Wang</Name>
        <Affiliation>Department of Biomedical Sciences, Chung Shan Medical University, Taiwan, Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Ting Hui Lin</Name>
        <Affiliation>Department of Biomedical Sciences, Chung Shan Medical University, Taiwan, Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Sue Hong Wang</Name>
        <Affiliation>Department of Biomedical Sciences, Chung Shan Medical University, Taiwan, Republic of China; Department of Medical Research, Chung Shan Medical University Hospital, Taiwan, Republic of China. Electronic address: wangsh@csmu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Using DR52c/Ni</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28554661</pubmedLink>
    <GrantList>
      <Grant>R01 ES025797</Grant>
      <Grant>R21 ES025885</Grant>
      <Grant>T32 AI074491</Grant>
      <Grant>T32 AR007534</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30214-4</DOI>
    <KeywordList>
      <Keywords>CD4(+) T cells</Keywords>
      <Keywords>HLA</Keywords>
      <Keywords>Joint implants</Keywords>
      <Keywords>Metal allergy</Keywords>
      <Keywords>Metal toxicology</Keywords>
      <Keywords>Tetramer</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yan Zhang</Name>
        <Affiliation>Department of Biomedical Research, National Jewish Health, Denver, CO 80206, USA; Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO 80045, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Wang</Name>
        <Affiliation>Department of Biomedical Research, National Jewish Health, Denver, CO 80206, USA; Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO 80045, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kirsten Anderson</Name>
        <Affiliation>Department of Biomedical Research, National Jewish Health, Denver, CO 80206, USA; Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO 80045, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Andrey Novikov</Name>
        <Affiliation>Department of Biomedical Research, National Jewish Health, Denver, CO 80206, USA; Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO 80045, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zikou Liu</Name>
        <Affiliation>Department of Biomedical Research, National Jewish Health, Denver, CO 80206, USA; Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO 80045, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Karin Pacheco</Name>
        <Affiliation>Department of Medicine, National Jewish Health, Denver, CO 80206, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Shaodong Dai</Name>
        <Affiliation>Department of Biomedical Research, National Jewish Health, Denver, CO 80206, USA; Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO 80045, USA. Electronic address: dais@njhealth.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nanotechnology in agriculture: Opportunities, toxicological implications, and occupational risks.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28554660</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30231-4</DOI>
    <KeywordList>
      <Keywords>Nano-enabled agrochemicals</Keywords>
      <Keywords>Nano-enhanced environmental remediation</Keywords>
      <Keywords>Nanocellulose</Keywords>
      <Keywords>Nanotechnology</Keywords>
      <Keywords>Nanotoxicology</Keywords>
      <Keywords>Occupational risk assessment and management</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ivo Iavicoli</Name>
        <Affiliation>Department of Public Health, Division of Occupational Medicine, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy. Electronic address: ivo.iavicoli@unina.it.</Affiliation>
      </Author>
      <Author>
        <Name>Veruscka Leso</Name>
        <Affiliation>Department of Public Health, Division of Occupational Medicine, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Donald H. Beezhold</Name>
        <Affiliation>National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, 1095 Willowdale Rd., Morgantown, WV, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Anna A. Shvedova</Name>
        <Affiliation>National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, 1095 Willowdale Rd., Morgantown, WV, United States; Department of Physiology and Pharmacology, School of Medicine, West Virginia University, Robert C. Byrd Health Sciences Center, P.O. Box 9229, Morgantown, WV, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Naloxegol, an opioid antagonist with reduced CNS penetration: Mode-of-action and human relevance for rat testicular tumours.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28554659</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30238-7</DOI>
    <KeywordList>
      <Keywords>Leydig cell tumour</Keywords>
      <Keywords>Luteinizing hormone</Keywords>
      <Keywords>Opioid antagonist</Keywords>
      <Keywords>Testis</Keywords>
      <Keywords>Testosterone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Håkan Andersson</Name>
        <Affiliation>Department of Pathology, Drug Safety &amp; Metabolism, Innovative Medicines and Early Development, AstraZeneca, Gothenburg, Sweden. Electronic address: bhanderssonx@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Terri Mitchard</Name>
        <Affiliation>Department of Regulatory Safety, Drug Safety &amp; Metabolism, Innovative Medicines and Early Development, AstraZeneca, Cambridge, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Nakpangi Johnson</Name>
        <Affiliation>Department of Laboratory Animal Sciences, Drug Safety &amp; Metabolism, Innovative Medicines and Early Development, AstraZeneca, Boston, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Eike Floettmann</Name>
        <Affiliation>Department of Regulatory Safety, Drug Safety &amp; Metabolism, Innovative Medicines and Early Development, AstraZeneca, Cambridge, United Kingdom; AstraZenweca, Department of Non-Clinical Drug Safety, Mundipharma Research Ltd., Cambridge, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Prolonged exposure to particulate chromate inhibits RAD51 nuclear import mediator proteins.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28554658</pubmedLink>
    <GrantList>
      <Grant>R01 ES016893</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30236-3</DOI>
    <KeywordList>
      <Keywords>BRCA2</Keywords>
      <Keywords>Nuclear import</Keywords>
      <Keywords>Particulate chromium (VI)</Keywords>
      <Keywords>RAD51 cytoplasmic accumulation</Keywords>
      <Keywords>RAD51C</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cynthia L. Browning</Name>
        <Affiliation>Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40292, United States; Graduate School of Biomedical Science and Engineering, University of Maine, Orono, ME 04469, United States. Electronic address: cynthia_browning@brown.edu.</Affiliation>
      </Author>
      <Author>
        <Name>John Pierce Wise</Name>
        <Affiliation>Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40292, United States; Graduate School of Biomedical Science and Engineering, University of Maine, Orono, ME 04469, United States. Electronic address: john.wise@louisville.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nickel-induced HIF-1α promotes growth arrest and senescence in normal human cells but lacks toxic effects in transformed cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28552779</pubmedLink>
    <GrantList>
      <Grant>R01 ES008786</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30234-X</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>HIF1A</Keywords>
      <Keywords>Hypoxia</Keywords>
      <Keywords>Nickel</Keywords>
      <Keywords>Senescence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michal W. Luczak</Name>
        <Affiliation>Department of Pathology and Laboratory Medicine, Brown University, Providence, RI 02912, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anatoly Zhitkovich</Name>
        <Affiliation>Department of Pathology and Laboratory Medicine, Brown University, Providence, RI 02912, USA. Electronic address: anatoly_zhitkovich@brown.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The impact of Zearalenone on the meiotic progression and primordial follicle assembly during early oogenesis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28552778</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30230-2</DOI>
    <KeywordList>
      <Keywords>DNA double-strand breaks</Keywords>
      <Keywords>Meiotic entry</Keywords>
      <Keywords>Mouse</Keywords>
      <Keywords>Primordial follicle assembly</Keywords>
      <Keywords>ZEA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ke Han Liu</Name>
        <Affiliation>College of Animal Science and Technology, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Feng Sun</Name>
        <Affiliation>College of Life Sciences, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Zhong Feng</Name>
        <Affiliation>Institute of Animal Sciences, Heilongjiang Academy of Agricultural Sciences, Harbin 150086, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shun Feng Cheng</Name>
        <Affiliation>College of Animal Science and Technology, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Li</Name>
        <Affiliation>Chengguo Station of Animal Husbandry and Veterinary, Laizhou 261437, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ya Peng Li</Name>
        <Affiliation>College of Animal Science and Technology, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Shen</Name>
        <Affiliation>College of Animal Science and Technology, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lan Li</Name>
        <Affiliation>College of Animal Science and Technology, Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China. Electronic address: lilan9600@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparison of the toxicity of sintered and unsintered indium-tin oxide particles in murine macrophage and epidermal cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28552777</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30235-1</DOI>
    <KeywordList>
      <Keywords>Indium</Keywords>
      <Keywords>Metals</Keywords>
      <Keywords>Occupational health</Keywords>
      <Keywords>Sintering</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nicole S. Olgun</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV, USA. Electronic address: nolgun@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Anna M. Morris</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tabatha Lynn Barber</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Aleksandr B. Stefaniak</Name>
        <Affiliation>Respiratory Health Division, National Institute for Occupational Safety and Health, Morgantown, WV, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael L. Kashon</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Diane Schwegler-Berry</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kristin J. Cummings</Name>
        <Affiliation>Respiratory Health Division, National Institute for Occupational Safety and Health, Morgantown, WV, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen S. Leonard</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Differential sensitivities of cellular XPA and PARP-1 to arsenite inhibition and zinc rescue.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28552776</pubmedLink>
    <GrantList>
      <Grant>P30 CA118100</Grant>
      <Grant>P42 ES025589</Grant>
      <Grant>R01 CA182969</Grant>
      <Grant>R01 ES021100</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30237-5</DOI>
    <KeywordList>
      <Keywords>Arsenite</Keywords>
      <Keywords>DNA repair</Keywords>
      <Keywords>PARP-1</Keywords>
      <Keywords>XPA</Keywords>
      <Keywords>Zinc</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiaofeng Ding</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, The University of New Mexico, Albuquerque, NM 87131, United States; College of Life Science, Hunan Normal University, Changsha, Hunan 410081, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xixi Zhou</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, The University of New Mexico, Albuquerque, NM 87131, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Karen L. Cooper</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, The University of New Mexico, Albuquerque, NM 87131, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Juliana Huestis</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, The University of New Mexico, Albuquerque, NM 87131, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Laurie G. Hudson</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, The University of New Mexico, Albuquerque, NM 87131, United States. Electronic address: LHudson@salud.unm.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Ke Jian Liu</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, The University of New Mexico, Albuquerque, NM 87131, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Brevetoxin-2, is a unique inhibitor of the C-terminal redox center of mammalian thioredoxin reductase-1.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28551108</pubmedLink>
    <GrantList>
      <Grant>R01 ES023569</Grant>
      <Grant>R25 GM061347</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30233-8</DOI>
    <KeywordList>
      <Keywords>Brevetoxin</Keywords>
      <Keywords>Karenia brevis</Keywords>
      <Keywords>Thioredoxin</Keywords>
      <Keywords>Thioredoxin reductase</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wei Chen</Name>
        <Affiliation>Department of Chemistry and Biochemistry, Florida International University, 11200 SW 8th Street, Miami, FL 33199, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Anupama Tuladhar</Name>
        <Affiliation>Department of Chemistry and Biochemistry, Florida International University, 11200 SW 8th Street, Miami, FL 33199, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Shantelle Rolle</Name>
        <Affiliation>Department of Chemistry and Biochemistry, Florida International University, 11200 SW 8th Street, Miami, FL 33199, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Yanhao Lai</Name>
        <Affiliation>Department of Chemistry and Biochemistry, Florida International University, 11200 SW 8th Street, Miami, FL 33199, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Freddy Rodriguez Del Rey</Name>
        <Affiliation>Department of Chemistry and Biochemistry, Florida International University, 11200 SW 8th Street, Miami, FL 33199, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Cristian E. Zavala</Name>
        <Affiliation>Department of Chemistry and Biochemistry, Florida International University, 11200 SW 8th Street, Miami, FL 33199, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Liu</Name>
        <Affiliation>Department of Chemistry and Biochemistry, Florida International University, 11200 SW 8th Street, Miami, FL 33199, United States; Biomolecular Sciences Institute, School of Integrated Sciences and Humanity, Florida International University, 11200 SW 8th Street, Miami, FL 33199, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Kathleen S. Rein</Name>
        <Affiliation>Department of Chemistry and Biochemistry, Florida International University, 11200 SW 8th Street, Miami, FL 33199, United States. Electronic address: reink@fiu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Impact of chlorpyrifos on human villous trophoblasts and chorionic villi.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28549829</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30232-6</DOI>
    <KeywordList>
      <Keywords>Basement membrane</Keywords>
      <Keywords>Chlorpyrifos</Keywords>
      <Keywords>Placental villi</Keywords>
      <Keywords>Trophoblast cells</Keywords>
      <Keywords>Xenobiotic transporters</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>M. E. Ridano</Name>
        <Affiliation>Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI), Universidad Nacional de Córdoba,CONICET, Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Córdoba, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>A. C. Racca</Name>
        <Affiliation>Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI), Universidad Nacional de Córdoba,CONICET, Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Córdoba, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>J. B. Flores-Martin</Name>
        <Affiliation>Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI), Universidad Nacional de Córdoba,CONICET, Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Córdoba, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>R. Fretes</Name>
        <Affiliation>Instituto de Investigaciones en Ciencias de la Salud (INICSA), Universidad Nacional de Córdoba, CONICET, Departamento de Histología y Embriología, Facultad de Medicina, Córdoba, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>C. L. Bandeira</Name>
        <Affiliation>Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>L. Reyna</Name>
        <Affiliation>Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI), Universidad Nacional de Córdoba,CONICET, Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Córdoba, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>E. Bevilacqua</Name>
        <Affiliation>Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>S. Genti-Raimondi</Name>
        <Affiliation>Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI), Universidad Nacional de Córdoba,CONICET, Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Córdoba, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>G. M. Panzetta-Dutari</Name>
        <Affiliation>Centro de Investigaciones en Bioquímica Clínica e Inmunología (CIBICI), Universidad Nacional de Córdoba,CONICET, Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Córdoba, Argentina. Electronic address: gpan@fcq.unc.edu.ar.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Deficiency of long isoforms of Nfe2l1 sensitizes MIN6 pancreatic β cells to arsenite-induced cytotoxicity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28549828</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30207-7</DOI>
    <KeywordList>
      <Keywords>Arsenite</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>MIN6</Keywords>
      <Keywords>Nfe2l1</Keywords>
      <Keywords>Pancreatic β-cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qi Cui</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingqi Fu</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China. Electronic address: jqfu@cmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Yuxin Hu</Name>
        <Affiliation>Experimental and Teaching Center, School of Public Health, China Medical University, No 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongfang Li</Name>
        <Affiliation>Research Center of Environment and Non-Communicable Disease, School of Public Health, China Medical University, No 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Bei Yang</Name>
        <Affiliation>Department of Histology and Embryology, School of Basic Medical Sciences, China Medical University, No 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Li</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Sun</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chengjie Chen</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Guifan Sun</Name>
        <Affiliation>Research Center of Environment and Non-Communicable Disease, School of Public Health, China Medical University, No 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanyuan Xu</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiang Zhang</Name>
        <Affiliation>Department of Environmental Health, Rollins School of Public Health, Emory University, 1518 Clifton Rd NE, Atlanta, GA 30322, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jingbo Pi</Name>
        <Affiliation>Program of Environmental Toxicology, School of Public Health, China Medical University, No 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, PR China. Electronic address: jbpi@cmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An impedance-based approach using human iPSC-derived cardiomyocytes significantly improves in vitro prediction of in vivo cardiotox liabilities.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28546047</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30229-6</DOI>
    <KeywordList>
      <Keywords>Cardiomyocytes</Keywords>
      <Keywords>Cardiotoxicity</Keywords>
      <Keywords>Drug discovery</Keywords>
      <Keywords>Impedance</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>iPSC</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bryan Koci</Name>
        <Affiliation>Boehringer-Ingelheim Pharmaceuticals, Ridgefield, CT, USA. Electronic address: lake23trout@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Gregory Luerman</Name>
        <Affiliation>Axiogenesis Inc, Plymouth Meeting, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anika Duenbostell</Name>
        <Affiliation>Axiogenesis AG, Cologne, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Ralf Kettenhofen</Name>
        <Affiliation>Axiogenesis AG, Cologne, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Heribert Bohlen</Name>
        <Affiliation>Axiogenesis AG, Cologne, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Luke Coyle</Name>
        <Affiliation>Boehringer-Ingelheim Pharmaceuticals, Ridgefield, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brian Knight</Name>
        <Affiliation>Boehringer-Ingelheim Pharmaceuticals, Ridgefield, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Warren Ku</Name>
        <Affiliation>Boehringer-Ingelheim Pharmaceuticals, Ridgefield, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Walter Volberg</Name>
        <Affiliation>Boehringer-Ingelheim Pharmaceuticals, Ridgefield, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph R. Woska</Name>
        <Affiliation>Boehringer-Ingelheim Pharmaceuticals, Ridgefield, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Martha P. Brown</Name>
        <Affiliation>Boehringer-Ingelheim Pharmaceuticals, Ridgefield, CT, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Zuotai and HgS differ from HgCl</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28536007</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30227-2</DOI>
    <KeywordList>
      <Keywords>Gene expression</Keywords>
      <Keywords>Hg accumulation and toxicity</Keywords>
      <Keywords>HgCl(2) and MeHg</Keywords>
      <Keywords>Transporters</Keywords>
      <Keywords>Weanling and aged rats</Keywords>
      <Keywords>Zuotai and HgS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bin Bin Zhang</Name>
        <Affiliation>Key Lab for Pharmacology of Ministry of Education, Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi 563000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Kai Li</Name>
        <Affiliation>Key Lab for Pharmacology of Ministry of Education, Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi 563000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Yu Hou</Name>
        <Affiliation>Key Lab for Pharmacology of Ministry of Education, Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi 563000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ya Luo</Name>
        <Affiliation>School of Public Health, Zunyi Medical University, Zunyi 563000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Zhen Shi</Name>
        <Affiliation>Guiyang Traditional Medical College, Guiyang 550004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cen Li</Name>
        <Affiliation>Key Lab of Pharmacology and Safety Evaluation of Tibetan Medicine in Qinghai, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining 810008, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Xin Wei</Name>
        <Affiliation>Key Lab of Pharmacology and Safety Evaluation of Tibetan Medicine in Qinghai, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining 810008, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Liu</Name>
        <Affiliation>Key Lab for Pharmacology of Ministry of Education, Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi 563000, China. Electronic address: JieLiu@zmc.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Molecular insights into the differences in anti-inflammatory activities of green tea catechins on IL-1β signaling in rheumatoid arthritis synovial fibroblasts.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28532672</pubmedLink>
    <GrantList>
      <Grant>R01 AR063104</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30210-7</DOI>
    <KeywordList>
      <Keywords>Catechins</Keywords>
      <Keywords>EGC</Keywords>
      <Keywords>EGCG</Keywords>
      <Keywords>Green tea</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Rheumatoid arthritis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sabrina Fechtner</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Washington State University College of Pharmacy, Spokane, WA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anil Singh</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Washington State University College of Pharmacy, Spokane, WA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mukesh Chourasia</Name>
        <Affiliation>Department of Pharmacoinformatics, National lnstitute of Pharmaceutical Education and Research, Hajipur, Bihar, India.</Affiliation>
      </Author>
      <Author>
        <Name>Salahuddin Ahmed</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Washington State University College of Pharmacy, Spokane, WA, USA. Electronic address: salah.ahmed@wsu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Ochratoxin A transport by the human breast cancer resistance protein (BCRP), multidrug resistance protein 2 (MRP2), and organic anion-transporting polypeptides 1A2, 1B1 and 2B1.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28532671</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30228-4</DOI>
    <KeywordList>
      <Keywords>BCRP</Keywords>
      <Keywords>MRP2</Keywords>
      <Keywords>OATP</Keywords>
      <Keywords>Ochratoxin A</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiaozhe Qi</Name>
        <Affiliation>Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science &amp; Nutritional Engineering, China Agricultural University, Beijing 100083, China.</Affiliation>
      </Author>
      <Author>
        <Name>Els Wagenaar</Name>
        <Affiliation>Division of Molecular Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Wentao Xu</Name>
        <Affiliation>Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science &amp; Nutritional Engineering, China Agricultural University, Beijing 100083, China; Beijing Laboratory for Food Quality and Safety, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, 100083, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kunlun Huang</Name>
        <Affiliation>Beijing Advanced Innovation Center for Food Nutrition and Human Health, College of Food Science &amp; Nutritional Engineering, China Agricultural University, Beijing 100083, China; Beijing Laboratory for Food Quality and Safety, College of Food Science and Nutritional Engineering, China Agricultural University, Beijing, 100083, China. Electronic address: foodsafety66@cau.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Alfred H. Schinkel</Name>
        <Affiliation>Division of Molecular Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands. Electronic address: a.schinkel@nki.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Early life allergen and air pollutant exposures alter longitudinal blood immune profiles in infant rhesus monkeys.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28529118</pubmedLink>
    <GrantList>
      <Grant>P01 ES011617</Grant>
      <Grant>P51 OD011107</Grant>
      <Grant>T32 ES007059</Grant>
      <Grant>P01 ES000628</Grant>
      <Grant>R01 HL081286</Grant>
      <Grant>R01 HL097087</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30200-4</DOI>
    <KeywordList>
      <Keywords>Cytokine</Keywords>
      <Keywords>House dust mite</Keywords>
      <Keywords>Infant</Keywords>
      <Keywords>Ozone</Keywords>
      <Keywords>Peripheral blood</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Candace M. Crowley</Name>
        <Affiliation>California National Primate Research Center, University of California, Davis, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Justin H. Fontaine</Name>
        <Affiliation>California National Primate Research Center, University of California, Davis, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Joan E. Gerriets</Name>
        <Affiliation>California National Primate Research Center, University of California, Davis, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Edward S. Schelegle</Name>
        <Affiliation>California National Primate Research Center, University of California, Davis, United States; Department of Anatomy, Physiology, and Cell Biology, School of Veterinary Medicine, University of California, Davis, CA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Dallas M. Hyde</Name>
        <Affiliation>California National Primate Research Center, University of California, Davis, United States; Department of Anatomy, Physiology, and Cell Biology, School of Veterinary Medicine, University of California, Davis, CA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa A. Miller</Name>
        <Affiliation>California National Primate Research Center, University of California, Davis, United States; Department of Anatomy, Physiology, and Cell Biology, School of Veterinary Medicine, University of California, Davis, CA, United States. Electronic address: lmiller@ucdavis.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cadmium stimulates metastasis-associated phenotype in triple-negative breast cancer cells through integrin and β-catenin signaling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28527916</pubmedLink>
    <GrantList>
      <Grant>P20 GM103430</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30211-9</DOI>
    <KeywordList>
      <Keywords>Breast cancer</Keywords>
      <Keywords>Cadmium</Keywords>
      <Keywords>Cell migration</Keywords>
      <Keywords>Integrin</Keywords>
      <Keywords>β-Catenin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhengxi Wei</Name>
        <Affiliation>Center for Molecular Toxicology, Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zahir A. Shaikh</Name>
        <Affiliation>Center for Molecular Toxicology, Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI 02881, USA. Electronic address: zshaikh@uri.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Methylparaben and butylparaben alter multipotent mesenchymal stem cell fates towards adipocyte lineage.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28527915</pubmedLink>
    <GrantList>
      <Grant>R15 AT008733</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30213-2</DOI>
    <KeywordList>
      <Keywords>Adiposity</Keywords>
      <Keywords>C3H10T1/2</Keywords>
      <Keywords>Endocrine disrupting chemicals</Keywords>
      <Keywords>Multipotent mesenchymal stem cell</Keywords>
      <Keywords>Obesity</Keywords>
      <Keywords>Parabens</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Pan Hu</Name>
        <Affiliation>Department of Nutrition, The University of Tennessee, Knoxville, TN, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Haley Overby</Name>
        <Affiliation>Department of Nutrition, The University of Tennessee, Knoxville, TN, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Emily Heal</Name>
        <Affiliation>Department of Nutrition, The University of Tennessee, Knoxville, TN, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Shu Wang</Name>
        <Affiliation>Department of Nutritional Sciences, Texas Tech University, Lubbock, TX, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jiangang Chen</Name>
        <Affiliation>Department of Public Health, The University of Tennessee, Knoxville, TN, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Chwan Li Shen</Name>
        <Affiliation>Department of Pathology, Texas Tech University Health Sciences Center, Lubbock, TX, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ling Zhao</Name>
        <Affiliation>Department of Nutrition, The University of Tennessee, Knoxville, TN, United States. Electronic address: ling.zhao@utk.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Impact of hepatic P450-mediated biotransformation on the disposition and respiratory tract toxicity of inhaled naphthalene.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28527914</pubmedLink>
    <GrantList>
      <Grant>P30 ES023513</Grant>
      <Grant>R01 ES020867</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30209-0</DOI>
    <KeywordList>
      <Keywords>Airway</Keywords>
      <Keywords>Inhalation</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Lung</Keywords>
      <Keywords>Metabolism</Keywords>
      <Keywords>Naphthalene</Keywords>
      <Keywords>P450</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nataliia Kovalchuk</Name>
        <Affiliation>Wadsworth Center, New York State Department of Health, School of Public Health, State University of New York, Albany, NY 12201, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jacklyn Kelty</Name>
        <Affiliation>UC Davis, Davis, CA 95616, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Lei Li</Name>
        <Affiliation>Wadsworth Center, New York State Department of Health, School of Public Health, State University of New York, Albany, NY 12201, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew Hartog</Name>
        <Affiliation>College of Nanoscale Science, SUNY Polytechnic Institute, Albany, NY 12203, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Qing Yu Zhang</Name>
        <Affiliation>Wadsworth Center, New York State Department of Health, School of Public Health, State University of New York, Albany, NY 12201, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia Edwards</Name>
        <Affiliation>UC Davis, Davis, CA 95616, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Van Winkle</Name>
        <Affiliation>UC Davis, Davis, CA 95616, United States. Electronic address: lsvanwinkle@ucdavis.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Xinxin Ding</Name>
        <Affiliation>College of Nanoscale Science, SUNY Polytechnic Institute, Albany, NY 12203, United States. Electronic address: xding@sunypoly.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Von Willebrand factor deficiency reduces liver fibrosis in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28527913</pubmedLink>
    <GrantList>
      <Grant>R01 ES017537</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30212-0</DOI>
    <KeywordList>
      <Keywords>Hemostatic disorders</Keywords>
      <Keywords>Liver cirrhosis</Keywords>
      <Keywords>Thrombosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nikita Joshi</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, Michigan State University, United States; Institute for Integrative Toxicology, Michigan State University, East Lansing, MI, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Anna K. Kopec</Name>
        <Affiliation>Department of Pathobiology &amp; Diagnostic Investigation, Michigan State University, United States; Institute for Integrative Toxicology, Michigan State University, East Lansing, MI, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jessica L. Ray</Name>
        <Affiliation>Department of Pathobiology &amp; Diagnostic Investigation, Michigan State University, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Holly Cline-Fedewa</Name>
        <Affiliation>Department of Pathobiology &amp; Diagnostic Investigation, Michigan State University, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Dafna J. Groeneveld</Name>
        <Affiliation>Surgical Research Laboratory, Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Ton Lisman</Name>
        <Affiliation>Surgical Research Laboratory, Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>James P. Luyendyk</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, Michigan State University, United States; Department of Pathobiology &amp; Diagnostic Investigation, Michigan State University, United States; Institute for Integrative Toxicology, Michigan State University, East Lansing, MI, United States. Electronic address: luyendyk@cvm.msu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Rebamipide ameliorates radiation-induced intestinal injury in a mouse model.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28526636</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30206-5</DOI>
    <KeywordList>
      <Keywords>Barrier function</Keywords>
      <Keywords>Intestine</Keywords>
      <Keywords>Radiotherapy</Keywords>
      <Keywords>Rebamipide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sehwan Shim</Name>
        <Affiliation>Laboratory of Radiation Exposure &amp; Therapeutics, National Radiation Emergency Medical Center, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyo Sun Jang</Name>
        <Affiliation>Laboratory of Radiation Exposure &amp; Therapeutics, National Radiation Emergency Medical Center, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyun Wook Myung</Name>
        <Affiliation>Laboratory of Radiation Exposure &amp; Therapeutics, National Radiation Emergency Medical Center, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Kyung Myung</Name>
        <Affiliation>Laboratory of Radiation Exposure &amp; Therapeutics, National Radiation Emergency Medical Center, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea; Department of Pathology, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Kyu Kang</Name>
        <Affiliation>Laboratory of Radiation Exposure &amp; Therapeutics, National Radiation Emergency Medical Center, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Min Jung Kim</Name>
        <Affiliation>Laboratory of Radiation Exposure &amp; Therapeutics, National Radiation Emergency Medical Center, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Bum Lee</Name>
        <Affiliation>Laboratory of Radiation Exposure &amp; Therapeutics, National Radiation Emergency Medical Center, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Won Suk Jang</Name>
        <Affiliation>Laboratory of Radiation Exposure &amp; Therapeutics, National Radiation Emergency Medical Center, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sun Joo Lee</Name>
        <Affiliation>Laboratory of Radiation Exposure &amp; Therapeutics, National Radiation Emergency Medical Center, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Young Woo Jin</Name>
        <Affiliation>Laboratory of Radiation Exposure &amp; Therapeutics, National Radiation Emergency Medical Center, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Sook Lee</Name>
        <Affiliation>Laboratory of Radiation Exposure &amp; Therapeutics, National Radiation Emergency Medical Center, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea; Department of Pathology, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sunhoo Park</Name>
        <Affiliation>Laboratory of Radiation Exposure &amp; Therapeutics, National Radiation Emergency Medical Center, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea; Department of Pathology, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea. Electronic address: sunhoo@kirams.re.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Arsenic exposures alter clinical indicators of anemia in a male population of smokers and non-smokers in Bangladesh.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28526635</pubmedLink>
    <GrantList>
      <Grant>S10 OD016384</Grant>
      <Grant>P42 ES010349</Grant>
      <Grant>M01 RR000997</Grant>
      <Grant>R01 ES019968</Grant>
      <Grant>P30 ES009089</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30208-9</DOI>
    <KeywordList>
      <Keywords>Anemia</Keywords>
      <Keywords>Arsenic</Keywords>
      <Keywords>Bangladesh</Keywords>
      <Keywords>Drinking water</Keywords>
      <Keywords>HEALS cohort</Keywords>
      <Keywords>Smokers</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Faruque Parvez</Name>
        <Affiliation>Mailman University School of Public Health, Department of Environmental Health, Columbia University, New York, NY 10032, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Sebastian Medina</Name>
        <Affiliation>The University of New Mexico College of Pharmacy, Department of Pharmaceutical Sciences, Albuquerque, NM 87131, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Regina M. Santella</Name>
        <Affiliation>Mailman University School of Public Health, Department of Environmental Health, Columbia University, New York, NY 10032, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Tariqul Islam</Name>
        <Affiliation>University of Chicago Field Research Office, Dhaka 1230, Bangladesh.</Affiliation>
      </Author>
      <Author>
        <Name>Fredine T. Lauer</Name>
        <Affiliation>The University of New Mexico College of Pharmacy, Department of Pharmaceutical Sciences, Albuquerque, NM 87131, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Nur Alam</Name>
        <Affiliation>University of Chicago Field Research Office, Dhaka 1230, Bangladesh.</Affiliation>
      </Author>
      <Author>
        <Name>Mahbubul Eunus</Name>
        <Affiliation>University of Chicago Field Research Office, Dhaka 1230, Bangladesh.</Affiliation>
      </Author>
      <Author>
        <Name>Mizanour Rahman</Name>
        <Affiliation>University of Chicago Field Research Office, Dhaka 1230, Bangladesh.</Affiliation>
      </Author>
      <Author>
        <Name>Pam Factor-Litvak</Name>
        <Affiliation>Mailman University School of Public Health, Department of Environmental Health, Columbia University, New York, NY 10032, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Habib Ahsan</Name>
        <Affiliation>University of Chicago, Division of Public Health, Chicago, IL 60637, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph H. Graziano</Name>
        <Affiliation>Mailman University School of Public Health, Department of Environmental Health, Columbia University, New York, NY 10032, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ke Jian Liu</Name>
        <Affiliation>The University of New Mexico College of Pharmacy, Department of Pharmaceutical Sciences, Albuquerque, NM 87131, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Scott W. Burchiel</Name>
        <Affiliation>The University of New Mexico College of Pharmacy, Department of Pharmaceutical Sciences, Albuquerque, NM 87131, United States. Electronic address: sburchiel@salud.unm.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Differential effects of the persistent DDT metabolite methylsulfonyl-DDE in nonstimulated and LH-stimulated neonatal porcine Leydig cells" [Toxicol. Appl. Pharmacol. 267 (2013) 247-255].</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28522354</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30205-3</DOI>
    <AuthorList>
      <Author>
        <Name>Cesilie Granum Castellanos</Name>
        <Affiliation>Department of Production Animal Clinical Sciences, Norwegian School of Veterinary Science, Postboks 8146 Dep, 0033, Oslo, Norway. Electronic address: cesilie.granum@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Irene Beate Sørvik</Name>
        <Affiliation>Department of Production Animal Clinical Sciences, Norwegian School of Veterinary Science, Postboks 8146 Dep, 0033, Oslo, Norway; Department of Pharmaceutical Biosciences, University of Oslo, Postboks 1068 Blindern, 0316 Oslo, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Marte Bruu Tanum</Name>
        <Affiliation>Department of Production Animal Clinical Sciences, Norwegian School of Veterinary Science, Postboks 8146 Dep, 0033, Oslo, Norway; The Climate and Pollution Agency (Klif), Postboks 8100 Dep, 0032 Oslo, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Steven Verhaegen</Name>
        <Affiliation>Department of Production Animal Clinical Sciences, Norwegian School of Veterinary Science, Postboks 8146 Dep, 0033, Oslo, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Ingvar Brandt</Name>
        <Affiliation>Department of Environmental Toxicology, Uppsala University, Norbyvägen 18 A, SE-752 36 Uppsala, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Erik Ropstad</Name>
        <Affiliation>Department of Production Animal Clinical Sciences, Norwegian School of Veterinary Science, Postboks 8146 Dep, 0033, Oslo, Norway.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A comprehensive review of metal-induced cellular transformation studies.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28506836</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30198-9</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Cadmium</Keywords>
      <Keywords>Cell transformation</Keywords>
      <Keywords>Chromium</Keywords>
      <Keywords>Comprehensive comparison</Keywords>
      <Keywords>Nickel</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qiao Yi Chen</Name>
        <Affiliation>Department of Environmental Medicine, New York University School of Medicine, 57 Old Forge, Tuxedo, NY 10987, United States. Electronic address: qyc203@nyu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Max Costa</Name>
        <Affiliation>Department of Environmental Medicine, New York University School of Medicine, 57 Old Forge, Tuxedo, NY 10987, United States. Electronic address: Max.Costa@nyumc.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Impact of common clandestine structural modifications on synthetic cathinone "bath salt" pharmacokinetics.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28506835</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30204-1</DOI>
    <KeywordList>
      <Keywords>Bath salts</Keywords>
      <Keywords>Butylone</Keywords>
      <Keywords>Methylone</Keywords>
      <Keywords>Pentylone</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Phenethylamine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gregory G. Grecco</Name>
        <Affiliation>The Ohio Attorney General's Center for the Future of Forensic Science, Bowling Green State University, Bowling Green, OH 43403, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David F. Kisor</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, Natural and Health Sciences, Manchester University, Fort Wayne, IN 45845, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph S. Magura</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, Natural and Health Sciences, Manchester University, Fort Wayne, IN 45845, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jon E. Sprague</Name>
        <Affiliation>The Ohio Attorney General's Center for the Future of Forensic Science, Bowling Green State University, Bowling Green, OH 43403, USA. Electronic address: jesprag@bgsu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Safety evaluation of dermal exposure to phthalates: Metabolism-dependent percutaneous absorption.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28506834</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30203-X</DOI>
    <KeywordList>
      <Keywords>Dermal exposure</Keywords>
      <Keywords>Metabolism</Keywords>
      <Keywords>Phthalates</Keywords>
      <Keywords>Risk identification</Keywords>
      <Keywords>Skin permeation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Masahiro Sugino</Name>
        <Affiliation>Faculty of Pharmaceutical Sciences, Josai University, 1-1 Keyakidai, Sakado, Saitama 350-0295, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tomomi Hatanaka</Name>
        <Affiliation>Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroaki Todo</Name>
        <Affiliation>Faculty of Pharmaceutical Sciences, Josai University, 1-1 Keyakidai, Sakado, Saitama 350-0295, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuko Mashimo</Name>
        <Affiliation>Faculty of Pharmaceutical Sciences, Josai University, 1-1 Keyakidai, Sakado, Saitama 350-0295, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takamasa Suzuki</Name>
        <Affiliation>Faculty of Pharmaceutical Sciences, Josai University, 1-1 Keyakidai, Sakado, Saitama 350-0295, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Miho Kobayashi</Name>
        <Affiliation>Faculty of Pharmaceutical Sciences, Josai University, 1-1 Keyakidai, Sakado, Saitama 350-0295, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Osamu Hosoya</Name>
        <Affiliation>Faculty of Pharmaceutical Sciences, Josai University, 1-1 Keyakidai, Sakado, Saitama 350-0295, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hideto Jinno</Name>
        <Affiliation>Faculty of Pharmacy, Meijo University, 150 Yagotoyama, Tempaku-ku, Nagoya 468-8503, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kazuhiko Juni</Name>
        <Affiliation>Faculty of Pharmaceutical Sciences, Josai University, 1-1 Keyakidai, Sakado, Saitama 350-0295, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kenji Sugibayashi</Name>
        <Affiliation>Faculty of Pharmaceutical Sciences, Josai University, 1-1 Keyakidai, Sakado, Saitama 350-0295, Japan. Electronic address: sugib@josai.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>HMGA2, a driver of inflammation, is associated with hypermethylation in acute liver injury.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28502886</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30199-0</DOI>
    <KeywordList>
      <Keywords>Acute liver injury (ALI)</Keywords>
      <Keywords>HMGA2</Keywords>
      <Keywords>Hypermethylation</Keywords>
      <Keywords>Kupffer cells (KCs)</Keywords>
      <Keywords>RAW264.7 cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Huimin Huang</Name>
        <Affiliation>The Key Laboratory of Major Autoimmune Diseases, Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, China; The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, China; Institute for Liver Diseases of Anhui Medical University, China.</Affiliation>
      </Author>
      <Author>
        <Name>Haidi Li</Name>
        <Affiliation>The Key Laboratory of Major Autoimmune Diseases, Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, China; The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, China; Institute for Liver Diseases of Anhui Medical University, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Chen</Name>
        <Affiliation>The Key Laboratory of Major Autoimmune Diseases, Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, China; The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, China; Institute for Liver Diseases of Anhui Medical University, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Yang</Name>
        <Affiliation>The Key Laboratory of Major Autoimmune Diseases, Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, China; The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, China; Institute for Liver Diseases of Anhui Medical University, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaofeng Li</Name>
        <Affiliation>The Key Laboratory of Major Autoimmune Diseases, Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, China; The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, China; Institute for Liver Diseases of Anhui Medical University, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wanxia Li</Name>
        <Affiliation>The Key Laboratory of Major Autoimmune Diseases, Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, China; The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, China; Institute for Liver Diseases of Anhui Medical University, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cheng Huang</Name>
        <Affiliation>The Key Laboratory of Major Autoimmune Diseases, Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, China; The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, China; Institute for Liver Diseases of Anhui Medical University, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoming Meng</Name>
        <Affiliation>The Key Laboratory of Major Autoimmune Diseases, Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, China; The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, China; Institute for Liver Diseases of Anhui Medical University, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lei Zhang</Name>
        <Affiliation>The Key Laboratory of Major Autoimmune Diseases, Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, China; The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, China; Institute for Liver Diseases of Anhui Medical University, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Li</Name>
        <Affiliation>The Key Laboratory of Major Autoimmune Diseases, Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, China; The Key Laboratory of Anti-inflammatory of Immune Medicines, Ministry of Education, China; Institute for Liver Diseases of Anhui Medical University, China. Electronic address: lj@ahmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inhibition of nicotinamide phosphoribosyltransferase and depletion of nicotinamide adenine dinucleotide contribute to arsenic trioxide suppression of oral squamous cell carcinoma.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28501332</pubmedLink>
    <GrantList>
      <Grant>R01 ES021100</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30202-8</DOI>
    <KeywordList>
      <Keywords>Arsenic trioxide</Keywords>
      <Keywords>FK866</Keywords>
      <Keywords>Nicotinamide adenine dinucleotide</Keywords>
      <Keywords>Nicotinamide phosphoribosyltransferase</Keywords>
      <Keywords>Squamous cell carcinoma</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xin Yue Wang</Name>
        <Affiliation>Laboratory of Oral and Maxillofacial Disease, Second Hospital of Dalian Medical University, Dalian, Liaoning 116023, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Zhi Wang</Name>
        <Affiliation>Department of Oral and Maxillofacial Surgery, Second Hospital of Dalian Medical University, Dalian, Liaoning 116023, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Gao</Name>
        <Affiliation>Department of Oral Anatomy, School of Stomatology, Dalian Medical University, Dalian, Liaoning 116044, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Fu Yin Zhang</Name>
        <Affiliation>Department of Oral and Maxillofacial Surgery, Second Hospital of Dalian Medical University, Dalian, Liaoning 116023, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Wang</Name>
        <Affiliation>Laboratory of Oral and Maxillofacial Disease, Second Hospital of Dalian Medical University, Dalian, Liaoning 116023, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ke Jian Liu</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA. Electronic address: kliu@salud.unm.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Bin Xiang</Name>
        <Affiliation>Laboratory of Oral and Maxillofacial Disease, Second Hospital of Dalian Medical University, Dalian, Liaoning 116023, PR China. Electronic address: xiangbin72@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The expression of keratin 6 is regulated by the activation of the ERK1/2 pathway in arsenite transformed human urothelial cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28501331</pubmedLink>
    <GrantList>
      <Grant>P20 GM103442</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30201-6</DOI>
    <KeywordList>
      <Keywords>Arsenite</Keywords>
      <Keywords>Biomarker</Keywords>
      <Keywords>Bladder cancer</Keywords>
      <Keywords>Keratin 6</Keywords>
      <Keywords>MAPK</Keywords>
      <Keywords>UROtsa</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Andrea Slusser-Nore</Name>
        <Affiliation>Department of Pathology, University of North Dakota, School of Medicine and Health Sciences, 1301 N. Columbia Road, Stop 9037, Grand Forks, ND 58202, United States. Electronic address: andrea.slusser@und.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Scott H. Garrett</Name>
        <Affiliation>Department of Pathology, University of North Dakota, School of Medicine and Health Sciences, 1301 N. Columbia Road, Stop 9037, Grand Forks, ND 58202, United States. Electronic address: scott.garrett@med.und.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Dong Zhou</Name>
        <Affiliation>Department of Pathology, University of North Dakota, School of Medicine and Health Sciences, 1301 N. Columbia Road, Stop 9037, Grand Forks, ND 58202, United States. Electronic address: xudong.zhou@med.und.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Donald A. Sens</Name>
        <Affiliation>Department of Pathology, University of North Dakota, School of Medicine and Health Sciences, 1301 N. Columbia Road, Stop 9037, Grand Forks, ND 58202, United States. Electronic address: donald.sens@med.und.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Mary Ann Sens</Name>
        <Affiliation>Department of Pathology, University of North Dakota, School of Medicine and Health Sciences, 1301 N. Columbia Road, Stop 9037, Grand Forks, ND 58202, United States. Electronic address: mary.sens@med.und.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Seema Somji</Name>
        <Affiliation>Department of Pathology, University of North Dakota, School of Medicine and Health Sciences, 1301 N. Columbia Road, Stop 9037, Grand Forks, ND 58202, United States. Electronic address: seema.somji@med.und.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of monocrotophos pesticide on cholinergic and dopaminergic neurotransmitter systems during early development in the sea urchin Hemicentrotus pulcherrimus.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28479505</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30197-7</DOI>
    <KeywordList>
      <Keywords>Cholinergic system</Keywords>
      <Keywords>Developmental neurotoxicity</Keywords>
      <Keywords>Dopaminergic system</Keywords>
      <Keywords>Monocrotophos pesticide</Keywords>
      <Keywords>Sea urchin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiaona Zhang</Name>
        <Affiliation>College of Marine Life Sciences, Ocean University of China, Qingdao 266003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuman Li</Name>
        <Affiliation>Nansi Lake Water Quality Monitoring Center of Shandong Province, Jining 272100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cuicui Wang</Name>
        <Affiliation>College of Marine Life Sciences, Ocean University of China, Qingdao 266003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hua Tian</Name>
        <Affiliation>College of Marine Life Sciences, Ocean University of China, Qingdao 266003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Wang</Name>
        <Affiliation>College of Marine Life Sciences, Ocean University of China, Qingdao 266003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shaoguo Ru</Name>
        <Affiliation>College of Marine Life Sciences, Ocean University of China, Qingdao 266003, China. Electronic address: rusg@ouc.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Genipin protects the liver from ischemia/reperfusion injury by modulating mitochondrial quality control.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28477916</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30190-4</DOI>
    <KeywordList>
      <Keywords>Genipin</Keywords>
      <Keywords>Ischemia and reperfusion</Keywords>
      <Keywords>Mitochondrial quality control</Keywords>
      <Keywords>Oxidative stress</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jun Kyu Shin</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, Suwon 440-746, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sun Mee Lee</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, Suwon 440-746, Republic of Korea. Electronic address: sunmee@skku.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Curcumin improves alcoholic fatty liver by inhibiting fatty acid biosynthesis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28476407</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30189-8</DOI>
    <KeywordList>
      <Keywords>Alcoholic fatty liver</Keywords>
      <Keywords>Curcumin</Keywords>
      <Keywords>Fatty acid biosynthesis</Keywords>
      <Keywords>Metabolomics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chang Guo</Name>
        <Affiliation>School of Life Sciences, Longyan University, Longyan 364012, People's Republic of China; Fujian Provincial Key Laboratory for the Prevention and Control of Animal Infectious Diseases and Biotechnology, Longyan 364012, People's Republic of China; Key Laboratory of Preventive Veterinary Medicine and Biotechnology (Longyan University), Fujian Province University, Longyan 364012, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingfan Ma</Name>
        <Affiliation>School of Life Sciences, Longyan University, Longyan 364012, People's Republic of China; Fujian Provincial Key Laboratory for the Prevention and Control of Animal Infectious Diseases and Biotechnology, Longyan 364012, People's Republic of China; Key Laboratory of Preventive Veterinary Medicine and Biotechnology (Longyan University), Fujian Province University, Longyan 364012, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Qionghong Zhong</Name>
        <Affiliation>School of Life Sciences, Longyan University, Longyan 364012, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Mengyuan Zhao</Name>
        <Affiliation>School of Life Sciences, Longyan University, Longyan 364012, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Tianxing Hu</Name>
        <Affiliation>School of Life Sciences, Longyan University, Longyan 364012, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Tong Chen</Name>
        <Affiliation>School of Life Sciences, Longyan University, Longyan 364012, People's Republic of China; Fujian Provincial Key Laboratory for the Prevention and Control of Animal Infectious Diseases and Biotechnology, Longyan 364012, People's Republic of China; Key Laboratory of Preventive Veterinary Medicine and Biotechnology (Longyan University), Fujian Province University, Longyan 364012, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Longxin Qiu</Name>
        <Affiliation>School of Life Sciences, Longyan University, Longyan 364012, People's Republic of China; Fujian Provincial Key Laboratory for the Prevention and Control of Animal Infectious Diseases and Biotechnology, Longyan 364012, People's Republic of China; Key Laboratory of Preventive Veterinary Medicine and Biotechnology (Longyan University), Fujian Province University, Longyan 364012, People's Republic of China. Electronic address: qlongxin@tom.com.</Affiliation>
      </Author>
      <Author>
        <Name>Longping Wen</Name>
        <Affiliation>School of Life Sciences, Longyan University, Longyan 364012, People's Republic of China; School of Life Sciences, University of Science and Technology of China, Hefei 230027, People's Republic of China. Electronic address: lpwen@ustc.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Structure-toxicity relationship of cefoperazone and its impurities to developing zebrafish by transcriptome and Raman analysis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28465218</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30188-6</DOI>
    <KeywordList>
      <Keywords>Cefoperazone</Keywords>
      <Keywords>Differentially expressed genes</Keywords>
      <Keywords>Impurities</Keywords>
      <Keywords>Raman mapping</Keywords>
      <Keywords>Transcriptomics</Keywords>
      <Keywords>Zebrafish embryos</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ying Han</Name>
        <Affiliation>National Institutes for Food and Drug Control, Beijing 100050, China; Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianqin Qian</Name>
        <Affiliation>National Institutes for Food and Drug Control, Beijing 100050, China; Zhejiang Institute for Food and Drug Control, Hangzhou 310000, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingpu Zhang</Name>
        <Affiliation>Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China. Electronic address: zhangjingpu@imb.pumc.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Changqin Hu</Name>
        <Affiliation>National Institutes for Food and Drug Control, Beijing 100050, China. Electronic address: hucq@nifdc.org.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Chen Wang</Name>
        <Affiliation>National Institutes for Food and Drug Control, Beijing 100050, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dual effect of silymarin on experimental non-alcoholic steatohepatitis induced by irinotecan.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28454924</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30180-1</DOI>
    <KeywordList>
      <Keywords>Cancer chemotherapy toxicity</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Irinotecan</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Silymarin</Keywords>
      <Keywords>Steatohepatitis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Eudmar Marcolino Assis-Júnior</Name>
        <Affiliation>Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceará, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Anielle Torres Melo</Name>
        <Affiliation>Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceará, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Venúcia Bruna Magalhães Pereira</Name>
        <Affiliation>Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceará, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Deysi Viviana Tenazoa Wong</Name>
        <Affiliation>Department of Pathology and Forensic Medicine, Faculty of Medicine, Federal University of Ceará, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Nathalia Ribeiro Pinho Sousa</Name>
        <Affiliation>Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceará, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Christiane Mendes Gonçalves Oliveira</Name>
        <Affiliation>Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceará, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Lara Raissa Cavalcante Malveira</Name>
        <Affiliation>Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceará, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Leonardo Silva Moreira</Name>
        <Affiliation>Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceará, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Marcellus Henrique Loiola Ponte Souza</Name>
        <Affiliation>Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceará, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Paulo Roberto Carvalho Almeida</Name>
        <Affiliation>Department of Pathology and Forensic Medicine, Faculty of Medicine, Federal University of Ceará, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Roberto César Pereira Lima-Júnior</Name>
        <Affiliation>Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceará, Brazil. Electronic address: robertocesar@ufc.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Quercetin, a natural product supplement, impairs mitochondrial bioenergetics and locomotor behavior in larval zebrafish (Danio rerio).</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28450151</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30181-3</DOI>
    <KeywordList>
      <Keywords>Gene expression</Keywords>
      <Keywords>Locomotor behavior</Keywords>
      <Keywords>Mitochondrial respiration</Keywords>
      <Keywords>Myosin</Keywords>
      <Keywords>Quercetin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ji Liang Zhang</Name>
        <Affiliation>Henan Open Laboratory of Key Subjects of Environmental and Animal Products Safety, College of Animal Science and Technology, Henan University of Science and Technology, Henan, China; Center for Environmental and Human Toxicology, Department of Physiological Sciences, College of Veterinary Medicine, UF Genetics Institute, University of Florida, Gainesville, FL 32611, USA. Electronic address: jlzhang@haust.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher Laurence Souders</Name>
        <Affiliation>Center for Environmental and Human Toxicology, Department of Physiological Sciences, College of Veterinary Medicine, UF Genetics Institute, University of Florida, Gainesville, FL 32611, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nancy D. Denslow</Name>
        <Affiliation>Center for Environmental and Human Toxicology, Department of Physiological Sciences, College of Veterinary Medicine, UF Genetics Institute, University of Florida, Gainesville, FL 32611, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher J. Martyniuk</Name>
        <Affiliation>Center for Environmental and Human Toxicology, Department of Physiological Sciences, College of Veterinary Medicine, UF Genetics Institute, University of Florida, Gainesville, FL 32611, USA. Electronic address: cmartyn@ufl.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In vivo inhibitory activity of andrographolide derivative ADN-9 against liver cancer and its mechanisms involved in inhibition of tumor angiogenesis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28438631</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30179-5</DOI>
    <KeywordList>
      <Keywords>Andrographolide</Keywords>
      <Keywords>Angiogenesis</Keywords>
      <Keywords>Derivative</Keywords>
      <Keywords>Liver cancer</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wei Yang</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Zhao</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yake Wang</Name>
        <Affiliation>Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Zhengzhou, Henan 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Haiwei Xu</Name>
        <Affiliation>Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Zhengzhou, Henan 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenwei Wu</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yangyang Hu</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kunkun Jiang</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Pengpeng Shen</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cuiyun Ma</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenzhen Guan</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Zhang</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiahui Ma</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ning Shang</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guangming Yan</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenji Wang</Name>
        <Affiliation>Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Zhengzhou, Henan 450001, China. Electronic address: wzhenji@zzu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Guifu Dai</Name>
        <Affiliation>School of Life Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Zhengzhou, Henan 450001, China; Henan Key Laboratory of Bioactive Macromolecules, Zhengzhou, Henan 450001, China. Electronic address: daiguifu@zzu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Identification of anti-viral activity of the cardenolides, Na</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28438630</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30174-6</DOI>
    <KeywordList>
      <Keywords>Cardenolide</Keywords>
      <Keywords>Coronavirus</Keywords>
      <Keywords>Na(+)/K(+)-ATPase</Keywords>
      <Keywords>Oleandrin</Keywords>
      <Keywords>Porcine transmissible gastroenteritis virus</Keywords>
      <Keywords>Reevesioside</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cheng Wei Yang</Name>
        <Affiliation>Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli 35053, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Hsin Yu Chang</Name>
        <Affiliation>Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli 35053, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Hsing Yu Hsu</Name>
        <Affiliation>Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli 35053, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Yue Zhi Lee</Name>
        <Affiliation>Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli 35053, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Hsun Shuo Chang</Name>
        <Affiliation>School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 807, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Ih Sheng Chen</Name>
        <Affiliation>School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 807, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Shiow Ju Lee</Name>
        <Affiliation>Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli 35053, Taiwan, ROC. Electronic address: slee@nhri.org.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Role of CRF1 receptor in post-incisional plasma extravasation and nociceptive responses in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28434951</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30178-3</DOI>
    <KeywordList>
      <Keywords>CRF 1 receptors</Keywords>
      <Keywords>Latent pain sensitization</Keywords>
      <Keywords>Plasma extravasation</Keywords>
      <Keywords>Post-operative pain</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Asunción Romero</Name>
        <Affiliation>Department of Anesthesiology, Pain Research Unit, Institut Municipal d'Investigació Medica, Hospital del Mar, Universitat Autonoma de Barcelona, Barcelona, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Antonio García-Carmona</Name>
        <Affiliation>Department of Pharmacology, University of Murcia, Murcia, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>María Luisa Laorden</Name>
        <Affiliation>Department of Pharmacology, University of Murcia, Murcia, Spain. Electronic address: laorden@um.es.</Affiliation>
      </Author>
      <Author>
        <Name>Margarita M. Puig</Name>
        <Affiliation>Department of Anesthesiology, Pain Research Unit, Institut Municipal d'Investigació Medica, Hospital del Mar, Universitat Autonoma de Barcelona, Barcelona, Spain.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pulmonary pathobiology induced by zinc oxide nanoparticles in mice: A 24-hour and 28-day follow-up study.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28433709</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30175-8</DOI>
    <KeywordList>
      <Keywords>Inflammation</Keywords>
      <Keywords>Nanoparticle</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Thyroid transcription factor-1</Keywords>
      <Keywords>Tumor protein p63</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hsiao Chi Chuang</Name>
        <Affiliation>School of Respiratory Therapy, College of Medicine, Taipei Medical University, Taipei, Taiwan; Division of Pulmonary Medicine, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan; Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan. Electronic address: r92841005@ntu.edu.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Kai Jen Chuang</Name>
        <Affiliation>School of Public Health, College of Public Health, Taipei Medical University, Taipei, Taiwan; Department of Public Health, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan. Electronic address: kjc@tmu.edu.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Jen Kun Chen</Name>
        <Affiliation>Institute of Biomedical Engineering &amp; Nanomedicine, National Health Research Institutes, Miaoli, Taiwan. Electronic address: jkchen@nhri.org.tw.</Affiliation>
      </Author>
      <Author>
        <Name>His En Hua</Name>
        <Affiliation>School of Respiratory Therapy, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yen Ling Shen</Name>
        <Affiliation>School of Respiratory Therapy, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Neng Liao</Name>
        <Affiliation>Institute of Biomedical Engineering &amp; Nanomedicine, National Health Research Institutes, Miaoli, Taiwan. Electronic address: 970730@nhri.org.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Chii Hong Lee</Name>
        <Affiliation>Department of Pathology, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan. Electronic address: hpan@mail.iosh.gov.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Chih Hong Pan</Name>
        <Affiliation>Institute of Occupational Safety and Health, Council of Labor Affairs, Executive Yuan, New Taipei City, Taiwan; School of Public Health, National Defense Medical Center, Taipei, Taiwan. Electronic address: b8301130@tmu.edu.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Kuan Yuan Chen</Name>
        <Affiliation>Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Kang Yun Lee</Name>
        <Affiliation>Division of Pulmonary Medicine, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan; Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ta Chih Hsiao</Name>
        <Affiliation>Graduate Institute of Environmental Engineering, National Central University, Taoyuan, Taiwan. Electronic address: tchsiao@ncu.edu.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Tsun Jen Cheng</Name>
        <Affiliation>Institute of Occupational Medicine and Industrial Hygiene, College of Public Health, National Taiwan University, Taipei, Taiwan; Institute of Environmental Health, College of Public Health, National Taiwan University, Taipei, Taiwan. Electronic address: tcheng@ntu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological characterisation of two novel selective aryl hydrocarbon receptor modulators in Sprague-Dawley rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28433708</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30177-1</DOI>
    <KeywordList>
      <Keywords>AH-receptor</Keywords>
      <Keywords>Ima-07101</Keywords>
      <Keywords>Ima-08401</Keywords>
      <Keywords>Selective modulators</Keywords>
      <Keywords>TCDD</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Selma Mahiout</Name>
        <Affiliation>Department of Food Hygiene and Environmental Health, Faculty of Veterinary Medicine, University of Helsinki, Finland. Electronic address: selma.mahiout@helsinki.fi.</Affiliation>
      </Author>
      <Author>
        <Name>Jere Lindén</Name>
        <Affiliation>Department of Basic Veterinary Sciences, Faculty of Veterinary Medicine, University of Helsinki, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>Javier Esteban</Name>
        <Affiliation>Instituto de Bioingeniería, Universidad Miguel Hernández de Elche, Elche, Alicante, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Ismael Sánchez-Pérez</Name>
        <Affiliation>Instituto de Bioingeniería, Universidad Miguel Hernández de Elche, Elche, Alicante, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Satu Sankari</Name>
        <Affiliation>Central Laboratory of the Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>Lars Pettersson</Name>
        <Affiliation>Immunahr AB, Lund, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Helen Håkansson</Name>
        <Affiliation>Institute of Environmental Medicine (IMM), Karolinska Institutet, Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Raimo Pohjanvirta</Name>
        <Affiliation>Department of Food Hygiene and Environmental Health, Faculty of Veterinary Medicine, University of Helsinki, Finland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Genetic susceptibility to toxicologic lung responses among inbred mouse strains following exposure to carbon nanotubes and profiling of underlying gene networks.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28433707</pubmedLink>
    <GrantList>
      <Grant>P30 ES006096</Grant>
      <Grant>T32 ES016646</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30176-X</DOI>
    <KeywordList>
      <Keywords>Carbon nanotubes</Keywords>
      <Keywords>Genetic susceptibility</Keywords>
      <Keywords>Inbred strains</Keywords>
      <Keywords>Mouse models</Keywords>
      <Keywords>Nanoparticles</Keywords>
      <Keywords>Toxicologic pathology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Evan A. Frank</Name>
        <Affiliation>University of Cincinnati College of Medicine, Department of Environmental Health, 160 Panzeca Way, Cincinnati, OH 45267, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Vinicius S. Carreira</Name>
        <Affiliation>University of Cincinnati College of Medicine, Department of Environmental Health, 160 Panzeca Way, Cincinnati, OH 45267, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Kumar Shanmukhappa</Name>
        <Affiliation>Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH 45229, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mario Medvedovic</Name>
        <Affiliation>University of Cincinnati College of Medicine, Department of Environmental Health, 160 Panzeca Way, Cincinnati, OH 45267, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel R. Prows</Name>
        <Affiliation>Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH 45229, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jagjit S. Yadav</Name>
        <Affiliation>University of Cincinnati College of Medicine, Department of Environmental Health, 160 Panzeca Way, Cincinnati, OH 45267, United States. Electronic address: Jagjit.yadav@uc.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mono-2-ethylhexyl phthalate inhibits human extravillous trophoblast invasion via the PPARγ pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28416457</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30163-1</DOI>
    <KeywordList>
      <Keywords>Early pregnancy loss</Keywords>
      <Keywords>Matrix metalloproteinase</Keywords>
      <Keywords>PPARγ</Keywords>
      <Keywords>Phthalates</Keywords>
      <Keywords>Tissue inhibitor of matrix metalloproteinase</Keywords>
      <Keywords>Trophoblast invasion</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Fumei Gao</Name>
        <Affiliation>Laboratory for Earth Surface Processes, College of Urban and Environmental Sciences, Peking University, Beijing 100871, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenxin Hu</Name>
        <Affiliation>Laboratory for Earth Surface Processes, College of Urban and Environmental Sciences, Peking University, Beijing 100871, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Li</Name>
        <Affiliation>Laboratory for Earth Surface Processes, College of Urban and Environmental Sciences, Peking University, Beijing 100871, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huan Shen</Name>
        <Affiliation>Reproductive Medical Center, Peking University People's Hospital, Peking University, Beijing 100044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianying Hu</Name>
        <Affiliation>Laboratory for Earth Surface Processes, College of Urban and Environmental Sciences, Peking University, Beijing 100871, China. Electronic address: hujy@urban.pku.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Licoricidin inhibits the growth of SW480 human colorectal adenocarcinoma cells in vitro and in vivo by inducing cycle arrest, apoptosis and autophagy.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28416456</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30164-3</DOI>
    <KeywordList>
      <Keywords>AMPK</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Autophagy</Keywords>
      <Keywords>Colorectal cancer</Keywords>
      <Keywords>Cycle arrest</Keywords>
      <Keywords>Licoricidin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shuai Ji</Name>
        <Affiliation>State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, 38 Xueyuan Road, Beijing 100191, China; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, School of Pharmacy, Xuzhou Medical University, 209 Tongshan Road, Xuzhou 221004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shunan Tang</Name>
        <Affiliation>State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, 38 Xueyuan Road, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kai Li</Name>
        <Affiliation>State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, 38 Xueyuan Road, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ziwei Li</Name>
        <Affiliation>State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, 38 Xueyuan Road, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenfei Liang</Name>
        <Affiliation>State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, 38 Xueyuan Road, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xue Qiao</Name>
        <Affiliation>State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, 38 Xueyuan Road, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Wang</Name>
        <Affiliation>State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, 38 Xueyuan Road, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Siwang Yu</Name>
        <Affiliation>State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, 38 Xueyuan Road, Beijing 100191, China. Electronic address: swang_yu@bjmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Min Ye</Name>
        <Affiliation>State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, 38 Xueyuan Road, Beijing 100191, China. Electronic address: yemin@bjmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Protection from Cr(VI)-induced malignant cell transformation and tumorigenesis of Cr(VI)-transformed cells by luteolin through Nrf2 signaling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28416455</pubmedLink>
    <GrantList>
      <Grant>P30 CA177558</Grant>
      <Grant>R01 ES020870</Grant>
      <Grant>R01 ES021771</Grant>
      <Grant>R01 ES025515</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30171-0</DOI>
    <KeywordList>
      <Keywords>Apoptosis resistance</Keywords>
      <Keywords>Carcinogenesis</Keywords>
      <Keywords>Hexavalent chromium</Keywords>
      <Keywords>Luteolin</Keywords>
      <Keywords>Nrf2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Young Ok Son</Name>
        <Affiliation>Center for Research on Environmental Disease, College of Medicine, University of Kentucky, 1095 VA Drive, Lexington, KY 40536, USA; National Creative Research Initiatives Center for Osteoarthritis Pathogenesis and School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Poyil Pratheeshkumar</Name>
        <Affiliation>Center for Research on Environmental Disease, College of Medicine, University of Kentucky, 1095 VA Drive, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yuting Wang</Name>
        <Affiliation>Center for Research on Environmental Disease, College of Medicine, University of Kentucky, 1095 VA Drive, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Donghern Kim</Name>
        <Affiliation>Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, 1095 VA Drive, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zhuo Zhang</Name>
        <Affiliation>Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, 1095 VA Drive, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xianglin Shi</Name>
        <Affiliation>Center for Research on Environmental Disease, College of Medicine, University of Kentucky, 1095 VA Drive, Lexington, KY 40536, USA; Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, 1095 VA Drive, Lexington, KY 40536, USA. Electronic address: xshi5@email.uky.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Arsenic activates the expression of 3β-HSD in mouse Leydig cells through repression of histone H3K9 methylation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28414027</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30161-8</DOI>
    <KeywordList>
      <Keywords>3β-Hydroxysteroid dehydrogenase</Keywords>
      <Keywords>Arsenic</Keywords>
      <Keywords>H3K9 methylation</Keywords>
      <Keywords>MLTC-1 cells</Keywords>
      <Keywords>Steroidogenesis disturbance</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ambreen Alamdar</Name>
        <Affiliation>Key Laboratory of Urban Environment and Health, Institute of Urban Environment, Chinese Academy of Sciences, Xiamen 361021, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Guochen Xi</Name>
        <Affiliation>Key Laboratory of Urban Environment and Health, Institute of Urban Environment, Chinese Academy of Sciences, Xiamen 361021, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Qingyu Huang</Name>
        <Affiliation>Key Laboratory of Urban Environment and Health, Institute of Urban Environment, Chinese Academy of Sciences, Xiamen 361021, PR China; Centre for Epigenetics, Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense M, Denmark. Electronic address: qyhuang@iue.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Meiping Tian</Name>
        <Affiliation>Key Laboratory of Urban Environment and Health, Institute of Urban Environment, Chinese Academy of Sciences, Xiamen 361021, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Syed Ali Musstjab Akber Shah Eqani</Name>
        <Affiliation>Key Laboratory of Urban Environment and Health, Institute of Urban Environment, Chinese Academy of Sciences, Xiamen 361021, PR China; Public Health and Environment Division, Department of Biosciences, COMSAT Institute of Information &amp; Technology, Islamabad, Pakistan.</Affiliation>
      </Author>
      <Author>
        <Name>Heqing Shen</Name>
        <Affiliation>Key Laboratory of Urban Environment and Health, Institute of Urban Environment, Chinese Academy of Sciences, Xiamen 361021, PR China. Electronic address: hqshen@iue.ac.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Targeting Oct2 and P53: Formononetin prevents cisplatin-induced acute kidney injury.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28414026</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30162-X</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Cisplatin</Keywords>
      <Keywords>Oct2</Keywords>
      <Keywords>Regeneration</Keywords>
      <Keywords>p53</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Di Huang</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chuangyuan Wang</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China; Provincial Key Laboratory for Pharmacokinetics and Transport, Dalian, Liaoning, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yingjie Duan</Name>
        <Affiliation>General hospital of Fuxin mining (Group) Co., Ltd, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiang Meng</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China; Provincial Key Laboratory for Pharmacokinetics and Transport, Dalian, Liaoning, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhihao Liu</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China; Provincial Key Laboratory for Pharmacokinetics and Transport, Dalian, Liaoning, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaokui Huo</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China; Provincial Key Laboratory for Pharmacokinetics and Transport, Dalian, Liaoning, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huijun Sun</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China; Provincial Key Laboratory for Pharmacokinetics and Transport, Dalian, Liaoning, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaodong Ma</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China; Provincial Key Laboratory for Pharmacokinetics and Transport, Dalian, Liaoning, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kexin Liu</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian, China; Provincial Key Laboratory for Pharmacokinetics and Transport, Dalian, Liaoning, China. Electronic address: kexinliu@dlmedu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Increased seizure susceptibility and other toxicity symptoms following acute sulforaphane treatment in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28412310</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30159-X</DOI>
    <KeywordList>
      <Keywords>Antiepileptic drugs</Keywords>
      <Keywords>Lethal dose</Keywords>
      <Keywords>Proconvulsant</Keywords>
      <Keywords>Sulforaphane</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Katarzyna Socała</Name>
        <Affiliation>Department of Animal Physiology, Institute of Biology and Biochemistry, Maria Curie-Skłodowska University, Lublin, Poland. Electronic address: ksocala@op.pl.</Affiliation>
      </Author>
      <Author>
        <Name>Dorota Nieoczym</Name>
        <Affiliation>Department of Animal Physiology, Institute of Biology and Biochemistry, Maria Curie-Skłodowska University, Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Edyta Kowalczuk-Vasilev</Name>
        <Affiliation>Institute of Animal Nutrition and Bromatology, University of Life Sciences, Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Elżbieta Wyska</Name>
        <Affiliation>Department of Pharmacokinetics and Physical Pharmacy, Jagiellonian University Medical College, Kraków, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Piotr Wlaź</Name>
        <Affiliation>Department of Animal Physiology, Institute of Biology and Biochemistry, Maria Curie-Skłodowska University, Lublin, Poland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The scaffold protein RACK1 is a target of endocrine disrupting chemicals (EDCs) with important implication in immunity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28412309</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30160-6</DOI>
    <KeywordList>
      <Keywords>Anabolic steroids</Keywords>
      <Keywords>Cytokines</Keywords>
      <Keywords>Endocrine disrupting chemicals</Keywords>
      <Keywords>Hormones</Keywords>
      <Keywords>Immune system</Keywords>
      <Keywords>Pesticides</Keywords>
      <Keywords>Signal transduction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Erica Buoso</Name>
        <Affiliation>Dipartimento di Scienze del Farmaco, Università degli Studi di Pavia, Viale Taramelli 12/14, 27100 Pavia, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Marilisa Galasso</Name>
        <Affiliation>Dipartimento di Scienze del Farmaco, Università degli Studi di Pavia, Viale Taramelli 12/14, 27100 Pavia, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Melania Ronfani</Name>
        <Affiliation>Dipartimento di Scienze del Farmaco, Università degli Studi di Pavia, Viale Taramelli 12/14, 27100 Pavia, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Angela Papale</Name>
        <Affiliation>Laboratory of Toxicology, Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Via Balzaretti 9, 20133 Milano, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Valentina Galbiati</Name>
        <Affiliation>Laboratory of Toxicology, Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Via Balzaretti 9, 20133 Milano, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Ivano Eberini</Name>
        <Affiliation>Laboratorio di Biochimica e Biofisica Computazionale, Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Marina Marinovich</Name>
        <Affiliation>Laboratory of Toxicology, Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Via Balzaretti 9, 20133 Milano, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Marco Racchi</Name>
        <Affiliation>Dipartimento di Scienze del Farmaco, Università degli Studi di Pavia, Viale Taramelli 12/14, 27100 Pavia, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Emanuela Corsini</Name>
        <Affiliation>Laboratory of Toxicology, Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Via Balzaretti 9, 20133 Milano, Italy. Electronic address: emanuela.corsini@unimi.it.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Genistein prevention of hyperglycemia and improvement of glucose tolerance in adult non-obese diabetic mice are associated with alterations of gut microbiome and immune homeostasis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28412308</pubmedLink>
    <GrantList>
      <Grant>R21 ES024487</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30158-8</DOI>
    <KeywordList>
      <Keywords>Genistein</Keywords>
      <Keywords>Glucose tolerance</Keywords>
      <Keywords>Gut microbiome</Keywords>
      <Keywords>Hyperglycemia</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>NOD mouse</Keywords>
      <Keywords>Type 1 diabetes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Guannan Huang</Name>
        <Affiliation>Department of Environmental Health Sciences, College of Public Health, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Joella Xu</Name>
        <Affiliation>Department of Veterinary Biosciences and Diagnostic Imaging, College of Veterinary Medicine, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel E. Lefever</Name>
        <Affiliation>Department of Veterinary Biosciences and Diagnostic Imaging, College of Veterinary Medicine, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Travis C. Glenn</Name>
        <Affiliation>Department of Environmental Health Sciences, College of Public Health, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Tamas Nagy</Name>
        <Affiliation>Department of Pathology, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Tai L. Guo</Name>
        <Affiliation>Department of Veterinary Biosciences and Diagnostic Imaging, College of Veterinary Medicine, United States. Electronic address: tlguo1@uga.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The 9th Conference on Metal Toxicity and Carcinogenesis: The conference overview.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28412307</pubmedLink>
    <GrantList>
      <Grant>R01 ES020870</Grant>
      <Grant>R01 ES025515</Grant>
      <Grant>R01 ES021771</Grant>
      <Grant>P30 CA177558</Grant>
      <Grant>R13 ES027336</Grant>
      <Grant>R01 ES021100</Grant>
      <Grant>P30 CA118100</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30156-4</DOI>
    <KeywordList>
      <Keywords>Carcinogenesis</Keywords>
      <Keywords>Conference</Keywords>
      <Keywords>Metals</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>James T. F. Wise</Name>
        <Affiliation>Divison of Nutritional Sciences, Pharmacology and Nutritional Sciences, College of Medicine, University of Kentucky, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lei Wang</Name>
        <Affiliation>Center for Research on Environmental Disease, College of Medicine, University of Kentucky, Lexington, KY 40536, USA; Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zhuo Zhang</Name>
        <Affiliation>Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xianglin Shi</Name>
        <Affiliation>Divison of Nutritional Sciences, Pharmacology and Nutritional Sciences, College of Medicine, University of Kentucky, Lexington, KY 40536, USA; Center for Research on Environmental Disease, College of Medicine, University of Kentucky, Lexington, KY 40536, USA; Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, KY 40536, USA. Electronic address: xshi5@uky.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Prolonged particulate chromate exposure does not inhibit homologous recombination repair in North Atlantic right whale (Eubalaena glacialis) lung cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28411036</pubmedLink>
    <GrantList>
      <Grant>R01 ES016893</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30155-2</DOI>
    <KeywordList>
      <Keywords>Genomic instability</Keywords>
      <Keywords>Hexavalent chromium</Keywords>
      <Keywords>Homologous recombination repair</Keywords>
      <Keywords>North Atlantic right whale lung fibroblasts</Keywords>
      <Keywords>Rad51</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cynthia L. Browning</Name>
        <Affiliation>Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville School of Medicine, 505 S Hancock St, CTRB, Louisville, KY 40292, USA; Graduate School of Biomedical Science and Engineering, University of Maine, 42 Stodder Hall, Orono, ME 04469, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Catherine F. Wise</Name>
        <Affiliation>Program in Environmental and Molecular Toxicology, Department of Biological Sciences, North Carolina State University, Raleigh, NC 27695, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John Pierce Wise</Name>
        <Affiliation>Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville School of Medicine, 505 S Hancock St, CTRB, Louisville, KY 40292, USA; Graduate School of Biomedical Science and Engineering, University of Maine, 42 Stodder Hall, Orono, ME 04469, USA. Electronic address: john.wise@louisville.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Altered ion transport in normal human bronchial epithelial cells following exposure to chemically distinct metal welding fume particles.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28411035</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30157-6</DOI>
    <KeywordList>
      <Keywords>Air-interface</Keywords>
      <Keywords>Airway epithelium</Keywords>
      <Keywords>Cell culture</Keywords>
      <Keywords>Ion channels</Keywords>
      <Keywords>Ion transport</Keywords>
      <Keywords>Lactate dehydrogenase</Keywords>
      <Keywords>Welding fume</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jeffrey S. Fedan</Name>
        <Affiliation>Pathology and Physiology Research Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, USA. Electronic address: jsf2@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Janet A. Thompson</Name>
        <Affiliation>Pathology and Physiology Research Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Terence G. Meighan</Name>
        <Affiliation>Pathology and Physiology Research Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Patti C. Zeidler-Erdely</Name>
        <Affiliation>Pathology and Physiology Research Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James M. Antonini</Name>
        <Affiliation>Pathology and Physiology Research Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>4-Acetylantroquinonol B suppresses autophagic flux and improves cisplatin sensitivity in highly aggressive epithelial cancer through the PI3K/Akt/mTOR/p70S6K signaling pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28408137</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30152-7</DOI>
    <KeywordList>
      <Keywords>4-AAQB</Keywords>
      <Keywords>4-Acetylantroquinonol B</Keywords>
      <Keywords>Atg-5</Keywords>
      <Keywords>Autophagy</Keywords>
      <Keywords>Chemoresistance</Keywords>
      <Keywords>Cisplatin</Keywords>
      <Keywords>LC3B-II</Keywords>
      <Keywords>Ovarian cancer</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mingche Liu</Name>
        <Affiliation>Graduate Institute of Biomedical Materials and Tissue Engineering, College of biomedical engineering, Taipei Medical University, Taipei, Taiwan; Department of Urology, Taipei Medical University Hospital, Taipei, Taiwan; Department of Urology, School of Medicine, college of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Oluwaseun Adebayo Bamodu</Name>
        <Affiliation>Department of Hematology and Oncology, Cancer Center, Taipei Medical University-Shuang Ho Hospital, New Taipei City, Taiwan; Department of Medical Research &amp; Education, Taipei Medical University-Shuang Ho Hospital, New Taipei City, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Chien Huang</Name>
        <Affiliation>Institute of Traditional Medicine, School of Medicine, National Yang Ming University, Taipei, Taiwan; Department of Surgery, Division of Thoracic Surgery, MacKay Memorial Hospital, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Muhammad Ary Zucha</Name>
        <Affiliation>Graduate Institute of Medical Sciences, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yen Kuang Lin</Name>
        <Affiliation>Biostatistics and Research Consultation Center, Taipei Medical University, Taipei 11031, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Alexander T. H. Wu</Name>
        <Affiliation>The Ph.D. Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chun Chih Huang</Name>
        <Affiliation>Center for General Education, National Taitung University, Taitung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Hwa Lee</Name>
        <Affiliation>Department of Pathology, Taipei Medical University-Shuang Ho Hospital, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chiou Chung Yuan</Name>
        <Affiliation>Obstetrics and Gynecology Department, Taipei Medical University-Shuang Ho Hospital, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>M. Hsiao</Name>
        <Affiliation>Genomics Research Center, Academia Sinica, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Li Deng</Name>
        <Affiliation>Beijing Bioprocess Key Laboratory, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China; Amoy-BUCT Industrial Bio-technovation Institute, Amoy, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yew Min Tzeng</Name>
        <Affiliation>Center for General Education, National Taitung University, Taitung, Taiwan; Department of Appiled Chemistry, Chaoyang University of Technology, Taichung, Taiwan. Electronic address: ymtzeng@nttu.edu.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Chi Tai Yeh</Name>
        <Affiliation>Department of Hematology and Oncology, Cancer Center, Taipei Medical University-Shuang Ho Hospital, New Taipei City, Taiwan; Department of Medical Research &amp; Education, Taipei Medical University-Shuang Ho Hospital, New Taipei City, Taiwan. Electronic address: ctyeh@s.tmu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pre-clinical therapeutic development of a series of metalloporphyrins for Parkinson's disease.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28400118</pubmedLink>
    <GrantList>
      <Grant>P30 NS048154</Grant>
      <Grant>R01 NS045748</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30153-9</DOI>
    <KeywordList>
      <Keywords>Antioxidants</Keywords>
      <Keywords>Dopamine</Keywords>
      <Keywords>Drug development</Keywords>
      <Keywords>MPTP</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Pharmacokinetic analysis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Li Ping Liang</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of Colorado Denver, Aurora, CO, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Huang</Name>
        <Affiliation>Department of Medicine, National Jewish Health, Denver, CO, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ruth Fulton</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of Colorado Denver, Aurora, CO, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jennifer N. Pearson-Smith</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of Colorado Denver, Aurora, CO, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Brian J. Day</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of Colorado Denver, Aurora, CO, United States; Department of Medicine, National Jewish Health, Denver, CO, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Manisha Patel</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of Colorado Denver, Aurora, CO, United States. Electronic address: manisha.patel@ucdenver.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of the potential activity of major dietary compounds as selective estrogen receptor modulators in two distinct cell models for proliferation and differentiation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28396216</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30154-0</DOI>
    <KeywordList>
      <Keywords>Breast cancer cell lines</Keywords>
      <Keywords>Differentiation</Keywords>
      <Keywords>PC12</Keywords>
      <Keywords>Phytoestrogens</Keywords>
      <Keywords>Proliferation</Keywords>
      <Keywords>SERM</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sylvain Lecomte</Name>
        <Affiliation>Institut de Recherche en Santé-Environnement-Travail (IRSET), Inserm UMR 1085, Team Transcription, Environment and Cancer, University of Rennes 1, 9 Avenue du Pr Léon Bernard, 35000 Rennes, France.</Affiliation>
      </Author>
      <Author>
        <Name>Marie Lelong</Name>
        <Affiliation>Institut de Recherche en Santé-Environnement-Travail (IRSET), Inserm UMR 1085, Team Transcription, Environment and Cancer, University of Rennes 1, 9 Avenue du Pr Léon Bernard, 35000 Rennes, France.</Affiliation>
      </Author>
      <Author>
        <Name>Gaëlle Bourgine</Name>
        <Affiliation>Institut de Recherche en Santé-Environnement-Travail (IRSET), Inserm UMR 1085, Team Transcription, Environment and Cancer, University of Rennes 1, 9 Avenue du Pr Léon Bernard, 35000 Rennes, France.</Affiliation>
      </Author>
      <Author>
        <Name>Theo Efstathiou</Name>
        <Affiliation>Laboratoire Nutrinov, Technopole Atalante Champeaux, 8 rue Jules Maillard de la Gournerie, 35012 Rennes Cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Christian Saligaut</Name>
        <Affiliation>Institut de Recherche en Santé-Environnement-Travail (IRSET), Inserm UMR 1085, Team Transcription, Environment and Cancer, University of Rennes 1, 9 Avenue du Pr Léon Bernard, 35000 Rennes, France.</Affiliation>
      </Author>
      <Author>
        <Name>Farzad Pakdel</Name>
        <Affiliation>Institut de Recherche en Santé-Environnement-Travail (IRSET), Inserm UMR 1085, Team Transcription, Environment and Cancer, University of Rennes 1, 9 Avenue du Pr Léon Bernard, 35000 Rennes, France. Electronic address: farzad.pakdel@univ-rennes1.fr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Combining transcriptomics and PBPK modeling indicates a primary role of hypoxia and altered circadian signaling in dichloromethane carcinogenicity in mouse lung and liver.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28392392</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30151-5</DOI>
    <KeywordList>
      <Keywords>Carcinogen</Keywords>
      <Keywords>Circadian cycle</Keywords>
      <Keywords>Dichloromethane</Keywords>
      <Keywords>Hypoxia</Keywords>
      <Keywords>Mouse</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Melvin E. Andersen</Name>
        <Affiliation>ScitoVation LLC, Six Davis Drive, PO Box 110566, Research Triangle Park, NC 27709-5566, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Michael B. Black</Name>
        <Affiliation>ScitoVation LLC, Six Davis Drive, PO Box 110566, Research Triangle Park, NC 27709-5566, United States. Electronic address: mblack@scitovation.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jerry L. Campbell</Name>
        <Affiliation>Ramboll-Enviro, Inc., Six Davis Drive, PO Box 13441, Research Triangle Park, NC 27709, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Salil N. Pendse</Name>
        <Affiliation>ScitoVation LLC, Six Davis Drive, PO Box 110566, Research Triangle Park, NC 27709-5566, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Harvey J. Clewell</Name>
        <Affiliation>ScitoVation LLC, Six Davis Drive, PO Box 110566, Research Triangle Park, NC 27709-5566, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Lynn H. Pottenger</Name>
        <Affiliation>Olin Corporation, 100 Larkin Center, Midland, MI 48674, United States.</Affiliation>
      </Author>
      <Author>
        <Name>James S. Bus</Name>
        <Affiliation>Exponent, Inc., 5806 Woodberry Drive, Midland, MI 48640, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Darol E. Dodd</Name>
        <Affiliation>Charles River, 640 N. Elizabeth St., Spencerville, OH 45887, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel C. Kemp</Name>
        <Affiliation>Quintiles, 4820 Emperor Blvd., Durham, NC 27703, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Patrick D. McMullen</Name>
        <Affiliation>ScitoVation LLC, Six Davis Drive, PO Box 110566, Research Triangle Park, NC 27709-5566, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Butyl paraben and propyl paraben modulate bisphenol A and estradiol concentrations in female and male mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28390971</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30142-4</DOI>
    <KeywordList>
      <Keywords>Bisphenol A</Keywords>
      <Keywords>Endocrine disruptor</Keywords>
      <Keywords>Estradiol</Keywords>
      <Keywords>Paraben</Keywords>
      <Keywords>Uterus</Keywords>
      <Keywords>p-Hydroxybenzoic acid ester</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tyler Pollock</Name>
        <Affiliation>Department of Psychology, Neuroscience &amp; Behaviour, McMaster University, Hamilton, Ontario L8S 4K1, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Rachel E. Weaver</Name>
        <Affiliation>Department of Psychology, Neuroscience &amp; Behaviour, McMaster University, Hamilton, Ontario L8S 4K1, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Ramtin Ghasemi</Name>
        <Affiliation>Department of Psychology, Neuroscience &amp; Behaviour, McMaster University, Hamilton, Ontario L8S 4K1, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Denys deCatanzaro</Name>
        <Affiliation>Department of Psychology, Neuroscience &amp; Behaviour, McMaster University, Hamilton, Ontario L8S 4K1, Canada. Electronic address: decatanz@mcmaster.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Improved physiologically based pharmacokinetic model for oral exposures to chromium in mice, rats, and humans to address temporal variation and sensitive populations.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28389273</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30137-0</DOI>
    <KeywordList>
      <Keywords>Chromium</Keywords>
      <Keywords>Gastrointestinal reduction</Keywords>
      <Keywords>Human variation</Keywords>
      <Keywords>Physiologically based model</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>C. R. Kirman</Name>
        <Affiliation>Summit Toxicology, PO Box 3209, Bozeman, MT 59715, United States. Electronic address: ckirman@summittoxicology.com.</Affiliation>
      </Author>
      <Author>
        <Name>M. Suh</Name>
        <Affiliation>ToxStrategies, Mission Viejo, CA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>D. M. Proctor</Name>
        <Affiliation>ToxStrategies, Mission Viejo, CA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>S. M. Hays</Name>
        <Affiliation>Summit Toxicology, PO Box 3209, Bozeman, MT 59715, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Developmental neurotoxicity of different pesticides in PC-12 cells in vitro.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28385489</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30141-2</DOI>
    <KeywordList>
      <Keywords>Biocides</Keywords>
      <Keywords>Developmental neurotoxicity</Keywords>
      <Keywords>Neonicotinoids</Keywords>
      <Keywords>Neurite outgrowth</Keywords>
      <Keywords>PC-12 cells</Keywords>
      <Keywords>Pesticides</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Verena Christen</Name>
        <Affiliation>University of Applied Sciences and Arts Northwestern Switzerland, School of Life Sciences, Gründenstrasse 40, CH-4132, Muttenz, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Manuel Rusconi</Name>
        <Affiliation>Federal Office of Public Health, Division Chemical Products, 3003 Bern, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Pierre Crettaz</Name>
        <Affiliation>Federal Office of Public Health, Division Chemical Products, 3003 Bern, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Karl Fent</Name>
        <Affiliation>University of Applied Sciences and Arts Northwestern Switzerland, School of Life Sciences, Gründenstrasse 40, CH-4132, Muttenz, Switzerland; Swiss Federal Institute of Technology Zürich (ETH Zürich), Department of Environmental Systems Sciences, Institute of Biogeochemistry and Pollution Dynamics, CH-8092 Zürich, Switzerland. Electronic address: karl.fent@bluewin.ch.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The monoamine oxidase inhibition properties of selected structural analogues of methylene blue.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28377303</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30140-0</DOI>
    <KeywordList>
      <Keywords>Cresyl violet</Keywords>
      <Keywords>Inhibition</Keywords>
      <Keywords>MAO</Keywords>
      <Keywords>Methylene blue</Keywords>
      <Keywords>Monoamine oxidase</Keywords>
      <Keywords>Nile blue</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anzelle Delport</Name>
        <Affiliation>Pharmaceutical Chemistry, School of Pharmacy, North-West University, Private Bag X6001, Potchefstroom 2520, South Africa; Centre of Excellence for Pharmaceutical Sciences, North-West University, Private Bag X6001, Potchefstroom 2520, South Africa.</Affiliation>
      </Author>
      <Author>
        <Name>Brian H. Harvey</Name>
        <Affiliation>Centre of Excellence for Pharmaceutical Sciences, North-West University, Private Bag X6001, Potchefstroom 2520, South Africa; Pharmacology, School of Pharmacy, North-West University, Private Bag X6001, Potchefstroom 2520, South Africa.</Affiliation>
      </Author>
      <Author>
        <Name>Anél Petzer</Name>
        <Affiliation>Pharmaceutical Chemistry, School of Pharmacy, North-West University, Private Bag X6001, Potchefstroom 2520, South Africa; Centre of Excellence for Pharmaceutical Sciences, North-West University, Private Bag X6001, Potchefstroom 2520, South Africa.</Affiliation>
      </Author>
      <Author>
        <Name>Jacobus P. Petzer</Name>
        <Affiliation>Pharmaceutical Chemistry, School of Pharmacy, North-West University, Private Bag X6001, Potchefstroom 2520, South Africa; Centre of Excellence for Pharmaceutical Sciences, North-West University, Private Bag X6001, Potchefstroom 2520, South Africa. Electronic address: jacques.petzer@nwu.ac.za.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Formaldehyde and co-exposure with benzene induce compensation of bone marrow and hematopoietic stem/progenitor cells in BALB/c mice during post-exposure period.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28373009</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30138-2</DOI>
    <KeywordList>
      <Keywords>Benzene</Keywords>
      <Keywords>Bone marrow</Keywords>
      <Keywords>Formaldehyde</Keywords>
      <Keywords>Hematotoxicity</Keywords>
      <Keywords>Myeloid progenitor</Keywords>
      <Keywords>Post-exposure</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chenxi Wei</Name>
        <Affiliation>Key Laboratory of Ecological Safety Monitoring and Evaluation, School of Life Sciences, Hunan Normal University, Changsha 410081, Hunan, China; Section of Environmental Biomedicine, Hubei Key Laboratory of Genetic Regulation and Integrative Biology, School of Life Sciences, Central China Normal University, Wuhan 430079, Hubei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mouying Chen</Name>
        <Affiliation>Key Laboratory of Ecological Safety Monitoring and Evaluation, School of Life Sciences, Hunan Normal University, Changsha 410081, Hunan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huihui You</Name>
        <Affiliation>Section of Environmental Biomedicine, Hubei Key Laboratory of Genetic Regulation and Integrative Biology, School of Life Sciences, Central China Normal University, Wuhan 430079, Hubei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Feng Qiu</Name>
        <Affiliation>Key Laboratory of Ecological Safety Monitoring and Evaluation, School of Life Sciences, Hunan Normal University, Changsha 410081, Hunan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huaxiao Wen</Name>
        <Affiliation>Section of Environmental Biomedicine, Hubei Key Laboratory of Genetic Regulation and Integrative Biology, School of Life Sciences, Central China Normal University, Wuhan 430079, Hubei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Junlin Yuan</Name>
        <Affiliation>Section of Environmental Biomedicine, Hubei Key Laboratory of Genetic Regulation and Integrative Biology, School of Life Sciences, Central China Normal University, Wuhan 430079, Hubei, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuanglin Xiang</Name>
        <Affiliation>Key Laboratory of Ecological Safety Monitoring and Evaluation, School of Life Sciences, Hunan Normal University, Changsha 410081, Hunan, China. Electronic address: xshlin@hunnu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Yang</Name>
        <Affiliation>Section of Environmental Biomedicine, Hubei Key Laboratory of Genetic Regulation and Integrative Biology, School of Life Sciences, Central China Normal University, Wuhan 430079, Hubei, China. Electronic address: yangxu@mail.ccnu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Loss of Nrf2 promotes rapid progression to heart failure following myocardial infarction.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28373008</pubmedLink>
    <GrantList>
      <Grant>T32 ES007091</Grant>
      <Grant>R01 HL089958</Grant>
      <Grant>R21 ES017473</Grant>
      <Grant>R01 GM111337</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30139-4</DOI>
    <KeywordList>
      <Keywords>Biomarkers</Keywords>
      <Keywords>Cardiovascular</Keywords>
      <Keywords>Remodeling</Keywords>
      <Keywords>Tissue repair</Keywords>
      <Keywords>Transcription factor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joshua Strom</Name>
        <Affiliation>Department of Pharmacology, College of Medicine, University of Arizona, 1501 N. Campbell Ave, Tucson, AZ 85724, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Qin M. Chen</Name>
        <Affiliation>Department of Pharmacology, College of Medicine, University of Arizona, 1501 N. Campbell Ave, Tucson, AZ 85724, United States. Electronic address: qchen@email.arizona.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Valproate induced hepatic steatosis by enhanced fatty acid uptake and triglyceride synthesis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28366540</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30136-9</DOI>
    <KeywordList>
      <Keywords>CD36</Keywords>
      <Keywords>DGAT2</Keywords>
      <Keywords>Fatty acid</Keywords>
      <Keywords>Hepatic steatosis</Keywords>
      <Keywords>SREBP-1c</Keywords>
      <Keywords>Valproate</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xupeng Bai</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Weipeng Hong</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Peiheng Cai</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yibei Chen</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chuncao Xu</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Di Cao</Name>
        <Affiliation>School of Chinese Materia Medica, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Weibang Yu</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhongxiang Zhao</Name>
        <Affiliation>School of Chinese Materia Medica, Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Min Huang</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Jin</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China. Electronic address: jinjing@mail.sysu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Caffeic acid phenethyl ester protects against glucocorticoid-induced osteoporosis in vivo: Impact on oxidative stress and RANKL/OPG signals.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28363435</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30131-X</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Caffeic acid phenethyl ester</Keywords>
      <Keywords>Dexamethasone</Keywords>
      <Keywords>GSH</Keywords>
      <Keywords>Osteoporosis</Keywords>
      <Keywords>SOD</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mai F. Tolba</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt; Chapman University, Irvine 92618, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ahmed T. El-Serafi</Name>
        <Affiliation>Sharjah Institute for Medical Research, University of Sharjah, Sharjah 27272, United Arab Emirates; Department of Medical Biochemistry, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Hany A. Omar</Name>
        <Affiliation>Sharjah Institute for Medical Research, University of Sharjah, Sharjah 27272, United Arab Emirates; Department of Pharmacology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef 62514, Egypt. Electronic address: hanyomar@sharjah.ac.ae.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Interleukin-24 as a target cytokine of environmental aryl hydrocarbon receptor agonist exposure in the lung.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28351761</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30123-0</DOI>
    <KeywordList>
      <Keywords>Aryl hydrocarbon receptor</Keywords>
      <Keywords>Cytokines</Keywords>
      <Keywords>Environmental aryl hydrocarbon receptor agonists</Keywords>
      <Keywords>Interleukin (IL)-24</Keywords>
      <Keywords>Particulate matter</Keywords>
      <Keywords>Polycyclic aromatic hydrocarbons</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yueh Hsia Luo</Name>
        <Affiliation>National Institute of Environmental Health Sciences, National Health Research Institutes, Zhunan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Chun Kuo</Name>
        <Affiliation>National Institute of Environmental Health Sciences, National Health Research Institutes, Zhunan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Hsien Tsai</Name>
        <Affiliation>National Institute of Environmental Health Sciences, National Health Research Institutes, Zhunan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chia Chi Ho</Name>
        <Affiliation>National Institute of Environmental Health Sciences, National Health Research Institutes, Zhunan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Ti Tsai</Name>
        <Affiliation>National Institute of Environmental Health Sciences, National Health Research Institutes, Zhunan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chin Yu Hsu</Name>
        <Affiliation>National Institute of Environmental Health Sciences, National Health Research Institutes, Zhunan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Cheng Chen</Name>
        <Affiliation>National Institute of Environmental Health Sciences, National Health Research Institutes, Zhunan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Pinpin Lin</Name>
        <Affiliation>National Institute of Environmental Health Sciences, National Health Research Institutes, Zhunan, Taiwan. Electronic address: pplin@nhri.org.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toward a systematic exploration of nano-bio interactions.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28344110</pubmedLink>
    <GrantList>
      <Grant>P30 ES005022</Grant>
      <Grant>R15 ES023148</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30115-1</DOI>
    <AuthorList>
      <Author>
        <Name>Xue Bai</Name>
        <Affiliation>School of Chemistry and Chemical Engineering, Shandong University, Jinan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fang Liu</Name>
        <Affiliation>School of Chemistry and Chemical Engineering, Shandong University, Jinan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yin Liu</Name>
        <Affiliation>School of Chemistry and Chemical Engineering, Shandong University, Jinan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cong Li</Name>
        <Affiliation>School of Chemistry and Chemical Engineering, Shandong University, Jinan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shenqing Wang</Name>
        <Affiliation>School of Chemistry and Chemical Engineering, Shandong University, Jinan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongyu Zhou</Name>
        <Affiliation>School of Environmental Science and Technology, Shandong University, Jinan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenyi Wang</Name>
        <Affiliation>Department of Chemistry, Rutgers University, Camden, NJ, United States; The Rutgers Center for Computational and Integrative Biology, Rutgers University, Camden, NJ, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Hao Zhu</Name>
        <Affiliation>Department of Chemistry, Rutgers University, Camden, NJ, United States; The Rutgers Center for Computational and Integrative Biology, Rutgers University, Camden, NJ, United States.</Affiliation>
      </Author>
      <Author>
        <Name>David A. Winkler</Name>
        <Affiliation>CSIRO Manufacturing, Bag 10, Clayton South MDC 3169, Australia; Monash Institute of Pharmaceutical Sciences, 392 Royal Parade, Parkville 3052, Australia; La Trobe Institute for Molecular Science, La Trobe University, Kingsbury Drive, Melbourne 3086, Australia; School of Chemical and Physical Sciences, Flinders University, Bedford Park 5042, Australia. Electronic address: d.winkler@latrobe.edu.au.</Affiliation>
      </Author>
      <Author>
        <Name>Bing Yan</Name>
        <Affiliation>School of Chemistry and Chemical Engineering, Shandong University, Jinan, China; School of Environmental Science and Technology, Shandong University, Jinan, China. Electronic address: drbingyan@yahoo.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The role of cPLA2 in Methylglyoxal-induced cell apoptosis of HUVECs.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28341536</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30124-2</DOI>
    <KeywordList>
      <Keywords>MGO</Keywords>
      <Keywords>NAC</Keywords>
      <Keywords>NF-κB</Keywords>
      <Keywords>apoptosis</Keywords>
      <Keywords>cPLA2</Keywords>
      <Keywords>p38</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jie Yuan</Name>
        <Affiliation>Jiangsu Provincial Key Lab of Cardiovascular Diseases and Molecular intervention, Department of Pharmacology, Nanjing Medical University, Nanjing 210029, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Zhu</Name>
        <Affiliation>Jiangsu Provincial Key Lab of Cardiovascular Diseases and Molecular intervention, Department of Pharmacology, Nanjing Medical University, Nanjing 210029, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yali Hong</Name>
        <Affiliation>Jiangsu Provincial Key Lab of Cardiovascular Diseases and Molecular intervention, Department of Pharmacology, Nanjing Medical University, Nanjing 210029, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zongxing Sun</Name>
        <Affiliation>Jiangsu Provincial Key Lab of Cardiovascular Diseases and Molecular intervention, Department of Pharmacology, Nanjing Medical University, Nanjing 210029, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xianjun Fang</Name>
        <Affiliation>Jiangsu Provincial Key Lab of Cardiovascular Diseases and Molecular intervention, Department of Pharmacology, Nanjing Medical University, Nanjing 210029, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Biao Wu</Name>
        <Affiliation>Department of Surgery, The First Affiliated Hospital, Nanchang University, PR China. Electronic address: wubiao@ncu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Shengnan Li</Name>
        <Affiliation>Jiangsu Provincial Key Lab of Cardiovascular Diseases and Molecular intervention, Department of Pharmacology, Nanjing Medical University, Nanjing 210029, PR China. Electronic address: snli@njmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors activate the aryl hydrocarbon receptor.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28336214</pubmedLink>
    <GrantList>
      <Grant>P20 GM103534</Grant>
      <Grant>P20 RR024475</Grant>
      <Grant>P30 CA023108</Grant>
      <Grant>R01 ES004869</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30116-3</DOI>
    <KeywordList>
      <Keywords>AHR agonists</Keywords>
      <Keywords>Aryl Hydrocarbon Receptor</Keywords>
      <Keywords>Cancer</Keywords>
      <Keywords>Clinical trials</Keywords>
      <Keywords>IDO inhibitors</Keywords>
      <Keywords>IDO1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Benjamin J. Moyer</Name>
        <Affiliation>Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Itzel Y. Rojas</Name>
        <Affiliation>Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Iain A. Murray</Name>
        <Affiliation>Center for Molecular Toxicology and Carcinogenesis, The Pennsylvania State University, University Park, PA 16802, United States; Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, PA 16802, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Seokwon Lee</Name>
        <Affiliation>Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Haley F. Hazlett</Name>
        <Affiliation>Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Gary H. Perdew</Name>
        <Affiliation>Center for Molecular Toxicology and Carcinogenesis, The Pennsylvania State University, University Park, PA 16802, United States; Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, PA 16802, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Craig R. Tomlinson</Name>
        <Affiliation>Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, United States; Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, United States. Electronic address: Craig.R.Tomlinson@Dartmouth.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Transient and permanent changes in DNA methylation patterns in inorganic arsenic-mediated epithelial-to-mesenchymal transition.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28336213</pubmedLink>
    <GrantList>
      <Grant>P30 CA177558</Grant>
      <Grant>R01 ES024478</Grant>
      <Grant>T32 CA165990</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30121-7</DOI>
    <KeywordList>
      <Keywords>DNA methylation</Keywords>
      <Keywords>EMT</Keywords>
      <Keywords>Epigenetics</Keywords>
      <Keywords>Infinium MethylationEPIC BeadChip</Keywords>
      <Keywords>Inorganic arsenic</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Meredith Eckstein</Name>
        <Affiliation>Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew Rea</Name>
        <Affiliation>Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yvonne N. Fondufe-Mittendorf</Name>
        <Affiliation>Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY 40536, USA. Electronic address: y.fondufe-mittendorf@uky.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>HSP90 and pCREB alterations are linked to mancozeb-dependent behavioral and neurodegenerative effects in a marine teleost.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28330765</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30122-9</DOI>
    <KeywordList>
      <Keywords>Behavioral impairments</Keywords>
      <Keywords>HSP90 mRNA</Keywords>
      <Keywords>Manganese/zinc-ethylene-bis-dithiocarbamate</Keywords>
      <Keywords>Neuronal damages</Keywords>
      <Keywords>Phosphorylated CREB factor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Merylin Zizza</Name>
        <Affiliation>Comparative Neuroanatomy Laboratory, Biology, Ecology and Earth Science Department (DiBEST), University of Calabria, Arcavacata of Rende, 87036, CS, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Mariana Di Lorenzo</Name>
        <Affiliation>Department of Biology, Section of Evolutionary and Comparative Biology, University of Naples Federico II, 80134 Naples, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Vincenza Laforgia</Name>
        <Affiliation>Department of Biology, Section of Evolutionary and Comparative Biology, University of Naples Federico II, 80134 Naples, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Emilia Furia</Name>
        <Affiliation>Department of Chemistry and Chemical Technologies (DCTC), University of Calabria, Arcavacata of Rende, 87036, CS, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Giovanni Sindona</Name>
        <Affiliation>Department of Chemistry and Chemical Technologies (DCTC), University of Calabria, Arcavacata of Rende, 87036, CS, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Marcello Canonaco</Name>
        <Affiliation>Comparative Neuroanatomy Laboratory, Biology, Ecology and Earth Science Department (DiBEST), University of Calabria, Arcavacata of Rende, 87036, CS, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Rosa Maria Facciolo</Name>
        <Affiliation>Comparative Neuroanatomy Laboratory, Biology, Ecology and Earth Science Department (DiBEST), University of Calabria, Arcavacata of Rende, 87036, CS, Italy. Electronic address: rm.facciolo@unical.it.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pharmacokinetics of opicapone, a third-generation COMT inhibitor, after single and multiple oral administration: A comparative study in the rat.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28322896</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30117-5</DOI>
    <KeywordList>
      <Keywords>Catechol-O-methyltransferase inhibitor</Keywords>
      <Keywords>Opicapone</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Rat</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Daniela Gonçalves</Name>
        <Affiliation>Laboratory of Pharmacology, Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal; CNC - Center for Neuroscience and Cell Biology, University of Coimbra, 3004-517 Coimbra, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Gilberto Alves</Name>
        <Affiliation>CNC - Center for Neuroscience and Cell Biology, University of Coimbra, 3004-517 Coimbra, Portugal; CICS-UBI - Health Sciences Research Centre, University of Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal. Electronic address: gilberto@fcsaude.ubi.pt.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Fortuna</Name>
        <Affiliation>Laboratory of Pharmacology, Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal; CNC - Center for Neuroscience and Cell Biology, University of Coimbra, 3004-517 Coimbra, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Patrício Soares-da-Silva</Name>
        <Affiliation>Department of Research and Development, BIAL - Portela &amp; Cª S.A., Av. da Siderurgia Nacional, 4745-457 S. Mamede do Coronado, Portugal; MedInUP - Center for Drug Discovery and Innovative Medicines, University Porto, Porto, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Amílcar Falcão</Name>
        <Affiliation>Laboratory of Pharmacology, Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal; CNC - Center for Neuroscience and Cell Biology, University of Coimbra, 3004-517 Coimbra, Portugal.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Baicalin benefits the anti-HBV therapy via inhibiting HBV viral RNAs.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28322895</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30120-5</DOI>
    <KeywordList>
      <Keywords>Anti-HBV</Keywords>
      <Keywords>Baicalin</Keywords>
      <Keywords>HBV RNAs</Keywords>
      <Keywords>Hepatocyte nuclear factors</Keywords>
      <Keywords>Nucleoside analog</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hai Huang</Name>
        <Affiliation>Department of Microbiology and Biopharmacy, School of Pharmacy, Fudan University, 826 Zhangheng Road, Shanghai 201203, China. Electronic address: HHai3552@sina.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Zhou</Name>
        <Affiliation>Department of Chemistry, Fudan University, 220 Han Dan Road, Shanghai 200433, China. Electronic address: zhouw@fudan.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Haiyan Zhu</Name>
        <Affiliation>Department of Microbiology and Biopharmacy, School of Pharmacy, Fudan University, 826 Zhangheng Road, Shanghai 201203, China. Electronic address: haiyanzhu@fudan.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Pei Zhou</Name>
        <Affiliation>Department of Microbiology and Biopharmacy, School of Pharmacy, Fudan University, 826 Zhangheng Road, Shanghai 201203, China. Electronic address: pzhou@shmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xunlong Shi</Name>
        <Affiliation>Department of Microbiology and Biopharmacy, School of Pharmacy, Fudan University, 826 Zhangheng Road, Shanghai 201203, China. Electronic address: xunlongshi@fudan.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Role of epithelial-mesenchymal transition (EMT) and fibroblast function in cerium oxide nanoparticles-induced lung fibrosis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28315692</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30119-9</DOI>
    <KeywordList>
      <Keywords>Cerium oxide</Keywords>
      <Keywords>Epithelial cells</Keywords>
      <Keywords>Epithelial-mesenchymal transition</Keywords>
      <Keywords>Lung fibrosis</Keywords>
      <Keywords>Nanoparticles</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jane Ma</Name>
        <Affiliation>Health Effects Laboratory Division, NIOSH, Morgantown, WV, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Bridget Bishoff</Name>
        <Affiliation>Mylan Pharmaceuticals, Morganntown, WV, United States.</Affiliation>
      </Author>
      <Author>
        <Name>R. R. Mercer</Name>
        <Affiliation>Health Effects Laboratory Division, NIOSH, Morgantown, WV, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Barger</Name>
        <Affiliation>Health Effects Laboratory Division, NIOSH, Morgantown, WV, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Diane Schwegler-Berry</Name>
        <Affiliation>Health Effects Laboratory Division, NIOSH, Morgantown, WV, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Vincent Castranova</Name>
        <Affiliation>School of Pharmacy, West Virginia University, Morgantown, WV, United States. Electronic address: vcastran@hsc.wvu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The effect of angiotensin receptor neprilysin inhibitor, sacubitril/valsartan, on central nervous system amyloid-β concentrations and clearance in the cynomolgus monkey.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28315356</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30118-7</DOI>
    <KeywordList>
      <Keywords>Alzheimer's disease</Keywords>
      <Keywords>Amyloid beta</Keywords>
      <Keywords>Angiotensin receptor neprilysin inhibitor</Keywords>
      <Keywords>LCZ696</Keywords>
      <Keywords>SILK-Aβ</Keywords>
      <Keywords>Sacubitril/valsartan</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Heidi A. Schoenfeld</Name>
        <Affiliation>Novartis Institutes for BioMedical Research, East Hanover, NJ, USA. Electronic address: heidi.schoenfeld@novartis.com.</Affiliation>
      </Author>
      <Author>
        <Name>Tim West</Name>
        <Affiliation>C2N Diagnostics, St. Louis, MO, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Philip B. Verghese</Name>
        <Affiliation>C2N Diagnostics, St. Louis, MO, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mary Holubasch</Name>
        <Affiliation>C2N Diagnostics, St. Louis, MO, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Neeta Shenoy</Name>
        <Affiliation>Novartis Institutes for BioMedical Research, Cambridge, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David Kagan</Name>
        <Affiliation>Novartis Institutes for BioMedical Research, Cambridge, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chiara Buono</Name>
        <Affiliation>Novartis Institutes for BioMedical Research, Cambridge, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Zhou</Name>
        <Affiliation>Novartis Institutes for BioMedical Research, East Hanover, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marc DeCristofaro</Name>
        <Affiliation>Novartis Institutes for BioMedical Research, East Hanover, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Julie Douville</Name>
        <Affiliation>Charles River Laboratories ULC, Montreal, Quebec, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Geoffrey G. Goodrich</Name>
        <Affiliation>Charles River Laboratories, Inc., Reno, NV, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Keith Mansfield</Name>
        <Affiliation>Novartis Institutes for BioMedical Research, Cambridge, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chandra Saravanan</Name>
        <Affiliation>Novartis Institutes for BioMedical Research, Cambridge, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Frederic Cumin</Name>
        <Affiliation>Novartis Institutes for BioMedical Research, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Randy L. Webb</Name>
        <Affiliation>Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Randall J. Bateman</Name>
        <Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>High-fat diet aggravates 2,2',4,4'-tetrabromodiphenyl ether-inhibited testosterone production via DAX-1 in Leydig cells in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28300557</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30114-X</DOI>
    <KeywordList>
      <Keywords>2,2′,4,4′-tetrabromodiphenyl ether</Keywords>
      <Keywords>DAX-1</Keywords>
      <Keywords>High-fat diet</Keywords>
      <Keywords>Insulin</Keywords>
      <Keywords>Primary Leydig cells</Keywords>
      <Keywords>Testosterone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhan Zhang</Name>
        <Affiliation>State Key Lab of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, PR China; Key Lab of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongquan Yu</Name>
        <Affiliation>State Key Lab of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, PR China; Key Lab of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hengsen Xu</Name>
        <Affiliation>Key Lab of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Wang</Name>
        <Affiliation>State Key Lab of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, PR China; Key Lab of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Minghui Ji</Name>
        <Affiliation>Key Lab of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Gu</Name>
        <Affiliation>Key Lab of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Yang</Name>
        <Affiliation>State Key Lab of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, PR China; Key Lab of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiansheng Zhu</Name>
        <Affiliation>State Key Lab of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, PR China; Key Lab of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Huibin Dong</Name>
        <Affiliation>Changzhou Center for Disease Control and Prevention, 203 Taishan Road, Changzhou 2013022, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shou Lin Wang</Name>
        <Affiliation>State Key Lab of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, PR China; Key Lab of Modern Toxicology of Ministry of Education, School of Public Health, Nanjing Medical University, 101 Longmian Avenue, Nanjing 211166, PR China. Electronic address: wangshl@njmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Maternal exposure to di(2-ethylhexyl)phthalate (DEHP) promotes the transgenerational inheritance of adult-onset reproductive dysfunctions through the female germline in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28286118</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30112-6</DOI>
    <KeywordList>
      <Keywords>Di(2-ethylhexyl)phthalate (DEHP)</Keywords>
      <Keywords>Maternal exposure</Keywords>
      <Keywords>Mouse</Keywords>
      <Keywords>Ovary</Keywords>
      <Keywords>Reproductive toxicity</Keywords>
      <Keywords>Transgenerational</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Paola Pocar</Name>
        <Affiliation>Department of Veterinary Medicine, University of Milan, 20133 Milan, Italy. Electronic address: paola.pocar@unimi.it.</Affiliation>
      </Author>
      <Author>
        <Name>Nadia Fiandanese</Name>
        <Affiliation>Department of Veterinary Medicine, University of Milan, 20133 Milan, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Berrini</Name>
        <Affiliation>Department of Veterinary Medicine, University of Milan, 20133 Milan, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Camillo Secchi</Name>
        <Affiliation>Department of Veterinary Medicine, University of Milan, 20133 Milan, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Vitaliano Borromeo</Name>
        <Affiliation>Department of Veterinary Medicine, University of Milan, 20133 Milan, Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Carvedilol prevents functional deficits in peripheral nerve mitochondria of rats with oxaliplatin-evoked painful peripheral neuropathy.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28286117</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30113-8</DOI>
    <KeywordList>
      <Keywords>Carvedilol</Keywords>
      <Keywords>Mitochondrial dysfunction</Keywords>
      <Keywords>Oxaliplatin</Keywords>
      <Keywords>Peripheral neuropathy &amp; dorsal root ganglion</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Aparna Areti</Name>
        <Affiliation>Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER)-Hyderabad, Balanagar, India.</Affiliation>
      </Author>
      <Author>
        <Name>Prashanth Komirishetty</Name>
        <Affiliation>Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER)-Hyderabad, Balanagar, India.</Affiliation>
      </Author>
      <Author>
        <Name>Ashutosh Kumar</Name>
        <Affiliation>Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER)-Hyderabad, Balanagar, India. Electronic address: ashutosh.niperhyd@gov.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Biatriosporin D displays anti-virulence activity through decreasing the intracellular cAMP levels.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28286116</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30102-3</DOI>
    <KeywordList>
      <Keywords>Anti-virulence</Keywords>
      <Keywords>Biatriosporin D</Keywords>
      <Keywords>Candida albicans</Keywords>
      <Keywords>Farnesol</Keywords>
      <Keywords>cAMP</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ming Zhang</Name>
        <Affiliation>Department of Natural Product Chemistry, Key Lab of Chemical Biology of Ministry of Education, Shandong University, No. 44 West Wenhua Road, Jinan City, Shandong Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenqiang Chang</Name>
        <Affiliation>Department of Natural Product Chemistry, Key Lab of Chemical Biology of Ministry of Education, Shandong University, No. 44 West Wenhua Road, Jinan City, Shandong Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongzhuo Shi</Name>
        <Affiliation>Department of Natural Product Chemistry, Key Lab of Chemical Biology of Ministry of Education, Shandong University, No. 44 West Wenhua Road, Jinan City, Shandong Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanhui Zhou</Name>
        <Affiliation>Department of Natural Product Chemistry, Key Lab of Chemical Biology of Ministry of Education, Shandong University, No. 44 West Wenhua Road, Jinan City, Shandong Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Sha Zheng</Name>
        <Affiliation>Department of Natural Product Chemistry, Key Lab of Chemical Biology of Ministry of Education, Shandong University, No. 44 West Wenhua Road, Jinan City, Shandong Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Li</Name>
        <Affiliation>Department of Natural Product Chemistry, Key Lab of Chemical Biology of Ministry of Education, Shandong University, No. 44 West Wenhua Road, Jinan City, Shandong Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lin Li</Name>
        <Affiliation>Department of Natural Product Chemistry, Key Lab of Chemical Biology of Ministry of Education, Shandong University, No. 44 West Wenhua Road, Jinan City, Shandong Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongxiang Lou</Name>
        <Affiliation>Department of Natural Product Chemistry, Key Lab of Chemical Biology of Ministry of Education, Shandong University, No. 44 West Wenhua Road, Jinan City, Shandong Province, China. Electronic address: louhongxiang@sdu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Molecular mechanisms of 3,3'4,4',5-pentachlorobiphenyl-induced epithelial-mesenchymal transition in human hepatocellular carcinoma cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28284859</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30101-1</DOI>
    <KeywordList>
      <Keywords>3,3′4,4′,5-Pentachlorobiphenyl</Keywords>
      <Keywords>Epithelial-mesenchymal transition</Keywords>
      <Keywords>Hepatocellular carcinoma</Keywords>
      <Keywords>PKM2</Keywords>
      <Keywords>STAT3/Snail1 pathway</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Li Song</Name>
        <Affiliation>Institute of Biotechnology, Key Laboratory of Chemical Biology and Molecular Engineering of National Ministry of Education, Shanxi University, Taiyuan 030006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Linlin Guo</Name>
        <Affiliation>Institute of Biotechnology, Key Laboratory of Chemical Biology and Molecular Engineering of National Ministry of Education, Shanxi University, Taiyuan 030006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhuoyu Li</Name>
        <Affiliation>Institute of Biotechnology, Key Laboratory of Chemical Biology and Molecular Engineering of National Ministry of Education, Shanxi University, Taiyuan 030006, China; College of Life Science, Zhejiang Chinese Medical University, Hangzhou 310053, China. Electronic address: lzy@sxu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inhibition of potassium currents is involved in antiarrhythmic effect of moderate ethanol on atrial fibrillation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28284858</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30110-2</DOI>
    <KeywordList>
      <Keywords>Action potential duration</Keywords>
      <Keywords>Atrial fibrillation</Keywords>
      <Keywords>Ethanol</Keywords>
      <Keywords>Ultra-rapid delayed rectifying potassium current</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Baode Yang</Name>
        <Affiliation>Department of Pharmacology, Health Science Center, Xi'an Jiaotong University, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chenxing Li</Name>
        <Affiliation>Department of Pharmacology, Health Science Center, Xi'an Jiaotong University, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Junyi Sun</Name>
        <Affiliation>Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, College of Stomatology, Xi'an Jiaotong University, Xi'an, China; Department of Periodontology, College of Stomatology, Xi'an Jiaotong University, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xinghui Wang</Name>
        <Affiliation>Basic Medical Experiment Teaching Center, Health Science Center, Xi'an Jiaotong University, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xinling Liu</Name>
        <Affiliation>Basic Medical Experiment Teaching Center, Health Science Center, Xi'an Jiaotong University, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chun Yang</Name>
        <Affiliation>Department of Cardiology, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lina Chen</Name>
        <Affiliation>Department of Pharmacology, Health Science Center, Xi'an Jiaotong University, Xi'an, China; Key Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University, Ministry of Education of China, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Zhou</Name>
        <Affiliation>Department of Pharmacology, Health Science Center, Xi'an Jiaotong University, Xi'an, China; Key Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University, Ministry of Education of China, Xi'an, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hao Hu</Name>
        <Affiliation>Department of Pharmacology, Health Science Center, Xi'an Jiaotong University, Xi'an, China; Key Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University, Ministry of Education of China, Xi'an, China. Electronic address: huhao@mail.xjtu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>TRPA1: Acrolein meets its target.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28284857</pubmedLink>
    <GrantList>
      <Grant>P50 DA036151</Grant>
      <Grant>U01 ES015674</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30111-4</DOI>
    <AuthorList>
      <Author>
        <Name>Satyanarayana Achanta</Name>
        <Affiliation>Department of Anesthesiology, Duke University School of Medicine, Durham, NC 27710, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Sven Eric Jordt</Name>
        <Affiliation>Department of Anesthesiology, Duke University School of Medicine, Durham, NC 27710, United States; Yale Tobacco Center of Regulatory Science (TCORS), Department of Psychiatry, Yale School of Medicine, New Haven, CT 06519, United States. Electronic address: sven.jordt@duke.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Ultrafine carbon particles promote rotenone-induced dopamine neuronal loss through activating microglial NADPH oxidase.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28283350</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30103-5</DOI>
    <KeywordList>
      <Keywords>NADPH oxidase</Keywords>
      <Keywords>Neuroinflammation</Keywords>
      <Keywords>Parkinson's disease</Keywords>
      <Keywords>Particulate matter</Keywords>
      <Keywords>Rotenone</Keywords>
      <Keywords>Ultrafine carbon black</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yinxi Wang</Name>
        <Affiliation>Department of Occupational and Environmental Health Sciences, School of Public Health, Peking University, 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dan Liu</Name>
        <Affiliation>Department of Occupational and Environmental Health Sciences, School of Public Health, Peking University, 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huifeng Zhang</Name>
        <Affiliation>Department of Occupational and Environmental Health Sciences, School of Public Health, Peking University, 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yixin Wang</Name>
        <Affiliation>Department of Occupational and Environmental Health Sciences, School of Public Health, Peking University, 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ling Wei</Name>
        <Affiliation>Beijing Center for Physical &amp; Chemical Analysis, Beijing 100089, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yutong Liu</Name>
        <Affiliation>School of Life Science, Beijing Normal University, Beijing 100875, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jieying Liao</Name>
        <Affiliation>Department of Translational Medicine, Xiamen Institute of Rare Earth Materials, Chinese Academy of Sciences, Xiamen 361024, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Ming Gao</Name>
        <Affiliation>Model Animal Research Center of Nanjing University, Nanjing 211800, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Zhou</Name>
        <Affiliation>Department of Occupational and Environmental Health Sciences, School of Public Health, Peking University, 100191, China. Electronic address: hardhui@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of the risk of perchlorate exposure in a population of late-gestation pregnant women in the United States: Application of probabilistic biologically-based dose response modeling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28263825</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30098-4</DOI>
    <KeywordList>
      <Keywords>Biologically based dose-response modeling</Keywords>
      <Keywords>Perchlorate</Keywords>
      <Keywords>Probabilistic risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>A. Lumen</Name>
        <Affiliation>Division of Biochemical Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, 3900 NCTR Rd, HFT-110, Jefferson, AR 72079, USA. Electronic address: Annie.Lumen@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>N. I. George</Name>
        <Affiliation>Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration, 3900 NCTR Rd, HFT-20, Jefferson, AR 72079, USA. Electronic address: Nysia.George@fda.hhs.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Suppressive immunoregulatory effects of three antidepressants via inhibition of the nuclear factor-κB activation assessed using primary macrophages of carp (Cyprinus carpio).</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28263824</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30100-X</DOI>
    <KeywordList>
      <Keywords>Cytokines</Keywords>
      <Keywords>Fish</Keywords>
      <Keywords>Immunotoxicity</Keywords>
      <Keywords>Nuclear factor-κB</Keywords>
      <Keywords>Pharmaceuticals</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wenhui Qiu</Name>
        <Affiliation>School of Environmental and Chemical Engineering, Shanghai University, Shanghai 200444, China; State Key Laboratory of Marine Environmental Science, Xiamen University, Xiamen, Fujian 361005, China; School of Environmental Science &amp; Engineering, Southern University of Science and Technology, Shenzhen, Guangdong 518055, China.</Affiliation>
      </Author>
      <Author>
        <Name>Minghong Wu</Name>
        <Affiliation>School of Environmental and Chemical Engineering, Shanghai University, Shanghai 200444, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuai Liu</Name>
        <Affiliation>School of Environmental and Chemical Engineering, Shanghai University, Shanghai 200444, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bei Chen</Name>
        <Affiliation>State Key Laboratory of Marine Environmental Science, Xiamen University, Xiamen, Fujian 361005, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chenyuan Pan</Name>
        <Affiliation>School of Environmental and Chemical Engineering, Shanghai University, Shanghai 200444, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Yang</Name>
        <Affiliation>School of Environmental and Chemical Engineering, Shanghai University, Shanghai 200444, China. Electronic address: mingyang@shu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Ke Jian Wang</Name>
        <Affiliation>State Key Laboratory of Marine Environmental Science, Xiamen University, Xiamen, Fujian 361005, China. Electronic address: wkjian@xmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Embryotoxic and pharmacologic potency ranking of six azoles in the rat whole embryo culture by morphological and transcriptomic analysis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28263823</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30099-6</DOI>
    <KeywordList>
      <Keywords>Azoles</Keywords>
      <Keywords>Embryonic development</Keywords>
      <Keywords>Retinoic acid</Keywords>
      <Keywords>Sterol biosynthesis</Keywords>
      <Keywords>Toxicogenomics</Keywords>
      <Keywords>Whole embryo culture</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Myrto Dimopoulou</Name>
        <Affiliation>Division of Toxicology, Wageningen University, The Netherlands; National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands. Electronic address: myrto.dimopoulou@wur.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Aart Verhoef</Name>
        <Affiliation>National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Jeroen L. A. Pennings</Name>
        <Affiliation>National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Bennard van Ravenzwaay</Name>
        <Affiliation>Division of Toxicology, Wageningen University, The Netherlands; BASF SE, Experimental Toxicology and Ecology, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Ivonne M. C. M. Rietjens</Name>
        <Affiliation>Division of Toxicology, Wageningen University, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Aldert H. Piersma</Name>
        <Affiliation>National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands; Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In vitro cardiotoxicity assessment of environmental chemicals using an organotypic human induced pluripotent stem cell-derived model.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28259702</pubmedLink>
    <GrantList>
      <Grant>P30 ES023512</Grant>
      <Grant>P42 ES027704</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30097-2</DOI>
    <KeywordList>
      <Keywords>Alternative methods</Keywords>
      <Keywords>Cardiomyocytes</Keywords>
      <Keywords>Cardiotoxicity</Keywords>
      <Keywords>Environmental toxicology</Keywords>
      <Keywords>High-content screening</Keywords>
      <Keywords>Induced pluripotent stem cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Oksana Sirenko</Name>
        <Affiliation>Molecular Devices, LLC, Sunnyvale, CA, USA. Electronic address: oksana.sirenko@moldev.com.</Affiliation>
      </Author>
      <Author>
        <Name>Fabian A. Grimm</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, Texas A&amp;M University, College Station, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kristen R. Ryan</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yasuhiro Iwata</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, Texas A&amp;M University, College Station, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Weihsueh A. Chiu</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, Texas A&amp;M University, College Station, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Frederick Parham</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jessica A. Wignall</Name>
        <Affiliation>ICF, Fairfax, VA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Blake Anson</Name>
        <Affiliation>Cellular Dynamics International, Madison, WI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Evan F. Cromwell</Name>
        <Affiliation>Protein Fluidics, Inc., Burlingame, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mamta Behl</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ivan Rusyn</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, Texas A&amp;M University, College Station, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Raymond R. Tice</Name>
        <Affiliation>Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Arsenic exposure from drinking water is associated with decreased gene expression and increased DNA methylation in peripheral blood.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28242323</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30086-8</DOI>
    <KeywordList>
      <Keywords>Arsenic metabolism efficiency</Keywords>
      <Keywords>Cancer</Keywords>
      <Keywords>Epigenetic</Keywords>
      <Keywords>Genome-wide</Keywords>
      <Keywords>Pathway analyses</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Syeda Shegufta Ameer</Name>
        <Affiliation>Department of Laboratory Medicine, Division of Occupational and Environmental Medicine, Lund University, Lund, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Karin Engström</Name>
        <Affiliation>Department of Laboratory Medicine, Division of Occupational and Environmental Medicine, Lund University, Lund, Sweden; Institute of Environmental Medicine, Unit of Metals &amp; Health, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Mohammad Bakhtiar Hossain</Name>
        <Affiliation>Department of Laboratory Medicine, Division of Occupational and Environmental Medicine, Lund University, Lund, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Gabriela Concha</Name>
        <Affiliation>Science Department, Risk Benefit Assessment Unit, National Food Agency, Uppsala, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Marie Vahter</Name>
        <Affiliation>Institute of Environmental Medicine, Unit of Metals &amp; Health, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Karin Broberg</Name>
        <Affiliation>Institute of Environmental Medicine, Unit of Metals &amp; Health, Karolinska Institutet, Stockholm, Sweden. Electronic address: Karin.broberg@ki.se.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of the inhibitory effects of pyrethroids against human carboxylesterases.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28242322</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30085-6</DOI>
    <KeywordList>
      <Keywords>Deltamethrin</Keywords>
      <Keywords>Human carboxylesterase 1</Keywords>
      <Keywords>Ligand-binding sites</Keywords>
      <Keywords>Pyrethroids</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wei Lei</Name>
        <Affiliation>The Second Affiliated Hospital of Dalian Medical University, Dalian 110623, China; Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dan Dan Wang</Name>
        <Affiliation>Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tong Yi Dou</Name>
        <Affiliation>Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Hou</Name>
        <Affiliation>Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Liang Feng</Name>
        <Affiliation>Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Heng Yin</Name>
        <Affiliation>Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qun Luo</Name>
        <Affiliation>Beijing National Laboratory for Molecular Science, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100080, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Sun</Name>
        <Affiliation>The Second Affiliated Hospital of Dalian Medical University, Dalian 110623, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guang Bo Ge</Name>
        <Affiliation>Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China. Electronic address: geguangbo@dicp.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Ling Yang</Name>
        <Affiliation>Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A tissue dose-based comparative exposure assessment of manganese using physiologically based pharmacokinetic modeling-The importance of homeostatic control for an essential metal.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28237878</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30082-0</DOI>
    <KeywordList>
      <Keywords>MOS</Keywords>
      <Keywords>Manganese</Keywords>
      <Keywords>Margin of safety</Keywords>
      <Keywords>PBPK</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>P. Robinan Gentry</Name>
        <Affiliation>Ramboll Environ US Corporation, 3701 Armand St., Monroe, LA 71201, United States. Electronic address: rgentry@ramboll.com.</Affiliation>
      </Author>
      <Author>
        <Name>Cynthia Van Landingham</Name>
        <Affiliation>Ramboll Environ US Corporation, 3701 Armand St., Monroe, LA 71201, United States.</Affiliation>
      </Author>
      <Author>
        <Name>William G. Fuller</Name>
        <Affiliation>Ramboll Environ US Corporation, 3701 Armand St., Monroe, LA 71201, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Sandra I. Sulsky</Name>
        <Affiliation>Ramboll Environ US Corporation, Amherst, MA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Tracy B. Greene</Name>
        <Affiliation>Ramboll Environ US Corporation, 3701 Armand St., Monroe, LA 71201, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Harvey J. Clewell</Name>
        <Affiliation>ScitoVation, RTP, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Melvin E. Andersen</Name>
        <Affiliation>ScitoVation, RTP, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Harry A. Roels</Name>
        <Affiliation>Université Catholique de Louvain, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Michael D. Taylor</Name>
        <Affiliation>NIPERA, Durham, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Athena M. Keene</Name>
        <Affiliation>Afton Chemical Corporation, Richmond, VA, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Osimertinib induces autophagy and apoptosis via reactive oxygen species generation in non-small cell lung cancer cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28237877</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30084-4</DOI>
    <KeywordList>
      <Keywords>AZD9291</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Autophagy</Keywords>
      <Keywords>Osimertinib</Keywords>
      <Keywords>ROS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zheng Hai Tang</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Xiang Cao</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.</Affiliation>
      </Author>
      <Author>
        <Name>Min Xia Su</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiuping Chen</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Jian Lu</Name>
        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China. Electronic address: jinjianlu@umac.mo.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Relation of polymorphism of arsenic metabolism genes to arsenic methylation capacity and developmental delay in preschool children in Taiwan.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28235556</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30083-2</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Arsenic methylation capacity</Keywords>
      <Keywords>Arsenic methyltransferase</Keywords>
      <Keywords>Developmental delays</Keywords>
      <Keywords>Polymorphism</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ru Lan Hsieh</Name>
        <Affiliation>Department of Physical Medicine and Rehabilitation, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan; Department of Physical Medicine and Rehabilitation, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chien Tien Su</Name>
        <Affiliation>Department of Family Medicine, Taipei Medical University Hospital, Taipei, Taiwan; School of Public Health, College of Public Health, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Horng Sheng Shiue</Name>
        <Affiliation>Department of Chinese Medicine, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taoyuan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Jen Chen</Name>
        <Affiliation>School of Public Health, College of Public Health, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Shiau Rung Huang</Name>
        <Affiliation>School of Public Health, College of Public Health, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Chin Lin</Name>
        <Affiliation>Department of Family Medicine, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan; Department of Health Examination, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan; Division of Family Medicine, School of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ming I. Lin</Name>
        <Affiliation>Department of Pediatrics, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Shu Chi Mu</Name>
        <Affiliation>Department of Pediatrics, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ray Jade Chen</Name>
        <Affiliation>Department of Digestive Surgery, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Mei Hsueh</Name>
        <Affiliation>Department of Family Medicine, Taipei Medical University Hospital, Taipei, Taiwan; Department of Public Health, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan. Electronic address: ymhsueh@tmu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dendritic cells' death induced by contact sensitizers is controlled by Nrf2 and depends on glutathione levels.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28219650</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30081-9</DOI>
    <KeywordList>
      <Keywords>Allergy</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Contact sensitizers</Keywords>
      <Keywords>Dendritic cells</Keywords>
      <Keywords>GSH,</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>Reactive species</Keywords>
      <Keywords>bcl-2</Keywords>
      <Keywords>ho-1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zeina El Ali</Name>
        <Affiliation>UMR996 - Inflammation, Chemokines and Immunopathology-, INSERM, Univ Paris-Sud, Université Paris-Saclay, 92296 Châtenay-Malabry, France.</Affiliation>
      </Author>
      <Author>
        <Name>Claudine Deloménie</Name>
        <Affiliation>IFR141 IPSIT, Univ Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, France.</Affiliation>
      </Author>
      <Author>
        <Name>Jérémie Botton</Name>
        <Affiliation>INSERM, UMR1153 Epidemiology and Biostatistics Sorbonne Paris Cité Center (CRESS), Team.</Affiliation>
      </Author>
      <Author>
        <Name>Marc Pallardy</Name>
        <Affiliation>UMR996 - Inflammation, Chemokines and Immunopathology-, INSERM, Univ Paris-Sud, Université Paris-Saclay, 92296 Châtenay-Malabry, France.</Affiliation>
      </Author>
      <Author>
        <Name>Saadia Kerdine-Römer</Name>
        <Affiliation>UMR996 - Inflammation, Chemokines and Immunopathology-, INSERM, Univ Paris-Sud, Université Paris-Saclay, 92296 Châtenay-Malabry, France. Electronic address: saadia.kerdine-romer@u-psud.fr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Morphological and behavioral responses of zebrafish after 24h of ketamine embryonic exposure.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28215996</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30080-7</DOI>
    <KeywordList>
      <Keywords>Behavior</Keywords>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Embryo</Keywords>
      <Keywords>Ketamine</Keywords>
      <Keywords>Larvae</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Luís M. Félix</Name>
        <Affiliation>Centre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro (UTAD), Vila Real, Portugal; Institute for Research and Innovation in Health (i3S), University of Porto (UP), Porto, Portugal; Laboratory Animal Science (LAS), Institute for Molecular and Cell Biology (IBMC), University of Porto (UP), Porto, Portugal. Electronic address: lfelix@utad.pt.</Affiliation>
      </Author>
      <Author>
        <Name>Cindy Serafim</Name>
        <Affiliation>Life Sciences and Environment School (ECVA), University of Trás-os-Montes and Alto Douro (UTAD), Vila Real, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Maria J. Martins</Name>
        <Affiliation>Life Sciences and Environment School (ECVA), University of Trás-os-Montes and Alto Douro (UTAD), Vila Real, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Ana M. Valentim</Name>
        <Affiliation>Centre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro (UTAD), Vila Real, Portugal; Institute for Research and Innovation in Health (i3S), University of Porto (UP), Porto, Portugal; Laboratory Animal Science (LAS), Institute for Molecular and Cell Biology (IBMC), University of Porto (UP), Porto, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Luís M. Antunes</Name>
        <Affiliation>Centre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro (UTAD), Vila Real, Portugal; Institute for Research and Innovation in Health (i3S), University of Porto (UP), Porto, Portugal; Laboratory Animal Science (LAS), Institute for Molecular and Cell Biology (IBMC), University of Porto (UP), Porto, Portugal; School of Agrarian and Veterinary Sciences (ECAV), University of Trás-os-Montes and Alto Douro (UTAD), Vila Real, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Manuela Matos</Name>
        <Affiliation>Biosystems &amp; Integrative Sciences Institute (BioISI), Faculty of Sciences, University of Lisboa, Lisboa, Portugal; Department of Genetics and Biotechnology (DGB), University of Trás-os-Montes and Alto Douro (UTAD), Vila Real, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Ana M. Coimbra</Name>
        <Affiliation>Centre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro (UTAD), Vila Real, Portugal.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Enhanced effect of geldanamycin nanocomposite against breast cancer cells growing in vitro and as xenograft with vanquished normal cell toxicity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28213093</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30069-8</DOI>
    <KeywordList>
      <Keywords>Breast cancer</Keywords>
      <Keywords>Geldanamycin</Keywords>
      <Keywords>Hepatocellular toxicity</Keywords>
      <Keywords>Hsp90</Keywords>
      <Keywords>Nanocomposite</Keywords>
      <Keywords>SPION</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Suma Prabhu</Name>
        <Affiliation>Department of Radiation Biology and Toxicology, School of Life Sciences, Manipal University, Manipal 576 104, Karnataka, India.</Affiliation>
      </Author>
      <Author>
        <Name>Preeta Ananthanarayanan</Name>
        <Affiliation>Department of Biotechnology, School of Life Sciences, Manipal University, Manipal 576 104, Karnataka, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sajida Kannangar Aziz</Name>
        <Affiliation>Department of Biotechnology, School of Life Sciences, Manipal University, Manipal 576 104, Karnataka, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sharada Rai</Name>
        <Affiliation>Department of Pathology, Kasturba Medical College, Mangalore Campus, Manipal University, Mangalore 575 001, Karnataka, India.</Affiliation>
      </Author>
      <Author>
        <Name>Srinivas Mutalik</Name>
        <Affiliation>Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal 576 104, Karnataka, India.</Affiliation>
      </Author>
      <Author>
        <Name>Satish Rao Bola Sadashiva</Name>
        <Affiliation>Department of Radiation Biology and Toxicology, School of Life Sciences, Manipal University, Manipal 576 104, Karnataka, India. Electronic address: rao.satish@manipal.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Prediction of thyroid C-cell carcinogenicity after chronic administration of GLP1-R agonists in rodents.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28213092</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30067-4</DOI>
    <KeywordList>
      <Keywords>C-cell carcinogenicity</Keywords>
      <Keywords>GLP-1r agonists</Keywords>
      <Keywords>PKPD modelling</Keywords>
      <Keywords>Pharmacology</Keywords>
      <Keywords>Prediction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Willem van den Brink</Name>
        <Affiliation>Systems Pharmacology, Division of Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands; Medicines Evaluation Board, Utrecht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Annette Emerenciana</Name>
        <Affiliation>Systems Pharmacology, Division of Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands; Medicines Evaluation Board, Utrecht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Francesco Bellanti</Name>
        <Affiliation>Systems Pharmacology, Division of Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Oscar Della Pasqua</Name>
        <Affiliation>Systems Pharmacology, Division of Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands; Clinical Pharmacology Modelling &amp; Simulation, GlaxoSmithKline, Stockley Park, Uxbridge, United Kingdom; Clinical Pharmacology &amp; Therapeutics, UCL, School of Life and Medical Sciences, London, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Jan Willem van der Laan</Name>
        <Affiliation>Division of Toxicology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands; Medicines Evaluation Board, Utrecht, The Netherlands. Electronic address: jw.vd.laan@cbg-meb.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Convergence of hepcidin deficiency, systemic iron overloading, heme accumulation, and REV-ERBα/β activation in aryl hydrocarbon receptor-elicited hepatotoxicity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28213091</pubmedLink>
    <GrantList>
      <Grant>P42 ES004911</Grant>
      <Grant>T32 GM092715</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30064-9</DOI>
    <KeywordList>
      <Keywords>Heme</Keywords>
      <Keywords>Hepcidin</Keywords>
      <Keywords>Iron</Keywords>
      <Keywords>NAFLD</Keywords>
      <Keywords>REV-ERBα/β</Keywords>
      <Keywords>TCDD</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kelly A. Fader</Name>
        <Affiliation>Department of Biochemistry &amp; Molecular Biology, Michigan State University, East Lansing, MI 48824, United States; Institute for Integrative Toxicology, Michigan State University, East Lansing, MI 48824, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Rance Nault</Name>
        <Affiliation>Department of Biochemistry &amp; Molecular Biology, Michigan State University, East Lansing, MI 48824, United States; Institute for Integrative Toxicology, Michigan State University, East Lansing, MI 48824, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mathew P. Kirby</Name>
        <Affiliation>Department of Biochemistry &amp; Molecular Biology, Michigan State University, East Lansing, MI 48824, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Gena Markous</Name>
        <Affiliation>Department of Biochemistry &amp; Molecular Biology, Michigan State University, East Lansing, MI 48824, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jason Matthews</Name>
        <Affiliation>Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo 0316, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy R. Zacharewski</Name>
        <Affiliation>Department of Biochemistry &amp; Molecular Biology, Michigan State University, East Lansing, MI 48824, United States; Institute for Integrative Toxicology, Michigan State University, East Lansing, MI 48824, United States. Electronic address: tzachare@msu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Glycyrrhetinic acid attenuates lipopolysaccharide-induced fulminant hepatic failure in d-galactosamine-sensitized mice by up-regulating expression of interleukin-1 receptor-associated kinase-M.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28213090</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30068-6</DOI>
    <KeywordList>
      <Keywords>Fulminant hepatic failure</Keywords>
      <Keywords>Glycyrrhetinic acid</Keywords>
      <Keywords>IRAK-M</Keywords>
      <Keywords>LPS</Keywords>
      <Keywords>TLR4</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xinru Yin</Name>
        <Affiliation>Department of Pharmacology, Chongqing Medical University, Chongqing 400016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xia Gong</Name>
        <Affiliation>Department of Anatomy, Chongqing Medical University, Chongqing 400016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Zhang</Name>
        <Affiliation>Laboratory of Stem Cell and Tissue Engineering, Chongqing Medical University, Chongqing 400016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rong Jiang</Name>
        <Affiliation>Laboratory of Stem Cell and Tissue Engineering, Chongqing Medical University, Chongqing 400016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ge Kuang</Name>
        <Affiliation>Department of Pharmacology, Chongqing Medical University, Chongqing 400016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bin Wang</Name>
        <Affiliation>Department of Anesthesiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xinyu Chen</Name>
        <Affiliation>Chongqing Traditional Chinese Medicine Hospital, Chongqing 400021, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingyuan Wan</Name>
        <Affiliation>Department of Pharmacology, Chongqing Medical University, Chongqing 400016, China. Electronic address: jywan@cqmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mdr1a plays a crucial role in regulating the analgesic effect and toxicity of aconitine by altering its pharmacokinetic characteristics.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28193520</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30065-0</DOI>
    <KeywordList>
      <Keywords>Aconitine</Keywords>
      <Keywords>Efficacy</Keywords>
      <Keywords>Mdr1a(−/−)</Keywords>
      <Keywords>P-glycoprotein</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lijun Zhu</Name>
        <Affiliation>International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinjun Wu</Name>
        <Affiliation>International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Min Zhao</Name>
        <Affiliation>International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenjie Song</Name>
        <Affiliation>International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoxiao Qi</Name>
        <Affiliation>International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Wang</Name>
        <Affiliation>International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Linlin Lu</Name>
        <Affiliation>International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, PR China; State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau (SAR) 999078, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhongqiu Liu</Name>
        <Affiliation>International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, PR China; State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau (SAR) 999078, PR China. Electronic address: liuzq@gzucm.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Thiamine deficiency induces endoplasmic reticulum stress and oxidative stress in human neurons derived from induced pluripotent stem cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28193519</pubmedLink>
    <GrantList>
      <Grant>I01 BX001721</Grant>
      <Grant>R01 AA015407</Grant>
      <Grant>R01 AA017226</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30066-2</DOI>
    <KeywordList>
      <Keywords>Endoplasmic reticulum stress</Keywords>
      <Keywords>Neurodegeneration</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
      <Keywords>Stem cells</Keywords>
      <Keywords>Vitamins</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xin Wang</Name>
        <Affiliation>Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40536, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mei Xu</Name>
        <Affiliation>Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40536, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jacqueline A. Frank</Name>
        <Affiliation>Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40536, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Zun Ji Ke</Name>
        <Affiliation>Department of Biochemistry, Shanghai University of Traditional Chinese Medicine, Shanghai, China 201203.</Affiliation>
      </Author>
      <Author>
        <Name>Jia Luo</Name>
        <Affiliation>Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40536, United States; Department of Biochemistry, Shanghai University of Traditional Chinese Medicine, Shanghai, China 201203. Electronic address: jialuo888@uky.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Activation of AMPK by berberine induces hepatic lipid accumulation by upregulation of fatty acid translocase CD36 in mice" [Toxicol. Appl. Pharmacol. 316 (2017) 74-82].</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28189653</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30062-5</DOI>
    <AuthorList>
      <Author>
        <Name>You Jin Choi</Name>
        <Affiliation>College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151-742, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kang Yo Lee</Name>
        <Affiliation>College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151-742, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Hwan Jung</Name>
        <Affiliation>College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151-742, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyung Sik Kim</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, Suwon 440-746, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Gayong Shim</Name>
        <Affiliation>College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151-742, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Mi Gyeong Kim</Name>
        <Affiliation>College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151-742, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Kyoung Oh</Name>
        <Affiliation>College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151-742, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seon Hee Oh</Name>
        <Affiliation>The Division of Natural Medical Sciences, College of Health Science, Chosun University, Gwangju 501-759, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dae Won Jun</Name>
        <Affiliation>Internal Medicine, Hanyang University School of Medicine, Seoul 133-791, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Byung Hoon Lee</Name>
        <Affiliation>College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151-742, Republic of Korea. Electronic address: lee@snu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Relationship between mercury in kidney, blood, and urine in environmentally exposed individuals, and implications for biomonitoring.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28189652</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30063-7</DOI>
    <KeywordList>
      <Keywords>Biomonitoring</Keywords>
      <Keywords>Blood</Keywords>
      <Keywords>Kidney</Keywords>
      <Keywords>Mercury</Keywords>
      <Keywords>Plasma</Keywords>
      <Keywords>Urine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Magnus Akerstrom</Name>
        <Affiliation>Department of Occupational and Environmental Medicine, Sahlgrenska University Hospital and Academy, University of Gothenburg, Gothenburg, Sweden. Electronic address: magnus.akerstrom@amm.gu.se.</Affiliation>
      </Author>
      <Author>
        <Name>Lars Barregard</Name>
        <Affiliation>Department of Occupational and Environmental Medicine, Sahlgrenska University Hospital and Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Lundh</Name>
        <Affiliation>Department of Occupational and Environmental Medicine, Lund University Hospital, Lund University, Lund, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Gerd Sallsten</Name>
        <Affiliation>Department of Occupational and Environmental Medicine, Sahlgrenska University Hospital and Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Amentoflavone protects dopaminergic neurons in MPTP-induced Parkinson's disease model mice through PI3K/Akt and ERK signaling pathways.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28185818</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30046-7</DOI>
    <KeywordList>
      <Keywords>1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)</Keywords>
      <Keywords>Amentoflavone</Keywords>
      <Keywords>Flavonoids</Keywords>
      <Keywords>Neuroinflammation</Keywords>
      <Keywords>Parkinson's disease</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qin Cao</Name>
        <Affiliation>The Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, Shanghai Key Laboratory of Complex Prescriptions, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Liyue Qin</Name>
        <Affiliation>The Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, Shanghai Key Laboratory of Complex Prescriptions, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fei Huang</Name>
        <Affiliation>The Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, Shanghai Key Laboratory of Complex Prescriptions, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai, China. Electronic address: Fei_H@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoshuang Wang</Name>
        <Affiliation>The Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, Shanghai Key Laboratory of Complex Prescriptions, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Liu Yang</Name>
        <Affiliation>The Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, Shanghai Key Laboratory of Complex Prescriptions, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hailian Shi</Name>
        <Affiliation>The Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, Shanghai Key Laboratory of Complex Prescriptions, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Wu</Name>
        <Affiliation>The Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, Shanghai Key Laboratory of Complex Prescriptions, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Beibei Zhang</Name>
        <Affiliation>The Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, Shanghai Key Laboratory of Complex Prescriptions, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ziyu Chen</Name>
        <Affiliation>The Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, Shanghai Key Laboratory of Complex Prescriptions, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaojun Wu</Name>
        <Affiliation>The Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, Shanghai Key Laboratory of Complex Prescriptions, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, 1200 Cailun Road, Shanghai, China. Electronic address: xiaojunwu320@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Xenobiotics and the Glucocorticoid Receptor.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28174120</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30060-1</DOI>
    <KeywordList>
      <Keywords>Glucocorticoid Receptor</Keywords>
      <Keywords>Glucocorticoids</Keywords>
      <Keywords>Nuclear receptor</Keywords>
      <Keywords>Xenobiotics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Linda S. M. Gulliver</Name>
        <Affiliation>Otago Medical School, University of Otago, PO Box 56, Dunedin 9054, New Zealand. Electronic address: linda.gulliver@otago.ac.nz.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Potential transfer of neurotoxic amino acid β-N-methylamino-alanine (BMAA) from mother to infant during breast-feeding: Predictions from human cell lines.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28174119</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30061-3</DOI>
    <KeywordList>
      <Keywords>Amino acid transporters</Keywords>
      <Keywords>BMAA</Keywords>
      <Keywords>Breast milk</Keywords>
      <Keywords>Cellular transport</Keywords>
      <Keywords>Neurodegeneration</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marie Andersson</Name>
        <Affiliation>Department of Environmental Toxicology, Uppsala University, Norbyvägen 18A, SE-752 36 Uppsala, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa Ersson</Name>
        <Affiliation>Department of Pharmaceutical Biosciences, Uppsala University, Box 591, SE-751 24 Uppsala, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Ingvar Brandt</Name>
        <Affiliation>Department of Environmental Toxicology, Uppsala University, Norbyvägen 18A, SE-752 36 Uppsala, Sweden. Electronic address: Ingvar.Brandt@ebc.uu.se.</Affiliation>
      </Author>
      <Author>
        <Name>Ulrika Bergström</Name>
        <Affiliation>Department of Environmental Toxicology, Uppsala University, Norbyvägen 18A, SE-752 36 Uppsala, Sweden; Swedish Defence Research Agency, Division of CBRN Defence and Security, SE-164 90 Stockholm, Sweden.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Anti-allergic activity of 2,4,6-trihydroxy-3-geranylacetophenone (tHGA) via attenuation of IgE-mediated mast cell activation and inhibition of passive systemic anaphylaxis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28167223</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30059-5</DOI>
    <KeywordList>
      <Keywords>Anaphylaxis</Keywords>
      <Keywords>IgE-mediated</Keywords>
      <Keywords>Mast cell degranulation</Keywords>
      <Keywords>RBL-2H3</Keywords>
      <Keywords>tHGA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ji Wei Tan</Name>
        <Affiliation>Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang 43400, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Daud Ahmad Israf</Name>
        <Affiliation>Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang 43400, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Hanis Hazeera Harith</Name>
        <Affiliation>Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang 43400, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Nur Fariesha Md Hashim</Name>
        <Affiliation>Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang 43400, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Chean Hui Ng</Name>
        <Affiliation>Faculty of Science, Universiti Putra Malaysia, Serdang 43300, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Khozirah Shaari</Name>
        <Affiliation>Faculty of Science, Universiti Putra Malaysia, Serdang 43300, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Chau Ling Tham</Name>
        <Affiliation>Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang 43400, Malaysia. Electronic address: chauling@upm.edu.my.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Identification of sperm mRNA biomarkers associated with testis injury during preclinical testing of pharmaceutical compounds.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28167222</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30058-3</DOI>
    <KeywordList>
      <Keywords>Biomarkers</Keywords>
      <Keywords>RNA</Keywords>
      <Keywords>Sperm</Keywords>
      <Keywords>Testis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Edward Dere</Name>
        <Affiliation>Division of Urology, Rhode Island Hospital, Providence, RI, USA; Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel J. Spade</Name>
        <Affiliation>Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Susan J. Hall</Name>
        <Affiliation>Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Aimee Altemus</Name>
        <Affiliation>Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James D. Smith</Name>
        <Affiliation>Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jonathan A. Phillips</Name>
        <Affiliation>Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey S. Moffit</Name>
        <Affiliation>Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kerry T. Blanchard</Name>
        <Affiliation>Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kim Boekelheide</Name>
        <Affiliation>Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA. Electronic address: kim_boekelheide@brown.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological evaluation of 5-methoxy-2-aminoindane (MEAI): Binge mitigating agent in development.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28167221</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30048-0</DOI>
    <KeywordList>
      <Keywords>5-Methoxy-2-aminoindane (MEAI)</Keywords>
      <Keywords>Acute toxicity</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Ethanol</Keywords>
      <Keywords>Subacute toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jakob A. Shimshoni</Name>
        <Affiliation>Kimron Veterinary Institute, Department of Toxicology, Bet Dagan, Israel. Electronic address: jakobshimshoni@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ilan Winkler</Name>
        <Affiliation>Pharmaseed Ltd, Ness Ziona, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Nir Edery</Name>
        <Affiliation>Kimron Veterinary Institute, Department of Pathology, Bet Dagan, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Ezekiel Golan</Name>
        <Affiliation>BSC BV Company, Veemarkt 61, Amsterdam, The Netherland.</Affiliation>
      </Author>
      <Author>
        <Name>René van Wettum</Name>
        <Affiliation>BSC BV Company, Veemarkt 61, Amsterdam, The Netherland.</Affiliation>
      </Author>
      <Author>
        <Name>David Nutt</Name>
        <Affiliation>Imperial College London, Neuropsychopharmacology Unit, London, UK.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Improving the International Agency for Research on Cancer's consideration of mechanistic evidence.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28162991</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30047-9</DOI>
    <KeywordList>
      <Keywords>Carcinogen classification</Keywords>
      <Keywords>Hazard assessment</Keywords>
      <Keywords>IARC</Keywords>
      <Keywords>Mode of Action</Keywords>
      <Keywords>Systematic review</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Julie Goodman</Name>
        <Affiliation>Gradient, 20 University Road, Cambridge, MA 02138, United States. Electronic address: jgoodman@gradientcorp.com.</Affiliation>
      </Author>
      <Author>
        <Name>Heather Lynch</Name>
        <Affiliation>Gradient, 20 University Road, Cambridge, MA 02138, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Environmental obesogen tributyltin chloride leads to abnormal hypothalamic-pituitary-gonadal axis function by disruption in kisspeptin/leptin signaling in female rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28161095</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30049-2</DOI>
    <KeywordList>
      <Keywords>Endocrine-disrupting chemicals</Keywords>
      <Keywords>HPG axis</Keywords>
      <Keywords>Kisspeptin</Keywords>
      <Keywords>Leptin</Keywords>
      <Keywords>Obesity</Keywords>
      <Keywords>Tributyltin chloride</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gabriela C. Sena</Name>
        <Affiliation>Department of Morphology, Federal University of Espírito Santo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Leandro C. Freitas-Lima</Name>
        <Affiliation>Department of Morphology, Federal University of Espírito Santo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Eduardo Merlo</Name>
        <Affiliation>Department of Morphology, Federal University of Espírito Santo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Priscila L. Podratz</Name>
        <Affiliation>Department of Morphology, Federal University of Espírito Santo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Julia F. P. de Araújo</Name>
        <Affiliation>Department of Morphology, Federal University of Espírito Santo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Poliane A. A. Brandão</Name>
        <Affiliation>Department of Chemistry, Federal University of Espírito Santo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Maria T. W. D. Carneiro</Name>
        <Affiliation>Department of Chemistry, Federal University of Espírito Santo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Marina C. Zicker</Name>
        <Affiliation>Department of Food Science, Faculty of Pharmacy, Federal University of Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Adaliene V. M. Ferreira</Name>
        <Affiliation>Department of Basic Nursing, Nursing School, Federal University of Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Christina M. Takiya</Name>
        <Affiliation>Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Carolina M. de Lemos Barbosa</Name>
        <Affiliation>Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Marcelo M. Morales</Name>
        <Affiliation>Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Paula Santos-Silva</Name>
        <Affiliation>Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Brazil; Experimental Endocrinology Research, Development and Innovation Group, Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Brazil; Postgraduate Program in Endocrinology, School of Medicine, Federal University of Rio de Janeiro, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Leandro Miranda-Alves</Name>
        <Affiliation>Experimental Endocrinology Research, Development and Innovation Group, Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Brazil; Postgraduate Program in Endocrinology, School of Medicine, Federal University of Rio de Janeiro, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ian V. Silva</Name>
        <Affiliation>Department of Morphology, Federal University of Espírito Santo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Jones B. Graceli</Name>
        <Affiliation>Department of Morphology, Federal University of Espírito Santo, Brazil. Electronic address: jbgraceli@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Ciproxifan, a histamine H</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28132918</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30037-6</DOI>
    <KeywordList>
      <Keywords>Ciproxifan</Keywords>
      <Keywords>Gi/Go-protein/PLA(2)/PGE(2)/EP(2) pathway</Keywords>
      <Keywords>Glutamate release</Keywords>
      <Keywords>H(3) receptor</Keywords>
      <Keywords>Hippocampus</Keywords>
      <Keywords>Voltage-dependent Ca(2+) channels</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cheng Wei Lu</Name>
        <Affiliation>Department of Anesthesiology, Far-Eastern Memorial Hospital, Pan-Chiao District, New Taipei City 22060, Taiwan; Department of Mechanical Engineering, Yuan Ze University, Taoyuan 320, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Tzu Yu Lin</Name>
        <Affiliation>Department of Anesthesiology, Far-Eastern Memorial Hospital, Pan-Chiao District, New Taipei City 22060, Taiwan; Department of Mechanical Engineering, Yuan Ze University, Taoyuan 320, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chia Ying Chang</Name>
        <Affiliation>Department of Anesthesiology, Far-Eastern Memorial Hospital, Pan-Chiao District, New Taipei City 22060, Taiwan; Department of Chemistry, Fu Jen Catholic University, No. 510, Chung-Cheng Road, Hsin-Chuang District, New Taipei City 24205, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Shu Kuei Huang</Name>
        <Affiliation>Department of Anesthesiology, Far-Eastern Memorial Hospital, Pan-Chiao District, New Taipei City 22060, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Su Jane Wang</Name>
        <Affiliation>School of Medicine, Fu Jen Catholic University, No. 510, Chung-Cheng Rd., Hsin-Chuang, New Taipei 24205, Taiwan; Research Center for Chinese Herbal Medicine, College of Human Ecology, Chang Gung University of Science and Technology, Taoyuan City, Taiwan. Electronic address: med0003@mail.fju.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Autophagy contributes to 4-Amino-2-Trifluoromethyl-Phenyl Retinate-induced differentiation in human acute promyelocytic leukemia NB4 cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28130038</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30036-4</DOI>
    <KeywordList>
      <Keywords>APL</Keywords>
      <Keywords>ATPR</Keywords>
      <Keywords>Autophagy</Keywords>
      <Keywords>Differentiation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yue Li</Name>
        <Affiliation>Anhui Key Laboratory of Bioactivity of Natural Products, School of Pharmacy, Anhui Medical University, Hefei, Anhui Province 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ge Li</Name>
        <Affiliation>Anhui Key Laboratory of Bioactivity of Natural Products, School of Pharmacy, Anhui Medical University, Hefei, Anhui Province 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ke Wang</Name>
        <Affiliation>Anhui Key Laboratory of Bioactivity of Natural Products, School of Pharmacy, Anhui Medical University, Hefei, Anhui Province 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ya Ya Xie</Name>
        <Affiliation>Anhui Key Laboratory of Bioactivity of Natural Products, School of Pharmacy, Anhui Medical University, Hefei, Anhui Province 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ren Peng Zhou</Name>
        <Affiliation>Anhui Key Laboratory of Bioactivity of Natural Products, School of Pharmacy, Anhui Medical University, Hefei, Anhui Province 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yao Meng</Name>
        <Affiliation>Anhui Key Laboratory of Bioactivity of Natural Products, School of Pharmacy, Anhui Medical University, Hefei, Anhui Province 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ran Ding</Name>
        <Affiliation>Anhui Key Laboratory of Bioactivity of Natural Products, School of Pharmacy, Anhui Medical University, Hefei, Anhui Province 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Fang Ge</Name>
        <Affiliation>Anhui Key Laboratory of Bioactivity of Natural Products, School of Pharmacy, Anhui Medical University, Hefei, Anhui Province 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fei Hu Chen</Name>
        <Affiliation>Anhui Key Laboratory of Bioactivity of Natural Products, School of Pharmacy, Anhui Medical University, Hefei, Anhui Province 230032, China. Electronic address: cfhchina@sohu.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessing interactions of binary mixtures of Penicillium mycotoxins (PMs) by using a bovine macrophage cell line (BoMacs).</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28130037</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30035-2</DOI>
    <KeywordList>
      <Keywords>Concentration addition (CA)</Keywords>
      <Keywords>Independent action (IA)</Keywords>
      <Keywords>Interaction</Keywords>
      <Keywords>Mixture toxicity</Keywords>
      <Keywords>Penicillium mycotoxins</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Se Young Oh</Name>
        <Affiliation>Department of Animal Biosciences, Ontario Agriculture College (OAC), University of Guelph, Guelph, ON N1G 2W1, Canada. Electronic address: ohs@uoguelph.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Nina Cedergreen</Name>
        <Affiliation>Department of Life Sciences, University of Copenhagen, Frederiksberg, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Alexandros Yiannikouris</Name>
        <Affiliation>Alltech Inc., Nicholasville, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>H. V. L. N. Swamy</Name>
        <Affiliation>Trouw Nutrition Pvt. Ltd. India, Karnataka State 560065, India.</Affiliation>
      </Author>
      <Author>
        <Name>Niel A. Karrow</Name>
        <Affiliation>Department of Animal Biosciences, Ontario Agriculture College (OAC), University of Guelph, Guelph, ON N1G 2W1, Canada. Electronic address: nkarrow@uoguelph.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Phagolysosome acidification is required for silica and engineered nanoparticle-induced lysosome membrane permeabilization and resultant NLRP3 inflammasome activity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28126413</pubmedLink>
    <GrantList>
      <Grant>P30 GM103338</Grant>
      <Grant>R01 ES023209</Grant>
      <Grant>S10 RR026325</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30032-7</DOI>
    <KeywordList>
      <Keywords>Lysosome membrane permeabilization</Keywords>
      <Keywords>MWCNT</Keywords>
      <Keywords>NLRP3 Inflammasome</Keywords>
      <Keywords>Silica</Keywords>
      <Keywords>TNB</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Forrest Jessop</Name>
        <Affiliation>Center for Environmental Health Sciences, Department of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, MT, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Raymond F. Hamilton</Name>
        <Affiliation>Center for Environmental Health Sciences, Department of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, MT, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph F. Rhoderick</Name>
        <Affiliation>Center for Environmental Health Sciences, Department of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, MT, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Paige Fletcher</Name>
        <Affiliation>Center for Environmental Health Sciences, Department of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, MT, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Andrij Holian</Name>
        <Affiliation>Center for Environmental Health Sciences, Department of Biomedical and Pharmaceutical Sciences, University of Montana, Missoula, MT, United States. Electronic address: andrij.holian@umontana.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Prenatal exposure to an environmentally relevant phthalate mixture disrupts reproduction in F1 female mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28126412</pubmedLink>
    <GrantList>
      <Grant>P01 ES022848</Grant>
      <Grant>R56 ES025147</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30030-3</DOI>
    <KeywordList>
      <Keywords>Environmentally relevant</Keywords>
      <Keywords>Female reproduction</Keywords>
      <Keywords>Phthalate mixture</Keywords>
      <Keywords>Prenatal exposure</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Changqing Zhou</Name>
        <Affiliation>Department of Comparative Biosciences, University of Illinois, Urbana 61802, IL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Liying Gao</Name>
        <Affiliation>Department of Comparative Biosciences, University of Illinois, Urbana 61802, IL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jodi A. Flaws</Name>
        <Affiliation>Department of Comparative Biosciences, University of Illinois, Urbana 61802, IL, USA. Electronic address: jflaws@illinois.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Perfluorooctanoic acid affects endocytosis involving clathrin light chain A and microRNA-133b-3p in mouse testes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28126411</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30034-0</DOI>
    <KeywordList>
      <Keywords>CLTA</Keywords>
      <Keywords>Endocytosis</Keywords>
      <Keywords>Perfluorooctanoic acid</Keywords>
      <Keywords>miRNA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yin Lu</Name>
        <Affiliation>Key Laboratory of Animal Ecology and Conservation Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianshe Wang</Name>
        <Affiliation>Key Laboratory of Animal Ecology and Conservation Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xuejiang Guo</Name>
        <Affiliation>State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing 210029, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shengmin Yan</Name>
        <Affiliation>Key Laboratory of Animal Ecology and Conservation Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiayin Dai</Name>
        <Affiliation>Key Laboratory of Animal Ecology and Conservation Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, PR China. Electronic address: daijy@ioz.ac.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Baicalein attenuates vinorelbine-induced vascular endothelial cell injury and chemotherapeutic phlebitis in rabbits.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28126410</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30033-9</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>MAPK</Keywords>
      <Keywords>NF-κB</Keywords>
      <Keywords>Oxidant stress</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gang Feng Ge</Name>
        <Affiliation>Zhejiang Chinese Medical University, Hangzhou 310053, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Wen Shi</Name>
        <Affiliation>Zhejiang Medical Science and Education Development Center, Hangzhou 310006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chen Huan Yu</Name>
        <Affiliation>Key Laboratory of Experimental Animal and Safety Evaluation, Zhejiang Academy of Medical Sciences, Hangzhou 310013, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Yin Jin</Name>
        <Affiliation>Key Laboratory of Experimental Animal and Safety Evaluation, Zhejiang Academy of Medical Sciences, Hangzhou 310013, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huan Huan Zhang</Name>
        <Affiliation>Key Laboratory of Experimental Animal and Safety Evaluation, Zhejiang Academy of Medical Sciences, Hangzhou 310013, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen You Zhang</Name>
        <Affiliation>Key Laboratory of Experimental Animal and Safety Evaluation, Zhejiang Academy of Medical Sciences, Hangzhou 310013, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Chen Wang</Name>
        <Affiliation>Zhejiang Chinese Medical University, Hangzhou 310053, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bing Yu</Name>
        <Affiliation>Zhejiang Chinese Medical University, Hangzhou 310053, China. Electronic address: Jellycook2002@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>IN0523 (Urs-12-ene-3α,24β-diol) a plant based derivative of boswellic acid protect Cisplatin induced urogenital toxicity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28122196</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30031-5</DOI>
    <KeywordList>
      <Keywords>Cisplatin</Keywords>
      <Keywords>Histopathology</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Sperm motility</Keywords>
      <Keywords>Urogenital</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Amarinder Singh</Name>
        <Affiliation>Academy of Scientific &amp; Innovative Research (AcSIR), New Delhi, India; PK-PD-Toxicology and Formulation Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu 180001, J&amp;K, India.</Affiliation>
      </Author>
      <Author>
        <Name>S. Arvinda</Name>
        <Affiliation>Deptt. of Pathology, Govt. Medical College, Jammu 180001, J&amp;K, India.</Affiliation>
      </Author>
      <Author>
        <Name>Surjeet Singh</Name>
        <Affiliation>PK-PD-Toxicology and Formulation Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu 180001, J&amp;K, India.</Affiliation>
      </Author>
      <Author>
        <Name>Jyotsna Suri</Name>
        <Affiliation>Deptt. of Pathology, Govt. Medical College, Jammu 180001, J&amp;K, India.</Affiliation>
      </Author>
      <Author>
        <Name>Surinder Koul</Name>
        <Affiliation>Bio-Organic Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu 180001, J&amp;K, India.</Affiliation>
      </Author>
      <Author>
        <Name>Dilip M. Mondhe</Name>
        <Affiliation>Cancer Pharmacology Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu 180001, J&amp;K, India.</Affiliation>
      </Author>
      <Author>
        <Name>Gurdarshan Singh</Name>
        <Affiliation>PK-PD-Toxicology and Formulation Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu 180001, J&amp;K, India. Electronic address: singh_gd@iiim.ac.in.</Affiliation>
      </Author>
      <Author>
        <Name>Ram Vishwakarma</Name>
        <Affiliation>Bio-Organic Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu 180001, J&amp;K, India.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Rosmarinic acid counteracts activation of hepatic stellate cells via inhibiting the ROS-dependent MMP-2 activity: Involvement of Nrf2 antioxidant system.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28115189</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30028-5</DOI>
    <KeywordList>
      <Keywords>HSC</Keywords>
      <Keywords>Liver fibrosis</Keywords>
      <Keywords>MMP-2</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>Rosmarinic acid</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Changfang Lu</Name>
        <Affiliation>The Institute of Medicine, Qiqihar Medical University, Qiqihar 161006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Zou</Name>
        <Affiliation>The Institute of Medicine, Qiqihar Medical University, Qiqihar 161006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuzhang Liu</Name>
        <Affiliation>The Institute of Medicine, Qiqihar Medical University, Qiqihar 161006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yingcai Niu</Name>
        <Affiliation>The Institute of Medicine, Qiqihar Medical University, Qiqihar 161006, China. Electronic address: nyc1968@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Identification of a compound isolated from German chamomile (Matricaria chamomilla) with dermal sensitization potential.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28109818</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30029-7</DOI>
    <KeywordList>
      <Keywords>DCYA</Keywords>
      <Keywords>German chamomile</Keywords>
      <Keywords>LLNA</Keywords>
      <Keywords>Skin sensitization</Keywords>
      <Keywords>in chemico methods</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cristina Avonto</Name>
        <Affiliation>National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, School of Pharmacy, The University of Mississippi, MS 38677, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Diego Rua</Name>
        <Affiliation>The Center for Food Safety and Applied Nutrition, US Food and Drug Administration, College Park, MD 20740, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Pradeep B. Lasonkar</Name>
        <Affiliation>National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, School of Pharmacy, The University of Mississippi, MS 38677, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Amar G. Chittiboyina</Name>
        <Affiliation>National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, School of Pharmacy, The University of Mississippi, MS 38677, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ikhlas A. Khan</Name>
        <Affiliation>National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, School of Pharmacy, The University of Mississippi, MS 38677, United States; Division of Pharmacognosy, Department of BioMolecular Sciences, School of Pharmacy, The University of Mississippi, MS 38677, United States. Electronic address: ikhan@olemiss.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Salecan protected against concanavalin A-induced acute liver injury by modulating T cell immune responses and NMR-based metabolic profiles.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28109817</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30027-3</DOI>
    <KeywordList>
      <Keywords>Acute liver injury</Keywords>
      <Keywords>ConA</Keywords>
      <Keywords>Inflammatory</Keywords>
      <Keywords>Metabolomics</Keywords>
      <Keywords>Salecan</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qi Sun</Name>
        <Affiliation>Center for Molecular Metabolism, Nanjing University of Science &amp; Technology, Nanjing 210094, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xi Xu</Name>
        <Affiliation>Center for Molecular Metabolism, Nanjing University of Science &amp; Technology, Nanjing 210094, PR China. Electronic address: xuxi@njust.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Yang</Name>
        <Affiliation>Center for Molecular Metabolism, Nanjing University of Science &amp; Technology, Nanjing 210094, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Dan Weng</Name>
        <Affiliation>Center for Molecular Metabolism, Nanjing University of Science &amp; Technology, Nanjing 210094, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Junsong Wang</Name>
        <Affiliation>Center for Molecular Metabolism, Nanjing University of Science &amp; Technology, Nanjing 210094, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianfa Zhang</Name>
        <Affiliation>Center for Molecular Metabolism, Nanjing University of Science &amp; Technology, Nanjing 210094, PR China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Discriminating between adaptive and carcinogenic liver hypertrophy in rat studies using logistic ridge regression analysis of toxicogenomic data: The mode of action and predictive models.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28108177</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30026-1</DOI>
    <KeywordList>
      <Keywords>Carcinogenicity</Keywords>
      <Keywords>Liver hypertrophy</Keywords>
      <Keywords>Logistic regression analysis</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Toxicogenomics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shujie Liu</Name>
        <Affiliation>R&amp;D, Safety Science Research, Kao Corporation, Tochigi, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Taisuke Kawamoto</Name>
        <Affiliation>R&amp;D, Safety Science Research, Kao Corporation, Tochigi, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Osamu Morita</Name>
        <Affiliation>R&amp;D, Safety Science Research, Kao Corporation, Tochigi, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kouichi Yoshinari</Name>
        <Affiliation>Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroshi Honda</Name>
        <Affiliation>R&amp;D, Safety Science Research, Kao Corporation, Tochigi, Japan. Electronic address: honda.hiroshi@kao.co.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The role of PTEN in regulation of hepatic macrophages activation and function in progression and reversal of liver fibrosis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28095306</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30025-X</DOI>
    <KeywordList>
      <Keywords>Hepatic fibrosis</Keywords>
      <Keywords>Kupffer cells</Keywords>
      <Keywords>Macrophges differentiation</Keywords>
      <Keywords>PI3K/Akt/STAT</Keywords>
      <Keywords>PTEN</Keywords>
      <Keywords>Reversal fibrosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yahui Cheng</Name>
        <Affiliation>School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; The Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Medical University, Ministry of Education, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University, ILD-AMU, Anhui Medical University, Hefei 230032, China; Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanyao Tian</Name>
        <Affiliation>School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; The Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Medical University, Ministry of Education, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University, ILD-AMU, Anhui Medical University, Hefei 230032, China; Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jialu Xia</Name>
        <Affiliation>School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; The Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Medical University, Ministry of Education, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University, ILD-AMU, Anhui Medical University, Hefei 230032, China; Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoqin Wu</Name>
        <Affiliation>School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; The Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Medical University, Ministry of Education, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University, ILD-AMU, Anhui Medical University, Hefei 230032, China; Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Yang</Name>
        <Affiliation>School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; The Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Medical University, Ministry of Education, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University, ILD-AMU, Anhui Medical University, Hefei 230032, China; Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaofeng Li</Name>
        <Affiliation>School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; The Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Medical University, Ministry of Education, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University, ILD-AMU, Anhui Medical University, Hefei 230032, China; Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cheng Huang</Name>
        <Affiliation>School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; The Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Medical University, Ministry of Education, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University, ILD-AMU, Anhui Medical University, Hefei 230032, China; Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoming Meng</Name>
        <Affiliation>School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; The Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Medical University, Ministry of Education, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University, ILD-AMU, Anhui Medical University, Hefei 230032, China; Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Taotao Ma</Name>
        <Affiliation>School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; The Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Medical University, Ministry of Education, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University, ILD-AMU, Anhui Medical University, Hefei 230032, China; Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Li</Name>
        <Affiliation>School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; The Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Medical University, Ministry of Education, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University, ILD-AMU, Anhui Medical University, Hefei 230032, China; Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China. Electronic address: lj@ahmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Zearalenone exposure impairs ovarian primordial follicle formation via down-regulation of Lhx8 expression in vitro.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28089945</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30014-5</DOI>
    <KeywordList>
      <Keywords>Folliculogenesis</Keywords>
      <Keywords>Lhx8</Keywords>
      <Keywords>Primordial follicle formation</Keywords>
      <Keywords>Zearalenone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Guo Liang Zhang</Name>
        <Affiliation>College of Animal Science and Technology, Northwest A&amp;F University, Yangling, Shaanxi 712100, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Feng Sun</Name>
        <Affiliation>Institute of Reproductive Sciences, College of Animal Science and Technology, Qingdao Agricultural University, Qingdao, Shandong 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Zhong Feng</Name>
        <Affiliation>Institute of Animal Sciences, Heilongjiang Academy of Agricultural Sciences, Harbin, Heilongjiang 150086, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Li</Name>
        <Affiliation>Chengguo Station of Animal Husbandry and Veterinary, Laizhou 261437, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ya Peng Li</Name>
        <Affiliation>Institute of Reproductive Sciences, College of Animal Science and Technology, Qingdao Agricultural University, Qingdao, Shandong 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fan Yang</Name>
        <Affiliation>Institute of Reproductive Sciences, College of Animal Science and Technology, Qingdao Agricultural University, Qingdao, Shandong 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Charles Martin Nyachoti</Name>
        <Affiliation>Department of Animal Science, University of Manitoba, Winnipeg, MB, R3T 2N2, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Shen</Name>
        <Affiliation>Institute of Reproductive Sciences, College of Animal Science and Technology, Qingdao Agricultural University, Qingdao, Shandong 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shi Duo Sun</Name>
        <Affiliation>College of Animal Science and Technology, Northwest A&amp;F University, Yangling, Shaanxi 712100, China. Electronic address: ssdsm@tom.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lan Li</Name>
        <Affiliation>Institute of Reproductive Sciences, College of Animal Science and Technology, Qingdao Agricultural University, Qingdao, Shandong 266109, China. Electronic address: lilan9600@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cutaneous exposure to vesicant phosgene oxime: Acute effects on the skin and systemic toxicity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28087322</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30013-3</DOI>
    <KeywordList>
      <Keywords>Mast cells</Keywords>
      <Keywords>Nettle agent</Keywords>
      <Keywords>Phosgene oxime</Keywords>
      <Keywords>SKH-1 hairless mouse</Keywords>
      <Keywords>Skin injury</Keywords>
      <Keywords>Systemic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Neera Tewari-Singh</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA. Electronic address: Neera.tewari-singh@ucdenver.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Dinesh G. Goswami</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rama Kant</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Claire R. Croutch</Name>
        <Affiliation>MRIGlobal, Kansas City, MO 64110, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert P. Casillas</Name>
        <Affiliation>MRIGlobal, Kansas City, MO 64110, USA.</Affiliation>
      </Author>
      <Author>
        <Name>David J. Orlicky</Name>
        <Affiliation>Department of Pathology, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rajesh Agarwal</Name>
        <Affiliation>Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Iron oxide nanoparticles modulate heat shock proteins and organ specific markers expression in mice male accessory organs.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28077287</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30012-1</DOI>
    <KeywordList>
      <Keywords>heat shock proteins</Keywords>
      <Keywords>iron accumulation</Keywords>
      <Keywords>iron oxide nanoparticles</Keywords>
      <Keywords>organ specific markers</Keywords>
      <Keywords>prostate gland</Keywords>
      <Keywords>seminal vesicle</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kiruthika Sundarraj</Name>
        <Affiliation>Molecular Toxicology Laboratory, Department of Biotechnology, Bharathiar University, Coimbatore - 641 046, Tamilnadu, INDIA.</Affiliation>
      </Author>
      <Author>
        <Name>Azhwar Raghunath</Name>
        <Affiliation>Molecular Toxicology Laboratory, Department of Biotechnology, Bharathiar University, Coimbatore - 641 046, Tamilnadu, INDIA.</Affiliation>
      </Author>
      <Author>
        <Name>Lakshmikanthan Panneerselvam</Name>
        <Affiliation>Molecular Toxicology Laboratory, Department of Biotechnology, Bharathiar University, Coimbatore - 641 046, Tamilnadu, INDIA.</Affiliation>
      </Author>
      <Author>
        <Name>Ekambaram Perumal</Name>
        <Affiliation>Molecular Toxicology Laboratory, Department of Biotechnology, Bharathiar University, Coimbatore - 641 046, Tamilnadu, INDIA. Electronic address: ekas2009@buc.edu.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Myeloid differentiation protein 2-dependent mechanisms in retinal ischemia-reperfusion injury.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28063877</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(17)30011-X</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>HMGB-1</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>MD2</Keywords>
      <Keywords>Retinal ischemia-reperfusion injury</Keywords>
      <Keywords>TLR4</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Luqing Ren</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianjian Tao</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China; The Eye Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huaicheng Chen</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China; The Eye Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Bian</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China; The Eye Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xi Yang</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China; The Eye Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Gaozhi Chen</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Zhang</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guang Liang</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wencan Wu</Name>
        <Affiliation>The Eye Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. Electronic address: wuwencan118@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Zongming Song</Name>
        <Affiliation>The Eye Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. Electronic address: szmeyes@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Wang</Name>
        <Affiliation>Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China. Electronic address: yi.wang1122@wmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A semi-quantitative translational pharmacology analysis to understand the relationship between in vitro ENT1 inhibition and the clinical incidence of dyspnoea and bronchospasm.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28041785</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30399-4</DOI>
    <KeywordList>
      <Keywords>Bronchospasm</Keywords>
      <Keywords>Dyspnoea</Keywords>
      <Keywords>ENT1</Keywords>
      <Keywords>Off-target pharmacology</Keywords>
      <Keywords>Respiratory disease</Keywords>
      <Keywords>Translation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lyn Rosenbrier Ribeiro</Name>
        <Affiliation>Discovery Safety, Drug Safety and Metabolism, AstraZeneca, Cambridge Science Park, Cambridge, United Kingdom. Electronic address: Lyn.Rosenbrierribeiro@AstraZeneca.com.</Affiliation>
      </Author>
      <Author>
        <Name>R. Ian Storer</Name>
        <Affiliation>Discovery Safety, Drug Safety and Metabolism, AstraZeneca, Cambridge Science Park, Cambridge, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In vitro neuroprotective potential of lichen metabolite fumarprotocetraric acid via intracellular redox modulation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28041784</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30398-2</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Fumarprotocetraric acid</Keywords>
      <Keywords>Lichens</Keywords>
      <Keywords>Mitochondria</Keywords>
      <Keywords>Oxidative stress</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Carlos Fernández-Moriano</Name>
        <Affiliation>Department of Pharmacology, Faculty of Pharmacy, University Complutense of Madrid, Plaza Ramón y Cajal s/n, 28040 Madrid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Pradeep Kumar Divakar</Name>
        <Affiliation>Department of Plant Biology II, Faculty of Pharmacy, University Complutense of Madrid, Plaza Ramón y Cajal s/n, 28040 Madrid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Crespo</Name>
        <Affiliation>Department of Plant Biology II, Faculty of Pharmacy, University Complutense of Madrid, Plaza Ramón y Cajal s/n, 28040 Madrid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>M. Pilar Gómez-Serranillos</Name>
        <Affiliation>Department of Pharmacology, Faculty of Pharmacy, University Complutense of Madrid, Plaza Ramón y Cajal s/n, 28040 Madrid, Spain. Electronic address: pserra@ucm.es.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Moving into advanced nanomaterials. Toxicity of rutile TiO</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28039000</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30397-0</DOI>
    <KeywordList>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>Interferences studies</Keywords>
      <Keywords>Kaolin nanoclay</Keywords>
      <Keywords>Titanium dioxide nanoparticles</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Maria João Bessa</Name>
        <Affiliation>Department of Environmental Health, Portuguese National Institute of Health, Rua Alexandre Herculano, 321, 4000-055 Porto, Portugal. Electronic address: mjbessa8@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Carla Costa</Name>
        <Affiliation>Department of Environmental Health, Portuguese National Institute of Health, Rua Alexandre Herculano, 321, 4000-055 Porto, Portugal; EPIUnit - Institute of Public Health, University of Porto, Rua das Taipas 135, 4050-600, Porto, Portugal. Electronic address: cstcosta@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Julian Reinosa</Name>
        <Affiliation>Electroceramic Department, Instituto de Cerámica y Vidrio, CSIC, Campus de Cantoblanco, Calle de Kelson, 5, 28049 Madrid, Spain. Electronic address: jjreinosa@icv.csic.es.</Affiliation>
      </Author>
      <Author>
        <Name>Cristiana Pereira</Name>
        <Affiliation>Department of Environmental Health, Portuguese National Institute of Health, Rua Alexandre Herculano, 321, 4000-055 Porto, Portugal; EPIUnit - Institute of Public Health, University of Porto, Rua das Taipas 135, 4050-600, Porto, Portugal. Electronic address: cristianacostapereira@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sónia Fraga</Name>
        <Affiliation>Department of Environmental Health, Portuguese National Institute of Health, Rua Alexandre Herculano, 321, 4000-055 Porto, Portugal; EPIUnit - Institute of Public Health, University of Porto, Rua das Taipas 135, 4050-600, Porto, Portugal. Electronic address: teixeirafraga@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>José Fernández</Name>
        <Affiliation>Electroceramic Department, Instituto de Cerámica y Vidrio, CSIC, Campus de Cantoblanco, Calle de Kelson, 5, 28049 Madrid, Spain. Electronic address: jfernandez@icv.csic.es.</Affiliation>
      </Author>
      <Author>
        <Name>Miguel A. Bañares</Name>
        <Affiliation>Catalytic Spectroscopy Laboratory, Instituto de Catálisis y Petroleoquímica, ICP-CSIC, Madrid, Spain. Electronic address: miguel.banares@csic.es.</Affiliation>
      </Author>
      <Author>
        <Name>João Paulo Teixeira</Name>
        <Affiliation>Department of Environmental Health, Portuguese National Institute of Health, Rua Alexandre Herculano, 321, 4000-055 Porto, Portugal; EPIUnit - Institute of Public Health, University of Porto, Rua das Taipas 135, 4050-600, Porto, Portugal. Electronic address: jpft12@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Carbonic anhydrase inhibition boosts the antitumor effects of Imatinib mesylate via potentiating the antiangiogenic and antimetastatic machineries.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28038999</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30396-9</DOI>
    <KeywordList>
      <Keywords>Acetazolamide</Keywords>
      <Keywords>Angiogenesis</Keywords>
      <Keywords>Carbonic anhydrase inhibition</Keywords>
      <Keywords>Imatinib</Keywords>
      <Keywords>Metastasis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Amal A. Abd-El Fattah</Name>
        <Affiliation>Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Hebatallah A. Darwish</Name>
        <Affiliation>Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt; Faculty of Pharmaceutical Sciences and Pharmaceutical Industries, Future University, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Nevine Fathy</Name>
        <Affiliation>Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt. Electronic address: nevine.abdallah@pharma.cu.edu.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Samia A. Shouman</Name>
        <Affiliation>Department of Cancer Biology, National Cancer Institute, Cairo University, Cairo 11796, Egypt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Activation of AMPK by berberine induces hepatic lipid accumulation by upregulation of fatty acid translocase CD36 in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28038998</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30395-7</DOI>
    <KeywordList>
      <Keywords>AICAR</Keywords>
      <Keywords>AMPK</Keywords>
      <Keywords>Berberine</Keywords>
      <Keywords>CD36</Keywords>
      <Keywords>Fatty acid uptake</Keywords>
      <Keywords>Fatty liver</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>You Jin Choi</Name>
        <Affiliation>College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151-742, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kang Yo Lee</Name>
        <Affiliation>College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151-742, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Hwan Jung</Name>
        <Affiliation>College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151-742, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyung Sik Kim</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, Suwon 440-746, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Gayong Shim</Name>
        <Affiliation>College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151-742, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Mi Gyeong Kim</Name>
        <Affiliation>College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151-742, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Kyoung Oh</Name>
        <Affiliation>College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151-742, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seon Hee Oh</Name>
        <Affiliation>The Division of Natural Medical Sciences, College of Health Science, Chosun University, Gwangju 501-759, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dae Won Jun</Name>
        <Affiliation>Internal Medicine, Hanyang University School of Medicine, Seoul 133-791, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Byung Hoon Lee</Name>
        <Affiliation>College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151-742, Republic of Korea. Electronic address: lee@snu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Relationships among DNA hypomethylation, Cd, and Pb exposure and risk of cigarette smoking-related urothelial carcinoma.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28025111</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30394-5</DOI>
    <KeywordList>
      <Keywords>Cigarette smoking</Keywords>
      <Keywords>Global DNA methylation</Keywords>
      <Keywords>Heavy metals</Keywords>
      <Keywords>Herbal medicine</Keywords>
      <Keywords>Urothelial carcinoma</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chi Jung Chung</Name>
        <Affiliation>Department of Health Risk Management, College of Public Health, China Medical University, Taichung, Taiwan; Department of Medical Research, China Medical University and Hospital, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Hsiang Chang</Name>
        <Affiliation>Department of Urology, China Medical University and Hospital, Taichung, Taiwan; Department of Medicine, College of Medicine, China Medical University and Hospital, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Saou Hsing Liou</Name>
        <Affiliation>Division of Environmental Health and Occupational Medicine, National Health Research Institutes, Zhunan, Miaoli County, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chiu Shong Liu</Name>
        <Affiliation>Department of Family Medicine, China Medical University and Hospital, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Huei Ju Liu</Name>
        <Affiliation>Division of Environmental Health and Occupational Medicine, National Health Research Institutes, Zhunan, Miaoli County, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Li Ching Hsu</Name>
        <Affiliation>Department of Health Risk Management, College of Public Health, China Medical University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Jhih Sheng Chen</Name>
        <Affiliation>Department of Chemistry, Fu Jen Catholic University, New Taipei City, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Ling Lee</Name>
        <Affiliation>Department of Chemistry, Fu Jen Catholic University, New Taipei City, Taiwan. Electronic address: 076308@mail.fju.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Hypomethylation of inflammatory genes (COX2, EGR1, and SOCS3) and increased urinary 8-nitroguanine in arsenic-exposed newborns and children.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28025110</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30393-3</DOI>
    <KeywordList>
      <Keywords>8-Nitroguanine</Keywords>
      <Keywords>DNA methylation</Keywords>
      <Keywords>Inflammatory genes</Keywords>
      <Keywords>Prenatal arsenic exposure</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Preeyaphan Phookphan</Name>
        <Affiliation>Laboratory of Environmental Toxicology, Chulabhorn Research Institute, Laksi, Bangkok, Thailand; Post-graduate Program in Environmental Toxicology, Chulabhorn Graduate Institute, Laksi, Bangkok, Thailand; Center of Excellence on Environmental Health, Toxicology (EHT), Office of the Higher Education Commission, Ministry of Education, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Panida Navasumrit</Name>
        <Affiliation>Laboratory of Environmental Toxicology, Chulabhorn Research Institute, Laksi, Bangkok, Thailand; Post-graduate Program in Environmental Toxicology, Chulabhorn Graduate Institute, Laksi, Bangkok, Thailand; Center of Excellence on Environmental Health, Toxicology (EHT), Office of the Higher Education Commission, Ministry of Education, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Somchamai Waraprasit</Name>
        <Affiliation>Laboratory of Environmental Toxicology, Chulabhorn Research Institute, Laksi, Bangkok, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Jeerawan Promvijit</Name>
        <Affiliation>Laboratory of Environmental Toxicology, Chulabhorn Research Institute, Laksi, Bangkok, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Krittinee Chaisatra</Name>
        <Affiliation>Laboratory of Environmental Toxicology, Chulabhorn Research Institute, Laksi, Bangkok, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Thitirat Ngaotepprutaram</Name>
        <Affiliation>Laboratory of Environmental Toxicology, Chulabhorn Research Institute, Laksi, Bangkok, Thailand.</Affiliation>
      </Author>
      <Author>
        <Name>Mathuros Ruchirawat</Name>
        <Affiliation>Laboratory of Environmental Toxicology, Chulabhorn Research Institute, Laksi, Bangkok, Thailand; Center of Excellence on Environmental Health, Toxicology (EHT), Office of the Higher Education Commission, Ministry of Education, Thailand. Electronic address: mathuros@cri.or.th.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>DEET potentiates the development and persistence of anticholinesterase dependent chronic pain signs in a rat model of Gulf War Illness pain.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28025109</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30392-1</DOI>
    <KeywordList>
      <Keywords>Chronic Pain</Keywords>
      <Keywords>DEET</Keywords>
      <Keywords>Gulf War Illness</Keywords>
      <Keywords>K(v)7</Keywords>
      <Keywords>chlorpyrifos</Keywords>
      <Keywords>pyridostigmine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>L. K. Flunker</Name>
        <Affiliation>Division of Neuroscience, Dept. of Oral and Maxillofacial Surgery, Box 100416, JHMHC, University of Florida College of Dentistry, Gainesville, FL 32610, USA. Electronic address: lflunker@dental.ufl.edu.</Affiliation>
      </Author>
      <Author>
        <Name>T. J. Nutter</Name>
        <Affiliation>Division of Neuroscience, Dept. of Oral and Maxillofacial Surgery, Box 100416, JHMHC, University of Florida College of Dentistry, Gainesville, FL 32610, USA. Electronic address: tnutter@dental.ufl.edu.</Affiliation>
      </Author>
      <Author>
        <Name>R. D. Johnson</Name>
        <Affiliation>Dept. of Physiological Sciences, University of Florida College of Veterinary Science, Gainesville, FL 32610, USA. Electronic address: rdjohnso@ufl.edu.</Affiliation>
      </Author>
      <Author>
        <Name>B. Y. Cooper</Name>
        <Affiliation>Division of Neuroscience, Dept. of Oral and Maxillofacial Surgery, Box 100416, JHMHC, University of Florida College of Dentistry, Gainesville, FL 32610, USA. Electronic address: bcooper@dental.ufl.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Di-(2-ethylhexyl) phthalate could disrupt the insulin signaling pathway in liver of SD rats and L02 cells via PPARγ.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28025108</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30388-X</DOI>
    <KeywordList>
      <Keywords>DEHP</Keywords>
      <Keywords>GLUT4</Keywords>
      <Keywords>Insulin resistance</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>PPARγ</Keywords>
      <Keywords>ROS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wang Zhang</Name>
        <Affiliation>Institute of Clinical Pharmacology of Anhui Medical University, Key Laboratory of Anti-inflammatory and Immune Medicine of Education Ministry, Anhui Collaborative Innovation Center of Anti-inflammatory and Immune Medicine, Hefei, 230032, Anhui, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Yue Shen</Name>
        <Affiliation>Institute of Clinical Pharmacology of Anhui Medical University, Key Laboratory of Anti-inflammatory and Immune Medicine of Education Ministry, Anhui Collaborative Innovation Center of Anti-inflammatory and Immune Medicine, Hefei, 230032, Anhui, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Wen Zhang</Name>
        <Affiliation>Institute of Clinical Pharmacology of Anhui Medical University, Key Laboratory of Anti-inflammatory and Immune Medicine of Education Ministry, Anhui Collaborative Innovation Center of Anti-inflammatory and Immune Medicine, Hefei, 230032, Anhui, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hao Chen</Name>
        <Affiliation>Institute of Clinical Pharmacology of Anhui Medical University, Key Laboratory of Anti-inflammatory and Immune Medicine of Education Ministry, Anhui Collaborative Innovation Center of Anti-inflammatory and Immune Medicine, Hefei, 230032, Anhui, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Ping Xu</Name>
        <Affiliation>Affiliated Anhui Provincial Hospital, Anhui Medical University, Hefei 230001, Anhui, China. Electronic address: xu_weiping666@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Wei</Name>
        <Affiliation>Institute of Clinical Pharmacology of Anhui Medical University, Key Laboratory of Anti-inflammatory and Immune Medicine of Education Ministry, Anhui Collaborative Innovation Center of Anti-inflammatory and Immune Medicine, Hefei, 230032, Anhui, China. Electronic address: wwei@ahmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Apigenin potentiates the antitumor activity of 5-FU on solid Ehrlich carcinoma: Crosstalk between apoptotic and JNK-mediated autophagic cell death platforms.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28025107</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30390-8</DOI>
    <KeywordList>
      <Keywords>5-FU</Keywords>
      <Keywords>Apigenin</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Autophay</Keywords>
      <Keywords>Ehrlich tumor</Keywords>
      <Keywords>JNK activity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hanaa H. Gaballah</Name>
        <Affiliation>Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Tanta University, Tanta, 3111, Egypt. Electronic address: hanaahibishy@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Rasha A. Gaber</Name>
        <Affiliation>Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Tanta University, Tanta, 3111, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Darin A. Mohamed</Name>
        <Affiliation>Histopathology Department, Faculty of Medicine, Tanta University, Tanta, 3111, Egypt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pharmacological activation of aldehyde dehydrogenase 2 promotes osteoblast differentiation via bone morphogenetic protein-2 and induces bone anabolic effect.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28017615</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30391-X</DOI>
    <KeywordList>
      <Keywords>Alda-1</Keywords>
      <Keywords>Bone regeneration</Keywords>
      <Keywords>Osteoanabolic</Keywords>
      <Keywords>Peak bone mass</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>Post-menopausal osteoporosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Monika Mittal</Name>
        <Affiliation>Division of Endocrinology and Centre for Research in Anabolic Skeletal Targets in Health and Illness (ASTHI), CSIR-Central Drug Research Institute, Lucknow 226031, India.</Affiliation>
      </Author>
      <Author>
        <Name>Subhashis Pal</Name>
        <Affiliation>Division of Endocrinology and Centre for Research in Anabolic Skeletal Targets in Health and Illness (ASTHI), CSIR-Central Drug Research Institute, Lucknow 226031, India.</Affiliation>
      </Author>
      <Author>
        <Name>Shyamsundar Pal China</Name>
        <Affiliation>Division of Endocrinology and Centre for Research in Anabolic Skeletal Targets in Health and Illness (ASTHI), CSIR-Central Drug Research Institute, Lucknow 226031, India.</Affiliation>
      </Author>
      <Author>
        <Name>Konica Porwal</Name>
        <Affiliation>Division of Endocrinology and Centre for Research in Anabolic Skeletal Targets in Health and Illness (ASTHI), CSIR-Central Drug Research Institute, Lucknow 226031, India.</Affiliation>
      </Author>
      <Author>
        <Name>Kapil Dev</Name>
        <Affiliation>Division of Medicinal and Process Chemistry, CSIR-Central Drug Research Institute, Lucknow 226031, India.</Affiliation>
      </Author>
      <Author>
        <Name>Richa Shrivastava</Name>
        <Affiliation>Division of Toxicology, CSIR-Central Drug Research Institute, Lucknow 226031, India.</Affiliation>
      </Author>
      <Author>
        <Name>Kanumuri Siva Rama Raju</Name>
        <Affiliation>Pharmaceutics Division, CSIR-Central Drug Research Institute, Lucknow 226031, India.</Affiliation>
      </Author>
      <Author>
        <Name>Mamunur Rashid</Name>
        <Affiliation>Pharmaceutics Division, CSIR-Central Drug Research Institute, Lucknow 226031, India.</Affiliation>
      </Author>
      <Author>
        <Name>Arun Kumar Trivedi</Name>
        <Affiliation>Biochemistry Division, CSIR-Central Drug Research Institute, Lucknow 226031, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sabyasachi Sanyal</Name>
        <Affiliation>Biochemistry Division, CSIR-Central Drug Research Institute, Lucknow 226031, India.</Affiliation>
      </Author>
      <Author>
        <Name>Muhammad Wahajuddin</Name>
        <Affiliation>Pharmaceutics Division, CSIR-Central Drug Research Institute, Lucknow 226031, India.</Affiliation>
      </Author>
      <Author>
        <Name>Smrati Bhaduria</Name>
        <Affiliation>Division of Toxicology, CSIR-Central Drug Research Institute, Lucknow 226031, India.</Affiliation>
      </Author>
      <Author>
        <Name>Rakesh Maurya</Name>
        <Affiliation>Division of Medicinal and Process Chemistry, CSIR-Central Drug Research Institute, Lucknow 226031, India.</Affiliation>
      </Author>
      <Author>
        <Name>Naibedya Chattopadhyay</Name>
        <Affiliation>Division of Endocrinology and Centre for Research in Anabolic Skeletal Targets in Health and Illness (ASTHI), CSIR-Central Drug Research Institute, Lucknow 226031, India. Electronic address: n_chattopadhyay@cdri.res.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Gemcitabine: Selective cytotoxicity, induction of inflammation and effects on urothelial function.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/28007550</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30389-1</DOI>
    <KeywordList>
      <Keywords>Bladder Cancer</Keywords>
      <Keywords>Gemcitabine</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Mitomycin C</Keywords>
      <Keywords>Urothelium</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Stefanie E. Farr</Name>
        <Affiliation>Centre for Urology Research, Faculty of Health Sciences and Medicine, Bond University, Robina, Queensland 4229, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Russ Chess-Williams</Name>
        <Affiliation>Centre for Urology Research, Faculty of Health Sciences and Medicine, Bond University, Robina, Queensland 4229, Australia.</Affiliation>
      </Author>
      <Author>
        <Name>Catherine M. McDermott</Name>
        <Affiliation>Centre for Urology Research, Faculty of Health Sciences and Medicine, Bond University, Robina, Queensland 4229, Australia. Electronic address: camcderm@bond.edu.au.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Emodin suppresses TGF-β1-induced epithelial-mesenchymal transition in alveolar epithelial cells through Notch signaling pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27989784</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30381-7</DOI>
    <KeywordList>
      <Keywords>Emodin</Keywords>
      <Keywords>Epithelial-mesenchymal transition</Keywords>
      <Keywords>Notch-1</Keywords>
      <Keywords>Pulmonary fibrosis</Keywords>
      <Keywords>RLE-6TN cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rundi Gao</Name>
        <Affiliation>Department of Respiration, The First Affiliated Hospital of Zhejiang Chinese Medicine University, NO. 56, Youdian Road, Shangcheng District, Hangzhou, Zhejiang Province 310006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ruilin Chen</Name>
        <Affiliation>Department of Respiration, The First Affiliated Hospital of Zhejiang Chinese Medicine University, NO. 56, Youdian Road, Shangcheng District, Hangzhou, Zhejiang Province 310006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Cao</Name>
        <Affiliation>Department of Respiration, The First Affiliated Hospital of Zhejiang Chinese Medicine University, NO. 56, Youdian Road, Shangcheng District, Hangzhou, Zhejiang Province 310006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Wang</Name>
        <Affiliation>Department of Pulmonary Function, The First Affiliated Hospital of Zhejiang Chinese Medicine University, NO. 56, Youdian Road, Shangcheng District, Hangzhou, Zhejiang Province 310006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kang Song</Name>
        <Affiliation>Department of Respiration, The First Affiliated Hospital of Zhejiang Chinese Medicine University, NO. 56, Youdian Road, Shangcheng District, Hangzhou, Zhejiang Province 310006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ya Zhang</Name>
        <Affiliation>Zhejiang Chinese Medicine University, No. 548, Binwen Road, Binjiang District, Hangzhou, Zhejiang Province 310006, China.</Affiliation>
      </Author>
      <Author>
        <Name>Junchao Yang</Name>
        <Affiliation>Department of Respiration, The First Affiliated Hospital of Zhejiang Chinese Medicine University, NO. 56, Youdian Road, Shangcheng District, Hangzhou, Zhejiang Province 310006, China. Electronic address: yangjunchaozj@zcmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Ilexgenin A exerts anti-inflammation and anti-angiogenesis effects through inhibition of STAT3 and PI3K pathways and exhibits synergistic effects with Sorafenib on hepatoma growth.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27986624</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30380-5</DOI>
    <KeywordList>
      <Keywords>Angiogenesis</Keywords>
      <Keywords>Ilexgenin A</Keywords>
      <Keywords>PI3K</Keywords>
      <Keywords>STAT3</Keywords>
      <Keywords>Sorafenib</Keywords>
      <Keywords>Synergy effect</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hao Yang</Name>
        <Affiliation>Medical and Pharmaceutical Institute, Yangzhou University, Yangzhou 225001, Jiangsu, PR China; College of Medicine, Yangzhou University, Yangzhou 225001, Jiangsu, PR China; Institute of Pharmacology and Toxicology, Jiangsu Kanion Pharmaceutical Co., Ltd., Lianyungang 222000, Jiangsu, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Wang</Name>
        <Affiliation>Medical and Pharmaceutical Institute, Yangzhou University, Yangzhou 225001, Jiangsu, PR China; College of Medicine, Yangzhou University, Yangzhou 225001, Jiangsu, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Hong Fan</Name>
        <Affiliation>Medical and Pharmaceutical Institute, Yangzhou University, Yangzhou 225001, Jiangsu, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ya Qi Zhang</Name>
        <Affiliation>Medical and Pharmaceutical Institute, Yangzhou University, Yangzhou 225001, Jiangsu, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Xian Zhao</Name>
        <Affiliation>Medical and Pharmaceutical Institute, Yangzhou University, Yangzhou 225001, Jiangsu, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Jun Dai</Name>
        <Affiliation>Medical and Pharmaceutical Institute, Yangzhou University, Yangzhou 225001, Jiangsu, PR China; Chinese Medicine Hospital of Yangzhou City, Yangzhou 225009, Jiangsu, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Liu</Name>
        <Affiliation>Medical and Pharmaceutical Institute, Yangzhou University, Yangzhou 225001, Jiangsu, PR China; College of Medicine, Yangzhou University, Yangzhou 225001, Jiangsu, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Jun Shen</Name>
        <Affiliation>Medical and Pharmaceutical Institute, Yangzhou University, Yangzhou 225001, Jiangsu, PR China; College of Medicine, Yangzhou University, Yangzhou 225001, Jiangsu, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chang Liu</Name>
        <Affiliation>Medical and Pharmaceutical Institute, Yangzhou University, Yangzhou 225001, Jiangsu, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Dong Sun</Name>
        <Affiliation>Medical and Pharmaceutical Institute, Yangzhou University, Yangzhou 225001, Jiangsu, PR China; Chinese Medicine Hospital of Yangzhou City, Yangzhou 225009, Jiangsu, PR China. Electronic address: zyykjc@sina.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yun Sun</Name>
        <Affiliation>Medical and Pharmaceutical Institute, Yangzhou University, Yangzhou 225001, Jiangsu, PR China; College of Medicine, Yangzhou University, Yangzhou 225001, Jiangsu, PR China. Electronic address: ysun@yzu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Enterolactone: A novel radiosensitizer for human breast cancer cell lines through impaired DNA repair and increased apoptosis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27984132</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30330-1</DOI>
    <KeywordList>
      <Keywords>Breast cancer</Keywords>
      <Keywords>Chromosomal aberrations</Keywords>
      <Keywords>DNA repair</Keywords>
      <Keywords>Enterolactone</Keywords>
      <Keywords>Micronuclei</Keywords>
      <Keywords>Radiosensitizer</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bahareh Bigdeli</Name>
        <Affiliation>Department of Biophysics, Institute of Biochemistry and Biophysics, University of Tehran, 16th Azar St., Enghelab Sq., Tehran, Iran. Electronic address: bhr.bigdeli@ut.ac.ir.</Affiliation>
      </Author>
      <Author>
        <Name>Bahram Goliaei</Name>
        <Affiliation>Department of Biophysics, Institute of Biochemistry and Biophysics, University of Tehran, 16th Azar St., Enghelab Sq., Tehran, Iran. Electronic address: goliaei@ut.ac.ir.</Affiliation>
      </Author>
      <Author>
        <Name>Nastaran Masoudi-Khoram</Name>
        <Affiliation>Department of Biophysics, Institute of Biochemistry and Biophysics, University of Tehran, 16th Azar St., Enghelab Sq., Tehran, Iran. Electronic address: n.masoudi@alumni.ut.ac.ir.</Affiliation>
      </Author>
      <Author>
        <Name>Najmeh Jooyan</Name>
        <Affiliation>Department of Biophysics, Institute of Biochemistry and Biophysics, University of Tehran, 16th Azar St., Enghelab Sq., Tehran, Iran. Electronic address: n.jooyan@ut.ac.ir.</Affiliation>
      </Author>
      <Author>
        <Name>Alireza Nikoofar</Name>
        <Affiliation>Department of Radiotherapy, Iran University of Medical Sciences (IUMS), Shahid Hemmat Highway, Tehran, Iran. Electronic address: nikoofar@iums.ac.ir.</Affiliation>
      </Author>
      <Author>
        <Name>Maryam Rouhani</Name>
        <Affiliation>Department of Biological Sciences, Institute for Advanced Studies in Basic Sciences (IASBS), Prof. Yousef Sobouti Blvd., Gava Zang, Zanjan, Iran. Electronic address: rouhani@iasbs.ac.ir.</Affiliation>
      </Author>
      <Author>
        <Name>Abbas Haghparast</Name>
        <Affiliation>Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Daneshjo St., Evin, Tehran, Iran. Electronic address: Haghparast@sbmu.ac.ir.</Affiliation>
      </Author>
      <Author>
        <Name>Fatemeh Mamashli</Name>
        <Affiliation>Department of Biophysics, Institute of Biochemistry and Biophysics, University of Tehran, 16th Azar St., Enghelab Sq., Tehran, Iran. Electronic address: mamashli@ut.ac.ir.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Enhanced photo(geno)toxicity of demethylated chlorpromazine metabolites.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27984131</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30333-7</DOI>
    <KeywordList>
      <Keywords>Comet assay</Keywords>
      <Keywords>Excited states</Keywords>
      <Keywords>Laser flash photolysis</Keywords>
      <Keywords>Metabolites</Keywords>
      <Keywords>Photosensitized DNA damage</Keywords>
      <Keywords>Phototoxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Fabrizio Palumbo</Name>
        <Affiliation>Instituto de Tecnología Química UPV-CSIC/Departamento de Química, Universitat Politècnica de València, Camino de Vera s/n, 46022 Valencia, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Guillermo Garcia-Lainez</Name>
        <Affiliation>Instituto de Investigación Sanitaria (IIS) La Fe, Hospital Universitari i Politècnic La Fe, Avenida de Fernando Abril Martorell 106, 46026 Valencia, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Limones-Herrero</Name>
        <Affiliation>Instituto de Tecnología Química UPV-CSIC/Departamento de Química, Universitat Politècnica de València, Camino de Vera s/n, 46022 Valencia, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>M. Dolores Coloma</Name>
        <Affiliation>Instituto de Investigación Sanitaria (IIS) La Fe, Hospital Universitari i Politècnic La Fe, Avenida de Fernando Abril Martorell 106, 46026 Valencia, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Javier Escobar</Name>
        <Affiliation>Instituto de Investigación Sanitaria (IIS) La Fe, Hospital Universitari i Politècnic La Fe, Avenida de Fernando Abril Martorell 106, 46026 Valencia, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>M. Consuelo Jiménez</Name>
        <Affiliation>Instituto de Tecnología Química UPV-CSIC/Departamento de Química, Universitat Politècnica de València, Camino de Vera s/n, 46022 Valencia, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Miguel A. Miranda</Name>
        <Affiliation>Instituto de Tecnología Química UPV-CSIC/Departamento de Química, Universitat Politècnica de València, Camino de Vera s/n, 46022 Valencia, Spain. Electronic address: mmiranda@qim.upv.es.</Affiliation>
      </Author>
      <Author>
        <Name>Inmaculada Andreu</Name>
        <Affiliation>Instituto de Tecnología Química UPV-CSIC/Departamento de Química, Universitat Politècnica de València, Camino de Vera s/n, 46022 Valencia, Spain; Instituto de Investigación Sanitaria (IIS) La Fe, Hospital Universitari i Politècnic La Fe, Avenida de Fernando Abril Martorell 106, 46026 Valencia, Spain. Electronic address: iandreur@qim.upv.es.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dual effect of insulin resistance and cadmium on human granulosa cells - In vitro study.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27984130</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30328-3</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Cadmium</Keywords>
      <Keywords>Human granulosa cells</Keywords>
      <Keywords>Insulin resistance</Keywords>
      <Keywords>Steroidogenesis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Muskaan Belani</Name>
        <Affiliation>Department of Biochemistry, Faculty of Science, The Maharaja Sayajirao University of Baroda, Vadodara 390 002, Gujarat, India.. Electronic address: muskaanbelani@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Preeti Shah</Name>
        <Affiliation>Nova IVI Fertility, Behind Xavier's Ladies Hostel, 108, Swastik Society Rd., Navrangpura, Ahmedabad 390009, Gujarat, India.. Electronic address: preeti.shah@novaivifertility.com.</Affiliation>
      </Author>
      <Author>
        <Name>Manish Banker</Name>
        <Affiliation>Nova IVI Fertility, Behind Xavier's Ladies Hostel, 108, Swastik Society Rd., Navrangpura, Ahmedabad 390009, Gujarat, India.. Electronic address: manish.banker@novaivifertility.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sarita Gupta</Name>
        <Affiliation>Department of Biochemistry, Faculty of Science, The Maharaja Sayajirao University of Baroda, Vadodara 390 002, Gujarat, India.. Electronic address: saritagupta9@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Aluminum exposure for one hour decreases vascular reactivity in conductance and resistance arteries in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27984129</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30331-3</DOI>
    <KeywordList>
      <Keywords>Acute exposure</Keywords>
      <Keywords>Aluminum</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Vascular reactivity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Patrícia Medeiros Schmidt</Name>
        <Affiliation>Postgraduate Program in Biochemistry, Universidade Federal do Pampa, Uruguaiana, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Alyne Goulart Escobar</Name>
        <Affiliation>Postgraduate Program in Biochemistry, Universidade Federal do Pampa, Uruguaiana, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>João Guilherme Dini Torres</Name>
        <Affiliation>Postgraduate Program in Biochemistry, Universidade Federal do Pampa, Uruguaiana, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Caroline Silveira Martinez</Name>
        <Affiliation>Postgraduate Program in Biochemistry, Universidade Federal do Pampa, Uruguaiana, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Danize Aparecida Rizzetti</Name>
        <Affiliation>Postgraduate Program in Biochemistry, Universidade Federal do Pampa, Uruguaiana, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Simone Noremberg Kunz</Name>
        <Affiliation>Postgraduate Program in Biochemistry, Universidade Federal do Pampa, Uruguaiana, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Dalton Valentim Vassallo</Name>
        <Affiliation>Department of Physiological Sciences, Universidade Federal do Espírito Santo, Espirito Santo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>María Jesús Alonso</Name>
        <Affiliation>Department of Basic Health Sciences, Universidad Rey Juan Carlos, Alcorcón, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Franck Maciel Peçanha</Name>
        <Affiliation>Postgraduate Program in Biochemistry, Universidade Federal do Pampa, Uruguaiana, Rio Grande do Sul, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Giulia Alessandra Wiggers</Name>
        <Affiliation>Postgraduate Program in Biochemistry, Universidade Federal do Pampa, Uruguaiana, Rio Grande do Sul, Brazil. Electronic address: giuliawp@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>DNA damage response in nephrotoxic and ischemic kidney injury.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27984128</pubmedLink>
    <GrantList>
      <Grant>I01 BX000319</Grant>
      <Grant>R01 DK058831</Grant>
      <Grant>R01 DK087843</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30332-5</DOI>
    <KeywordList>
      <Keywords>Acute kidney injury</Keywords>
      <Keywords>Cisplatin</Keywords>
      <Keywords>DNA damage response</Keywords>
      <Keywords>Renal ischemia/reperfusion</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mingjuan Yan</Name>
        <Affiliation>Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Chengyuan Tang</Name>
        <Affiliation>Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhengwei Ma</Name>
        <Affiliation>Department of Cellular Biology &amp; Anatomy, Medical College of Georgia at Augusta University and Charlie Norwood VA Medical Center, Augusta, GA 30912, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Shuang Huang</Name>
        <Affiliation>Department of Anatomy and Cell Biology, University of Florida College of Medicine, Gainesville, FL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zheng Dong</Name>
        <Affiliation>Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, PR China; Department of Cellular Biology &amp; Anatomy, Medical College of Georgia at Augusta University and Charlie Norwood VA Medical Center, Augusta, GA 30912, USA. Electronic address: zdong@augusta.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Physiologically based pharmacokinetic toolkit to evaluate environmental exposures: Applications of the dioxin model to study real life exposures.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27956220</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30379-9</DOI>
    <KeywordList>
      <Keywords>Berkeley-Madonna</Keywords>
      <Keywords>Dioxin</Keywords>
      <Keywords>PBPK</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Claude Emond</Name>
        <Affiliation>BioSimulation Consulting Inc, Newark, DE, USA. Electronic address: claude.emond@biosmc.com.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia Ruiz</Name>
        <Affiliation>Division of Toxicology and Human Health Sciences, Agency for Toxic Substances and Disease Registry, Atlanta, GA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Moiz Mumtaz</Name>
        <Affiliation>Division of Toxicology and Human Health Sciences, Agency for Toxic Substances and Disease Registry, Atlanta, GA, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Sub-chronic 90-day toxicity of neamine in SD rats and its anti-liver cancer activity in vitro and in vivo.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27940282</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30378-7</DOI>
    <KeywordList>
      <Keywords>Angiogenesis</Keywords>
      <Keywords>Angiogenin</Keywords>
      <Keywords>Liver cancer</Keywords>
      <Keywords>Neamine</Keywords>
      <Keywords>Sub-chronic toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yanli Wu</Name>
        <Affiliation>Department of pharmacology, School of Pharmacy, Huazhong University of Science and Technology, Wuhan 400030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongdong Feng</Name>
        <Affiliation>Department of Gastrointestinal Surgery, Tongji Hospital, Huazhong University of Science and Technology, Wuhan 400030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanling Li</Name>
        <Affiliation>Department of pharmacology, School of Pharmacy, Huazhong University of Science and Technology, Wuhan 400030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yiping Xu</Name>
        <Affiliation>Department of hygienic toxicology, School of Public Health, Huazhong University of Science and Technology, Wuhan 400030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Nian Shi</Name>
        <Affiliation>Department of hygienic toxicology, School of Public Health, Huazhong University of Science and Technology, Wuhan 400030, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guo Fu Hu</Name>
        <Affiliation>Molecular Oncology Research Institute, Tufts Medical Center, Tufts University, Boston 02111, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yunxia Wu</Name>
        <Affiliation>Department of pharmacology, School of Pharmacy, Huazhong University of Science and Technology, Wuhan 400030, China. Electronic address: wuyunxia@hust.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Clozapine-induced agranulocytosis: Evidence for an immune-mediated mechanism from a patient-specific in-vitro approach.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27939987</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30375-1</DOI>
    <KeywordList>
      <Keywords>Antigen-specific lymphocytes</Keywords>
      <Keywords>Clozapine</Keywords>
      <Keywords>Clozapine-induced agranulocytosis</Keywords>
      <Keywords>PBMC in vitro immune assay</Keywords>
      <Keywords>Personalized Medicine</Keywords>
      <Keywords>Side effects</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Francesca Regen</Name>
        <Affiliation>Dept. of Psychiatry, Campus Benjamin Franklin, Charité, University Medicine Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Irmelin Herzog</Name>
        <Affiliation>Dept. of Psychiatry, Campus Benjamin Franklin, Charité, University Medicine Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Eric Hahn</Name>
        <Affiliation>Dept. of Psychiatry, Campus Benjamin Franklin, Charité, University Medicine Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Claudia Ruehl</Name>
        <Affiliation>Dept. of Psychiatry, Campus Benjamin Franklin, Charité, University Medicine Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Nathalie Le Bret</Name>
        <Affiliation>Dept. of Psychiatry, Campus Benjamin Franklin, Charité, University Medicine Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Dettling</Name>
        <Affiliation>Dept. of Psychiatry, Campus Benjamin Franklin, Charité, University Medicine Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Isabella Heuser</Name>
        <Affiliation>Dept. of Psychiatry, Campus Benjamin Franklin, Charité, University Medicine Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Julian Hellmann-Regen</Name>
        <Affiliation>Dept. of Psychiatry, Campus Benjamin Franklin, Charité, University Medicine Berlin, Germany; Berlin Institute of Health (BIH), Berlin, Germany. Electronic address: julian.hellmann@charite.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Methylation of Septin9 mediated by DNMT3a enhances hepatic stellate cells activation and liver fibrogenesis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27939986</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30373-8</DOI>
    <KeywordList>
      <Keywords>DNA methylation</Keywords>
      <Keywords>DNMT3a</Keywords>
      <Keywords>Septin9</Keywords>
      <Keywords>apoptosis</Keywords>
      <Keywords>liver fibrosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yuting Wu</Name>
        <Affiliation>School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; The Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Medical University, Ministry of Education, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University, ILD-AMU, Anhui Medical University, Hefei 230032, China; Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China. Electronic address: wuyuting1302@sina.com.</Affiliation>
      </Author>
      <Author>
        <Name>Fangtian Bu</Name>
        <Affiliation>School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; The Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Medical University, Ministry of Education, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University, ILD-AMU, Anhui Medical University, Hefei 230032, China; Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Haixia Yu</Name>
        <Affiliation>School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; The Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Medical University, Ministry of Education, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University, ILD-AMU, Anhui Medical University, Hefei 230032, China; Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wanxia Li</Name>
        <Affiliation>School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; The Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Medical University, Ministry of Education, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University, ILD-AMU, Anhui Medical University, Hefei 230032, China; Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cheng Huang</Name>
        <Affiliation>School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; The Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Medical University, Ministry of Education, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University, ILD-AMU, Anhui Medical University, Hefei 230032, China; Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoming Meng</Name>
        <Affiliation>School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; The Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Medical University, Ministry of Education, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University, ILD-AMU, Anhui Medical University, Hefei 230032, China; Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lei Zhang</Name>
        <Affiliation>School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; The Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Medical University, Ministry of Education, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University, ILD-AMU, Anhui Medical University, Hefei 230032, China; Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Taotao Ma</Name>
        <Affiliation>School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; The Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Medical University, Ministry of Education, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University, ILD-AMU, Anhui Medical University, Hefei 230032, China; Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Li</Name>
        <Affiliation>School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; The Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Medical University, Ministry of Education, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University, ILD-AMU, Anhui Medical University, Hefei 230032, China; Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China. Electronic address: lj@ahmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dihydroartemisinin protects against alcoholic liver injury through alleviating hepatocyte steatosis in a farnesoid X receptor-dependent manner.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27939985</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30374-X</DOI>
    <KeywordList>
      <Keywords>Alcoholic liver injury</Keywords>
      <Keywords>Dihydroartemisinin</Keywords>
      <Keywords>Farnesoid X receptor</Keywords>
      <Keywords>Hepatocyte</Keywords>
      <Keywords>Steatosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wenxuan Xu</Name>
        <Affiliation>Department of Pharmacology, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunfeng Lu</Name>
        <Affiliation>Department of Pharmacology, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Yao</Name>
        <Affiliation>Department of Pharmacology, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Feng Zhang</Name>
        <Affiliation>Department of Pharmacology, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiangjuan Shao</Name>
        <Affiliation>Department of Pharmacology, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shizhong Zheng</Name>
        <Affiliation>Department of Pharmacology, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China. Electronic address: nytws@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>EX4 stabilizes and activates Nrf2 via PKCδ, contributing to the prevention of oxidative stress-induced pancreatic beta cell damage.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27939242</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30377-5</DOI>
    <KeywordList>
      <Keywords>Beta cell</Keywords>
      <Keywords>Exendin-4</Keywords>
      <Keywords>INS-1 cell</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Type 2 diabetes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mi Hwi Kim</Name>
        <Affiliation>College of Pharmacy, Gachon Institute of Pharmaceutical Science, Gachon University, Yeonsu-ku, Incheon, South Korea; Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Yeonsu-ku, Incheon, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eung Hwi Kim</Name>
        <Affiliation>College of Pharmacy, Gachon Institute of Pharmaceutical Science, Gachon University, Yeonsu-ku, Incheon, South Korea; Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Yeonsu-ku, Incheon, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hye Seung Jung</Name>
        <Affiliation>Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dongki Yang</Name>
        <Affiliation>Department of Physiology, Gachon University College of Medicine, Incheon, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Young Park</Name>
        <Affiliation>College of Pharmacy, Natural Medicine Research Institute, Mokpo National University, Muan-gun, Jeonnam, South Korea. Electronic address: parkey@mokpo.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Hee Sook Jun</Name>
        <Affiliation>College of Pharmacy, Gachon Institute of Pharmaceutical Science, Gachon University, Yeonsu-ku, Incheon, South Korea; Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Yeonsu-ku, Incheon, South Korea; Gachon Medical Research Institute, Gil Hospital, Incheon, South Korea. Electronic address: hsjun@gachon.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The anti-ALS drug riluzole attenuates pericyte loss in the diabetic retinopathy of streptozotocin-treated mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27939241</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30376-3</DOI>
    <KeywordList>
      <Keywords>Diabetic retinopathy</Keywords>
      <Keywords>Pericyte</Keywords>
      <Keywords>Protein kinase C</Keywords>
      <Keywords>Riluzole</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jeong A. Choi</Name>
        <Affiliation>Neural Injury Research Center, Asan Institute for Life Sciences, University of Ulsan College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yoo Ri Chung</Name>
        <Affiliation>Department of Ophthalmology, University of Ulsan College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyae Ran Byun</Name>
        <Affiliation>Neural Injury Research Center, Asan Institute for Life Sciences, University of Ulsan College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hwangseo Park</Name>
        <Affiliation>Department of Bioscience and Biotechnology, Sejong University, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jae Young Koh</Name>
        <Affiliation>Neural Injury Research Center, Asan Institute for Life Sciences, University of Ulsan College of Medicine, Seoul, Republic of Korea; Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Electronic address: jkko@amc.seoul.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Young Hee Yoon</Name>
        <Affiliation>Department of Ophthalmology, University of Ulsan College of Medicine, Seoul, Republic of Korea. Electronic address: yhyoon@amc.seoul.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>MicroRNAs: small molecules with big effects.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27927287</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30349-0</DOI>
    <AuthorList>
      <Author>
        <Name>Erik J. Tokar</Name>
        <Affiliation>Stem Cell Toxicology Group, National Toxicology Program Laboratory, Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA.. Electronic address: tokare@niehs.nih.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute lung injury and persistent small airway disease in a rabbit model of chlorine inhalation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27913141</pubmedLink>
    <GrantList>
      <Grant>U01 ES015673</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30372-6</DOI>
    <KeywordList>
      <Keywords>Airway hyperreactivity</Keywords>
      <Keywords>Bronchiolitis obliterans</Keywords>
      <Keywords>Chlorine</Keywords>
      <Keywords>Hypoxemia</Keywords>
      <Keywords>Lung injury</Keywords>
      <Keywords>Rabbit</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sadiatu Musah</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, School of Public Health and Information Sciences, University of Louisville, Louisville, KY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Connie F. Schlueter</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, School of Public Health and Information Sciences, University of Louisville, Louisville, KY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>David M. Humphrey</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, School of Public Health and Information Sciences, University of Louisville, Louisville, KY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Karen S. Powell</Name>
        <Affiliation>Research Resource Facilities, University of Louisville, Louisville, KY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew M. Roberts</Name>
        <Affiliation>Department of Physiology, University of Louisville, Louisville, KY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Gary W. Hoyle</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, School of Public Health and Information Sciences, University of Louisville, Louisville, KY, United States. Electronic address: Gary.Hoyle@louisville.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparative analysis of TCDD-induced AhR-mediated gene expression in human, mouse and rat primary B cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27913140</pubmedLink>
    <GrantList>
      <Grant>P42 ES004911</Grant>
      <Grant>R01 ES002520</Grant>
      <Grant>T32 GM092715</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30364-7</DOI>
    <KeywordList>
      <Keywords>AhR</Keywords>
      <Keywords>B cell</Keywords>
      <Keywords>IgM</Keywords>
      <Keywords>TCDD</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Natalia Kovalova</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Michigan State University, Lansing, MI 48824, USA; Institute for Integrative Toxicology, Michigan State University, Lansing, MI 48824, USA. Electronic address: kovalova@msu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Rance Nault</Name>
        <Affiliation>Institute for Integrative Toxicology, Michigan State University, Lansing, MI 48824, USA; Department of Biochemistry &amp; Molecular Biology, Michigan State University, East Lansing, MI 48824, USA. Electronic address: naultran@msu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Crawford</Name>
        <Affiliation>Institute for Integrative Toxicology, Michigan State University, Lansing, MI 48824, USA. Electronic address: crawfo28@msu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy R. Zacharewski</Name>
        <Affiliation>Institute for Integrative Toxicology, Michigan State University, Lansing, MI 48824, USA; Department of Biochemistry &amp; Molecular Biology, Michigan State University, East Lansing, MI 48824, USA. Electronic address: tzachare@msu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Norbert E. Kaminski</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Michigan State University, Lansing, MI 48824, USA; Institute for Integrative Toxicology, Michigan State University, Lansing, MI 48824, USA. Electronic address: kamins11@msu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Benznidazole, the trypanocidal drug used for Chagas disease, induces hepatic NRF2 activation and attenuates the inflammatory response in a murine model of sepsis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27899278</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30370-2</DOI>
    <KeywordList>
      <Keywords>Benznidazole</Keywords>
      <Keywords>CLP</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>NRF2</Keywords>
      <Keywords>Sepsis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Flavia Lambertucci</Name>
        <Affiliation>Instituto de Fisiología Experimental (IFISE-CONICET), Suipacha 570, 2000 Rosario, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Omar Motiño</Name>
        <Affiliation>Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM, Arturo Duperier 4, 28029 Madrid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Silvina Villar</Name>
        <Affiliation>Instituto de Inmunología, Facultad de Ciencias Médicas, UNR, Suipacha 531, 2000 Rosario, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Pablo Rigalli</Name>
        <Affiliation>Instituto de Fisiología Experimental (IFISE-CONICET), Suipacha 570, 2000 Rosario, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>María de Luján Alvarez</Name>
        <Affiliation>Instituto de Fisiología Experimental (IFISE-CONICET), Suipacha 570, 2000 Rosario, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Viviana A. Catania</Name>
        <Affiliation>Instituto de Fisiología Experimental (IFISE-CONICET), Suipacha 570, 2000 Rosario, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Paloma Martín-Sanz</Name>
        <Affiliation>Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM, Arturo Duperier 4, 28029 Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Monforte de Lemos 3-5, 28029 Madrid, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Cristina Ester Carnovale</Name>
        <Affiliation>Instituto de Fisiología Experimental (IFISE-CONICET), Suipacha 570, 2000 Rosario, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Ariel Darío Quiroga</Name>
        <Affiliation>Instituto de Fisiología Experimental (IFISE-CONICET), Suipacha 570, 2000 Rosario, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Eleazar Francés</Name>
        <Affiliation>Instituto de Fisiología Experimental (IFISE-CONICET), Suipacha 570, 2000 Rosario, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>María Teresa Ronco</Name>
        <Affiliation>Instituto de Fisiología Experimental (IFISE-CONICET), Suipacha 570, 2000 Rosario, Argentina. Electronic address: ronco@ifise-conicet.gov.ar.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Protective role of hypoxia-inducible factor-1α-dependent CD39 and CD73 in fulminant acute liver failure.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27899277</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30371-4</DOI>
    <KeywordList>
      <Keywords>Acute liver failure</Keywords>
      <Keywords>CD39</Keywords>
      <Keywords>CD73</Keywords>
      <Keywords>HIF-1α</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Eunyoung Tak</Name>
        <Affiliation>Asan Institute for Life Sciences and Asan-Minnesota Institute for Innovating Transplantation, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dong Hwan Jung</Name>
        <Affiliation>Division of Liver Transplantation and Hepatobiliary Surgery, Asan-Minnesota Institute for Innovating Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seok Hwan Kim</Name>
        <Affiliation>Division of Liver Transplantation and Hepatobiliary Surgery, Asan-Minnesota Institute for Innovating Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Gil Chun Park</Name>
        <Affiliation>Division of Liver Transplantation and Hepatobiliary Surgery, Asan-Minnesota Institute for Innovating Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dae Young Jun</Name>
        <Affiliation>Asan Institute for Life Sciences and Asan-Minnesota Institute for Innovating Transplantation, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jooyoung Lee</Name>
        <Affiliation>Asan Institute for Life Sciences and Asan-Minnesota Institute for Innovating Transplantation, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Hyun Jung</Name>
        <Affiliation>Department of Surgery, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Varvara A. Kirchner</Name>
        <Affiliation>Division of Transplantation, Department of Surgery and Asan-Minnesota Institute for Innovating Transplantation, University of Minnesota, Minneapolis, MN, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Shin Hwang</Name>
        <Affiliation>Division of Liver Transplantation and Hepatobiliary Surgery, Asan-Minnesota Institute for Innovating Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Gi Won Song</Name>
        <Affiliation>Division of Liver Transplantation and Hepatobiliary Surgery, Asan-Minnesota Institute for Innovating Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Electronic address: drsong71@amc.seoul.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Sung Gyu Lee</Name>
        <Affiliation>Division of Liver Transplantation and Hepatobiliary Surgery, Asan-Minnesota Institute for Innovating Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The unexpected teratogenicity of RXR antagonist UVI3003 via activation of PPARγ in Xenopus tropicalis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27894914</pubmedLink>
    <GrantList>
      <Grant>R01 ES023316</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30369-6</DOI>
    <KeywordList>
      <Keywords>Peroxisome proliferator activated receptor γ</Keywords>
      <Keywords>Retinoid X receptor</Keywords>
      <Keywords>TPT</Keywords>
      <Keywords>Teratogenicity</Keywords>
      <Keywords>UVI3003</Keywords>
      <Keywords>Xenopus</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jingmin Zhu</Name>
        <Affiliation>State Key Laboratory of Estuarine and Coastal Research, East China Normal University, Shanghai 200062, China.</Affiliation>
      </Author>
      <Author>
        <Name>Amanda Janesick</Name>
        <Affiliation>Department of Developmental and Cell Biology, University of California, Irvine, California 92697-2300, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lijiao Wu</Name>
        <Affiliation>State Key Laboratory of Estuarine and Coastal Research, East China Normal University, Shanghai 200062, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lingling Hu</Name>
        <Affiliation>State Key Laboratory of Estuarine and Coastal Research, East China Normal University, Shanghai 200062, China.</Affiliation>
      </Author>
      <Author>
        <Name>Weiyi Tang</Name>
        <Affiliation>Department of Developmental and Cell Biology, University of California, Irvine, California 92697-2300, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bruce Blumberg</Name>
        <Affiliation>Department of Developmental and Cell Biology, University of California, Irvine, California 92697-2300, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Huahong Shi</Name>
        <Affiliation>State Key Laboratory of Estuarine and Coastal Research, East China Normal University, Shanghai 200062, China. Electronic address: hhshi@des.ecnu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The regulation of cellular apoptosis by the ROS-triggered PERK/EIF2α/chop pathway plays a vital role in bisphenol A-induced male reproductive toxicity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27894913</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30368-4</DOI>
    <KeywordList>
      <Keywords>Bisphenol A</Keywords>
      <Keywords>Endoplasmic reticulum stress</Keywords>
      <Keywords>Male reproductive toxicity</Keywords>
      <Keywords>PERK/EIF2α/chop pathway</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Li Yin</Name>
        <Affiliation>Institute of Toxicology, College of Preventive Medicine, Third Military Medical University, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanlin Dai</Name>
        <Affiliation>Institute of Toxicology, College of Preventive Medicine, Third Military Medical University, Chongqing 400038, China; Medical Laboratory Technology Department, Chuxiong Medical College, Yunnan 675005, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhihong Cui</Name>
        <Affiliation>Institute of Toxicology, College of Preventive Medicine, Third Military Medical University, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Jiang</Name>
        <Affiliation>Institute of Toxicology, College of Preventive Medicine, Third Military Medical University, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenbin Liu</Name>
        <Affiliation>Institute of Toxicology, College of Preventive Medicine, Third Military Medical University, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fei Han</Name>
        <Affiliation>Institute of Toxicology, College of Preventive Medicine, Third Military Medical University, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ao Lin</Name>
        <Affiliation>Institute of Toxicology, College of Preventive Medicine, Third Military Medical University, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jia Cao</Name>
        <Affiliation>Institute of Toxicology, College of Preventive Medicine, Third Military Medical University, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinyi Liu</Name>
        <Affiliation>Institute of Toxicology, College of Preventive Medicine, Third Military Medical University, Chongqing 400038, China. Electronic address: jinyiliutmmu@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>SIRT1 protects cardiac cells against apoptosis induced by zearalenone or its metabolites α- and β-zearalenol through an autophagy-dependent pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27889531</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30367-2</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Autophagy</Keywords>
      <Keywords>SIRT1</Keywords>
      <Keywords>ZEN</Keywords>
      <Keywords>α-ZOL</Keywords>
      <Keywords>β-ZOL</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Intidhar Ben Salem</Name>
        <Affiliation>Laboratory for Research on Biologically Compatible Compounds, Faculty of Dentistry, Rue Avicenne, 5019 Monastir, Tunisia; Faculty of Sciences of Bizerte, Carthage University, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Manel Boussabbeh</Name>
        <Affiliation>Laboratory for Research on Biologically Compatible Compounds, Faculty of Dentistry, Rue Avicenne, 5019 Monastir, Tunisia; Faculty of Sciences of Bizerte, Carthage University, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Julie Pires Da Silva</Name>
        <Affiliation>Inserm UMR-S 1180, Univ Paris-Sud, Université Paris Saclay, 92296 Chatenay-Malabry, France.</Affiliation>
      </Author>
      <Author>
        <Name>Arnaud Guilbert</Name>
        <Affiliation>Inserm UMR-S 1180, Univ Paris-Sud, Université Paris Saclay, 92296 Chatenay-Malabry, France.</Affiliation>
      </Author>
      <Author>
        <Name>Hassen Bacha</Name>
        <Affiliation>Laboratory for Research on Biologically Compatible Compounds, Faculty of Dentistry, Rue Avicenne, 5019 Monastir, Tunisia.</Affiliation>
      </Author>
      <Author>
        <Name>Salwa Abid-Essefi</Name>
        <Affiliation>Laboratory for Research on Biologically Compatible Compounds, Faculty of Dentistry, Rue Avicenne, 5019 Monastir, Tunisia. Electronic address: salwaabid@yahoo.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Christophe Lemaire</Name>
        <Affiliation>Université Versailles St-Quentin, Inserm UMR-S 1180, Univ Paris-Sud, Université Paris Saclay, 92296 Chatenay-Malabry, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Secretory function of ovarian cells and myometrial contractions in cow are affected by chlorinated insecticides (chlordane, heptachlor, mirex) in vitro.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27888061</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30366-0</DOI>
    <KeywordList>
      <Keywords>Chlordane</Keywords>
      <Keywords>Cow</Keywords>
      <Keywords>Heptachlor</Keywords>
      <Keywords>Mirex</Keywords>
      <Keywords>Ovary</Keywords>
      <Keywords>Uterus</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michael Hubert Wrobel</Name>
        <Affiliation>Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Tuwima Street 10, 10-748 Olsztyn, Poland. Electronic address: m.wrobel@pan.olsztyn.pl.</Affiliation>
      </Author>
      <Author>
        <Name>Jaroslaw Mlynarczuk</Name>
        <Affiliation>Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Tuwima Street 10, 10-748 Olsztyn, Poland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A data-driven weighting scheme for multivariate phenotypic endpoints recapitulates zebrafish developmental cascades.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27884602</pubmedLink>
    <GrantList>
      <Grant>P30 ES025128</Grant>
      <Grant>U01 ES027294</Grant>
      <Grant>R01 ES023788</Grant>
      <Grant>T32 ES007329</Grant>
      <Grant>R01 ES019604</Grant>
      <Grant>RC4 ES019764</Grant>
      <Grant>P42 ES016465</Grant>
      <Grant>P30 ES000210</Grant>
      <Grant>P42 ES005948</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30365-9</DOI>
    <KeywordList>
      <Keywords>Bayesian</Keywords>
      <Keywords>Developmental cascade</Keywords>
      <Keywords>High-dimensional</Keywords>
      <Keywords>Multiple endpoints</Keywords>
      <Keywords>Multivariate</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>Scoring</Keywords>
      <Keywords>ToxRefDB</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Guozhu Zhang</Name>
        <Affiliation>Bioinformatics Research Center, North Carolina State University, Raleigh, NC, USA. Electronic address: gzhang6@ncsu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Kyle R. Roell</Name>
        <Affiliation>Bioinformatics Research Center, North Carolina State University, Raleigh, NC, USA. Electronic address: krroell@ncsu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa Truong</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, Sinnhuber Aquatic Research Laboratory, Oregon State University, Corvallis, OR, USA. Electronic address: lisa.truong@oregonstate.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Robert L. Tanguay</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, Sinnhuber Aquatic Research Laboratory, Oregon State University, Corvallis, OR, USA. Electronic address: robert.tanguay@oregonstate.edu.</Affiliation>
      </Author>
      <Author>
        <Name>David M. Reif</Name>
        <Affiliation>Bioinformatics Research Center, North Carolina State University, Raleigh, NC, USA; Department of Biological Sciences, Center for Human Health and the Environment, North Carolina State University, Raleigh, NC, USA. Electronic address: dmreif@ncsu.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Conflicts of Interest: None declared.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Multidrug and toxin extrusion proteins mediate cellular transport of cadmium.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27871888</pubmedLink>
    <GrantList>
      <Grant>R01 GM099742</Grant>
      <Grant>U01 FD004320</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30362-3</DOI>
    <KeywordList>
      <Keywords>Cadmium</Keywords>
      <Keywords>Detoxification</Keywords>
      <Keywords>Kidney</Keywords>
      <Keywords>Multidrug and toxin extrusion protein</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>Transporter</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hong Yang</Name>
        <Affiliation>Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland at Baltimore, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Dong Guo</Name>
        <Affiliation>Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland at Baltimore, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Obinna N. Obianom</Name>
        <Affiliation>Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland at Baltimore, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Tong Su</Name>
        <Affiliation>Department of Oral Maxillofacial Surgery, the First Affiliated Hospital, Xiangya Medical School, Central South University, Hunan 410007, China.</Affiliation>
      </Author>
      <Author>
        <Name>James E. Polli</Name>
        <Affiliation>Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland at Baltimore, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Shu</Name>
        <Affiliation>Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland at Baltimore, MD, USA. Electronic address: yshu@rx.umaryland.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>Statement The authors declare that they have no financial or personal conflicts of interest that influenced, or could be perceived to have influenced, this work.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A silk peptide fraction restores cognitive function in AF64A-induced Alzheimer disease model rats by increasing expression of choline acetyltransferase gene.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27871887</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30363-5</DOI>
    <KeywordList>
      <Keywords>Acetylcholine</Keywords>
      <Keywords>Alzheimer disease</Keywords>
      <Keywords>Choline acetyltransferase</Keywords>
      <Keywords>Cognitive function</Keywords>
      <Keywords>Silk peptide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yeseul Cha</Name>
        <Affiliation>College of Veterinary Medicine, Veterinary Medical Center, Chungbuk National University, Cheongju, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sang Hoon Lee</Name>
        <Affiliation>Department of Food Science and Technology, Chungbuk National University, Cheongju, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Su Kil Jang</Name>
        <Affiliation>Division of Marine Molecular Biotechnology, Gangneung-Wonju National University, Gangneung, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Haiyu Guo</Name>
        <Affiliation>College of Veterinary Medicine, Veterinary Medical Center, Chungbuk National University, Cheongju, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Young Hwan Ban</Name>
        <Affiliation>College of Veterinary Medicine, Veterinary Medical Center, Chungbuk National University, Cheongju, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dongsun Park</Name>
        <Affiliation>College of Veterinary Medicine, Veterinary Medical Center, Chungbuk National University, Cheongju, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Gwi Yeong Jang</Name>
        <Affiliation>Department of Food Science and Technology, Chungbuk National University, Cheongju, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sungho Yeon</Name>
        <Affiliation>Department of Food Science and Technology, Chungbuk National University, Cheongju, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jeong Yong Lee</Name>
        <Affiliation>Worldway Co., Ltd., Sejong, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ehn Kyoung Choi</Name>
        <Affiliation>College of Veterinary Medicine, Veterinary Medical Center, Chungbuk National University, Cheongju, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seong Soo Joo</Name>
        <Affiliation>Division of Marine Molecular Biotechnology, Gangneung-Wonju National University, Gangneung, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Heon Sang Jeong</Name>
        <Affiliation>Department of Food Science and Technology, Chungbuk National University, Cheongju, Republic of Korea. Electronic address: hsjeong@cbu.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Yun Bae Kim</Name>
        <Affiliation>College of Veterinary Medicine, Veterinary Medical Center, Chungbuk National University, Cheongju, Republic of Korea. Electronic address: solar93@cbu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Obeticholic acid protects against carbon tetrachloride-induced acute liver injury and inflammation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27865854</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30355-6</DOI>
    <KeywordList>
      <Keywords>Acute liver injury</Keywords>
      <Keywords>Carbon tetrachloride (CCl(4))</Keywords>
      <Keywords>Farnesoid X receptor (FXR)</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Obeticholic acid</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Da Gang Zhang</Name>
        <Affiliation>First Affiliated Hospital, Anhui Medical University, Hefei 230022, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cheng Zhang</Name>
        <Affiliation>Department of Toxicology, Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Xian Wang</Name>
        <Affiliation>First Affiliated Hospital, Anhui Medical University, Hefei 230022, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bi Wei Wang</Name>
        <Affiliation>Department of Toxicology, Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hua Wang</Name>
        <Affiliation>Department of Toxicology, Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhi Hui Zhang</Name>
        <Affiliation>Department of Toxicology, Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Hua Chen</Name>
        <Affiliation>Department of Toxicology, Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Lu</Name>
        <Affiliation>Second Affiliated Hospital, Anhui Medical University, Hefei 230601, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Tao</Name>
        <Affiliation>Second Affiliated Hospital, Anhui Medical University, Hefei 230601, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jian Qing Wang</Name>
        <Affiliation>Second Affiliated Hospital, Anhui Medical University, Hefei 230601, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xi Chen</Name>
        <Affiliation>First Affiliated Hospital, Anhui Medical University, Hefei 230022, China.</Affiliation>
      </Author>
      <Author>
        <Name>De Xiang Xu</Name>
        <Affiliation>Department of Toxicology, Anhui Medical University, Hefei 230032, China. Electronic address: xudex@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Low doses of arsenic, via perturbing p53, promotes tumorigenesis" [Toxicol. Appl. Pharmacol. (2016) 98-104].</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27851896</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30354-4</DOI>
    <AuthorList>
      <Author>
        <Name>Suthakar Ganapathy</Name>
        <Affiliation>Center for Drug Development, Northeastern University, Boston, USA. Electronic address: s.ganapathy@neu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Li</Name>
        <Affiliation>The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China; The Institute of Clinic Sciences, Sahlgrenska Academy, Gothenburg, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Johan Fagman</Name>
        <Affiliation>The Institute of Clinic Sciences, Sahlgrenska Academy, Gothenburg, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Tianqi Yu</Name>
        <Affiliation>Center for Drug Development, Northeastern University, Boston, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Lafontant</Name>
        <Affiliation>Center for Drug Development, Northeastern University, Boston, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Guojun Zhang</Name>
        <Affiliation>The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Changyan Chen</Name>
        <Affiliation>The Institute of Clinic Sciences, Sahlgrenska Academy, Gothenburg, Sweden.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Single toxin dose-response models revisited.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27847315</pubmedLink>
    <GrantList>
      <Grant>P20 GM103534</Grant>
      <Grant>P41 RR001395</Grant>
      <Grant>P30 GM106394</Grant>
      <Grant>P42 ES007373</Grant>
      <Grant>P20 RR018787</Grant>
      <Grant>P30 CA023108</Grant>
      <Grant>UL1 TR001086</Grant>
      <Grant>P20 ES018175</Grant>
      <Grant>P20 GM103413</Grant>
      <Grant>P01 CA091597</Grant>
      <Grant>P01 ES022832</Grant>
      <Grant>P01 EB002180</Grant>
      <Grant>P01 CA190193</Grant>
      <Grant>R01 ES019324</Grant>
      <Grant>P20 GM104416</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30337-4</DOI>
    <KeywordList>
      <Keywords>Daphnia mortality acute tests</Keywords>
      <Keywords>Hill equation</Keywords>
      <Keywords>Logit</Keywords>
      <Keywords>Mortality function</Keywords>
      <Keywords>Probit</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Eugene Demidenko</Name>
        <Affiliation>Department of Biomedical Data Science, Geisel School of Medicine at Dartmouth, Hanover, NH03756, USA. Electronic address: eugened@dartmouth.edu.</Affiliation>
      </Author>
      <Author>
        <Name>S. P. Glaholt</Name>
        <Affiliation>Indiana University, School of Public &amp; Environmental Affairs, Bloomington, IN47405, USA; Department of Biological Sciences, Dartmouth College, Hanover, NH03755, USA. Electronic address: sglaholt@indiana.edu.</Affiliation>
      </Author>
      <Author>
        <Name>E. Kyker-Snowman</Name>
        <Affiliation>Department of Natural Resources and the Environment, University of New Hampshire, Durham, NH03824, USA. Electronic address: ek2002@wildcats.unh.edu.</Affiliation>
      </Author>
      <Author>
        <Name>J. R. Shaw</Name>
        <Affiliation>Indiana University, School of Public &amp; Environmental Affairs, Bloomington, IN47405, USA. Electronic address: joeshaw@indiana.edu.</Affiliation>
      </Author>
      <Author>
        <Name>C. Y. Chen</Name>
        <Affiliation>Department of Biological Sciences, Dartmouth College, Hanover, NH03755, USA. Electronic address: Celia.Y.Chen@dartmouth.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Sibutramine provokes apoptosis of aortic endothelial cells through altered production of reactive oxygen and nitrogen species.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27838152</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30338-6</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Endothelial cell</Keywords>
      <Keywords>Nitric oxide</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
      <Keywords>Sibutramine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yoshifumi Morikawa</Name>
        <Affiliation>Forensic Science Laboratory, Gifu Prefectural Police Headquarters, Gifu 500-8501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Akinobu Shibata</Name>
        <Affiliation>Laboratory of Biochemistry, Gifu Pharmaceutical University, Gifu 501-1196, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Naoko Okumura</Name>
        <Affiliation>Laboratory of Biochemistry, Gifu Pharmaceutical University, Gifu 501-1196, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Akira Ikari</Name>
        <Affiliation>Laboratory of Biochemistry, Gifu Pharmaceutical University, Gifu 501-1196, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yasuhide Sasajima</Name>
        <Affiliation>Forensic Science Laboratory, Gifu Prefectural Police Headquarters, Gifu 500-8501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Koichi Suenami</Name>
        <Affiliation>Forensic Science Laboratory, Gifu Prefectural Police Headquarters, Gifu 500-8501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kiyohito Sato</Name>
        <Affiliation>Forensic Science Laboratory, Gifu Prefectural Police Headquarters, Gifu 500-8501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuji Takekoshi</Name>
        <Affiliation>Forensic Science Laboratory, Gifu Prefectural Police Headquarters, Gifu 500-8501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Ossama El-Kabbani</Name>
        <Affiliation>Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Toshiyuki Matsunaga</Name>
        <Affiliation>Laboratory of Biochemistry, Gifu Pharmaceutical University, Gifu 501-1196, Japan. Electronic address: matsunagat@gifu-pu.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Estimation of iodine nutrition and thyroid function status in late-gestation pregnant women in the United States: Development and application of a population-based pregnancy model.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27818216</pubmedLink>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30335-0</DOI>
    <KeywordList>
      <Keywords>Biologically-base dose-response modeling</Keywords>
      <Keywords>Biomonitoring</Keywords>
      <Keywords>Iodine</Keywords>
      <Keywords>Reverse dosimetry</Keywords>
      <Keywords>Thyroid hormones</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>A. Lumen</Name>
        <Affiliation>Division of Biochemical Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USA. Electronic address: Annie.Lumen@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>N. I. George</Name>
        <Affiliation>Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, USA. Electronic address: Nysia.George@fda.hhs.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Proteomics analysis of dendritic cell activation by contact allergens reveals possible biomarkers regulated by Nrf2.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27816475</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30336-2</DOI>
    <KeywordList>
      <Keywords>2D-PAGE</Keywords>
      <Keywords>Allergic contact dermatitis</Keywords>
      <Keywords>Dendritic cell</Keywords>
      <Keywords>Keap1/Nrf2</Keywords>
      <Keywords>Proteomics</Keywords>
      <Keywords>Sensitization</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Franz Mussotter</Name>
        <Affiliation>German Federal Institute for Risk Assessment (BfR), Department of Chemical and Product Safety, Berlin, Germany. Electronic address: franz.mussotter@bfr.bund.de.</Affiliation>
      </Author>
      <Author>
        <Name>Janina Melanie Tomm</Name>
        <Affiliation>Helmholtz Centre for Environmental Research (UFZ), Department of Molecular Systems Biology, Leipzig, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Zeina El Ali</Name>
        <Affiliation>INSERM UMR 996, Univ Paris-Sud, Université Paris-Saclay, Chátenay-Malabry, France.</Affiliation>
      </Author>
      <Author>
        <Name>Marc Pallardy</Name>
        <Affiliation>INSERM UMR 996, Univ Paris-Sud, Université Paris-Saclay, Chátenay-Malabry, France.</Affiliation>
      </Author>
      <Author>
        <Name>Saadia Kerdine-Römer</Name>
        <Affiliation>INSERM UMR 996, Univ Paris-Sud, Université Paris-Saclay, Chátenay-Malabry, France.</Affiliation>
      </Author>
      <Author>
        <Name>Mario Götz</Name>
        <Affiliation>German Federal Institute for Risk Assessment (BfR), Department of Chemical and Product Safety, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Martin von Bergen</Name>
        <Affiliation>Helmholtz Centre for Environmental Research (UFZ), Department of Molecular Systems Biology, Leipzig, Germany; University of Leipzig, Institute of Biochemistry, Leipzig, Germany; Aalborg University, Department of Chemistry and Bioscience, Aalborg, Denmark.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Haase</Name>
        <Affiliation>German Federal Institute for Risk Assessment (BfR), Department of Chemical and Product Safety, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Luch</Name>
        <Affiliation>German Federal Institute for Risk Assessment (BfR), Department of Chemical and Product Safety, Berlin, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Regulation of steroid hormones and energy status with cysteamine and its effect on spermatogenesis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27815134</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30334-9</DOI>
    <KeywordList>
      <Keywords>Cysteamine</Keywords>
      <Keywords>Energy Status</Keywords>
      <Keywords>Spermatogenesis</Keywords>
      <Keywords>Steroid Hormone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yandi Wang</Name>
        <Affiliation>College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, PR China; Key Laboratory of Animal Reproduction and Germplasm Enhancement, Universities of Shandong, Qingdao 266109, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Zhao</Name>
        <Affiliation>Key Laboratory of Animal Reproduction and Germplasm Enhancement, Universities of Shandong, Qingdao 266109, PR China; College of Chemistry and Pharmaceutical Sciences, Qingdao Agricultural University, Qingdao 266109, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuai Yu</Name>
        <Affiliation>College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, PR China; Key Laboratory of Animal Reproduction and Germplasm Enhancement, Universities of Shandong, Qingdao 266109, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanni Feng</Name>
        <Affiliation>College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, PR China; Key Laboratory of Animal Reproduction and Germplasm Enhancement, Universities of Shandong, Qingdao 266109, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongfu Zhang</Name>
        <Affiliation>State Key Laboratory of Animal Nutrition, Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Kou</Name>
        <Affiliation>Shouguang Hongde Farmer Co., Weifang 262700, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Meiqiang Chu</Name>
        <Affiliation>College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, PR China; Key Laboratory of Animal Reproduction and Germplasm Enhancement, Universities of Shandong, Qingdao 266109, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Liantao Cui</Name>
        <Affiliation>College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, PR China; Key Laboratory of Animal Reproduction and Germplasm Enhancement, Universities of Shandong, Qingdao 266109, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lan Li</Name>
        <Affiliation>College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, PR China; Key Laboratory of Animal Reproduction and Germplasm Enhancement, Universities of Shandong, Qingdao 266109, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Pengfei Zhang</Name>
        <Affiliation>College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, PR China; College of Chemistry and Pharmaceutical Sciences, Qingdao Agricultural University, Qingdao 266109, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Shen</Name>
        <Affiliation>College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, PR China; Key Laboratory of Animal Reproduction and Germplasm Enhancement, Universities of Shandong, Qingdao 266109, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lingjiang Min</Name>
        <Affiliation>College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, PR China; Key Laboratory of Animal Reproduction and Germplasm Enhancement, Universities of Shandong, Qingdao 266109, PR China. Electronic address: mlj020963@hotmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Locomotor activity and tissue levels following acute administration of lambda- and gamma-cyhalothrin in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27794438</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30329-5</DOI>
    <KeywordList>
      <Keywords>Cyhalothrin</Keywords>
      <Keywords>Motor activity</Keywords>
      <Keywords>Neurotoxicity</Keywords>
      <Keywords>Pyrethroids</Keywords>
      <Keywords>Toxicokinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Virginia C. Moser</Name>
        <Affiliation>Toxicity Assessment Division, National Health Effects and Environmental Research Laboratory, Office of Research and Development, US Environmental Protection Agency, Research Triangle Park, NC, USA. Electronic address: Moser.ginger@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Zhiwei Liu</Name>
        <Affiliation>FMC Corporation, 701 Princeton South Corporate Center, Ewing, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Christopher Schlosser</Name>
        <Affiliation>Health Effects Division, Office of Pesticide Programs, Office of Chemical Safety and Pollution Prevention, US Environmental Protection Agency, Washington, DC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Terri L. Spanogle</Name>
        <Affiliation>FMC Corporation, 701 Princeton South Corporate Center, Ewing, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Appavu Chandrasekaran</Name>
        <Affiliation>FMC Corporation, 701 Princeton South Corporate Center, Ewing, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Katherine L. McDaniel</Name>
        <Affiliation>Toxicity Assessment Division, National Health Effects and Environmental Research Laboratory, Office of Research and Development, US Environmental Protection Agency, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cadmium modulates hematopoietic stem and progenitor cells and skews toward myelopoiesis in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27771405</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30317-9</DOI>
    <KeywordList>
      <Keywords>Cadmium</Keywords>
      <Keywords>Hematopoiesis</Keywords>
      <Keywords>Hematopoietic stem and progenitor cells</Keywords>
      <Keywords>Myelopoiesis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yandong Zhang</Name>
        <Affiliation>School of Public Health and Key Laboratory of Public Health, MOE, Fudan University, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xinchun Yu</Name>
        <Affiliation>School of Public Health and Key Laboratory of Public Health, MOE, Fudan University, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuhui Sun</Name>
        <Affiliation>Key Laboratory of Medical Molecular Virology, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qian Li</Name>
        <Affiliation>School of Public Health and Key Laboratory of Public Health, MOE, Fudan University, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yunli Xie</Name>
        <Affiliation>Insititute of Brain Sciences, Fudan University, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiang Li</Name>
        <Affiliation>Putuo District Center for Disease Control and Prevention, Shanghai 200062, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yifan Zhao</Name>
        <Affiliation>School of Public Health and Key Laboratory of Public Health, MOE, Fudan University, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianfeng Pei</Name>
        <Affiliation>School of Public Health and Key Laboratory of Public Health, MOE, Fudan University, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenmin Zhang</Name>
        <Affiliation>School of Public Health and Key Laboratory of Public Health, MOE, Fudan University, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Peng Xue</Name>
        <Affiliation>School of Public Health and Key Laboratory of Public Health, MOE, Fudan University, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhijun Zhou</Name>
        <Affiliation>School of Public Health and Key Laboratory of Public Health, MOE, Fudan University, Shanghai 200032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yubin Zhang</Name>
        <Affiliation>School of Public Health and Key Laboratory of Public Health, MOE, Fudan University, Shanghai 200032, China. Electronic address: yz001@fudan.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Occupational exposures at a polyvinyl chloride production facility are associated with significant changes to the plasma metabolome.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27765658</pubmedLink>
    <GrantList>
      <Grant>R03 DK107912</Grant>
      <Grant>P20 GM113226</Grant>
      <Grant>R01 DK054774</Grant>
      <Grant>K01 DK096042</Grant>
      <Grant>P50 AA024337</Grant>
      <Grant>K23 AA018399</Grant>
      <Grant>R01 AA023681</Grant>
      <Grant>R13 ES024661</Grant>
      <Grant>T35 ES014559</Grant>
      <Grant>R01 ES021375</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30302-7</DOI>
    <KeywordList>
      <Keywords>Hemangiosarcoma</Keywords>
      <Keywords>Metabolomics</Keywords>
      <Keywords>Occupational Health</Keywords>
      <Keywords>TASH</Keywords>
      <Keywords>Toxicant Associated Steatohepatitis</Keywords>
      <Keywords>Vinyl Chloride</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>John J. Guardiola</Name>
        <Affiliation>University of Louisville Department of Medicine, Louisville, KY 40206, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Juliane I. Beier</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Louisville, KY 40206, USA.</Affiliation>
      </Author>
      <Author>
        <Name>K. Cameron Falkner</Name>
        <Affiliation>Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Louisville, KY 40206, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Benjamin Wheeler</Name>
        <Affiliation>Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Louisville, KY 40206, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Craig James McClain</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Louisville, KY 40206, USA; Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Louisville, KY 40206, USA; The Robley Rex Veterans Affairs Medical Center, Louisville, KY, 40206, USA; The Kentucky One Health Jewish Hospital Liver Transplant Program, Louisville, KY 40202, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Matt Cave</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Louisville, KY 40206, USA; Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Louisville, KY 40206, USA; The Robley Rex Veterans Affairs Medical Center, Louisville, KY, 40206, USA; The Kentucky One Health Jewish Hospital Liver Transplant Program, Louisville, KY 40202, USA; Department of Biochemistry and Molecular Biology, Louisville, KY, 40202, USA. Electronic address: matt.cave@louisville.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Intraperitoneal exposure of whitefish to microcystin-LR induces rapid liver injury followed by regeneration and resilience to subsequent exposures.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27765657</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30315-5</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Cyanobacteria</Keywords>
      <Keywords>Fishes</Keywords>
      <Keywords>Histopathology</Keywords>
      <Keywords>Regeneration</Keywords>
      <Keywords>Tissue distribution</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Maciej Woźny</Name>
        <Affiliation>Department of Environmental Biotechnology, Faculty of Environmental Sciences, University of Warmia and Mazury in Olsztyn, ul. Słoneczna 45G, 10-709 Olsztyn, Poland. Electronic address: maciej.wozny@uwm.edu.pl.</Affiliation>
      </Author>
      <Author>
        <Name>Bogdan Lewczuk</Name>
        <Affiliation>Department of Histology and Embryology, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, ul. M. Oczapowskiego 13, 10-713 Olsztyn, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Natalia Ziółkowska</Name>
        <Affiliation>Department of Histology and Embryology, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, ul. M. Oczapowskiego 13, 10-713 Olsztyn, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Piotr Gomułka</Name>
        <Affiliation>Department of Ichthyology, Faculty of Environmental Sciences, University of Warmia and Mazury in Olsztyn, ul. M. Oczapowskiego 5, 10-719 Olsztyn, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Stefan Dobosz</Name>
        <Affiliation>Department of the Salmonid Research in Rutki, Inland Fisheries Institute in Olsztyn, Rutki, 83-330 Żukowo, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Alicja Łakomiak</Name>
        <Affiliation>Department of Environmental Biotechnology, Faculty of Environmental Sciences, University of Warmia and Mazury in Olsztyn, ul. Słoneczna 45G, 10-709 Olsztyn, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Maciej Florczyk</Name>
        <Affiliation>Department of Environmental Biotechnology, Faculty of Environmental Sciences, University of Warmia and Mazury in Olsztyn, ul. Słoneczna 45G, 10-709 Olsztyn, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Paweł Brzuzan</Name>
        <Affiliation>Department of Environmental Biotechnology, Faculty of Environmental Sciences, University of Warmia and Mazury in Olsztyn, ul. Słoneczna 45G, 10-709 Olsztyn, Poland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of a human recombinant alkaline phosphatase on renal hemodynamics, oxygenation and inflammation in two models of acute kidney injury.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27760303</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30316-7</DOI>
    <KeywordList>
      <Keywords>Acute kidney injury</Keywords>
      <Keywords>Alkaline phosphatase</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Ischemia-reperfusion</Keywords>
      <Keywords>Lipopolysaccharide</Keywords>
      <Keywords>Therapy</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Esther Peters</Name>
        <Affiliation>Department of Intensive Care Medicine, Radboud university medical center, PO Box 9101, Internal Mailbox 710, 6500 HB, Nijmegen, The Netherlands; Department of Pharmacology and Toxicology, Radboud university medical center, PO Box 9101, Internal Mailbox 149, 6500 HB, Nijmegen, The Netherlands. Electronic address: esther.peters@radboudumc.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Bülent Ergin</Name>
        <Affiliation>Department of Translational Physiology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. Electronic address: b.ergin@amc.uva.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Asli Kandil</Name>
        <Affiliation>Department of Biology, Faculty of Science, Istanbul University, PK 34134, Vezneciler, Istanbul, Turkey. Electronic address: aslikandil@istanbul.edu.tr.</Affiliation>
      </Author>
      <Author>
        <Name>Ebru Gurel-Gurevin</Name>
        <Affiliation>Department of Biology, Faculty of Science, Istanbul University, PK 34134, Vezneciler, Istanbul, Turkey. Electronic address: egurelgurevin@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea van Elsas</Name>
        <Affiliation>AM-Pharma, Rumpsterweg 6, 3981 AK, Bunnik, The Netherlands. Electronic address: a.vanelsas@am-pharma.com.</Affiliation>
      </Author>
      <Author>
        <Name>Rosalinde Masereeuw</Name>
        <Affiliation>Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, PO Box 80082, 3508 TB Utrecht, The Netherlands. Electronic address: r.masereeuw@uu.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Pickkers</Name>
        <Affiliation>Department of Intensive Care Medicine, Radboud university medical center, PO Box 9101, Internal Mailbox 710, 6500 HB, Nijmegen, The Netherlands. Electronic address: peter.pickkers@radboudumc.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Can Ince</Name>
        <Affiliation>Department of Translational Physiology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. Electronic address: c.ince@amc.uva.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Progressive effects of silver nanoparticles on hormonal regulation of reproduction in male rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27746313</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30314-3</DOI>
    <KeywordList>
      <Keywords>Reproductive toxicity</Keywords>
      <Keywords>Sex hormones</Keywords>
      <Keywords>Silver nanoparticles</Keywords>
      <Keywords>Steroid metabolism</Keywords>
      <Keywords>Steroidogenesis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>K. Dziendzikowska</Name>
        <Affiliation>Division of Nutrition Physiology, Department of Dietetics, Faculty of Human Nutrition and Consumer Science, Warsaw University of Life Sciences - SGGW, Nowoursynowska 159C, 02-776 Warsaw, Poland. Electronic address: k.dziendzikowska@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>A. Krawczyńska</Name>
        <Affiliation>Laboratory of Molecular Biology, The Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences, Instytucka 3, 05-110 Jabłonna, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>M. Oczkowski</Name>
        <Affiliation>Division of Nutrition Physiology, Department of Dietetics, Faculty of Human Nutrition and Consumer Science, Warsaw University of Life Sciences - SGGW, Nowoursynowska 159C, 02-776 Warsaw, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>T. Królikowski</Name>
        <Affiliation>Division of Nutrition Physiology, Department of Dietetics, Faculty of Human Nutrition and Consumer Science, Warsaw University of Life Sciences - SGGW, Nowoursynowska 159C, 02-776 Warsaw, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>K. Brzóska</Name>
        <Affiliation>Centre for Radiobiology and Biological Dosimetry, Institute of Nuclear Chemistry and Technology, Dorodna 16, 03-195 Warsaw, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>A. Lankoff</Name>
        <Affiliation>Centre for Radiobiology and Biological Dosimetry, Institute of Nuclear Chemistry and Technology, Dorodna 16, 03-195 Warsaw, Poland; Department of Radiobiology and Immunology, Institute of Biology, Jan Kochanowski University, Świetokrzyska 15, 25-406 Kielce, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>M. Dziendzikowski</Name>
        <Affiliation>Airworthiness Division, Air Force Institute of Technology, Ks. Boleslawa 6, 01-494 Warsaw, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>T. Stępkowski</Name>
        <Affiliation>Centre for Radiobiology and Biological Dosimetry, Institute of Nuclear Chemistry and Technology, Dorodna 16, 03-195 Warsaw, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>M. Kruszewski</Name>
        <Affiliation>Department of Medical Biology and Translational Research, Faculty of Medicine, University of Information Technology and Management, Sucharskiego 2, 35-225 Rzeszów, Poland; Department of Molecular Biology and Translational Research, Institute of Rural Health, Jaczewskiego 2, 20-090 Lublin, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>J. Gromadzka-Ostrowska</Name>
        <Affiliation>Division of Nutrition Physiology, Department of Dietetics, Faculty of Human Nutrition and Consumer Science, Warsaw University of Life Sciences - SGGW, Nowoursynowska 159C, 02-776 Warsaw, Poland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nerve cell-mimicking liposomes as biosensor for botulinum neurotoxin complete physiological activity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27743862</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30311-8</DOI>
    <KeywordList>
      <Keywords>Animal testing alternatives</Keywords>
      <Keywords>Botulinum neurotoxin</Keywords>
      <Keywords>In vitro</Keywords>
      <Keywords>Liposome</Keywords>
      <Keywords>Potency testing</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Oliver G. Weingart</Name>
        <Affiliation>Institute for Food, Nutrition and Health, ETH Zurich, Schmelzbergstrasse 7, CH-8092 Zurich, Switzerland. Electronic address: Oliver.Weingart@hest.ethz.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Martin J. Loessner</Name>
        <Affiliation>Institute for Food, Nutrition and Health, ETH Zurich, Schmelzbergstrasse 7, CH-8092 Zurich, Switzerland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Up-regulation of granzyme B and perforin by staphylococcal enterotoxin C2 mutant induces enhanced cytotoxicity in Hepa1-6 cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27742270</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30310-6</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Granzyme B</Keywords>
      <Keywords>Perforin</Keywords>
      <Keywords>Staphylococcal enterotoxins</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Guojun Zhang</Name>
        <Affiliation>Institute of Applied Ecology, Chinese Academy of Sciences, No.72 Wenhua Road Shenhe Dis., Shenyang, Liaoning, China; University of Chinese Academy of Sciences, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mingkai Xu</Name>
        <Affiliation>Institute of Applied Ecology, Chinese Academy of Sciences, No.72 Wenhua Road Shenhe Dis., Shenyang, Liaoning, China. Electronic address: mkxu@iae.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Huiwen Zhang</Name>
        <Affiliation>Institute of Applied Ecology, Chinese Academy of Sciences, No.72 Wenhua Road Shenhe Dis., Shenyang, Liaoning, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yubo Song</Name>
        <Affiliation>Institute of Applied Ecology, Chinese Academy of Sciences, No.72 Wenhua Road Shenhe Dis., Shenyang, Liaoning, China; University of Chinese Academy of Sciences, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jian Wang</Name>
        <Affiliation>Institute of Applied Ecology, Chinese Academy of Sciences, No.72 Wenhua Road Shenhe Dis., Shenyang, Liaoning, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chenggang Zhang</Name>
        <Affiliation>Institute of Applied Ecology, Chinese Academy of Sciences, No.72 Wenhua Road Shenhe Dis., Shenyang, Liaoning, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>High risks of lung disease associated with early-life and moderate lifetime arsenic exposure in northern Chile.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27725189</pubmedLink>
    <GrantList>
      <Grant>P42 ES004705</Grant>
      <Grant>R01 ES014032</Grant>
      <Grant>R01 ES017463</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30307-6</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Chile</Keywords>
      <Keywords>Drinking water</Keywords>
      <Keywords>Early life</Keywords>
      <Keywords>Long-term exposures</Keywords>
      <Keywords>Lung function</Keywords>
      <Keywords>Pulmonary disease</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Craig Steinmaus</Name>
        <Affiliation>Arsenic Health Effects Research Program, UC Berkeley School of Public Health, Berkeley, CA, USA. Electronic address: craigs@berkeley.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Catterina Ferreccio</Name>
        <Affiliation>School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile; Advanced Center for Chronic Diseases (ACCDiS), FONDAP, Santiago, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Johanna Acevedo</Name>
        <Affiliation>School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile; Advanced Center for Chronic Diseases (ACCDiS), FONDAP, Santiago, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>John R. Balmes</Name>
        <Affiliation>Arsenic Health Effects Research Program, UC Berkeley School of Public Health, Berkeley, CA, USA; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jane Liaw</Name>
        <Affiliation>Arsenic Health Effects Research Program, UC Berkeley School of Public Health, Berkeley, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia Troncoso</Name>
        <Affiliation>Laboratorio de Anatomía Patológica Dra. Patricia Troncoso, Iquique, Chile; Hospital Felix Bulnes, Departmento de Anatomía Patológica, Santiago, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>David C. Dauphiné</Name>
        <Affiliation>Arsenic Health Effects Research Program, UC Berkeley School of Public Health, Berkeley, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anthony Nardone</Name>
        <Affiliation>Global Health Sciences Program, University of California, San Francisco, San Francisco, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Allan H. Smith</Name>
        <Affiliation>Arsenic Health Effects Research Program, UC Berkeley School of Public Health, Berkeley, CA, USA.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>The authors of “High risks of lung disease associated with early-life and moderate lifetime arsenic exposure in northern Chile” declare they have no conflicts of interest. Dr. CraigSteinmaus has done consulting work on the health effects of arsenic for industry and environmental organizations.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>TRPA1 mediates changes in heart rate variability and cardiac mechanical function in mice exposed to acrolein.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27746315</pubmedLink>
    <GrantList>
      <Grant>T32 ES007126</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30309-X</DOI>
    <KeywordList>
      <Keywords>Acrolein</Keywords>
      <Keywords>Air pollution</Keywords>
      <Keywords>Arrhythmia</Keywords>
      <Keywords>Cardiac</Keywords>
      <Keywords>Heart rate variability</Keywords>
      <Keywords>TRPA1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nicole Kurhanewicz</Name>
        <Affiliation>Curriculum in Toxicology, School of Medicine, University of North Carolina, Chapel Hill, NC 27599, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Rachel McIntosh-Kastrinsky</Name>
        <Affiliation>Department of Environmental Sciences and Engineering, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC 27599, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Haiyan Tong</Name>
        <Affiliation>Environmental Public Health Division, National Health and Environmental Effects Research Laboratory, US Environmental Protection Agency, Research Triangle Park, NC 27711, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Allen Ledbetter</Name>
        <Affiliation>Environmental Public Health Division, National Health and Environmental Effects Research Laboratory, US Environmental Protection Agency, Research Triangle Park, NC 27711, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Leon Walsh</Name>
        <Affiliation>Environmental Public Health Division, National Health and Environmental Effects Research Laboratory, US Environmental Protection Agency, Research Triangle Park, NC 27711, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Aimen Farraj</Name>
        <Affiliation>Environmental Public Health Division, National Health and Environmental Effects Research Laboratory, US Environmental Protection Agency, Research Triangle Park, NC 27711, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mehdi Hazari</Name>
        <Affiliation>Environmental Public Health Division, National Health and Environmental Effects Research Laboratory, US Environmental Protection Agency, Research Triangle Park, NC 27711, United States. Electronic address: hazari.mehdi@epa.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Identification of the key pathway of oxazolinoanthracyclines mechanism of action in cells derived from human solid tumors.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27780733</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30327-1</DOI>
    <KeywordList>
      <Keywords>Anticancer drug</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Necrosis</Keywords>
      <Keywords>Oxazolinoanthracycline</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marta Denel-Bobrowska</Name>
        <Affiliation>Department of Medical Biophysics, Institute of Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland. Electronic address: mdenel@biol.uni.lodz.pl.</Affiliation>
      </Author>
      <Author>
        <Name>Małgorzata Łukawska</Name>
        <Affiliation>Department of Modified Antibiotics, Institute of Biotechnology and Antibiotics, 5 Staroscinska St., 02-516 Warsaw, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Aneta Rogalska</Name>
        <Affiliation>Department of Medical Biophysics, Institute of Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Ewa Forma</Name>
        <Affiliation>Department of Cytobiochemistry, Institute of Biochemistry, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Magdalena Bryś</Name>
        <Affiliation>Department of Cytobiochemistry, Institute of Biochemistry, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Irena Oszczapowicz</Name>
        <Affiliation>Department of Modified Antibiotics, Institute of Biotechnology and Antibiotics, 5 Staroscinska St., 02-516 Warsaw, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Agnieszka Marczak</Name>
        <Affiliation>Department of Medical Biophysics, Institute of Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/143, 90-236 Lodz, Poland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inhibition of glycogen synthase kinase 3beta ameliorates triptolide-induced acute cardiac injury by desensitizing mitochondrial permeability transition.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27751939</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30308-8</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Cardioprotection</Keywords>
      <Keywords>GSK-3β</Keywords>
      <Keywords>Mitochondrial permeability transition pore</Keywords>
      <Keywords>SB 216763</Keywords>
      <Keywords>Triptolide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wenwen Wang</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanqin Yang</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhewen Xiong</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiamin Kong</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xinlu Fu</Name>
        <Affiliation>Laboratory Animals Center, Sun Yat-sen University, Guangzhou 510006, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Feihai Shen</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, PR China. Electronic address: shenfh3@mail.sysu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Zhiying Huang</Name>
        <Affiliation>School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, PR China. Electronic address: hzhiying@mail.sysu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Carvedilol suppresses circulating and hepatic IL-6 responsible for hepatocarcinogenesis of chronically damaged liver in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27746314</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30313-1</DOI>
    <KeywordList>
      <Keywords>CCL(4)</Keywords>
      <Keywords>Carvedilol</Keywords>
      <Keywords>E &amp; N-cadherin</Keywords>
      <Keywords>Hepatic cirrhosis</Keywords>
      <Keywords>Hepatocellular cancer</Keywords>
      <Keywords>IL-6</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mohamed Balaha</Name>
        <Affiliation>Pharmacology Department, Faculty of Medicine, Tanta University, El-Gish Street, Postal No. 31527 Tanta, Egypt. Electronic address: Mohamed.Balaha@Med.Tanta.Edu.Eg.</Affiliation>
      </Author>
      <Author>
        <Name>Samah Kandeel</Name>
        <Affiliation>Histology Department, Faculty of Medicine, Tanta University, El-Gish Street, Postal No. 31527 Tanta, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Waleed Barakat</Name>
        <Affiliation>Pharmacology Department, Faculty of Medicine, Tanta University, El-Gish Street, Postal No. 31527 Tanta, Egypt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>UDCA and CDCA alleviate 17α-ethinylestradiol-induced cholestasis through PKA-AMPK pathways in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27743861</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30312-X</DOI>
    <KeywordList>
      <Keywords>AMPK</Keywords>
      <Keywords>CDCA</Keywords>
      <Keywords>ICP</Keywords>
      <Keywords>PKA</Keywords>
      <Keywords>UDCA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiaojiaoyang Li</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zihang Yuan</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Runping Liu</Name>
        <Affiliation>Department of Microbiology and Immunology, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hozeifa M. Hassan</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing, China; Department of Pharmacology, Faculty of Pharmacy, University of Gezira, Wad-Medani, Sudan.</Affiliation>
      </Author>
      <Author>
        <Name>Hang Yang</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rong Sun</Name>
        <Affiliation>Shandong Research Academy of Traditional Chinese Medicine, Jinan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Luyong Zhang</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing, China; Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, Nanjing, China. Electronic address: lyzhang@cpu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenzhou Jiang</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing, China; Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, Nanjing, China. Electronic address: beaglejiang@cpu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Estimation of human percutaneous bioavailability for two novel brominated flame retardants, 2-ethylhexyl 2,3,4,5-tetrabromobenzoate (EH-TBB) and bis(2-ethylhexyl) tetrabromophthalate (BEH-TEBP).</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27732871</pubmedLink>
    <GrantList>
      <Grant>Z99 CA999999</Grant>
      <Grant>ZIA BC011476-01</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30306-4</DOI>
    <KeywordList>
      <Keywords>2-Ethylhexyl 2–3,4,5-tetrabromobenzoate</Keywords>
      <Keywords>Bis(2-ethylhexyl) tetrabromophthalate</Keywords>
      <Keywords>Brominated flame retardant</Keywords>
      <Keywords>Dermal bioavailability</Keywords>
      <Keywords>Parallelogram method</Keywords>
      <Keywords>Persistent organic pollutant</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gabriel A. Knudsen</Name>
        <Affiliation>NCI Laboratory of Toxicology and Toxicokinetics, 111 T W Alexander Dr., Research Triangle Park, NC, USA. Electronic address: gabriel.knudsen@nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Michael F. Hughes</Name>
        <Affiliation>Integrated Systems Toxicology Division, National Health and Environmental Effects Research Laboratory, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. Michael Sanders</Name>
        <Affiliation>NCI Laboratory of Toxicology and Toxicokinetics, 111 T W Alexander Dr., Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Samantha M. Hall</Name>
        <Affiliation>NCI Laboratory of Toxicology and Toxicokinetics, 111 T W Alexander Dr., Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Linda S. Birnbaum</Name>
        <Affiliation>NCI Laboratory of Toxicology and Toxicokinetics, 111 T W Alexander Dr., Research Triangle Park, NC, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Omeprazole induces heme oxygenase-1 in fetal human pulmonary microvascular endothelial cells via hydrogen peroxide-independent Nrf2 signaling pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27725188</pubmedLink>
    <GrantList>
      <Grant>R01 ES009132</Grant>
      <Grant>K08 HD073323</Grant>
      <Grant>R01 ES019689</Grant>
      <Grant>R01 HL129794</Grant>
      <Grant>R01 HL087174</Grant>
      <Grant>R01 HL112516</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30303-9</DOI>
    <KeywordList>
      <Keywords>Aryl hydrocarbon receptor</Keywords>
      <Keywords>Fetal human pulmonary microvascular endothelial cells</Keywords>
      <Keywords>Heme oxygenase-1</Keywords>
      <Keywords>Hydrogen peroxide</Keywords>
      <Keywords>Nuclear factor erythroid 2-related factor 2</Keywords>
      <Keywords>Omeprazole</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ananddeep Patel</Name>
        <Affiliation>Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, TX 77030, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Shaojie Zhang</Name>
        <Affiliation>Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, TX 77030, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Amrit Kumar Shrestha</Name>
        <Affiliation>Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, TX 77030, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Paramahamsa Maturu</Name>
        <Affiliation>Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, TX 77030, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Bhagavatula Moorthy</Name>
        <Affiliation>Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, TX 77030, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Binoy Shivanna</Name>
        <Affiliation>Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, TX 77030, United States. Electronic address: shivanna@bcm.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Identification of gene expression profiling associated with erlotinib-related skin toxicity in pancreatic adenocarcinoma patients.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27720938</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30304-0</DOI>
    <KeywordList>
      <Keywords>Erlotinib</Keywords>
      <Keywords>Microarray</Keywords>
      <Keywords>Pancreatic ductal adenocarcinoma</Keywords>
      <Keywords>Skin rash</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Octavio Caba</Name>
        <Affiliation>Department of Health Sciences, University of Jaen, Jaen, Spain. Electronic address: ocaba@ujaen.es.</Affiliation>
      </Author>
      <Author>
        <Name>Antonio Irigoyen</Name>
        <Affiliation>Department of Medical Oncology, Virgen de la Salud Hospital, Toledo, Spain. Electronic address: antonioirigoyen@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Cristina Jimenez-Luna</Name>
        <Affiliation>Institute of Biopathology and Regenerative Medicine (IBIMER), Center of Biomedical Research (CIBM), University of Granada, Granada, Spain. Electronic address: crisjilu@ugr.es.</Affiliation>
      </Author>
      <Author>
        <Name>Manuel Benavides</Name>
        <Affiliation>Department of Medical Oncology, Virgen de la Victoria Hospital, Malaga, Spain. Electronic address: manuel.benavides.sspa@juntadeandalucia.es.</Affiliation>
      </Author>
      <Author>
        <Name>Francisco M. Ortuño</Name>
        <Affiliation>Department of Computer Architecture and Computer Technology, Research Center for Information and Communications Technologies, University of Granada, Granada, Spain. Electronic address: fortuno@ugr.es.</Affiliation>
      </Author>
      <Author>
        <Name>Javier Gallego</Name>
        <Affiliation>Department of Medical Oncology, General Universitario de Elche Hospital, Alicante, Spain. Electronic address: j.gallegoplazas@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ignacio Rojas</Name>
        <Affiliation>Department of Computer Architecture and Computer Technology, Research Center for Information and Communications Technologies, University of Granada, Granada, Spain. Electronic address: irojas@ugr.es.</Affiliation>
      </Author>
      <Author>
        <Name>Carmen Guillen-Ponce</Name>
        <Affiliation>Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid, Spain. Electronic address: carmen.guillen@salud.madrid.org.</Affiliation>
      </Author>
      <Author>
        <Name>Carolina Torres</Name>
        <Affiliation>Department of Medicine, Division of Gastroenterology and Hepatology, University of Illinois at Chicago, Chicago, IL, USA. Electronic address: ctorres@uic.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Enrique Aranda</Name>
        <Affiliation>Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Córdoba, Spain. Electronic address: enrique.aranda@imibic.org.</Affiliation>
      </Author>
      <Author>
        <Name>Jose Prados</Name>
        <Affiliation>Institute of Biopathology and Regenerative Medicine (IBIMER), Center of Biomedical Research (CIBM), University of Granada, Granada, Spain. Electronic address: jcprados@ugr.es.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Role of dietary fatty acids in liver injury caused by vinyl chloride metabolites in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27693805</pubmedLink>
    <GrantList>
      <Grant>R03 DK107912</Grant>
      <Grant>U01 AA021893</Grant>
      <Grant>U01 AA021901</Grant>
      <Grant>P20 GM113226</Grant>
      <Grant>K01 DK096042</Grant>
      <Grant>P50 AA024337</Grant>
      <Grant>T32 ES011564</Grant>
      <Grant>T35 ES014559</Grant>
      <Grant>R01 AA023681</Grant>
      <Grant>R01 AA021978</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30292-7</DOI>
    <KeywordList>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>PVC</Keywords>
      <Keywords>Plastic</Keywords>
      <Keywords>Saturated fat</Keywords>
      <Keywords>TASH</Keywords>
      <Keywords>Unsaturated fat</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lisanne C. Anders</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY 40292, USA; Department of Medicine, University of Louisville Health Sciences Center, Louisville, KY 40292, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Heegook Yeo</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY 40292, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brenna R. Kaelin</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY 40292, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anna L. Lang</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY 40292, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Adrienne M. Bushau</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY 40292, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Amanda N. Douglas</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY 40292, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Matt Cave</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY 40292, USA; Department of Medicine, University of Louisville Health Sciences Center, Louisville, KY 40292, USA; Hepatobiology and Toxicology Program, University of Louisville Health Sciences Center, Louisville, KY 40292, USA; Diabetes and Obesity Center, University of Louisville Health Sciences Center, Louisville, KY 40292, USA; Robley Rex Louisville VAMC, Louisville, KY 40206, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gavin E. Arteel</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY 40292, USA; Hepatobiology and Toxicology Program, University of Louisville Health Sciences Center, Louisville, KY 40292, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Craig J. McClain</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY 40292, USA; Department of Medicine, University of Louisville Health Sciences Center, Louisville, KY 40292, USA; Hepatobiology and Toxicology Program, University of Louisville Health Sciences Center, Louisville, KY 40292, USA; Diabetes and Obesity Center, University of Louisville Health Sciences Center, Louisville, KY 40292, USA; Robley Rex Louisville VAMC, Louisville, KY 40206, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Juliane I. Beier</Name>
        <Affiliation>Department of Pharmacology and Toxicology, University of Louisville Health Sciences Center, Louisville, KY 40292, USA; Hepatobiology and Toxicology Program, University of Louisville Health Sciences Center, Louisville, KY 40292, USA. Electronic address: juliane.beier@louisville.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) increases necroinflammation and hepatic stellate cell activation but does not exacerbate experimental liver fibrosis in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27693115</pubmedLink>
    <GrantList>
      <Grant>P20 GM103408</Grant>
      <Grant>P20 GM109095</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30291-5</DOI>
    <KeywordList>
      <Keywords>Collagen</Keywords>
      <Keywords>Fibrosis</Keywords>
      <Keywords>Hepatic stellate cell</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>TCDD</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cheri L. Lamb</Name>
        <Affiliation>Biomolecular Sciences Graduate Program, Boise State University, Boise, ID 83725, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Giovan N. Cholico</Name>
        <Affiliation>Biomolecular Sciences Graduate Program, Boise State University, Boise, ID 83725, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Xinzhu Pu</Name>
        <Affiliation>Biomolecular Research Center, Boise State University, Boise, ID 83725, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Gerald D. Hagler</Name>
        <Affiliation>Department of Biological Sciences, Boise State University, Boise, ID 83725, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Kenneth A. Cornell</Name>
        <Affiliation>Biomolecular Sciences Graduate Program, Boise State University, Boise, ID 83725, United States; Biomolecular Research Center, Boise State University, Boise, ID 83725, United States; Department of Chemistry and Biochemistry, Boise State University, Boise, ID 83725, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Kristen A. Mitchell</Name>
        <Affiliation>Biomolecular Sciences Graduate Program, Boise State University, Boise, ID 83725, United States; Department of Biological Sciences, Boise State University, Boise, ID 83725, United States. Electronic address: kristenmitchell@boisestate.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dapoxetine attenuates testosterone-induced prostatic hyperplasia in rats by the regulation of inflammatory and apoptotic proteins.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27687055</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30290-3</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Benign prostatic hyperplasia</Keywords>
      <Keywords>Dapoxetine</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Proliferating cell nuclear antigen</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rabab H. Sayed</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt. Electronic address: rabab.sayed@pharma.cu.edu.eg.</Affiliation>
      </Author>
      <Author>
        <Name>Muhammed A. Saad</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Ayman E. El-Sahar</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of Trans-Resveratrol on hyperglycemia-induced abnormal spermatogenesis, DNA damage and alterations in poly (ADP-ribose) polymerase signaling in rat testis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27687054</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30289-7</DOI>
    <KeywordList>
      <Keywords>Cell survival</Keywords>
      <Keywords>DNA damage</Keywords>
      <Keywords>Germ cell toxicity</Keywords>
      <Keywords>Glucotoxicity</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Parthanatos</Keywords>
      <Keywords>Type 1 diabetes mellitus</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ala Abdelali</Name>
        <Affiliation>Department of Anatomy, Faculty of Medicine, Kuwait University.</Affiliation>
      </Author>
      <Author>
        <Name>Maie Al-Bader</Name>
        <Affiliation>Department of Physiology, Faculty of Medicine, Kuwait University.</Affiliation>
      </Author>
      <Author>
        <Name>Narayana Kilarkaje</Name>
        <Affiliation>Department of Anatomy, Faculty of Medicine, Kuwait University. Electronic address: knarayana@hsc.edu.kw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A microtubule inhibitor, ABT-751, induces autophagy and delays apoptosis in Huh-7 cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27678524</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30287-3</DOI>
    <KeywordList>
      <Keywords>ABT-751</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Autophagy</Keywords>
      <Keywords>Huh-7</Keywords>
      <Keywords>Microtubule</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ren Jie Wei</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan; Department of Pathology, Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Su Shuan Lin</Name>
        <Affiliation>Department of Pathology, Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Ren Wu</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Lih Ren Chen</Name>
        <Affiliation>Department of Biotechnology, Southern Taiwan University of Science and Technology, Tainan, Taiwan; Division of Physiology, Livestock Research Institute, Council of Agriculture, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chien Feng Li</Name>
        <Affiliation>Department of Biotechnology, Southern Taiwan University of Science and Technology, Tainan, Taiwan; Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan; National Institute of Cancer Research, National Health Research Institute, Tainan, Taiwan; Institute of Clinical Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Han De Chen</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chien Ting Chou</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ya Chun Chen</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Shih Shin Liang</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan; Department of Biotechnology, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Shang Tao Chien</Name>
        <Affiliation>Department of Pathology, Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yow Ling Shiue</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan; Department of Biological Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan; Doctoral Degree Program in Marine Biotechnology, National Sun Yat-sen University, Kaohsiung, Taiwan. Electronic address: ylshiue@mail.nsysu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Characterization of heme oxygenase and biliverdin reductase gene expression in zebrafish (Danio rerio): Basal expression and response to pro-oxidant exposures.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27671773</pubmedLink>
    <GrantList>
      <Grant>R00 ES017044</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30288-5</DOI>
    <KeywordList>
      <Keywords>Biliverdin reductase</Keywords>
      <Keywords>Cadmium</Keywords>
      <Keywords>Heme oxygenase</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>Pro-oxidant</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Andrew Holowiecki</Name>
        <Affiliation>Department of Biological Sciences, University of Alabama, Tuscaloosa, AL 35487, USA; Molecular Cardiovascular Biology Division and Heart Institute, Cincinnati Children's Research Foundation, Cincinnati, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Britton O'Shields</Name>
        <Affiliation>Department of Biological Sciences, University of Alabama, Tuscaloosa, AL 35487, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew J. Jenny</Name>
        <Affiliation>Department of Biological Sciences, University of Alabama, Tuscaloosa, AL 35487, USA. Electronic address: mjjenny@ua.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>There are no competing interests.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dietary flavonoid derivatives enhance chemotherapeutic effect by inhibiting the DNA damage response pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27664008</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30285-X</DOI>
    <KeywordList>
      <Keywords>Chemotherapy sensitizer</Keywords>
      <Keywords>Chk1</Keywords>
      <Keywords>Cisplatin</Keywords>
      <Keywords>DNA damage response</Keywords>
      <Keywords>Dietary flavonoids</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ching Ying Kuo</Name>
        <Affiliation>Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>István Zupkó</Name>
        <Affiliation>Department of Pharmacodynamics and Biopharmacy, University of Szeged, Eötvös Utca 6, Szeged H-6720, Hungary.</Affiliation>
      </Author>
      <Author>
        <Name>Fang Rong Chang</Name>
        <Affiliation>Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Attila Hunyadi</Name>
        <Affiliation>Institute of Pharmacognosy, Faculty of Pharmacy, University of Szeged, Eötvös Utca 6, Szeged H-6720, Hungary.</Affiliation>
      </Author>
      <Author>
        <Name>Chin Chung Wu</Name>
        <Affiliation>Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Teng Song Weng</Name>
        <Affiliation>Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Chun Wang</Name>
        <Affiliation>Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 80708, Taiwan; PhD Program in Translational Medicine, College of Medicine and PhD Program in Toxicology, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 80708, Taiwan; Research Center for Natural Product and Drug Development, Kaohsiung Medical University, Kaohsiung 80708, Taiwan; Translational Research Center and Cancer Center, Kaohsiung Medical University Hospital, Kaohsiung 80756, Taiwan; Department of Marine Biotechnology and Resources, National Sun Yat-Sen University, Kaohsiung 80424, Taiwan; Department of Fragrance and Cosmetic Science, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 80708, Taiwan. Electronic address: wanghc@kmu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Downregulation of NEDD9 by apigenin suppresses migration, invasion, and metastasis of colorectal cancer cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27664007</pubmedLink>
    <GrantList>
      <Grant>P30 CA177558</Grant>
      <Grant>R01 AA017226</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30282-4</DOI>
    <KeywordList>
      <Keywords>Apigenin</Keywords>
      <Keywords>Colorectal cancer</Keywords>
      <Keywords>Invasion</Keywords>
      <Keywords>Metastasis</Keywords>
      <Keywords>Migration</Keywords>
      <Keywords>NEDD9</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jin Dai</Name>
        <Affiliation>Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Peter G. Van Wie</Name>
        <Affiliation>Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Leonard Yenwong Fai</Name>
        <Affiliation>Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Donghern Kim</Name>
        <Affiliation>Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lei Wang</Name>
        <Affiliation>Center for Research on Environmental Disease, University of Kentucky, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Pratheeshkumar Poyil</Name>
        <Affiliation>Center for Research on Environmental Disease, University of Kentucky, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jia Luo</Name>
        <Affiliation>Department of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zhuo Zhang</Name>
        <Affiliation>Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY 40536, USA. Electronic address: Zhuo.Zhang@uky.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Differential modulation of FXR activity by chlorophacinone and ivermectin analogs.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27773686</pubmedLink>
    <GrantList>
      <Grant>ZIA TR000038-01</Grant>
      <Grant>ZIA TR000038-02</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30326-X</DOI>
    <KeywordList>
      <Keywords>Chlorophacinone</Keywords>
      <Keywords>Diphacinone</Keywords>
      <Keywords>Farnesoid X receptor</Keywords>
      <Keywords>Ivermetin</Keywords>
      <Keywords>Moxidectin</Keywords>
      <Keywords>Nuclear receptor</Keywords>
      <Keywords>Tox21</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chia Wen Hsu</Name>
        <Affiliation>NIH Chemical Genomics Center, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jui Hua Hsieh</Name>
        <Affiliation>National Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ruili Huang</Name>
        <Affiliation>NIH Chemical Genomics Center, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Dirk Pijnenburg</Name>
        <Affiliation>PamGene International B.V., Wolvenhoek 10, 5211 HH 's-Hertogenbosch, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Thai Khuc</Name>
        <Affiliation>NIH Chemical Genomics Center, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jon Hamm</Name>
        <Affiliation>Integrated Laboratory System, Inc., Morrisville, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jinghua Zhao</Name>
        <Affiliation>NIH Chemical Genomics Center, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Caitlin Lynch</Name>
        <Affiliation>NIH Chemical Genomics Center, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rinie van Beuningen</Name>
        <Affiliation>PamGene International B.V., Wolvenhoek 10, 5211 HH 's-Hertogenbosch, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoqing Chang</Name>
        <Affiliation>Integrated Laboratory System, Inc., Morrisville, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>René Houtman</Name>
        <Affiliation>PamGene International B.V., Wolvenhoek 10, 5211 HH 's-Hertogenbosch, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Menghang Xia</Name>
        <Affiliation>NIH Chemical Genomics Center, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD, USA. Electronic address: mxia@mail.nih.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Isoliquiritigenin exhibits anti-proliferative properties in the pituitary independent of estrogen receptor function.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27702603</pubmedLink>
    <GrantList>
      <Grant>P50 AT006268</Grant>
      <Grant>R01 DK076647</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30301-5</DOI>
    <KeywordList>
      <Keywords>Estrogen</Keywords>
      <Keywords>Isoliquiritigenin</Keywords>
      <Keywords>Pituitary development</Keywords>
      <Keywords>Proliferation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Karen E. Weis</Name>
        <Affiliation>Department of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, 524 Burrill Hall, 407 South Goodwin Avenue, Urbana, IL 61801, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Lori T. Raetzman</Name>
        <Affiliation>Department of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, 524 Burrill Hall, 407 South Goodwin Avenue, Urbana, IL 61801, United States. Electronic address: raetzman@life.illinois.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Friedelane-type triterpenoids as selective anti-inflammatory agents by regulation of differential signaling pathways in LPS-stimulated macrophages.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27751938</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30305-2</DOI>
    <KeywordList>
      <Keywords>Antioxidant enzymes</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Lipopolysaccharide</Keywords>
      <Keywords>Macrophages</Keywords>
      <Keywords>Nitric oxide synthase</Keywords>
      <Keywords>Triterpenoids</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Andrea Villar-Lorenzo</Name>
        <Affiliation>Instituto de Investigaciones Biomédicas Alberto Sols (IIBm) (CSIC/UAM), C/ Arturo Duperier 4, 28029 Madrid, Spain; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERdem), ISCIII, 28029 Madrid, Spain. Electronic address: avillar@iib.uam.es.</Affiliation>
      </Author>
      <Author>
        <Name>Alejandro E. Ardiles</Name>
        <Affiliation>Instituto Universitario de Bio-Orgánica Antonio González, Departamento de Química Orgánica, Universidad de La Laguna, Avenida Astrofísico Francisco Sánchez 2, 38206 La Laguna, Tenerife, Spain; Facultad de Ciencias de la Salud, Universidad Arturo Prat, Casilla 121, Iquique 1110939, Chile. Electronic address: ale_csic@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ana I. Arroba</Name>
        <Affiliation>Instituto de Investigaciones Biomédicas Alberto Sols (IIBm) (CSIC/UAM), C/ Arturo Duperier 4, 28029 Madrid, Spain; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERdem), ISCIII, 28029 Madrid, Spain. Electronic address: aarroba@iib.uam.es.</Affiliation>
      </Author>
      <Author>
        <Name>Enrique Hernández-Jiménez</Name>
        <Affiliation>Tumor Immunology Laboratory (IdiPAZ), 28029 Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERres), ISCIII, 28029 Madrid, Spain. Electronic address: enheji@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Virginia Pardo</Name>
        <Affiliation>Instituto de Investigaciones Biomédicas Alberto Sols (IIBm) (CSIC/UAM), C/ Arturo Duperier 4, 28029 Madrid, Spain; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERdem), ISCIII, 28029 Madrid, Spain. Electronic address: vpardo@iib.uam.es.</Affiliation>
      </Author>
      <Author>
        <Name>Eduardo López-Collazo</Name>
        <Affiliation>Tumor Immunology Laboratory (IdiPAZ), 28029 Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERres), ISCIII, 28029 Madrid, Spain. Electronic address: elopezc@salud.madrid.org.</Affiliation>
      </Author>
      <Author>
        <Name>Ignacio A. Jiménez</Name>
        <Affiliation>Instituto Universitario de Bio-Orgánica Antonio González, Departamento de Química Orgánica, Universidad de La Laguna, Avenida Astrofísico Francisco Sánchez 2, 38206 La Laguna, Tenerife, Spain. Electronic address: ignadiaz@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Isabel L. Bazzocchi</Name>
        <Affiliation>Instituto Universitario de Bio-Orgánica Antonio González, Departamento de Química Orgánica, Universidad de La Laguna, Avenida Astrofísico Francisco Sánchez 2, 38206 La Laguna, Tenerife, Spain. Electronic address: ilopez@ull.es.</Affiliation>
      </Author>
      <Author>
        <Name>Águeda González-Rodríguez</Name>
        <Affiliation>Instituto de Investigaciones Biomédicas Alberto Sols (IIBm) (CSIC/UAM), C/ Arturo Duperier 4, 28029 Madrid, Spain; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERdem), ISCIII, 28029 Madrid, Spain. Electronic address: aguedagr@iib.uam.es.</Affiliation>
      </Author>
      <Author>
        <Name>Ángela M. Valverde</Name>
        <Affiliation>Instituto de Investigaciones Biomédicas Alberto Sols (IIBm) (CSIC/UAM), C/ Arturo Duperier 4, 28029 Madrid, Spain; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERdem), ISCIII, 28029 Madrid, Spain. Electronic address: avalverde@iib.uam.es.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Characterization of acquired paclitaxel resistance of breast cancer cells and involvement of ABC transporters.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27664577</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30286-1</DOI>
    <KeywordList>
      <Keywords>ABC transporter</Keywords>
      <Keywords>ABCB1</Keywords>
      <Keywords>Breast cancer cells</Keywords>
      <Keywords>Doxorubicin</Keywords>
      <Keywords>Paclitaxel resistance</Keywords>
      <Keywords>Taxane SB-T-1216</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Vlasta Němcová-Fürstová</Name>
        <Affiliation>Division of Cell and Molecular Biology, Third Faculty of Medicine, Charles University, Prague, Czech Republic. Electronic address: vlasta.furstova@lf3.cuni.cz.</Affiliation>
      </Author>
      <Author>
        <Name>Dana Kopperová</Name>
        <Affiliation>Division of Cell and Molecular Biology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Kamila Balušíková</Name>
        <Affiliation>Division of Cell and Molecular Biology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Marie Ehrlichová</Name>
        <Affiliation>Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Veronika Brynychová</Name>
        <Affiliation>Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Radka Václavíková</Name>
        <Affiliation>Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Petr Daniel</Name>
        <Affiliation>Division of Cell and Molecular Biology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Pavel Souček</Name>
        <Affiliation>Toxicogenomics Unit, National Institute of Public Health, Prague, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Jan Kovář</Name>
        <Affiliation>Division of Cell and Molecular Biology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cystathionine metabolic enzymes play a role in the inflammation resolution of human keratinocytes in response to sub-cytotoxic formaldehyde exposure.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27664576</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30283-6</DOI>
    <KeywordList>
      <Keywords>Cystathionine γ-lyase (CTH)</Keywords>
      <Keywords>Cystathionine-β-synthase (CBS)</Keywords>
      <Keywords>Formaldehyde</Keywords>
      <Keywords>Gene Ontology (GO) enrichment analysis</Keywords>
      <Keywords>Human keratinocytes</Keywords>
      <Keywords>Inflammation resolution</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Eunyoung Lee</Name>
        <Affiliation>College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea; Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyoung June Kim</Name>
        <Affiliation>Basic Research and Innovation Division, AmorePacific Corporation R&amp;D Center, Yongin, Gyeounggi-do 17074, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Moonyoung Lee</Name>
        <Affiliation>College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sun Hee Jin</Name>
        <Affiliation>College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea; Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Soo Hyun Hong</Name>
        <Affiliation>College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea; Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seyeon Ahn</Name>
        <Affiliation>College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea; Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sae On Kim</Name>
        <Affiliation>College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea; Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dong Wook Shin</Name>
        <Affiliation>Basic Research and Innovation Division, AmorePacific Corporation R&amp;D Center, Yongin, Gyeounggi-do 17074, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Taek Lee</Name>
        <Affiliation>Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul 03722, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Minsoo Noh</Name>
        <Affiliation>College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea; Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea. Electronic address: minsoonoh@snu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Choline supplementation alleviates fluoride-induced testicular toxicity by restoring the NGF and MEK expression in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27664006</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30284-8</DOI>
    <KeywordList>
      <Keywords>Choline supplementation</Keywords>
      <Keywords>Fluoride</Keywords>
      <Keywords>MEK</Keywords>
      <Keywords>NGF</Keywords>
      <Keywords>Testicular toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jianhai Zhang</Name>
        <Affiliation>Shanxi Key Laboratory of Ecological Animal Science and Environmental Veterinary Medicine, Shanxi Agricultural University, Taigu, Shanxi 030801, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yufang Zhang</Name>
        <Affiliation>Shanxi Key Laboratory of Ecological Animal Science and Environmental Veterinary Medicine, Shanxi Agricultural University, Taigu, Shanxi 030801, China; Veterinary Station in Chen Villages of Lin Country, Linxian, Shanxi 033200, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chen Liang</Name>
        <Affiliation>Shanxi Key Laboratory of Ecological Animal Science and Environmental Veterinary Medicine, Shanxi Agricultural University, Taigu, Shanxi 030801, China.</Affiliation>
      </Author>
      <Author>
        <Name>Nasui Wang</Name>
        <Affiliation>Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia, Charlottesville, VA 22908, USA; Division of Endocrinology and Metabolism, Department of Medicine, The First Affiliated Hospital of Shantou University Medical College, Shantou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Heping Zheng</Name>
        <Affiliation>Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA 22908, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jundong Wang</Name>
        <Affiliation>Shanxi Key Laboratory of Ecological Animal Science and Environmental Veterinary Medicine, Shanxi Agricultural University, Taigu, Shanxi 030801, China. Electronic address: wangjd53@outlook.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Riccardin D-N induces lysosomal membrane permeabilization by inhibiting acid sphingomyelinase and interfering with sphingomyelin metabolism in vivo.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27660101</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30272-1</DOI>
    <KeywordList>
      <Keywords>Acid sphingomyelinase</Keywords>
      <Keywords>Cathepsin</Keywords>
      <Keywords>Lysosome</Keywords>
      <Keywords>Sphingomyelin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lin Li</Name>
        <Affiliation>Department of Natural Product Chemistry, Key Lab of Chemical Biology of MOE (Ministry of Education), Shandong University, Jinan 250012, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huanmin Niu</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, School of Medicine, Shandong University, Jinan 250012, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bin Sun</Name>
        <Affiliation>Department of Natural Product Chemistry, Key Lab of Chemical Biology of MOE (Ministry of Education), Shandong University, Jinan 250012, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanan Xiao</Name>
        <Affiliation>School of Pharmaceutical Science, Shandong University, Jinan 250012, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Li</Name>
        <Affiliation>Department of Natural Product Chemistry, Key Lab of Chemical Biology of MOE (Ministry of Education), Shandong University, Jinan 250012, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huiqing Yuan</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, School of Medicine, Shandong University, Jinan 250012, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongxiang Lou</Name>
        <Affiliation>Department of Natural Product Chemistry, Key Lab of Chemical Biology of MOE (Ministry of Education), Shandong University, Jinan 250012, China. Electronic address: louhongxiang@sdu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A comprehensive evaluation of novel oximes in creation of butyrylcholinesterase-based nerve agent bioscavengers.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27654152</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30281-2</DOI>
    <KeywordList>
      <Keywords>Antidotes</Keywords>
      <Keywords>Benzimidazole oximes</Keywords>
      <Keywords>Butyrylcholinesterase</Keywords>
      <Keywords>Imidazole oximes</Keywords>
      <Keywords>Nerve agents</Keywords>
      <Keywords>Reactivation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Maja Katalinić</Name>
        <Affiliation>Institute for Medical Research and Occupational Health, POB 291, HR-10001 Zagreb, Croatia.</Affiliation>
      </Author>
      <Author>
        <Name>Nikolina Maček Hrvat</Name>
        <Affiliation>Institute for Medical Research and Occupational Health, POB 291, HR-10001 Zagreb, Croatia.</Affiliation>
      </Author>
      <Author>
        <Name>Krešimir Baumann</Name>
        <Affiliation>Department of Chemistry, Faculty of Science, University of Zagreb, HR-10001 Zagreb, Croatia.</Affiliation>
      </Author>
      <Author>
        <Name>Sara Morasi Piperčić</Name>
        <Affiliation>Department of Chemistry, Faculty of Science, University of Zagreb, HR-10001 Zagreb, Croatia.</Affiliation>
      </Author>
      <Author>
        <Name>Sandro Makarić</Name>
        <Affiliation>Department of Chemistry, Faculty of Science, University of Zagreb, HR-10001 Zagreb, Croatia.</Affiliation>
      </Author>
      <Author>
        <Name>Srđanka Tomić</Name>
        <Affiliation>Department of Chemistry, Faculty of Science, University of Zagreb, HR-10001 Zagreb, Croatia.</Affiliation>
      </Author>
      <Author>
        <Name>Ozren Jović</Name>
        <Affiliation>Department of Chemistry, Faculty of Science, University of Zagreb, HR-10001 Zagreb, Croatia.</Affiliation>
      </Author>
      <Author>
        <Name>Tomica Hrenar</Name>
        <Affiliation>Department of Chemistry, Faculty of Science, University of Zagreb, HR-10001 Zagreb, Croatia.</Affiliation>
      </Author>
      <Author>
        <Name>Ante Miličević</Name>
        <Affiliation>Institute for Medical Research and Occupational Health, POB 291, HR-10001 Zagreb, Croatia.</Affiliation>
      </Author>
      <Author>
        <Name>Dubravko Jelić</Name>
        <Affiliation>Fidelta Ltd., HR-10001 Zagreb, Croatia.</Affiliation>
      </Author>
      <Author>
        <Name>Suzana Žunec</Name>
        <Affiliation>Institute for Medical Research and Occupational Health, POB 291, HR-10001 Zagreb, Croatia.</Affiliation>
      </Author>
      <Author>
        <Name>Ines Primožič</Name>
        <Affiliation>Department of Chemistry, Faculty of Science, University of Zagreb, HR-10001 Zagreb, Croatia. Electronic address: ines.primozic@chem.pmf.hr.</Affiliation>
      </Author>
      <Author>
        <Name>Zrinka Kovarik</Name>
        <Affiliation>Institute for Medical Research and Occupational Health, POB 291, HR-10001 Zagreb, Croatia. Electronic address: zkovarik@imi.hr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Sex-related differential susceptibility to doxorubicin-induced cardiotoxicity in B6C3F</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27644598</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30270-8</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Cardiotoxicity</Keywords>
      <Keywords>DNA damage</Keywords>
      <Keywords>Doxorubicin</Keywords>
      <Keywords>Mouse model</Keywords>
      <Keywords>Sex-based differences</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>G. Ronald Jenkins</Name>
        <Affiliation>Personalized Medicine Branch, Division of Systems Biology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Taewon Lee</Name>
        <Affiliation>Department of Mathematics, Korea University, Sejong, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Carrie L. Moland</Name>
        <Affiliation>Personalized Medicine Branch, Division of Systems Biology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Vikrant Vijay</Name>
        <Affiliation>Personalized Medicine Branch, Division of Systems Biology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Eugene H. Herman</Name>
        <Affiliation>Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, The National Cancer Institute, Rockville, MD 20850-9734, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Sherry M. Lewis</Name>
        <Affiliation>Office of Scientific Coordination, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Kelly J. Davis</Name>
        <Affiliation>Toxicologic Pathology Associates, National Center for Toxicological Research, Jefferson, AR 72079, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Levan Muskhelishvili</Name>
        <Affiliation>Toxicologic Pathology Associates, National Center for Toxicological Research, Jefferson, AR 72079, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Susan Kerr</Name>
        <Affiliation>Arkansas Heart Hospital, Little Rock, AR 72211, United States.</Affiliation>
      </Author>
      <Author>
        <Name>James C. Fuscoe</Name>
        <Affiliation>Personalized Medicine Branch, Division of Systems Biology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Varsha G. Desai</Name>
        <Affiliation>Personalized Medicine Branch, Division of Systems Biology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, United States. Electronic address: varsha.desai@fda.hhs.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A mouse model of alcoholic liver fibrosis-associated acute kidney injury identifies key molecular pathways.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27641628</pubmedLink>
    <GrantList>
      <Grant>U01 AA021908</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30269-1</DOI>
    <AuthorList>
      <Author>
        <Name>Shinji Furuya</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, Texas A&amp;M University, College Station, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Grace A. Chappell</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, Texas A&amp;M University, College Station, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yasuhiro Iwata</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, Texas A&amp;M University, College Station, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Takeki Uehara</Name>
        <Affiliation>Laboratory of Veterinary Pathology, Osaka Prefecture University, Osaka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuki Kato</Name>
        <Affiliation>Laboratory of Veterinary Pathology, Osaka Prefecture University, Osaka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hiroshi Kono</Name>
        <Affiliation>First Department of Surgery, University of Yamanashi, Yamanashi, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Ramon Bataller</Name>
        <Affiliation>Division of Gastroenterology &amp; Hepatology, Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ivan Rusyn</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, Texas A&amp;M University, College Station, TX, USA. Electronic address: irusyn@tamu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mechanisms of tramadol-related neurotoxicity in the rat: Does diazepam/tramadol combination play a worsening role in overdose?</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27641627</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30271-X</DOI>
    <KeywordList>
      <Keywords>Diazepam</Keywords>
      <Keywords>Poisoning</Keywords>
      <Keywords>Respiratory depression</Keywords>
      <Keywords>Seizure</Keywords>
      <Keywords>Serotonin</Keywords>
      <Keywords>Tramadol</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Camille Lagard</Name>
        <Affiliation>Inserm, U1144, Paris, France; UMR-S 1144, Paris-Descartes University, Paris, France; UMR-S 1144, Paris-Diderot University, Paris, France. Electronic address: camille.lagard@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lucie Chevillard</Name>
        <Affiliation>Inserm, U1144, Paris, France; UMR-S 1144, Paris-Descartes University, Paris, France; UMR-S 1144, Paris-Diderot University, Paris, France. Electronic address: luciechevillard@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Isabelle Malissin</Name>
        <Affiliation>Assistance Publique - Hôpitaux de Paris, Lariboisière Hospital, Department of Medical and Toxicological Critical Care, Paris, France. Electronic address: isabellemalissin@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia Risède</Name>
        <Affiliation>Inserm, U1144, Paris, France; UMR-S 1144, Paris-Descartes University, Paris, France; UMR-S 1144, Paris-Diderot University, Paris, France. Electronic address: patricia.risede@inserm.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Jacques Callebert</Name>
        <Affiliation>Inserm, U1144, Paris, France; UMR-S 1144, Paris-Descartes University, Paris, France; UMR-S 1144, Paris-Diderot University, Paris, France; Assistance Publique - Hôpitaux de Paris, Lariboisière Hospital, Laboratory of Biochemistry and Molecular Biology, Paris, France. Electronic address: jacques.callebert@aphp.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Laurence Labat</Name>
        <Affiliation>Inserm, U1144, Paris, France; UMR-S 1144, Paris-Descartes University, Paris, France; UMR-S 1144, Paris-Diderot University, Paris, France; Assistance Publique - Hôpitaux de Paris, Cochin Hospital, Laboratory of Toxicology, Paris, France. Electronic address: laurence.labat@aphp.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Marie Launay</Name>
        <Affiliation>Assistance Publique - Hôpitaux de Paris, Lariboisière Hospital, Laboratory of Biochemistry and Molecular Biology, Paris, France; Inserm, U942, Paris, France. Electronic address: jean-marie.launay@aphp.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Louis Laplanche</Name>
        <Affiliation>Inserm, U1144, Paris, France; UMR-S 1144, Paris-Descartes University, Paris, France; UMR-S 1144, Paris-Diderot University, Paris, France; Assistance Publique - Hôpitaux de Paris, Lariboisière Hospital, Laboratory of Biochemistry and Molecular Biology, Paris, France. Electronic address: jean-louis.laplanche@aphp.fr.</Affiliation>
      </Author>
      <Author>
        <Name>Bruno Mégarbane</Name>
        <Affiliation>Inserm, U1144, Paris, France; UMR-S 1144, Paris-Descartes University, Paris, France; UMR-S 1144, Paris-Diderot University, Paris, France; Assistance Publique - Hôpitaux de Paris, Lariboisière Hospital, Department of Medical and Toxicological Critical Care, Paris, France. Electronic address: bruno-megarbane@wanadoo.fr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nrf2 but not autophagy inhibition is associated with the survival of wild-type epidermal growth factor receptor non-small cell lung cancer cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27639429</pubmedLink>
    <GrantList>
      <Grant>R01 DK102142</Grant>
      <Grant>S10 RR027564</Grant>
      <Grant>P20 GM103549</Grant>
      <Grant>R01 AA020518</Grant>
      <Grant>P20 GM104936</Grant>
      <Grant>R37 AA020518</Grant>
      <Grant>P20 RR021940</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30268-X</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Autophagy</Keywords>
      <Keywords>EGFR</Keywords>
      <Keywords>Lung cancer</Keywords>
      <Keywords>Nrf2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yan Zhou</Name>
        <Affiliation>Department of Pulmonary, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China; Department of Pharmacology, Toxicology and Therapeutics, The University of Kansas Medical Center, Kansas City, KS 66160, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Li</Name>
        <Affiliation>Department of Pharmacology, Toxicology and Therapeutics, The University of Kansas Medical Center, Kansas City, KS 66160, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Min Ni</Name>
        <Affiliation>Department of Pharmacology, Toxicology and Therapeutics, The University of Kansas Medical Center, Kansas City, KS 66160, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Xing Ding</Name>
        <Affiliation>Department of Pharmacology, Toxicology and Therapeutics, The University of Kansas Medical Center, Kansas City, KS 66160, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hua Zhong</Name>
        <Affiliation>Department of Pulmonary, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China. Electronic address: eddiedong8@hotmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicity of ricin A chain is reduced in mammalian cells by inhibiting its interaction with the ribosome.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27639428</pubmedLink>
    <GrantList>
      <Grant>R01 AI072425</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30262-9</DOI>
    <KeywordList>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Depurination</Keywords>
      <Keywords>Mammalian cells</Keywords>
      <Keywords>Ribosome binding</Keywords>
      <Keywords>Ricin A chain</Keywords>
      <Keywords>Therapeutic target</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Amanda E. Jetzt</Name>
        <Affiliation>Department of Animal Sciences, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901-8520, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Ping Li</Name>
        <Affiliation>Department of Plant Biology and Pathology, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901-8520, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Nilgun E. Tumer</Name>
        <Affiliation>Department of Plant Biology and Pathology, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901-8520, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Wendie S. Cohick</Name>
        <Affiliation>Department of Animal Sciences, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901-8520, United States. Electronic address: cohick@aesop.rutgers.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>All authors certify that they have no conflict of interest relevant to this work.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Propagation of damage in the rat brain following sarin exposure: Differential progression of early processes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27639427</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30266-6</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Brain Damage</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Necrosis</Keywords>
      <Keywords>Sarin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shlomi Lazar</Name>
        <Affiliation>Department of Pharmacology, Israel Institute for Biological Research, Ness Ziona, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Inbal Egoz</Name>
        <Affiliation>Department of Pharmacology, Israel Institute for Biological Research, Ness Ziona, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Rachel Brandeis</Name>
        <Affiliation>Department of Pharmacology, Israel Institute for Biological Research, Ness Ziona, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Shira Chapman</Name>
        <Affiliation>Department of Pharmacology, Israel Institute for Biological Research, Ness Ziona, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Eugenia Bloch-Shilderman</Name>
        <Affiliation>Department of Pharmacology, Israel Institute for Biological Research, Ness Ziona, Israel.</Affiliation>
      </Author>
      <Author>
        <Name>Ettie Grauer</Name>
        <Affiliation>Department of Pharmacology, Israel Institute for Biological Research, Ness Ziona, Israel. Electronic address: ettieg@iibr.gov.il.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inhibition of autophagy by andrographolide resensitizes cisplatin-resistant non-small cell lung carcinoma cells via activation of the Akt/mTOR pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27639426</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30267-8</DOI>
    <KeywordList>
      <Keywords>Andrographolide</Keywords>
      <Keywords>Autophagy</Keywords>
      <Keywords>Cisplatin resistance</Keywords>
      <Keywords>NSCLC</Keywords>
      <Keywords>PTEN</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shanwei Mi</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, China.</Affiliation>
      </Author>
      <Author>
        <Name>Gang Xiang</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, China.</Affiliation>
      </Author>
      <Author>
        <Name>Daolu Yuwen</Name>
        <Affiliation>Department of Clinical Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jian Gao</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenjie Guo</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xuefeng Wu</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xudong Wu</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Sun</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongqian Su</Name>
        <Affiliation>Department of Clinical Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Shen</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, China. Electronic address: shenyan@nju.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Qiang Xu</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing 210093, China. Electronic address: molpharm@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Gallic acid-capped gold nanoparticles inhibit EGF-induced MMP-9 expression through suppression of p300 stabilization and NFκB/c-Jun activation in breast cancer MDA-MB-231 cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27634460</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30265-4</DOI>
    <KeywordList>
      <Keywords>Breast cancer</Keywords>
      <Keywords>EGF</Keywords>
      <Keywords>Gallic acid-capped gold nanoparticles</Keywords>
      <Keywords>MMP-9</Keywords>
      <Keywords>NFκB/AP-1</Keywords>
      <Keywords>p300</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ying Jung Chen</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Chin Lee</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chia Hui Huang</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Long Sen Chang</Name>
        <Affiliation>Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan; Department of Biotechnology, Kaohsiung Medical University, Kaohsiung 807, Taiwan. Electronic address: lschang@mail.nsysu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Systematic network assessment of the carcinogenic activities of cadmium.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27634459</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30264-2</DOI>
    <KeywordList>
      <Keywords>Cadmium</Keywords>
      <Keywords>Carcinogenesis</Keywords>
      <Keywords>Network assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Peizhan Chen</Name>
        <Affiliation>Key Laboratory of Food Safety Research, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaohua Duan</Name>
        <Affiliation>Key Laboratory of Food Safety Research, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mian Li</Name>
        <Affiliation>Key Laboratory of Food Safety Research, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Huang</Name>
        <Affiliation>Key Laboratory of Food Safety Research, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingquan Li</Name>
        <Affiliation>Key Laboratory of Food Safety Research, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China; Key Laboratory of Food Safety Risk Assessment, Ministry of Health, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ruiai Chu</Name>
        <Affiliation>Key Laboratory of Food Safety Research, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China; Key Laboratory of Food Safety Risk Assessment, Ministry of Health, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hao Ying</Name>
        <Affiliation>Key Laboratory of Food Safety Research, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China; Key Laboratory of Food Safety Risk Assessment, Ministry of Health, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Haiyun Song</Name>
        <Affiliation>Key Laboratory of Food Safety Research, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China; Key Laboratory of Food Safety Risk Assessment, Ministry of Health, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xudong Jia</Name>
        <Affiliation>Key Laboratory of Food Safety Risk Assessment, Ministry of Health, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qian Ba</Name>
        <Affiliation>Key Laboratory of Food Safety Research, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China; Key Laboratory of Food Safety Risk Assessment, Ministry of Health, Beijing, China. Electronic address: qba@sibs.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Wang</Name>
        <Affiliation>Key Laboratory of Food Safety Research, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China; Key Laboratory of Food Safety Risk Assessment, Ministry of Health, Beijing, China; School of Life Science and Technology, ShanghaiTech University, Shanghai, China. Electronic address: huiwang@sibs.ac.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Endoplasmic reticulum stress-mediated neuronal apoptosis by acrylamide exposure.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27634458</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30263-0</DOI>
    <KeywordList>
      <Keywords>Acrylamide</Keywords>
      <Keywords>Endoplasmic reticulum stress</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
      <Keywords>SH-SY5Y cells</Keywords>
      <Keywords>Zebrafish</Keywords>
      <Keywords>eIF2α–ATF4 pathway</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yuta Komoike</Name>
        <Affiliation>Department of Hygiene and Public Health I, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan. Electronic address: komoike@research.twmu.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Masato Matsuoka</Name>
        <Affiliation>Department of Hygiene and Public Health I, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan. Electronic address: matsuoka@research.twmu.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Neogambogic acid prevents silica-induced fibrosis via inhibition of high-mobility group box 1 and MCP-1-induced protein 1.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27616297</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.09.003</DOI>
    <KeywordList>
      <Keywords>HMGB1</Keywords>
      <Keywords>MCPIP1</Keywords>
      <Keywords>Neogambogic acid</Keywords>
      <Keywords>Silicosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wei Zhang</Name>
        <Affiliation>Department of Physiology, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China; Department of Pharmacology, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China; Key Laboratory of Developmental Genes and Human Disease, Southeast University, Nanjing 210096, China; Department of Respiration, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mei Zhang</Name>
        <Affiliation>Department of Respiration, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China. Electronic address: meizhang1717@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Zhongjiang Wang</Name>
        <Affiliation>Department of Radiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yusi Cheng</Name>
        <Affiliation>Department of Physiology, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Haijun Liu</Name>
        <Affiliation>Department of Physiology, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zewei Zhou</Name>
        <Affiliation>Department of Physiology, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China; Department of Pharmacology, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bing Han</Name>
        <Affiliation>Department of Pharmacology, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Baoan Chen</Name>
        <Affiliation>Department of Hematology and Oncology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Honghong Yao</Name>
        <Affiliation>Department of Pharmacology, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China; Key Laboratory of Developmental Genes and Human Disease, Southeast University, Nanjing 210096, China. Electronic address: yaohh@seu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Chao</Name>
        <Affiliation>Department of Physiology, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China; Key Laboratory of Developmental Genes and Human Disease, Southeast University, Nanjing 210096, China; Department of Respiration, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China. Electronic address: chaojie@seu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dietary n-3 PUFAs augment caspase 8 activation in Staphylococcal aureus enterotoxin B stimulated T-cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27614254</pubmedLink>
    <GrantList>
      <Grant>P30 ES020957</Grant>
      <Grant>R21 ES021285</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.09.002</DOI>
    <KeywordList>
      <Keywords>Autoimmunity</Keywords>
      <Keywords>CD95</Keywords>
      <Keywords>Caspase 8</Keywords>
      <Keywords>Mercury</Keywords>
      <Keywords>T-cells</Keywords>
      <Keywords>n-3 PUFA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>R. Gill</Name>
        <Affiliation>Department of Immunology and Microbiology, Wayne State University, Detroit, MI, United States.</Affiliation>
      </Author>
      <Author>
        <Name>K. L. Jen</Name>
        <Affiliation>Department of Nutrition and Food Science, Wayne State University, Detroit, MI, United States; Center for Urban Responses to Environmental Stressors (CURES), Wayne State University, Detroit, MI, United States.</Affiliation>
      </Author>
      <Author>
        <Name>M. J. J. McCabe</Name>
        <Affiliation>Department of Environmental Medicine, University of Rochester, Rochester, NY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>A. Rosenspire</Name>
        <Affiliation>Department of Immunology and Microbiology, Wayne State University, Detroit, MI, United States; Center for Urban Responses to Environmental Stressors (CURES), Wayne State University, Detroit, MI, United States. Electronic address: arosenspire@wayne.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>STATEMENT The authors declare that there are no conflicts of interest</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Restoration of enterohepatic bile acid pathways in pregnant mice following short term activation of Fxr by GW4064.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27609522</pubmedLink>
    <GrantList>
      <Grant>F31 HD082965</Grant>
      <Grant>R01 ES020522</Grant>
      <Grant>T32 ES007148</Grant>
      <Grant>R25 ES020721</Grant>
      <Grant>P30 ES005022</Grant>
      <Grant>R01 GM104037</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30244-7</DOI>
    <KeywordList>
      <Keywords>Bile acids</Keywords>
      <Keywords>Cyp7a1</Keywords>
      <Keywords>Fxr</Keywords>
      <Keywords>GW4064</Keywords>
      <Keywords>Pregnancy</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jamie E. Moscovitz</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Rutgers University Ernest Mario School of Pharmacy, 170 Frelinghuysen Rd., Piscataway, NJ 08854, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Kong</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Rutgers University Ernest Mario School of Pharmacy, 170 Frelinghuysen Rd., Piscataway, NJ 08854, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kyle Buckley</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Rutgers University Ernest Mario School of Pharmacy, 170 Frelinghuysen Rd., Piscataway, NJ 08854, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brian Buckley</Name>
        <Affiliation>Environmental and Occupational Health Sciences Institute, 170 Frelinghuysen Rd., Piscataway, NJ 08854, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Grace L. Guo</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Rutgers University Ernest Mario School of Pharmacy, 170 Frelinghuysen Rd., Piscataway, NJ 08854, USA; Environmental and Occupational Health Sciences Institute, 170 Frelinghuysen Rd., Piscataway, NJ 08854, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lauren M. Aleksunes</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Rutgers University Ernest Mario School of Pharmacy, 170 Frelinghuysen Rd., Piscataway, NJ 08854, USA; Environmental and Occupational Health Sciences Institute, 170 Frelinghuysen Rd., Piscataway, NJ 08854, USA. Electronic address: aleksunes@eohsi.rutgers.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In vitro assessment of TAT - Ciliary Neurotrophic Factor therapeutic potential for peripheral nerve regeneration.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27597256</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.09.001</DOI>
    <KeywordList>
      <Keywords>Cell trafficking</Keywords>
      <Keywords>Ciliary Neurotrophic Factor</Keywords>
      <Keywords>Peripheral nerve regeneration</Keywords>
      <Keywords>Polyvinyl alcohol</Keywords>
      <Keywords>TAT sequence</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Silvia Barbon</Name>
        <Affiliation>Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Via Marzolo 5, 35131 Padua, Italy; Foundation for Biology and Regenerative Medicine, Tissue Engineering and Signaling (TES) ONLUS, Via De Sanctis 10, Caselle di Selvazzano Dentro, 35030 Padua, Italy. Electronic address: silvia.barbon@yahoo.it.</Affiliation>
      </Author>
      <Author>
        <Name>Elena Stocco</Name>
        <Affiliation>Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Via Marzolo 5, 35131 Padua, Italy; Foundation for Biology and Regenerative Medicine, Tissue Engineering and Signaling (TES) ONLUS, Via De Sanctis 10, Caselle di Selvazzano Dentro, 35030 Padua, Italy. Electronic address: elena.stocco@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Alessandro Negro</Name>
        <Affiliation>Department of Biomedical Sciences, University of Padova, Via Colombo 3, 35121 Padua, Italy. Electronic address: alessandro.negro@unipd.it.</Affiliation>
      </Author>
      <Author>
        <Name>Daniele Dalzoppo</Name>
        <Affiliation>Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Via Marzolo 5, 35131 Padua, Italy. Electronic address: daniele.dalzoppo@unipd.it.</Affiliation>
      </Author>
      <Author>
        <Name>Luca Borgio</Name>
        <Affiliation>Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Via Marzolo 5, 35131 Padua, Italy. Electronic address: borgio.luca@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Senthilkumar Rajendran</Name>
        <Affiliation>Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Via Marzolo 5, 35131 Padua, Italy. Electronic address: senthilstem@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Francesca Grandi</Name>
        <Affiliation>Department of Women's and Children's Health, Pediatric Surgery, University of Padua, Via Giustiniani 3, 35121 Padua, Italy. Electronic address: francesca.grandi7825@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Porzionato</Name>
        <Affiliation>Section of Human Anatomy, Department of Molecular Medicine, University of Padua, Via Gabelli 65, 35121 Padua, Italy. Electronic address: andrea.porzionato@unipd.it.</Affiliation>
      </Author>
      <Author>
        <Name>Veronica Macchi</Name>
        <Affiliation>Section of Human Anatomy, Department of Molecular Medicine, University of Padua, Via Gabelli 65, 35121 Padua, Italy. Electronic address: veronica.macchi@unipd.it.</Affiliation>
      </Author>
      <Author>
        <Name>Raffaele De Caro</Name>
        <Affiliation>Section of Human Anatomy, Department of Molecular Medicine, University of Padua, Via Gabelli 65, 35121 Padua, Italy. Electronic address: raffaele.decaro@unipd.it.</Affiliation>
      </Author>
      <Author>
        <Name>Pier Paolo Parnigotto</Name>
        <Affiliation>Foundation for Biology and Regenerative Medicine, Tissue Engineering and Signaling (TES) ONLUS, Via De Sanctis 10, Caselle di Selvazzano Dentro, 35030 Padua, Italy. Electronic address: pierpaolo.parnigotto@unipd.it.</Affiliation>
      </Author>
      <Author>
        <Name>Claudio Grandi</Name>
        <Affiliation>Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Via Marzolo 5, 35131 Padua, Italy. Electronic address: claudio.grandi@unipd.it.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Autophagy deficiency in macrophages enhances NLRP3 inflammasome activity and chronic lung disease following silica exposure.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27594529</pubmedLink>
    <GrantList>
      <Grant>P20 RR017670</Grant>
      <Grant>P30 GM103338</Grant>
      <Grant>R01 ES023209</Grant>
      <Grant>S10 RR026325</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.08.029</DOI>
    <KeywordList>
      <Keywords>Atg5</Keywords>
      <Keywords>Autophagy</Keywords>
      <Keywords>HMGB1</Keywords>
      <Keywords>IL-18</Keywords>
      <Keywords>NLRP3 Inflammasome</Keywords>
      <Keywords>Silicosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Forrest Jessop</Name>
        <Affiliation>Center for Environmental Health Sciences, University of Montana, Missoula, Montana, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Raymond F. Hamilton</Name>
        <Affiliation>Center for Environmental Health Sciences, University of Montana, Missoula, Montana, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph F. Rhoderick</Name>
        <Affiliation>Center for Environmental Health Sciences, University of Montana, Missoula, Montana, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Pamela K. Shaw</Name>
        <Affiliation>Center for Environmental Health Sciences, University of Montana, Missoula, Montana, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Andrij Holian</Name>
        <Affiliation>Center for Environmental Health Sciences, University of Montana, Missoula, Montana, United States. Electronic address: andrij.holian@umontana.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A new brominated chalcone derivative suppresses the growth of gastric cancer cells in vitro and in vivo involving ROS mediated up-regulation of DR5 and 4 expression and apoptosis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27594528</pubmedLink>
    <GrantList>
      <Grant>R01 CA122558</Grant>
      <Grant>R01 CA193967</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.08.023</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Brominated chalcone</Keywords>
      <Keywords>Gastric cancer cells</Keywords>
      <Keywords>ROS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Saiyang Zhang</Name>
        <Affiliation>School of Pharmaceutical Sciences, Key Laboratory of State Ministry of Education, Key Laboratory of Henan province for Drug Quality Control and Evaluation, Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tingyu Li</Name>
        <Affiliation>School of Pharmaceutical Sciences, Key Laboratory of State Ministry of Education, Key Laboratory of Henan province for Drug Quality Control and Evaluation, Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanbing Zhang</Name>
        <Affiliation>School of Pharmaceutical Sciences, Key Laboratory of State Ministry of Education, Key Laboratory of Henan province for Drug Quality Control and Evaluation, Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hongde Xu</Name>
        <Affiliation>School of Pharmaceutical Sciences, Key Laboratory of State Ministry of Education, Key Laboratory of Henan province for Drug Quality Control and Evaluation, Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongchun Li</Name>
        <Affiliation>School of Pharmaceutical Sciences, Key Laboratory of State Ministry of Education, Key Laboratory of Henan province for Drug Quality Control and Evaluation, Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaolin Zi</Name>
        <Affiliation>Department of Urology, University of California, Irvine, Orange, USA; Department of Pharmacology, University of California, Irvine, Orange, USA; Department of Pharmaceutical Sciences, University of California, Irvine, Orange, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Haiyang Yu</Name>
        <Affiliation>Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin Key Laboratory of TCM Chemistry and Analysis, Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, 312 Anshanxi Road, Nankai District, Tianjin 300193, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinfeng Li</Name>
        <Affiliation>Kidney Transplantation, The First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe Road, Erqi District, Zhengzhou, Henan 450001, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cheng Yun Jin</Name>
        <Affiliation>School of Pharmaceutical Sciences, Key Laboratory of State Ministry of Education, Key Laboratory of Henan province for Drug Quality Control and Evaluation, Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan 450001, China. Electronic address: cyjin@zzu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Min Liu</Name>
        <Affiliation>School of Pharmaceutical Sciences, Key Laboratory of State Ministry of Education, Key Laboratory of Henan province for Drug Quality Control and Evaluation, Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou University, 100 Kexue Avenue, Zhengzhou, Henan 450001, China. Electronic address: liuhm@zzu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Role of TRPA1 in acute cardiopulmonary toxicity of inhaled acrolein.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27592100</pubmedLink>
    <GrantList>
      <Grant>P50 HL120163</Grant>
      <Grant>R21 ES024030</Grant>
      <Grant>R01 HL089380</Grant>
      <Grant>U54 HL120163</Grant>
      <Grant>T35 ES014559</Grant>
      <Grant>P20 GM103492</Grant>
      <Grant>R01 HL122676</Grant>
    </GrantList>
    <Year>2017</Year>
    <DOI>S0041-008X(16)30251-4</DOI>
    <KeywordList>
      <Keywords>Aldehydes</Keywords>
      <Keywords>Cardiac dysfunction</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Pulmonary injury</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Daniel J. Conklin</Name>
        <Affiliation>Diabetes and Obesity Center, Institute of Molecular Cardiology, Division of Cardiovascular Medicine, Department of Medicine, School of Medicine, University of Louisville, Louisville, KY 40292, United States. Electronic address: dj.conklin@louisville.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Petra Haberzettl</Name>
        <Affiliation>Diabetes and Obesity Center, Institute of Molecular Cardiology, Division of Cardiovascular Medicine, Department of Medicine, School of Medicine, University of Louisville, Louisville, KY 40292, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ganapathy Jagatheesan</Name>
        <Affiliation>Diabetes and Obesity Center, Institute of Molecular Cardiology, Division of Cardiovascular Medicine, Department of Medicine, School of Medicine, University of Louisville, Louisville, KY 40292, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Maiying Kong</Name>
        <Affiliation>Department of Bioinformatics and Biostatistics, School of Public Health &amp; Information Sciences, University of Louisville, Louisville, KY 40292, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Gary W. Hoyle</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, School of Public Health &amp; Information Sciences, University of Louisville, Louisville, KY 40292, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Acute respiratory changes and pulmonary inflammation involving a pathway of TGF-β1 induction in a rat model of chlorine-induced lung injury.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27586366</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.08.027</DOI>
    <KeywordList>
      <Keywords>Airway hyperresponsiveness</Keywords>
      <Keywords>Chemical-induced lung injury</Keywords>
      <Keywords>Chlorine</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Respiratory mechanics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Elisabeth Wigenstam</Name>
        <Affiliation>Swedish Defence Research Agency, CBRN Defence and Security, Umeå, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Linda Elfsmark</Name>
        <Affiliation>Swedish Defence Research Agency, CBRN Defence and Security, Umeå, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Koch</Name>
        <Affiliation>Swedish Defence Research Agency, CBRN Defence and Security, Umeå, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Anders Bucht</Name>
        <Affiliation>Swedish Defence Research Agency, CBRN Defence and Security, Umeå, Sweden; Department of Public Health and Clinical Medicine, Unit of Respiratory Medicine, Umeå University, Umeå, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Sofia Jonasson</Name>
        <Affiliation>Swedish Defence Research Agency, CBRN Defence and Security, Umeå, Sweden. Electronic address: sofia.jonasson@foi.se.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Gene polymorphisms and the risk of warfarin-induced bleeding complications at therapeutic international normalized ratio (INR).</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27581200</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.08.026</DOI>
    <KeywordList>
      <Keywords>Bleeding</Keywords>
      <Keywords>Cytochrome P450 subfamily 2C polypeptide 9 (CYP2C9)</Keywords>
      <Keywords>Genotype</Keywords>
      <Keywords>International normalized ratio (INR)</Keywords>
      <Keywords>NQO1</Keywords>
      <Keywords>Polymorphism</Keywords>
      <Keywords>Warfarin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Leyla Pourgholi</Name>
        <Affiliation>Department of Pathology and Laboratory Medicine, Tehran Heart Center, Tehran University of Medical Sciences, P.O. Box 1411713138, Tehran, Iran; Department of Pharmacology &amp; Toxicology, School of Pharmacy, Kerman University of Medical Sciences, P.O. Box 7616911319, Kerman, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Hamidreza Goodarzynejad</Name>
        <Affiliation>Department of Cardiac Research, Tehran Heart Center, Tehran University of Medical Sciences, P.O. Box 1411713138, Tehran, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Ali Mandegary</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, School of Pharmacy, Kerman University of Medical Sciences, P.O. Box 7616911319, Kerman, Iran; Gastroenterology and Hepatology Research Center, Afzalipour's Hospital, Imam Highway, P.O. Box 7616913911, Kerman, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Shayan Ziaee</Name>
        <Affiliation>Department of Pathology and Laboratory Medicine, Tehran Heart Center, Tehran University of Medical Sciences, P.O. Box 1411713138, Tehran, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Azita Hajhosseini Talasaz</Name>
        <Affiliation>Department of Cardiac Research, Tehran Heart Center, Tehran University of Medical Sciences, P.O. Box 1411713138, Tehran, Iran; Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences.</Affiliation>
      </Author>
      <Author>
        <Name>Arash Jalali</Name>
        <Affiliation>Department of Cardiac Research, Tehran Heart Center, Tehran University of Medical Sciences, P.O. Box 1411713138, Tehran, Iran.</Affiliation>
      </Author>
      <Author>
        <Name>Mohammadali Boroumand</Name>
        <Affiliation>Department of Pathology and Laboratory Medicine, Tehran Heart Center, Tehran University of Medical Sciences, P.O. Box 1411713138, Tehran, Iran. Electronic address: maboroumand@yahoo.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Ocular toxicity of AUY922 in pigmented and albino rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27576608</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.08.025</DOI>
    <KeywordList>
      <Keywords>AUY922</Keywords>
      <Keywords>Electroretinography</Keywords>
      <Keywords>HSP90 inhibitor</Keywords>
      <Keywords>Histopathology</Keywords>
      <Keywords>Ocular toxicity</Keywords>
      <Keywords>Rodents</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Danielle Roman</Name>
        <Affiliation>Preclinical Safety, Novartis Pharma AG, Basel, Switzerland. Electronic address: danielle.roman@novartis.com.</Affiliation>
      </Author>
      <Author>
        <Name>James VerHoeve</Name>
        <Affiliation>Ocular Services on Demand, Madison, WI, USA; University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Heiko Schadt</Name>
        <Affiliation>Preclinical Safety, Novartis Pharma AG, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Axel Vicart</Name>
        <Affiliation>Preclinical Safety, Novartis Pharma AG, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Ursula Junker Walker</Name>
        <Affiliation>Preclinical Safety, Novartis Pharma AG, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Oliver Turner</Name>
        <Affiliation>Preclinical Safety, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Terrilyn A. Richardson</Name>
        <Affiliation>Pharmaceutical Sciences, College of Pharmacy, Northeast Ohio Medical University, Rootstown, OH, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Suzanne T. Wolford</Name>
        <Affiliation>Covance Laboratories Inc., Madison, WI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Paul E. Miller</Name>
        <Affiliation>Comparative Ophthalmic Research Laboratory (CORL), University of Wisconsin, Veterinary Medical Teaching Hospital, Madison, WI, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Zhou</Name>
        <Affiliation>Drug Metabolism and Pharmacokinetics, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Lu</Name>
        <Affiliation>Biologics Clinical Pharmacology, Janssen BioTherapeutics at Johnson &amp; Johnson, Spring House, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mikhail Akimov</Name>
        <Affiliation>Oncology Global Development, Novartis Pharma AG, Basel, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>William Kluwe</Name>
        <Affiliation>Preclinical Safety, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>AHR2 morpholino knockdown reduces the toxicity of total particulate matter to zebrafish embryos.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27576004</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.08.024</DOI>
    <KeywordList>
      <Keywords>AHR pathway</Keywords>
      <Keywords>Cigarette smoke</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Total particulate matter (TPM)</Keywords>
      <Keywords>Zebrafish development</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Andrey Massarsky</Name>
        <Affiliation>Nicholas School of the Environment, Duke University, Durham, NC 27708, USA. Electronic address: andrey.massarsky@duke.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Audrey J. Bone</Name>
        <Affiliation>Nicholas School of the Environment, Duke University, Durham, NC 27708, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wu Dong</Name>
        <Affiliation>Nicholas School of the Environment, Duke University, Durham, NC 27708, USA; School of Animal Science and Technology, Inner Mongolia Provincial Key Laboratory for Toxicants and Animal Disease, Inner Mongolia University for the Nationalities, Tongliao, Inner Mongolia 028000, China.</Affiliation>
      </Author>
      <Author>
        <Name>David E. Hinton</Name>
        <Affiliation>Nicholas School of the Environment, Duke University, Durham, NC 27708, USA.</Affiliation>
      </Author>
      <Author>
        <Name>G. L. Prasad</Name>
        <Affiliation>RAI Services Company, Winston-Salem, NC 27101, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard T. Di Giulio</Name>
        <Affiliation>Nicholas School of the Environment, Duke University, Durham, NC 27708, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Subcellular mechanisms involved in apoptosis induced by aminoglycoside antibiotics: Insights on p53, proteasome and endoplasmic reticulum.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27568863</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.08.020</DOI>
    <KeywordList>
      <Keywords>Aminoglycosides</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Endoplasmic reticulum</Keywords>
      <Keywords>Gentamicin</Keywords>
      <Keywords>Proteasome</Keywords>
      <Keywords>p53</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sophie Denamur</Name>
        <Affiliation>Université catholique de Louvain, Louvain Drug Research Institute, Cellular and Molecular Pharmacology, UCL B1.73.05, avenue E. Mounier, 73 - B1200 Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Lidvine Boland</Name>
        <Affiliation>Université catholique de Louvain, Louvain Drug Research Institute, Cellular and Molecular Pharmacology, UCL B1.73.05, avenue E. Mounier, 73 - B1200 Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Maxime Beyaert</Name>
        <Affiliation>Université catholique de Louvain, de Duve Institute, Laboratory of Physiological Chemistry, UCL B1.75.08, avenue Hippocrate, 75 B -1200 Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Sandrine L. Verstraeten</Name>
        <Affiliation>Université catholique de Louvain, Louvain Drug Research Institute, Cellular and Molecular Pharmacology, UCL B1.73.05, avenue E. Mounier, 73 - B1200 Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Marianne Fillet</Name>
        <Affiliation>University of Liege, CIRM, Department of Pharmacy, Laboratory for the Analysis of Medicines, Quartier Hopital, Avenue Hippocrate, 15, B36, Tower 4, 4000 Liège 1, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Paul M. Tulkens</Name>
        <Affiliation>Université catholique de Louvain, Louvain Drug Research Institute, Cellular and Molecular Pharmacology, UCL B1.73.05, avenue E. Mounier, 73 - B1200 Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Françoise Bontemps</Name>
        <Affiliation>Université catholique de Louvain, de Duve Institute, Laboratory of Physiological Chemistry, UCL B1.75.08, avenue Hippocrate, 75 B -1200 Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Marie Paule Mingeot-Leclercq</Name>
        <Affiliation>Université catholique de Louvain, Louvain Drug Research Institute, Cellular and Molecular Pharmacology, UCL B1.73.05, avenue E. Mounier, 73 - B1200 Brussels, Belgium.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Coagulin-L ameliorates TLR4 induced oxidative damage and immune response by regulating mitochondria and NOX-derived ROS.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27568862</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.08.022</DOI>
    <KeywordList>
      <Keywords>Coagulin-L</Keywords>
      <Keywords>Endotoxemia</Keywords>
      <Keywords>NADPH oxidase</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>ROS</Keywords>
      <Keywords>TLR4</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sukka Santosh Reddy</Name>
        <Affiliation>Pharmacology Division, CSIR-Central Drug Research Institute, Lucknow 226031, India.</Affiliation>
      </Author>
      <Author>
        <Name>Parul Chauhan</Name>
        <Affiliation>Medicinal and Process Chemistry Division, CSIR-Central Drug Research Institute, Lucknow 226031, India.</Affiliation>
      </Author>
      <Author>
        <Name>Preeti Maurya</Name>
        <Affiliation>Pharmacology Division, CSIR-Central Drug Research Institute, Lucknow 226031, India; Academy of Scientific and Innovative Research, New Delhi 110025, India.</Affiliation>
      </Author>
      <Author>
        <Name>Deepika Saini</Name>
        <Affiliation>Medicinal and Process Chemistry Division, CSIR-Central Drug Research Institute, Lucknow 226031, India.</Affiliation>
      </Author>
      <Author>
        <Name>Prem Prakash Yadav</Name>
        <Affiliation>Medicinal and Process Chemistry Division, CSIR-Central Drug Research Institute, Lucknow 226031, India. Electronic address: pp_yadav@cdri.res.in.</Affiliation>
      </Author>
      <Author>
        <Name>Manoj Kumar Barthwal</Name>
        <Affiliation>Pharmacology Division, CSIR-Central Drug Research Institute, Lucknow 226031, India. Electronic address: manojbarthwal@cdri.res.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>6-Shogaol, an active compound of ginger, alleviates allergic dermatitis-like skin lesions via cytokine inhibition by activating the Nrf2 pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27562088</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30242-3</DOI>
    <KeywordList>
      <Keywords>2,4-Dinitrochlorobenzene</Keywords>
      <Keywords>6-Shogaol</Keywords>
      <Keywords>Allergic dermatitis</Keywords>
      <Keywords>Antiinflammation</Keywords>
      <Keywords>Antioxidant</Keywords>
      <Keywords>Nrf2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gunhyuk Park</Name>
        <Affiliation>The K-herb Research Center, Korea Institute of Oriental Medicine, 1672 Yuseong-daero, Yuseong-gu, Daejeon 34054, Republic of Korea. Electronic address: uranos5@kiom.re.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Dal Seok Oh</Name>
        <Affiliation>The K-herb Research Center, Korea Institute of Oriental Medicine, 1672 Yuseong-daero, Yuseong-gu, Daejeon 34054, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Mi Gi Lee</Name>
        <Affiliation>Major in Cosmeceutical Science, Division of Bio-technology and Convergence, Daegu Haany University, Gyeongsan, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Chang Eon Lee</Name>
        <Affiliation>Major in Cosmeceutical Science, Division of Bio-technology and Convergence, Daegu Haany University, Gyeongsan, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Ung Kim</Name>
        <Affiliation>Department of Pharmaceutical Engineering, College of Biomedical Science, Daegu Haany University, Republic of Korea. Electronic address: ykim@dhu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>PKC-alpha modulation by miR-483-3p in platinum-resistant ovarian carcinoma cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27554045</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30220-4</DOI>
    <KeywordList>
      <Keywords>Drug response</Keywords>
      <Keywords>Ovarian carcinoma</Keywords>
      <Keywords>PKC-alpha</Keywords>
      <Keywords>Platinum compounds</Keywords>
      <Keywords>miR-483-3p</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Noemi Arrighetti</Name>
        <Affiliation>Molecular Pharmacology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 42, Milan 20133, Italy. Electronic address: Noemi.Arrighetti@istitutotumori.mi.it.</Affiliation>
      </Author>
      <Author>
        <Name>Giacomo Cossa</Name>
        <Affiliation>Molecular Pharmacology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 42, Milan 20133, Italy. Electronic address: Gia.Cossa@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Loris De Cecco</Name>
        <Affiliation>Functional Genomics and Bioinformatics, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 42, Milan 20133, Italy. Electronic address: Loris.Dececco@istitutotumori.mi.it.</Affiliation>
      </Author>
      <Author>
        <Name>Simone Stucchi</Name>
        <Affiliation>Molecular Pharmacology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 42, Milan 20133, Italy. Electronic address: Simone.Stucchi@istitutotumori.mi.it.</Affiliation>
      </Author>
      <Author>
        <Name>Nives Carenini</Name>
        <Affiliation>Molecular Pharmacology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 42, Milan 20133, Italy. Electronic address: Nives.Carenini@istitutotumori.mi.it.</Affiliation>
      </Author>
      <Author>
        <Name>Elisabetta Corna</Name>
        <Affiliation>Molecular Pharmacology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 42, Milan 20133, Italy. Electronic address: Elisabetta.Corna@istitutotumori.mi.it.</Affiliation>
      </Author>
      <Author>
        <Name>Paolo Gandellini</Name>
        <Affiliation>Molecular Pharmacology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 42, Milan 20133, Italy. Electronic address: Paolo.Gandellini@istitutotumori.mi.it.</Affiliation>
      </Author>
      <Author>
        <Name>Nadia Zaffaroni</Name>
        <Affiliation>Molecular Pharmacology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 42, Milan 20133, Italy. Electronic address: Nadia.Zaffaroni@istitutotumori.mi.it.</Affiliation>
      </Author>
      <Author>
        <Name>Paola Perego</Name>
        <Affiliation>Molecular Pharmacology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 42, Milan 20133, Italy. Electronic address: paola.perego@istitutotumori.mi.it.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Gatti</Name>
        <Affiliation>Molecular Pharmacology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, via Amadeo 42, Milan 20133, Italy. Electronic address: Laura.Gatti@istitutotumori.mi.it.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Triptolide disrupts the actin-based Sertoli-germ cells adherens junctions by inhibiting Rho GTPases expression.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27554044</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30240-X</DOI>
    <KeywordList>
      <Keywords>Adherens Junctions</Keywords>
      <Keywords>Ectoplasmic Specializations</Keywords>
      <Keywords>Rho GTPases</Keywords>
      <Keywords>Triptolide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiang Wang</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fang Zhao</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhong Ming Lv</Name>
        <Affiliation>Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Qin Shi</Name>
        <Affiliation>Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Yong Zhang</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing 210009, China; Key Laboratory of Drug Quality Control and Pharmacovigilance, China Pharmaceutical University, Nanjing, China; State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China. Electronic address: lyzhang@cpu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Yan</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing 210009, China. Electronic address: brookming@cpu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Destabilization of mitochondrial functions as a target against breast cancer progression: Role of TPP(+)-linked-polyhydroxybenzoates.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27554043</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.08.018</DOI>
    <KeywordList>
      <Keywords>Human breast cancer</Keywords>
      <Keywords>Mitochondrially-targeted decyl polyhydroxybenzoates</Keywords>
      <Keywords>Transmembrane potential</Keywords>
      <Keywords>Triphenylphosphonium-derivatives</Keywords>
      <Keywords>Weak uncoupling of the oxidative phosphorylation system</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cristian Sandoval-Acuña</Name>
        <Affiliation>Clinical and Molecular Pharmacology Program, Institute of Biomedical Sciences (ICBM), Faculty of Medicine, University of Chile, Av. Independencia 1027, Santiago 8380453, Chile; Laboratory of Antioxidants, Nutrition and Food Technology Institute, University of Chile, El Líbano 5524, Santiago 7830490, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Sebastián Fuentes-Retamal</Name>
        <Affiliation>Clinical and Molecular Pharmacology Program, Institute of Biomedical Sciences (ICBM), Faculty of Medicine, University of Chile, Av. Independencia 1027, Santiago 8380453, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Daniela Guzmán-Rivera</Name>
        <Affiliation>Clinical and Molecular Pharmacology Program, Institute of Biomedical Sciences (ICBM), Faculty of Medicine, University of Chile, Av. Independencia 1027, Santiago 8380453, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Liliana Peredo-Silva</Name>
        <Affiliation>Clinical and Molecular Pharmacology Program, Institute of Biomedical Sciences (ICBM), Faculty of Medicine, University of Chile, Av. Independencia 1027, Santiago 8380453, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Matías Madrid-Rojas</Name>
        <Affiliation>Department of Chemistry, Faculty of Basic Sciences, Metropolitan Educational Sciences University, Av. José Pedro Alessandri 774, Santiago 7760197, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Solange Rebolledo</Name>
        <Affiliation>Department of Chemistry, Faculty of Basic Sciences, Metropolitan Educational Sciences University, Av. José Pedro Alessandri 774, Santiago 7760197, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Vicente Castro-Castillo</Name>
        <Affiliation>Department of Organic and Physical Chemistry, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santos Dumont 964, Santiago 8380494, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Mario Pavani</Name>
        <Affiliation>Clinical and Molecular Pharmacology Program, Institute of Biomedical Sciences (ICBM), Faculty of Medicine, University of Chile, Av. Independencia 1027, Santiago 8380453, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Mabel Catalán</Name>
        <Affiliation>Clinical and Molecular Pharmacology Program, Institute of Biomedical Sciences (ICBM), Faculty of Medicine, University of Chile, Av. Independencia 1027, Santiago 8380453, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Diego Maya</Name>
        <Affiliation>Clinical and Molecular Pharmacology Program, Institute of Biomedical Sciences (ICBM), Faculty of Medicine, University of Chile, Av. Independencia 1027, Santiago 8380453, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>José A. Jara</Name>
        <Affiliation>Unit of Pharmacology and Pharmacogenetics, Institute of Dental Sciences Research (ICOD), Faculty of Dentistry, University of Chile, Sergio Livingstone Polhammer 94, Santiago 8380492, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Eduardo Parra</Name>
        <Affiliation>School of Medicine, Faculty of Health Sciences, University of Tarapacá, Av. General Velásquez 1775, Arica 1000007, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Gloria M. Calaf</Name>
        <Affiliation>Institute for Advanced Research, University of Tarapacá, Antofagasta 1520, Arica 1001236, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Hernán Speisky</Name>
        <Affiliation>Laboratory of Antioxidants, Nutrition and Food Technology Institute, University of Chile, El Líbano 5524, Santiago 7830490, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Jorge Ferreira</Name>
        <Affiliation>Clinical and Molecular Pharmacology Program, Institute of Biomedical Sciences (ICBM), Faculty of Medicine, University of Chile, Av. Independencia 1027, Santiago 8380453, Chile. Electronic address: jferreir@med.uchile.cl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicology and Applied Pharmacology (TAAP): Building on the past for the new science of the twenty-first century.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27554042</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.08.016</DOI>
    <AuthorList>
      <Author>
        <Name>Lawrence H. Lash</Name>
        <Affiliation>Department of Pharmacology, Wayne State University School of Medicine, Detroit, MI 48201, USA. Electronic address: l.h.lash@wayne.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Larry Lash</Name>
        <Affiliation>Department of Pharmacology, Wayne State University School of Medicine, Detroit, MI 48201, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chemopreventive effect and angiogenic activity of punicalagin isolated from leaves of Lafoensia pacari A. St.-Hil.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27546523</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30238-1</DOI>
    <KeywordList>
      <Keywords>Angiogenesis</Keywords>
      <Keywords>Anticytotoxicity</Keywords>
      <Keywords>Antigenotoxicity</Keywords>
      <Keywords>Chemoprevention</Keywords>
      <Keywords>DNA repair</Keywords>
      <Keywords>Punicalagin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cristiene Costa Carneiro</Name>
        <Affiliation>Instituto de Ciências Biológicas, Universidade Federal de Goiás, 74001970 Goiânia, GO, Brazil. Electronic address: profacristiene@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Suzana da Costa Santos</Name>
        <Affiliation>Instituto de Química, Universidade Federal de Goiás, 74001970 Goiânia, GO, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ruy de Souza Lino</Name>
        <Affiliation>Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, 74605050 Goiânia, GO, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Teresa Freitas Bara</Name>
        <Affiliation>Faculdade de Farmácia, Universidade Federal de Goiás, 74605170 Goiânia, GO, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Beatriz Abdallah Chaibub</Name>
        <Affiliation>Faculdade de Farmácia, Universidade Federal de Goiás, 74605170 Goiânia, GO, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Paulo Roberto de Melo Reis</Name>
        <Affiliation>Laboratório de Estudos Experimentais e Biotecnológicos, Pontifícia Universidade Católica de Goiás, 74605010 Goiânia, GO, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Dwight Assis Chaves</Name>
        <Affiliation>Laboratório de Estudos Experimentais e Biotecnológicos, Pontifícia Universidade Católica de Goiás, 74605010 Goiânia, GO, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Antônio Jorge Ribeiro da Silva</Name>
        <Affiliation>Núcleo de Pesquisas de Produtos Naturais, Centro de Ciências da Saúde, Universidade Federal do Rio de Janeiro, 21941590 Rio de Janeiro, RJ, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Luana Santos Silva</Name>
        <Affiliation>Instituto de Ciências Biológicas, Universidade Federal de Goiás, 74001970 Goiânia, GO, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Daniela de Melo E Silva</Name>
        <Affiliation>Instituto de Ciências Biológicas, Universidade Federal de Goiás, 74001970 Goiânia, GO, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Lee Chen-Chen</Name>
        <Affiliation>Instituto de Ciências Biológicas, Universidade Federal de Goiás, 74001970 Goiânia, GO, Brazil.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>SHP-1 is directly activated by the aryl hydrocarbon receptor and regulates BCL-6 in the presence of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27546522</pubmedLink>
    <GrantList>
      <Grant>P42 ES004911</Grant>
      <Grant>R01 ES002520</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30237-X</DOI>
    <KeywordList>
      <Keywords>Aryl hydrocarbon receptor</Keywords>
      <Keywords>Human B cell activation</Keywords>
      <Keywords>PTPN6</Keywords>
      <Keywords>SHP-1</Keywords>
      <Keywords>TCDD immunotoxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ashwini S. Phadnis-Moghe</Name>
        <Affiliation>Genetics Program, Michigan State University, East Lansing, MI 48824, United States; Institute for Integrative Toxicology, Michigan State University, East Lansing, MI 48824, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jinpeng Li</Name>
        <Affiliation>Genetics Program, Michigan State University, East Lansing, MI 48824, United States; Institute for Integrative Toxicology, Michigan State University, East Lansing, MI 48824, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Robert B. Crawford</Name>
        <Affiliation>Institute for Integrative Toxicology, Michigan State University, East Lansing, MI 48824, United States; Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI 48824, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Norbert E. Kaminski</Name>
        <Affiliation>Institute for Integrative Toxicology, Michigan State University, East Lansing, MI 48824, United States; Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI 48824, United States. Electronic address: kamins11@msu.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Phenotypically anchored transcriptome profiling of developmental exposure to the antimicrobial agent, triclosan, reveals hepatotoxicity in embryonic zebrafish.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27538710</pubmedLink>
    <GrantList>
      <Grant>P30 ES000210</Grant>
      <Grant>P42 ES016465</Grant>
      <Grant>T32 ES007060</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30227-7</DOI>
    <KeywordList>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Phenotypic anchoring</Keywords>
      <Keywords>ToxCast</Keywords>
      <Keywords>Transcriptomics</Keywords>
      <Keywords>Triclosan</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Derik E. Haggard</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Pamela D. Noyes</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR, United States; Office of Science Coordination and Policy (OSCP), Office of Chemical Safety and Pollution Prevention, U.S. Environmental Protection Agency, Washington, DC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Katrina M. Waters</Name>
        <Affiliation>Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Robert L. Tanguay</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR, United States. Electronic address: Robert.Tanguay@oregonstate.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>The authors have no conflicts of interest to declare.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chronic plus binge ethanol exposure causes more severe pancreatic injury and inflammation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27538709</pubmedLink>
    <GrantList>
      <Grant>T32 DK007778</Grant>
      <Grant>R01 AA015407</Grant>
      <Grant>R01 AA017226</Grant>
      <Grant>P30 CA177558</Grant>
      <Grant>I01 BX001721</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30228-9</DOI>
    <KeywordList>
      <Keywords>Alcohol</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Drinking pattern</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Insulin</Keywords>
      <Keywords>Pancreatitis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhenhua Ren</Name>
        <Affiliation>Department of Anatomy, School of Basic Medicine, Anhui Medical University, Hefei, Anhui, China 230032; Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40536, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Fanmuyi Yang</Name>
        <Affiliation>Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40536, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Wang</Name>
        <Affiliation>Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40536, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Yongchao Wang</Name>
        <Affiliation>Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40536, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mei Xu</Name>
        <Affiliation>Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40536, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jacqueline A. Frank</Name>
        <Affiliation>Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40536, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Zun Ji Ke</Name>
        <Affiliation>Department of Biochemistry, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhuo Zhang</Name>
        <Affiliation>Department of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, KY 40536, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Xianglin Shi</Name>
        <Affiliation>Department of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, KY 40536, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jia Luo</Name>
        <Affiliation>Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40536, United States. Electronic address: jialuo888@uky.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Role of aryl hydrocarbon receptor polymorphisms on TCDD-mediated CYP1B1 induction and IgM suppression by human B cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27535091</pubmedLink>
    <GrantList>
      <Grant>P42 ES004911</Grant>
      <Grant>R01 ES002520</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.08.011</DOI>
    <KeywordList>
      <Keywords>2,3,7,8-Tetrachlorodibenzo-p-dioxin</Keywords>
      <Keywords>B cells</Keywords>
      <Keywords>Single nucleotide polymorphisms</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Natalia Kovalova</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Michigan State University, Lansing, MI 48824, USA; Institute for Integrative Toxicology, Michigan State University, Lansing, MI 48824, USA. Electronic address: kovalova@msu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Manzan</Name>
        <Affiliation>Institute for Integrative Toxicology, Michigan State University, Lansing, MI 48824, USA. Electronic address: ale.manzan@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Robert Crawford</Name>
        <Affiliation>Institute for Integrative Toxicology, Michigan State University, Lansing, MI 48824, USA. Electronic address: crawfo28@msu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Norbert Kaminski</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Michigan State University, Lansing, MI 48824, USA; Institute for Integrative Toxicology, Michigan State University, Lansing, MI 48824, USA. Electronic address: kamins11@msu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Environmentally relevant organophosphate triesters in herring gulls: In vitro biotransformation and kinetics and diester metabolite formation using a hepatic microsomal assay.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27523639</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30222-8</DOI>
    <KeywordList>
      <Keywords>Herring gull</Keywords>
      <Keywords>In vitro biotransformation</Keywords>
      <Keywords>Liver microsomes</Keywords>
      <Keywords>Metabolism</Keywords>
      <Keywords>Organophosphate esters</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alana K. Greaves</Name>
        <Affiliation>Wildlife and Landscape Directorate, Science and Technology Branch, Environment and Climate Change Canada, National Wildlife Research Centre, Carleton University, Ottawa, ON K1A 0H3, Canada; Department of Chemistry, Carleton University, Ottawa, ON K1S 5B6, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Guanyong Su</Name>
        <Affiliation>Wildlife and Landscape Directorate, Science and Technology Branch, Environment and Climate Change Canada, National Wildlife Research Centre, Carleton University, Ottawa, ON K1A 0H3, Canada; Department of Chemistry, Carleton University, Ottawa, ON K1S 5B6, Canada. Electronic address: guanyong.su85@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Robert J. Letcher</Name>
        <Affiliation>Wildlife and Landscape Directorate, Science and Technology Branch, Environment and Climate Change Canada, National Wildlife Research Centre, Carleton University, Ottawa, ON K1A 0H3, Canada; Department of Chemistry, Carleton University, Ottawa, ON K1S 5B6, Canada. Electronic address: robert.letcher@canada.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Global gene expression profiles in brain regions reflecting abnormal neuronal and glial functions targeting myelin sheaths after 28-day exposure to cuprizone in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27523638</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30224-1</DOI>
    <KeywordList>
      <Keywords>Cuprizone (CPZ)</Keywords>
      <Keywords>Expression microarray</Keywords>
      <Keywords>Glial cell development</Keywords>
      <Keywords>KLOTHO</Keywords>
      <Keywords>Myelination</Keywords>
      <Keywords>Synaptic transmission</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hajime Abe</Name>
        <Affiliation>Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shi, Tokyo 183-8509, Japan; Pathogenetic Veterinary Science, United Graduate School of Veterinary Sciences, Gifu University, 1-1 Yanagido, Gifu-shi, Gifu 501-1193, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Fumiyo Saito</Name>
        <Affiliation>Chemicals Evaluation and Research Institute, Japan, 1-4-25 Koraku, Bunkyo-ku, Tokyo 112-0004, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takeshi Tanaka</Name>
        <Affiliation>Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shi, Tokyo 183-8509, Japan; Pathogenetic Veterinary Science, United Graduate School of Veterinary Sciences, Gifu University, 1-1 Yanagido, Gifu-shi, Gifu 501-1193, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Sayaka Mizukami</Name>
        <Affiliation>Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shi, Tokyo 183-8509, Japan; Pathogenetic Veterinary Science, United Graduate School of Veterinary Sciences, Gifu University, 1-1 Yanagido, Gifu-shi, Gifu 501-1193, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yousuke Watanabe</Name>
        <Affiliation>Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shi, Tokyo 183-8509, Japan; Pathogenetic Veterinary Science, United Graduate School of Veterinary Sciences, Gifu University, 1-1 Yanagido, Gifu-shi, Gifu 501-1193, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Nobuya Imatanaka</Name>
        <Affiliation>Chemicals Evaluation and Research Institute, Japan, 1-4-25 Koraku, Bunkyo-ku, Tokyo 112-0004, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yumi Akahori</Name>
        <Affiliation>Chemicals Evaluation and Research Institute, Japan, 1-4-25 Koraku, Bunkyo-ku, Tokyo 112-0004, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Toshinori Yoshida</Name>
        <Affiliation>Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shi, Tokyo 183-8509, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Makoto Shibutani</Name>
        <Affiliation>Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shi, Tokyo 183-8509, Japan. Electronic address: mshibuta@cc.tuat.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Role of necroptosis in autophagy signaling during hepatic ischemia and reperfusion.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27521978</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30225-3</DOI>
    <KeywordList>
      <Keywords>Autophagy</Keywords>
      <Keywords>Ischemia/reperfusion</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Necroptosis</Keywords>
      <Keywords>Necrostatin-1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jeong Min Hong</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seok Joo Kim</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sun Mee Lee</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea. Electronic address: sunmee@skku.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chlorpyrifos- and chlorpyrifos oxon-induced neurite retraction in pre-differentiated N2a cells is associated with transient hyperphosphorylation of neurofilament heavy chain and ERK 1/2.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27521977</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30223-X</DOI>
    <KeywordList>
      <Keywords>Chlorpyrifos</Keywords>
      <Keywords>Microtubules</Keywords>
      <Keywords>Mouse N2a neuroblastoma cells</Keywords>
      <Keywords>Neurite outgrowth</Keywords>
      <Keywords>Neurofilaments</Keywords>
      <Keywords>Neurotoxicity</Keywords>
      <Keywords>Organophosphate toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ramya A. Sindi</Name>
        <Affiliation>Interdisciplinary Biomedical Research Centre, School of Science and Technology, Nottingham Trent University, Clifton Lane, Nottingham NG11 8NS, UK; School of Applied Medical Sciences, Umm Al-Qura University, Makkah, Saudi Arabia. Electronic address: ramya.sindi2010@my.ntu.ac.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Wayne Harris</Name>
        <Affiliation>Interdisciplinary Biomedical Research Centre, School of Science and Technology, Nottingham Trent University, Clifton Lane, Nottingham NG11 8NS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Gordon Arnott</Name>
        <Affiliation>School of Science and Technology, Nottingham Trent University, Nottingham NG11 8NS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>John Flaskos</Name>
        <Affiliation>Laboratory of Biochemistry and Toxicology, School of Veterinary Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.</Affiliation>
      </Author>
      <Author>
        <Name>Chris Lloyd Mills</Name>
        <Affiliation>School of Science and Technology, Nottingham Trent University, Nottingham NG11 8NS, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Alan J. Hargreaves</Name>
        <Affiliation>Interdisciplinary Biomedical Research Centre, School of Science and Technology, Nottingham Trent University, Clifton Lane, Nottingham NG11 8NS, UK. Electronic address: alan.hargreaves@ntu.ac.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Interaction between amiodarone and hepatitis-C virus nucleotide inhibitors in human induced pluripotent stem cell-derived cardiomyocytes and HEK-293 Cav1.2 over-expressing cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27520758</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30221-6</DOI>
    <KeywordList>
      <Keywords>Amiodarone</Keywords>
      <Keywords>Calcium handling mechanism;</Keywords>
      <Keywords>Drug-drug interaction</Keywords>
      <Keywords>Hepatitis-C virus nucleoside inhibitors</Keywords>
      <Keywords>Sofosbuvir</Keywords>
      <Keywords>hiPSC-derived cardiomyocytes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Armando Lagrutta</Name>
        <Affiliation>Merck Research Laboratories, SALAR Division, Safety &amp; Exploratory Pharmacology (SEP) Department, West Point, PA, USA. Electronic address: armando_lagrutta@merck.com.</Affiliation>
      </Author>
      <Author>
        <Name>Haoyu Zeng</Name>
        <Affiliation>Merck Research Laboratories, SALAR Division, Safety &amp; Exploratory Pharmacology (SEP) Department, West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John Imredy</Name>
        <Affiliation>Merck Research Laboratories, SALAR Division, Safety &amp; Exploratory Pharmacology (SEP) Department, West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bharathi Balasubramanian</Name>
        <Affiliation>Merck Research Laboratories, SALAR Division, Safety &amp; Exploratory Pharmacology (SEP) Department, West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Spencer Dech</Name>
        <Affiliation>Merck Research Laboratories, SALAR Division, Safety &amp; Exploratory Pharmacology (SEP) Department, West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Edward Lis</Name>
        <Affiliation>Merck Research Laboratories, SALAR Division, Safety &amp; Exploratory Pharmacology (SEP) Department, West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jixin Wang</Name>
        <Affiliation>Merck Research Laboratories, SALAR Division, Safety &amp; Exploratory Pharmacology (SEP) Department, West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Zhai</Name>
        <Affiliation>Merck Research Laboratories, SALAR Division, Safety &amp; Exploratory Pharmacology (SEP) Department, West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joseph DeGeorge</Name>
        <Affiliation>Merck Research Laboratories, SALAR Division, Safety &amp; Exploratory Pharmacology (SEP) Department, West Point, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Frederick Sannajust</Name>
        <Affiliation>Merck Research Laboratories, SALAR Division, Safety &amp; Exploratory Pharmacology (SEP) Department, West Point, PA, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Hepatocyte-protective effect of nectandrin B, a nutmeg lignan, against oxidative stress: Role of Nrf2 activation through ERK phosphorylation and AMPK-dependent inhibition of GSK-3β.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27511913</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30218-6</DOI>
    <KeywordList>
      <Keywords>Antioxidant enzymes</Keywords>
      <Keywords>ERK</Keywords>
      <Keywords>GSK-3β</Keywords>
      <Keywords>Hepatocyte protection</Keywords>
      <Keywords>Nectandrin B</Keywords>
      <Keywords>Nrf2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jae Sook Song</Name>
        <Affiliation>Department of Pharmacy, College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Gyeonggi-do 15588, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Kyung Kim</Name>
        <Affiliation>Department of Pharmacy, College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Gyeonggi-do 15588, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Won Choi</Name>
        <Affiliation>Department of Pharmacy, College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Gyeonggi-do 15588, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Won Keun Oh</Name>
        <Affiliation>College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Young Mi Kim</Name>
        <Affiliation>Department of Pharmacy, College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Gyeonggi-do 15588, Republic of Korea. Electronic address: ymikim12@hanyang.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Salvianolic acid B protects against paraquat-induced pulmonary injury by mediating Nrf2/Nox4 redox balance and TGF-β1/Smad3 signaling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27507327</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.08.004</DOI>
    <KeywordList>
      <Keywords>NOX4</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>Paraquat</Keywords>
      <Keywords>Pulmonary fibrosis</Keywords>
      <Keywords>Salvianolic acid B</Keywords>
      <Keywords>TGF-β1/Smad3 signaling pathway</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bin Liu</Name>
        <Affiliation>Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Logistic University of Chinese People's Armed Police Force, Tianjin 300162, China. Electronic address: iamicehe@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Cao</Name>
        <Affiliation>Logistics University of Chinese People's Armed Police Force, Tianjin 300162, China; Tianjin Key Laboratory of Cardiovascular Remodeling and Target Organ Injury, Tianjin, 300162, China. Electronic address: caobo19814@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Di Zhang</Name>
        <Affiliation>Department of Otorhinolaryngology Head and Neck Surgery, Institute of Otorhinolaryngology, Tianjin First Center Hospital, Tianjin 300192, China. Electronic address: zhangdibad@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Na Xiao</Name>
        <Affiliation>Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Logistic University of Chinese People's Armed Police Force, Tianjin 300162, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Chen</Name>
        <Affiliation>Logistics University of Chinese People's Armed Police Force, Tianjin 300162, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guo Qiang Li</Name>
        <Affiliation>Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Logistic University of Chinese People's Armed Police Force, Tianjin 300162, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shou Chun Peng</Name>
        <Affiliation>Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Logistic University of Chinese People's Armed Police Force, Tianjin 300162, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Qing Wei</Name>
        <Affiliation>Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Logistic University of Chinese People's Armed Police Force, Tianjin 300162, China. Electronic address: luqing-wei@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Disruption of motor behavior and injury to the CNS induced by 3-thienylboronic acid in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27495897</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30217-4</DOI>
    <KeywordList>
      <Keywords>Basal ganglia</Keywords>
      <Keywords>Boron</Keywords>
      <Keywords>Boron-containing compounds</Keywords>
      <Keywords>Cerebellum</Keywords>
      <Keywords>Movement disorders</Keywords>
      <Keywords>Raman spectroscopy</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>E. D. Farfán-García</Name>
        <Affiliation>Academias de Fisiología Humana, Bioquímica y Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina del Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón s/n, 11340 Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>M. Pérez-Rodríguez</Name>
        <Affiliation>Academias de Fisiología Humana, Bioquímica y Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina del Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón s/n, 11340 Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>C. Espinosa-García</Name>
        <Affiliation>Departamento de Biología de la Reproducción, Universidad Autónoma Metropolitana (UAM), 09310 Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>N. T. Castillo-Mendieta</Name>
        <Affiliation>Academias de Fisiología Humana, Bioquímica y Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina del Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón s/n, 11340 Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>M. Maldonado-Castro</Name>
        <Affiliation>Academias de Fisiología Humana, Bioquímica y Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina del Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón s/n, 11340 Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>E. Querejeta</Name>
        <Affiliation>Academias de Fisiología Humana, Bioquímica y Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina del Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón s/n, 11340 Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>J. G. Trujillo-Ferrara</Name>
        <Affiliation>Academias de Fisiología Humana, Bioquímica y Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina del Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón s/n, 11340 Ciudad de México, Mexico.</Affiliation>
      </Author>
      <Author>
        <Name>M. A. Soriano-Ursúa</Name>
        <Affiliation>Academias de Fisiología Humana, Bioquímica y Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina del Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón s/n, 11340 Ciudad de México, Mexico. Electronic address: msoriano@ipn.mx.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>DEHP exposure in utero disturbs sex determination and is potentially linked with precocious puberty in female mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27495896</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30216-2</DOI>
    <KeywordList>
      <Keywords>DEHP</Keywords>
      <Keywords>Follicular atresia</Keywords>
      <Keywords>Gonadal development</Keywords>
      <Keywords>Granulosa cells</Keywords>
      <Keywords>In utero exposure</Keywords>
      <Keywords>Sex determination</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yongan Wang</Name>
        <Affiliation>Key Laboratory of Industrial Ecology and Environmental Engineering (MOE), School of Environmental Science and Technology, Dalian University of Technology, Dalian, Liaoning 116024, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qing Yang</Name>
        <Affiliation>School of Life Science and Biotechnology, Dalian University of Technology, Dalian, Liaoning 116024, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Liu</Name>
        <Affiliation>Key Laboratory of Industrial Ecology and Environmental Engineering (MOE), School of Environmental Science and Technology, Dalian University of Technology, Dalian, Liaoning 116024, China. Electronic address: liu_wei@dlut.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Mingxi Yu</Name>
        <Affiliation>Key Laboratory of Industrial Ecology and Environmental Engineering (MOE), School of Environmental Science and Technology, Dalian University of Technology, Dalian, Liaoning 116024, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhou Zhang</Name>
        <Affiliation>Key Laboratory of Industrial Ecology and Environmental Engineering (MOE), School of Environmental Science and Technology, Dalian University of Technology, Dalian, Liaoning 116024, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoyu Cui</Name>
        <Affiliation>Key Laboratory of Industrial Ecology and Environmental Engineering (MOE), School of Environmental Science and Technology, Dalian University of Technology, Dalian, Liaoning 116024, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Additive effects of levonorgestrel and ethinylestradiol on brain aromatase (cyp19a1b) in zebrafish specific in vitro and in vivo bioassays.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27491593</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30215-0</DOI>
    <KeywordList>
      <Keywords>Brain aromatase</Keywords>
      <Keywords>Ethinylestradiol</Keywords>
      <Keywords>Levonorgestrel</Keywords>
      <Keywords>Mixture</Keywords>
      <Keywords>Transgenic zebrafish</Keywords>
      <Keywords>U251-MG cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>N. Hinfray</Name>
        <Affiliation>INERIS, Unité d'écotoxicologie in vitro et in vivo, Verneuil-en-Halatte, France. Electronic address: nathalie.hinfray@ineris.fr.</Affiliation>
      </Author>
      <Author>
        <Name>C. Tebby</Name>
        <Affiliation>INERIS, Unité Modèles pour l'Ecotoxicologie et la Toxicologie, Verneuil-en-Halatte, France.</Affiliation>
      </Author>
      <Author>
        <Name>C. Garoche</Name>
        <Affiliation>INERIS, Unité d'écotoxicologie in vitro et in vivo, Verneuil-en-Halatte, France.</Affiliation>
      </Author>
      <Author>
        <Name>B. Piccini</Name>
        <Affiliation>INERIS, Unité d'écotoxicologie in vitro et in vivo, Verneuil-en-Halatte, France.</Affiliation>
      </Author>
      <Author>
        <Name>G. Bourgine</Name>
        <Affiliation>IRSET, équipe NEED, Université de Rennes 1, Rennes, France.</Affiliation>
      </Author>
      <Author>
        <Name>S. Aït-Aïssa</Name>
        <Affiliation>INERIS, Unité d'écotoxicologie in vitro et in vivo, Verneuil-en-Halatte, France.</Affiliation>
      </Author>
      <Author>
        <Name>O. Kah</Name>
        <Affiliation>IRSET, équipe NEED, Université de Rennes 1, Rennes, France.</Affiliation>
      </Author>
      <Author>
        <Name>F. Pakdel</Name>
        <Affiliation>IRSET, Inserm U1085, équipe TREC, Université de Rennes 1, Rennes, France.</Affiliation>
      </Author>
      <Author>
        <Name>F. Brion</Name>
        <Affiliation>INERIS, Unité d'écotoxicologie in vitro et in vivo, Verneuil-en-Halatte, France.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Terbinafine inhibits gap junctional intercellular communication.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27487578</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30214-9</DOI>
    <KeywordList>
      <Keywords>Gap junctional intercellular communication</Keywords>
      <Keywords>I-YFP GJIC assay</Keywords>
      <Keywords>Naftifine</Keywords>
      <Keywords>Terbinafine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ju Yeun Lee</Name>
        <Affiliation>College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 21983, Republic of Korea. Electronic address: whitewndus@naver.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sei Mee Yoon</Name>
        <Affiliation>College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 21983, Republic of Korea; Department of Integrated OMICS for Biomedical Sciences, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-749, Republic of Korea. Electronic address: sei_mee@naver.com.</Affiliation>
      </Author>
      <Author>
        <Name>Eun Ju Choi</Name>
        <Affiliation>College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 21983, Republic of Korea. Electronic address: yureas@naver.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jinu Lee</Name>
        <Affiliation>College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 21983, Republic of Korea. Electronic address: jinulee@yonsei.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A preliminary evaluation of immune stimulation following exposure to metal particles and ions using the mouse popliteal lymph node assay.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27478144</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30212-5</DOI>
    <KeywordList>
      <Keywords>Hypersensitivity</Keywords>
      <Keywords>Immune stimulation</Keywords>
      <Keywords>Lymph node cell activation</Keywords>
      <Keywords>Metal-on-metal implants</Keywords>
      <Keywords>Metals</Keywords>
      <Keywords>Particles</Keywords>
      <Keywords>Popliteal lymph node assay</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Brooke E. Tvermoes</Name>
        <Affiliation>Cardno ChemRisk, LLC.; 4940 Pearl East Circle Suite 100; Boulder, CO 80301, United States. Electronic address: brooke.tvermoes@cardno.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kenneth M. Unice</Name>
        <Affiliation>Cardno ChemRisk, LLC.; 20 Stanwix St. Suite 505; Pittsburgh, PA 15222, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Bethany Winans</Name>
        <Affiliation>Cardno ChemRisk, LLC.; 101 2nd St. Suite 700; San Francisco, CA 94105, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Kovochich</Name>
        <Affiliation>Cardno ChemRisk, LLC.; 130 Vantis Suite 170; Aliso Viejo, CA 92656, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Whitney V. Christian</Name>
        <Affiliation>Cardno ChemRisk, LLC.; 20 Stanwix St. Suite 505; Pittsburgh, PA 15222, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ellen Donovan</Name>
        <Affiliation>Cardno ChemRisk, LLC.; 101 2nd St. Suite 700; San Francisco, CA 94105, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ernest S. Fung</Name>
        <Affiliation>Cardno ChemRisk, LLC.; 130 Vantis Suite 170; Aliso Viejo, CA 92656, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Brent L. Finley</Name>
        <Affiliation>Cardno ChemRisk, LLC.; 101 2nd St. Suite 700; San Francisco, CA 94105, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ian Kimber</Name>
        <Affiliation>University of Manchester, Faculty of Life Sciences, Oxford Road, Manchester M13 9PT, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Dennis J. Paustenbach</Name>
        <Affiliation>Cardno ChemRisk, LLC.; 101 2nd St. Suite 700; San Francisco, CA 94105, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Andrographolide inhibits adipogenesis of 3T3-L1 cells by suppressing C/EBPβ expression and activation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27475717</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30213-7</DOI>
    <KeywordList>
      <Keywords>3T3-L1</Keywords>
      <Keywords>Adipogenesis</Keywords>
      <Keywords>Andrographolide</Keywords>
      <Keywords>CCAAT/enhancer-binding protein</Keywords>
      <Keywords>Mitotic clonal expansion</Keywords>
      <Keywords>cAMP response element-binding protein</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ching Chu Chen</Name>
        <Affiliation>Division of Endocrinology and Metabolism, Department of Medicine, China Medical University Hospital, Taichung, Taiwan; Division of Endocrinology and Metabolism, Department of Chinese Medicine, China Medical University, China Medical University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Ting Chuang</Name>
        <Affiliation>Department of Nutrition, China Medical University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ai Hsuan Lin</Name>
        <Affiliation>Department of Nutrition, China Medical University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chia Wen Tsai</Name>
        <Affiliation>Department of Nutrition, China Medical University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chin Shiu Huang</Name>
        <Affiliation>Department of Health and Nutrition Biotechnology, Asia University, Taichung, Taiwan; Department of Medical Research, China Medical University Hospital, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yun Ting Chen</Name>
        <Affiliation>Department of Nutrition, China Medical University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Haw Wen Chen</Name>
        <Affiliation>Department of Nutrition, China Medical University, Taichung, Taiwan. Electronic address: chenhw@mail.cmu.edu.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Chong Kuei Lii</Name>
        <Affiliation>Department of Nutrition, China Medical University, Taichung, Taiwan; Department of Health and Nutrition Biotechnology, Asia University, Taichung, Taiwan. Electronic address: cklii@mail.cmu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>TBECH, 1,2-dibromo-4-(1,2 dibromoethyl) cyclohexane, alters androgen receptor regulation in response to mutations associated with prostate cancer.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27473015</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30210-1</DOI>
    <KeywordList>
      <Keywords>Endocrine disrupting compounds</Keywords>
      <Keywords>Nuclear localization</Keywords>
      <Keywords>Receptor</Keywords>
      <Keywords>Steroid hormone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joubert Banjop Kharlyngdoh</Name>
        <Affiliation>Biology, Örebro Life Science Center, School of Science and Technology, Örebro University, SE-701 82 Örebro, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Solomon Asnake</Name>
        <Affiliation>Biology, Örebro Life Science Center, School of Science and Technology, Örebro University, SE-701 82 Örebro, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Ajay Pradhan</Name>
        <Affiliation>Biology, Örebro Life Science Center, School of Science and Technology, Örebro University, SE-701 82 Örebro, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Per Erik Olsson</Name>
        <Affiliation>Biology, Örebro Life Science Center, School of Science and Technology, Örebro University, SE-701 82 Örebro, Sweden. Electronic address: per-erik.olsson@oru.se.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A simple physiologically based pharmacokinetic model evaluating the effect of anti-nicotine antibodies on nicotine disposition in the brains of rats and humans.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27473014</pubmedLink>
    <GrantList>
      <Grant>U01 DA036850</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30209-5</DOI>
    <KeywordList>
      <Keywords>Anti-nicotine antibodies</Keywords>
      <Keywords>Nicotine dependence</Keywords>
      <Keywords>Nicotine disposition</Keywords>
      <Keywords>Nicotine vaccine</Keywords>
      <Keywords>PBPK</Keywords>
      <Keywords>Physiologically based pharmacokinetic model</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kyle Saylor</Name>
        <Affiliation>Department of Biological Systems Engineering, Virginia Tech, Seitz Hall, RM 210, 155 Ag Quad Lane, Blacksburg, VA 24061, USA. Electronic address: saylor@vt.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Chenming Zhang</Name>
        <Affiliation>Department of Biological Systems Engineering, Virginia Tech, Seitz Hall, RM 210, 155 Ag Quad Lane, Blacksburg, VA 24061, USA. Electronic address: chzhang2@vt.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Lack of TAK1 in dendritic cells inhibits the contact hypersensitivity response induced by trichloroethylene in local lymph node assay.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27473013</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30211-3</DOI>
    <KeywordList>
      <Keywords>Contact hypersensitivity</Keywords>
      <Keywords>Dendritic cells</Keywords>
      <Keywords>Local lymph node assay</Keywords>
      <Keywords>Transforming growth factor-β activated kinase-1</Keywords>
      <Keywords>Trichloroethylene</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Pan Yao</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Peking University, Beijing 100191, China; Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chu Hongqian</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Peking University, Beijing 100191, China; Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Meng Qinghe</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Peking University, Beijing 100191, China; Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shang Lanqin</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Peking University, Beijing 100191, China; Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiang Jianjun</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Peking University, Beijing 100191, China; Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Xiaohua</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Peking University, Beijing 100191, China; Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Xuetao</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Peking University, Beijing 100191, China; Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, Beijing 100191, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hao Weidong</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Peking University, Beijing 100191, China; Beijing Key Laboratory of Toxicological Research and Risk Assessment for Food Safety, Beijing 100191, China. Electronic address: whao@bjmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Different roles of ROS and Nrf2 in Cr(VI)-induced inflammatory responses in normal and Cr(VI)-transformed cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27470422</pubmedLink>
    <GrantList>
      <Grant>R01 ES015518</Grant>
      <Grant>R01 ES020870</Grant>
      <Grant>T32 ES007266</Grant>
      <Grant>P30 CA177558</Grant>
      <Grant>R01 ES017244</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30200-9</DOI>
    <KeywordList>
      <Keywords>Hexavalent chromium</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>ROS</Keywords>
      <Keywords>Transformed cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ram Vinod Roy</Name>
        <Affiliation>Center for Research on Environmental Disease, University of Kentucky, 1095 VA Drive, Lexington, KY 40536, USA; Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, 1095 VA Drive, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Poyil Pratheeshkumar</Name>
        <Affiliation>Center for Research on Environmental Disease, University of Kentucky, 1095 VA Drive, Lexington, KY 40536, USA; Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, 1095 VA Drive, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Ok Son</Name>
        <Affiliation>Center for Research on Environmental Disease, University of Kentucky, 1095 VA Drive, Lexington, KY 40536, USA; Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, 1095 VA Drive, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lei Wang</Name>
        <Affiliation>Center for Research on Environmental Disease, University of Kentucky, 1095 VA Drive, Lexington, KY 40536, USA; Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, 1095 VA Drive, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John Andrew Hitron</Name>
        <Affiliation>Center for Research on Environmental Disease, University of Kentucky, 1095 VA Drive, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sasidharan Padmaja Divya</Name>
        <Affiliation>Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, 1095 VA Drive, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zhuo Zhang</Name>
        <Affiliation>Department of Toxicology and Cancer Biology, College of Medicine, University of Kentucky, 1095 VA Drive, Lexington, KY 40536, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xianglin Shi</Name>
        <Affiliation>Center for Research on Environmental Disease, University of Kentucky, 1095 VA Drive, Lexington, KY 40536, USA. Electronic address: xshi5@email.uky.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Activating transcription factor 4 underlies the pathogenesis of arsenic trioxide-mediated impairment of macrophage innate immune functions.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27461142</pubmedLink>
    <GrantList>
      <Grant>U01 NS095678</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30199-5</DOI>
    <KeywordList>
      <Keywords>ATF4</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Arsenic</Keywords>
      <Keywords>Ca(++) homeostasis</Keywords>
      <Keywords>Macrophage functions</Keywords>
      <Keywords>UPR</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ritesh K. Srivastava</Name>
        <Affiliation>Department of Dermatology and Skin Diseases Research Center, University of Alabama at Birmingham, Birmingham, AL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Changzhao Li</Name>
        <Affiliation>Department of Dermatology and Skin Diseases Research Center, University of Alabama at Birmingham, Birmingham, AL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Wang</Name>
        <Affiliation>Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zhiping Weng</Name>
        <Affiliation>Department of Dermatology and Skin Diseases Research Center, University of Alabama at Birmingham, Birmingham, AL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Craig A. Elmets</Name>
        <Affiliation>Department of Dermatology and Skin Diseases Research Center, University of Alabama at Birmingham, Birmingham, AL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin S. Harrod</Name>
        <Affiliation>Department of Anesthesiology and Perioperative Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jessy S. Deshane</Name>
        <Affiliation>Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: treena@uab.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Mohammad Athar</Name>
        <Affiliation>Department of Dermatology and Skin Diseases Research Center, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: mathar@uab.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Chronic preclinical safety evaluation of EPO-018B, a pegylated peptidic erythropoiesis-stimulating agent in monkeys and rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27457977</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30198-3</DOI>
    <KeywordList>
      <Keywords>Chronic toxicity</Keywords>
      <Keywords>Cynomolgus Monkeys</Keywords>
      <Keywords>EPO-018B</Keywords>
      <Keywords>Sprague-Dawley Rats</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xue Lian Gong</Name>
        <Affiliation>Department of Hygiene and Toxicology, Second Military Medical University, Shanghai 200433, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Lei Gu</Name>
        <Affiliation>Department of Hygiene and Toxicology, Second Military Medical University, Shanghai 200433, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Chun Chen</Name>
        <Affiliation>Department of Hygiene and Toxicology, Second Military Medical University, Shanghai 200433, China; Department of Pharmacy, No.422 Hospital, Zhanjiang 524005, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hai Zhu</Name>
        <Affiliation>Department of Hygiene and Toxicology, Second Military Medical University, Shanghai 200433, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhen Na Xia</Name>
        <Affiliation>Department of Hygiene and Toxicology, Second Military Medical University, Shanghai 200433, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jian Zhong Li</Name>
        <Affiliation>Department of Biochemical Pharmacy, Second Military Medical University, Shanghai 200433, China. Electronic address: lijianzhong1234@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Guo Cai Lu</Name>
        <Affiliation>Department of Hygiene and Toxicology, Second Military Medical University, Shanghai 200433, China. Electronic address: newdrug@smmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A newly synthesized macakurzin C-derivative attenuates acute and chronic skin inflammation: The Nrf2/heme oxygenase signaling as a potential target.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27450019</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30197-1</DOI>
    <KeywordList>
      <Keywords>Anti-inflammatory activity</Keywords>
      <Keywords>Oxazolone-induced atopic dermatitis</Keywords>
      <Keywords>Synthetic flavonoid</Keywords>
      <Keywords>TPA-induced acute inflammation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Muhammad Akram</Name>
        <Affiliation>College of Pharmacy Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Iljin Shin</Name>
        <Affiliation>College of Pharmacy and Research Institute of Pharmaceutical Science and Technology (RIPST), Ajou University, Suwon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Kyeong A. Kim</Name>
        <Affiliation>College of Pharmacy Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Dabi Noh</Name>
        <Affiliation>College of Pharmacy Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Seung Hoon Baek</Name>
        <Affiliation>College of Pharmacy and Research Institute of Pharmaceutical Science and Technology (RIPST), Ajou University, Suwon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sun Young Chang</Name>
        <Affiliation>College of Pharmacy and Research Institute of Pharmaceutical Science and Technology (RIPST), Ajou University, Suwon, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyoungsu Kim</Name>
        <Affiliation>College of Pharmacy and Research Institute of Pharmaceutical Science and Technology (RIPST), Ajou University, Suwon, Republic of Korea. Electronic address: hkimajou@ajou.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Ok Nam Bae</Name>
        <Affiliation>College of Pharmacy Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Republic of Korea. Electronic address: onbae@hanyang.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The study of the mechanism of arsenite toxicity in respiration-deficient cells reveals that NADPH oxidase-derived superoxide promotes the same downstream events mediated by mitochondrial superoxide in respiration-proficient cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27450018</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30196-X</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Arsenite</Keywords>
      <Keywords>Autophagy</Keywords>
      <Keywords>ER Stress</Keywords>
      <Keywords>Mitochondria</Keywords>
      <Keywords>NADPH Oxidase</Keywords>
      <Keywords>Superoxide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Andrea Guidarelli</Name>
        <Affiliation>Dipartimento di Scienze Biomolecolari, Università degli Studi di Urbino "Carlo Bo", 61029 Urbino, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Mara Fiorani</Name>
        <Affiliation>Dipartimento di Scienze Biomolecolari, Università degli Studi di Urbino "Carlo Bo", 61029 Urbino, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Silvia Carloni</Name>
        <Affiliation>Dipartimento di Scienze Biomolecolari, Università degli Studi di Urbino "Carlo Bo", 61029 Urbino, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Liana Cerioni</Name>
        <Affiliation>Dipartimento di Scienze Biomolecolari, Università degli Studi di Urbino "Carlo Bo", 61029 Urbino, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Walter Balduini</Name>
        <Affiliation>Dipartimento di Scienze Biomolecolari, Università degli Studi di Urbino "Carlo Bo", 61029 Urbino, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Orazio Cantoni</Name>
        <Affiliation>Dipartimento di Scienze Biomolecolari, Università degli Studi di Urbino "Carlo Bo", 61029 Urbino, Italy. Electronic address: orazio.cantoni@uniurb.it.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Development of a PBPK model of thiocyanate in rats with an extrapolation to humans: A computational study to quantify the mechanism of action of thiocyanate kinetics in thyroid.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27445130</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30195-8</DOI>
    <KeywordList>
      <Keywords>Bayesian</Keywords>
      <Keywords>NIS</Keywords>
      <Keywords>PBPK model</Keywords>
      <Keywords>TPO</Keywords>
      <Keywords>Thiocyanate</Keywords>
      <Keywords>Thyroid</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marie Emilie Willemin</Name>
        <Affiliation>Division of Biochemical Toxicology, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR 72079, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Annie Lumen</Name>
        <Affiliation>Division of Biochemical Toxicology, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR 72079, USA. Electronic address: Annie.Lumen@fda.hhs.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Triazine herbicides inhibit relaxin signaling and disrupt nitric oxide homeostasis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27431321</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30190-9</DOI>
    <KeywordList>
      <Keywords>Antagonist</Keywords>
      <Keywords>Atrazine</Keywords>
      <Keywords>RXFP1</Keywords>
      <Keywords>Relaxin signaling</Keywords>
      <Keywords>Reproductive toxicity</Keywords>
      <Keywords>Simazine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Si Eun Park</Name>
        <Affiliation>School of Pharmacy, Chung-Ang University, Seoul 156-756, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sa Rang Lim</Name>
        <Affiliation>School of Pharmacy, Chung-Ang University, Seoul 156-756, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyung Kyoon Choi</Name>
        <Affiliation>School of Pharmacy, Chung-Ang University, Seoul 156-756, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jeehyeon Bae</Name>
        <Affiliation>School of Pharmacy, Chung-Ang University, Seoul 156-756, Republic of Korea. Electronic address: jeehyeon@cau.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Low doses of arsenic, via perturbing p53, promotes tumorigenesis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27425828</pubmedLink>
    <GrantList>
      <Grant>R01 CA100498</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.07.009</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>ER stress</Keywords>
      <Keywords>Tumorigenesis</Keywords>
      <Keywords>p53</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Suthakar Ganapathy</Name>
        <Affiliation>Center for Drug Development, Northeastern University, Boston, USA. Electronic address: s.ganapathy@neu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Li</Name>
        <Affiliation>The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China; The Institute of Clinic Sciences, Sahlgrenska Academy, Gothenburg, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Johan Fagman</Name>
        <Affiliation>The Institute of Clinic Sciences, Sahlgrenska Academy, Gothenburg, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Tianqi Yu</Name>
        <Affiliation>Center for Drug Development, Northeastern University, Boston, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Lafontant</Name>
        <Affiliation>Center for Drug Development, Northeastern University, Boston, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Guojun Zhang</Name>
        <Affiliation>The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Changyan Chen</Name>
        <Affiliation>Center for Drug Development, Northeastern University, Boston, USA; The Institute of Clinic Sciences, Sahlgrenska Academy, Gothenburg, Sweden.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>MicroRNA-mediated Th2 bias in methimazole-induced acute liver injury in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27421576</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30182-X</DOI>
    <KeywordList>
      <Keywords>Drug-induced liver injury</Keywords>
      <Keywords>Methimazole</Keywords>
      <Keywords>Mouse</Keywords>
      <Keywords>T helper 2</Keywords>
      <Keywords>miR-29b-1-5p</Keywords>
      <Keywords>miR-449a-5p</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yasuaki Uematsu</Name>
        <Affiliation>Department of Drug Safety Sciences, Division of Clinical Pharmacology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan; Preclinical Research Laboratories, Sumitomo Dainippon Pharma Co., Ltd., 1-98 Kasugade-naka, 3-chome, Konohana-ku, Osaka, Japan. Electronic address: yasuaki-uematsu@ds-pharma.co.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Sho Akai</Name>
        <Affiliation>Department of Drug Safety Sciences, Division of Clinical Pharmacology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tomoaki Tochitani</Name>
        <Affiliation>Preclinical Research Laboratories, Sumitomo Dainippon Pharma Co., Ltd., 1-98 Kasugade-naka, 3-chome, Konohana-ku, Osaka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shingo Oda</Name>
        <Affiliation>Department of Drug Safety Sciences, Division of Clinical Pharmacology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Toru Yamada</Name>
        <Affiliation>Preclinical Research Laboratories, Sumitomo Dainippon Pharma Co., Ltd., 1-98 Kasugade-naka, 3-chome, Konohana-ku, Osaka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tsuyoshi Yokoi</Name>
        <Affiliation>Department of Drug Safety Sciences, Division of Clinical Pharmacology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mangiferin, a novel nuclear factor kappa B-inducing kinase inhibitor, suppresses metastasis and tumor growth in a mouse metastatic melanoma model.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27417526</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.07.005</DOI>
    <KeywordList>
      <Keywords>Mangiferin</Keywords>
      <Keywords>Melanoma</Keywords>
      <Keywords>Nuclear factor kappa B (NF-κB)</Keywords>
      <Keywords>Nuclear factor kappa B-inducing kinase (NIK)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tomoya Takeda</Name>
        <Affiliation>Division of Pharmacotherapy, Kinki University School of Pharmacy, Kowakae, Higashi-, Osaka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Masanobu Tsubaki</Name>
        <Affiliation>Division of Pharmacotherapy, Kinki University School of Pharmacy, Kowakae, Higashi-, Osaka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kotaro Sakamoto</Name>
        <Affiliation>Division of Pharmacotherapy, Kinki University School of Pharmacy, Kowakae, Higashi-, Osaka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Eri Ichimura</Name>
        <Affiliation>Division of Pharmacotherapy, Kinki University School of Pharmacy, Kowakae, Higashi-, Osaka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Aya Enomoto</Name>
        <Affiliation>Division of Pharmacotherapy, Kinki University School of Pharmacy, Kowakae, Higashi-, Osaka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuri Suzuki</Name>
        <Affiliation>Division of Pharmacotherapy, Kinki University School of Pharmacy, Kowakae, Higashi-, Osaka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tatsuki Itoh</Name>
        <Affiliation>Department of Food Science and Nutrition, Kinki University School of Agriculture, Nara, Nara, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Motohiro Imano</Name>
        <Affiliation>Department of Surgery, Kinki University School of Medicine, Osakasayama, Osaka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Genzoh Tanabe</Name>
        <Affiliation>Laboratory of Pharmaceutical Organic Chemistry, School of Pharmacy, Kinki University, Kowakae, Higashi-, Osaka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Osamu Muraoka</Name>
        <Affiliation>Laboratory of Pharmaceutical Organic Chemistry, School of Pharmacy, Kinki University, Kowakae, Higashi-, Osaka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hideaki Matsuda</Name>
        <Affiliation>Department of Natural Drugs Resources, Kinki University School of Pharmacy, Kowakae, Higashi-, Osaka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takao Satou</Name>
        <Affiliation>Department of Pathology, Kinki University School of Medicine, Osakasayama, Osaka, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shozo Nishida</Name>
        <Affiliation>Division of Pharmacotherapy, Kinki University School of Pharmacy, Kowakae, Higashi-, Osaka, Japan. Electronic address: nishida@phar.kindai.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cadmium-induced neural tube defects and fetal growth restriction: Association with disturbance of placental folate transport.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27417525</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.07.007</DOI>
    <KeywordList>
      <Keywords>Cadmium</Keywords>
      <Keywords>Fetal growth restriction</Keywords>
      <Keywords>Folate</Keywords>
      <Keywords>Neural tube defects</Keywords>
      <Keywords>Placenta</Keywords>
      <Keywords>Proton-coupled folate transporter</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gui Bin Zhang</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Anhui Medical University, Hefei, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Hua Wang</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Anhui Medical University, Hefei, PR China. Electronic address: wanghuadev@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Hu</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Anhui Medical University, Hefei, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Min Yin Guo</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Anhui Medical University, Hefei, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Wang</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Anhui Medical University, Hefei, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Zhou</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Anhui Medical University, Hefei, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhen Yu</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Anhui Medical University, Hefei, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Lin Fu</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Anhui Medical University, Hefei, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Hua Chen</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Anhui Medical University, Hefei, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>De Xiang Xu</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Anhui Medical University, Hefei, PR China. Electronic address: xudex@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of realgar on GSH synthesis in the mouse hippocampus: Involvement of system XAG(-), system XC(-), MRP-1 and Nrf2.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27412851</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30180-6</DOI>
    <KeywordList>
      <Keywords>Glutathione</Keywords>
      <Keywords>MRP-1</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>Realgar</Keywords>
      <Keywords>System X(AG)(−)</Keywords>
      <Keywords>System X(C)(−)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yanlei Wang</Name>
        <Affiliation>Department of Health Laboratory Technology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, People's Republic of China; School of Basic Medical Sciences, North China University of Science and Technology, 46 Xinhua Road, Tangshan, Hebei 063009, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Mo Chen</Name>
        <Affiliation>Department of Health Laboratory Technology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yinghua Zhang</Name>
        <Affiliation>Department of Health Laboratory Technology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Taoguang Huo</Name>
        <Affiliation>Department of Health Laboratory Technology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Fang</Name>
        <Affiliation>Department of Health Laboratory Technology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, People's Republic of China; School of Pharmacy, Liaoning University of Traditional Chinese Medicine, No. 77 Shenning1 Road, Double D Port, Dalian, Liaoning 116600, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xuexin Jiao</Name>
        <Affiliation>Department of Health Laboratory Technology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Mingmei Yuan</Name>
        <Affiliation>Department of Health Laboratory Technology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, People's Republic of China; School of Pharmacy, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Jiang</Name>
        <Affiliation>Department of Health Laboratory Technology, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, People's Republic of China. Electronic address: jianghong@mail.cmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Reduction of hexavalent chromium by fasted and fed human gastric fluid. I. Chemical reduction and mitigation of mutagenicity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27404458</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.07.004</DOI>
    <KeywordList>
      <Keywords>Colorimetric method</Keywords>
      <Keywords>Drinking water</Keywords>
      <Keywords>Gastric fluid</Keywords>
      <Keywords>Hexavalent chromium</Keywords>
      <Keywords>Mutagenicity test</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Silvio De Flora</Name>
        <Affiliation>Department of Health Sciences, University of Genoa, 16132 Genoa, Italy. Electronic address: sdf@unige.it.</Affiliation>
      </Author>
      <Author>
        <Name>Anna Camoirano</Name>
        <Affiliation>Department of Health Sciences, University of Genoa, 16132 Genoa, Italy. Electronic address: Anna.Fiorenza.Camoirano@unige.it.</Affiliation>
      </Author>
      <Author>
        <Name>Rosanna T. Micale</Name>
        <Affiliation>Department of Health Sciences, University of Genoa, 16132 Genoa, Italy. Electronic address: rosannamicale@yahoo.it.</Affiliation>
      </Author>
      <Author>
        <Name>Sebastiano La Maestra</Name>
        <Affiliation>Department of Health Sciences, University of Genoa, 16132 Genoa, Italy. Electronic address: lamaestra78@yahoo.it.</Affiliation>
      </Author>
      <Author>
        <Name>Vincenzo Savarino</Name>
        <Affiliation>Gastroenterology Unit, Department of Internal Medicine, University of Genoa, 16132 Genoa, Italy. Electronic address: vsavarin@unige.it.</Affiliation>
      </Author>
      <Author>
        <Name>Patrizia Zentilin</Name>
        <Affiliation>Gastroenterology Unit, Department of Internal Medicine, University of Genoa, 16132 Genoa, Italy. Electronic address: Patrizia.Zentilin@unige.it.</Affiliation>
      </Author>
      <Author>
        <Name>Elisa Marabotto</Name>
        <Affiliation>Gastroenterology Unit, Department of Internal Medicine, University of Genoa, 16132 Genoa, Italy. Electronic address: emarabotto@libero.it.</Affiliation>
      </Author>
      <Author>
        <Name>Mina Suh</Name>
        <Affiliation>ToxStrategies, Mission Viejo, CA 92692, USA. Electronic address: msuh@toxstrategies.com.</Affiliation>
      </Author>
      <Author>
        <Name>Deborah M. Proctor</Name>
        <Affiliation>ToxStrategies, Mission Viejo, CA 92692, USA. Electronic address: dproctor@toxstrategies.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Reduction of hexavalent chromium by fasted and fed human gastric fluid. II. Ex vivo gastric reduction modeling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27396814</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.07.002</DOI>
    <KeywordList>
      <Keywords>Hexavalent chromium</Keywords>
      <Keywords>Speciated Isotope Dilution Mass Spectrometry (SIDMS)</Keywords>
      <Keywords>human gastric fluid</Keywords>
      <Keywords>stomach reduction kinetics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Christopher R. Kirman</Name>
        <Affiliation>Summit Toxicology, Orange Village, OH, 44022, USA. Electronic address: ckirman@summittoxicology.com.</Affiliation>
      </Author>
      <Author>
        <Name>Mina Suh</Name>
        <Affiliation>ToxStrategies, Inc., Mission Viejo, CA, 92692, USA. Electronic address: msuh@toxstrategies.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sean M. Hays</Name>
        <Affiliation>Summit Toxicology, Allenspark, CO, 8040, USA. Electronic address: shays@summittoxicology.com.</Affiliation>
      </Author>
      <Author>
        <Name>Hakan Gürleyük</Name>
        <Affiliation>Brooks Applied Labs, Bothell, WA, 98011, USA. Electronic address: hakan@brooksrand.com.</Affiliation>
      </Author>
      <Author>
        <Name>Russ Gerads</Name>
        <Affiliation>Brooks Applied Labs, Bothell, WA, 98011, USA. Electronic address: russ@brooksrand.com.</Affiliation>
      </Author>
      <Author>
        <Name>Silvio De Flora</Name>
        <Affiliation>Department of Health Sciences, University of Genoa, 16132 Genoa, Italy. Electronic address: sdf@unige.it.</Affiliation>
      </Author>
      <Author>
        <Name>William Parker</Name>
        <Affiliation>Duke University Medical Center, Department of Surgery, Durham, NC, 27710, USA. Electronic address: william.parker@duke.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Shu Lin</Name>
        <Affiliation>Duke University Medical Center, Department of Surgery, Durham, NC, 27710, USA. Electronic address: shu.lin@duke.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Laurie C. Haws</Name>
        <Affiliation>ToxStrategies, Inc., Katy, TX, 77494, USA. Electronic address: lhaws@toxstrategies.com.</Affiliation>
      </Author>
      <Author>
        <Name>Mark A. Harris</Name>
        <Affiliation>ToxStrategies, Inc., Austin, TX, 78751, USA. Electronic address: mharris@toxstrategies.com.</Affiliation>
      </Author>
      <Author>
        <Name>Deborah M. Proctor</Name>
        <Affiliation>ToxStrategies, Inc., Mission Viejo, CA, 92692, USA. Electronic address: dproctor@toxstrategies.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Role of histone deacetylases(HDACs) in progression and reversal of liver fibrosis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27396813</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.07.003</DOI>
    <KeywordList>
      <Keywords>HDAC2</Keywords>
      <Keywords>HDACs</Keywords>
      <Keywords>Liver fibrosis</Keywords>
      <Keywords>Reversal of liver fibrosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xing Li</Name>
        <Affiliation>School of Pharmacy, Anhui Medical University, Hefei 230032, China; Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; The Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Medical University, Ministry of Education, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University (ILD-AMU), Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Qin Wu</Name>
        <Affiliation>School of Pharmacy, Anhui Medical University, Hefei 230032, China; Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; The Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Medical University, Ministry of Education, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University (ILD-AMU), Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tao Xu</Name>
        <Affiliation>School of Pharmacy, Anhui Medical University, Hefei 230032, China; Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; The Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Medical University, Ministry of Education, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University (ILD-AMU), Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Feng Li</Name>
        <Affiliation>School of Pharmacy, Anhui Medical University, Hefei 230032, China; Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; The Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Medical University, Ministry of Education, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University (ILD-AMU), Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Yang</Name>
        <Affiliation>School of Pharmacy, Anhui Medical University, Hefei 230032, China; Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; The Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Medical University, Ministry of Education, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University (ILD-AMU), Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wan Xia Li</Name>
        <Affiliation>School of Pharmacy, Anhui Medical University, Hefei 230032, China; Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; The Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Medical University, Ministry of Education, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University (ILD-AMU), Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cheng Huang</Name>
        <Affiliation>School of Pharmacy, Anhui Medical University, Hefei 230032, China; Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; The Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Medical University, Ministry of Education, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University (ILD-AMU), Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Ming Meng</Name>
        <Affiliation>School of Pharmacy, Anhui Medical University, Hefei 230032, China; Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; The Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Medical University, Ministry of Education, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University (ILD-AMU), Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Li</Name>
        <Affiliation>School of Pharmacy, Anhui Medical University, Hefei 230032, China; Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; The Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Medical University, Ministry of Education, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University (ILD-AMU), Anhui Medical University, Hefei 230032, China. Electronic address: lijun@ahmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Valproic acid exposure decreases Cbp/p300 protein expression and histone acetyltransferase activity in P19 cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27381264</pubmedLink>
    <GrantList />
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.07.001</DOI>
    <KeywordList>
      <Keywords>Cbp/p300</Keywords>
      <Keywords>Histone acetyltransferase</Keywords>
      <Keywords>P19 cells</Keywords>
      <Keywords>Teratogen</Keywords>
      <Keywords>Valproic acid</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Christina L. Lamparter</Name>
        <Affiliation>Department of Biomedical and Molecular Sciences, Graduate Program in Pharmacology and Toxicology, Queen's University, Kingston, Ontario K7L 3N6, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Louise M. Winn</Name>
        <Affiliation>Department of Biomedical and Molecular Sciences, Graduate Program in Pharmacology and Toxicology, Queen's University, Kingston, Ontario K7L 3N6, Canada; School of Environmental Studies, Queen's University, Kingston, Ontario K7L 3N6, Canada. Electronic address: winnl@queensu.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>P-gp, MRP2 and OAT1/OAT3 mediate the drug-drug interaction between resveratrol and methotrexate.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27377006</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.06.030</DOI>
    <KeywordList>
      <Keywords>Drug-drug interaction</Keywords>
      <Keywords>Methotrexate</Keywords>
      <Keywords>Resveratrol</Keywords>
      <Keywords>Transporter</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yongming Jia</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhihao Liu</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian 116044, China; Provincial Key Laboratory for Pharmacokinetics and Transport, Liaoning, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Changyuan Wang</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian 116044, China; Provincial Key Laboratory for Pharmacokinetics and Transport, Liaoning, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiang Meng</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian 116044, China; Provincial Key Laboratory for Pharmacokinetics and Transport, Liaoning, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaokui Huo</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian 116044, China; Provincial Key Laboratory for Pharmacokinetics and Transport, Liaoning, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Liu</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian 116044, China; Provincial Key Laboratory for Pharmacokinetics and Transport, Liaoning, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huijun Sun</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian 116044, China; Provincial Key Laboratory for Pharmacokinetics and Transport, Liaoning, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Pengyuan Sun</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaobo Yang</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaodong Ma</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kexin Liu</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, Dalian 116044, China; Provincial Key Laboratory for Pharmacokinetics and Transport, Liaoning, Dalian Medical University, Dalian 116044, China. Electronic address: kexinliu@dlmedu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Statin-induced myotoxicity is exacerbated by aging: A biophysical and molecular biology study in rats treated with atorvastatin.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27377005</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.06.032</DOI>
    <KeywordList>
      <Keywords>Energy metabolism dysfunction</Keywords>
      <Keywords>Ion channels</Keywords>
      <Keywords>Protein kinase C</Keywords>
      <Keywords>Senescence</Keywords>
      <Keywords>Skeletal muscle atrophy</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Giulia Maria Camerino</Name>
        <Affiliation>Section of Pharmacology, Department of Pharmacy &amp; Drug Sciences, University of Bari - Aldo Moro, Bari, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Michela De Bellis</Name>
        <Affiliation>Section of Pharmacology, Department of Pharmacy &amp; Drug Sciences, University of Bari - Aldo Moro, Bari, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Elena Conte</Name>
        <Affiliation>Section of Pharmacology, Department of Pharmacy &amp; Drug Sciences, University of Bari - Aldo Moro, Bari, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Antonella Liantonio</Name>
        <Affiliation>Section of Pharmacology, Department of Pharmacy &amp; Drug Sciences, University of Bari - Aldo Moro, Bari, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Kejla Musaraj</Name>
        <Affiliation>Section of Pharmacology, Department of Pharmacy &amp; Drug Sciences, University of Bari - Aldo Moro, Bari, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Cannone</Name>
        <Affiliation>Section of Pharmacology, Department of Pharmacy &amp; Drug Sciences, University of Bari - Aldo Moro, Bari, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Adriano Fonzino</Name>
        <Affiliation>Section of Pharmacology, Department of Pharmacy &amp; Drug Sciences, University of Bari - Aldo Moro, Bari, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Arcangela Giustino</Name>
        <Affiliation>Department of Biomedical Sciences and Human Oncology, University of Bari - Aldo Moro, Medical School, Bari, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Annamaria De Luca</Name>
        <Affiliation>Section of Pharmacology, Department of Pharmacy &amp; Drug Sciences, University of Bari - Aldo Moro, Bari, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Rossella Romano</Name>
        <Affiliation>Section of Pharmacology, Department of Pharmacy &amp; Drug Sciences, University of Bari - Aldo Moro, Bari, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Claudia Camerino</Name>
        <Affiliation>Department of Medical Sciences, Neurosciences and Sense Organs, University of Bari - Aldo Moro, Bari, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Antonio Laghezza</Name>
        <Affiliation>Section of Medicinal Chemistry, Department of Pharmacy &amp; Drug Sciences, University of Bari - Aldo Moro, Bari, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Fulvio Loiodice</Name>
        <Affiliation>Section of Medicinal Chemistry, Department of Pharmacy &amp; Drug Sciences, University of Bari - Aldo Moro, Bari, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Francois Desaphy</Name>
        <Affiliation>Department of Biomedical Sciences and Human Oncology, University of Bari - Aldo Moro, Medical School, Bari, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Diana Conte Camerino</Name>
        <Affiliation>Section of Pharmacology, Department of Pharmacy &amp; Drug Sciences, University of Bari - Aldo Moro, Bari, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Sabata Pierno</Name>
        <Affiliation>Section of Pharmacology, Department of Pharmacy &amp; Drug Sciences, University of Bari - Aldo Moro, Bari, Italy. Electronic address: sabata.pierno@uniba.it.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Endogenous glucocorticoids exacerbate cholestasis-associated liver injury and hypercholesterolemia in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27374722</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.06.031</DOI>
    <KeywordList>
      <Keywords>Adrenalectomy</Keywords>
      <Keywords>Cholestatic liver disease</Keywords>
      <Keywords>Experimental mouse model</Keywords>
      <Keywords>Glucocorticoids</Keywords>
      <Keywords>Hypercholesterolemia</Keywords>
      <Keywords>RU-486</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rick van der Geest</Name>
        <Affiliation>Leiden Academic Centre for Drug Research, The Netherlands. Electronic address: r.van.der.geest@lacdr.leidenuniv.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Amber B. Ouweneel</Name>
        <Affiliation>Leiden Academic Centre for Drug Research, The Netherlands. Electronic address: a.b.ouweneel@lacdr.leidenuniv.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Ronald J. van der Sluis</Name>
        <Affiliation>Leiden Academic Centre for Drug Research, The Netherlands. Electronic address: r.vandersluis@lacdr.leidenuniv.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Albert K. Groen</Name>
        <Affiliation>University Medical Center Groningen, The Netherlands. Electronic address: a.k.groen@umcg.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Miranda Van Eck</Name>
        <Affiliation>Leiden Academic Centre for Drug Research, The Netherlands. Electronic address: m.eck@lacdr.leidenuniv.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Menno Hoekstra</Name>
        <Affiliation>Leiden Academic Centre for Drug Research, The Netherlands. Electronic address: hoekstra@lacdr.leidenuniv.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Systemic metabolic derangement, pulmonary effects, and insulin insufficiency following subchronic ozone exposure in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27368153</pubmedLink>
    <GrantList>
      <Grant>T32 ES007126</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.06.027</DOI>
    <KeywordList>
      <Keywords>Insulin resistance</Keywords>
      <Keywords>Metabolism</Keywords>
      <Keywords>Ozone</Keywords>
      <Keywords>Pancreatic beta cells</Keywords>
      <Keywords>Stress response</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Desinia B. Miller</Name>
        <Affiliation>Curriculum in Toxicology, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Samantha J. Snow</Name>
        <Affiliation>Environmental Public Health Division, National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Andres Henriquez</Name>
        <Affiliation>Curriculum in Toxicology, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mette C. Schladweiler</Name>
        <Affiliation>Environmental Public Health Division, National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Allen D. Ledbetter</Name>
        <Affiliation>Environmental Public Health Division, National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Judy E. Richards</Name>
        <Affiliation>Environmental Public Health Division, National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Debora L. Andrews</Name>
        <Affiliation>Environmental Public Health Division, National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Urmila P. Kodavanti</Name>
        <Affiliation>Environmental Public Health Division, National Health and Environmental Effects Research Laboratory, U.S. Environmental Protection Agency, Research Triangle Park, NC, United States. Electronic address: kodavanti.urmila@epa.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Involvement of the histamine H4 receptor in clozapine-induced hematopoietic toxicity: Vulnerability under granulocytic differentiation of HL-60 cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27368152</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.06.028</DOI>
    <KeywordList>
      <Keywords>Agranulocytosis</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Clozapine</Keywords>
      <Keywords>HL-60 cells</Keywords>
      <Keywords>Histamine H(4) receptor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Aya Goto</Name>
        <Affiliation>Division of Clinical Sciences and Neuropsychopharmacology, Faculty and Graduate School of Pharmacy, Meijo University, 150 Yagotoyama, Tempaku-ku, Nagoya 468-8503, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Akihiro Mouri</Name>
        <Affiliation>Division of Clinical Sciences and Neuropsychopharmacology, Faculty and Graduate School of Pharmacy, Meijo University, 150 Yagotoyama, Tempaku-ku, Nagoya 468-8503, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tomoko Nagai</Name>
        <Affiliation>Division of Clinical Sciences and Neuropsychopharmacology, Faculty and Graduate School of Pharmacy, Meijo University, 150 Yagotoyama, Tempaku-ku, Nagoya 468-8503, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Akira Yoshimi</Name>
        <Affiliation>Division of Clinical Sciences and Neuropsychopharmacology, Faculty and Graduate School of Pharmacy, Meijo University, 150 Yagotoyama, Tempaku-ku, Nagoya 468-8503, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Mako Ukigai</Name>
        <Affiliation>Division of Clinical Sciences and Neuropsychopharmacology, Faculty and Graduate School of Pharmacy, Meijo University, 150 Yagotoyama, Tempaku-ku, Nagoya 468-8503, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tomomi Tsubai</Name>
        <Affiliation>Division of Clinical Sciences and Neuropsychopharmacology, Faculty and Graduate School of Pharmacy, Meijo University, 150 Yagotoyama, Tempaku-ku, Nagoya 468-8503, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hirotake Hida</Name>
        <Affiliation>Division of Clinical Sciences and Neuropsychopharmacology, Faculty and Graduate School of Pharmacy, Meijo University, 150 Yagotoyama, Tempaku-ku, Nagoya 468-8503, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Norio Ozaki</Name>
        <Affiliation>Department of Psychiatry, Graduate School of Medicine, Nagoya University, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yukihiro Noda</Name>
        <Affiliation>Division of Clinical Sciences and Neuropsychopharmacology, Faculty and Graduate School of Pharmacy, Meijo University, 150 Yagotoyama, Tempaku-ku, Nagoya 468-8503, Japan. Electronic address: ynoda@meijo-u.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>5-lipoxygenase activation is involved in the mechanisms of chronic hepatic injury in a rat model of chronic aluminum overload exposure.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27368151</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30171-5</DOI>
    <KeywordList>
      <Keywords>5-Lipoxygenase</Keywords>
      <Keywords>Caffeic acid</Keywords>
      <Keywords>Chronic aluminum load</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Liver function</Keywords>
      <Keywords>Oxidative stress</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shaoshan Mai</Name>
        <Affiliation>Department of Pharmacology, Chongqing Medical University, Key Laboratory of Biochemistry and Molecular Pharmacology, Chongqing 400016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qin He</Name>
        <Affiliation>Department of Heptobiliary Surgery, 1st Affiliated Hospital, Chongqing Medical University, Chongqing 400016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Wang</Name>
        <Affiliation>Department of Pharmacology, Chongqing Medical University, Key Laboratory of Biochemistry and Molecular Pharmacology, Chongqing 400016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xinyue Hu</Name>
        <Affiliation>Department of Pharmacology, Chongqing Medical University, Key Laboratory of Biochemistry and Molecular Pharmacology, Chongqing 400016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Luo</Name>
        <Affiliation>Department of Pharmacology, Chongqing Medical University, Key Laboratory of Biochemistry and Molecular Pharmacology, Chongqing 400016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Yang</Name>
        <Affiliation>Department of Pharmacology, Chongqing Medical University, Key Laboratory of Biochemistry and Molecular Pharmacology, Chongqing 400016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shengnan Kuang</Name>
        <Affiliation>Department of Pharmacology, Chongqing Medical University, Key Laboratory of Biochemistry and Molecular Pharmacology, Chongqing 400016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoyan Tian</Name>
        <Affiliation>Department of Pharmacology, Chongqing Medical University, Key Laboratory of Biochemistry and Molecular Pharmacology, Chongqing 400016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Ma</Name>
        <Affiliation>Department of Pharmacology, Chongqing Medical University, Key Laboratory of Biochemistry and Molecular Pharmacology, Chongqing 400016, China.</Affiliation>
      </Author>
      <Author>
        <Name>Junqing Yang</Name>
        <Affiliation>Department of Pharmacology, Chongqing Medical University, Key Laboratory of Biochemistry and Molecular Pharmacology, Chongqing 400016, China. Electronic address: 1139627371@qq.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>BDE-99, but not BDE-47, is a transient aryl hydrocarbon receptor agonist in zebrafish liver cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27343407</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30157-0</DOI>
    <KeywordList>
      <Keywords>Ahr activation</Keywords>
      <Keywords>BDE-99</Keywords>
      <Keywords>CYP1A</Keywords>
      <Keywords>Reporter-gene assay</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jie Yang</Name>
        <Affiliation>School of Life Sciences, The Chinese University of Hong Kong, Sha Tin, N.T., Hong Kong Special Administrative Region.</Affiliation>
      </Author>
      <Author>
        <Name>Jinyong Zhu</Name>
        <Affiliation>School of Life Sciences, The Chinese University of Hong Kong, Sha Tin, N.T., Hong Kong Special Administrative Region.</Affiliation>
      </Author>
      <Author>
        <Name>King Ming Chan</Name>
        <Affiliation>School of Life Sciences, The Chinese University of Hong Kong, Sha Tin, N.T., Hong Kong Special Administrative Region. Electronic address: kingchan@cuhk.edu.hk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of drug-induced arrhythmic risk using limit cycle and autocorrelation analysis of human iPSC-cardiomyocyte contractility.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27343406</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30159-4</DOI>
    <KeywordList>
      <Keywords>Arrhythmia</Keywords>
      <Keywords>Autocorrelation</Keywords>
      <Keywords>Human induced pluripotent stem cell cardiomyocytes (hiPSC-CMs)</Keywords>
      <Keywords>Label-free impedance</Keywords>
      <Keywords>Limit cycle</Keywords>
      <Keywords>Python v2.7 software</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>R. Jason Kirby</Name>
        <Affiliation>Sanford Burnham Prebys Medical Discovery Institute, Conrad Prebys Center for Chemical Genomics, 6400 Sanger Rd, Orlando, FL 32827, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Feng Qi</Name>
        <Affiliation>Sanford Burnham Prebys Medical Discovery Institute, Applied Bioinformatics Facility, 6400 Sanger Rd, Orlando, FL 32827, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sharangdhar Phatak</Name>
        <Affiliation>Sanford Burnham Prebys Medical Discovery Institute, Conrad Prebys Center for Chemical Genomics, 6400 Sanger Rd, Orlando, FL 32827, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Layton H. Smith</Name>
        <Affiliation>Sanford Burnham Prebys Medical Discovery Institute, Conrad Prebys Center for Chemical Genomics, 6400 Sanger Rd, Orlando, FL 32827, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Siobhan Malany</Name>
        <Affiliation>Sanford Burnham Prebys Medical Discovery Institute, Conrad Prebys Center for Chemical Genomics, 6400 Sanger Rd, Orlando, FL 32827, USA. Electronic address: smalany@sbpdiscovery.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Activation of angiotensin-converting enzyme 2 (ACE2) attenuates allergic airway inflammation in rat asthma model.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27343405</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.06.026</DOI>
    <KeywordList>
      <Keywords>Airway response</Keywords>
      <Keywords>Angiotensin-converting enzyme 2 (ACE2)</Keywords>
      <Keywords>Asthma</Keywords>
      <Keywords>Diminazene aceturate</Keywords>
      <Keywords>Fibrosis</Keywords>
      <Keywords>Renin angiotensin system (RAS)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Vaibhav Shrirang Dhawale</Name>
        <Affiliation>Laboratory of Epigenetics and Diseases, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S Nagar, Punjab 160062, India.</Affiliation>
      </Author>
      <Author>
        <Name>Venkateswara Rao Amara</Name>
        <Affiliation>Laboratory of Epigenetics and Diseases, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S Nagar, Punjab 160062, India.</Affiliation>
      </Author>
      <Author>
        <Name>Pinakin Arun Karpe</Name>
        <Affiliation>Laboratory of Epigenetics and Diseases, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S Nagar, Punjab 160062, India.</Affiliation>
      </Author>
      <Author>
        <Name>Vajir Malek</Name>
        <Affiliation>Laboratory of Epigenetics and Diseases, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S Nagar, Punjab 160062, India.</Affiliation>
      </Author>
      <Author>
        <Name>Deep Patel</Name>
        <Affiliation>Laboratory of Epigenetics and Diseases, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S Nagar, Punjab 160062, India.</Affiliation>
      </Author>
      <Author>
        <Name>Kulbhushan Tikoo</Name>
        <Affiliation>Laboratory of Epigenetics and Diseases, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S Nagar, Punjab 160062, India.. Electronic address: tikoo.k@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effect of simvastatin on vascular tone in porcine coronary artery: Potential role of the mitochondria.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27343404</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30158-2</DOI>
    <KeywordList>
      <Keywords>Mitochondria</Keywords>
      <Keywords>Statins</Keywords>
      <Keywords>Vasodilatation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>H. Almukhtar</Name>
        <Affiliation>Cell Signaling and Pharmacology Research Group, School of Life Sciences, University of Nottingham, Medical School, Nottingham NG7 2UH, UK.</Affiliation>
      </Author>
      <Author>
        <Name>M. J. Garle</Name>
        <Affiliation>Cell Signaling and Pharmacology Research Group, School of Life Sciences, University of Nottingham, Medical School, Nottingham NG7 2UH, UK.</Affiliation>
      </Author>
      <Author>
        <Name>P. A. Smith</Name>
        <Affiliation>Cell Signaling and Pharmacology Research Group, School of Life Sciences, University of Nottingham, Medical School, Nottingham NG7 2UH, UK.</Affiliation>
      </Author>
      <Author>
        <Name>R. E. Roberts</Name>
        <Affiliation>Cell Signaling and Pharmacology Research Group, School of Life Sciences, University of Nottingham, Medical School, Nottingham NG7 2UH, UK. Electronic address: richard.roberts@nottingham.ac.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Bifunctional alkylating agent-mediated MGMT-DNA cross-linking and its proteolytic cleavage in 16HBE cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27342729</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30156-9</DOI>
    <KeywordList>
      <Keywords>Bifunctional alkylating agent</Keywords>
      <Keywords>DNA damage and repair</Keywords>
      <Keywords>DNA-protein cross-link</Keywords>
      <Keywords>MGMT</Keywords>
      <Keywords>Nitrogen mustard</Keywords>
      <Keywords>Proteolysis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jin Cheng</Name>
        <Affiliation>Institute of Toxicology, School of Preventive Medicine, the Third Military Medical University, 30 Gaotanyan Avenue, Shapingba District, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Feng Ye</Name>
        <Affiliation>Institute of Toxicology, School of Preventive Medicine, the Third Military Medical University, 30 Gaotanyan Avenue, Shapingba District, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guorong Dan</Name>
        <Affiliation>Institute of Toxicology, School of Preventive Medicine, the Third Military Medical University, 30 Gaotanyan Avenue, Shapingba District, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanpeng Zhao</Name>
        <Affiliation>Institute of Toxicology, School of Preventive Medicine, the Third Military Medical University, 30 Gaotanyan Avenue, Shapingba District, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bin Wang</Name>
        <Affiliation>Institute of Toxicology, School of Preventive Medicine, the Third Military Medical University, 30 Gaotanyan Avenue, Shapingba District, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiqing Zhao</Name>
        <Affiliation>Institute of Toxicology, School of Preventive Medicine, the Third Military Medical University, 30 Gaotanyan Avenue, Shapingba District, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Sai</Name>
        <Affiliation>Institute of Toxicology, School of Preventive Medicine, the Third Military Medical University, 30 Gaotanyan Avenue, Shapingba District, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhongmin Zou</Name>
        <Affiliation>Institute of Toxicology, School of Preventive Medicine, the Third Military Medical University, 30 Gaotanyan Avenue, Shapingba District, Chongqing 400038, China. Electronic address: zouzhmin@yahoo.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Suppressed osteoclast differentiation at the chondro-osseous junction mediates endochondral ossification retardation in long bones of Wistar fetal rats with prenatal ethanol exposure.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27338645</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30155-7</DOI>
    <KeywordList>
      <Keywords>Endochondral ossification retardation</Keywords>
      <Keywords>Osteoclast</Keywords>
      <Keywords>Osteoprotegerin (OPG)</Keywords>
      <Keywords>Prenatal ethanol exposure</Keywords>
      <Keywords>Receptor activator for nuclear factor-κb ligand (RANKL)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhengqi Pan</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xianrong Zhang</Name>
        <Affiliation>Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yangfan Shangguan</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hang Hu</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Liaobin Chen</Name>
        <Affiliation>Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan 430071, China. Electronic address: lbchen@whu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Wang</Name>
        <Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan 430071, China. Electronic address: wanghui19@whu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Smoking-related microRNAs and mRNAs in human peripheral blood mononuclear cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27321975</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30154-5</DOI>
    <KeywordList>
      <Keywords>Integrative analysis</Keywords>
      <Keywords>Smoke reduction</Keywords>
      <Keywords>mRNA</Keywords>
      <Keywords>microRNA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ming Wei Su</Name>
        <Affiliation>Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Sung Liang Yu</Name>
        <Affiliation>Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Chang Lin</Name>
        <Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ching Hui Tsai</Name>
        <Affiliation>Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Po Hua Chen</Name>
        <Affiliation>School of Medicine, National Taiwan University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yungling Leo Lee</Name>
        <Affiliation>Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan. Electronic address: leolee@ntu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Modulation of P-glycoprotein activity by novel synthetic curcumin derivatives in sensitive and multidrug-resistant T-cell acute lymphoblastic leukemia cell lines.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27318188</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30136-3</DOI>
    <KeywordList>
      <Keywords>Cancer</Keywords>
      <Keywords>Chemotherapy</Keywords>
      <Keywords>Curcumin derivatives</Keywords>
      <Keywords>Multidrug resistance</Keywords>
      <Keywords>P-glycoprotein</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Edna Ooko</Name>
        <Affiliation>Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Tahseen Alsalim</Name>
        <Affiliation>Department of Chemistry, College of Education for Pure Sciences, University of Basrah, P.O. Box 49 Basrah, Al Basrah, Iraq.</Affiliation>
      </Author>
      <Author>
        <Name>Bahjat Saeed</Name>
        <Affiliation>Department of Chemistry, College of Education for Pure Sciences, University of Basrah, P.O. Box 49 Basrah, Al Basrah, Iraq.</Affiliation>
      </Author>
      <Author>
        <Name>Mohamed E. M. Saeed</Name>
        <Affiliation>Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Onat Kadioglu</Name>
        <Affiliation>Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Hanna S. Abbo</Name>
        <Affiliation>Department of Chemistry, University of the Western Cape, P/B X17, Bellville, 7535 Cape Town, South Africa.</Affiliation>
      </Author>
      <Author>
        <Name>Salam J. J. Titinchi</Name>
        <Affiliation>Department of Chemistry, University of the Western Cape, P/B X17, Bellville, 7535 Cape Town, South Africa. Electronic address: stitinchi@uwc.ac.za.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Efferth</Name>
        <Affiliation>Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany. Electronic address: efferth@uni-mainz.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nrf2 activation ameliorates cytotoxic effects of arsenic trioxide in acute promyelocytic leukemia cells through increased glutathione levels and arsenic efflux from cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27317373</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30151-X</DOI>
    <KeywordList>
      <Keywords>Acute promyelocytic leukemia</Keywords>
      <Keywords>Arsenic trioxide</Keywords>
      <Keywords>Carnosic acid</Keywords>
      <Keywords>Glutathione</Keywords>
      <Keywords>Nrf2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shoichi Nishimoto</Name>
        <Affiliation>Department of Analytical Biochemistry, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose, Tokyo 204-8588, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Toshihiro Suzuki</Name>
        <Affiliation>Department of Analytical Biochemistry, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose, Tokyo 204-8588, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shin Koike</Name>
        <Affiliation>Department of Analytical Biochemistry, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose, Tokyo 204-8588, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Yuan</Name>
        <Affiliation>Department of Applied Biochemistry, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo 192-0392, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Norio Takagi</Name>
        <Affiliation>Department of Applied Biochemistry, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo 192-0392, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuki Ogasawara</Name>
        <Affiliation>Department of Analytical Biochemistry, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose, Tokyo 204-8588, Japan. Electronic address: yo@my-pharm.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dioscin protects against ANIT-induced cholestasis via regulating Oatps, Mrp2 and Bsep expression in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27317372</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30153-3</DOI>
    <KeywordList>
      <Keywords>ANIT-induced cholestasis</Keywords>
      <Keywords>Bsep</Keywords>
      <Keywords>Dioscin</Keywords>
      <Keywords>Mrp2</Keywords>
      <Keywords>Oatps</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Aijie Zhang</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, China; State Key Laboratory of Drug Delivery Technology and Pharmacokinetics, Tianjin Institute of Pharmaceutical Research, Tianjin, China. Electronic address: zhangaijie1986@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yongming Jia</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, China. Electronic address: yongmingjiahlj@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Qinghan Xu</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, China. Electronic address: xulianglinyao@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Changyuan Wang</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, China; Provincial Key Laboratory for Pharmacokinetics and Transport, Liaoning, Dalian Medical University, China. Electronic address: wangcyuan@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Qi Liu</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, China; Provincial Key Laboratory for Pharmacokinetics and Transport, Liaoning, Dalian Medical University, China. Electronic address: llaqii@yahoo.com.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Qiang Meng</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, China; Provincial Key Laboratory for Pharmacokinetics and Transport, Liaoning, Dalian Medical University, China. Electronic address: mengq531@yahoo.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Jinyong Peng</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, China; Provincial Key Laboratory for Pharmacokinetics and Transport, Liaoning, Dalian Medical University, China. Electronic address: jinyongpeng2005@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Huijun Sun</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, China; Provincial Key Laboratory for Pharmacokinetics and Transport, Liaoning, Dalian Medical University, China. Electronic address: sunhuijun@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Pengyuan Sun</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, China. Electronic address: spfar1004@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaokui Huo</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, China; Provincial Key Laboratory for Pharmacokinetics and Transport, Liaoning, Dalian Medical University, China. Electronic address: huoxiaokui@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Kexin Liu</Name>
        <Affiliation>Department of Clinical Pharmacology, College of Pharmacy, Dalian Medical University, China; Provincial Key Laboratory for Pharmacokinetics and Transport, Liaoning, Dalian Medical University, China. Electronic address: kexinliu@dlmedu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Analysis of real-time mixture cytotoxicity data following repeated exposure using BK/TD models.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27317371</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30152-1</DOI>
    <KeywordList>
      <Keywords>Cell viability</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Impedance</Keywords>
      <Keywords>Mixture</Keywords>
      <Keywords>Repeated dose toxicity</Keywords>
      <Keywords>TK/TD models</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>S. Teng</Name>
        <Affiliation>Models for Toxicology and Ecotoxicology Unit, INERIS, Parc Technologique Alata, BP 2, 60550 Verneuil-en-Halatte, France.</Affiliation>
      </Author>
      <Author>
        <Name>C. Tebby</Name>
        <Affiliation>Models for Toxicology and Ecotoxicology Unit, INERIS, Parc Technologique Alata, BP 2, 60550 Verneuil-en-Halatte, France.</Affiliation>
      </Author>
      <Author>
        <Name>S. Barcellini-Couget</Name>
        <Affiliation>ODESIA Neosciences, Sophia Antipolis, 400 route des chappes, 06903 Sophia Antipolis, France.</Affiliation>
      </Author>
      <Author>
        <Name>G. De Sousa</Name>
        <Affiliation>INRA, ToxAlim, 400 route des Chappes, BP, 167 06903 Sophia Antipolis, Cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>C. Brochot</Name>
        <Affiliation>Models for Toxicology and Ecotoxicology Unit, INERIS, Parc Technologique Alata, BP 2, 60550 Verneuil-en-Halatte, France.</Affiliation>
      </Author>
      <Author>
        <Name>R. Rahmani</Name>
        <Affiliation>INRA, ToxAlim, 400 route des Chappes, BP, 167 06903 Sophia Antipolis, Cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>A. R. R. Pery</Name>
        <Affiliation>AgroParisTech, UMR 1402 INRA-AgroParisTech Ecosys, 78850 Thiverval Grignon, France; INRA, UMR 1402 INRA-AgroParisTech Ecosys, 78850 Thiverval Grignon, France. Electronic address: alexandre.pery@agroparistech.fr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effect of TCDD on the fate of epithelial cells isolated from human fetal palatal shelves (hFPECs).</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27312872</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30150-8</DOI>
    <KeywordList>
      <Keywords>2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)</Keywords>
      <Keywords>Cell proliferation</Keywords>
      <Keywords>Cleft palate</Keywords>
      <Keywords>Human fetal palatal epithelial cell (hFPECs)</Keywords>
      <Keywords>PI3K/AKT pathway</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhan Gao</Name>
        <Affiliation>School of Public Health, Xinxiang Medical University, 453003, China; The Fifth Affiliated Hospital, Zhengzhou University, 450052, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongjun Bu</Name>
        <Affiliation>School of Public Health, Xinxiang Medical University, 453003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guofu Zhang</Name>
        <Affiliation>School of Public Health, Xinxiang Medical University, 453003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaozhuan Liu</Name>
        <Affiliation>Medical College, Henan University of Science &amp; Technology, 471023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xugang Wang</Name>
        <Affiliation>School of Public Health, Xinxiang Medical University, 453003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shibin Ding</Name>
        <Affiliation>School of Public Health, Xinxiang Medical University, 453003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Erhui Wang</Name>
        <Affiliation>School of Public Health, Xinxiang Medical University, 453003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ruling Shi</Name>
        <Affiliation>School of Public Health, Xinxiang Medical University, 453003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiaoyun Li</Name>
        <Affiliation>The Fifth Affiliated Hospital, Zhengzhou University, 450052, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianhong Fu</Name>
        <Affiliation>The Fifth Affiliated Hospital, Zhengzhou University, 450052, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zengli Yu</Name>
        <Affiliation>School of Public Health, Xinxiang Medical University, 453003, China; Public Health College, Zhengzhou University, 450001, China. Electronic address: zly@zzu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27312871</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30147-8</DOI>
    <KeywordList>
      <Keywords>Angioplasty</Keywords>
      <Keywords>Atherosclerosis</Keywords>
      <Keywords>Proliferation</Keywords>
      <Keywords>Restenosis</Keywords>
      <Keywords>TW-01</Keywords>
      <Keywords>Vascular smooth muscle cell</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chao Feng Lin</Name>
        <Affiliation>The Ph.D. Program for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan; Department of Medicine, MacKay Medical College, New Taipei City, Taiwan; Division of Cardiology, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan; Division of Cardiology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Han Li Huang</Name>
        <Affiliation>The Ph.D. Program for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chieh Yu Peng</Name>
        <Affiliation>Chinese Medicine Research and Development Center, China Medical University Hospital, Taichung 404, Taiwan; School of Pharmacy, College of Pharmacy, China Medical University, Taichung 404, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Ching Lee</Name>
        <Affiliation>The Center of Translational Medicine, Taipei Medical University, Taipei, Taiwan; Ph.D. Program for Biotechnology in Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Po Wang</Name>
        <Affiliation>College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Che Ming Teng</Name>
        <Affiliation>College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan; Pharmacological Institute, College of Medicine, National Taiwan University, Taipei 100, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Shiow Lin Pan</Name>
        <Affiliation>The Ph.D. Program for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan; Department of Pharmacology, College of Medicine, Taipei Medical University, Taipei 10031, Taiwan. Electronic address: slpan@tmu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nrf2-dependent protection against acute sodium arsenite toxicity in zebrafish.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27306194</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30146-6</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Detoxification</Keywords>
      <Keywords>Gene induction</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>Sulforaphane</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yuji Fuse</Name>
        <Affiliation>Department of Molecular and Developmental Biology, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Vu Thanh Nguyen</Name>
        <Affiliation>Department of Molecular and Developmental Biology, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Makoto Kobayashi</Name>
        <Affiliation>Department of Molecular and Developmental Biology, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan. Electronic address: makobayash@md.tsukuba.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Blood morphology and the levels of selected cytokines related to hematopoiesis in occupational short-term exposure to lead.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27298078</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30149-1</DOI>
    <KeywordList>
      <Keywords>Blood morphology</Keywords>
      <Keywords>Cytokines</Keywords>
      <Keywords>Hematopoiesis</Keywords>
      <Keywords>Subacute exposure to lead</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michał Dobrakowski</Name>
        <Affiliation>Department of Biochemistry, School of Medicine with the Division of Dentistry, Medical University of Silesia, ul. Jordana 19, 41-808 Zabrze, Poland. Electronic address: michal.dobrakowski@poczta.fm.</Affiliation>
      </Author>
      <Author>
        <Name>Marta Boroń</Name>
        <Affiliation>Institute of Occupational Medicine and Environmental Health in Sosnowiec, ul. Kościelna 13, 41-200 Sosnowiec, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Zenon P. Czuba</Name>
        <Affiliation>Department of Microbiology and Immunology, School of Medicine with the Division of Dentistry, Medical University of Silesia, ul. Jordana 19, 41-808 Zabrze, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Ewa Birkner</Name>
        <Affiliation>Department of Biochemistry, School of Medicine with the Division of Dentistry, Medical University of Silesia, ul. Jordana 19, 41-808 Zabrze, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Artur Chwalba</Name>
        <Affiliation>SP ZOZ Municipal Hospital, Department of Internal Medicine, ul. Strzelców Bytomskich 11, 41-500 Chorzów, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Edyta Hudziec</Name>
        <Affiliation>Department of Biochemistry, School of Medicine with the Division of Dentistry, Medical University of Silesia, ul. Jordana 19, 41-808 Zabrze, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Sławomir Kasperczyk</Name>
        <Affiliation>Department of Biochemistry, School of Medicine with the Division of Dentistry, Medical University of Silesia, ul. Jordana 19, 41-808 Zabrze, Poland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Combined effects of DNA methyltransferase 1 and 3A polymorphisms and urinary total arsenic levels on the risk for clear cell renal cell carcinoma.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27292127</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30145-4</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>DNMT</Keywords>
      <Keywords>Renal cell carcinoma</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shu Mei Yang</Name>
        <Affiliation>School of Public Health, College of Public Health and Nutrition, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Yuan Huang</Name>
        <Affiliation>Department of Urology, National Taiwan University Hospital, College of Medicine National Taiwan University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Horng Sheng Shiue</Name>
        <Affiliation>Department of Chinese Medicine, Chang Gung Memorial Hospital and College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yeong Shiau Pu</Name>
        <Affiliation>Department of Urology, National Taiwan University Hospital, College of Medicine National Taiwan University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Hsun Hsieh</Name>
        <Affiliation>School of Public Health, College of Public Health and Nutrition, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Jen Chen</Name>
        <Affiliation>School of Public Health, College of Public Health and Nutrition, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Chin Lin</Name>
        <Affiliation>Department of Family Medicine, Shung Ho Hospital, Taipei Medical University, Taipei, Taiwan; Department of Health Examination, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan; Division of Family Medicine, School of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Mei Hsueh</Name>
        <Affiliation>School of Public Health, College of Public Health and Nutrition, Taipei Medical University, Taipei, Taiwan; Department of Public Health, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan. Electronic address: ymhsueh@tmu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Epigenetic modification of miR-10a regulates renal damage by targeting CREB1 in type 2 diabetes mellitus.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27292126</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.06.010</DOI>
    <KeywordList>
      <Keywords>CREB1</Keywords>
      <Keywords>HDAC3</Keywords>
      <Keywords>Kidney damage</Keywords>
      <Keywords>Type 2 diabetes</Keywords>
      <Keywords>miR-10a</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qun Shan</Name>
        <Affiliation>Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou 221116, Jiangsu Province, PR China. Electronic address: shanp@jsnu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Guihong Zheng</Name>
        <Affiliation>Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou 221116, Jiangsu Province, PR China. Electronic address: ghzhengsd@jsnu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Aihua Zhu</Name>
        <Affiliation>Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou 221116, Jiangsu Province, PR China. Electronic address: ahzhu@jsnu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Li Cao</Name>
        <Affiliation>Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou 221116, Jiangsu Province, PR China. Electronic address: 948113717@qq.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Lu</Name>
        <Affiliation>Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou 221116, Jiangsu Province, PR China. Electronic address: lu-jun75@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Dongmei Wu</Name>
        <Affiliation>Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou 221116, Jiangsu Province, PR China. Electronic address: wdm8610@jsnu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>ZiFeng Zhang</Name>
        <Affiliation>Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou 221116, Jiangsu Province, PR China. Electronic address: zhangzifengsuper@jsnu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Shaohua Fan</Name>
        <Affiliation>Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou 221116, Jiangsu Province, PR China. Electronic address: fshfly@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Chunhui Sun</Name>
        <Affiliation>Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou 221116, Jiangsu Province, PR China. Electronic address: 306484866@qq.com.</Affiliation>
      </Author>
      <Author>
        <Name>Bin Hu</Name>
        <Affiliation>Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou 221116, Jiangsu Province, PR China. Electronic address: hubin@jsnu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanlin Zheng</Name>
        <Affiliation>Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou 221116, Jiangsu Province, PR China. Electronic address: ylzheng@jsnu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Environmental contaminants and microRNA regulation: Transcription factors as regulators of toxicant-altered microRNA expression.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27292125</pubmedLink>
    <GrantList>
      <Grant>P42 ES005948</Grant>
      <Grant>T32 ES007018</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30143-0</DOI>
    <KeywordList>
      <Keywords>Environmental toxicants</Keywords>
      <Keywords>Promoters</Keywords>
      <Keywords>Transcription factors</Keywords>
      <Keywords>miRNA</Keywords>
      <Keywords>microRNA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>James Sollome</Name>
        <Affiliation>Department of Environmental Science &amp; Engineering, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Elizabeth Martin</Name>
        <Affiliation>Department of Environmental Science &amp; Engineering, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Praveen Sethupathy</Name>
        <Affiliation>Department of Genetics, School of Medicine, University of North Carolina, Chapel Hill, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rebecca C. Fry</Name>
        <Affiliation>Department of Environmental Science &amp; Engineering, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, USA; Curriculum in Toxicology, School of Medicine, University of North Carolina, Chapel Hill, NC, USA. Electronic address: rfry@unc.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>TLR4/MyD88/NF-κB signaling and PPAR-γ within the paraventricular nucleus are involved in the effects of telmisartan in hypertension.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27292124</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30148-X</DOI>
    <KeywordList>
      <Keywords>AT1 receptor</Keywords>
      <Keywords>Hypertension</Keywords>
      <Keywords>PPAR-γ</Keywords>
      <Keywords>Paraventricular nucleus</Keywords>
      <Keywords>Toll-like receptor 4</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hong Bao Li</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Key Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiang Li</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Key Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chan Juan Huo</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Key Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qing Su</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Key Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Guo</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Key Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zu Yi Yuan</Name>
        <Affiliation>Department of Cardiovascular Medicine, First Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guo Qing Zhu</Name>
        <Affiliation>Key Laboratory of Cardiovascular Disease and Molecular Intervention, Department of Physiology, Nanjing Medical University, Nanjing 210029, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Lian Shi</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an 710061, China. Electronic address: shxl@mail.xjtu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Jun Liu</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an 710061, China. Electronic address: jupet@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Ming Kang</Name>
        <Affiliation>Department of Physiology and Pathophysiology, Key Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an Jiaotong University Cardiovascular Research Center, Xi'an 710061, China. Electronic address: ykang@mail.xjtu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Differences in toxicity of anionic and cationic PAMAM and PPI dendrimers in zebrafish embryos and cancer cell lines.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27288734</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30142-9</DOI>
    <KeywordList>
      <Keywords>Dendrimers</Keywords>
      <Keywords>Human cell lines</Keywords>
      <Keywords>Polyamidoamine (PAMAM)</Keywords>
      <Keywords>Polypropylenimine (PPI)</Keywords>
      <Keywords>Toxicity</Keywords>
      <Keywords>Zebrafish embryo</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lambert Bodewein</Name>
        <Affiliation>Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology, Frankfurt &amp; Aachen, Germany; Institute of Environmental Research (Biology V), RWTH Aachen University, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Frank Schmelter</Name>
        <Affiliation>Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Molecular Biology Division, Aachen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Stefano Di Fiore</Name>
        <Affiliation>Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Molecular Biology Division, Aachen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Henner Hollert</Name>
        <Affiliation>Institute of Environmental Research (Biology V), RWTH Aachen University, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Rainer Fischer</Name>
        <Affiliation>Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology, Frankfurt &amp; Aachen, Germany; Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Molecular Biology Division, Aachen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Martina Fenske</Name>
        <Affiliation>Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology, Frankfurt &amp; Aachen, Germany. Electronic address: martina.fenske@ime.fraunhofer.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Kinin B1 receptor blockade and ACE inhibition attenuate cardiac postinfarction remodeling and heart failure in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27288733</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30139-9</DOI>
    <KeywordList>
      <Keywords>Angiotensin 1 converting enzyme</Keywords>
      <Keywords>Cardiac function</Keywords>
      <Keywords>Cardiac remodeling</Keywords>
      <Keywords>Hemodynamics</Keywords>
      <Keywords>Kinin B1 receptor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xinchun Lin</Name>
        <Affiliation>Department of Research, Mount Sinai Medical Center, Miami Beach, FL 33140, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Christian Bernloehr</Name>
        <Affiliation>Boehringer Ingelheim Pharma GmbH &amp; Co.KG, Biberach, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Tobias Hildebrandt</Name>
        <Affiliation>Boehringer Ingelheim Pharma GmbH &amp; Co.KG, Biberach, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Florian J. Stadler</Name>
        <Affiliation>Shenzhen Engineering Laboratory for Advanced Technology of Ceramics, Shenzhen 518060, PR China. Electronic address: fjstadler@szu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Henri Doods</Name>
        <Affiliation>Boehringer Ingelheim Pharma GmbH &amp; Co.KG, Biberach, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Dongmei Wu</Name>
        <Affiliation>Department of Research, Mount Sinai Medical Center, Miami Beach, FL 33140, USA; Department of BIN Convergence Technology, Chonbuk National University, South Korea. Electronic address: dongmeiwu@bellsouth.net.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Lysosomotropic cationic drugs induce cytostatic and cytotoxic effects: Role of liposolubility and autophagic flux and antagonism by cholesterol ablation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27288732</pubmedLink>
    <GrantList />
    <Year>2016</Year>
    <DOI>S0041-008X(16)30140-5</DOI>
    <KeywordList>
      <Keywords>Antiproliferative effect</Keywords>
      <Keywords>Autophagic flux</Keywords>
      <Keywords>Cation trapping</Keywords>
      <Keywords>Lysosomotropic drugs</Keywords>
      <Keywords>Quinacrine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alexandre Parks</Name>
        <Affiliation>Axe Maladies Infectieuses et Immunitaires, CHU de Québec-Université Laval, Québec, QC G1V 4G2, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>François Marceau</Name>
        <Affiliation>Axe Maladies Infectieuses et Immunitaires, CHU de Québec-Université Laval, Québec, QC G1V 4G2, Canada. Electronic address: francois.marceau@crchul.ulaval.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of ABCG2-mediated transport of pesticides across the rabbit placenta barrier using a novel MDCKII in vitro model.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27288731</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30141-7</DOI>
    <KeywordList>
      <Keywords>ABCG2 (BCRP)</Keywords>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Pesticides</Keywords>
      <Keywords>Placenta</Keywords>
      <Keywords>Rabbit</Keywords>
      <Keywords>Transport</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sandra Halwachs</Name>
        <Affiliation>Institute of Pharmacology, Pharmacy and Toxicology, Faculty of Veterinary Medicine, Universität Leipzig, Leipzig, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Ingo Schäfer</Name>
        <Affiliation>Molecular Cell Therapy, Center for Biotechnology and Biomedicine, Faculty of Medicine, Universität Leipzig, Leipzig, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Carsten Kneuer</Name>
        <Affiliation>Federal Institute for Risk Assessment (BfR), Pesticide Safety, Max-Dohrn-Straße 8-10, D-10589 Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Seibel</Name>
        <Affiliation>Molecular Cell Therapy, Center for Biotechnology and Biomedicine, Faculty of Medicine, Universität Leipzig, Leipzig, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Walther Honscha</Name>
        <Affiliation>Institute of Pharmacology, Pharmacy and Toxicology, Faculty of Veterinary Medicine, Universität Leipzig, Leipzig, Germany. Electronic address: honscha@vetmed.uni-leipzig.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Activation of aryl hydrocarbon receptor reduces carbendazim-induced cell death.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27286660</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.06.004</DOI>
    <KeywordList>
      <Keywords>Aryl hydrocarbon receptor</Keywords>
      <Keywords>Carbendazim</Keywords>
      <Keywords>Cytochrome P450</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kuo Liang Wei</Name>
        <Affiliation>Division of Gastroenterology and Hepatology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chiayi 61363, Taiwan, ROC; College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Fei Yun Chen</Name>
        <Affiliation>Department of Biochemical Science and Technology, National Chiayi University, Chiayi 60004, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Chih Yi Lin</Name>
        <Affiliation>Department of Biochemical Science and Technology, National Chiayi University, Chiayi 60004, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Guan Lun Gao</Name>
        <Affiliation>Department of Biochemical Science and Technology, National Chiayi University, Chiayi 60004, Taiwan, ROC; Department of Biological Resources, National Chiayi University, Chiayi, 60004, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Ya Kao</Name>
        <Affiliation>Department of Biochemical Science and Technology, National Chiayi University, Chiayi 60004, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Chi Hui Yeh</Name>
        <Affiliation>Department of Environmental Engineering, College of Engineering, Da-Yeh University, Dacun, Changhua 51591, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Chang Rong Chen</Name>
        <Affiliation>Department of Biochemical Science and Technology, National Chiayi University, Chiayi 60004, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Hao Chun Huang</Name>
        <Affiliation>Division of Gastroenterology and Hepatology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chiayi 61363, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Ren Tsai</Name>
        <Affiliation>Division of Applied Toxicology, Taiwan Agricultural Chemicals and Toxic Substances Research Institute, Council of Agriculture, Executive Yuan, Taichung 41358, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Koa Jen Jong</Name>
        <Affiliation>Department of Biological Resources, National Chiayi University, Chiayi, 60004, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Wan Jung Li</Name>
        <Affiliation>Department of Biochemical Science and Technology, National Chiayi University, Chiayi 60004, Taiwan, ROC.</Affiliation>
      </Author>
      <Author>
        <Name>Jyan Gwo Joseph Su</Name>
        <Affiliation>Department of Biochemical Science and Technology, National Chiayi University, Chiayi 60004, Taiwan, ROC. Electronic address: jgjsu@mail.ncyu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Hypoxia-induced pulmonary arterial hypertension augments lung injury and airway reactivity caused by ozone exposure.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27286659</pubmedLink>
    <GrantList>
      <Grant>K12 GM088021</Grant>
      <Grant>R01 ES014639</Grant>
      <Grant>R56 ES014639</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30137-5</DOI>
    <KeywordList>
      <Keywords>Chronic obstructive pulmonary disease (COPD)</Keywords>
      <Keywords>Fasudil</Keywords>
      <Keywords>Hypoxia</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Ozone</Keywords>
      <Keywords>Pulmonary hypertension</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Katherine E. Zychowski</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of New Mexico College of Pharmacy, Albuquerque, NM 87131, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Selita N. Lucas</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of New Mexico College of Pharmacy, Albuquerque, NM 87131, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Bethany Sanchez</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of New Mexico College of Pharmacy, Albuquerque, NM 87131, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Guy Herbert</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of New Mexico College of Pharmacy, Albuquerque, NM 87131, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Matthew J. Campen</Name>
        <Affiliation>Department of Pharmaceutical Sciences, University of New Mexico College of Pharmacy, Albuquerque, NM 87131, United States. Electronic address: mcampen@salud.unm.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mobilization and removing of cadmium from kidney by GMDTC utilizing renal glucose reabsorption pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27282297</pubmedLink>
    <GrantList>
      <Grant>K07 CA178293</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30135-1</DOI>
    <KeywordList>
      <Keywords>Cadmium decorporation</Keywords>
      <Keywords>Cadmium induced renal dysfunction</Keywords>
      <Keywords>Chelating agent</Keywords>
      <Keywords>GMDTC</Keywords>
      <Keywords>Renal glucose reabsorption pathway</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiaojiang Tang</Name>
        <Affiliation>Guangdong Medical Laboratory Animal Center, China. Electronic address: river-t@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jinqiu Zhu</Name>
        <Affiliation>Department of Epidemiology and Environmental Health, The State University of New York, Buffalo, NY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zhiyong Zhong</Name>
        <Affiliation>Guangdong Medical Laboratory Animal Center, China.</Affiliation>
      </Author>
      <Author>
        <Name>Minhui Luo</Name>
        <Affiliation>Guangdong Medical Laboratory Animal Center, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guangxian Li</Name>
        <Affiliation>Guangdong Medical Laboratory Animal Center, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhihong Gong</Name>
        <Affiliation>Department of Epidemiology and Environmental Health, The State University of New York, Buffalo, NY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Chenzi Zhang</Name>
        <Affiliation>Guangdong Medical Laboratory Animal Center, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fan Fei</Name>
        <Affiliation>Guangdong Medical Laboratory Animal Center, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaolin Ruan</Name>
        <Affiliation>Guangdong Poison Control Center, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinlin Zhou</Name>
        <Affiliation>Golden Health (Foshan) Technology Co., Ltd, China.</Affiliation>
      </Author>
      <Author>
        <Name>Gaofeng Liu</Name>
        <Affiliation>School of Chemistry and Chemical Engineering, Sun Yat-Sen University, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guoding Li</Name>
        <Affiliation>Guangdong Medical Laboratory Animal Center, China.</Affiliation>
      </Author>
      <Author>
        <Name>James Olson</Name>
        <Affiliation>Department of Epidemiology and Environmental Health, The State University of New York, Buffalo, NY, USA; Department of Pharmacology and Toxicology, The State University of New York, Buffalo, NY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xuefeng Ren</Name>
        <Affiliation>Guangdong Medical Laboratory Animal Center, China; Department of Epidemiology and Environmental Health, The State University of New York, Buffalo, NY, USA; Department of Pharmacology and Toxicology, The State University of New York, Buffalo, NY, USA. Electronic address: xuefengr@buffalo.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mitragynine and its potential blocking effects on specific cardiac potassium channels.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27260674</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30134-X</DOI>
    <KeywordList>
      <Keywords>Cardiotoxicity</Keywords>
      <Keywords>GIRK</Keywords>
      <Keywords>Kir2.1</Keywords>
      <Keywords>Mitragynine</Keywords>
      <Keywords>hERG</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yea Lu Tay</Name>
        <Affiliation>Malaysian Institute of Pharmaceuticals &amp; Nutraceuticals, NIBM, Ministry of Science, Technology &amp; Innovation (MOSTI), Pulau Pinang, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Fan Teah</Name>
        <Affiliation>Malaysian Institute of Pharmaceuticals &amp; Nutraceuticals, NIBM, Ministry of Science, Technology &amp; Innovation (MOSTI), Pulau Pinang, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Yoong Min Chong</Name>
        <Affiliation>Malaysian Institute of Pharmaceuticals &amp; Nutraceuticals, NIBM, Ministry of Science, Technology &amp; Innovation (MOSTI), Pulau Pinang, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Mohd Fadzly Amar Jamil</Name>
        <Affiliation>Clinical Research Center, Hospital Seberang Jaya, Kementerian Kesihatan Malaysia, Pulau Pinang, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Sina Kollert</Name>
        <Affiliation>Institute of Physiology, University of Wurzburg, Wurzburg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Mohd Ilham Adenan</Name>
        <Affiliation>Atta-ur-Rahman Institute for Natural Product Discovery, Universiti Teknologi MARA (UiTM), Selangor Darul Ehsan, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Habibah Abdul Wahab</Name>
        <Affiliation>Pharmaceutical Design &amp; Simulation (PhDS) Laboratory, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Pulau Pinang, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Frank Döring</Name>
        <Affiliation>Institute of Physiology, University of Wurzburg, Wurzburg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Erhard Wischmeyer</Name>
        <Affiliation>Institute of Physiology, University of Wurzburg, Wurzburg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Mei Lan Tan</Name>
        <Affiliation>Malaysian Institute of Pharmaceuticals &amp; Nutraceuticals, NIBM, Ministry of Science, Technology &amp; Innovation (MOSTI), Pulau Pinang, Malaysia; Advanced Medical and Dental Institute, Universiti Sains Malaysia, Pulau Pinang, Malaysia. Electronic address: tanml@usm.my.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inhibition by ketamine and amphetamine analogs of the neurogenic nitrergic vasodilations in porcine basilar arteries.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27260673</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30132-6</DOI>
    <KeywordList>
      <Keywords>Amphetamine</Keywords>
      <Keywords>Basilar artery</Keywords>
      <Keywords>Ketamine</Keywords>
      <Keywords>Methamphetamine</Keywords>
      <Keywords>Nicotinic acetylcholine receptor</Keywords>
      <Keywords>Nitrergic neurogenic vasodilation</Keywords>
      <Keywords>Sympathetic-parasympathetic interaction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mei Fang Chen</Name>
        <Affiliation>Department of Medical Research, Buddhist Tzu Chi General Hospital, Hualien, Taiwan; Tzu Chi Center for Vascular Medicine, Buddhist Tzu Chi General Hospital, Hualien, Taiwan; Tzu Chi University of Science and Technology, Hualien, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Su Yu Lai</Name>
        <Affiliation>Department of Pharmacology and Toxicology, College of Medicine, Tzu Chi University, Hualien, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Po Cheng Kung</Name>
        <Affiliation>Department of Pharmacology and Toxicology, College of Medicine, Tzu Chi University, Hualien, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yo Cheng Lin</Name>
        <Affiliation>Department of Pharmacology and Toxicology, College of Medicine, Tzu Chi University, Hualien, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Hui I. Yang</Name>
        <Affiliation>Department of Medical Research, Buddhist Tzu Chi General Hospital, Hualien, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Po Yi Chen</Name>
        <Affiliation>Department of Medical Research, Buddhist Tzu Chi General Hospital, Hualien, Taiwan; Department of Pharmacology and Toxicology, College of Medicine, Tzu Chi University, Hualien, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ingrid Y. Liu</Name>
        <Affiliation>Department of Molecular Biology and Human Genetics, Tzu Chi University, Hualien, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ahai Chang Lua</Name>
        <Affiliation>Department of Laboratory Medicine and Biotechnology &amp; Graduate Institute of Medical Biotechnology, Tzu Chi University, Hualien, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Tony Jer Fu Lee</Name>
        <Affiliation>Department of Medical Research, Buddhist Tzu Chi General Hospital, Hualien, Taiwan; Tzu Chi Center for Vascular Medicine, Buddhist Tzu Chi General Hospital, Hualien, Taiwan; Department of Life Sciences, College of Life Sciences, Tzu Chi University, Hualien, Taiwan; Department of Pharmacology and Toxicology, College of Medicine, Tzu Chi University, Hualien, Taiwan; Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, IL, USA. Electronic address: tlee@mail.tcu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects and mechanisms of cavidine protecting mice against LPS-induced endotoxic shock.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27260672</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30133-8</DOI>
    <KeywordList>
      <Keywords>Cavidine</Keywords>
      <Keywords>Endotoxic shock</Keywords>
      <Keywords>HMGB1</Keywords>
      <Keywords>IL-6</Keywords>
      <Keywords>TNF-α</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Weifeng Li</Name>
        <Affiliation>School of Pharmacy, Xi'an Jiaotong University, Xi'an, 710061, PR China. Electronic address: liwf@mail.xjtu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Hailin Zhang</Name>
        <Affiliation>School of Pharmacy, Xi'an Jiaotong University, Xi'an, 710061, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaofeng Niu</Name>
        <Affiliation>School of Pharmacy, Xi'an Jiaotong University, Xi'an, 710061, PR China. Electronic address: niuxf@mail.xjtu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xiumei Wang</Name>
        <Affiliation>School of Pharmacy, Xi'an Jiaotong University, Xi'an, 710061, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Wang</Name>
        <Affiliation>School of Pharmacy, Xi'an Jiaotong University, Xi'an, 710061, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zehong He</Name>
        <Affiliation>School of Pharmacy, Xi'an Jiaotong University, Xi'an, 710061, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Huan Yao</Name>
        <Affiliation>School of Pharmacy, Xi'an Jiaotong University, Xi'an, 710061, PR China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Several synthetic progestins disrupt the glial cell specific-brain aromatase expression in developing zebra fish.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27245768</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30131-4</DOI>
    <KeywordList>
      <Keywords>Brain aromatase</Keywords>
      <Keywords>Progestins</Keywords>
      <Keywords>Radial glial cells</Keywords>
      <Keywords>Zebrafish</Keywords>
      <Keywords>cyp19a1b-GFP</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Joel Cano-Nicolau</Name>
        <Affiliation>Team NEED, Institut de recherche en Santé Environnement et Travail (Irset), INSERM U1085, Université de Rennes 1, Campus de Beaulieu, SFR Biosit, 35042 Rennes cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Clémentine Garoche</Name>
        <Affiliation>Unité d'Ecotoxicologie in vitro et in vivo, Institut National de l'Environnement Industriel et des Risques (INERIS), BP 2, 60550 Verneuil-en-Halatte, France.</Affiliation>
      </Author>
      <Author>
        <Name>Nathalie Hinfray</Name>
        <Affiliation>Unité d'Ecotoxicologie in vitro et in vivo, Institut National de l'Environnement Industriel et des Risques (INERIS), BP 2, 60550 Verneuil-en-Halatte, France.</Affiliation>
      </Author>
      <Author>
        <Name>Elisabeth Pellegrini</Name>
        <Affiliation>Team NEED, Institut de recherche en Santé Environnement et Travail (Irset), INSERM U1085, Université de Rennes 1, Campus de Beaulieu, SFR Biosit, 35042 Rennes cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Noureddine Boujrad</Name>
        <Affiliation>TREK, Institut de recherche en Santé Environnement et Travail (Irset), INSERM U1085, Université de Rennes 1, Campus de Beaulieu, SFR Biosit, 35042 Rennes cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Farzad Pakdel</Name>
        <Affiliation>TREK, Institut de recherche en Santé Environnement et Travail (Irset), INSERM U1085, Université de Rennes 1, Campus de Beaulieu, SFR Biosit, 35042 Rennes cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Olivier Kah</Name>
        <Affiliation>Team NEED, Institut de recherche en Santé Environnement et Travail (Irset), INSERM U1085, Université de Rennes 1, Campus de Beaulieu, SFR Biosit, 35042 Rennes cedex, France. Electronic address: oliver.kah@univ-rennes1.fr.</Affiliation>
      </Author>
      <Author>
        <Name>François Brion</Name>
        <Affiliation>Unité d'Ecotoxicologie in vitro et in vivo, Institut National de l'Environnement Industriel et des Risques (INERIS), BP 2, 60550 Verneuil-en-Halatte, France. Electronic address: francois.brion@ineris.fr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Honokiol induces autophagic cell death in malignant glioma through reactive oxygen species-mediated regulation of the p53/PI3K/Akt/mTOR signaling pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27236003</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.05.018</DOI>
    <KeywordList>
      <Keywords>Autophagy</Keywords>
      <Keywords>Honokiol</Keywords>
      <Keywords>Malignant glioma</Keywords>
      <Keywords>ROS</Keywords>
      <Keywords>p53/PI3K/Akt/mTOR</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chien Ju Lin</Name>
        <Affiliation>Graduate Institute of Medical Sciences, Taipei Medical University, Taipei, Taiwan; Comprehensive Cancer Center, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ta Liang Chen</Name>
        <Affiliation>Anesthetics and Toxicology Research Center, Taipei Medical University Hospital, Taipei, Taiwan; Department of Anesthesiology, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Yun Tseng</Name>
        <Affiliation>Department of Neurosurgery, Shuang-Ho Hospital, Taipei Medical University, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Gong Jhe Wu</Name>
        <Affiliation>Department of Anesthesiology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ming Hui Hsieh</Name>
        <Affiliation>Anesthetics and Toxicology Research Center, Taipei Medical University Hospital, Taipei, Taiwan; Department of Anesthesiology, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yung Wei Lin</Name>
        <Affiliation>Brain Disease Research Center, Taipei Medical University Wan-Fang Hospital, Taipei, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ruei Ming Chen</Name>
        <Affiliation>Graduate Institute of Medical Sciences, Taipei Medical University, Taipei, Taiwan; Anesthetics and Toxicology Research Center, Taipei Medical University Hospital, Taipei, Taiwan; Brain Disease Research Center, Taipei Medical University Wan-Fang Hospital, Taipei, Taiwan; Comprehensive Cancer Center, Taipei Medical University, Taipei, Taiwan. Electronic address: rmchen@tmu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>TCDD modulation of gut microbiome correlated with liver and immune toxicity in streptozotocin (STZ)-induced hyperglycemic mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27221631</pubmedLink>
    <GrantList>
      <Grant>R21 ES024487</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.05.016</DOI>
    <KeywordList>
      <Keywords>Hyperglycemia</Keywords>
      <Keywords>Immunotoxicity</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Microbiome</Keywords>
      <Keywords>TCDD</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Daniel E. Lefever</Name>
        <Affiliation>Department of Veterinary Biosciences and Diagnostic Imaging, University of Georgia, Athens, GA 30602-7382, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Joella Xu</Name>
        <Affiliation>Department of Veterinary Biosciences and Diagnostic Imaging, University of Georgia, Athens, GA 30602-7382, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Yingjia Chen</Name>
        <Affiliation>Department of Veterinary Biosciences and Diagnostic Imaging, University of Georgia, Athens, GA 30602-7382, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Guannan Huang</Name>
        <Affiliation>Department of Environmental Health Sciences, University of Georgia, Athens, GA 30602-7382, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Nagy Tamas</Name>
        <Affiliation>Department of Veterinary Pathology, University of Georgia, Athens, GA 30602-7382, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Tai L. Guo</Name>
        <Affiliation>Department of Veterinary Biosciences and Diagnostic Imaging, University of Georgia, Athens, GA 30602-7382, United States. Electronic address: tlguo1@uga.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Health effects following subacute exposure to geogenic dusts from arsenic-rich sediment at the Nellis Dunes Recreation Area, Las Vegas, NV.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27221630</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.05.017</DOI>
    <KeywordList>
      <Keywords>Geogenic dust</Keywords>
      <Keywords>Heavy metals</Keywords>
      <Keywords>Immunotoxicity</Keywords>
      <Keywords>Lung exposure</Keywords>
      <Keywords>Minerals</Keywords>
      <Keywords>Neurotoxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jamie DeWitt</Name>
        <Affiliation>Department of Pharmacology and Toxicology, East Carolina University, Greenville, NC 27834, USA. Electronic address: dewittj@ecu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Brenda Buck</Name>
        <Affiliation>Department of Geoscience, University of Nevada, Las Vegas, NV 89154, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Dirk Goossens</Name>
        <Affiliation>Department of Geoscience, University of Nevada, Las Vegas, NV 89154, USA; Department of Earth and Environmental Sciences, KU Leuven, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Qing Hu</Name>
        <Affiliation>Department of Pharmacology and Toxicology, East Carolina University, Greenville, NC 27834, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rebecca Chow</Name>
        <Affiliation>Department of Geoscience, University of Nevada, Las Vegas, NV 89154, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Winnie David</Name>
        <Affiliation>Department of Geoscience, University of Nevada, Las Vegas, NV 89154, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sharon Young</Name>
        <Affiliation>Department of Geoscience, University of Nevada, Las Vegas, NV 89154, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanxin Teng</Name>
        <Affiliation>Department of Geoscience, University of Nevada, Las Vegas, NV 89154, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mallory Leetham-Spencer</Name>
        <Affiliation>Department of Microbiology and Immunology, Montana State University, Bozeman, MT 59717, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lacey Murphy</Name>
        <Affiliation>Department of Microbiology and Immunology, Montana State University, Bozeman, MT 59717, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James Pollard</Name>
        <Affiliation>Department of Geoscience, University of Nevada, Las Vegas, NV 89154, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brett McLaurin</Name>
        <Affiliation>Department of Environmental, Geographical, and Geological Sciences, Bloomsburg University of Pennsylvania, Bloomsburg, PA,17815, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Russell Gerads</Name>
        <Affiliation>Brooks Rand Labs, LLC, Bothell, WA 98011, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Deborah Keil</Name>
        <Affiliation>Department of Microbiology and Immunology, Montana State University, Bozeman, MT 59717, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Arsenic silences hepatic PDK4 expression through activation of histone H3K9 methylatransferase G9a.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27217333</pubmedLink>
    <GrantList>
      <Grant>R21 AA022482</Grant>
      <Grant>R01 DK080440</Grant>
      <Grant>I01 BX002634</Grant>
      <Grant>R01 DK104656</Grant>
      <Grant>P30 DK034989</Grant>
      <Grant>R01 ES025909</Grant>
      <Grant>R21 CA191507</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.05.015</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>BRD4770</Keywords>
      <Keywords>G9a</Keywords>
      <Keywords>H3K9 methylation</Keywords>
      <Keywords>PDK4</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xi Zhang</Name>
        <Affiliation>Department of Physiology and Neurobiology and The Institute for Systems Genomics, University of Connecticut, Storrs, CT 062696, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jianguo Wu</Name>
        <Affiliation>Department of Physiology and Neurobiology and The Institute for Systems Genomics, University of Connecticut, Storrs, CT 062696, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jonathan Choiniere</Name>
        <Affiliation>Department of Physiology and Neurobiology and The Institute for Systems Genomics, University of Connecticut, Storrs, CT 062696, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Zhihong Yang</Name>
        <Affiliation>Department of Physiology and Neurobiology and The Institute for Systems Genomics, University of Connecticut, Storrs, CT 062696, United States; Veterans Affairs Connecticut Healthcare System, West Haven, CT 06516, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Huang</Name>
        <Affiliation>Department of Physiology and Neurobiology and The Institute for Systems Genomics, University of Connecticut, Storrs, CT 062696, United States; School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jason Bennett</Name>
        <Affiliation>Department of Physiology and Neurobiology and The Institute for Systems Genomics, University of Connecticut, Storrs, CT 062696, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Li Wang</Name>
        <Affiliation>Department of Physiology and Neurobiology and The Institute for Systems Genomics, University of Connecticut, Storrs, CT 062696, United States; Veterans Affairs Connecticut Healthcare System, West Haven, CT 06516, United States; School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China; Department of Internal Medicine, Section of Digestive Diseases, Yale University, New Haven, CT 06520, United States. Electronic address: li.wang@uconn.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Epigenetic silencing of miR-218 by the lncRNA CCAT1, acting via BMI1, promotes an altered cell cycle transition in the malignant transformation of HBE cells induced by cigarette smoke extract.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27212446</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.05.012</DOI>
    <KeywordList>
      <Keywords>Carcinogenesis</Keywords>
      <Keywords>Cell cycle</Keywords>
      <Keywords>Cigarette smoke extract (CSE)</Keywords>
      <Keywords>lncRNAs</Keywords>
      <Keywords>miRNAs</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lu Lu</Name>
        <Affiliation>Institute of Toxicology, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Xu</Name>
        <Affiliation>Institute of Toxicology, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Fei Luo</Name>
        <Affiliation>Institute of Toxicology, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xinlu Liu</Name>
        <Affiliation>Institute of Toxicology, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaolin Lu</Name>
        <Affiliation>Institute of Toxicology, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Qianlei Yang</Name>
        <Affiliation>Institute of Toxicology, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Junchao Xue</Name>
        <Affiliation>Institute of Toxicology, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Chen</Name>
        <Affiliation>Institute of Toxicology, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Le Shi</Name>
        <Affiliation>Institute of Toxicology, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Qizhan Liu</Name>
        <Affiliation>Institute of Toxicology, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China. Electronic address: drqzliu@hotmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mustard vesicant-induced lung injury: Advances in therapy.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27212445</pubmedLink>
    <GrantList>
      <Grant>P30 ES005022</Grant>
      <Grant>R01 ES004738</Grant>
      <Grant>U54 AR055073</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30120-X</DOI>
    <KeywordList>
      <Keywords>Fibrosis</Keywords>
      <Keywords>Inflammatory mediators</Keywords>
      <Keywords>Lung injury</Keywords>
      <Keywords>Mustard gas</Keywords>
      <Keywords>Therapeutic approaches</Keywords>
      <Keywords>Vesicant</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Barry Weinberger</Name>
        <Affiliation>Division of Neonatal and Perinatal Medicine, Hofstra Northwell School of Medicine, Cohen Children's Medical Center of New York, New Hyde Park, NY 11040, USA. Electronic address: bweinberger@northwell.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Rama Malaviya</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Vasanthi R. Sunil</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Alessandro Venosa</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Diane E. Heck</Name>
        <Affiliation>Department of Environmental Health Science, New York Medical College, School of Public Health, Valhalla, NY 10595, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey D. Laskin</Name>
        <Affiliation>Department of Environmental and Occupational Health, School of Public Health, Rutgers University, Piscataway, NJ 08854, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Debra L. Laskin</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The effects of MEK1/2 inhibition on cigarette smoke exposure-induced ET receptor upregulation in rat cerebral arteries.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27212444</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.05.013</DOI>
    <KeywordList>
      <Keywords>Cerebral artery</Keywords>
      <Keywords>Cigarette smoke</Keywords>
      <Keywords>Endothelin receptor</Keywords>
      <Keywords>MEK1/2</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Receptor upregulation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lei Cao</Name>
        <Affiliation>Division of Experimental Vascular Research, Institute of Clinical Sciences in Lund, Lund University, Sweden; Department of Pharmacology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.</Affiliation>
      </Author>
      <Author>
        <Name>Na Na Ping</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Xiao Cao</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Li</Name>
        <Affiliation>Department of Hepatobiliary Surgery, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. Electronic address: 13572512207@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Cai</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.</Affiliation>
      </Author>
      <Author>
        <Name>Karin Warfvinge</Name>
        <Affiliation>Division of Experimental Vascular Research, Institute of Clinical Sciences in Lund, Lund University, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Lars Edvinsson</Name>
        <Affiliation>Division of Experimental Vascular Research, Institute of Clinical Sciences in Lund, Lund University, Sweden.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Development of HSPA1A promoter-driven luciferase reporter gene assays in human cells for assessing the oxidative damage induced by silver nanoparticles.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27211842</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.05.010</DOI>
    <KeywordList>
      <Keywords>HSPA1A</Keywords>
      <Keywords>Luciferase reporter</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Silver nanoparticles</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lili Xin</Name>
        <Affiliation>School of Public Health, Medical College of Soochow University, 199 Renai Road, Suzhou 215123, Jiangsu, China; Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, School of Public Health, Soochow University, Suzhou 215123, China. Electronic address: llxin@suda.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Jianshu Wang</Name>
        <Affiliation>Suzhou Center for Disease Prevention and Control, 72 Sanxiang Road, Suzhou, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Leshuai W. Zhang</Name>
        <Affiliation>School of Radiation Medicine and Protection &amp; School for Radiological and Interdisciplinary Sciences (RAD-X), Soochow University, 215123, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bizhong Che</Name>
        <Affiliation>School of Public Health, Medical College of Soochow University, 199 Renai Road, Suzhou 215123, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guangzhu Dong</Name>
        <Affiliation>School of Public Health, Medical College of Soochow University, 199 Renai Road, Suzhou 215123, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guoqiang Fan</Name>
        <Affiliation>Suzhou Industrial Park Centers for Disease Control and Prevention, 58 Suqian Road, Suzhou, Jiangsu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Kaiming Cheng</Name>
        <Affiliation>Suzhou Industrial Park Centers for Disease Control and Prevention, 58 Suqian Road, Suzhou, Jiangsu, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Sinomenine attenuates renal fibrosis through Nrf2-mediated inhibition of oxidative stress and TGFβ signaling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27211841</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.05.009</DOI>
    <KeywordList>
      <Keywords>Nrf2</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Renal fibrosis</Keywords>
      <Keywords>Sinomenine</Keywords>
      <Keywords>TGFβ</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tian Qin</Name>
        <Affiliation>School of Life Science &amp; Technology, China Pharmaceutical University, Nanjing 210009, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shasha Yin</Name>
        <Affiliation>Jiangsu Key Laboratory of Molecular Medicine, Nanjing University School of Medicine, Nanjing 210093, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Yang</Name>
        <Affiliation>Jiangsu Key Laboratory of Molecular Medicine, Nanjing University School of Medicine, Nanjing 210093, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qin Zhang</Name>
        <Affiliation>Jiangsu Key Laboratory of Molecular Medicine, Nanjing University School of Medicine, Nanjing 210093, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yangyang Liu</Name>
        <Affiliation>Jiangsu Key Laboratory of Molecular Medicine, Nanjing University School of Medicine, Nanjing 210093, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fengjie Huang</Name>
        <Affiliation>School of Life Science &amp; Technology, China Pharmaceutical University, Nanjing 210009, China. Electronic address: hfj@cpu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Wangsen Cao</Name>
        <Affiliation>Jiangsu Key Laboratory of Molecular Medicine, Nanjing University School of Medicine, Nanjing 210093, China. Electronic address: wangsencao@nju.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Curcumin rescues high fat diet-induced obesity and insulin sensitivity in mice through regulating SREBP pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27208389</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.05.011</DOI>
    <KeywordList>
      <Keywords>Curcumin</Keywords>
      <Keywords>Insulin resistance</Keywords>
      <Keywords>Obesity</Keywords>
      <Keywords>SREBPs</Keywords>
      <Keywords>Type 2 diabetes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lili Ding</Name>
        <Affiliation>The Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, The State Administration of TCM (SATCM) Key Laboratory for New Resources and Quality Evaluation of Chinese Medicine, Shanghai Key Laboratory of Complex Prescriptions, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; Shanghai R&amp;D Center for Standardization of Traditional Chinese Medicines, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinmei Li</Name>
        <Affiliation>The Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, The State Administration of TCM (SATCM) Key Laboratory for New Resources and Quality Evaluation of Chinese Medicine, Shanghai Key Laboratory of Complex Prescriptions, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; Shanghai R&amp;D Center for Standardization of Traditional Chinese Medicines, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Baoliang Song</Name>
        <Affiliation>The State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Xiao</Name>
        <Affiliation>The State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China.</Affiliation>
      </Author>
      <Author>
        <Name>Binfeng Zhang</Name>
        <Affiliation>The Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, The State Administration of TCM (SATCM) Key Laboratory for New Resources and Quality Evaluation of Chinese Medicine, Shanghai Key Laboratory of Complex Prescriptions, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; Shanghai R&amp;D Center for Standardization of Traditional Chinese Medicines, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Meng Qi</Name>
        <Affiliation>The Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, The State Administration of TCM (SATCM) Key Laboratory for New Resources and Quality Evaluation of Chinese Medicine, Shanghai Key Laboratory of Complex Prescriptions, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; Shanghai R&amp;D Center for Standardization of Traditional Chinese Medicines, Shanghai 201203, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wendong Huang</Name>
        <Affiliation>Department of Diabetes and Metabolic Diseases Research, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Li Yang</Name>
        <Affiliation>The Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, The State Administration of TCM (SATCM) Key Laboratory for New Resources and Quality Evaluation of Chinese Medicine, Shanghai Key Laboratory of Complex Prescriptions, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; Shanghai R&amp;D Center for Standardization of Traditional Chinese Medicines, Shanghai 201203, China. Electronic address: yangli7951@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Zhengtao Wang</Name>
        <Affiliation>The Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, The State Administration of TCM (SATCM) Key Laboratory for New Resources and Quality Evaluation of Chinese Medicine, Shanghai Key Laboratory of Complex Prescriptions, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; Shanghai R&amp;D Center for Standardization of Traditional Chinese Medicines, Shanghai 201203, China. Electronic address: ztwang@shutcm.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Bronchopulmonary C-fibers' IL1RI contributes to the prolonged apneic response to intra-atrial injection of capsaicin by prenatal nicotinic exposure in rat pups.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27180639</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30114-4</DOI>
    <KeywordList>
      <Keywords>IL-1 type I receptor</Keywords>
      <Keywords>Nodose/jugular ganglion</Keywords>
      <Keywords>Pulmonary C-fiber-mediated apnea</Keywords>
      <Keywords>SIDS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lei Zhao</Name>
        <Affiliation>Pathophysiology Program, Lovelace Respiratory Research Institute, Albuquerque, NM, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jianguo Zhuang</Name>
        <Affiliation>Pathophysiology Program, Lovelace Respiratory Research Institute, Albuquerque, NM, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Fadi Xu</Name>
        <Affiliation>Pathophysiology Program, Lovelace Respiratory Research Institute, Albuquerque, NM, USA. Electronic address: fxu@lrri.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The trypanocidal benznidazole promotes adaptive response to oxidative injury: Involvement of the nuclear factor-erythroid 2-related factor-2 (Nrf2) and multidrug resistance associated protein 2 (MRP2).</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27180241</pubmedLink>
    <GrantList>
      <Grant>R01 DK069557</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.05.007</DOI>
    <KeywordList>
      <Keywords>Benznidazole</Keywords>
      <Keywords>Multidrug resistance associated protein 2</Keywords>
      <Keywords>Nuclear factor-erythroid 2-related factor-2</Keywords>
      <Keywords>Oxidative stress</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Juan Pablo Rigalli</Name>
        <Affiliation>Institute of Experimental Physiology (IFISE-CONICET), Suipacha 570, 2000 Rosario, Argentina; Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Heidelberg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Virginia Gabriela Perdomo</Name>
        <Affiliation>Institute of Experimental Physiology (IFISE-CONICET), Suipacha 570, 2000 Rosario, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Nadia Ciriaci</Name>
        <Affiliation>Institute of Experimental Physiology (IFISE-CONICET), Suipacha 570, 2000 Rosario, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Eleazar Antonio Francés</Name>
        <Affiliation>Institute of Experimental Physiology (IFISE-CONICET), Suipacha 570, 2000 Rosario, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>María Teresa Ronco</Name>
        <Affiliation>Institute of Experimental Physiology (IFISE-CONICET), Suipacha 570, 2000 Rosario, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Amy Michele Bataille</Name>
        <Affiliation>University of Connecticut, School of Pharmacy, Department of Pharmaceutical Sciences, Storrs, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Carolina Inés Ghanem</Name>
        <Affiliation>Institute of Pharmacological Investigations (ININFA-CONICET), University of Buenos Aires, Buenos Aires, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>María Laura Ruiz</Name>
        <Affiliation>Institute of Experimental Physiology (IFISE-CONICET), Suipacha 570, 2000 Rosario, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>José Enrique Manautou</Name>
        <Affiliation>University of Connecticut, School of Pharmacy, Department of Pharmaceutical Sciences, Storrs, CT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Viviana Alicia Catania</Name>
        <Affiliation>Institute of Experimental Physiology (IFISE-CONICET), Suipacha 570, 2000 Rosario, Argentina. Electronic address: vcatania@fbioyf.unr.edu.ar.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Activation of the Constitutive Androstane Receptor induces hepatic lipogenesis and regulates Pnpla3 gene expression in a LXR-independent way.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27180240</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30112-0</DOI>
    <KeywordList>
      <Keywords>Constitutive Androstane Receptor</Keywords>
      <Keywords>Lipogenesis</Keywords>
      <Keywords>Liver X Receptor</Keywords>
      <Keywords>Non-alcoholic fatty liver disease</Keywords>
      <Keywords>PNPLA3/adiponutrin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alice Marmugi</Name>
        <Affiliation>INRA, TOXALIM (Research Centre in Food Toxicology), Toulouse, France; Université de Toulouse, INP, UPS, TOXALIM, Toulouse, France.</Affiliation>
      </Author>
      <Author>
        <Name>Céline Lukowicz</Name>
        <Affiliation>INRA, TOXALIM (Research Centre in Food Toxicology), Toulouse, France; Université de Toulouse, INP, UPS, TOXALIM, Toulouse, France.</Affiliation>
      </Author>
      <Author>
        <Name>Frederic Lasserre</Name>
        <Affiliation>INRA, TOXALIM (Research Centre in Food Toxicology), Toulouse, France; Université de Toulouse, INP, UPS, TOXALIM, Toulouse, France.</Affiliation>
      </Author>
      <Author>
        <Name>Alexandra Montagner</Name>
        <Affiliation>INRA, TOXALIM (Research Centre in Food Toxicology), Toulouse, France; Université de Toulouse, INP, UPS, TOXALIM, Toulouse, France.</Affiliation>
      </Author>
      <Author>
        <Name>Arnaud Polizzi</Name>
        <Affiliation>INRA, TOXALIM (Research Centre in Food Toxicology), Toulouse, France; Université de Toulouse, INP, UPS, TOXALIM, Toulouse, France.</Affiliation>
      </Author>
      <Author>
        <Name>Simon Ducheix</Name>
        <Affiliation>INRA, TOXALIM (Research Centre in Food Toxicology), Toulouse, France; Université de Toulouse, INP, UPS, TOXALIM, Toulouse, France.</Affiliation>
      </Author>
      <Author>
        <Name>Adeline Goron</Name>
        <Affiliation>INRA, TOXALIM (Research Centre in Food Toxicology), Toulouse, France; Université de Toulouse, INP, UPS, TOXALIM, Toulouse, France.</Affiliation>
      </Author>
      <Author>
        <Name>Laurence Gamet-Payrastre</Name>
        <Affiliation>INRA, TOXALIM (Research Centre in Food Toxicology), Toulouse, France; Université de Toulouse, INP, UPS, TOXALIM, Toulouse, France.</Affiliation>
      </Author>
      <Author>
        <Name>Sabine Gerbal-Chaloin</Name>
        <Affiliation>Institute of Regenerative Medicine and Biotherapy, INSERM, U1183 Montpellier, France.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Marc Pascussi</Name>
        <Affiliation>Centre National de la Recherche Scientifique, UMR5203, Institut de Génomique Fonctionnelle, Montpellier, France.</Affiliation>
      </Author>
      <Author>
        <Name>Marthe Moldes</Name>
        <Affiliation>Centre de Recherche Saint-Antoine, INSERM, UMR 938, Sorbonne Universités, Université Paris 6, Paris, France; Institut Hospitalo-Universitaire ICAN, Paris, France.</Affiliation>
      </Author>
      <Author>
        <Name>Thierry Pineau</Name>
        <Affiliation>INRA, TOXALIM (Research Centre in Food Toxicology), Toulouse, France; Université de Toulouse, INP, UPS, TOXALIM, Toulouse, France.</Affiliation>
      </Author>
      <Author>
        <Name>Hervé Guillou</Name>
        <Affiliation>INRA, TOXALIM (Research Centre in Food Toxicology), Toulouse, France; Université de Toulouse, INP, UPS, TOXALIM, Toulouse, France.</Affiliation>
      </Author>
      <Author>
        <Name>Laila Mselli-Lakhal</Name>
        <Affiliation>INRA, TOXALIM (Research Centre in Food Toxicology), Toulouse, France; Université de Toulouse, INP, UPS, TOXALIM, Toulouse, France. Electronic address: laila.lakhal@toulouse.inra.fr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Obaculactone protects against bleomycin-induced pulmonary fibrosis in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27180239</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30111-9</DOI>
    <KeywordList>
      <Keywords>Bleomycin</Keywords>
      <Keywords>Drug candidate</Keywords>
      <Keywords>Obaculactone</Keywords>
      <Keywords>Pulmonary fibrosis</Keywords>
      <Keywords>TGF-β1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xingqi Wang</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zijun Ouyang</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qian You</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuai He</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qianqian Meng</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunhui Hu</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xudong Wu</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Shen</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Sun</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China. Electronic address: yangsun@nju.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Xuefeng Wu</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China. Electronic address: wuxf@nju.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Qiang Xu</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China. Electronic address: molpharm@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Global gene expression and morphological alterations in the mammary gland after gestational exposure to bisphenol A, genistein and indole-3-carbinol in female Sprague-Dawley offspring.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27178563</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30110-7</DOI>
    <KeywordList>
      <Keywords>Bisphenol A</Keywords>
      <Keywords>Genistein and indole 3-carbinol</Keywords>
      <Keywords>Mammary gland development and gene expression</Keywords>
      <Keywords>Pregnancy</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tony F. Grassi</Name>
        <Affiliation>UNESP - Univ. Estadual Paulista, Botucatu Medical School, Department of Pathology, Botucatu, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Glenda N. da Silva</Name>
        <Affiliation>UFOP - Federal University of Ouro Preto, Analysis Clinical Department, Ouro Preto, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Lucas T. Bidinotto</Name>
        <Affiliation>Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, SP, Brazil; Barretos School of Health Sciences, Dr. Paulo Prata - FACISB, Barretos, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Bruna F. Rossi</Name>
        <Affiliation>UNESP - Univ. Estadual Paulista, Botucatu Biosciences Institute, Department of Morphology, Botucatu, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Marília M. Quinalha</Name>
        <Affiliation>UNESP - Univ. Estadual Paulista, Botucatu Biosciences Institute, Department of Morphology, Botucatu, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Kass</Name>
        <Affiliation>UNL - Universidad Nacional del Litoral, School of Biochemistry and Biological Sciences, Human Pathology Department, Instituto de Salud y Ambiente del Litoral (ISAL, CONICET-UNL), Santa Fe, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Mónica Muñoz-de-Toro</Name>
        <Affiliation>UNL - Universidad Nacional del Litoral, School of Biochemistry and Biological Sciences, Human Pathology Department, Instituto de Salud y Ambiente del Litoral (ISAL, CONICET-UNL), Santa Fe, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Luís F. Barbisan</Name>
        <Affiliation>UNESP - Univ. Estadual Paulista, Botucatu Biosciences Institute, Department of Morphology, Botucatu, SP, Brazil. Electronic address: barbisan@ibb.unesp.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Arsenic trioxide mediates HAPI microglia inflammatory response and subsequent neuron apoptosis through p38/JNK MAPK/STAT3 pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27174766</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30109-0</DOI>
    <KeywordList>
      <Keywords>Arsenic trioxide</Keywords>
      <Keywords>IL-1β</Keywords>
      <Keywords>Microglia</Keywords>
      <Keywords>P38/JNK MAPK</Keywords>
      <Keywords>STAT3</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jiamin Mao</Name>
        <Affiliation>Department of Environmental Health, School of Public Health, Nantong University, Nantong, Jiangsu 226001, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianbing Yang</Name>
        <Affiliation>Department of Pediatrics, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Zhang</Name>
        <Affiliation>Department of Nutrition and Food Hygiene, School of Public Health, Nantong University, Nantong, Jiangsu 226001, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Ting Li</Name>
        <Affiliation>Department of Environmental Health, School of Public Health, Nantong University, Nantong, Jiangsu 226001, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Cheng Wang</Name>
        <Affiliation>Department of Nutrition and Food Hygiene, School of Public Health, Nantong University, Nantong, Jiangsu 226001, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Lingfei Xu</Name>
        <Affiliation>Department of Environmental Health, School of Public Health, Nantong University, Nantong, Jiangsu 226001, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiaoyun Hu</Name>
        <Affiliation>Department of Environmental Health, School of Public Health, Nantong University, Nantong, Jiangsu 226001, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoke Wang</Name>
        <Affiliation>Department of Environmental Health, School of Public Health, Nantong University, Nantong, Jiangsu 226001, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Shengyang Jiang</Name>
        <Affiliation>Department of Environmental Health, School of Public Health, Nantong University, Nantong, Jiangsu 226001, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoke Nie</Name>
        <Affiliation>Department of Nutrition and Food Hygiene, School of Public Health, Nantong University, Nantong, Jiangsu 226001, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Gang Chen</Name>
        <Affiliation>Department of Environmental Health, School of Public Health, Nantong University, Nantong, Jiangsu 226001, People's Republic of China. Electronic address: chengang@ntu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The spleen as an extramedullary source of inflammatory cells responding to acetaminophen-induced liver injury.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27163765</pubmedLink>
    <GrantList>
      <Grant>T32 ES007148</Grant>
      <Grant>P30 ES005022</Grant>
      <Grant>R01 GM034310</Grant>
      <Grant>U54 AR055073</Grant>
      <Grant>R01 ES004738</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.04.019</DOI>
    <KeywordList>
      <Keywords>Acetaminophen</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Macrophages</Keywords>
      <Keywords>Myeloid derived suppressor cells</Keywords>
      <Keywords>Spleen</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mili Mandal</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA. Electronic address: milimandal@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Carol R. Gardner</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA. Electronic address: cgardner@pharmacy.rutgers.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Richard Sun</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA. Electronic address: fishpower52@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Hyejeong Choi</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA. Electronic address: choi@eohsi.rutgers.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Sonali Lad</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA. Electronic address: sonurose92@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Vladimir Mishin</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA. Electronic address: mishinv@eohsi.rutgers.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey D. Laskin</Name>
        <Affiliation>Department of Environmental and Occupational Health, School of Public Health, Rutgers University, Piscataway, NJ 08854, USA. Electronic address: jlaskin@eohsi.rutgers.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Debra L. Laskin</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ 08854, USA. Electronic address: laskin@eohsi.rutgers.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>The authors declare no conflicts of interest.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Corrigendum to "Use of a combined effect model approach for discriminating between ABCB1- and ABCC1-type efflux activities in native bivalve gill tissue" [Toxicol. Appl. Pharmacol. (2016) 56-67].</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27157384</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30090-4</DOI>
    <AuthorList>
      <Author>
        <Name>Melissa Faria</Name>
        <Affiliation>Department of Environmental Chemistry, IDAEA-CSIC, Jordi Girona 18, 08034 Barcelona, Spain; CESAM &amp; Departamento de Biologia, Universidade de Aveiro, 3810-193 Aveiro, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Vasiliy Pavlichenko</Name>
        <Affiliation>Siberian Institute of Plant Physiology and Biochemistry, Siberian Branch of Russian Academy of Sciences (SIPPB SB RAS), Lermontov Str. 132, 664033 Irkutsk, Russia; Department of Bioanalytical Ecotoxicology, UFZ - Helmholtz Centre for Environmental Research, Permoserstr. 15, D-04318 Leipzig, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Kathleen Burkhardt-Medicke</Name>
        <Affiliation>Department of Bioanalytical Ecotoxicology, UFZ - Helmholtz Centre for Environmental Research, Permoserstr. 15, D-04318 Leipzig, Germany; Institute of Hydrobiology, Dresden University of Technology, D-01062 Dresden, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Amadeu M. V. M. Soares</Name>
        <Affiliation>CESAM &amp; Departamento de Biologia, Universidade de Aveiro, 3810-193 Aveiro, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Rolf Altenburger</Name>
        <Affiliation>Department of Bioanalytical Ecotoxicology, UFZ - Helmholtz Centre for Environmental Research, Permoserstr. 15, D-04318 Leipzig, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Carlos Barata</Name>
        <Affiliation>Department of Environmental Chemistry, IDAEA-CSIC, Jordi Girona 18, 08034 Barcelona, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Till Luckenbach</Name>
        <Affiliation>Department of Bioanalytical Ecotoxicology, UFZ - Helmholtz Centre for Environmental Research, Permoserstr. 15, D-04318 Leipzig, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Modulation of expression and activity of intestinal multidrug resistance-associated protein 2 by xenobiotics.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27155371</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30100-4</DOI>
    <KeywordList>
      <Keywords>Drug transport</Keywords>
      <Keywords>Drug-drug interactions</Keywords>
      <Keywords>Intestinal chemical barrier</Keywords>
      <Keywords>Multidrug resistance-associated protein 2</Keywords>
      <Keywords>Nutrient-drug interaction</Keywords>
      <Keywords>Pregnane-X-receptor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Guillermo Nicolás Tocchetti</Name>
        <Affiliation>Instituto de Fisiología Experimental, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, CONICET, Suipacha 570, 2000 Rosario, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Pablo Rigalli</Name>
        <Affiliation>Instituto de Fisiología Experimental, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, CONICET, Suipacha 570, 2000 Rosario, Argentina; Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Maite Rocío Arana</Name>
        <Affiliation>Instituto de Fisiología Experimental, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, CONICET, Suipacha 570, 2000 Rosario, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Silvina Stella Maris Villanueva</Name>
        <Affiliation>Instituto de Fisiología Experimental, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, CONICET, Suipacha 570, 2000 Rosario, Argentina.</Affiliation>
      </Author>
      <Author>
        <Name>Aldo Domingo Mottino</Name>
        <Affiliation>Instituto de Fisiología Experimental, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, CONICET, Suipacha 570, 2000 Rosario, Argentina. Electronic address: amottino@unr.edu.ar.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The role of hepatocyte nuclear factor 4-alpha in perfluorooctanoic acid- and perfluorooctanesulfonic acid-induced hepatocellular dysfunction.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27153767</pubmedLink>
    <GrantList>
      <Grant>P20 GM103549</Grant>
      <Grant>P20 RR021940</Grant>
      <Grant>R01 DK098414</Grant>
      <Grant>T32 ES007079</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.05.001</DOI>
    <KeywordList>
      <Keywords>Hepatocyte nuclear factor 4-alpha</Keywords>
      <Keywords>Human hepatocyte</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Perfluorooctanesulfonic acid</Keywords>
      <Keywords>Perfluorooctanoic acid</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kevin M. Beggs</Name>
        <Affiliation>Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd, 4052 HLSIC, Kansas City, KS 66160, United States. Electronic address: kbeggs2@kumc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Steven R. McGreal</Name>
        <Affiliation>Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd, 4052 HLSIC, Kansas City, KS 66160, United States. Electronic address: smcgreal@kumc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Alex McCarthy</Name>
        <Affiliation>Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd, 4052 HLSIC, Kansas City, KS 66160, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Sumedha Gunewardena</Name>
        <Affiliation>Department of Molecular and Integrative Physiology, University of Kansas Medical Center, 3901 Rainbow Blvd, 2027 HLSIC, Kansas City, KS 66160, United States. Electronic address: sgunewardena@kumc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Jed N. Lampe</Name>
        <Affiliation>Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd, 4052 HLSIC, Kansas City, KS 66160, United States. Electronic address: jlampe@kumc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Christoper Lau</Name>
        <Affiliation>Developmental Toxicology Branch, Toxicity Assessment Division, National Health and Environmental Effects Research Laboratory, Office of Research and Development, US Environmental Protection Agency, Research Triangle Park, NC 27711, United States. Electronic address: lau.christopher@epa.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Udayan Apte</Name>
        <Affiliation>Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd, 4052 HLSIC, Kansas City, KS 66160, United States. Electronic address: uapte@kumc.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>2,3,7,8-Tetrachlorodibenzo-p-dioxin has both pro-carcinogenic and anti-carcinogenic effects on neuroendocrine prostate carcinoma formation in TRAMP mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27151233</pubmedLink>
    <GrantList>
      <Grant>P30 CA014520</Grant>
      <Grant>R01 ES001332</Grant>
      <Grant>R01 CA095751</Grant>
      <Grant>R37 ES001332</Grant>
      <Grant>P30 ES023512</Grant>
      <Grant>T32 ES007015</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30099-0</DOI>
    <KeywordList>
      <Keywords>2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)</Keywords>
      <Keywords>3,3′-Diindolylmethane</Keywords>
      <Keywords>Indole-3-carbinol</Keywords>
      <Keywords>Neuroendocrine prostate cancer</Keywords>
      <Keywords>TRAMP mice</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Robert W. Moore</Name>
        <Affiliation>School of Pharmacy, 777 Highland Ave., University of Wisconsin-Madison, Madison, WI 53705, USA; Molecular and Environmental Toxicology Center, 1400 University Ave., University of Wisconsin-Madison, Madison, WI 53706, USA. Electronic address: robert.moore@wisc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Wayne A. Fritz</Name>
        <Affiliation>School of Pharmacy, 777 Highland Ave., University of Wisconsin-Madison, Madison, WI 53705, USA; Molecular and Environmental Toxicology Center, 1400 University Ave., University of Wisconsin-Madison, Madison, WI 53706, USA. Electronic address: Wayne.Fritz@covance.com.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew J. Schneider</Name>
        <Affiliation>School of Pharmacy, 777 Highland Ave., University of Wisconsin-Madison, Madison, WI 53705, USA. Electronic address: ajschnei@wisc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Tien Min Lin</Name>
        <Affiliation>School of Pharmacy, 777 Highland Ave., University of Wisconsin-Madison, Madison, WI 53705, USA. Electronic address: tlin1@facstaff.wisc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Amanda M. Branam</Name>
        <Affiliation>School of Pharmacy, 777 Highland Ave., University of Wisconsin-Madison, Madison, WI 53705, USA; Molecular and Environmental Toxicology Center, 1400 University Ave., University of Wisconsin-Madison, Madison, WI 53706, USA. Electronic address: bran2117@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Stephen Safe</Name>
        <Affiliation>Department of Veterinary Physiology and Pharmacology, 4466 TAMU, Texas A&amp;M University, College Station, TX 77843, USA. Electronic address: SSAFE@cvm.tamu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Richard E. Peterson</Name>
        <Affiliation>School of Pharmacy, 777 Highland Ave., University of Wisconsin-Madison, Madison, WI 53705, USA; Molecular and Environmental Toxicology Center, 1400 University Ave., University of Wisconsin-Madison, Madison, WI 53706, USA. Electronic address: richard.peterson@wisc.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>ABC transporters affect the elimination and toxicity of CdTe quantum dots in liver and kidney cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27131644</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30098-9</DOI>
    <KeywordList>
      <Keywords>Kidney cells</Keywords>
      <Keywords>Liver cells</Keywords>
      <Keywords>Multi-resistance associated proteins</Keywords>
      <Keywords>P-glycoprotein</Keywords>
      <Keywords>Quantum dot elimination</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mingli Chen</Name>
        <Affiliation>CAS Key Lab of Bio-Medical Diagnostics, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, Jiangsu 215163, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Huancai Yin</Name>
        <Affiliation>CAS Key Lab of Bio-Medical Diagnostics, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, Jiangsu 215163, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Pengli Bai</Name>
        <Affiliation>CAS Key Lab of Bio-Medical Diagnostics, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, Jiangsu 215163, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Peng Miao</Name>
        <Affiliation>CAS Key Lab of Bio-Medical Diagnostics, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, Jiangsu 215163, PR China; University of Chinese Academy of Sciences, Beijing 100049, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xudong Deng</Name>
        <Affiliation>Department of Chemical Engineering, McMaster University, Hamilton, Ontario, L8S 4L7, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Yingxue Xu</Name>
        <Affiliation>CAS Key Lab of Bio-Medical Diagnostics, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, Jiangsu 215163, PR China; University of Chinese Academy of Sciences, Beijing 100049, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Hu</Name>
        <Affiliation>CAS Key Lab of Bio-Medical Diagnostics, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, Jiangsu 215163, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jian Yin</Name>
        <Affiliation>CAS Key Lab of Bio-Medical Diagnostics, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, Jiangsu 215163, PR China. Electronic address: yinj@sibet.ac.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Resveratrol protects the ovary against chromium-toxicity by enhancing endogenous antioxidant enzymes and inhibiting metabolic clearance of estradiol.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27129868</pubmedLink>
    <GrantList>
      <Grant>P30 ES023512</Grant>
      <Grant>R01 ES025234</Grant>
      <Grant>R21 ES020561</Grant>
      <Grant>S10 RR022532</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30097-7</DOI>
    <KeywordList>
      <Keywords>Antioxidants</Keywords>
      <Keywords>Chromium</Keywords>
      <Keywords>Ovary</Keywords>
      <Keywords>Oxidative Stress</Keywords>
      <Keywords>Resveratrol</Keywords>
      <Keywords>Steroidogenesis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sakhila K. Banu</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&amp;M University, College Station, TX 77843, USA. Electronic address: skbanu@cvm.tamu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Jone A. Stanley</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&amp;M University, College Station, TX 77843, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kirthiram K. Sivakumar</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&amp;M University, College Station, TX 77843, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joe A. Arosh</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&amp;M University, College Station, TX 77843, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Robert C. Burghardt</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&amp;M University, College Station, TX 77843, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mustard vesicants alter expression of the endocannabinoid system in mouse skin.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27125198</pubmedLink>
    <GrantList>
      <Grant>U01 NS079249</Grant>
      <Grant>T32 ES007148</Grant>
      <Grant>P30 ES005022</Grant>
      <Grant>U54 AR055073</Grant>
      <Grant>R01 ES004738</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30089-8</DOI>
    <KeywordList>
      <Keywords>Endocannabinoids</Keywords>
      <Keywords>Epidermis</Keywords>
      <Keywords>FAAH</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Sulfur mustard</Keywords>
      <Keywords>Vesicants</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Irene M. Wohlman</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Gabriella M. Composto</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Diane E. Heck</Name>
        <Affiliation>Environmental Health Science, New York Medical College, Valhalla, NY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ned D. Heindel</Name>
        <Affiliation>Department of Chemistry, Lehigh University, Bethlehem, PA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>C. Jeffrey Lacey</Name>
        <Affiliation>Department of Chemistry, Lehigh University, Bethlehem, PA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Christophe D. Guillon</Name>
        <Affiliation>Department of Chemistry, Lehigh University, Bethlehem, PA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Robert P. Casillas</Name>
        <Affiliation>MRIGlobal, Kansas City, MO, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Claire R. Croutch</Name>
        <Affiliation>MRIGlobal, Kansas City, MO, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Donald R. Gerecke</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Debra L. Laskin</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Laurie B. Joseph</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey D. Laskin</Name>
        <Affiliation>Environmental and Occupational Health, Rutgers University School of Public Health, Piscataway, NJ, United States. Electronic address: jlaskin@eohsi.rutgers.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>An extensive cocktail approach for rapid risk assessment of in vitro CYP450 direct reversible inhibition by xenobiotic exposure.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27105555</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.04.013</DOI>
    <KeywordList>
      <Keywords>Cytochrome P450</Keywords>
      <Keywords>Human liver microsomes</Keywords>
      <Keywords>IC(50)</Keywords>
      <Keywords>Pesticides</Keywords>
      <Keywords>Risk assessment</Keywords>
      <Keywords>UHPLC-MS/MS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dany Spaggiari</Name>
        <Affiliation>School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Boulevard d'Yvoy 20, 1211 Geneva 4, Switzerland. Electronic address: dany.spaggiari@unige.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Youssef Daali</Name>
        <Affiliation>Clinical Pharmacology and Toxicology Service, Geneva University Hospitals, Rue Gabrielle Perret-Gentil, 1211 Genève 14, Switzerland. Electronic address: youssef.daali@hcuge.ch.</Affiliation>
      </Author>
      <Author>
        <Name>Serge Rudaz</Name>
        <Affiliation>School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Boulevard d'Yvoy 20, 1211 Geneva 4, Switzerland; Swiss Centre for Applied Human Toxicology, University of Geneva, Boulevard d'Yvoy 20, 1211 Geneva 4, Switzerland. Electronic address: serge.rudaz@unige.ch.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mitochondrial-targeted aryl hydrocarbon receptor and the impact of 2,3,7,8-tetrachlorodibenzo-p-dioxin on cellular respiration and the mitochondrial proteome.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27105554</pubmedLink>
    <GrantList>
      <Grant>P42 ES004911</Grant>
      <Grant>T32 ES007255</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.04.005</DOI>
    <KeywordList>
      <Keywords>2,3,7,8-Tetrachlorodibenzo-p-dioxin, TCDD</Keywords>
      <Keywords>Aryl hydrocarbon receptor</Keywords>
      <Keywords>Mitochondria</Keywords>
      <Keywords>Oxidative phosphorylation</Keywords>
      <Keywords>Proteomics</Keywords>
      <Keywords>SILAC</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hye Jin Hwang</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI 48824, United States; Center for Mitochondrial Science and Medicine, Michigan State University, East Lansing, MI 48824, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Peter Dornbos</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI 48824, United States; Institute for Integrative Toxicology, Michigan State University, East Lansing, MI 48824-1319, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle Steidemann</Name>
        <Affiliation>Institute for Integrative Toxicology, Michigan State University, East Lansing, MI 48824-1319, United States; Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI 48824, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Taylor K. Dunivin</Name>
        <Affiliation>Department of Microbiology and Molecular Genetics, Michigan State University, East Lansing, MI 48824, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mike Rizzo</Name>
        <Affiliation>Institute for Integrative Toxicology, Michigan State University, East Lansing, MI 48824-1319, United States; Cell and Molecular Biology Graduate Program, Michigan State University, East Lansing, MI 48824, United States.</Affiliation>
      </Author>
      <Author>
        <Name>John J. LaPres</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI 48824, United States; Center for Mitochondrial Science and Medicine, Michigan State University, East Lansing, MI 48824, United States. Electronic address: lapres@msu.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of novel biomarkers of nephrotoxicity in Cynomolgus monkeys treated with gentamicin.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27105553</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30087-4</DOI>
    <KeywordList>
      <Keywords>Cynomolgus monkeys</Keywords>
      <Keywords>Gentamicin</Keywords>
      <Keywords>Kidney</Keywords>
      <Keywords>Safety biomarkers</Keywords>
      <Keywords>Singleplex and multiplex assays</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jean Charles Gautier</Name>
        <Affiliation>Sanofi R&amp;D, Vitry-sur-Seine, France. Electronic address: jean-charles.gautier@sanofi.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaobing Zhou</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs (NCSED), National Institutes for Food and Drug Control, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Yang</Name>
        <Affiliation>Sanofi R&amp;D, Bridgewater, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Thierry Gury</Name>
        <Affiliation>Sanofi R&amp;D, Vitry-sur-Seine, France.</Affiliation>
      </Author>
      <Author>
        <Name>Zhe Qu</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs (NCSED), National Institutes for Food and Drug Control, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xavier Palazzi</Name>
        <Affiliation>Sanofi R&amp;D, Vitry-sur-Seine, France.</Affiliation>
      </Author>
      <Author>
        <Name>Jean François Léonard</Name>
        <Affiliation>Sanofi R&amp;D, Vitry-sur-Seine, France.</Affiliation>
      </Author>
      <Author>
        <Name>Mohamed Slaoui</Name>
        <Affiliation>Sanofi R&amp;D, Vitry-sur-Seine, France.</Affiliation>
      </Author>
      <Author>
        <Name>Yaligara Veeranagouda</Name>
        <Affiliation>Sanofi R&amp;D, Vitry-sur-Seine, France.</Affiliation>
      </Author>
      <Author>
        <Name>Isabelle Guizon</Name>
        <Affiliation>Sanofi R&amp;D, Vitry-sur-Seine, France.</Affiliation>
      </Author>
      <Author>
        <Name>Eric Boitier</Name>
        <Affiliation>Sanofi R&amp;D, Vitry-sur-Seine, France.</Affiliation>
      </Author>
      <Author>
        <Name>Aziz Filali-Ansary</Name>
        <Affiliation>Sanofi R&amp;D, Vitry-sur-Seine, France.</Affiliation>
      </Author>
      <Author>
        <Name>Bart H. J. van den Berg</Name>
        <Affiliation>Natural and Medical Sciences Institute at the University Tübingen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Oliver Poetz</Name>
        <Affiliation>Natural and Medical Sciences Institute at the University Tübingen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Joos</Name>
        <Affiliation>Natural and Medical Sciences Institute at the University Tübingen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Tianyi Zhang</Name>
        <Affiliation>Frontage Laboratories, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jufeng Wang</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs (NCSED), National Institutes for Food and Drug Control, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Philippe Detilleux</Name>
        <Affiliation>Sanofi R&amp;D, Vitry-sur-Seine, France.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Li</Name>
        <Affiliation>National Center for Safety Evaluation of Drugs (NCSED), National Institutes for Food and Drug Control, Beijing, China. Electronic address: libo@nifdc.org.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mitochondrial nucleoid clusters protect newly synthesized mtDNA during Doxorubicin- and Ethidium Bromide-induced mitochondrial stress.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27102948</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.04.011</DOI>
    <KeywordList>
      <Keywords>Doxorubicin</Keywords>
      <Keywords>Ethidium Bromide</Keywords>
      <Keywords>Mitochondrial DNA stress</Keywords>
      <Keywords>Mitochondrial transcription factor A</Keywords>
      <Keywords>Nucleoid clusters</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lukáš Alán</Name>
        <Affiliation>Dept. 75, Institute of Physiology, Academy of Sciences of the Czech Republic v.v.i, Czech Republic. Electronic address: lukas.alan@fgu.cas.cz.</Affiliation>
      </Author>
      <Author>
        <Name>Tomáš Špaček</Name>
        <Affiliation>Dept. 75, Institute of Physiology, Academy of Sciences of the Czech Republic v.v.i, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>David Pajuelo Reguera</Name>
        <Affiliation>Dept. 75, Institute of Physiology, Academy of Sciences of the Czech Republic v.v.i, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Martin Jabůrek</Name>
        <Affiliation>Dept. 75, Institute of Physiology, Academy of Sciences of the Czech Republic v.v.i, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Petr Ježek</Name>
        <Affiliation>Dept. 75, Institute of Physiology, Academy of Sciences of the Czech Republic v.v.i, Czech Republic.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of mitochondrial dysfunction-related, drug-induced hepatotoxicity in primary rat hepatocytes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27095095</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.04.010</DOI>
    <KeywordList>
      <Keywords>Drug-induced liver injury</Keywords>
      <Keywords>Galactose</Keywords>
      <Keywords>Mitochondrial toxicity</Keywords>
      <Keywords>Oxygen requirement</Keywords>
      <Keywords>Primary rat hepatocytes</Keywords>
      <Keywords>Transferrin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cong Liu</Name>
        <Affiliation>Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shuichi Sekine</Name>
        <Affiliation>Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan. Electronic address: ssekine@faculty.chiba-u.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Kousei Ito</Name>
        <Affiliation>Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Calcium channel blockers ameliorate iron overload-associated hepatic fibrosis by altering iron transport and stellate cell apoptosis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27095094</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.04.008</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Calcium channel blockers</Keywords>
      <Keywords>Fibrosis</Keywords>
      <Keywords>Hepatic stellate cells</Keywords>
      <Keywords>Iron overload</Keywords>
      <Keywords>Transmembrane transport</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ying Zhang</Name>
        <Affiliation>Department of Pharmacology, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, People's Republic of China; Department of Pathology, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, People's Republic of China; Hebei Key Laboratory of Chinese Medicine Research on Cardio-Cerebrovascular Disease, Shijiazhuang 050200, Hebei, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Zhao</Name>
        <Affiliation>Department of Hepatobiliary Surgery, The Third Hospital of Hebei Medical University, Shijiazhuang 050051, Hebei, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanzhong Chang</Name>
        <Affiliation>Laboratory of Molecular Iron Metabolism, College of Life Science, Hebei Normal University, Shijiazhuang 050024, Hebei, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanyuan Zhang</Name>
        <Affiliation>Department of Pharmacology, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xi Chu</Name>
        <Affiliation>Department of Pharmacy, The Forth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xuan Zhang</Name>
        <Affiliation>Department of Pharmacology, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenyi Liu</Name>
        <Affiliation>Department of Medicinal Chemistry, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Hui Guo</Name>
        <Affiliation>Department of Medicinal Chemistry, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Na Wang</Name>
        <Affiliation>Department of Physiology, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yonggang Gao</Name>
        <Affiliation>Department of Pharmacology, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianping Zhang</Name>
        <Affiliation>Department of Pharmacology, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, People's Republic of China. Electronic address: zhangjianping14@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Li Chu</Name>
        <Affiliation>Department of Pharmacology, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, People's Republic of China; Hebei Key Laboratory of Integrative Medicine on Liver-Kidney Patterns, Shijiazhuang 050200, Hebei, People's Republic of China. Electronic address: chuli0614@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Alteration of canonical and non-canonical WNT-signaling by crystalline silica in human lung epithelial cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27095093</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.04.003</DOI>
    <KeywordList>
      <Keywords>Epithelium</Keywords>
      <Keywords>Fibrosis</Keywords>
      <Keywords>Pathway-analysis</Keywords>
      <Keywords>Pneumoconiosis</Keywords>
      <Keywords>Silica</Keywords>
      <Keywords>WNT</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Timothy N. Perkins</Name>
        <Affiliation>Department of Respiratory Medicine, Maastricht University Medical Centre +, Maastricht University Maastricht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Mieke A. Dentener</Name>
        <Affiliation>Department of Respiratory Medicine, Maastricht University Medical Centre +, Maastricht University Maastricht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Frank R. Stassen</Name>
        <Affiliation>Department of Medical Microbiology, Maastricht University Medical Centre +, Maastricht University Maastricht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Gernot G. Rohde</Name>
        <Affiliation>Department of Respiratory Medicine, Maastricht University Medical Centre +, Maastricht University Maastricht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Brooke T. Mossman</Name>
        <Affiliation>Department of Pathology, University of Vermont College of Medicine, Burlington, VT, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Emiel F. M. Wouters</Name>
        <Affiliation>Department of Respiratory Medicine, Maastricht University Medical Centre +, Maastricht University Maastricht, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Niki L. Reynaert</Name>
        <Affiliation>Department of Respiratory Medicine, Maastricht University Medical Centre +, Maastricht University Maastricht, The Netherlands. Electronic address: n.reynaert@maastrichtuniversity.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Comparison of the inhibitory effects of tolcapone and entacapone against human UDP-glucuronosyltransferases.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27089846</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.04.009</DOI>
    <KeywordList>
      <Keywords>Drug-drug interactions (DDI)</Keywords>
      <Keywords>Entacapone</Keywords>
      <Keywords>Inhibitory effects</Keywords>
      <Keywords>Tolcapone</Keywords>
      <Keywords>UDP-glucosyltransferases</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xia Lv</Name>
        <Affiliation>Laboratory of Pharmaceutical Resource Discovery, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China; State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xin Xin Wang</Name>
        <Affiliation>RSKT Biopharma Inc., Dalian 116023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Hou</Name>
        <Affiliation>Dalian Medical University, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhong Ze Fang</Name>
        <Affiliation>RSKT Biopharma Inc., Dalian 116023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Jing Wu</Name>
        <Affiliation>Laboratory of Pharmaceutical Resource Discovery, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China; State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yun Feng Cao</Name>
        <Affiliation>RSKT Biopharma Inc., Dalian 116023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shu Wen Liu</Name>
        <Affiliation>State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Southern Medical University, Guangzhou 510515, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guang Bo Ge</Name>
        <Affiliation>Laboratory of Pharmaceutical Resource Discovery, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China; State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Southern Medical University, Guangzhou 510515, China. Electronic address: geguangbo@dicp.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Ling Yang</Name>
        <Affiliation>Laboratory of Pharmaceutical Resource Discovery, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China; Jiangxi University of Traditional Chinese Medicine, Nanchang 330006, China. Electronic address: ylingdicp@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Advantageous use of HepaRG cells for the screening and mechanistic study of drug-induced steatosis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27089845</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.04.007</DOI>
    <KeywordList>
      <Keywords>Drug</Keywords>
      <Keywords>HepaRG</Keywords>
      <Keywords>Screening</Keywords>
      <Keywords>Steatosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Laia Tolosa</Name>
        <Affiliation>Unidad de Hepatología Experimental, Instituto de Investigación Sanitaria La Fe, Valencia 46026, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>M. José Gómez-Lechón</Name>
        <Affiliation>Unidad de Hepatología Experimental, Instituto de Investigación Sanitaria La Fe, Valencia 46026, Spain; CIBERehd, FIS, Barcelona 08036, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Nuria Jiménez</Name>
        <Affiliation>Unidad de Hepatología Experimental, Instituto de Investigación Sanitaria La Fe, Valencia 46026, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>David Hervás</Name>
        <Affiliation>Biostatistics Unit, Instituto de Investigación Sanitaria La Fe, Valencia 46026, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Ramiro Jover</Name>
        <Affiliation>Unidad de Hepatología Experimental, Instituto de Investigación Sanitaria La Fe, Valencia 46026, Spain; CIBERehd, FIS, Barcelona 08036, Spain; Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Universidad de Valencia, Valencia 46010, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>M. Teresa Donato</Name>
        <Affiliation>Unidad de Hepatología Experimental, Instituto de Investigación Sanitaria La Fe, Valencia 46026, Spain; CIBERehd, FIS, Barcelona 08036, Spain; Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Universidad de Valencia, Valencia 46010, Spain. Electronic address: donato_mte@gva.es.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A semisynthetic diterpenoid lactone inhibits NF-κB signalling to ameliorate inflammation and airway hyperresponsiveness in a mouse asthma model.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27089844</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.04.004</DOI>
    <KeywordList>
      <Keywords>A549 cell line</Keywords>
      <Keywords>Airway hyperresponsiveness</Keywords>
      <Keywords>Andrographolide analogues</Keywords>
      <Keywords>Mouse asthma model</Keywords>
      <Keywords>NF-κB</Keywords>
      <Keywords>Ovalbumin</Keywords>
      <Keywords>Oxidative stress</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>J. C. W. Lim</Name>
        <Affiliation>Pharmacotherapeutics Unit, Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>F. Y. Goh</Name>
        <Affiliation>Department of Pharmacology, Yong Loo Lin School of Medicine, National University Health System, Singapore.</Affiliation>
      </Author>
      <Author>
        <Name>S. R. Sagineedu</Name>
        <Affiliation>Laboratory of Natural Products, Institute of Bioscience, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>A. C. H. Yong</Name>
        <Affiliation>Faculty of Pharmacy, Segi University, Jalan Teknologi, 47810 Petaling Jaya, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>S. M. Sidik</Name>
        <Affiliation>Histopathology Unit, Department of Pathology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>N. H. Lajis</Name>
        <Affiliation>Laboratory of Natural Products, Institute of Bioscience, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>W. S. F. Wong</Name>
        <Affiliation>Department of Pharmacology, Yong Loo Lin School of Medicine, National University Health System, Singapore; Immunology Program, Life Science Institute, National University of Singapore, Singapore. Electronic address: fred_wong@nuhs.edu.sg.</Affiliation>
      </Author>
      <Author>
        <Name>J. Stanslas</Name>
        <Affiliation>Pharmacotherapeutics Unit, Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia; Laboratory of Natural Products, Institute of Bioscience, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia. Electronic address: rcxjs@upm.edu.my.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Crosstalk between liver antioxidant and the endocannabinoid systems after chronic administration of the FAAH inhibitor, URB597, to hypertensive rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27086176</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.04.006</DOI>
    <KeywordList>
      <Keywords>Endocannabinoid system</Keywords>
      <Keywords>Hypertension</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>URB597</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michał Biernacki</Name>
        <Affiliation>Department of Analytical Chemistry Medical University of Bialystok, Mickiewicza 2D, 15-222 Bialystok, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Wojciech Łuczaj</Name>
        <Affiliation>Department of Analytical Chemistry Medical University of Bialystok, Mickiewicza 2D, 15-222 Bialystok, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Agnieszka Gęgotek</Name>
        <Affiliation>Department of Analytical Chemistry Medical University of Bialystok, Mickiewicza 2D, 15-222 Bialystok, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Marek Toczek</Name>
        <Affiliation>Department of Experimental Physiology and Pathophysiology Medical University of Bialystok, Mickiewicza 2A, 15-222 Bialystok, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Katarzyna Bielawska</Name>
        <Affiliation>Department of Analytical Chemistry Medical University of Bialystok, Mickiewicza 2D, 15-222 Bialystok, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Elżbieta Skrzydlewska</Name>
        <Affiliation>Department of Analytical Chemistry Medical University of Bialystok, Mickiewicza 2D, 15-222 Bialystok, Poland. Electronic address: elzbieta.skrzydlewska@umb.edu.pl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nonselective inhibition of the epigenetic transcriptional regulator BET induces marked lymphoid and hematopoietic toxicity in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27078884</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30059-X</DOI>
    <KeywordList>
      <Keywords>Bromodomain</Keywords>
      <Keywords>Epigenetics</Keywords>
      <Keywords>Immunology</Keywords>
      <Keywords>Lymphocytes</Keywords>
      <Keywords>Toxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dong U. Lee</Name>
        <Affiliation>Department of Safety Assessment, Genentech, Inc., South San Francisco, CA 94080, USA. Electronic address: lee.dong@gene.com.</Affiliation>
      </Author>
      <Author>
        <Name>Paula Katavolos</Name>
        <Affiliation>Department of Safety Assessment, Genentech, Inc., South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Gopinath Palanisamy</Name>
        <Affiliation>Department of Safety Assessment, Genentech, Inc., South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Arna Katewa</Name>
        <Affiliation>Department of Research Immunology, Genentech, Inc., South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Charly Sioson</Name>
        <Affiliation>Department of Safety Assessment, Genentech, Inc., South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Janice Corpuz</Name>
        <Affiliation>Department of Safety Assessment, Genentech, Inc., South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jodie Pang</Name>
        <Affiliation>Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kevin DeMent</Name>
        <Affiliation>Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Edna Choo</Name>
        <Affiliation>Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nico Ghilardi</Name>
        <Affiliation>Department of Research Immunology, Genentech, Inc., South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Dolores Diaz</Name>
        <Affiliation>Department of Safety Assessment, Genentech, Inc., South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Dimitry M. Danilenko</Name>
        <Affiliation>Department of Safety Assessment, Genentech, Inc., South San Francisco, CA 94080, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Serca2a and Na(+)/Ca(2+) exchanger are involved in left ventricular function following cardiac remodelling of female rats treated with anabolic androgenic steroid.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27074353</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.04.001</DOI>
    <KeywordList>
      <Keywords>Cardiac function</Keywords>
      <Keywords>Left ventricular hypertrophy</Keywords>
      <Keywords>NCX</Keywords>
      <Keywords>Nandrolone decanoate</Keywords>
      <Keywords>Resistive exercise</Keywords>
      <Keywords>SERCA2a</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Andrews Marques do Nascimento</Name>
        <Affiliation>Department of Physiological Sciences, Federal University of Espirito Santo, Vitória, Espirito Santo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ewelyne Miranda de Lima</Name>
        <Affiliation>Department of Physiological Sciences, Federal University of Espirito Santo, Vitória, Espirito Santo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Girlandia Alexandre Brasil</Name>
        <Affiliation>Department of Physiological Sciences, Federal University of Espirito Santo, Vitória, Espirito Santo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Izabela Facco Caliman</Name>
        <Affiliation>Department of Physiological Sciences, Federal University of Espirito Santo, Vitória, Espirito Santo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Josiane Fernandes da Silva</Name>
        <Affiliation>Department of Physiology and Biophysic, Federal University of Minas Gerais, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Virgínia Soares Lemos</Name>
        <Affiliation>Department of Physiology and Biophysic, Federal University of Minas Gerais, Minas Gerais, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Tadeu Uggere de Andrade</Name>
        <Affiliation>Department of Pharmacy, University Vila Velha, Vila Velha, Espirito Santo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Nazaré Souza Bissoli</Name>
        <Affiliation>Department of Physiological Sciences, Federal University of Espirito Santo, Vitória, Espirito Santo, Brazil. Electronic address: nazarebissoli@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Specific histone modification responds to arsenic-induced oxidative stress.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27068294</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.03.015</DOI>
    <KeywordList>
      <Keywords>Arsenic exposure</Keywords>
      <Keywords>Arsenicosis</Keywords>
      <Keywords>Biomarker</Keywords>
      <Keywords>H3K18ac modification</Keywords>
      <Keywords>H3K36me3 modification</Keywords>
      <Keywords>Oxidative stress response</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lu Ma</Name>
        <Affiliation>Department of Toxicology, Guangzhou Key Laboratory of Environmental Pollution and Health Risk Assessment, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Li</Name>
        <Affiliation>Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Department of Toxicology, School of Public Health, Guizhou Medical University, Guiyang, Guizhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhengbao Zhan</Name>
        <Affiliation>Department of Toxicology, Guangzhou Key Laboratory of Environmental Pollution and Health Risk Assessment, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Liping Chen</Name>
        <Affiliation>Department of Toxicology, Guangzhou Key Laboratory of Environmental Pollution and Health Risk Assessment, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Daochuan Li</Name>
        <Affiliation>Department of Toxicology, Guangzhou Key Laboratory of Environmental Pollution and Health Risk Assessment, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qing Bai</Name>
        <Affiliation>Department of Toxicology, Guangzhou Key Laboratory of Environmental Pollution and Health Risk Assessment, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chen Gao</Name>
        <Affiliation>Department of Toxicology, Guangzhou Key Laboratory of Environmental Pollution and Health Risk Assessment, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Li</Name>
        <Affiliation>Department of Toxicology, Guangzhou Key Laboratory of Environmental Pollution and Health Risk Assessment, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaowen Zeng</Name>
        <Affiliation>Department of Toxicology, Guangzhou Key Laboratory of Environmental Pollution and Health Risk Assessment, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhini He</Name>
        <Affiliation>Department of Toxicology, Guangzhou Key Laboratory of Environmental Pollution and Health Risk Assessment, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shan Wang</Name>
        <Affiliation>Department of Toxicology, Guangzhou Key Laboratory of Environmental Pollution and Health Risk Assessment, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongmei Xiao</Name>
        <Affiliation>Department of Toxicology, Guangzhou Key Laboratory of Environmental Pollution and Health Risk Assessment, School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Chen</Name>
        <Affiliation>Department of Toxicology, Guangzhou Key Laboratory of Environmental Pollution and Health Risk Assessment, School of Public Health, Sun Yat-sen University, Guangzhou, China. Electronic address: chenwen@mail.sysu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Aihua Zhang</Name>
        <Affiliation>Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Department of Toxicology, School of Public Health, Guizhou Medical University, Guiyang, Guizhou, China. Electronic address: aihuagzykd@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of developmental exposure to perfluorooctanoic acid (PFOA) on long bone morphology and bone cell differentiation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27068293</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.04.002</DOI>
    <KeywordList>
      <Keywords>Bone toxicity</Keywords>
      <Keywords>Osteogenesis</Keywords>
      <Keywords>PFOA</Keywords>
      <Keywords>Resorption</Keywords>
      <Keywords>Stem cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>A. Koskela</Name>
        <Affiliation>Institute of Cancer Research and Translational Medicine, MRC Oulu and Department of Anatomy and Cell Biology, Faculty of Medicine, University of Oulu, Oulu, Finland. Electronic address: antti.koskela@oulu.fi.</Affiliation>
      </Author>
      <Author>
        <Name>M. A. Finnilä</Name>
        <Affiliation>Research Unit of Medical Imaging, Physics and Technology, University of Oulu, Oulu, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>M. Korkalainen</Name>
        <Affiliation>National Institute for Health and Welfare, Department of Health Protection, Kuopio, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>S. Spulber</Name>
        <Affiliation>Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>J. Koponen</Name>
        <Affiliation>National Institute for Health and Welfare, Department of Health Protection, Kuopio, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>H. Håkansson</Name>
        <Affiliation>Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>J. Tuukkanen</Name>
        <Affiliation>Institute of Cancer Research and Translational Medicine, MRC Oulu and Department of Anatomy and Cell Biology, Faculty of Medicine, University of Oulu, Oulu, Finland.</Affiliation>
      </Author>
      <Author>
        <Name>M. Viluksela</Name>
        <Affiliation>National Institute for Health and Welfare, Department of Health Protection, Kuopio, Finland; Department of Environmental and Biological Sciences, University of Eastern Finland, Kuopio, Finland.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nodularin induces tumor necrosis factor-alpha and mitogen-activated protein kinases (MAPK) and leads to induction of endoplasmic reticulum stress.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27061667</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30066-7</DOI>
    <KeywordList>
      <Keywords>ER stress response</Keywords>
      <Keywords>MAPK signalling</Keywords>
      <Keywords>Nodularin</Keywords>
      <Keywords>TNF-α</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nicole Meili</Name>
        <Affiliation>University of Applied Sciences and Arts Northwestern Switzerland (FHNW), Gründenstrasse 40, CH-4132 Muttenz, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Verena Christen</Name>
        <Affiliation>University of Applied Sciences and Arts Northwestern Switzerland (FHNW), Gründenstrasse 40, CH-4132 Muttenz, Switzerland.</Affiliation>
      </Author>
      <Author>
        <Name>Karl Fent</Name>
        <Affiliation>University of Applied Sciences and Arts Northwestern Switzerland (FHNW), Gründenstrasse 40, CH-4132 Muttenz, Switzerland; Swiss Federal Institute of Technology Zürich (ETH Zürich), Department of Environmental Systems Science, CH-8092 Zürich, Switzerland. Electronic address: karl.fent@fhnw.ch.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Tea polyphenols EGCG and TF restrict tongue and liver carcinogenesis simultaneously induced by N-nitrosodiethylamine in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27058323</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30067-9</DOI>
    <KeywordList>
      <Keywords>EGCG</Keywords>
      <Keywords>Gli1</Keywords>
      <Keywords>Liver carcinogenesis</Keywords>
      <Keywords>TF</Keywords>
      <Keywords>Tongue carcinogenesis</Keywords>
      <Keywords>β-catenin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Subhayan Sur</Name>
        <Affiliation>Dept. of Oncogene Regulation, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Kolkata 700 026, West Bengal, India. Electronic address: subhayansur18@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Debolina Pal</Name>
        <Affiliation>Dept. of Oncogene Regulation, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Kolkata 700 026, West Bengal, India.</Affiliation>
      </Author>
      <Author>
        <Name>Rituparna Roy</Name>
        <Affiliation>Dept. of Oncogene Regulation, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Kolkata 700 026, West Bengal, India.</Affiliation>
      </Author>
      <Author>
        <Name>Atish Barua</Name>
        <Affiliation>Dept. of Oncogene Regulation, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Kolkata 700 026, West Bengal, India.</Affiliation>
      </Author>
      <Author>
        <Name>Anup Roy</Name>
        <Affiliation>North Bengal Medical College and Hospital, West Bengal, India.</Affiliation>
      </Author>
      <Author>
        <Name>Prosenjit Saha</Name>
        <Affiliation>Dept. of Oncogene Regulation, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Kolkata 700 026, West Bengal, India.</Affiliation>
      </Author>
      <Author>
        <Name>Chinmay Kumar Panda</Name>
        <Affiliation>Dept. of Oncogene Regulation, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Kolkata 700 026, West Bengal, India. Electronic address: ckpanda.cnci@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>14-Deoxy-11,12-didehydroandrographolide induces DDIT3-dependent endoplasmic reticulum stress-mediated autophagy in T-47D breast carcinoma cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27049118</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30069-2</DOI>
    <KeywordList>
      <Keywords>14-Deoxy-11,12-didehydroandrographolide</Keywords>
      <Keywords>Autophagy</Keywords>
      <Keywords>DDIT3/CHOP</Keywords>
      <Keywords>Endoplasmic reticulum stress</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Heng Kean Tan</Name>
        <Affiliation>Malaysian Institute of Pharmaceuticals &amp; Nutraceuticals, National Institutes of Biotechnology Malaysia (NIBM), Ministry of Science, Technology &amp; Innovation, Halaman Bukit Gambir, Pulau Pinang, Malaysia; Advanced Medical &amp; Dental Institute, Universiti Sains Malaysia, Pulau Pinang, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Tengku Sifzizul Tengku Muhammad</Name>
        <Affiliation>Malaysian Institute of Pharmaceuticals &amp; Nutraceuticals, National Institutes of Biotechnology Malaysia (NIBM), Ministry of Science, Technology &amp; Innovation, Halaman Bukit Gambir, Pulau Pinang, Malaysia; Institute of Marine Biotechnology, Universiti Malaysia Terengganu, Kuala Terengganu, Terengganu, Malaysia.</Affiliation>
      </Author>
      <Author>
        <Name>Mei Lan Tan</Name>
        <Affiliation>Malaysian Institute of Pharmaceuticals &amp; Nutraceuticals, National Institutes of Biotechnology Malaysia (NIBM), Ministry of Science, Technology &amp; Innovation, Halaman Bukit Gambir, Pulau Pinang, Malaysia; Advanced Medical &amp; Dental Institute, Universiti Sains Malaysia, Pulau Pinang, Malaysia. Electronic address: tanml@usm.my.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inhibition of the aryl hydrocarbon receptor prevents Western diet-induced obesity. Model for AHR activation by kynurenine via oxidized-LDL, TLR2/4, TGFβ, and IDO1.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27020609</pubmedLink>
    <GrantList>
      <Grant>P20 GM103534</Grant>
      <Grant>P30 CA023108</Grant>
      <Grant>R01 CA126618</Grant>
      <Grant>S10 RR025048</Grant>
      <Grant>P20 RR024475</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30056-4</DOI>
    <KeywordList>
      <Keywords>Aryl hydrocarbon receptor</Keywords>
      <Keywords>Liver steatosis</Keywords>
      <Keywords>Obesity</Keywords>
      <Keywords>TLR2/TGFβ/PI3K/NF-κB/IDO1/AHR axis</Keywords>
      <Keywords>α-Naphthoflavone and CH-223191</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Benjamin J. Moyer</Name>
        <Affiliation>Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Itzel Y. Rojas</Name>
        <Affiliation>Department of Medicine, Geisel School of Medicine at Dartmouth, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, United States; Department of Pharmacology &amp; Toxicology, Geisel School of Medicine at Dartmouth, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Joanna S. Kerley-Hamilton</Name>
        <Affiliation>Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Haley F. Hazlett</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, Geisel School of Medicine at Dartmouth, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, United States; Department of Immunology &amp; Microbiology, Geisel School of Medicine at Dartmouth, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Krishnamurthy V. Nemani</Name>
        <Affiliation>Department of Radiology, Geisel School of Medicine at Dartmouth, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Heidi W. Trask</Name>
        <Affiliation>Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Rachel J. West</Name>
        <Affiliation>Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Leslie E. Lupien</Name>
        <Affiliation>Department of Medicine, Geisel School of Medicine at Dartmouth, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Alan J. Collins</Name>
        <Affiliation>Department of Immunology &amp; Microbiology, Geisel School of Medicine at Dartmouth, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Carol S. Ringelberg</Name>
        <Affiliation>Department of Genetics, Geisel School of Medicine at Dartmouth, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Barjor Gimi</Name>
        <Affiliation>Department of Radiology, Geisel School of Medicine at Dartmouth, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, United States.</Affiliation>
      </Author>
      <Author>
        <Name>William B. Kinlaw</Name>
        <Affiliation>Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, United States; Department of Medicine, Geisel School of Medicine at Dartmouth, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Craig R. Tomlinson</Name>
        <Affiliation>Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, United States; Department of Medicine, Geisel School of Medicine at Dartmouth, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, United States; Department of Pharmacology &amp; Toxicology, Geisel School of Medicine at Dartmouth, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, United States. Electronic address: Craig.R.Tomlinson@Dartmouth.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Beneficial effects of vitamin C treatment on pregnant rats exposed to formaldehyde: Reversal of immunosuppression in the offspring.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27020608</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30057-6</DOI>
    <KeywordList>
      <Keywords>Acute lung inflammation</Keywords>
      <Keywords>Bone marrow</Keywords>
      <Keywords>LPS</Keywords>
      <Keywords>NF-kappa B</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Toll-like receptor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Beatriz Silva Ibrahim</Name>
        <Affiliation>Department of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Éric Diego Barioni</Name>
        <Affiliation>Department of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Cíntia Heluany</Name>
        <Affiliation>Department of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Tárcio Teodoro Braga</Name>
        <Affiliation>Department of Immunology, University of São Paulo, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Carine Cristiane Drewes</Name>
        <Affiliation>Department of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Silvia Goes Costa</Name>
        <Affiliation>Post Graduate Program in Biophotonics Applied to Health Sciences, University Nove de Julho (UNINOVE), São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Niels Olsen Saraiva Câmara</Name>
        <Affiliation>Department of Immunology, University of São Paulo, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Sandra Helena Poliselli Farsky</Name>
        <Affiliation>Department of Clinical and Toxicological Analyses, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Adriana Lino-Dos-Santos-Franco</Name>
        <Affiliation>Post Graduate Program in Biophotonics Applied to Health Sciences, University Nove de Julho (UNINOVE), São Paulo, Brazil. Electronic address: alsantosfranco@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Goniothalamin prevents the development of chemically induced and spontaneous colitis in rodents and induces apoptosis in the HT-29 human colon tumor cell line.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/27016270</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30055-2</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Chronic inflammation</Keywords>
      <Keywords>Colitis</Keywords>
      <Keywords>Goniothalamin</Keywords>
      <Keywords>HT-29 cells</Keywords>
      <Keywords>IL-10 deficient mice</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Débora Barbosa Vendramini-Costa</Name>
        <Affiliation>Department of Organic Chemistry, Institute of Chemistry, University of Campinas, Campinas, SP, Brazil; Chemical, Biological and Agricultural Pluridisciplinary Research Center (CPQBA), University of Campinas, Campinas, SP, Brazil. Electronic address: vendramini.debora@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Antonio Alcaide</Name>
        <Affiliation>Department of Pharmacology, Faculty of Pharmacy, University of Seville, Seville, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Karin Juliane Pelizzaro-Rocha</Name>
        <Affiliation>Department of Biochemistry, Institute of Biology, University of Campinas, Campinas, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Elena Talero</Name>
        <Affiliation>Department of Pharmacology, Faculty of Pharmacy, University of Seville, Seville, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Javier Ávila-Román</Name>
        <Affiliation>Department of Pharmacology, Faculty of Pharmacy, University of Seville, Seville, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Sofia Garcia-Mauriño</Name>
        <Affiliation>Department of Plant Biology and Ecology, Faculty of Biology, University of Seville, Seville, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Ronaldo Aloise Pilli</Name>
        <Affiliation>Department of Organic Chemistry, Institute of Chemistry, University of Campinas, Campinas, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>João Ernesto de Carvalho</Name>
        <Affiliation>Chemical, Biological and Agricultural Pluridisciplinary Research Center (CPQBA), University of Campinas, Campinas, SP, Brazil; Faculty of Pharmaceutical Sciences, University of Campinas, Campinas, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Virginia Motilva</Name>
        <Affiliation>Department of Pharmacology, Faculty of Pharmacy, University of Seville, Seville, Spain.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>In vitro and in vivo evaluations of the P-glycoprotein-mediated efflux of dibenzoylhydrazines.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26995013</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.03.008</DOI>
    <KeywordList>
      <Keywords>Bidirectional transport assay</Keywords>
      <Keywords>Brain to plasma concentration ratio</Keywords>
      <Keywords>Dibenzoylhydrazines</Keywords>
      <Keywords>MDR1-LLCPK1 cells</Keywords>
      <Keywords>P-glycoprotein</Keywords>
      <Keywords>Quinidine transport inhibition</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ken Ichi Miyata</Name>
        <Affiliation>Graduate School of Agriculture, Kyoto University, Kyoto 606-8502, Japan; Otsuka Pharmaceutical Co., Ltd., Tokushima 771-0182, Japan. Electronic address: Miyata.Kenichi@otsuka.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Yoshiaki Nakagawa</Name>
        <Affiliation>Graduate School of Agriculture, Kyoto University, Kyoto 606-8502, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yasuhisa Kimura</Name>
        <Affiliation>Graduate School of Agriculture, Kyoto University, Kyoto 606-8502, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kazumitsu Ueda</Name>
        <Affiliation>Graduate School of Agriculture, Kyoto University, Kyoto 606-8502, Japan; Institute for Integrated Cell-Material Sciences (WPI-iCeMS), Kyoto University, Kyoto 606-8502, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Miki Akamatsu</Name>
        <Affiliation>Graduate School of Agriculture, Kyoto University, Kyoto 606-8502, Japan. Electronic address: akamatsu@kais.kyoto-u.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Deoxynivalenol exposure induces autophagy/apoptosis and epigenetic modification changes during porcine oocyte maturation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26988607</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30052-7</DOI>
    <KeywordList>
      <Keywords>Autophagy</Keywords>
      <Keywords>Cell cycle</Keywords>
      <Keywords>Deoxynivalenol</Keywords>
      <Keywords>Epigenetic modifications</Keywords>
      <Keywords>Porcine oocyte</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jun Han</Name>
        <Affiliation>College of Animal Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiao Chu Wang</Name>
        <Affiliation>College of Animal Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cheng Cheng Zhu</Name>
        <Affiliation>College of Animal Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Liu</Name>
        <Affiliation>College of Animal Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Zhang</Name>
        <Affiliation>College of Animal Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiang Shun Cui</Name>
        <Affiliation>Department of Animal Science, Chungbuk National University, Cheongju 361-763, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Nam Hyung Kim</Name>
        <Affiliation>Department of Animal Science, Chungbuk National University, Cheongju 361-763, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Shao Chen Sun</Name>
        <Affiliation>College of Animal Science and Technology, Nanjing Agricultural University, Nanjing 210095, China. Electronic address: sunsc@njau.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Disruption of estrogen homeostasis as a mechanism for uterine toxicity in Wistar Han rats treated with tetrabromobisphenol A.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26988606</pubmedLink>
    <GrantList>
      <Grant>Z99 CA999999</Grant>
      <Grant>ZIA BC011476</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.03.007</DOI>
    <KeywordList>
      <Keywords>Estrogen homeostasis</Keywords>
      <Keywords>Gene expression</Keywords>
      <Keywords>Rats</Keywords>
      <Keywords>TBBPA</Keywords>
      <Keywords>Tetrabromobisphenol A</Keywords>
      <Keywords>Uterine toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>J. Michael Sanders</Name>
        <Affiliation>Laboratory of Toxicology and Toxicokinetics, National Cancer Institute at the National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, United States. Electronic address: sander10@mail.nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Sherry J. Coulter</Name>
        <Affiliation>Laboratory of Toxicology and Toxicokinetics, National Cancer Institute at the National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Gabriel A. Knudsen</Name>
        <Affiliation>Laboratory of Toxicology and Toxicokinetics, National Cancer Institute at the National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, United States.</Affiliation>
      </Author>
      <Author>
        <Name>June K. Dunnick</Name>
        <Affiliation>National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Grace E. Kissling</Name>
        <Affiliation>National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Linda S. Birnbaum</Name>
        <Affiliation>Laboratory of Toxicology and Toxicokinetics, National Cancer Institute at the National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Metformin, besides exhibiting strong in vivo anti-inflammatory properties, increases mptp-induced damage to the nigrostriatal dopaminergic system.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26971375</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.03.004</DOI>
    <KeywordList>
      <Keywords>Diabetes mellitus</Keywords>
      <Keywords>Dopaminergic system</Keywords>
      <Keywords>MPTP</Keywords>
      <Keywords>Metformin</Keywords>
      <Keywords>Parkinson's disease</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Afrah A. K. Ismaiel</Name>
        <Affiliation>Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia, Universidad de Sevilla, and Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Ana M. Espinosa-Oliva</Name>
        <Affiliation>Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia, Universidad de Sevilla, and Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Martiniano Santiago</Name>
        <Affiliation>Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia, Universidad de Sevilla, and Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Albert García-Quintanilla</Name>
        <Affiliation>Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia, Universidad de Sevilla, and Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>María J. Oliva-Martín</Name>
        <Affiliation>Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia, Universidad de Sevilla, and Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Antonio J. Herrera</Name>
        <Affiliation>Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia, Universidad de Sevilla, and Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>José L. Venero</Name>
        <Affiliation>Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia, Universidad de Sevilla, and Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Rocío M. de Pablos</Name>
        <Affiliation>Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia, Universidad de Sevilla, and Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain. Electronic address: depablos@us.es.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>TCDD promoted EMT of hFPECs via AhR, which involved the activation of EGFR/ERK signaling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26971374</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.03.005</DOI>
    <KeywordList>
      <Keywords>2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)</Keywords>
      <Keywords>Cleft palate</Keywords>
      <Keywords>EGFR/ERK pathway</Keywords>
      <Keywords>Epithelial-mesenchymal transition (EMT)</Keywords>
      <Keywords>Human fetal palatal epithelial cells (hFPECs)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhan Gao</Name>
        <Affiliation>School of Public Health, Xinxiang Medical University, 453003, China; The Fifth Affiliated Hospital, Zhengzhou University, 450052, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongjun Bu</Name>
        <Affiliation>School of Public Health, Xinxiang Medical University, 453003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaozhuan Liu</Name>
        <Affiliation>Medical College, Henan University of Science &amp; Technology, 471023, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xugang Wang</Name>
        <Affiliation>School of Public Health, Xinxiang Medical University, 453003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Guofu Zhang</Name>
        <Affiliation>School of Public Health, Xinxiang Medical University, 453003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Erhui Wang</Name>
        <Affiliation>School of Public Health, Xinxiang Medical University, 453003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shibin Ding</Name>
        <Affiliation>School of Public Health, Xinxiang Medical University, 453003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongfeng Liu</Name>
        <Affiliation>School of Public Health, Xinxiang Medical University, 453003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ruling Shi</Name>
        <Affiliation>School of Public Health, Xinxiang Medical University, 453003, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiaoyun Li</Name>
        <Affiliation>The Fifth Affiliated Hospital, Zhengzhou University, 450052, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianhong Fu</Name>
        <Affiliation>The Fifth Affiliated Hospital, Zhengzhou University, 450052, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zengli Yu</Name>
        <Affiliation>School of Public Health, Xinxiang Medical University, 453003, China; School of Public Health, Zhengzhou University, 450001, China. Electronic address: zly@zzu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}, 1 a novel resveratrol analog, differentially regulates estrogen receptors α and β in breast cancer cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26970359</pubmedLink>
    <GrantList>
      <Grant>R01 CA109551</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.03.003</DOI>
    <KeywordList>
      <Keywords>Breast cancer inhibition</Keywords>
      <Keywords>Estrogen receptors</Keywords>
      <Keywords>Resveratrol analogs</Keywords>
      <Keywords>TIMBD</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Amruta Ronghe</Name>
        <Affiliation>Division of Pharmacology and Toxicology, School of Pharmacy, University of Missouri-Kansas City, Kansas City, MO 64108, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anwesha Chatterjee</Name>
        <Affiliation>Division of Pharmacology and Toxicology, School of Pharmacy, University of Missouri-Kansas City, Kansas City, MO 64108, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bhupendra Singh</Name>
        <Affiliation>Department of Genetics, School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Prasad Dandawate</Name>
        <Affiliation>ISTRA, Department of Chemistry, Abeda Inamdar Senior College, University of Pune, India.</Affiliation>
      </Author>
      <Author>
        <Name>Fatma Abdalla</Name>
        <Affiliation>Division of Pharmacology and Toxicology, School of Pharmacy, University of Missouri-Kansas City, Kansas City, MO 64108, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Nimee K. Bhat</Name>
        <Affiliation>Division of Pharmacology and Toxicology, School of Pharmacy, University of Missouri-Kansas City, Kansas City, MO 64108, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Subhash Padhye</Name>
        <Affiliation>ISTRA, Department of Chemistry, Abeda Inamdar Senior College, University of Pune, India.</Affiliation>
      </Author>
      <Author>
        <Name>Hari K. Bhat</Name>
        <Affiliation>Division of Pharmacology and Toxicology, School of Pharmacy, University of Missouri-Kansas City, Kansas City, MO 64108, USA. Electronic address: bhath@umkc.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Prenatal low-dose methylmercury exposure impairs neurite outgrowth and synaptic protein expression and suppresses TrkA pathway activity and eEF1A1 expression in the rat cerebellum.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26965727</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.03.002</DOI>
    <KeywordList>
      <Keywords>Methylmercury</Keywords>
      <Keywords>Neurite outgrowth</Keywords>
      <Keywords>Prenatal</Keywords>
      <Keywords>Synaptic protein expression</Keywords>
      <Keywords>TrkA pathway</Keywords>
      <Keywords>eEF1A1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Masatake Fujimura</Name>
        <Affiliation>Department of Basic Medical Sciences, National Institute for Minamata Disease, Kumamoto, Japan. Electronic address: fujimura@nimd.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Fusako Usuki</Name>
        <Affiliation>Department of Clinical Medicine, National Institute for Minamata Disease, Kumamoto, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Jinping Cheng</Name>
        <Affiliation>School of Environmental Science and Engineering, Shanghai Jiao Tong University, Shanghai 200240, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenchang Zhao</Name>
        <Affiliation>School of Environmental Science and Engineering, Shanghai Jiao Tong University, Shanghai 200240, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Development and assessment of countermeasure formulations for treatment of lung injury induced by chlorine inhalation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26952014</pubmedLink>
    <GrantList>
      <Grant>U01 ES015673</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.03.001</DOI>
    <KeywordList>
      <Keywords>Acute lung injury</Keywords>
      <Keywords>Airway hyperreactivity</Keywords>
      <Keywords>Microencapsulation</Keywords>
      <Keywords>Pulmonary edema</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gary W. Hoyle</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, School of Public Health and Information Sciences, University of Louisville, Louisville, KY, United States. Electronic address: Gary.Hoyle@louisville.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Chen</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, School of Public Health and Information Sciences, University of Louisville, Louisville, KY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Connie F. Schlueter</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, School of Public Health and Information Sciences, University of Louisville, Louisville, KY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Yiqun Mo</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, School of Public Health and Information Sciences, University of Louisville, Louisville, KY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>David M. Humphrey</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, School of Public Health and Information Sciences, University of Louisville, Louisville, KY, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Greg Rawson</Name>
        <Affiliation>Microencapsulation and Nanomaterials Department, Chemistry and Chemical Engineering Division, Southwest Research Institute, San Antonio, TX, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Joe A. Niño</Name>
        <Affiliation>Microencapsulation and Nanomaterials Department, Chemistry and Chemical Engineering Division, Southwest Research Institute, San Antonio, TX, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Kenneth H. Carson</Name>
        <Affiliation>Microencapsulation and Nanomaterials Department, Chemistry and Chemical Engineering Division, Southwest Research Institute, San Antonio, TX, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Uterine responses to feeding soy protein isolate and treatment with 17β-estradiol differ in ovariectomized female rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26945725</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.02.019</DOI>
    <KeywordList>
      <Keywords>Endometrial cancer</Keywords>
      <Keywords>Estradiol</Keywords>
      <Keywords>Selective estrogen receptor modulator</Keywords>
      <Keywords>Soy</Keywords>
      <Keywords>Uterus</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Martin J. Ronis</Name>
        <Affiliation>Department of Pharmacology &amp; Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans, LA 70112, United States. Electronic address: mronis@lsuhsc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Horacio Gomez-Acevedo</Name>
        <Affiliation>Arkansas Children's Nutrition Center, University of Arkansas for Medical Sciences, Little Rock, AR 72202, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Michael L. Blackburn</Name>
        <Affiliation>Arkansas Children's Nutrition Center, University of Arkansas for Medical Sciences, Little Rock, AR 72202, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mario A. Cleves</Name>
        <Affiliation>Arkansas Children's Nutrition Center, University of Arkansas for Medical Sciences, Little Rock, AR 72202, United States; Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR 72202, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Rohit Singhal</Name>
        <Affiliation>Department of Pharmacology &amp; Toxicology, University of Arkansas for Medical Sciences, Little Rock, AR 72202, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas M. Badger</Name>
        <Affiliation>Arkansas Children's Nutrition Center, University of Arkansas for Medical Sciences, Little Rock, AR 72202, United States; Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR 72202, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Iron depletion in HCT116 cells diminishes the upregulatory effect of phenethyl isothiocyanate on heme oxygenase-1.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26945724</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.02.024</DOI>
    <KeywordList>
      <Keywords>Deferoxamine</Keywords>
      <Keywords>Heme oxygenase-1</Keywords>
      <Keywords>Iron</Keywords>
      <Keywords>Phenethyl isothiocyanate</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michael P. Bolloskis</Name>
        <Affiliation>Cellular and Molecular Nutrition Research Laboratory, Department of Nutrition, University of North Carolina at Greensboro, Greensboro, NC 27412, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Fabiana P. Carvalho</Name>
        <Affiliation>Cellular and Molecular Nutrition Research Laboratory, Department of Nutrition, University of North Carolina at Greensboro, Greensboro, NC 27412, USA.</Affiliation>
      </Author>
      <Author>
        <Name>George Loo</Name>
        <Affiliation>Cellular and Molecular Nutrition Research Laboratory, Department of Nutrition, University of North Carolina at Greensboro, Greensboro, NC 27412, USA. Electronic address: g_loo@uncg.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Municipal wastewater affects adipose deposition in male mice and increases 3T3-L1 cell differentiation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26944108</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.02.023</DOI>
    <KeywordList>
      <Keywords>Adipocytes differentiation</Keywords>
      <Keywords>Adipose deposition</Keywords>
      <Keywords>Endocrine disruptors</Keywords>
      <Keywords>Wastewater</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Giorgio Biasiotto</Name>
        <Affiliation>Laboratory of Biotechnology, Civic Hospital of Brescia, Brescia, Italy; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Isabella Zanella</Name>
        <Affiliation>Laboratory of Biotechnology, Civic Hospital of Brescia, Brescia, Italy; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Alice Masserdotti</Name>
        <Affiliation>Laboratory of Biotechnology, Civic Hospital of Brescia, Brescia, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Roberta Pedrazzani</Name>
        <Affiliation>DIMI Department of Mechanical and Industrial Engineering, University of Brescia, via Branze 38, I-25123 Brescia, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Matteo Papa</Name>
        <Affiliation>DICATAM Department of Civil, Environmental, Architectural Engineering and Mathematics, University of Brescia, via Branze 43, I-25123 Brescia, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Luigi Caimi</Name>
        <Affiliation>Laboratory of Biotechnology, Civic Hospital of Brescia, Brescia, Italy; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Diego Di Lorenzo</Name>
        <Affiliation>Laboratory of Biotechnology, Civic Hospital of Brescia, Brescia, Italy. Electronic address: diego.dilorenzo@yahoo.it.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Photosensitized 2-amino-3-hydroxypyridine-induced mitochondrial apoptosis via Smac/DIABLO in human skin cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26933830</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.02.022</DOI>
    <KeywordList>
      <Keywords>A132 (2-amino-3-hydroxypyridine)</Keywords>
      <Keywords>Caspase 3</Keywords>
      <Keywords>Phototoxicity</Keywords>
      <Keywords>Smac/DIABLO</Keywords>
      <Keywords>UV radiation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shruti Goyal</Name>
        <Affiliation>Photobiology Laboratory, Systems Toxicology and Health Risk Assessment Group, CSIR - Indian Institute of Toxicology Research (CSIR-IITR), M.G, Marg, Lucknow 226001, Uttar Pradesh, India; Academy of Scientific and Innovative Research (AcSIR), CSIR - IITR, Lucknow 226001, India.</Affiliation>
      </Author>
      <Author>
        <Name>Saroj Kumar Amar</Name>
        <Affiliation>Photobiology Laboratory, Systems Toxicology and Health Risk Assessment Group, CSIR - Indian Institute of Toxicology Research (CSIR-IITR), M.G, Marg, Lucknow 226001, Uttar Pradesh, India; Academy of Scientific and Innovative Research (AcSIR), CSIR - IITR, Lucknow 226001, India.</Affiliation>
      </Author>
      <Author>
        <Name>Ashish Dwivedi</Name>
        <Affiliation>Photobiology Laboratory, Systems Toxicology and Health Risk Assessment Group, CSIR - Indian Institute of Toxicology Research (CSIR-IITR), M.G, Marg, Lucknow 226001, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Syed Faiz Mujtaba</Name>
        <Affiliation>Photobiology Laboratory, Systems Toxicology and Health Risk Assessment Group, CSIR - Indian Institute of Toxicology Research (CSIR-IITR), M.G, Marg, Lucknow 226001, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Hari Narayan Kushwaha</Name>
        <Affiliation>Photobiology Laboratory, Systems Toxicology and Health Risk Assessment Group, CSIR - Indian Institute of Toxicology Research (CSIR-IITR), M.G, Marg, Lucknow 226001, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Deepti Chopra</Name>
        <Affiliation>Photobiology Laboratory, Systems Toxicology and Health Risk Assessment Group, CSIR - Indian Institute of Toxicology Research (CSIR-IITR), M.G, Marg, Lucknow 226001, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Manish Kumar Pal</Name>
        <Affiliation>Photobiology Laboratory, Systems Toxicology and Health Risk Assessment Group, CSIR - Indian Institute of Toxicology Research (CSIR-IITR), M.G, Marg, Lucknow 226001, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Dhirendra Singh</Name>
        <Affiliation>Photobiology Laboratory, Systems Toxicology and Health Risk Assessment Group, CSIR - Indian Institute of Toxicology Research (CSIR-IITR), M.G, Marg, Lucknow 226001, Uttar Pradesh, India.</Affiliation>
      </Author>
      <Author>
        <Name>Rajnish Kumar Chaturvedi</Name>
        <Affiliation>Developmental Toxicology Division, CSIR - Indian Institute of Toxicology Research, P. O. Box 80, M.G. Marg, Lucknow 226001, India.</Affiliation>
      </Author>
      <Author>
        <Name>Ratan Singh Ray</Name>
        <Affiliation>Photobiology Laboratory, Systems Toxicology and Health Risk Assessment Group, CSIR - Indian Institute of Toxicology Research (CSIR-IITR), M.G, Marg, Lucknow 226001, Uttar Pradesh, India; Academy of Scientific and Innovative Research (AcSIR), CSIR - IITR, Lucknow 226001, India. Electronic address: ratanray.2011@rediffmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Use of a combined effect model approach for discriminating between ABCB1- and ABCC1-type efflux activities in native bivalve gill tissue.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26929997</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.02.020</DOI>
    <KeywordList>
      <Keywords>Dreissena polymorpha</Keywords>
      <Keywords>Environment-tissue barrier</Keywords>
      <Keywords>Mixture effect modeling</Keywords>
      <Keywords>Multidrug resistance associated protein (MRP)</Keywords>
      <Keywords>Multixenobiotic resistance</Keywords>
      <Keywords>P-glycoprotein</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Melissa Faria</Name>
        <Affiliation>Department of Environmental Chemistry, IDAEA-CSIC, Jordi Girona 18, 08034 Barcelona, Spain; CESAM &amp; Departamento de Biologia, Universidade de Aveiro, 3810-193 Aveiro, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Vasiliy Pavlichenko</Name>
        <Affiliation>Siberian Institute of Plant Physiology and Biochemistry, Siberian Branch of Russian Academy of Sciences (SIPPB SB RAS), Lermontov Str. 132, 664033, Irkutsk, Russia; Department of Bioanalytical Ecotoxicology, UFZ - Helmholtz Centre for Environmental Research, Permoserstr. 15, D-04318 Leipzig, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Kathleen Burkhardt-Medicke</Name>
        <Affiliation>Department of Bioanalytical Ecotoxicology, UFZ - Helmholtz Centre for Environmental Research, Permoserstr. 15, D-04318 Leipzig, Germany; Institute of Hydrobiology, Dresden University of Technology, D-01062 Dresden, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Amadeu M. V. M. Soares</Name>
        <Affiliation>CESAM &amp; Departamento de Biologia, Universidade de Aveiro, 3810-193 Aveiro, Portugal.</Affiliation>
      </Author>
      <Author>
        <Name>Rolf Altenburger</Name>
        <Affiliation>Department of Bioanalytical Ecotoxicology, UFZ - Helmholtz Centre for Environmental Research, Permoserstr. 15, D-04318 Leipzig, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Carlos Barata</Name>
        <Affiliation>Department of Environmental Chemistry, IDAEA-CSIC, Jordi Girona 18, 08034 Barcelona, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Till Luckenbach</Name>
        <Affiliation>Department of Bioanalytical Ecotoxicology, UFZ - Helmholtz Centre for Environmental Research, Permoserstr. 15, D-04318 Leipzig, Germany. Electronic address: till.luckenbach@ufz.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cellular uptake of lead in the blood-cerebrospinal fluid barrier: Novel roles of Connexin 43 hemichannel and its down-regulations via Erk phosphorylation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26926986</pubmedLink>
    <GrantList>
      <Grant>ES-R01 07331</Grant>
      <Grant>ES-R01 10563</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.02.021</DOI>
    <KeywordList>
      <Keywords>Choroid plexus</Keywords>
      <Keywords>Connexin 43</Keywords>
      <Keywords>Erk</Keywords>
      <Keywords>Lead</Keywords>
      <Keywords>Src</Keywords>
      <Keywords>iZCx43</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Han Song</Name>
        <Affiliation>Department of Occupational and Environmental Health and the Ministry-of-Education's Key Laboratory of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Fourth Military Medical University, Xi'an 710032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Gang Zheng</Name>
        <Affiliation>Department of Occupational and Environmental Health and the Ministry-of-Education's Key Laboratory of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Fourth Military Medical University, Xi'an 710032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Liu</Name>
        <Affiliation>Department of Occupational and Environmental Health and the Ministry-of-Education's Key Laboratory of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Fourth Military Medical University, Xi'an 710032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xue Feng Shen</Name>
        <Affiliation>Department of Occupational and Environmental Health and the Ministry-of-Education's Key Laboratory of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Fourth Military Medical University, Xi'an 710032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zai Hua Zhao</Name>
        <Affiliation>Department of Occupational and Environmental Health and the Ministry-of-Education's Key Laboratory of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Fourth Military Medical University, Xi'an 710032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Aschner</Name>
        <Affiliation>Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Jing Luo</Name>
        <Affiliation>Department of Occupational and Environmental Health and the Ministry-of-Education's Key Laboratory of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Fourth Military Medical University, Xi'an 710032, China. Electronic address: luowenj@fmmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Yuan Chen</Name>
        <Affiliation>Department of Occupational and Environmental Health and the Ministry-of-Education's Key Laboratory of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Fourth Military Medical University, Xi'an 710032, China. Electronic address: jy_chen@fmmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Differences in allergic inflammatory responses between urban PM2.5 and fine particle derived from desert-dust in murine lungs.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26917405</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.02.017</DOI>
    <KeywordList>
      <Keywords>Eosinophilia</Keywords>
      <Keywords>Fine particulate matter</Keywords>
      <Keywords>M2 macrophages</Keywords>
      <Keywords>Microbial element</Keywords>
      <Keywords>PM2.5</Keywords>
      <Keywords>Th2 immune response</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Miao He</Name>
        <Affiliation>Environment and Non-communicable Disease Research Center, School of Public Health, China Medical University, Shenyang 110122, China; Department of Health Sciences, Oita University of Nursing and Health Sciences, Oita 870-1201, Japan. Electronic address: hemiao@mail.cmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Takamichi Ichinose</Name>
        <Affiliation>Department of Health Sciences, Oita University of Nursing and Health Sciences, Oita 870-1201, Japan. Electronic address: ichinose@oita-nhs.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Makoto Kobayashi</Name>
        <Affiliation>Department of Respiratory Medicine, Kanazawa Medical University, Ishikawa 920-0293, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Keiichi Arashidani</Name>
        <Affiliation>Department of Immunology and Parasitology, School of Medicine, University of Occupational and Environmental Health, Fukuoka 807-8555, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Seiichi Yoshida</Name>
        <Affiliation>Department of Health Sciences, Oita University of Nursing and Health Sciences, Oita 870-1201, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Masataka Nishikawa</Name>
        <Affiliation>Environmental Chemistry Division, National Institute for Environmental Studies, Ibaraki 305-8506, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hirohisa Takano</Name>
        <Affiliation>Environmental Health Division, Department of Environmental Engineering, Graduate School of Engineering, Kyoto University, Kyoto 615-8530, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Guifan Sun</Name>
        <Affiliation>Environment and Non-communicable Disease Research Center, School of Public Health, China Medical University, Shenyang 110122, China.</Affiliation>
      </Author>
      <Author>
        <Name>Takayuki Shibamoto</Name>
        <Affiliation>Department of Environmental Toxicology, University of California, Davis, CA 95616, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Phenotype anchoring in zebrafish reveals a potential role for matrix metalloproteinases (MMPs) in tamoxifen's effects on skin epithelium.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26908177</pubmedLink>
    <GrantList>
      <Grant>K99 ES025280</Grant>
      <Grant>P30 ES000210</Grant>
      <Grant>P42 ES016465</Grant>
      <Grant>T32 ES007060</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.02.013</DOI>
    <KeywordList>
      <Keywords>Matrix metalloproteinases</Keywords>
      <Keywords>Skin epithelium</Keywords>
      <Keywords>Tamoxifen</Keywords>
      <Keywords>Zebrafish</Keywords>
      <Keywords>mmp13a</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sean M. Bugel</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, Environmental Health Sciences Center, Sinnhuber Aquatic Research Laboratory, Oregon State University, Corvallis, OR 97331, United States. Electronic address: Sean.Bugel@oregonstate.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Leah C. Wehmas</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, Environmental Health Sciences Center, Sinnhuber Aquatic Research Laboratory, Oregon State University, Corvallis, OR 97331, United States. Electronic address: wehmasl@onid.oregonstate.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Jane K. La Du</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, Environmental Health Sciences Center, Sinnhuber Aquatic Research Laboratory, Oregon State University, Corvallis, OR 97331, United States. Electronic address: Jane.LaDu@oregonstate.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Robert L. Tanguay</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, Environmental Health Sciences Center, Sinnhuber Aquatic Research Laboratory, Oregon State University, Corvallis, OR 97331, United States. Electronic address: Robert.Tanguay@oregonstate.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Hexavalent chromium induces chromosome instability in human urothelial cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26908176</pubmedLink>
    <GrantList>
      <Grant>R01 ES016893</Grant>
      <Grant>ES016893</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.02.015</DOI>
    <KeywordList>
      <Keywords>Aneuploidy</Keywords>
      <Keywords>Bladder cancer</Keywords>
      <Keywords>Chromate</Keywords>
      <Keywords>Chromium</Keywords>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Urothelial</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sandra S. Wise</Name>
        <Affiliation>Wise Laboratory of Environmental and Genetic Toxicology, Maine Center for Toxicology and Environmental Health, Department of Applied Medical Science, University of Southern Maine, Science Building, 96 Falmouth Street, Portland, ME 04103, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Amie L. Holmes</Name>
        <Affiliation>Wise Laboratory of Environmental and Genetic Toxicology, Maine Center for Toxicology and Environmental Health, Department of Applied Medical Science, University of Southern Maine, Science Building, 96 Falmouth Street, Portland, ME 04103, USA; Department of Radiation Oncology, Dana Farber Cancer Institute, 450 Brookline Ave., Boston, MA 02215, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Louis Liou</Name>
        <Affiliation>Department of Pathology, Boston University School of Medicine, 670 Albany St., Boston, MA 02118, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rosalyn M. Adam</Name>
        <Affiliation>Department of Surgery, Harvard Medical School, Boston, MA 02115, USA.</Affiliation>
      </Author>
      <Author>
        <Name>John Pierce Wise</Name>
        <Affiliation>Wise Laboratory of Environmental and Genetic Toxicology, Maine Center for Toxicology and Environmental Health, Department of Applied Medical Science, University of Southern Maine, Science Building, 96 Falmouth Street, Portland, ME 04103, USA. Electronic address: john.wise@louisville.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nanotoxicology ten years later: Lights and shadows.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26908175</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.02.014</DOI>
    <KeywordList>
      <Keywords>Global representation</Keywords>
      <Keywords>Nanomaterials</Keywords>
      <Keywords>Nanotechnology</Keywords>
      <Keywords>Nanotoxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anna Shvedova</Name>
        <Affiliation>Pathology and Physiology Research Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, USA; Department of Physiology &amp; Pharmacology, WVU, Morgantown, WV, USA. Electronic address: ats1@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Antonio Pietroiusti</Name>
        <Affiliation>Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Valerian Kagan</Name>
        <Affiliation>Department of Environmental and Occupational Health, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Elevated nuclear sphingoid base-1-phosphates and decreased histone deacetylase activity after fumonisin B1 treatment in mouse embryonic fibroblasts.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26905748</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.02.018</DOI>
    <KeywordList>
      <Keywords>Fumonisin B1</Keywords>
      <Keywords>Histone acetylation</Keywords>
      <Keywords>Histone deacetylase (HDAC)</Keywords>
      <Keywords>Neural tube defect (NTD)</Keywords>
      <Keywords>Sphinganine-1-phosphate (Sa1P)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nicole M. Gardner</Name>
        <Affiliation>Department of Pharmacology, Creighton University School of Medicine, Omaha, NE 68178, United States. Electronic address: nicolegardner@creighton.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Ronald T. Riley</Name>
        <Affiliation>USDA-ARS, Toxicology and Mycotoxin Research Unit, Athens, GA 30605, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jency L. Showker</Name>
        <Affiliation>USDA-ARS, Toxicology and Mycotoxin Research Unit, Athens, GA 30605, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Kenneth A. Voss</Name>
        <Affiliation>USDA-ARS, Toxicology and Mycotoxin Research Unit, Athens, GA 30605, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew J. Sachs</Name>
        <Affiliation>Department of Pharmacology, Creighton University School of Medicine, Omaha, NE 68178, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Joyce R. Maddox</Name>
        <Affiliation>Department of Pharmacology, Creighton University School of Medicine, Omaha, NE 68178, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Janee B. Gelineau-van Waes</Name>
        <Affiliation>Department of Pharmacology, Creighton University School of Medicine, Omaha, NE 68178, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Fibrosis biomarkers in workers exposed to MWCNTs.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26902652</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.02.016</DOI>
    <KeywordList>
      <Keywords>Fibrosis</Keywords>
      <Keywords>KL-6</Keywords>
      <Keywords>MWCNT</Keywords>
      <Keywords>Osteopontin</Keywords>
      <Keywords>TGF-beta</Keywords>
      <Keywords>Workers</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Liliya M. Fatkhutdinova</Name>
        <Affiliation>Kazan State Medical University, ul. Butlerova 49, Kazan 420012, Russia. Electronic address: liliya.fatkhutdinova@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Timur O. Khaliullin</Name>
        <Affiliation>Kazan State Medical University, ul. Butlerova 49, Kazan 420012, Russia; Department of Physiology &amp; Pharmacology, WVU, Morgantown, WV, USA. Electronic address: Khaliullin.40k@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Olga L. Vasil'yeva</Name>
        <Affiliation>Kazan State Medical University, ul. Butlerova 49, Kazan 420012, Russia. Electronic address: volgaleon@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ramil R. Zalyalov</Name>
        <Affiliation>Kazan State Medical University, ul. Butlerova 49, Kazan 420012, Russia. Electronic address: zalyalov.ramil@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ilshat G. Mustafin</Name>
        <Affiliation>Kazan State Medical University, ul. Butlerova 49, Kazan 420012, Russia. Electronic address: ilshat64@mail.ru.</Affiliation>
      </Author>
      <Author>
        <Name>Elena R. Kisin</Name>
        <Affiliation>National Institute for Occupational Safety and Health, Morgantown, WV, USA. Electronic address: edk8@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>M. Eileen Birch</Name>
        <Affiliation>National Institute for Occupational Safety and Health, Cincinnati, OH, USA. Electronic address: mib2@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Naveena Yanamala</Name>
        <Affiliation>National Institute for Occupational Safety and Health, Morgantown, WV, USA. Electronic address: wqu1@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Anna A. Shvedova</Name>
        <Affiliation>National Institute for Occupational Safety and Health, Morgantown, WV, USA; Department of Physiology &amp; Pharmacology, WVU, Morgantown, WV, USA. Electronic address: ats1@cdc.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Desert dust induces TLR signaling to trigger Th2-dominant lung allergic inflammation via a MyD88-dependent signaling pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26882889</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.02.011</DOI>
    <KeywordList>
      <Keywords>Asthma</Keywords>
      <Keywords>Desert dust</Keywords>
      <Keywords>MyD88 deficiency</Keywords>
      <Keywords>TLR deficiency</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Miao He</Name>
        <Affiliation>Environment and Non-communicable Disease Research Center, School of Public Health, China Medical University, Shenyang 110122, China. Electronic address: hemiao@mail.cmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Takamichi Ichinose</Name>
        <Affiliation>Department of Health Sciences, Oita University of Nursing and Health Sciences, Oita 870-1201, Japan. Electronic address: ichinose@oita-nhs.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Song</Name>
        <Affiliation>Department of Immunology and Parasitology, School of Medicine, University of Occupational and Environmental Health, Fukuoka 807-8555, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yasuhiro Yoshida</Name>
        <Affiliation>Department of Immunology and Parasitology, School of Medicine, University of Occupational and Environmental Health, Fukuoka 807-8555, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kanae Bekki</Name>
        <Affiliation>Department of Environmental Health, National Institute of Public Health, Saitama 351-0197, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Keiichi Arashidani</Name>
        <Affiliation>Department of Immunology and Parasitology, School of Medicine, University of Occupational and Environmental Health, Fukuoka 807-8555, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Seiichi Yoshida</Name>
        <Affiliation>Department of Health Sciences, Oita University of Nursing and Health Sciences, Oita 870-1201, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Masataka Nishikawa</Name>
        <Affiliation>Environmental Chemistry Division, National Institute for Environmental Studies, Ibaraki 305-8506, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Hirohisa Takano</Name>
        <Affiliation>Environmental Health Division, Department of Environmental Engineering, Graduate School of Engineering, Kyoto University, Kyoto 615-8530, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takayuki Shibamoto</Name>
        <Affiliation>Department of Environmental Toxicology, University of California, Davis, CA 95616, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Guifan Sun</Name>
        <Affiliation>Environment and Non-communicable Disease Research Center, School of Public Health, China Medical University, Shenyang 110122, China.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Investigation of the therapeutic potential of N-acetyl cysteine and the tools used to define nigrostriatal degeneration in vivo.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26879220</pubmedLink>
    <GrantList>
      <Grant>R03 NS088395</Grant>
      <Grant>R15 NS093539</Grant>
      <Grant>R03NS088395</Grant>
      <Grant>R15NS093539</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.02.010</DOI>
    <KeywordList>
      <Keywords>Dopamine</Keywords>
      <Keywords>FluoroGold</Keywords>
      <Keywords>N-acetylcysteine</Keywords>
      <Keywords>Neurodegeneration</Keywords>
      <Keywords>Parkinson's disease</Keywords>
      <Keywords>Retrograde</Keywords>
      <Keywords>The reference trap</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Negin Nouraei</Name>
        <Affiliation>Division of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Lauren Zarger</Name>
        <Affiliation>Division of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Justin N. Weilnau</Name>
        <Affiliation>Division of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jimin Han</Name>
        <Affiliation>Division of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel M. Mason</Name>
        <Affiliation>Division of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Rehana K. Leak</Name>
        <Affiliation>Division of Pharmaceutical Sciences, Duquesne University, Pittsburgh, PA, United States. Electronic address: leakr@duq.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>10-Oxo-trans-11-octadecenoic acid generated from linoleic acid by a gut lactic acid bacterium Lactobacillus plantarum is cytoprotective against oxidative stress.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26879219</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.02.012</DOI>
    <KeywordList>
      <Keywords>Gut microorganism</Keywords>
      <Keywords>Hydroxy and oxo fatty acids</Keywords>
      <Keywords>Lactic acid bacterium</Keywords>
      <Keywords>Nrf2-ARE pathway</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Polyunsaturated fatty acids</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hidehiro Furumoto</Name>
        <Affiliation>Division of Applied Biosciences, Graduate School of Agriculture, Kyoto University, Kitashirakawa Oiwake-cho, Sakyo-ku, Kyoto 606-8502, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tharnath Nanthirudjanar</Name>
        <Affiliation>Division of Applied Biosciences, Graduate School of Agriculture, Kyoto University, Kitashirakawa Oiwake-cho, Sakyo-ku, Kyoto 606-8502, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Toshiaki Kume</Name>
        <Affiliation>Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29, Simoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yasuhiko Izumi</Name>
        <Affiliation>Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29, Simoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Si Bum Park</Name>
        <Affiliation>Laboratory of Industrial Microbiology, Graduate School of Agriculture, Kyoto University, Kitashirakawa Oiwake-cho, Sakyo-ku, Kyoto 606-8502, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Nahoko Kitamura</Name>
        <Affiliation>Division of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kitashirakawa Oiwake-cho, Sakyo-ku, Kyoto 606-8502, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Shigenobu Kishino</Name>
        <Affiliation>Division of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kitashirakawa Oiwake-cho, Sakyo-ku, Kyoto 606-8502, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Ogawa</Name>
        <Affiliation>Division of Applied Life Sciences, Graduate School of Agriculture, Kyoto University, Kitashirakawa Oiwake-cho, Sakyo-ku, Kyoto 606-8502, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takashi Hirata</Name>
        <Affiliation>Division of Applied Biosciences, Graduate School of Agriculture, Kyoto University, Kitashirakawa Oiwake-cho, Sakyo-ku, Kyoto 606-8502, Japan; Faculty of Rehabilitation, Shijonawategakuen University, 5-11-10, Hojo, Daitou-shi, Osaka 574-0011, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tatsuya Sugawara</Name>
        <Affiliation>Division of Applied Biosciences, Graduate School of Agriculture, Kyoto University, Kitashirakawa Oiwake-cho, Sakyo-ku, Kyoto 606-8502, Japan. Electronic address: sugawara@kais.kyoto-u.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>BFD-22 a new potential inhibitor of BRAF inhibits the metastasis of B16F10 melanoma cells and simultaneously increased the tumor immunogenicity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26876618</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.02.008</DOI>
    <KeywordList>
      <Keywords>Anti-metastatic</Keywords>
      <Keywords>BFD-22</Keywords>
      <Keywords>Benzofuroxan derivatives</Keywords>
      <Keywords>Cell death</Keywords>
      <Keywords>Melanoma</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Adilson Kleber Ferreira</Name>
        <Affiliation>Laboratory of Tumor Immunology, University of São Paulo, São Paulo, SP, Brazil; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, Groningen, The Netherlands. Electronic address: ferreira-kleber@usp.br.</Affiliation>
      </Author>
      <Author>
        <Name>Kerly Fernanda Mesquita Pasqualoto</Name>
        <Affiliation>Biochemistry and Biophysics Laboratory, Butantan Institute, São Paulo, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Frank A. E. Kruyt</Name>
        <Affiliation>Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, Groningen, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Fanny Palace-Berl</Name>
        <Affiliation>Laboratory of Drug Design and Development, University of São Paulo, São Paulo, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ricardo Alexandre Azevedo</Name>
        <Affiliation>Laboratory of Tumor Immunology, University of São Paulo, São Paulo, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Kely Medeiros Turra</Name>
        <Affiliation>Laboratory of Cytopathology, Department of Clinical Chemistry and Toxicology, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Cecilia Pessoa Rodrigues</Name>
        <Affiliation>Laboratory of Tumor Immunology, University of São Paulo, São Paulo, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ana Carolina Franco Ferreira</Name>
        <Affiliation>Laboratory of Tumor Immunology, University of São Paulo, São Paulo, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Maria Alejandra Clavijo Salomón</Name>
        <Affiliation>Laboratory of Tumor Immunology, University of São Paulo, São Paulo, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Paulo Luiz de Sá Junior</Name>
        <Affiliation>Laboratory of Genetics, Butantan Institute, São Paulo, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Camyla Fernandes Farias</Name>
        <Affiliation>Experimental Oncology Section, The Federal University of São Paulo, São Paulo, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Carlos Rogerio Figueiredo</Name>
        <Affiliation>Experimental Oncology Section, The Federal University of São Paulo, São Paulo, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Leoberto Costa Tavares</Name>
        <Affiliation>Laboratory of Drug Design and Development, University of São Paulo, São Paulo, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>José Alexandre Marzagão Barbuto</Name>
        <Affiliation>Laboratory of Tumor Immunology, University of São Paulo, São Paulo, SP, Brazil; Cell and Molecular Therapy Center NUCEL-NETCEM, University of São Paulo, SP, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Salomão Dória Jorge</Name>
        <Affiliation>Laboratory of Tumor Immunology, University of São Paulo, São Paulo, SP, Brazil. Electronic address: sdjorge@usp.br.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Equol inhibits growth, induces atresia, and inhibits steroidogenesis of mouse antral follicles in vitro.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26876617</pubmedLink>
    <GrantList>
      <Grant>T35OD011145</Grant>
      <Grant>P50AT006268</Grant>
      <Grant>R03 ES023972</Grant>
      <Grant>R03ES023972</Grant>
      <Grant>T35 OD011145</Grant>
      <Grant>P50 AT006268</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.02.009</DOI>
    <KeywordList>
      <Keywords>Antral follicle</Keywords>
      <Keywords>Atresia</Keywords>
      <Keywords>Equol</Keywords>
      <Keywords>Ovary</Keywords>
      <Keywords>Steroidogenesis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sharada Mahalingam</Name>
        <Affiliation>Department of Comparative Biosciences, College of Veterinary Medicine, University of Illinois, 2001 S. Lincoln Ave, Urbana, IL 61802, United States. Electronic address: mahalin2@illinois.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Liying Gao</Name>
        <Affiliation>Department of Comparative Biosciences, College of Veterinary Medicine, University of Illinois, 2001 S. Lincoln Ave, Urbana, IL 61802, United States. Electronic address: lgao@uiuc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Marni Gonnering</Name>
        <Affiliation>Department of Comparative Biosciences, College of Veterinary Medicine, University of Illinois, 2001 S. Lincoln Ave, Urbana, IL 61802, United States. Electronic address: mgonne2@illinois.edu.</Affiliation>
      </Author>
      <Author>
        <Name>William Helferich</Name>
        <Affiliation>Department of Food Science and Human Nutrition, University of Illinois, 905 S. Goodwin, Urbana, IL 61801, United States. Electronic address: helferic@illinois.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Jodi A. Flaws</Name>
        <Affiliation>Department of Comparative Biosciences, College of Veterinary Medicine, University of Illinois, 2001 S. Lincoln Ave, Urbana, IL 61802, United States. Electronic address: jflaws@illinois.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The value of integrating pre-clinical data to predict nausea and vomiting risk in humans as illustrated by AZD3514, a novel androgen receptor modulator.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26876616</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.02.007</DOI>
    <KeywordList>
      <Keywords>Gastrointestinal adverse effects</Keywords>
      <Keywords>Nausea</Keywords>
      <Keywords>Pre-clinical animal models</Keywords>
      <Keywords>Translation</Keywords>
      <Keywords>Vomiting</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Claire Grant</Name>
        <Affiliation>Drug Safety and Metabolism, AstraZeneca, Alderley Park, Macclesfield SK10 4TG, United Kingdom. Electronic address: claire.grant@astrazeneca.com.</Affiliation>
      </Author>
      <Author>
        <Name>Lorna Ewart</Name>
        <Affiliation>Drug Safety and Metabolism, AstraZeneca, Da Vinci Building, Melbourn Science Park, Cambridge Road, Melbourn, Royston SG8 6HB, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel Muthas</Name>
        <Affiliation>Respiratory, Inflammation and Autoimmunity iMED, AstraZeneca, Pepparedsleden 1, 431 83 Mölndal, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Damian Deavall</Name>
        <Affiliation>Drug Safety and Metabolism, AstraZeneca, Alderley Park, Macclesfield SK10 4TG, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Simon A. Smith</Name>
        <Affiliation>Oncology Translational Medicine Unit, Early Clinical Development, AstraZeneca, Da Vinci Building, Melbourn Science Park, Melbourn, Royston SG8 6HB, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Glen Clack</Name>
        <Affiliation>Translational Medicine Unit, Early Clinical Development, AstraZeneca, Alderley Park, Macclesfield SK10 4TG, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Pete Newham</Name>
        <Affiliation>Drug Safety and Metabolism, AstraZeneca, Darwin Building, Cambridge Science Park, Milton Road, Cambridge CB4 0WG, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Tributyltin chloride increases phenylephrine-induced contraction and vascular stiffness in mesenteric resistance arteries from female rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26873547</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.02.005</DOI>
    <KeywordList>
      <Keywords>Arterial remodelling</Keywords>
      <Keywords>Endothelial dysfunction</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Resistance artery</Keywords>
      <Keywords>Tributyltin chloride</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rogério Faustino Ribeiro Júnior</Name>
        <Affiliation>Department of Physiological Sciences, Federal University of Espirito Santo, Vitoria, ES, Brazil. Electronic address: rogeriofaustinoribeiro@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Vinicius Bermond Marques</Name>
        <Affiliation>Department of Physiological Sciences, Federal University of Espirito Santo, Vitoria, ES, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Dieli Oliveira Nunes</Name>
        <Affiliation>Department of Physiological Sciences, Federal University of Espirito Santo, Vitoria, ES, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Karoline de Sousa Ronconi</Name>
        <Affiliation>Department of Physiological Sciences, Federal University of Espirito Santo, Vitoria, ES, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Julia F. P. de Araújo</Name>
        <Affiliation>Department of Morphology, Federal University of Espírito Santo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Paula Lopes Rodrigues</Name>
        <Affiliation>Department of Physiological Sciences, Federal University of Espirito Santo, Vitoria, ES, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Alessandra Simão Padilha</Name>
        <Affiliation>Department of Physiological Sciences, Federal University of Espirito Santo, Vitoria, ES, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Dalton Valentim Vassallo</Name>
        <Affiliation>Department of Physiological Sciences, Federal University of Espirito Santo, Vitoria, ES, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Jones B. Graceli</Name>
        <Affiliation>Department of Morphology, Federal University of Espírito Santo, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Ivanita Stefanon</Name>
        <Affiliation>Department of Physiological Sciences, Federal University of Espirito Santo, Vitoria, ES, Brazil.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Early transcriptional changes in cardiac mitochondria during chronic doxorubicin exposure and mitigation by dexrazoxane in mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26873546</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.02.003</DOI>
    <KeywordList>
      <Keywords>Biomarkers</Keywords>
      <Keywords>Cardiotoxicity</Keywords>
      <Keywords>Dexrazoxane</Keywords>
      <Keywords>Doxorubicin</Keywords>
      <Keywords>Mitochondria</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Vikrant Vijay</Name>
        <Affiliation>Personalized Medicine Branch, Division of Systems Biology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Carrie L. Moland</Name>
        <Affiliation>Personalized Medicine Branch, Division of Systems Biology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Tao Han</Name>
        <Affiliation>Personalized Medicine Branch, Division of Systems Biology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, United States.</Affiliation>
      </Author>
      <Author>
        <Name>James C. Fuscoe</Name>
        <Affiliation>Personalized Medicine Branch, Division of Systems Biology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Taewon Lee</Name>
        <Affiliation>Department of Mathematics, Korea University, Sejong, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Eugene H. Herman</Name>
        <Affiliation>Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, The National Cancer Institute, 9609 Medical Center Drive, Rockville, MD 20850-9734, United States.</Affiliation>
      </Author>
      <Author>
        <Name>G. Ronald Jenkins</Name>
        <Affiliation>Personalized Medicine Branch, Division of Systems Biology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Sherry M. Lewis</Name>
        <Affiliation>Office of Scientific Coordination, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Connie A. Cummings</Name>
        <Affiliation>UltraPath Imaging, 2228 Page Road, Durham, NC 27703, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Gao</Name>
        <Affiliation>Biomarkers and Alternative Models Branch, Division of Systems Biology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Zhijun Cao</Name>
        <Affiliation>Biomarkers and Alternative Models Branch, Division of Systems Biology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Li Rong Yu</Name>
        <Affiliation>Biomarkers and Alternative Models Branch, Division of Systems Biology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Varsha G. Desai</Name>
        <Affiliation>Personalized Medicine Branch, Division of Systems Biology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, United States. Electronic address: varsha.desai@fda.hhs.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Discovery of unique and ENM- specific pathophysiologic pathways: Comparison of the translocation of inhaled iridium nanoparticles from nasal epithelium versus alveolar epithelium towards the brain of rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26861261</pubmedLink>
    <GrantList>
      <Grant>R01 HL074022</Grant>
      <Grant>HL074022</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.02.004</DOI>
    <KeywordList>
      <Keywords>Brain accumulation</Keywords>
      <Keywords>Iridium nanoparticle</Keywords>
      <Keywords>Neuronal pathway from upper respiratory tract</Keywords>
      <Keywords>Nose-only and intratracheal inhalation</Keywords>
      <Keywords>Quantitative biokinetics</Keywords>
      <Keywords>Systemic pathway from lower respiratory tract</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wolfgang G. Kreyling</Name>
        <Affiliation>Helmholtz Zentrum München - German Research Center for Environmental Health, Institute of Epidemiology 2, Ingolstaedter Landstrasse 1, 85764 Neuherberg, Munich, Germany. Electronic address: kreyling@helmholtz-muenchen.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cytochrome P450 20A1 in zebrafish: Cloning, regulation and potential involvement in hyperactivity disorders.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26853319</pubmedLink>
    <GrantList>
      <Grant>P42 ES007381</Grant>
      <Grant>P01 ES021923</Grant>
      <Grant>P01ES021923</Grant>
      <Grant>U41 HG003345</Grant>
      <Grant>P30ES000210</Grant>
      <Grant>P42ES007381</Grant>
      <Grant>P30 ES000210</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.02.001</DOI>
    <KeywordList>
      <Keywords>Behavioral disorders</Keywords>
      <Keywords>Cytochrome P450 20A1</Keywords>
      <Keywords>Methylmercury</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Benjamin Lemaire</Name>
        <Affiliation>Biology Department, Woods Hole Oceanographic Institution, Woods Hole, Massachusetts, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Akira Kubota</Name>
        <Affiliation>Biology Department, Woods Hole Oceanographic Institution, Woods Hole, Massachusetts, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Conor M. O'Meara</Name>
        <Affiliation>Biology Department, Woods Hole Oceanographic Institution, Woods Hole, Massachusetts, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>David C. Lamb</Name>
        <Affiliation>Institute of Life Science, Medical School, Swansea University, Swansea, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Robert L. Tanguay</Name>
        <Affiliation>Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, Oregon, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>Jared V. Goldstone</Name>
        <Affiliation>Biology Department, Woods Hole Oceanographic Institution, Woods Hole, Massachusetts, United States of America.</Affiliation>
      </Author>
      <Author>
        <Name>John J. Stegeman</Name>
        <Affiliation>Biology Department, Woods Hole Oceanographic Institution, Woods Hole, Massachusetts, United States of America.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Theophylline, a methylxanthine drug induces osteopenia and alters calciotropic hormones, and prophylactic vitamin D treatment protects against these changes in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26851681</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.02.002</DOI>
    <KeywordList>
      <Keywords>25-Hydoxylase</Keywords>
      <Keywords>Biomechanical strength</Keywords>
      <Keywords>Fibroblast growth factor-23</Keywords>
      <Keywords>Fracture healing</Keywords>
      <Keywords>Micro-computed tomography</Keywords>
      <Keywords>Receptor–activator of nuclear factor kappa B ligand</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Subhashis Pal</Name>
        <Affiliation>Division of Endocrinology and Center for Research in Anabolic Skeletal Target in Health and Illness (ASTHI), Central Drug Research Institute (CDRI), Council of Scientific and Industrial Research (CSIR), Lucknow 226021, India.</Affiliation>
      </Author>
      <Author>
        <Name>Kainat Khan</Name>
        <Affiliation>Division of Endocrinology and Center for Research in Anabolic Skeletal Target in Health and Illness (ASTHI), Central Drug Research Institute (CDRI), Council of Scientific and Industrial Research (CSIR), Lucknow 226021, India.</Affiliation>
      </Author>
      <Author>
        <Name>Shyamsundar Pal China</Name>
        <Affiliation>Division of Endocrinology and Center for Research in Anabolic Skeletal Target in Health and Illness (ASTHI), Central Drug Research Institute (CDRI), Council of Scientific and Industrial Research (CSIR), Lucknow 226021, India.</Affiliation>
      </Author>
      <Author>
        <Name>Monika Mittal</Name>
        <Affiliation>Division of Endocrinology and Center for Research in Anabolic Skeletal Target in Health and Illness (ASTHI), Central Drug Research Institute (CDRI), Council of Scientific and Industrial Research (CSIR), Lucknow 226021, India.</Affiliation>
      </Author>
      <Author>
        <Name>Konica Porwal</Name>
        <Affiliation>Division of Endocrinology and Center for Research in Anabolic Skeletal Target in Health and Illness (ASTHI), Central Drug Research Institute (CDRI), Council of Scientific and Industrial Research (CSIR), Lucknow 226021, India.</Affiliation>
      </Author>
      <Author>
        <Name>Richa Shrivastava</Name>
        <Affiliation>Division of Toxicology, CDRI-CSIR, Lucknow 226021, India.</Affiliation>
      </Author>
      <Author>
        <Name>Isha Taneja</Name>
        <Affiliation>Pharmacokinetics and Metabolism Division, CDRI-CSIR, Lucknow 226021, India.</Affiliation>
      </Author>
      <Author>
        <Name>Zakir Hossain</Name>
        <Affiliation>Pharmacokinetics and Metabolism Division, CDRI-CSIR, Lucknow 226021, India.</Affiliation>
      </Author>
      <Author>
        <Name>Dhanaraju Mandalapu</Name>
        <Affiliation>Division of Medicinal and Process Chemistry, CDRI-CSIR, Lucknow 226021, India.</Affiliation>
      </Author>
      <Author>
        <Name>Jiaur R. Gayen</Name>
        <Affiliation>Pharmacokinetics and Metabolism Division, CDRI-CSIR, Lucknow 226021, India.</Affiliation>
      </Author>
      <Author>
        <Name>Muhammad Wahajuddin</Name>
        <Affiliation>Pharmacokinetics and Metabolism Division, CDRI-CSIR, Lucknow 226021, India.</Affiliation>
      </Author>
      <Author>
        <Name>Vishnu Lal Sharma</Name>
        <Affiliation>Division of Medicinal and Process Chemistry, CDRI-CSIR, Lucknow 226021, India.</Affiliation>
      </Author>
      <Author>
        <Name>Arun K. Trivedi</Name>
        <Affiliation>Division of Biochemistry, CDRI-CSIR, Lucknow 226021, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sabyasachi Sanyal</Name>
        <Affiliation>Division of Biochemistry, CDRI-CSIR, Lucknow 226021, India.</Affiliation>
      </Author>
      <Author>
        <Name>Smrati Bhadauria</Name>
        <Affiliation>Division of Toxicology, CDRI-CSIR, Lucknow 226021, India.</Affiliation>
      </Author>
      <Author>
        <Name>Madan M. Godbole</Name>
        <Affiliation>Department of Medical Endocrinology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226014, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sushil K. Gupta</Name>
        <Affiliation>Department of Medical Endocrinology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 226014, India.</Affiliation>
      </Author>
      <Author>
        <Name>Naibedya Chattopadhyay</Name>
        <Affiliation>Division of Endocrinology and Center for Research in Anabolic Skeletal Target in Health and Illness (ASTHI), Central Drug Research Institute (CDRI), Council of Scientific and Industrial Research (CSIR), Lucknow 226021, India. Electronic address: n_chattopadhyay@cdri.res.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Role of miR-155 in fluorooctane sulfonate-induced oxidative hepatic damage via the Nrf2-dependent pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26844784</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.01.023</DOI>
    <KeywordList>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>PFOS</Keywords>
      <Keywords>miR155</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Chong Wan</Name>
        <Affiliation>Laboratory of Environment and Health, College of Life Sciences, University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, China.</Affiliation>
      </Author>
      <Author>
        <Name>Rui Han</Name>
        <Affiliation>Laboratory of Environment and Health, College of Life Sciences, University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, China.</Affiliation>
      </Author>
      <Author>
        <Name>Limin Liu</Name>
        <Affiliation>Laboratory of Environment and Health, College of Life Sciences, University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fang Zhang</Name>
        <Affiliation>Laboratory of Environment and Health, College of Life Sciences, University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, China. Electronic address: zhangfang@ucas.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Fang Li</Name>
        <Affiliation>Laboratory of Environment and Health, College of Life Sciences, University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, China.</Affiliation>
      </Author>
      <Author>
        <Name>Mingdeng Xiang</Name>
        <Affiliation>State Key Laboratory of Environmental Criteria and Risk Assessment, Chinese Research Academy of Environmental Sciences, Beijing 100012, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenjun Ding</Name>
        <Affiliation>Laboratory of Environment and Health, College of Life Sciences, University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, China. Electronic address: dingwj@ucas.ac.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pathophysiologic mechanisms of biomedical nanomaterials.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26827823</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.01.022</DOI>
    <KeywordList>
      <Keywords>Biomedical effects</Keywords>
      <Keywords>Nano-bio interaction</Keywords>
      <Keywords>Nanomaterials</Keywords>
      <Keywords>Pathophysiologic effects</Keywords>
      <Keywords>Safety</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Liming Wang</Name>
        <Affiliation>CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics and National Center for Nanoscience and Technology of China, No. 11 Beiyitiao, Zhongguancun, Beijing 100190, China. Electronic address: wangliming@ihep.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Chunying Chen</Name>
        <Affiliation>CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics and National Center for Nanoscience and Technology of China, No. 11 Beiyitiao, Zhongguancun, Beijing 100190, China. Electronic address: chenchy@nanoctr.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Partial contribution of the Keap1-Nrf2 system to cadmium-mediated metallothionein expression in vascular endothelial cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26827822</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.01.020</DOI>
    <KeywordList>
      <Keywords>Antioxidant response element</Keywords>
      <Keywords>Cadmium</Keywords>
      <Keywords>Keap1</Keywords>
      <Keywords>Metallothionein</Keywords>
      <Keywords>Nrf2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yasuhiro Shinkai</Name>
        <Affiliation>Environmental Biology Laboratory, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Tomoki Kimura</Name>
        <Affiliation>Faculty of Science and Engineering, Setsunan University, 17-8 Ikedanaka-machi, Neyagawa, Osaka 572-8508, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Ayaka Itagaki</Name>
        <Affiliation>Faculty of Pharmaceutical Sciences, Hokuriku University, Ho-3 Kanagawa, Kanazawa, 920-1181, Ishikawa, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Chika Yamamoto</Name>
        <Affiliation>Faculty of Pharmaceutical Sciences, Hokuriku University, Ho-3 Kanagawa, Kanazawa, 920-1181, Ishikawa, Japan; Faculty of Pharmaceutical Sciences, Toho University, 2-2-1 Miyama, Funabashi, Chiba 274-8510, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Keiko Taguchi</Name>
        <Affiliation>Department of Medical Biochemistry, Tohoku University Graduate School of Medicine, 2-1 Seiryo-cho, Aoba-ku, Sendai 980-8575, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Masayuki Yamamoto</Name>
        <Affiliation>Department of Medical Biochemistry, Tohoku University Graduate School of Medicine, 2-1 Seiryo-cho, Aoba-ku, Sendai 980-8575, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yoshito Kumagai</Name>
        <Affiliation>Environmental Biology Laboratory, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan. Electronic address: yk-em-tu@md.tsukuba.ac.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Toshiyuki Kaji</Name>
        <Affiliation>Faculty of Pharmaceutical Sciences, Hokuriku University, Ho-3 Kanagawa, Kanazawa, 920-1181, Ishikawa, Japan; Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan. Electronic address: t-kaji@rs.tus.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Nephron segment specific microRNA biomarkers of pre-clinical drug-induced renal toxicity: Opportunities and challenges.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26827821</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30021-7</DOI>
    <KeywordList>
      <Keywords>Acute kidney injury</Keywords>
      <Keywords>Biomarkers</Keywords>
      <Keywords>Drug induced nephrotoxicity</Keywords>
      <Keywords>MicroRNAs</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rounak Nassirpour</Name>
        <Affiliation>Drug Safety, Pfizer Worldwide Research and Development, 1 Burtt Rd, Andover, MA 01810, United States. Electronic address: Rounak.nassirpour@pfizer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Shashi K. Ramaiah</Name>
        <Affiliation>Drug Safety, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, MA 02139, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Laurence O. Whiteley</Name>
        <Affiliation>Drug Safety, Pfizer Worldwide Research and Development, 1 Burtt Rd, Andover, MA 01810, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A redox proteomics approach to investigate the mode of action of nanomaterials.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26827820</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.01.019</DOI>
    <KeywordList>
      <Keywords>Acellular tests</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Protein carbonylation</Keywords>
      <Keywords>Proteomics</Keywords>
      <Keywords>Toxicity mechanisms</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Christian Riebeling</Name>
        <Affiliation>German Federal Institute for Risk Assessment (BfR), Department of Chemicals and Product Safety, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Martin Wiemann</Name>
        <Affiliation>IBE R&amp;D gGmbH, Institute for Lung Health, Münster, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Jürgen Schnekenburger</Name>
        <Affiliation>Biomedical Technology Center, Westfälische Wilhelms-University, Münster, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas A. J. Kuhlbusch</Name>
        <Affiliation>Institute of Energy and Environmental Technology (IUTA) e.V., Air Quality &amp; Sustainable Nanotechnology, Duisburg, Germany; Center for Nanointegration CENIDE, University of Duisburg-Essen, Duisburg, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Wendel Wohlleben</Name>
        <Affiliation>BASF SE, Material Physics, Ludwigshafen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Andreas Luch</Name>
        <Affiliation>German Federal Institute for Risk Assessment (BfR), Department of Chemicals and Product Safety, Berlin, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Haase</Name>
        <Affiliation>German Federal Institute for Risk Assessment (BfR), Department of Chemicals and Product Safety, Berlin, Germany. Electronic address: andrea.haase@bfr.bund.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Urinary microRNAs as potential biomarkers of pesticide exposure.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26826490</pubmedLink>
    <GrantList>
      <Grant>HHSN275200800015C</Grant>
      <Grant>P01 ES009601</Grant>
      <Grant>P30 ES007033</Grant>
      <Grant>U54 HD083091</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30018-7</DOI>
    <KeywordList>
      <Keywords>Exposure biomarkers</Keywords>
      <Keywords>MicroRNA</Keywords>
      <Keywords>Organophosphate</Keywords>
      <Keywords>Pesticides</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Brittany A. Weldon</Name>
        <Affiliation>Institute for Risk Analysis and Risk Communication, University of Washington, Seattle, WA, United States; Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Sara Pacheco Shubin</Name>
        <Affiliation>Institute for Risk Analysis and Risk Communication, University of Washington, Seattle, WA, United States; Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Marissa N. Smith</Name>
        <Affiliation>Institute for Risk Analysis and Risk Communication, University of Washington, Seattle, WA, United States; Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Tomomi Workman</Name>
        <Affiliation>Institute for Risk Analysis and Risk Communication, University of Washington, Seattle, WA, United States; Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Alexander Artemenko</Name>
        <Affiliation>Institute for Risk Analysis and Risk Communication, University of Washington, Seattle, WA, United States; Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>William C. Griffith</Name>
        <Affiliation>Institute for Risk Analysis and Risk Communication, University of Washington, Seattle, WA, United States; Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Beti Thompson</Name>
        <Affiliation>Fred Hutchinson Cancer Research Center, Seattle, WA, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Elaine M. Faustman</Name>
        <Affiliation>Institute for Risk Analysis and Risk Communication, University of Washington, Seattle, WA, United States; Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA, United States. Electronic address: faustman@uw.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Development of complex-shaped liver multicellular spheroids as a human-based model for nanoparticle toxicity assessment in vitro.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26825373</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30016-3</DOI>
    <KeywordList>
      <Keywords>3D cell culture</Keywords>
      <Keywords>hepatocytes</Keywords>
      <Keywords>hydrogels</Keywords>
      <Keywords>nanoparticles</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Monika Dubiak-Szepietowska</Name>
        <Affiliation>Department of Medical Engineering and Biotechnology, Ernst-Abbe-University of Applied Sciences Jena, Carl-Zeiss Promenade 2, 07745 Jena, Germany. Electronic address: Monika.Dubiak-Szepietowska@fh-jena.de.</Affiliation>
      </Author>
      <Author>
        <Name>Aleksandra Karczmarczyk</Name>
        <Affiliation>Department of Medical Engineering and Biotechnology, Ernst-Abbe-University of Applied Sciences Jena, Carl-Zeiss Promenade 2, 07745 Jena, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Martin Jönsson-Niedziółka</Name>
        <Affiliation>Institute of Physical Chemistry, Polish Academy of Sciences, ul. Kasprzaka 44/52, 01-224 Warszawa, Poland.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Winckler</Name>
        <Affiliation>Institute of Pharmacy, Friedrich Schiller University Jena, Semmelweissstraße 10, 07743 Jena, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Karl Heinz Feller</Name>
        <Affiliation>Department of Medical Engineering and Biotechnology, Ernst-Abbe-University of Applied Sciences Jena, Carl-Zeiss Promenade 2, 07745 Jena, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>DNA damage-inducible transcript 4 (DDIT4) mediates methamphetamine-induced autophagy and apoptosis through mTOR signaling pathway in cardiomyocytes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26825372</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.01.017</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Autophagy</Keywords>
      <Keywords>Cardiotoxicity</Keywords>
      <Keywords>DDIT4 (DNA damage-inducible transcript 4)</Keywords>
      <Keywords>Methamphetamine</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rui Chen</Name>
        <Affiliation>Department of Forensic Medicine, School of Basic Medical Science, Southern Medical University, Guangzhou 510515, People's Republic of China; Department of Forensic Medicine, Guangdong Medical University, Dongguan 523808, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Bin Wang</Name>
        <Affiliation>Department of Forensic Medicine, School of Basic Medical Science, Southern Medical University, Guangzhou 510515, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Ling Chen</Name>
        <Affiliation>Department of Forensic Medicine, School of Basic Medical Science, Southern Medical University, Guangzhou 510515, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Dunpeng Cai</Name>
        <Affiliation>Department of Forensic Medicine, School of Basic Medical Science, Southern Medical University, Guangzhou 510515, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Bing Li</Name>
        <Affiliation>Department of Forensic Medicine, School of Basic Medical Science, Southern Medical University, Guangzhou 510515, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Chuanxiang Chen</Name>
        <Affiliation>Department of Forensic Medicine, School of Basic Medical Science, Southern Medical University, Guangzhou 510515, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Enping Huang</Name>
        <Affiliation>Department of Forensic Medicine, School of Basic Medical Science, Southern Medical University, Guangzhou 510515, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Chao Liu</Name>
        <Affiliation>Guangzhou Forensic Science Institute, Guangzhou 510030, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhoumeng Lin</Name>
        <Affiliation>Institute of Computational Comparative Medicine and Department of Anatomy and Physiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Bing Xie</Name>
        <Affiliation>Department of Forensic Medicine, School of Basic Medical Science, Southern Medical University, Guangzhou 510515, People's Republic of China. Electronic address: xieweib@126.com.</Affiliation>
      </Author>
      <Author>
        <Name>Huijun Wang</Name>
        <Affiliation>Department of Forensic Medicine, School of Basic Medical Science, Southern Medical University, Guangzhou 510515, People's Republic of China. Electronic address: hjwang711@yahoo.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of nefazodone-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26821276</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.01.015</DOI>
    <KeywordList>
      <Keywords>Action potentials</Keywords>
      <Keywords>Cardiotoxicity</Keywords>
      <Keywords>Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)</Keywords>
      <Keywords>Ion channels</Keywords>
      <Keywords>Nefazodone</Keywords>
      <Keywords>Patch clamp</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sujeong Lee</Name>
        <Affiliation>Next-generation Pharmaceutical Research Center, Korea Institute of Toxicology, Korea Research Institute of Chemical Technology, 141 Gajeong-ro, Yuseong-gu, Daejeon 305-343, South Korea. Electronic address: crystalee@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Hyang Ae Lee</Name>
        <Affiliation>Next-generation Pharmaceutical Research Center, Korea Institute of Toxicology, Korea Research Institute of Chemical Technology, 141 Gajeong-ro, Yuseong-gu, Daejeon 305-343, South Korea; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 110-799, South Korea; Human and Environmental Toxicology Program, University of Science and Technology, 217 Gajeong-ro, Yuseong-gu, Daejeon 305-350, South Korea. Electronic address: hyangaelee@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sung Woo Choi</Name>
        <Affiliation>Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 110-799, South Korea. Electronic address: djmaya@snu.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Sung Joon Kim</Name>
        <Affiliation>Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, 110-799, South Korea. Electronic address: sjoonkim@snu.ac.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Ki Suk Kim</Name>
        <Affiliation>Next-generation Pharmaceutical Research Center, Korea Institute of Toxicology, Korea Research Institute of Chemical Technology, 141 Gajeong-ro, Yuseong-gu, Daejeon 305-343, South Korea; Human and Environmental Toxicology Program, University of Science and Technology, 217 Gajeong-ro, Yuseong-gu, Daejeon 305-350, South Korea. Electronic address: idkks00@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Pharmacological evaluation of the mechanisms involved in increased adiposity in zebrafish triggered by the environmental contaminant tributyltin.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26812627</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30009-6</DOI>
    <KeywordList>
      <Keywords>Adipocyte</Keywords>
      <Keywords>Nuclear receptors</Keywords>
      <Keywords>Obesity</Keywords>
      <Keywords>Obesogen</Keywords>
      <Keywords>Tributyltin chloride</Keywords>
      <Keywords>Zebrafish</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Nafia Ouadah-Boussouf</Name>
        <Affiliation>Maladies Rares: Génétique et Métabolisme (MRGM), Univ. Bordeaux, INSERM, U1211, F-33615 Pessac, France.</Affiliation>
      </Author>
      <Author>
        <Name>Patrick J. Babin</Name>
        <Affiliation>Maladies Rares: Génétique et Métabolisme (MRGM), Univ. Bordeaux, INSERM, U1211, F-33615 Pessac, France. Electronic address: p.babin@gpp.u-bordeaux1.fr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Role of NLRC5 in progression and reversal of hepatic fibrosis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26806094</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30014-X</DOI>
    <KeywordList>
      <Keywords>HSCs reversion</Keywords>
      <Keywords>Hepatic fibrosis</Keywords>
      <Keywords>NLRC5</Keywords>
      <Keywords>Reversal of hepatic fibrosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xuejiao Liu</Name>
        <Affiliation>School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; Institute for Liver Diseases, Anhui Medical University, Hefei 230032, China. Electronic address: liuxuejiao0615@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yuting Wu</Name>
        <Affiliation>School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; Institute for Liver Diseases, Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Yang</Name>
        <Affiliation>School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; Institute for Liver Diseases, Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wanxia Li</Name>
        <Affiliation>School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; Institute for Liver Diseases, Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cheng Huang</Name>
        <Affiliation>School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; Institute for Liver Diseases, Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoming Meng</Name>
        <Affiliation>School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; Institute for Liver Diseases, Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Li</Name>
        <Affiliation>School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; Institute for Liver Diseases, Anhui Medical University, Hefei 230032, China; School of Pharmacy, Anhui Medical University, Mei Shan load, Hefei 230032, Anhui Province, China. Electronic address: lj@ahmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Molybdenum induces pancreatic β-cell dysfunction and apoptosis via interdependent of JNK and AMPK activation-regulated mitochondria-dependent and ER stress-triggered pathways.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26806093</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30013-8</DOI>
    <KeywordList>
      <Keywords>AMPK</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>ER stress</Keywords>
      <Keywords>JNK</Keywords>
      <Keywords>Molybdenum</Keywords>
      <Keywords>Pancreatic β-cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tsung Yuan Yang</Name>
        <Affiliation>Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan; Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung 402, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Cheng Chieh Yen</Name>
        <Affiliation>Department of Occupational Safety and Health, College of Health Care and Management, Chung Shan Medical University, Taichung 402, Taiwan; Department of Occupational Medicine, Chung Shan Medical University Hospital, Taichung 402, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Kuan I. Lee</Name>
        <Affiliation>Department of Emergency, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung 427, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chin Chuan Su</Name>
        <Affiliation>Department of Otorhinolaryngology, Head and Neck Surgery, Changhua Christian Hospital, Changhua County 500, Taiwan; Graduate Institute of Basic Medical Science, School of Medicine, College of Medicine, China Medical University, Taichung 404, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ching Yao Yang</Name>
        <Affiliation>Department of Surgery, National Taiwan University Hospital, Taipei 100, Taiwan; Department of Surgery, College of Medicine, National Taiwan University, Taipei 100, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chin Ching Wu</Name>
        <Affiliation>Department of Public Health, China Medical University, Taichung 404, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Shang Shu Hsieh</Name>
        <Affiliation>Department of Emergency, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung 427, Taiwan. Electronic address: gile1123@yahoo.com.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Kwo Chang Ueng</Name>
        <Affiliation>Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung 402, Taiwan; School of Medicine, Chung Shan Medical University, Taichung 402, Taiwan. Electronic address: kcueng@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Chun Fa Huang</Name>
        <Affiliation>School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung 404, Taiwan. Electronic address: cfhuang@mail.cmu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>PBPK modeling of the cis- and trans-permethrin isomers and their major urinary metabolites in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26802525</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30012-6</DOI>
    <KeywordList>
      <Keywords>3-Phenoxybenzoic acid</Keywords>
      <Keywords>Bayesian calibration</Keywords>
      <Keywords>Metabolites</Keywords>
      <Keywords>PBPK model</Keywords>
      <Keywords>cis- and trans-3-(2,2 dichlorovinyl)-2,2-dimethyl-(1-cyclopropane) carboxylic acid</Keywords>
      <Keywords>cis/trans-Permethrin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marie Emilie Willemin</Name>
        <Affiliation>Institut National de l'Environnement Industriel et des Risques (INERIS), Unité Modèles pour l'Ecotoxicologie et la Toxicologie (METO), Parc ALATA BP2, 60550, Verneuil en Halatte, France; Sorbonne University, Université de Technologie de Compiègne, CNRS, UMR 7338 Biomechanics and Bioengineering, Centre de recherche Royallieu CS 60319,60203 Compiègnee Cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Sophie Desmots</Name>
        <Affiliation>Institut National de l'Environnement Industriel et des Risques (INERIS), Unité Toxicologie Expérimentale (TOXI), Parc ALATA BP2, 60550, Verneuil en Halatte, France.</Affiliation>
      </Author>
      <Author>
        <Name>Rozenn Le Grand</Name>
        <Affiliation>Centre Hospitalo-Universitaire de Limoges, Service de Pharmacologie et de Toxicologie - Pharmacovigilance, 2, avenue Martin Luther King, 87042 Limoges, France.</Affiliation>
      </Author>
      <Author>
        <Name>François Lestremau</Name>
        <Affiliation>Institut National de l'Environnement Industriel et des Risques (INERIS), Unité Innovation pour la Mesure (NOVA), Parc ALATA BP2, 60550, Verneuil en Halatte, France.</Affiliation>
      </Author>
      <Author>
        <Name>Florence A. Zeman</Name>
        <Affiliation>Institut National de l'Environnement Industriel et des Risques (INERIS), Unité Modèles pour l'Ecotoxicologie et la Toxicologie (METO), Parc ALATA BP2, 60550, Verneuil en Halatte, France.</Affiliation>
      </Author>
      <Author>
        <Name>Eric Leclerc</Name>
        <Affiliation>Sorbonne University, Université de Technologie de Compiègne, CNRS, UMR 7338 Biomechanics and Bioengineering, Centre de recherche Royallieu CS 60319,60203 Compiègnee Cedex, France.</Affiliation>
      </Author>
      <Author>
        <Name>Christian Moesch</Name>
        <Affiliation>Centre Hospitalo-Universitaire de Limoges, Service de Pharmacologie et de Toxicologie - Pharmacovigilance, 2, avenue Martin Luther King, 87042 Limoges, France.</Affiliation>
      </Author>
      <Author>
        <Name>Céline Brochot</Name>
        <Affiliation>Institut National de l'Environnement Industriel et des Risques (INERIS), Unité Modèles pour l'Ecotoxicologie et la Toxicologie (METO), Parc ALATA BP2, 60550, Verneuil en Halatte, France. Electronic address: celine.brochot@ineris.fr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Genistein exposure inhibits growth and alters steroidogenesis in adult mouse antral follicles.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26792615</pubmedLink>
    <GrantList>
      <Grant>P50 AT006268</Grant>
      <Grant>R03 ES023972</Grant>
      <Grant>P50AT006268</Grant>
      <Grant>R03ES023972</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.12.026</DOI>
    <KeywordList>
      <Keywords>Follicle</Keywords>
      <Keywords>Genistein</Keywords>
      <Keywords>Ovary</Keywords>
      <Keywords>Steroidogenesis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shreya Patel</Name>
        <Affiliation>Department of Comparative Biosciences, University of Illinois, 2001 S. Lincoln Ave, Urbana, IL 61802, United States. Electronic address: Shreya.patel214@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Jackye Peretz</Name>
        <Affiliation>Department of Comparative Biosciences, University of Illinois, 2001 S. Lincoln Ave, Urbana, IL 61802, United States. Electronic address: Jackye.peretz@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Xiang Pan</Name>
        <Affiliation>Department of Food Science and Human Nutrition, University of Illinois, 905 S. Goodwin, Urbana, IL 61801, United States. Electronic address: yxpan@illinois.edu.</Affiliation>
      </Author>
      <Author>
        <Name>William G. Helferich</Name>
        <Affiliation>Department of Food Science and Human Nutrition, University of Illinois, 905 S. Goodwin, Urbana, IL 61801, United States. Electronic address: helferic@illinois.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Jodi A. Flaws</Name>
        <Affiliation>Department of Comparative Biosciences, University of Illinois, 2001 S. Lincoln Ave, Urbana, IL 61802, United States. Electronic address: jflaws@illinois.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Protective effect of Ac-SDKP on alveolar epithelial cells through inhibition of EMT via TGF-β1/ROCK1 pathway in silicosis in rat.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26785300</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30011-4</DOI>
    <KeywordList>
      <Keywords>Epithelial–mesenchymal transition</Keywords>
      <Keywords>N-acetyl-seryl-aspartyl-lysyl-proline</Keywords>
      <Keywords>Silicosis</Keywords>
      <Keywords>TGF-β1/ROCK1 pathway</Keywords>
      <Keywords>Type II alveolar epithelial cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Haijing Deng</Name>
        <Affiliation>School of Basic Medical Sciences, North China University of Science and Technology, Tangshan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Xu</Name>
        <Affiliation>Medical Research Center, International Science and Technology Cooperation Base of Geriatric Medicine, North China University of Science and Technology, Tangshan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xianghong Zhang</Name>
        <Affiliation>Pathology Department, Hebei Medical University, Shi Jiazhuang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yue Sun</Name>
        <Affiliation>Medical Research Center, International Science and Technology Cooperation Base of Geriatric Medicine, North China University of Science and Technology, Tangshan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ruimin Wang</Name>
        <Affiliation>Medical Research Center, International Science and Technology Cooperation Base of Geriatric Medicine, North China University of Science and Technology, Tangshan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Darrell Brann</Name>
        <Affiliation>Department of Neuroscience and Regenerative Medicine, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Fang Yang</Name>
        <Affiliation>Medical Research Center, International Science and Technology Cooperation Base of Geriatric Medicine, North China University of Science and Technology, Tangshan, China. Electronic address: fangyang1978@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inflammatory mediators in a short-time mouse model of doxorubicin-induced cardiotoxicity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26780402</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.01.006</DOI>
    <KeywordList>
      <Keywords>Cardiotoxicity</Keywords>
      <Keywords>Cytokines</Keywords>
      <Keywords>Doxorubicin</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Nitric oxide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michela Pecoraro</Name>
        <Affiliation>Department of Pharmacy, University of Salerno, Fisciano, SA, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Mariagiovanna Del Pizzo</Name>
        <Affiliation>Department of Pharmacy, University of Salerno, Fisciano, SA, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Stefania Marzocco</Name>
        <Affiliation>Department of Pharmacy, University of Salerno, Fisciano, SA, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Rosalinda Sorrentino</Name>
        <Affiliation>Department of Pharmacy, University of Salerno, Fisciano, SA, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Michele Ciccarelli</Name>
        <Affiliation>Department of Medicine and Surgery, University of Salerno, Baronissi, SA, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Guido Iaccarino</Name>
        <Affiliation>Department of Medicine and Surgery, University of Salerno, Baronissi, SA, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Aldo Pinto</Name>
        <Affiliation>Department of Pharmacy, University of Salerno, Fisciano, SA, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Ada Popolo</Name>
        <Affiliation>Department of Pharmacy, University of Salerno, Fisciano, SA, Italy. Electronic address: apopolo@unisa.it.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Relationship of antioxidant and oxidative stress markers in different organs following copper toxicity in a rat model.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26780401</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.01.007</DOI>
    <KeywordList>
      <Keywords>Copper toxicity</Keywords>
      <Keywords>Glutathione</Keywords>
      <Keywords>Lipid peroxidation</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Rat</Keywords>
      <Keywords>Total antioxidant capacity</Keywords>
      <Keywords>Wilson disease</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Vijay Kumar</Name>
        <Affiliation>Department of Neurology, Sanjay Gandhi Post Graduate Medical Sciences, Lucknow, India.</Affiliation>
      </Author>
      <Author>
        <Name>Jayantee Kalita</Name>
        <Affiliation>Department of Neurology, Sanjay Gandhi Post Graduate Medical Sciences, Lucknow, India. Electronic address: jayanteek@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Himangsu K. Bora</Name>
        <Affiliation>National Laboratory Animal Centre, CSIR-Central Drug Research Institute, Lucknow, India.</Affiliation>
      </Author>
      <Author>
        <Name>Usha K. Misra</Name>
        <Affiliation>Department of Neurology, Sanjay Gandhi Post Graduate Medical Sciences, Lucknow, India.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>SATB2 expression increased anchorage-independent growth and cell migration in human bronchial epithelial cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26780400</pubmedLink>
    <GrantList>
      <Grant>P30ES000260</Grant>
      <Grant>R01 ES022935</Grant>
      <Grant>R01 ES022935,</Grant>
      <Grant>P30 ES000260</Grant>
      <Grant>ES023174</Grant>
      <Grant>R01 ES023174</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.01.008</DOI>
    <KeywordList>
      <Keywords>Cell migration</Keywords>
      <Keywords>Metal carcinogenesis</Keywords>
      <Keywords>SATB2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Feng Wu</Name>
        <Affiliation>Department of Environmental Medicine, New York University School of Medicine, 57 Old Forge Road, Tuxedo, NY 10987, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ashley Jordan</Name>
        <Affiliation>Department of Environmental Medicine, New York University School of Medicine, 57 Old Forge Road, Tuxedo, NY 10987, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Kluz</Name>
        <Affiliation>Department of Environmental Medicine, New York University School of Medicine, 57 Old Forge Road, Tuxedo, NY 10987, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Steven Shen</Name>
        <Affiliation>Center for Health Informatics and Bioinformatics, New York University Langone Medical Center, New York, NY 10016, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Sun</Name>
        <Affiliation>Department of Environmental Medicine, New York University School of Medicine, 57 Old Forge Road, Tuxedo, NY 10987, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Laura A. Cartularo</Name>
        <Affiliation>Department of Environmental Medicine, New York University School of Medicine, 57 Old Forge Road, Tuxedo, NY 10987, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Max Costa</Name>
        <Affiliation>Department of Environmental Medicine, New York University School of Medicine, 57 Old Forge Road, Tuxedo, NY 10987, USA. Electronic address: Max.Costa@nyumc.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Short-term toxicity assessments of an antibiotic metabolite in Wistar rats and its metabonomics analysis by ultra-high performance liquid chromatography coupled to quadrupole time-of-flight mass spectrometry.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26780399</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.01.004</DOI>
    <KeywordList>
      <Keywords>4-Epi-oxytetracycline</Keywords>
      <Keywords>Antibiotic metabolites</Keywords>
      <Keywords>Metabonomics</Keywords>
      <Keywords>Safety study</Keywords>
      <Keywords>Wistar rats</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hongxing Han</Name>
        <Affiliation>College of Life Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hailong Xiao</Name>
        <Affiliation>Hangzhou Institute for Food and Drug Control, Hangzhou 310004, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenmei Lu</Name>
        <Affiliation>College of Life Sciences, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, China. Electronic address: lzhenmei@zju.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mice housed on coal dust-contaminated sand: A model to evaluate the impacts of coal mining on health.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26774687</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30010-2</DOI>
    <KeywordList>
      <Keywords>Colombia</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>Mining</Keywords>
      <Keywords>Total suspended particles</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Karina Caballero-Gallardo</Name>
        <Affiliation>Environmental and Computational Chemistry Group, School of Pharmaceutical Sciences, Zaragocilla Campus, University of Cartagena, Cartagena, 130014, Colombia. Electronic address: kcaballerog@unicartagena.edu.co.</Affiliation>
      </Author>
      <Author>
        <Name>Jesus Olivero-Verbel</Name>
        <Affiliation>Environmental and Computational Chemistry Group, School of Pharmaceutical Sciences, Zaragocilla Campus, University of Cartagena, Cartagena, 130014, Colombia. Electronic address: joliverov@unicartagena.edu.co.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Understanding the immunogenicity and antigenicity of nanomaterials: Past, present and future.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26773813</pubmedLink>
    <GrantList>
      <Grant>HHSN261200800001C</Grant>
      <Grant>HHSN261200800001E</Grant>
      <Grant>HHSN261200800001E</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.01.005</DOI>
    <KeywordList>
      <Keywords>Anaphylaxis</Keywords>
      <Keywords>Antibody</Keywords>
      <Keywords>Antigenicity</Keywords>
      <Keywords>Cytokines</Keywords>
      <Keywords>Immunogenicity</Keywords>
      <Keywords>Nanoparticles</Keywords>
      <Keywords>Phagocytosis</Keywords>
      <Keywords>Preclinical</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anna N. Ilinskaya</Name>
        <Affiliation>Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, NCI at Frederick, Frederick, MD 21702, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Marina A. Dobrovolskaia</Name>
        <Affiliation>Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, NCI at Frederick, Frederick, MD 21702, USA. Electronic address: marina@mail.nih.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inhibition of human anthracycline reductases by emodin - A possible remedy for anthracycline resistance.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26773812</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.01.003</DOI>
    <KeywordList>
      <Keywords>Aldo-keto reductases</Keywords>
      <Keywords>Anthracycline resistance</Keywords>
      <Keywords>Cardiotoxicity</Keywords>
      <Keywords>Daunorubicin</Keywords>
      <Keywords>Enzyme inhibition</Keywords>
      <Keywords>Short-chain dehydrogenases/reductases</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jan Hintzpeter</Name>
        <Affiliation>Institute of Toxicology and Pharmacology for Natural Scientists, University Medical School Schleswig-Holstein, Campus Kiel, Brunswiker Str. 10, 24105 Kiel, Germany. Electronic address: hintzpeter@toxi.uni-kiel.de.</Affiliation>
      </Author>
      <Author>
        <Name>Jan Moritz Seliger</Name>
        <Affiliation>Institute of Toxicology and Pharmacology for Natural Scientists, University Medical School Schleswig-Holstein, Campus Kiel, Brunswiker Str. 10, 24105 Kiel, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Jakub Hofman</Name>
        <Affiliation>Department of Biochemical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, 50005 Hradec Kralove, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Hans Joerg Martin</Name>
        <Affiliation>Institute of Toxicology and Pharmacology for Natural Scientists, University Medical School Schleswig-Holstein, Campus Kiel, Brunswiker Str. 10, 24105 Kiel, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Vladimir Wsol</Name>
        <Affiliation>Department of Biochemical Sciences, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, 50005 Hradec Kralove, Czech Republic.</Affiliation>
      </Author>
      <Author>
        <Name>Edmund Maser</Name>
        <Affiliation>Institute of Toxicology and Pharmacology for Natural Scientists, University Medical School Schleswig-Holstein, Campus Kiel, Brunswiker Str. 10, 24105 Kiel, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of defined mixtures of persistent organic pollutants (POPs) on multiple cellular responses in the human hepatocarcinoma cell line, HepG2, using high content analysis screening.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26772051</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(16)30001-1</DOI>
    <KeywordList>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>High content analysis</Keywords>
      <Keywords>Mixtures</Keywords>
      <Keywords>Persistent organic pollutants</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jodie Wilson</Name>
        <Affiliation>Institute for Global Food Security, School of Biological Sciences, Queen's University Belfast, Northern Ireland, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Hanne Friis Berntsen</Name>
        <Affiliation>Norwegian University of Life Sciences, Oslo, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Karin Elisabeth Zimmer</Name>
        <Affiliation>Norwegian University of Life Sciences, Oslo, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Caroline Frizzell</Name>
        <Affiliation>Institute for Global Food Security, School of Biological Sciences, Queen's University Belfast, Northern Ireland, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Steven Verhaegen</Name>
        <Affiliation>Norwegian University of Life Sciences, Oslo, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Erik Ropstad</Name>
        <Affiliation>Norwegian University of Life Sciences, Oslo, Norway.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa Connolly</Name>
        <Affiliation>Institute for Global Food Security, School of Biological Sciences, Queen's University Belfast, Northern Ireland, United Kingdom. Electronic address: l.connolly@qub.ac.uk.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Enzymatic oxidative biodegradation of nanoparticles: Mechanisms, significance and applications.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26768553</pubmedLink>
    <GrantList>
      <Grant>R01 CA165065</Grant>
      <Grant>NS061817</Grant>
      <Grant>R01 ES020693</Grant>
      <Grant>R01 OH008282</Grant>
      <Grant>U19 AI068021</Grant>
      <Grant>P01 HL070807</Grant>
      <Grant>HL086884</Grant>
      <Grant>P30 CA047904</Grant>
      <Grant>U19AIO68021</Grant>
      <Grant>P30CA047904</Grant>
      <Grant>R01 NS076511</Grant>
      <Grant>ES020693</Grant>
      <Grant>R01ES019304</Grant>
      <Grant>NS076511</Grant>
      <Grant>OH008282</Grant>
      <Grant>R01 NS061817</Grant>
      <Grant>CA165065</Grant>
      <Grant>P01 HL114453</Grant>
      <Grant>R01 ES019304</Grant>
      <Grant>R01 HL086884</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2016.01.002</DOI>
    <KeywordList>
      <Keywords>Carbon nanotubes</Keywords>
      <Keywords>Free radicals</Keywords>
      <Keywords>Graphene oxide</Keywords>
      <Keywords>Oxidants</Keywords>
      <Keywords>Peroxidase activity</Keywords>
      <Keywords>Phagocytes</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Irina I. Vlasova</Name>
        <Affiliation>Department of Environmental and Occupational Health, Center for Free Radical and Antioxidant Health, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15219, United States; Research Institute for Physico-Chemical Medicine, Federal Medico-Biological Agency, Moscow 119453, Russia.</Affiliation>
      </Author>
      <Author>
        <Name>Alexandr A. Kapralov</Name>
        <Affiliation>Department of Environmental and Occupational Health, Center for Free Radical and Antioxidant Health, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15219, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Zachary P. Michael</Name>
        <Affiliation>Department of Chemistry, University of Pittsburgh, Pittsburgh, PA 15260, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Seth C. Burkert</Name>
        <Affiliation>Department of Chemistry, University of Pittsburgh, Pittsburgh, PA 15260, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Michael R. Shurin</Name>
        <Affiliation>Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA 15261, United States; Department of Immunology, University of Pittsburgh Medical Center, Pittsburgh, PA 15261, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Alexander Star</Name>
        <Affiliation>Department of Chemistry, University of Pittsburgh, Pittsburgh, PA 15260, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Anna A. Shvedova</Name>
        <Affiliation>Pathology and Physiology Research Branch, Health Effects Laboratory Division (HELD), National Institute for Occupational Safety and Health (NIOSH) and Department of Physiology and Pharmacology, West Virginia University, Morgantown, WV 26505, United States. Electronic address: ats@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Valerian E. Kagan</Name>
        <Affiliation>Department of Environmental and Occupational Health, Center for Free Radical and Antioxidant Health, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15219, United States; Department of Chemistry, University of Pittsburgh, Pittsburgh, PA 15260, United States; Departments of Pharmacology and Chemical Biology and Radiation Oncology, University of Pittsburgh, Pittsburgh, PA 15260, United States. Electronic address: kagan@pitt.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The enhancing effect of genistein on apoptosis induced by trichostatin A in lung cancer cells with wild type p53 genes is associated with upregulation of histone acetyltransferase.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26768552</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.12.028</DOI>
    <KeywordList>
      <Keywords>Genistein</Keywords>
      <Keywords>Histone acetyltransferase</Keywords>
      <Keywords>Human lung cancer cells</Keywords>
      <Keywords>Trichostatin A</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tzu Chin Wu</Name>
        <Affiliation>Chest Clinic, Chung Shan Medical University Hospital, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Chin Lin</Name>
        <Affiliation>Department of Nutritional Science, Chung Shan Medical University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Hsiao Ling Chen</Name>
        <Affiliation>Department of Health and Nutrition Biotechnology, Asia University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Pei Ru Huang</Name>
        <Affiliation>Department of Nutritional Science, Chung Shan Medical University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Shang Yu Liu</Name>
        <Affiliation>Department of Nutritional Science, Chung Shan Medical University, Taichung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Shu Lan Yeh</Name>
        <Affiliation>Department of Nutritional Science, Chung Shan Medical University, Taichung, Taiwan; Department of Nutrition, Chung Shan Medical University Hospital, Taichung, Taiwan. Electronic address: suzyyeh@csmu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Gossypol induces pyroptosis in mouse macrophages via a non-canonical inflammasome pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26765310</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.12.027</DOI>
    <KeywordList>
      <Keywords>Gossypol</Keywords>
      <Keywords>HMGB1</Keywords>
      <Keywords>Inflammasome</Keywords>
      <Keywords>Interleukin-1β</Keywords>
      <Keywords>Pyroptosis</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qiu Ru Lin</Name>
        <Affiliation>Department of Immunobiology, College of Life Science and Technology, Jinan University, Guangzhou 510632, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chen Guang Li</Name>
        <Affiliation>Department of Immunobiology, College of Life Science and Technology, Jinan University, Guangzhou 510632, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qing Bing Zha</Name>
        <Affiliation>Department of Fetal Medicine, The First Affiliated Hospital of Jinan University, Guangzhou 510632, China.</Affiliation>
      </Author>
      <Author>
        <Name>Li Hui Xu</Name>
        <Affiliation>Department of Cell Biology, College of Life Science and Technology, Jinan University, Guangzhou 510632, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hao Pan</Name>
        <Affiliation>Department of Immunobiology, College of Life Science and Technology, Jinan University, Guangzhou 510632, China.</Affiliation>
      </Author>
      <Author>
        <Name>Gao Xiang Zhao</Name>
        <Affiliation>Department of Immunobiology, College of Life Science and Technology, Jinan University, Guangzhou 510632, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dong Yun Ouyang</Name>
        <Affiliation>Department of Immunobiology, College of Life Science and Technology, Jinan University, Guangzhou 510632, China. Electronic address: dongyun1967@aliyun.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xian Hui He</Name>
        <Affiliation>Department of Immunobiology, College of Life Science and Technology, Jinan University, Guangzhou 510632, China. Electronic address: thexh@jnu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The role of heme oxygenase-1 in drug metabolizing dysfunction in the alcoholic fatty liver exposed to ischemic injury.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26747958</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.12.025</DOI>
    <KeywordList>
      <Keywords>Alcoholic fatty liver</Keywords>
      <Keywords>Cytochrome P450 isozymes</Keywords>
      <Keywords>Endoplasmic reticulum stress</Keywords>
      <Keywords>Heme oxygenase-1</Keywords>
      <Keywords>Hepatic ischemia/reperfusion</Keywords>
      <Keywords>Oxidative stress</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sang Won Park</Name>
        <Affiliation>Department of Pharmacology, Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju 52727, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jung Woo Kang</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do 16419, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Sun Mee Lee</Name>
        <Affiliation>School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do 16419, Republic of Korea. Electronic address: sunmee@skku.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The combination of ethanol with mephedrone increases the signs of neurotoxicity and impairs neurogenesis and learning in adolescent CD-1 mice.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26747301</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.12.019</DOI>
    <KeywordList>
      <Keywords>Adolescence</Keywords>
      <Keywords>Alcohol</Keywords>
      <Keywords>Cathinones</Keywords>
      <Keywords>Mephedrone</Keywords>
      <Keywords>Neurogenesis</Keywords>
      <Keywords>Neurotoxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Andrés Ciudad-Roberts</Name>
        <Affiliation>Department of Pharmacology and Therapeutic Chemistry (Pharmacology Section); Institute of Biomedicine (IBUB), Faculty of Pharmacy, Universitat de Barcelona, Barcelona, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Leticia Duart-Castells</Name>
        <Affiliation>Department of Pharmacology and Therapeutic Chemistry (Pharmacology Section); Institute of Biomedicine (IBUB), Faculty of Pharmacy, Universitat de Barcelona, Barcelona, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>Jorge Camarasa</Name>
        <Affiliation>Department of Pharmacology and Therapeutic Chemistry (Pharmacology Section); Institute of Biomedicine (IBUB), Faculty of Pharmacy, Universitat de Barcelona, Barcelona, Spain.</Affiliation>
      </Author>
      <Author>
        <Name>David Pubill</Name>
        <Affiliation>Department of Pharmacology and Therapeutic Chemistry (Pharmacology Section); Institute of Biomedicine (IBUB), Faculty of Pharmacy, Universitat de Barcelona, Barcelona, Spain. Electronic address: d.pubill@ub.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Elena Escubedo</Name>
        <Affiliation>Department of Pharmacology and Therapeutic Chemistry (Pharmacology Section); Institute of Biomedicine (IBUB), Faculty of Pharmacy, Universitat de Barcelona, Barcelona, Spain.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Dioscin alleviates BDL- and DMN-induced hepatic fibrosis via Sirt1/Nrf2-mediated inhibition of p38 MAPK pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26747300</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.12.024</DOI>
    <KeywordList>
      <Keywords>Dioscin</Keywords>
      <Keywords>Hepatic fibrosis</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Sirt1</Keywords>
      <Keywords>p38 MAPK</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lina Gu</Name>
        <Affiliation>College of Pharmacy, Dalian Medical University, Western 9 Lvshunnan Road, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xufeng Tao</Name>
        <Affiliation>College of Pharmacy, Dalian Medical University, Western 9 Lvshunnan Road, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Youwei Xu</Name>
        <Affiliation>College of Pharmacy, Dalian Medical University, Western 9 Lvshunnan Road, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xu Han</Name>
        <Affiliation>College of Pharmacy, Dalian Medical University, Western 9 Lvshunnan Road, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Qi</Name>
        <Affiliation>College of Pharmacy, Dalian Medical University, Western 9 Lvshunnan Road, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lina Xu</Name>
        <Affiliation>College of Pharmacy, Dalian Medical University, Western 9 Lvshunnan Road, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lianhong Yin</Name>
        <Affiliation>College of Pharmacy, Dalian Medical University, Western 9 Lvshunnan Road, Dalian 116044, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinyong Peng</Name>
        <Affiliation>College of Pharmacy, Dalian Medical University, Western 9 Lvshunnan Road, Dalian 116044, China. Electronic address: jinyongpeng2014@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A cellular model to study drug-induced liver injury in nonalcoholic fatty liver disease: Application to acetaminophen.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26739624</pubmedLink>
    <GrantList>
      <Grant>R01 DK070195</Grant>
      <Grant>T32 ES007079</Grant>
      <Grant>P20 RR021940</Grant>
      <Grant>T32 ES007079-26A2</Grant>
      <Grant>R01 DK102142</Grant>
      <Grant>P20 GM103549</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.12.020</DOI>
    <KeywordList>
      <Keywords>Acetaminophen</Keywords>
      <Keywords>CYP2E1</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Liver</Keywords>
      <Keywords>NAFLD</Keywords>
      <Keywords>Obesity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Anaïs Michaut</Name>
        <Affiliation>INSERM, U991, Université de Rennes 1, Rennes, France.</Affiliation>
      </Author>
      <Author>
        <Name>Dounia Le Guillou</Name>
        <Affiliation>INSERM, U991, Université de Rennes 1, Rennes, France.</Affiliation>
      </Author>
      <Author>
        <Name>Caroline Moreau</Name>
        <Affiliation>INSERM, U991, Université de Rennes 1, Rennes, France; Service de Biochimie et Toxicologie, CHU Pontchaillou, Rennes, France.</Affiliation>
      </Author>
      <Author>
        <Name>Simon Bucher</Name>
        <Affiliation>INSERM, U991, Université de Rennes 1, Rennes, France.</Affiliation>
      </Author>
      <Author>
        <Name>Mitchell R. McGill</Name>
        <Affiliation>Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sophie Martinais</Name>
        <Affiliation>INSERM, U991, Université de Rennes 1, Rennes, France.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas Gicquel</Name>
        <Affiliation>INSERM, U991, Université de Rennes 1, Rennes, France; Service de Biochimie et Toxicologie, CHU Pontchaillou, Rennes, France.</Affiliation>
      </Author>
      <Author>
        <Name>Isabelle Morel</Name>
        <Affiliation>INSERM, U991, Université de Rennes 1, Rennes, France; Service de Biochimie et Toxicologie, CHU Pontchaillou, Rennes, France.</Affiliation>
      </Author>
      <Author>
        <Name>Marie Anne Robin</Name>
        <Affiliation>INSERM, U991, Université de Rennes 1, Rennes, France.</Affiliation>
      </Author>
      <Author>
        <Name>Hartmut Jaeschke</Name>
        <Affiliation>Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bernard Fromenty</Name>
        <Affiliation>INSERM, U991, Université de Rennes 1, Rennes, France. Electronic address: bernard.fromenty@inserm.fr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Lovastatin prevents cisplatin-induced activation of pro-apoptotic DNA damage response (DDR) of renal tubular epithelial cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26739623</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.12.023</DOI>
    <KeywordList>
      <Keywords>Cisplatin</Keywords>
      <Keywords>DNA damage response</Keywords>
      <Keywords>Lovastatin</Keywords>
      <Keywords>Nephrotoxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Katharina Krüger</Name>
        <Affiliation>Institute of Toxicology, Medical Faculty, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Verena Ziegler</Name>
        <Affiliation>Institute of Toxicology, Medical Faculty, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Christina Hartmann</Name>
        <Affiliation>Institute of Toxicology, Medical Faculty, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Christian Henninger</Name>
        <Affiliation>Institute of Toxicology, Medical Faculty, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Jürgen Thomale</Name>
        <Affiliation>Institute of Cell Biology, University Duisburg-Essen, 45122 Essen, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Nicole Schupp</Name>
        <Affiliation>Institute of Toxicology, Medical Faculty, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Gerhard Fritz</Name>
        <Affiliation>Institute of Toxicology, Medical Faculty, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany. Electronic address: fritz@uni-duesseldorf.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Current understanding of interactions between nanoparticles and the immune system.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26739622</pubmedLink>
    <GrantList>
      <Grant>HHSN261200800001C</Grant>
      <Grant>HHSN261200800001E</Grant>
      <Grant>Z99 CA999999</Grant>
      <Grant>HHSN261200800001E</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.12.022</DOI>
    <KeywordList>
      <Keywords>Drug delivery</Keywords>
      <Keywords>Immunology</Keywords>
      <Keywords>Immunotoxicity</Keywords>
      <Keywords>Nanoparticles</Keywords>
      <Keywords>Preclinical</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marina A. Dobrovolskaia</Name>
        <Affiliation>Nanotechnology Characterization Laboratory, Cancer Research Technology Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, NCI at Frederick, Frederick, MD 21702, USA. Electronic address: marina@mail.nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Michael Shurin</Name>
        <Affiliation>Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA; Department of Immunology, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Anna A. Shvedova</Name>
        <Affiliation>Health Effects Laboratory Division, National Institute of Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV 26505, USA; Department of Physiology and Pharmacology, West Virginia University, Morgantown, WV 26506, USA. Electronic address: ats1@cdc.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>PTP1B confers liver fibrosis by regulating the activation of hepatic stellate cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26739621</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.12.021</DOI>
    <KeywordList>
      <Keywords>Activation</Keywords>
      <Keywords>Hepatic stellate cell (HSC)</Keywords>
      <Keywords>Inactivation</Keywords>
      <Keywords>Liver fibrosis</Keywords>
      <Keywords>Protein tyrosine phosphatase 1B (PTP1B)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Pei Jie Chen</Name>
        <Affiliation>School of Pharmacy, Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; Institute for Liver Diseases, Anhui Medical University (ILD-AMU), Hefei 230032, China; Anhui Institute of Innovative Drugs, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuang Peng Cai</Name>
        <Affiliation>School of Pharmacy, Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; Institute for Liver Diseases, Anhui Medical University (ILD-AMU), Hefei 230032, China; Anhui Institute of Innovative Drugs, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Yang</Name>
        <Affiliation>School of Pharmacy, Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; Institute for Liver Diseases, Anhui Medical University (ILD-AMU), Hefei 230032, China; Anhui Institute of Innovative Drugs, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wan Xia Li</Name>
        <Affiliation>School of Pharmacy, Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; Institute for Liver Diseases, Anhui Medical University (ILD-AMU), Hefei 230032, China; Anhui Institute of Innovative Drugs, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cheng Huang</Name>
        <Affiliation>School of Pharmacy, Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; Institute for Liver Diseases, Anhui Medical University (ILD-AMU), Hefei 230032, China; Anhui Institute of Innovative Drugs, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Ming Meng</Name>
        <Affiliation>School of Pharmacy, Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; Institute for Liver Diseases, Anhui Medical University (ILD-AMU), Hefei 230032, China; Anhui Institute of Innovative Drugs, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Li</Name>
        <Affiliation>School of Pharmacy, Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China; Institute for Liver Diseases, Anhui Medical University (ILD-AMU), Hefei 230032, China; Anhui Institute of Innovative Drugs, Hefei 230032, China. Electronic address: lj@ahmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Biomarkers of susceptibility: State of the art and implications for occupational exposure to engineered nanomaterials.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26724381</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.12.018</DOI>
    <KeywordList>
      <Keywords>Epigenetic alterations</Keywords>
      <Keywords>Genetic variances</Keywords>
      <Keywords>Nanomaterial risk assessment</Keywords>
      <Keywords>Nanomaterial susceptibility factors</Keywords>
      <Keywords>Occupational biomonitoring</Keywords>
      <Keywords>Toxicogenomic information</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ivo Iavicoli</Name>
        <Affiliation>Department of Public Health, Division of Occupational Medicine, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy. Electronic address: ivo.iavicoli@unina.it.</Affiliation>
      </Author>
      <Author>
        <Name>Veruscka Leso</Name>
        <Affiliation>Institute of Public Health, Section of Occupational Medicine, Catholic University of the Sacred Heart, Largo Francesco Vito 1, 00168 Rome, Italy. Electronic address: veruscka@email.it.</Affiliation>
      </Author>
      <Author>
        <Name>Paul A. Schulte</Name>
        <Affiliation>National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, 4676 Columbia Parkway, MS C-14, Cincinnati, OH 45226, USA. Electronic address: pas4@cdc.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>New frontiers in nanotoxicology: Gut microbiota/microbiome-mediated effects of engineered nanomaterials.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26723910</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.12.017</DOI>
    <KeywordList>
      <Keywords>Engineered nanomaterials</Keywords>
      <Keywords>Microbiome</Keywords>
      <Keywords>Microbiota</Keywords>
      <Keywords>Toxic effects</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Antonio Pietroiusti</Name>
        <Affiliation>Department of Biomedicine and Prevention, University of Rome Tor Vergata, via Montpellier 1, 00133 Rome, Italy. Electronic address: pietroiu@uniroma2.it.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Magrini</Name>
        <Affiliation>Department of Biomedicine and Prevention, University of Rome Tor Vergata, via Montpellier 1, 00133 Rome, Italy.</Affiliation>
      </Author>
      <Author>
        <Name>Luisa Campagnolo</Name>
        <Affiliation>Department of Biomedicine and Prevention, University of Rome Tor Vergata, via Montpellier 1, 00133 Rome, Italy.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Recent advances, and unresolved issues, in the application of computational modelling to the prediction of the biological effects of nanomaterials.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26723909</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.12.016</DOI>
    <KeywordList>
      <Keywords>Computational modelling</Keywords>
      <Keywords>Molecular dynamics</Keywords>
      <Keywords>Nanotoxicology</Keywords>
      <Keywords>Quantitative structure–property relationship, QSPR</Keywords>
      <Keywords>Recent advances</Keywords>
      <Keywords>Unresolved issues</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David A. Winkler</Name>
        <Affiliation>CSIRO Manufacturing Flagship, Bag 10 Clayton South MDC 3169 Australia; Monash Institute of Pharmaceutical Sciences, 392 Royal Parade, Parkville 3052, Australia; Latrobe Institute for Molecular Science, Bundoora 3083, Australia; School of Chemical and Physical Sciences, Flinders University, Bedford Park 5042, Australia. Electronic address: dave.winkler@csiro.au.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Emerging systems biology approaches in nanotoxicology: Towards a mechanism-based understanding of nanomaterial hazard and risk.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26721310</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.12.014</DOI>
    <KeywordList>
      <Keywords>Engineered nanomaterials</Keywords>
      <Keywords>Metabolomics</Keywords>
      <Keywords>Proteomics</Keywords>
      <Keywords>Systems toxicology</Keywords>
      <Keywords>Toxicogenomics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Pedro M. Costa</Name>
        <Affiliation>Nanosafety &amp; Nanomedicine Laboratory, Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
      </Author>
      <Author>
        <Name>Bengt Fadeel</Name>
        <Affiliation>Nanosafety &amp; Nanomedicine Laboratory, Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. Electronic address: Bengt.Fadeel@ki.se.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mitigation of arsenic-induced acquired cancer phenotype in prostate cancer stem cells by miR-143 restoration.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26721309</pubmedLink>
    <GrantList>
      <Grant>ZIA ES102925-06</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>S0041-008X(15)30159-9</DOI>
    <KeywordList>
      <Keywords>Arsenic</Keywords>
      <Keywords>Cancer</Keywords>
      <Keywords>Prostate</Keywords>
      <Keywords>Stem cells</Keywords>
      <Keywords>miRNA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ntube N. O. Ngalame</Name>
        <Affiliation>Stem Cell Toxicology Group, National Toxicology Program Laboratory, Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA. Electronic address: ngalamenn@niehs.nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Ngome L. Makia</Name>
        <Affiliation>Stem Cell Toxicology Group, National Toxicology Program Laboratory, Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA. Electronic address: makianl@niehs.nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Michael P. Waalkes</Name>
        <Affiliation>Stem Cell Toxicology Group, National Toxicology Program Laboratory, Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA. Electronic address: waalkes@niehs.nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Erik J. Tokar</Name>
        <Affiliation>Stem Cell Toxicology Group, National Toxicology Program Laboratory, Division of the National Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA. Electronic address: tokare@mail.nih.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Developmental toxicity of engineered nanomaterials in rodents.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26721308</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.12.015</DOI>
    <KeywordList>
      <Keywords>Developmental toxicity</Keywords>
      <Keywords>Gestation</Keywords>
      <Keywords>Nanomaterials</Keywords>
      <Keywords>Nanoparticles</Keywords>
      <Keywords>Prenatal exposure</Keywords>
      <Keywords>Teratogenicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Makoto Ema</Name>
        <Affiliation>Research Institute of Science for Safety and Sustainability, National Institute of Advanced Industrial Science and Technology (AIST), 16-1 Onogawa, Tsukuba, Ibaraki 305-8569, Japan. Electronic address: ema-makoto@aist.go.jp.</Affiliation>
      </Author>
      <Author>
        <Name>Masashi Gamo</Name>
        <Affiliation>Research Institute of Science for Safety and Sustainability, National Institute of Advanced Industrial Science and Technology (AIST), 16-1 Onogawa, Tsukuba, Ibaraki 305-8569, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Kazumasa Honda</Name>
        <Affiliation>Research Institute of Science for Safety and Sustainability, National Institute of Advanced Industrial Science and Technology (AIST), 16-1 Onogawa, Tsukuba, Ibaraki 305-8569, Japan.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of acute ethanol exposure on cytokine production by primary airway smooth muscle cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26721307</pubmedLink>
    <GrantList>
      <Grant>P30ES06676</Grant>
      <Grant>UL1TR000071</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.12.011</DOI>
    <KeywordList>
      <Keywords>AMPK signaling</Keywords>
      <Keywords>Acetaldehyde</Keywords>
      <Keywords>Cytokines</Keywords>
      <Keywords>Ethanol</Keywords>
      <Keywords>Fatty acid ethyl esters</Keywords>
      <Keywords>Human airway smooth muscle cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lata Kaphalia</Name>
        <Affiliation>Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mridul Kalita</Name>
        <Affiliation>Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Bhupendra S. Kaphalia</Name>
        <Affiliation>Department of Pathology, University of Texas Medical Branch, Galveston, TX, United States.</Affiliation>
      </Author>
      <Author>
        <Name>William J. Calhoun</Name>
        <Affiliation>Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, United States. Electronic address: William.Calhoun@utmb.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Zebrafish embryos as a screen for DNA methylation modifications after compound exposure.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26712470</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.12.012</DOI>
    <KeywordList>
      <Keywords>DNA methylation</Keywords>
      <Keywords>Environmental contaminant exposure</Keywords>
      <Keywords>Epigenetics</Keywords>
      <Keywords>Screening</Keywords>
      <Keywords>Zebrafish embryo</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Manon C. Bouwmeester</Name>
        <Affiliation>Center for Health Protection, National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Sander Ruiter</Name>
        <Affiliation>Center for Health Protection, National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Tobias Lommelaars</Name>
        <Affiliation>Center for Health Protection, National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Josefine Sippel</Name>
        <Affiliation>Center for Health Protection, National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Hennie M. Hodemaekers</Name>
        <Affiliation>Center for Health Protection, National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Evert Jan van den Brandhof</Name>
        <Affiliation>Center for Environmental Quality, National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Jeroen L. A. Pennings</Name>
        <Affiliation>Center for Health Protection, National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Jorke H. Kamstra</Name>
        <Affiliation>Institute for Environmental Studies (IVM), VU University, De Boelelaan 1085, 1081 HV Amsterdam, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Jaroslav Jelinek</Name>
        <Affiliation>Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, PA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jean Pierre J. Issa</Name>
        <Affiliation>Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, PA, USA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Juliette Legler</Name>
        <Affiliation>Institute for Environmental Studies (IVM), VU University, De Boelelaan 1085, 1081 HV Amsterdam, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Leo T. M. van der Ven</Name>
        <Affiliation>Center for Health Protection, National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands. Electronic address: leo.van.der.ven@rivm.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Concurrent acetylation of FoxO1/3a and p53 due to sirtuins inhibition elicit Bim/PUMA mediated mitochondrial dysfunction and apoptosis in berberine-treated HepG2 cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26712469</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.12.006</DOI>
    <KeywordList>
      <Keywords>Berberine</Keywords>
      <Keywords>Bim</Keywords>
      <Keywords>FoxO</Keywords>
      <Keywords>PUMA</Keywords>
      <Keywords>SIRT-1</Keywords>
      <Keywords>SIRT-3</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shatrunajay Shukla</Name>
        <Affiliation>Herbal Research Section, CSIR - Indian Institute of Toxicology Research, Post Box No. 80, Mahatma Gandhi Marg, Lucknow-226001, India; Department of Medical Elementology and Toxicology, Jamia Hamdard (Hamdard University), Hamdard Nagar, New Delhi -110062, India.</Affiliation>
      </Author>
      <Author>
        <Name>Ankita Sharma</Name>
        <Affiliation>Herbal Research Section, CSIR - Indian Institute of Toxicology Research, Post Box No. 80, Mahatma Gandhi Marg, Lucknow-226001, India.</Affiliation>
      </Author>
      <Author>
        <Name>Vivek Kumar Pandey</Name>
        <Affiliation>Herbal Research Section, CSIR - Indian Institute of Toxicology Research, Post Box No. 80, Mahatma Gandhi Marg, Lucknow-226001, India; Academy of Scientific and Innovative Research, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sheikh Raisuddin</Name>
        <Affiliation>Department of Medical Elementology and Toxicology, Jamia Hamdard (Hamdard University), Hamdard Nagar, New Delhi -110062, India.</Affiliation>
      </Author>
      <Author>
        <Name>Poonam Kakkar</Name>
        <Affiliation>Herbal Research Section, CSIR - Indian Institute of Toxicology Research, Post Box No. 80, Mahatma Gandhi Marg, Lucknow-226001, India; Academy of Scientific and Innovative Research, India. Electronic address: kakkarp59@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Bisphenol A sulfonation is impaired in metabolic and liver disease.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26712468</pubmedLink>
    <GrantList>
      <Grant>HHSN267200700004C</Grant>
      <Grant>2 P20 GM103430</Grant>
      <Grant>HHSN267200700004C</Grant>
      <Grant>HHSN267200700004G</Grant>
      <Grant>K22ES013782</Grant>
      <Grant>R15 ES025404</Grant>
      <Grant>K22 ES013782</Grant>
      <Grant>R01 ES016042</Grant>
      <Grant>R01ES016042</Grant>
      <Grant>N01-DK-7-0004</Grant>
      <Grant>P20 GM103430</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.12.009</DOI>
    <KeywordList>
      <Keywords>Bisphenol A</Keywords>
      <Keywords>Cirrhosis</Keywords>
      <Keywords>Diabetes</Keywords>
      <Keywords>Obesity</Keywords>
      <Keywords>Phase-II</Keywords>
      <Keywords>Steatosis</Keywords>
      <Keywords>Sulfotransferase</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Emine B. Yalcin</Name>
        <Affiliation>Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Supriya R. Kulkarni</Name>
        <Affiliation>Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Angela L. Slitt</Name>
        <Affiliation>Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI, United States. Electronic address: angela_slitt@uri.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Roberta King</Name>
        <Affiliation>Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI, United States. Electronic address: rking@uri.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Small structural changes on a hydroquinone scaffold determine the complex I inhibition or uncoupling of tumoral oxidative phosphorylation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26712467</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.12.005</DOI>
    <KeywordList>
      <Keywords>Anti-cancer agents</Keywords>
      <Keywords>Complex I</Keywords>
      <Keywords>Hydroquinones</Keywords>
      <Keywords>Oxidative phosphorylation</Keywords>
      <Keywords>Uncouplers</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Félix A. Urra</Name>
        <Affiliation>Programa de Farmacología Molecular y Clínica, Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Independencia 1027, Casilla 7, Santiago, Chile. Electronic address: felix.urra@qf.uchile.cl.</Affiliation>
      </Author>
      <Author>
        <Name>Miguel Córdova-Delgado</Name>
        <Affiliation>Departamento de Química Orgánica y Físico-Química, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Casilla 233, Santiago 1, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Michel Lapier</Name>
        <Affiliation>Programa de Farmacología Molecular y Clínica, Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Independencia 1027, Casilla 7, Santiago, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Andrea Orellana-Manzano</Name>
        <Affiliation>Programa de Farmacología Molecular y Clínica, Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Independencia 1027, Casilla 7, Santiago, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Luis Acevedo-Arévalo</Name>
        <Affiliation>Departamento de Química Orgánica y Físico-Química, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Casilla 233, Santiago 1, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Hernán Pessoa-Mahana</Name>
        <Affiliation>Departamento de Química Orgánica y Físico-Química, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Casilla 233, Santiago 1, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Jaime M. González-Vivanco</Name>
        <Affiliation>Departamento de Química Orgánica y Físico-Química, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Casilla 233, Santiago 1, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Maximiliano Martínez-Cifuentes</Name>
        <Affiliation>Instituto de Química de Recursos Naturales, Universidad de Talca, Casilla 747, Talca, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Oney Ramírez-Rodríguez</Name>
        <Affiliation>Departamento de Química Orgánica y Físico-Química, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Casilla 233, Santiago 1, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Juan Pablo Millas-Vargas</Name>
        <Affiliation>Departamento de Química Orgánica y Físico-Química, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Casilla 233, Santiago 1, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Boris Weiss-López</Name>
        <Affiliation>Departamento de Química, Facultad de Ciencias, Universidad de Chile, Casilla 653, Santiago, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Mario Pavani</Name>
        <Affiliation>Programa de Farmacología Molecular y Clínica, Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Independencia 1027, Casilla 7, Santiago, Chile.</Affiliation>
      </Author>
      <Author>
        <Name>Jorge Ferreira</Name>
        <Affiliation>Programa de Farmacología Molecular y Clínica, Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Independencia 1027, Casilla 7, Santiago, Chile. Electronic address: jferreir@med.uchile.cl.</Affiliation>
      </Author>
      <Author>
        <Name>Ramiro Araya-Maturana</Name>
        <Affiliation>Instituto de Química de Recursos Naturales, Universidad de Talca, Casilla 747, Talca, Chile. Electronic address: raraya@utalca.cl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Human dermal absorption of chlorinated organophosphate flame retardants; implications for human exposure.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26712466</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.12.004</DOI>
    <KeywordList>
      <Keywords>Dermal absorption</Keywords>
      <Keywords>EPISKIN</Keywords>
      <Keywords>Human exposure</Keywords>
      <Keywords>Organophosphate flame retardants</Keywords>
      <Keywords>PFRs</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mohamed Abou-Elwafa Abdallah</Name>
        <Affiliation>Division of Environmental Health and Risk Management, School of Geography, Earth, and Environmental Sciences, University of Birmingham, Birmingham B15 2TT, United Kingdom; Department of Analytical Chemistry, Faculty of Pharmacy, Assiut University, 71526 Assiut, Egypt. Electronic address: mae_abdallah@yahoo.co.uk.</Affiliation>
      </Author>
      <Author>
        <Name>Gopal Pawar</Name>
        <Affiliation>Division of Environmental Health and Risk Management, School of Geography, Earth, and Environmental Sciences, University of Birmingham, Birmingham B15 2TT, United Kingdom.</Affiliation>
      </Author>
      <Author>
        <Name>Stuart Harrad</Name>
        <Affiliation>Division of Environmental Health and Risk Management, School of Geography, Earth, and Environmental Sciences, University of Birmingham, Birmingham B15 2TT, United Kingdom.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Suppression of NRF2-ARE activity sensitizes chemotherapeutic agent-induced cytotoxicity in human acute monocytic leukemia cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26708503</pubmedLink>
    <GrantList>
      <Grant>ES016005</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.12.008</DOI>
    <KeywordList>
      <Keywords>Arsenic trioxide</Keywords>
      <Keywords>Chemotherapeutic resistance</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>Ethionamide</Keywords>
      <Keywords>Isoniazid</Keywords>
      <Keywords>Leukemia</Keywords>
      <Keywords>NRF2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hui Peng</Name>
        <Affiliation>The Hamner Institutes for Health Sciences, 6 Davis Drive, Research Triangle Park, NC, USA; Institute of Disease Control and Prevention, Academy of Military Medical Sciences, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huihui Wang</Name>
        <Affiliation>School of Public Health, China Medical University, 77 Puhe Road, Shenyang North New Area, Shenyang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Peng Xue</Name>
        <Affiliation>The Hamner Institutes for Health Sciences, 6 Davis Drive, Research Triangle Park, NC, USA; Key Laboratory of the Public Health Safety, Ministry of Education, School of Public Health, Fudan University, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongyong Hou</Name>
        <Affiliation>School of Public Health, China Medical University, 77 Puhe Road, Shenyang North New Area, Shenyang, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jian Dong</Name>
        <Affiliation>The Hamner Institutes for Health Sciences, 6 Davis Drive, Research Triangle Park, NC, USA; Institute of Biology and Medicine, Wuhan University of Science and Technology, Wuhan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Tong Zhou</Name>
        <Affiliation>The Hamner Institutes for Health Sciences, 6 Davis Drive, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Weidong Qu</Name>
        <Affiliation>Key Laboratory of the Public Health Safety, Ministry of Education, School of Public Health, Fudan University, Shanghai, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuangqing Peng</Name>
        <Affiliation>Institute of Disease Control and Prevention, Academy of Military Medical Sciences, Beijing, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Li</Name>
        <Affiliation>Unilever, Safety &amp; Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Paul L. Carmichael</Name>
        <Affiliation>Unilever, Safety &amp; Environmental Assurance Centre, Colworth Science Park, Sharnbrook, Bedfordshire MK44 1LQ, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Bud Nelson</Name>
        <Affiliation>The Hamner Institutes for Health Sciences, 6 Davis Drive, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Rebecca Clewell</Name>
        <Affiliation>The Hamner Institutes for Health Sciences, 6 Davis Drive, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Qiang Zhang</Name>
        <Affiliation>The Hamner Institutes for Health Sciences, 6 Davis Drive, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Melvin E. Andersen</Name>
        <Affiliation>The Hamner Institutes for Health Sciences, 6 Davis Drive, Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jingbo Pi</Name>
        <Affiliation>School of Public Health, China Medical University, 77 Puhe Road, Shenyang North New Area, Shenyang, China; The Hamner Institutes for Health Sciences, 6 Davis Drive, Research Triangle Park, NC, USA. Electronic address: jpi@mail.cmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The ovarian DNA damage repair response is induced prior to phosphoramide mustard-induced follicle depletion, and ataxia telangiectasia mutated inhibition prevents PM-induced follicle depletion.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26708502</pubmedLink>
    <GrantList>
      <Grant>R00ES016818</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.12.010</DOI>
    <KeywordList>
      <Keywords>ATM inhibitor</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>DNA repair</Keywords>
      <Keywords>Ovary</Keywords>
      <Keywords>PKC delta</Keywords>
      <Keywords>PM</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Shanthi Ganesan</Name>
        <Affiliation>Department of Animal Science, Iowa State University, Ames, IA 50011, USA. Electronic address: shanthig@iastate.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Aileen F. Keating</Name>
        <Affiliation>Department of Animal Science, Iowa State University, Ames, IA 50011, USA. Electronic address: akeating@iastate.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of the β1 auxiliary subunit on modification of Rat Na(v)1.6 sodium channels expressed in HEK293 cells by the pyrethroid insecticides tefluthrin and deltamethrin.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26708501</pubmedLink>
    <GrantList>
      <Grant>R01 ES013686</Grant>
      <Grant>R01-ES013686</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.12.007</DOI>
    <KeywordList>
      <Keywords>Functional reconstitution</Keywords>
      <Keywords>HEK293 cells</Keywords>
      <Keywords>Na(v)1.6 isoform</Keywords>
      <Keywords>Pyrethroid insecticide</Keywords>
      <Keywords>Voltage-gated sodium channel</Keywords>
      <Keywords>β Subunits</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bingjun He</Name>
        <Affiliation>College of Life Sciences, Nankai University, Tianjin 300071, China.</Affiliation>
      </Author>
      <Author>
        <Name>David M. Soderlund</Name>
        <Affiliation>Department of Entomology, Cornell University, Geneva, NY 14456, USA. Electronic address: dms6@cornell.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Application of small RNA sequencing to identify microRNAs in acute kidney injury and fibrosis.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26707937</pubmedLink>
    <GrantList>
      <Grant>R01 ES017543</Grant>
      <Grant>R56 ES017543</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>S0041-008X(15)30148-4</DOI>
    <KeywordList>
      <Keywords>Folic Acid</Keywords>
      <Keywords>Kidney Fibrosis</Keywords>
      <Keywords>Kidney Toxicity</Keywords>
      <Keywords>Small RNA Sequencing</Keywords>
      <Keywords>miRNAs</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Kathryn L. Pellegrini</Name>
        <Affiliation>Department of Medicine, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Cory V. Gerlach</Name>
        <Affiliation>Department of Medicine, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Sciences, Harvard Medical School, Boston, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Florin L. Craciun</Name>
        <Affiliation>Department of Medicine, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Krithika Ramachandran</Name>
        <Affiliation>Department of Medicine, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Vanesa Bijol</Name>
        <Affiliation>Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Haydn T. Kissick</Name>
        <Affiliation>Department of Surgery, Urology Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Vishal S. Vaidya</Name>
        <Affiliation>Department of Medicine, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Sciences, Harvard Medical School, Boston, MA, USA. Electronic address: vvaidya@bwh.harvard.edu.</Affiliation>
      </Author>
    </AuthorList>
    <CoiStatement>The authors have no competing interests to declare.</CoiStatement>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Irinotecan (CPT-11)-induced elevation of bile acids potentiates suppression of IL-10 expression.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26706406</pubmedLink>
    <GrantList>
      <Grant>Z01 BC005562-20</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.12.003</DOI>
    <KeywordList>
      <Keywords>Bile acids</Keywords>
      <Keywords>Interleukin-10</Keywords>
      <Keywords>Irinotecan (CPT-11)</Keywords>
      <Keywords>Metabolomics</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhong Ze Fang</Name>
        <Affiliation>Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA; Department of Toxicology, School of Public Health, Tianjin Medical University, Tianjin, China; Joint Center for Translational Medicine, Dalian Institute of Chemical Physics, Chinese Academy of Sciences and First Affiliated Hospital of Liaoning Medical University, Dalian, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dunfang Zhang</Name>
        <Affiliation>State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yun Feng Cao</Name>
        <Affiliation>Joint Center for Translational Medicine, Dalian Institute of Chemical Physics, Chinese Academy of Sciences and First Affiliated Hospital of Liaoning Medical University, Dalian, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cen Xie</Name>
        <Affiliation>Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Dan Lu</Name>
        <Affiliation>Department of Immunology, Tianjin Key Laboratory of Cellular and Molecular Immunology, Tianjin Medical University, Tianjin, China.</Affiliation>
      </Author>
      <Author>
        <Name>Dong Xue Sun</Name>
        <Affiliation>Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Naoki Tanaka</Name>
        <Affiliation>Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Changtao Jiang</Name>
        <Affiliation>Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Qianming Chen</Name>
        <Affiliation>State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Chen</Name>
        <Affiliation>State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China.</Affiliation>
      </Author>
      <Author>
        <Name>Haina Wang</Name>
        <Affiliation>School of Pharmaceutical Sciences, Shandong University, Jinan, China.</Affiliation>
      </Author>
      <Author>
        <Name>Frank J. Gonzalez</Name>
        <Affiliation>Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: gonzalef@mail.nih.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Genetically obese (ob/ob) mice are resistant to the lethal effects of thioacetamide hepatotoxicity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26701066</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.12.001</DOI>
    <KeywordList>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Thioacetamide</Keywords>
      <Keywords>ob/ob</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Young Suk Won</Name>
        <Affiliation>Laboratory Animal Resource Center, Korea Research Institute of Bioscience and Biotechnology, Chungbuk, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ji Won Song</Name>
        <Affiliation>Department of Veterinary Pathology, College of Veterinary Medicine, Chungnam National University, Daejeon, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jong Hwan Lim</Name>
        <Affiliation>Huons Research Center, Gyonggido, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Mee Young Lee</Name>
        <Affiliation>Herbal Medicine Formulation Research Group, Korea Institute of Oriental Medicine, Daejeon, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Og Sung Moon</Name>
        <Affiliation>Laboratory Animal Resource Center, Korea Research Institute of Bioscience and Biotechnology, Chungbuk, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyoung Chin Kim</Name>
        <Affiliation>Laboratory Animal Resource Center, Korea Research Institute of Bioscience and Biotechnology, Chungbuk, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hwa Young Son</Name>
        <Affiliation>Department of Veterinary Pathology, College of Veterinary Medicine, Chungnam National University, Daejeon, South Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyo Jung Kwon</Name>
        <Affiliation>Department of Veterinary Pathology, College of Veterinary Medicine, Chungnam National University, Daejeon, South Korea. Electronic address: hyojung@cnu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Immunotoxicological and neurotoxicological profile of health effects following subacute exposure to geogenic dust from sand dunes at the Nellis Dunes Recreation Area, Las Vegas, NV.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26644169</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.11.020</DOI>
    <KeywordList>
      <Keywords>Geogenic dust</Keywords>
      <Keywords>Heavy metals</Keywords>
      <Keywords>Immunotoxicity</Keywords>
      <Keywords>Lung exposure</Keywords>
      <Keywords>Minerals</Keywords>
      <Keywords>Neurotoxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Deborah Keil</Name>
        <Affiliation>Department of Microbiology and Immunology, Montana State University, Bozeman, MT 59717, USA. Electronic address: Deborah.Keil@montana.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Brenda Buck</Name>
        <Affiliation>Department of Geoscience, University of Nevada, Las Vegas, NV 89154, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Dirk Goossens</Name>
        <Affiliation>Department of Geoscience, University of Nevada, Las Vegas, NV 89154, USA; Geography Research Group, Department of Earth and Environmental Sciences, KU Leuven, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Yuanxin Teng</Name>
        <Affiliation>Department of Geoscience, University of Nevada, Las Vegas, NV 89154, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mallory Leetham</Name>
        <Affiliation>Department of Microbiology and Immunology, Montana State University, Bozeman, MT 59717, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lacey Murphy</Name>
        <Affiliation>Department of Microbiology and Immunology, Montana State University, Bozeman, MT 59717, USA.</Affiliation>
      </Author>
      <Author>
        <Name>James Pollard</Name>
        <Affiliation>Department of Geoscience, University of Nevada, Las Vegas, NV 89154, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Margaret Eggers</Name>
        <Affiliation>Center for Biofilm Engineering, Montana State University, Bozeman, MT 59717, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Brett McLaurin</Name>
        <Affiliation>Department of Environmental, Geographical, and Geological Sciences, Bloomsburg University of Pennsylvania, Bloomsburg, PA 17815, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Russell Gerads</Name>
        <Affiliation>Brooks Rand Labs, LLC, Bothell, WA 98011, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jamie DeWitt</Name>
        <Affiliation>Department of Pharmacology and Toxicology, East Carolina University, Greenville, NC 27834, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Experimental models of hepatotoxicity related to acute liver failure.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26631581</pubmedLink>
    <GrantList>
      <Grant>R01 DK070195</Grant>
      <Grant>R01 AA012916</Grant>
      <Grant>R01 DK102142</Grant>
      <Grant>P20 GM103549</Grant>
      <Grant>R01 AA12916</Grant>
      <Grant>5P20RR021940</Grant>
      <Grant>P20 RR021940</Grant>
      <Grant>8 P20 GM103549</Grant>
      <Grant>335476</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.11.016</DOI>
    <KeywordList>
      <Keywords>Acetaminophen</Keywords>
      <Keywords>Acute liver failure</Keywords>
      <Keywords>Concanavalin A</Keywords>
      <Keywords>D-galactosamine</Keywords>
      <Keywords>Fas ligand</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michaël Maes</Name>
        <Affiliation>Department of In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel, Brussels, Belgium.</Affiliation>
      </Author>
      <Author>
        <Name>Mathieu Vinken</Name>
        <Affiliation>Department of In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel, Brussels, Belgium. Electronic address: mvinken@vub.ac.be.</Affiliation>
      </Author>
      <Author>
        <Name>Hartmut Jaeschke</Name>
        <Affiliation>Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mitochondrial events responsible for morphine's cardioprotection against ischemia/reperfusion injury.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26631580</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.11.019</DOI>
    <KeywordList>
      <Keywords>Complex I activity</Keywords>
      <Keywords>Mitochondrial Src tyrosine kinase</Keywords>
      <Keywords>Mitochondrial oxidative stress</Keywords>
      <Keywords>PP2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Haiyan He</Name>
        <Affiliation>Department of Physiology &amp; Pathophysiology, Tianjin Medical University, Tianjin 300070, PR China; Department of Pharmacology, Tianjin Medical University, Tianjin 300070, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jin Huh</Name>
        <Affiliation>Department of Anesthesia and Pain Medicine, Medical College, Kangwon National University, Chuncheon City, Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Huihua Wang</Name>
        <Affiliation>Department of Anesthesiology, The Second Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang Province, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Kang</Name>
        <Affiliation>Department of Pharmacology, Tianjin Medical University, Tianjin 300070, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jianshi Lou</Name>
        <Affiliation>Department of Pharmacology, Tianjin Medical University, Tianjin 300070, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhelong Xu</Name>
        <Affiliation>Department of Physiology &amp; Pathophysiology, Tianjin Medical University, Tianjin 300070, PR China. Electronic address: zxu@tmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Evaluation of microRNAs-208 and 133a/b as differential biomarkers of acute cardiac and skeletal muscle toxicity in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26627004</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(15)30142-3</DOI>
    <KeywordList>
      <Keywords>Biomarker</Keywords>
      <Keywords>Cardiotoxicity</Keywords>
      <Keywords>Skeletal myotoxicity</Keywords>
      <Keywords>miR-133a/b</Keywords>
      <Keywords>miR-208</Keywords>
      <Keywords>miRNA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jacqueline Calvano</Name>
        <Affiliation>Drug Safety Evaluation, Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick, NJ 08903, United States. Electronic address: Jacqueline.Calvano@bms.com.</Affiliation>
      </Author>
      <Author>
        <Name>William Achanzar</Name>
        <Affiliation>Drug Safety Evaluation, Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick, NJ 08903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Bethanne Murphy</Name>
        <Affiliation>Drug Safety Evaluation, Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick, NJ 08903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Janet DiPiero</Name>
        <Affiliation>Discovery Toxicology, Bristol-Myers Squibb, Route 206 and Province Line Road, Lawrenceville, NJ 08540, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Clifford Hixson</Name>
        <Affiliation>Drug Safety Evaluation, Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick, NJ 08903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Cecilia Parrula</Name>
        <Affiliation>Drug Safety Evaluation, Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick, NJ 08903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Holly Burr</Name>
        <Affiliation>Drug Safety Evaluation, Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick, NJ 08903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Raja Mangipudy</Name>
        <Affiliation>Drug Safety Evaluation, Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick, NJ 08903, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Tirmenstein</Name>
        <Affiliation>Drug Safety Evaluation, Bristol-Myers Squibb, 1 Squibb Drive, New Brunswick, NJ 08903, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Inhibition of poly(ADP-ribose)polymerase-1 and DNA repair by uranium.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26627003</pubmedLink>
    <GrantList>
      <Grant>5R25GM060201-15</Grant>
      <Grant>P20 MD004811</Grant>
      <Grant>UL1TR001449</Grant>
      <Grant>UL1 TR001449</Grant>
      <Grant>R25 GM060201</Grant>
      <Grant>8UL1TR000041</Grant>
      <Grant>2K12GM088021</Grant>
      <Grant>UL1 TR000041</Grant>
      <Grant>K12 GM088021</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.11.017</DOI>
    <KeywordList>
      <Keywords>DNA damage</Keywords>
      <Keywords>DNA repair</Keywords>
      <Keywords>Poly(ADP-ribose) polymerase-1 (PARP-1)</Keywords>
      <Keywords>Uranium</Keywords>
      <Keywords>Zinc finger</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Karen L. Cooper</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Erica J. Dashner</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ranalda Tsosie</Name>
        <Affiliation>Department of Chemistry and Biochemistry, University of Montana, Missoula, MT 59812, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Young Mi Cho</Name>
        <Affiliation>Department of Food and Nutrition, College of Human Ecology, Hanyang University, Seoul 133-791, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Johnnye Lewis</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA; Community Environmental Health Program, University of New Mexico Health Sciences Center College of Pharmacy, Albuquerque, NM 87131, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Laurie G. Hudson</Name>
        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA. Electronic address: lhudson@salud.unm.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The role of microRNAs in the development and progression of chemical-associated cancers.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26621330</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(15)30140-X</DOI>
    <KeywordList>
      <Keywords>Cancer</Keywords>
      <Keywords>Chemical carcinogens</Keywords>
      <Keywords>Exposure</Keywords>
      <Keywords>microRNAs</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Igor P. Pogribny</Name>
        <Affiliation>Division of Biochemical Toxicology, National Center for Toxicological Research, United States Food and Drug Administration, Jefferson, AR 72079, USA. Electronic address: igor.pogribny@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Frederick A. Beland</Name>
        <Affiliation>Division of Biochemical Toxicology, National Center for Toxicological Research, United States Food and Drug Administration, Jefferson, AR 72079, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Ivan Rusyn</Name>
        <Affiliation>Department of Veterinary Integrative Biosciences, Texas A&amp;M University, College Station, TX 77843, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Aryl hydrocarbon receptor-dependent up-regulation of the heterodimeric amino acid transporter LAT1 (SLC7A5)/CD98hc (SLC3A2) by diesel exhaust particle extract in human bronchial epithelial cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26621329</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.11.014</DOI>
    <KeywordList>
      <Keywords>Amino acid transporter</Keywords>
      <Keywords>Aryl hydrocarbon receptor</Keywords>
      <Keywords>Diesel exhaust particle</Keywords>
      <Keywords>Leucin</Keywords>
      <Keywords>Lung</Keywords>
      <Keywords>Matrix metalloproteinase-2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Marc Le Vee</Name>
        <Affiliation>Institut de Recherches en Santé, Environnement et Travail (IRSET), UMR INSERM U1085, Faculté de Pharmacie, 2 Avenue du Pr Léon Bernard, 35043 Rennes, France.</Affiliation>
      </Author>
      <Author>
        <Name>Elodie Jouan</Name>
        <Affiliation>Institut de Recherches en Santé, Environnement et Travail (IRSET), UMR INSERM U1085, Faculté de Pharmacie, 2 Avenue du Pr Léon Bernard, 35043 Rennes, France.</Affiliation>
      </Author>
      <Author>
        <Name>Valérie Lecureur</Name>
        <Affiliation>Institut de Recherches en Santé, Environnement et Travail (IRSET), UMR INSERM U1085, Faculté de Pharmacie, 2 Avenue du Pr Léon Bernard, 35043 Rennes, France.</Affiliation>
      </Author>
      <Author>
        <Name>Olivier Fardel</Name>
        <Affiliation>Institut de Recherches en Santé, Environnement et Travail (IRSET), UMR INSERM U1085, Faculté de Pharmacie, 2 Avenue du Pr Léon Bernard, 35043 Rennes, France; Pôle Biologie, Centre Hospitalier Universitaire, 2 rue Henri Le Guilloux, 35033 Rennes, France. Electronic address: olivier.fardel@univ-rennes1.fr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Improved bioavailability of targeted Curcumin delivery efficiently regressed cardiac hypertrophy by modulating apoptotic load within cardiac microenvironment.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26612707</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.11.011</DOI>
    <KeywordList>
      <Keywords>Cardiac hypertrophy</Keywords>
      <Keywords>Cardiomyocyte apoptosis</Keywords>
      <Keywords>Cardiomyocyte targeted delivery</Keywords>
      <Keywords>Curcumin</Keywords>
      <Keywords>p53 ubiquitination</Keywords>
      <Keywords>p53–p300 interaction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Aramita Ray</Name>
        <Affiliation>Genetics and Molecular Cardiology Laboratory, Department of Zoology, University of Calcutta, 35, Ballygunge Circular Road, Kolkata 700 019, West Bengal, India. Electronic address: aramitaray@yahoo.co.in.</Affiliation>
      </Author>
      <Author>
        <Name>Santanu Rana</Name>
        <Affiliation>Genetics and Molecular Cardiology Laboratory, Department of Zoology, University of Calcutta, 35, Ballygunge Circular Road, Kolkata 700 019, West Bengal, India. Electronic address: rana.santanu@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Durba Banerjee</Name>
        <Affiliation>Genetics and Molecular Cardiology Laboratory, Department of Zoology, University of Calcutta, 35, Ballygunge Circular Road, Kolkata 700 019, West Bengal, India. Electronic address: durba.research@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Arkadeep Mitra</Name>
        <Affiliation>Genetics and Molecular Cardiology Laboratory, Department of Zoology, University of Calcutta, 35, Ballygunge Circular Road, Kolkata 700 019, West Bengal, India. Electronic address: arkadeep.mitra@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ritwik Datta</Name>
        <Affiliation>Genetics and Molecular Cardiology Laboratory, Department of Zoology, University of Calcutta, 35, Ballygunge Circular Road, Kolkata 700 019, West Bengal, India. Electronic address: rdatta30@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Shaon Naskar</Name>
        <Affiliation>Genetics and Molecular Cardiology Laboratory, Department of Zoology, University of Calcutta, 35, Ballygunge Circular Road, Kolkata 700 019, West Bengal, India. Electronic address: shaon.me@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Sagartirtha Sarkar</Name>
        <Affiliation>Genetics and Molecular Cardiology Laboratory, Department of Zoology, University of Calcutta, 35, Ballygunge Circular Road, Kolkata 700 019, West Bengal, India. Electronic address: sagartirtha.sarkar@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Tissue-specific in vivo genetic toxicity of nine polycyclic aromatic hydrocarbons assessed using the Muta™Mouse transgenic rodent assay.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26603514</pubmedLink>
    <GrantList>
      <Grant>C313/A14329</Grant>
      <Grant>101126/B/13/Z</Grant>
      <Grant>101126/Z/13/Z</Grant>
      <Grant>101126</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.11.010</DOI>
    <KeywordList>
      <Keywords>Genotoxicity</Keywords>
      <Keywords>Micronucleus</Keywords>
      <Keywords>Mutation</Keywords>
      <Keywords>Muta™Mouse</Keywords>
      <Keywords>Polycyclic aromatic hydrocarbon</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Alexandra S. Long</Name>
        <Affiliation>Faculty of Graduate and Postdoctoral Studies, Department of Biology, University of Ottawa, Ottawa, ON, Canada; Mechanistic Studies Division, Environmental Health Science and Research Bureau, Health Canada, Ottawa, ON, Canada. Electronic address: alexandra.long@hc-sc.gc.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Christine L. Lemieux</Name>
        <Affiliation>Air Health Science Division, Water and Air Quality Bureau, Health Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Volker M. Arlt</Name>
        <Affiliation>Analytical and Environmental Sciences Division, MRC-PHE Centre for Environment and Health, King's College London, London, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Paul A. White</Name>
        <Affiliation>Faculty of Graduate and Postdoctoral Studies, Department of Biology, University of Ottawa, Ottawa, ON, Canada; Mechanistic Studies Division, Environmental Health Science and Research Bureau, Health Canada, Ottawa, ON, Canada.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Grouping nanomaterials to predict their potential to induce pulmonary inflammation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26603513</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.11.009</DOI>
    <KeywordList>
      <Keywords>Grouping</Keywords>
      <Keywords>Inhalation toxicology</Keywords>
      <Keywords>Nanoparticles</Keywords>
      <Keywords>Risk assessment</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hedwig M. Braakhuis</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands; Department of Toxicogenomics, Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands. Electronic address: hedwig.braakhuis@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>Agnes G. Oomen</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands.</Affiliation>
      </Author>
      <Author>
        <Name>Flemming R. Cassee</Name>
        <Affiliation>National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands; Institute of Risk Assessment Sciences, Utrecht University, PO Box 80.163, 3508 TD Utrecht, The Netherlands.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The estrogen-dependent baroreflex dysfunction caused by nicotine in female rats is mediated via NOS/HO inhibition: Role of sGC/PI3K/MAPKERK.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26597895</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.10.014</DOI>
    <KeywordList>
      <Keywords>Arterial baroreceptors</Keywords>
      <Keywords>Estrogen</Keywords>
      <Keywords>Heme oxygenase</Keywords>
      <Keywords>Mitogen activated protein kinases</Keywords>
      <Keywords>Nicotine</Keywords>
      <Keywords>Nitric oxide synthase</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mohamed A. Fouda</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Hanan M. El-Gowelli</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Sahar M. El-Gowilly</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Mahmoud M. El-Mas</Name>
        <Affiliation>Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Egypt. Electronic address: mahelm@hotmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The concept of bio-corona in modulating the toxicity of engineered nanomaterials (ENM).</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26592323</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.11.008</DOI>
    <KeywordList>
      <Keywords>Corona</Keywords>
      <Keywords>Nanomedicine</Keywords>
      <Keywords>Nanotoxicology</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dana Westmeier</Name>
        <Affiliation>Department of Nanobiomedicine/ENT, University Medical Center of Mainz, Langenbeckstr. 1, 55101 Mainz, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Roland H. Stauber</Name>
        <Affiliation>Department of Nanobiomedicine/ENT, University Medical Center of Mainz, Langenbeckstr. 1, 55101 Mainz, Germany.</Affiliation>
      </Author>
      <Author>
        <Name>Dominic Docter</Name>
        <Affiliation>Department of Nanobiomedicine/ENT, University Medical Center of Mainz, Langenbeckstr. 1, 55101 Mainz, Germany. Electronic address: docter@uni-mainz.de.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Fibroblast growth factor 21 attenuates hepatic fibrogenesis through TGF-β/smad2/3 and NF-κB signaling pathways.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26592322</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.11.012</DOI>
    <KeywordList>
      <Keywords>Fibroblast growth factor 21</Keywords>
      <Keywords>Hepatic fibrogenesis</Keywords>
      <Keywords>Hepatic stellate cells</Keywords>
      <Keywords>NF-κB</Keywords>
      <Keywords>TGF-β</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Pengfei Xu</Name>
        <Affiliation>Biopharmaceutical Lab, College of Life Science, Northeast Agricultural University, Harbin, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yingjie Zhang</Name>
        <Affiliation>Biopharmaceutical Lab, College of Life Science, Northeast Agricultural University, Harbin, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yunye Liu</Name>
        <Affiliation>Biopharmaceutical Lab, College of Life Science, Northeast Agricultural University, Harbin, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Qingyan Yuan</Name>
        <Affiliation>Biopharmaceutical Lab, College of Life Science, Northeast Agricultural University, Harbin, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Liying Song</Name>
        <Affiliation>Biopharmaceutical Lab, College of Life Science, Northeast Agricultural University, Harbin, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Mingyao Liu</Name>
        <Affiliation>Biopharmaceutical Lab, College of Life Science, Northeast Agricultural University, Harbin, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhihang Liu</Name>
        <Affiliation>Biopharmaceutical Lab, College of Life Science, Northeast Agricultural University, Harbin, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yongbi Yang</Name>
        <Affiliation>Biopharmaceutical Lab, College of Life Science, Northeast Agricultural University, Harbin, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Junyan Li</Name>
        <Affiliation>Biopharmaceutical Lab, College of Life Science, Northeast Agricultural University, Harbin, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Deshan Li</Name>
        <Affiliation>Biopharmaceutical Lab, College of Life Science, Northeast Agricultural University, Harbin, PR China. Electronic address: deshanli@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Guiping Ren</Name>
        <Affiliation>Biopharmaceutical Lab, College of Life Science, Northeast Agricultural University, Harbin, PR China. Electronic address: renguiping@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Histone deacetylase inhibitor trichostatin A resensitizes gemcitabine resistant urothelial carcinoma cells via suppression of TG-interacting factor.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26589485</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.11.007</DOI>
    <KeywordList>
      <Keywords>AKT</Keywords>
      <Keywords>Gemcitabine resistance</Keywords>
      <Keywords>TG-interacting factor</Keywords>
      <Keywords>Trichostatin A</Keywords>
      <Keywords>Urothelial carcinoma</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bi Wen Yeh</Name>
        <Affiliation>Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan; Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Urology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Ming Li</Name>
        <Affiliation>Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Urology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Ching Chia Li</Name>
        <Affiliation>Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Urology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Urology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Wan Yi Kang</Name>
        <Affiliation>Department of Pathology, Kuo General Hospital, Tainan 701, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chun Nung Huang</Name>
        <Affiliation>Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Urology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Tzyh Chyuan Hour</Name>
        <Affiliation>Institute of Biochemistry, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Zi Miao Liu</Name>
        <Affiliation>Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Jeng Wu</Name>
        <Affiliation>Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Urology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Urology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan. Electronic address: wejewu@kmu.edu.tw.</Affiliation>
      </Author>
      <Author>
        <Name>Huei Sheng Huang</Name>
        <Affiliation>Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan. Electronic address: huanghs@mail.ncku.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Developmental cuprizone exposure impairs oligodendrocyte lineages differentially in cortical and white matter tissues and suppresses glutamatergic neurogenesis signals and synaptic plasticity in the hippocampal dentate gyrus of rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26577399</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.11.006</DOI>
    <KeywordList>
      <Keywords>Cuprizone (CPZ)</Keywords>
      <Keywords>Expression microarray</Keywords>
      <Keywords>Glial cell development</Keywords>
      <Keywords>Klotho</Keywords>
      <Keywords>Myelinogenesis</Keywords>
      <Keywords>Neuronal plasticity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Hajime Abe</Name>
        <Affiliation>Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shi, Tokyo 183-8509, Japan; Pathogenetic Veterinary Science, United Graduate School of Veterinary Sciences, Gifu University, 1-1 Yanagido, Gifu-shi, Gifu 501-1193, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Fumiyo Saito</Name>
        <Affiliation>Chemicals Evaluation and Research Institute, Japan, 1-4-25 Koraku, Bunkyo-ku, Tokyo 112-0004, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Takeshi Tanaka</Name>
        <Affiliation>Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shi, Tokyo 183-8509, Japan; Pathogenetic Veterinary Science, United Graduate School of Veterinary Sciences, Gifu University, 1-1 Yanagido, Gifu-shi, Gifu 501-1193, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Sayaka Mizukami</Name>
        <Affiliation>Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shi, Tokyo 183-8509, Japan; Pathogenetic Veterinary Science, United Graduate School of Veterinary Sciences, Gifu University, 1-1 Yanagido, Gifu-shi, Gifu 501-1193, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yasuko Hasegawa-Baba</Name>
        <Affiliation>Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shi, Tokyo 183-8509, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Nobuya Imatanaka</Name>
        <Affiliation>Chemicals Evaluation and Research Institute, Japan, 1-4-25 Koraku, Bunkyo-ku, Tokyo 112-0004, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yumi Akahori</Name>
        <Affiliation>Chemicals Evaluation and Research Institute, Japan, 1-4-25 Koraku, Bunkyo-ku, Tokyo 112-0004, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Toshinori Yoshida</Name>
        <Affiliation>Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shi, Tokyo 183-8509, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Makoto Shibutani</Name>
        <Affiliation>Laboratory of Veterinary Pathology, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu-shi, Tokyo 183-8509, Japan. Electronic address: mshibuta@cc.tuat.ac.jp.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Oleanolic acid acetate inhibits rheumatoid arthritis by modulating T cell immune responses and matrix-degrading enzymes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26570984</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.11.005</DOI>
    <KeywordList>
      <Keywords>Collagen-induced arthritis</Keywords>
      <Keywords>Inflammatory cytokine</Keywords>
      <Keywords>Lymph nodes</Keywords>
      <Keywords>Matrix metalloproteinase</Keywords>
      <Keywords>Oleanolic acid acetate</Keywords>
      <Keywords>Synovial fibroblasts</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jin Kyeong Choi</Name>
        <Affiliation>Department of Pharmacology, School of Medicine, Kyungpook National University, Daegu 700-422, Republic of Korea; Molecular Immunology Section, Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sung Wan Kim</Name>
        <Affiliation>Department of Thoracic and Cardiovascular Surgery, CHA Gumi Medical Center, CHA University, Gumi 730-040, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Duk Sil Kim</Name>
        <Affiliation>Department of Thoracic and Cardiovascular Surgery, CHA Gumi Medical Center, CHA University, Gumi 730-040, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jong Yeong Lee</Name>
        <Affiliation>Department of Pharmacology, School of Medicine, Kyungpook National University, Daegu 700-422, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Soyoung Lee</Name>
        <Affiliation>Department of Pharmacology, School of Medicine, Kyungpook National University, Daegu 700-422, Republic of Korea; Bio-Materials Research Institute, Korea Research Institute of Bioscience and Biotechnology, Jeongeup 580-185, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyun Mee Oh</Name>
        <Affiliation>Bio-Materials Research Institute, Korea Research Institute of Bioscience and Biotechnology, Jeongeup 580-185, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Yeong Su Ha</Name>
        <Affiliation>Department of Molecular Medicine, School of Medicine, Kyungpook National University, Daegu 700-422, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Jeongsoo Yoo</Name>
        <Affiliation>Department of Molecular Medicine, School of Medicine, Kyungpook National University, Daegu 700-422, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Pil Hoon Park</Name>
        <Affiliation>College of Pharmacy, Yeungnam University, Gyeongbuk 712-749, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Tae Yong Shin</Name>
        <Affiliation>College of Pharmacy, Woosuk University, Jeonju 565-701, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Taeg Kyu Kwon</Name>
        <Affiliation>Department of Immunology, School of Medicine, Keimyung University, Daegu 704-701, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Mun Chual Rho</Name>
        <Affiliation>Bio-Materials Research Institute, Korea Research Institute of Bioscience and Biotechnology, Jeongeup 580-185, Republic of Korea. Electronic address: rho-m@kribb.re.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Sang Hyun Kim</Name>
        <Affiliation>Department of Pharmacology, School of Medicine, Kyungpook National University, Daegu 700-422, Republic of Korea. Electronic address: shkim72@knu.ac.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Integrative analysis of genes and miRNA alterations in human embryonic stem cells-derived neural cells after exposure to silver nanoparticles.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26551752</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.11.004</DOI>
    <KeywordList>
      <Keywords>Developmental neurotoxicity</Keywords>
      <Keywords>Gene expression profiling</Keywords>
      <Keywords>Human embryonic stem cells derived neural cells</Keywords>
      <Keywords>Nanotoxicity</Keywords>
      <Keywords>Silver nanoparticles</Keywords>
      <Keywords>miRNA profiling</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jung Hwa Oh</Name>
        <Affiliation>Korea Institute of Toxicology (KIT), Daejeon 34114, Republic of Korea; Department of human and environmental toxicology, University of Science &amp; Technology, Daejeon 34113, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Mi Young Son</Name>
        <Affiliation>Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahangno, Yuseong-gu, Daejeon 34141, Republic of Korea; Department of functional genomics, University of Science &amp; Technology, 217 Gajungro, Yuseong-gu, Daejeon 34113, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Mi Sun Choi</Name>
        <Affiliation>Korea Institute of Toxicology (KIT), Daejeon 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Soojin Kim</Name>
        <Affiliation>Korea Institute of Toxicology (KIT), Daejeon 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>A. Young Choi</Name>
        <Affiliation>Korea Institute of Toxicology (KIT), Daejeon 34114, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Hyang Ae Lee</Name>
        <Affiliation>Korea Institute of Toxicology (KIT), Daejeon 34114, Republic of Korea; Department of human and environmental toxicology, University of Science &amp; Technology, Daejeon 34113, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Ki Suk Kim</Name>
        <Affiliation>Korea Institute of Toxicology (KIT), Daejeon 34114, Republic of Korea; Department of human and environmental toxicology, University of Science &amp; Technology, Daejeon 34113, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Janghwan Kim</Name>
        <Affiliation>Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahangno, Yuseong-gu, Daejeon 34141, Republic of Korea; Department of functional genomics, University of Science &amp; Technology, 217 Gajungro, Yuseong-gu, Daejeon 34113, Republic of Korea.</Affiliation>
      </Author>
      <Author>
        <Name>Chang Woo Song</Name>
        <Affiliation>Korea Institute of Toxicology (KIT), Daejeon 34114, Republic of Korea; Department of human and environmental toxicology, University of Science &amp; Technology, Daejeon 34113, Republic of Korea. Electronic address: cwsong@kitox.re.kr.</Affiliation>
      </Author>
      <Author>
        <Name>Seokjoo Yoon</Name>
        <Affiliation>Korea Institute of Toxicology (KIT), Daejeon 34114, Republic of Korea; Department of human and environmental toxicology, University of Science &amp; Technology, Daejeon 34113, Republic of Korea. Electronic address: sjyoon@kitox.re.kr.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Carbon black nanoparticles induce biphasic gene expression changes associated with inflammatory responses in the lungs of C57BL/6 mice following a single intratracheal instillation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26551751</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.11.003</DOI>
    <KeywordList>
      <Keywords>Biphasic response</Keywords>
      <Keywords>Carbon black nanoparticles</Keywords>
      <Keywords>Cell cycle regulation</Keywords>
      <Keywords>DNA repair</Keywords>
      <Keywords>Inflammation</Keywords>
      <Keywords>Muscle contraction</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Mainul Husain</Name>
        <Affiliation>Environmental Health Science and Research Bureau, Healthy Environments and Consumer Safety Branch, Health Canada, Ottawa, ON, Canada. Electronic address: mainul.husain@hc-sc.gc.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Zdenka O. Kyjovska</Name>
        <Affiliation>National Research Centre for the Working Environment, Copenhagen, Denmark. Electronic address: zky@nrcwe.dk.</Affiliation>
      </Author>
      <Author>
        <Name>Julie Bourdon-Lacombe</Name>
        <Affiliation>Water and Air Quality Bureau, Safe Environments Directorate, HECSB, Health Canada, Ottawa, ON, Canada. Electronic address: julie.bourdon-lacombe@hc-sc.gc.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Anne T. Saber</Name>
        <Affiliation>National Research Centre for the Working Environment, Copenhagen, Denmark. Electronic address: ats@nrcwe.dk.</Affiliation>
      </Author>
      <Author>
        <Name>Keld A. Jensen</Name>
        <Affiliation>National Research Centre for the Working Environment, Copenhagen, Denmark. Electronic address: kaj@arbejdsmiljoforskning.dk.</Affiliation>
      </Author>
      <Author>
        <Name>Nicklas R. Jacobsen</Name>
        <Affiliation>National Research Centre for the Working Environment, Copenhagen, Denmark. Electronic address: nrj@nrcwe.dk.</Affiliation>
      </Author>
      <Author>
        <Name>Andrew Williams</Name>
        <Affiliation>Environmental Health Science and Research Bureau, Healthy Environments and Consumer Safety Branch, Health Canada, Ottawa, ON, Canada. Electronic address: andrew.williams@hc-sc.gc.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Håkan Wallin</Name>
        <Affiliation>National Research Centre for the Working Environment, Copenhagen, Denmark; Institute of Public Health, University of Copenhagen, Denmark. Electronic address: hwa@nrcwe.dk.</Affiliation>
      </Author>
      <Author>
        <Name>Sabina Halappanavar</Name>
        <Affiliation>Environmental Health Science and Research Bureau, Healthy Environments and Consumer Safety Branch, Health Canada, Ottawa, ON, Canada. Electronic address: sabina.halappanavar@hc-sc.gc.ca.</Affiliation>
      </Author>
      <Author>
        <Name>Ulla Vogel</Name>
        <Affiliation>National Research Centre for the Working Environment, Copenhagen, Denmark; Institute of Micro- and Nanotechnology, Technical University of Denmark, Lyngby, Denmark. Electronic address: ubv@nrcwe.dk.</Affiliation>
      </Author>
      <Author>
        <Name>Carole L. Yauk</Name>
        <Affiliation>Environmental Health Science and Research Bureau, Healthy Environments and Consumer Safety Branch, Health Canada, Ottawa, ON, Canada. Electronic address: carole.yauk@hc-sc.gc.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>PFOS induces adipogenesis and glucose uptake in association with activation of Nrf2 signaling pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26548598</pubmedLink>
    <GrantList>
      <Grant>P20 GM103430</Grant>
      <Grant>P20 RR016457</Grant>
      <Grant>5R01ES016042</Grant>
      <Grant>5K22ES013782</Grant>
      <Grant>P20RR016457-10</Grant>
      <Grant>R15 ES025404</Grant>
      <Grant>K22 ES013782</Grant>
      <Grant>R01 ES016042</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.11.002</DOI>
    <KeywordList>
      <Keywords>ARE</Keywords>
      <Keywords>Adipogenesis</Keywords>
      <Keywords>Glucose uptake</Keywords>
      <Keywords>Nrf2</Keywords>
      <Keywords>PFOS</Keywords>
      <Keywords>Pparγ</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jialin Xu</Name>
        <Affiliation>Institute of Biochemistry and Molecular Biology, College of Life and Health Sciences, Northeastern University, Shenyang 110819, PR China; Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, RI 02881, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Prajakta Shimpi</Name>
        <Affiliation>Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, RI 02881, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Laura Armstrong</Name>
        <Affiliation>Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, RI 02881, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Deanna Salter</Name>
        <Affiliation>Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, RI 02881, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Angela L. Slitt</Name>
        <Affiliation>Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, RI 02881, United States. Electronic address: aslitt@uri.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Superoxide produced in the matrix of mitochondria enhances methylmercury toxicity in human neuroblastoma cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26545714</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.11.001</DOI>
    <KeywordList>
      <Keywords>Inorganic mercury</Keywords>
      <Keywords>Methylmercury</Keywords>
      <Keywords>Mitochondria</Keywords>
      <Keywords>Neurotoxicity</Keywords>
      <Keywords>ROS</Keywords>
      <Keywords>Superoxide</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Ryan J. Mailloux</Name>
        <Affiliation>University of Ottawa, Department of Biology, Center for Advanced Research in Environmental Genomics, Ottawa, ON, K1N 6N5, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Emmanuel Yumvihoze</Name>
        <Affiliation>University of Ottawa, Department of Biology, Center for Advanced Research in Environmental Genomics, Ottawa, ON, K1N 6N5, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Hing Man Chan</Name>
        <Affiliation>University of Ottawa, Department of Biology, Center for Advanced Research in Environmental Genomics, Ottawa, ON, K1N 6N5, Canada. Electronic address: laurie.chan@uottawa.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Genetic variation in metallothionein and metal-regulatory transcription factor 1 in relation to urinary cadmium, copper, and zinc.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26529669</pubmedLink>
    <GrantList>
      <Grant>U54 CA132383</Grant>
      <Grant>U01 CA063731</Grant>
      <Grant>U54 CA132381</Grant>
      <Grant>R01CA097366</Grant>
      <Grant>K05 CA152715</Grant>
      <Grant>U54CA132381</Grant>
      <Grant>R01 CA097366</Grant>
      <Grant>U01CA63731</Grant>
      <Grant>U54CA132383</Grant>
    </GrantList>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.10.024</DOI>
    <KeywordList>
      <Keywords>Cadmium</Keywords>
      <Keywords>Copper</Keywords>
      <Keywords>Metal-regulatory transcription factor 1</Keywords>
      <Keywords>Metallothionein</Keywords>
      <Keywords>Zinc</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Scott V. Adams</Name>
        <Affiliation>Public Health Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109, USA. Electronic address: sadams@fhcrc.org.</Affiliation>
      </Author>
      <Author>
        <Name>Brian Barrick</Name>
        <Affiliation>Department of Plant and Environmental Sciences, New Mexico State University, Box 30003 MSC 3Q, Las Cruces, NM 88003, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Emily P. Christopher</Name>
        <Affiliation>Public Health Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Martin M. Shafer</Name>
        <Affiliation>Environmental Chemistry and Technology, Wisconsin State Laboratory of Hygiene, University of Wisconsin, 2601 Agriculture Dr., Madison, WI 53718, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Karen W. Makar</Name>
        <Affiliation>Public Health Science Biomarker Laboratory, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoling Song</Name>
        <Affiliation>Public Health Science Biomarker Laboratory, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Johanna W. Lampe</Name>
        <Affiliation>Public Health Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hugo Vilchis</Name>
        <Affiliation>Border Epidemiology and Environmental Health Center, New Mexico State University, Box 30001 MSC 3BEC, Las Cruces, NM 88003, USA.</Affiliation>
      </Author>
      <Author>
        <Name>April Ulery</Name>
        <Affiliation>Department of Plant and Environmental Sciences, New Mexico State University, Box 30003 MSC 3Q, Las Cruces, NM 88003, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Polly A. Newcomb</Name>
        <Affiliation>Public Health Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Arsenic induces structural and compositional colonic microbiome change and promotes host nitrogen and amino acid metabolism.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26529668</pubmedLink>
    <GrantList>
      <Grant>R01ES013781</Grant>
      <Grant>R01ES013781-02S1</Grant>
      <Grant>P20HL113452</Grant>
      <Grant>P20 HL113452</Grant>
      <Grant>R01 ES013781</Grant>
    </GrantList>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.10.020</DOI>
    <KeywordList>
      <Keywords>Arginine</Keywords>
      <Keywords>Arsenic</Keywords>
      <Keywords>Bacteroidetes</Keywords>
      <Keywords>Colon microbiome</Keywords>
      <Keywords>Firmicutes</Keywords>
      <Keywords>Nitrite/nitrate</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rishu Dheer</Name>
        <Affiliation>Department of Biological Sciences, Duquesne University, Pittsburgh, PA 15282, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jena Patterson</Name>
        <Affiliation>Department of Biological Sciences, Duquesne University, Pittsburgh, PA 15282, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Mark Dudash</Name>
        <Affiliation>Department of Biological Sciences, Duquesne University, Pittsburgh, PA 15282, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Elyse N. Stachler</Name>
        <Affiliation>Department of Civil and Environmental Engineering, University of Pittsburgh Swanson School of Engineering, Pittsburgh, PA 15261, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Kyle J. Bibby</Name>
        <Affiliation>Department of Civil and Environmental Engineering, University of Pittsburgh Swanson School of Engineering, Pittsburgh, PA 15261, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Donna B. Stolz</Name>
        <Affiliation>Department of Cell Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Sruti Shiva</Name>
        <Affiliation>Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh 15261, United States; Vascular Medicine Institute, University of Pittsburgh, Pittsburgh 15261, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Zeneng Wang</Name>
        <Affiliation>Department of Cellular and Molecular Medicine, Cleveland Clinic Lerner Research Institute, Cleveland, OH 44195, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Stanley L. Hazen</Name>
        <Affiliation>Department of Cellular and Molecular Medicine, Cleveland Clinic Lerner Research Institute, Cleveland, OH 44195, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Aaron Barchowsky</Name>
        <Affiliation>Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh 15261, United States; Vascular Medicine Institute, University of Pittsburgh, Pittsburgh 15261, United States; Department of Environmental and Occupational Health, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA 15219, United States. Electronic address: aab20@pitt.edu.</Affiliation>
      </Author>
      <Author>
        <Name>John F. Stolz</Name>
        <Affiliation>Department of Biological Sciences, Duquesne University, Pittsburgh, PA 15282, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Ghrelin protects against depleted uranium-induced apoptosis of MC3T3-E1 cells through oxidative stress-mediated p38-mitogen-activated protein kinase pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26529667</pubmedLink>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.10.022</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Depleted uranium</Keywords>
      <Keywords>Ghrelin</Keywords>
      <Keywords>Osteoblast</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Reactive oxygen species</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yuhui Hao</Name>
        <Affiliation>State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Combined Injury, Chongqing Engineering Research Center for Nanomedicine, College of Preventive Medicine, Third Military Medical University, No. 30 Gaotanyan Street, Shapingba District, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cong Liu</Name>
        <Affiliation>State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Combined Injury, Chongqing Engineering Research Center for Nanomedicine, College of Preventive Medicine, Third Military Medical University, No. 30 Gaotanyan Street, Shapingba District, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiawei Huang</Name>
        <Affiliation>State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Combined Injury, Chongqing Engineering Research Center for Nanomedicine, College of Preventive Medicine, Third Military Medical University, No. 30 Gaotanyan Street, Shapingba District, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Gu</Name>
        <Affiliation>State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Combined Injury, Chongqing Engineering Research Center for Nanomedicine, College of Preventive Medicine, Third Military Medical University, No. 30 Gaotanyan Street, Shapingba District, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Li</Name>
        <Affiliation>State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Combined Injury, Chongqing Engineering Research Center for Nanomedicine, College of Preventive Medicine, Third Military Medical University, No. 30 Gaotanyan Street, Shapingba District, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhangyou Yang</Name>
        <Affiliation>State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Combined Injury, Chongqing Engineering Research Center for Nanomedicine, College of Preventive Medicine, Third Military Medical University, No. 30 Gaotanyan Street, Shapingba District, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Liu</Name>
        <Affiliation>State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Combined Injury, Chongqing Engineering Research Center for Nanomedicine, College of Preventive Medicine, Third Military Medical University, No. 30 Gaotanyan Street, Shapingba District, Chongqing 400038, China.</Affiliation>
      </Author>
      <Author>
        <Name>Weidong Wang</Name>
        <Affiliation>Department of Radiation Oncology, Shanghai Jiao Tong University Affiliated Sixth People Hospital, Shanghai 200233, PR China. Electronic address: wwdwyl@sina.com.</Affiliation>
      </Author>
      <Author>
        <Name>Rong Li</Name>
        <Affiliation>State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Combined Injury, Chongqing Engineering Research Center for Nanomedicine, College of Preventive Medicine, Third Military Medical University, No. 30 Gaotanyan Street, Shapingba District, Chongqing 400038, China. Electronic address: yuhui_hao@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Osthole promotes neuronal differentiation and inhibits apoptosis via Wnt/β-catenin signaling in an Alzheimer's disease model.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26525509</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.10.013</DOI>
    <KeywordList>
      <Keywords>Alzheimer's disease</Keywords>
      <Keywords>Differentiation</Keywords>
      <Keywords>Neural stem cells</Keywords>
      <Keywords>Neurons</Keywords>
      <Keywords>Osthole</Keywords>
      <Keywords>Proliferation</Keywords>
      <Keywords>Wnt/β-catenin signaling</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yingjia Yao</Name>
        <Affiliation>School of Pharmacy, Liaoning University of Traditional Chinese Medicine; Dalian 116600, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhong Gao</Name>
        <Affiliation>Department of Interventional Therapy, Dalian Municipal Central Hospital, Dalian 116033, China.</Affiliation>
      </Author>
      <Author>
        <Name>Wenbo Liang</Name>
        <Affiliation>Medical College of Dalian University, Dalian 116600, Liaoning, China.</Affiliation>
      </Author>
      <Author>
        <Name>Liang Kong</Name>
        <Affiliation>School of Pharmacy, Liaoning University of Traditional Chinese Medicine; Dalian 116600, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanan Jiao</Name>
        <Affiliation>School of Pharmacy, Liaoning University of Traditional Chinese Medicine; Dalian 116600, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shaoheng Li</Name>
        <Affiliation>School of Pharmacy, Liaoning University of Traditional Chinese Medicine; Dalian 116600, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhenyu Tao</Name>
        <Affiliation>School of Pharmacy, Liaoning University of Traditional Chinese Medicine; Dalian 116600, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuhui Yan</Name>
        <Affiliation>School of Pharmacy, Liaoning University of Traditional Chinese Medicine; Dalian 116600, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingxian Yang</Name>
        <Affiliation>School of Pharmacy, Liaoning University of Traditional Chinese Medicine; Dalian 116600, China. Electronic address: jingxianyang@yahoo.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Prenatal nicotinic exposure upregulates pulmonary C-fiber NK1R expression to prolong pulmonary C-fiber-mediated apneic response.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26524655</pubmedLink>
    <GrantList>
      <Grant>HL119683</Grant>
      <Grant>HL-107462</Grant>
      <Grant>HL-96914</Grant>
      <Grant>R01 HL107462</Grant>
      <Grant>R01 HL119683</Grant>
    </GrantList>
    <Year>2016</Year>
    <DOI>10.1016/j.taap.2015.10.023</DOI>
    <KeywordList>
      <Keywords>Adenosine</Keywords>
      <Keywords>NK1R</Keywords>
      <Keywords>Nodose/jugular ganglion</Keywords>
      <Keywords>SIDS</Keywords>
      <Keywords>TRPV1</Keywords>
      <Keywords>nAChRs</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lei Zhao</Name>
        <Affiliation>Pathophysiology Program, Lovelace Respiratory Research Institute, Albuquerque, NM, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jianguo Zhuang</Name>
        <Affiliation>Pathophysiology Program, Lovelace Respiratory Research Institute, Albuquerque, NM, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Na Zang</Name>
        <Affiliation>Pathophysiology Program, Lovelace Respiratory Research Institute, Albuquerque, NM, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Lin</Name>
        <Affiliation>Pathophysiology Program, Lovelace Respiratory Research Institute, Albuquerque, NM, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lu Yuan Lee</Name>
        <Affiliation>Department of Physiology, University of Kentucky, Lexington, KY, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Fadi Xu</Name>
        <Affiliation>Pathophysiology Program, Lovelace Respiratory Research Institute, Albuquerque, NM, USA; Department of Physiology, University of Kentucky, Lexington, KY, USA. Electronic address: fxu@lrri.org.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>H2S induces vasoconstriction of rat cerebral arteries via cAMP/adenylyl cyclase pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26524654</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.10.021</DOI>
    <KeywordList>
      <Keywords>Cerebral artery</Keywords>
      <Keywords>Constriction</Keywords>
      <Keywords>Hydrogen sulfide</Keywords>
      <Keywords>Sodium hydrosulfide</Keywords>
      <Keywords>cAMP</Keywords>
      <Keywords>β-Adrenoceptor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sen Li</Name>
        <Affiliation>Department of Pharmacology, Medical College, Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Na Na Ping</Name>
        <Affiliation>Department of Pharmacology, Medical College, Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lei Cao</Name>
        <Affiliation>Department of Pharmacology, Medical College, Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China. Electronic address: leicao@mail.xjtu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Yan Ni Mi</Name>
        <Affiliation>Department of Pharmacology, Medical College, Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yong Xiao Cao</Name>
        <Affiliation>Department of Pharmacology, Medical College, Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China. Electronic address: yxy@xjtu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Development of a physiologically based pharmacokinetic model for assessment of human exposure to bisphenol A.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26522835</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.10.016</DOI>
    <KeywordList>
      <Keywords>BPA</Keywords>
      <Keywords>Bisphenol A</Keywords>
      <Keywords>Human</Keywords>
      <Keywords>PBPK</Keywords>
      <Keywords>Physiologically based pharmacokinetic model</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xiaoxia Yang</Name>
        <Affiliation>Division of Biochemical Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, United States. Electronic address: xiaoxia.yang@fda.hhs.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Daniel R. Doerge</Name>
        <Affiliation>Division of Biochemical Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Justin G. Teeguarden</Name>
        <Affiliation>Health Effects and Exposure Science, Pacific Northwest National Laboratory, Richland, WA 99352, United States; Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR 97331, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey W. Fisher</Name>
        <Affiliation>Division of Biochemical Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Selenite exacerbates hepatic insulin resistance in mouse model of type 2 diabetes through oxidative stress-mediated JNK pathway.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26522834</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.10.019</DOI>
    <KeywordList>
      <Keywords>Diabetes mellitus</Keywords>
      <Keywords>Insulin resistance</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Selenium</Keywords>
      <Keywords>Selenoprotein</Keywords>
      <Keywords>c-Jun N-terminal kinase</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jun Zhou</Name>
        <Affiliation>Hubei Key Laboratory of Bioinorganic Chemistry &amp; Materia Medica, School of Chemistry and Chemical Engineering, Huazhong University of Science and Technology, Wuhan 430074, PR China. Electronic address: hustzhj@hust.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Gang Xu</Name>
        <Affiliation>Hubei Key Laboratory of Bioinorganic Chemistry &amp; Materia Medica, School of Chemistry and Chemical Engineering, Huazhong University of Science and Technology, Wuhan 430074, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhaoshuai Bai</Name>
        <Affiliation>Hubei Key Laboratory of Bioinorganic Chemistry &amp; Materia Medica, School of Chemistry and Chemical Engineering, Huazhong University of Science and Technology, Wuhan 430074, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Kaicheng Li</Name>
        <Affiliation>Hubei Key Laboratory of Bioinorganic Chemistry &amp; Materia Medica, School of Chemistry and Chemical Engineering, Huazhong University of Science and Technology, Wuhan 430074, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Junyan Yan</Name>
        <Affiliation>Hubei Key Laboratory of Bioinorganic Chemistry &amp; Materia Medica, School of Chemistry and Chemical Engineering, Huazhong University of Science and Technology, Wuhan 430074, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Fen Li</Name>
        <Affiliation>Hubei Key Laboratory of Bioinorganic Chemistry &amp; Materia Medica, School of Chemistry and Chemical Engineering, Huazhong University of Science and Technology, Wuhan 430074, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Shuai Ma</Name>
        <Affiliation>Hubei Key Laboratory of Bioinorganic Chemistry &amp; Materia Medica, School of Chemistry and Chemical Engineering, Huazhong University of Science and Technology, Wuhan 430074, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Huibi Xu</Name>
        <Affiliation>Hubei Key Laboratory of Bioinorganic Chemistry &amp; Materia Medica, School of Chemistry and Chemical Engineering, Huazhong University of Science and Technology, Wuhan 430074, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Kaixun Huang</Name>
        <Affiliation>Hubei Key Laboratory of Bioinorganic Chemistry &amp; Materia Medica, School of Chemistry and Chemical Engineering, Huazhong University of Science and Technology, Wuhan 430074, PR China. Electronic address: hxxzrf@hust.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Application of physiologically-based pharmacokinetic modeling to explore the role of kidney transporters in renal reabsorption of perfluorooctanoic acid in the rat.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26522833</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
    </GrantList>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.10.017</DOI>
    <KeywordList>
      <Keywords>IVIVE</Keywords>
      <Keywords>Oat1</Keywords>
      <Keywords>Oat3</Keywords>
      <Keywords>Oatp1a1</Keywords>
      <Keywords>PBPK</Keywords>
      <Keywords>PFOA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Rachel Rogers Worley</Name>
        <Affiliation>Agency for Toxic Substances and Disease Registry, Division of Community Health Investigations, 4770 Buford Highway, Atlanta, GA 30341, United States; Interdisciplinary Toxicology Program, University of Georgia, 341 Pharmacy South, Athens, GA 30602, United States. Electronic address: idz7@cdc.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey Fisher</Name>
        <Affiliation>Interdisciplinary Toxicology Program, University of Georgia, 341 Pharmacy South, Athens, GA 30602, United States; Food and Drug Administration, National Center for Toxicological Research, 3900 NCTR Road, Jefferson, AR 72079, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Omeprazole increases the efficacy of a soluble epoxide hydrolase inhibitor in a PGE₂ induced pain model.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26522832</pubmedLink>
    <GrantList>
      <Grant>P42ES004699</Grant>
      <Grant>R01 ES002710</Grant>
      <Grant>P42 ES004699</Grant>
      <Grant>R21 AR062866</Grant>
      <Grant>T32 GM099608</Grant>
      <Grant>R21AR062866</Grant>
    </GrantList>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.10.018</DOI>
    <KeywordList>
      <Keywords>Cytochrome P450 1A</Keywords>
      <Keywords>Epoxyeicosatrienoic acid</Keywords>
      <Keywords>Omeprazole</Keywords>
      <Keywords>Prostaglandin E(2) induced hyperalgesia</Keywords>
      <Keywords>Time dependent P450 induction</Keywords>
      <Keywords>sEH inhibitor TPPU</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sumanta Kumar Goswami</Name>
        <Affiliation>Department of Entomology and Nematology, UC Davis Comprehensive Cancer Center, University of California, Davis, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bora Inceoglu</Name>
        <Affiliation>Department of Entomology and Nematology, UC Davis Comprehensive Cancer Center, University of California, Davis, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Yang</Name>
        <Affiliation>Department of Entomology and Nematology, UC Davis Comprehensive Cancer Center, University of California, Davis, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Debin Wan</Name>
        <Affiliation>Department of Entomology and Nematology, UC Davis Comprehensive Cancer Center, University of California, Davis, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sean D. Kodani</Name>
        <Affiliation>Department of Entomology and Nematology, UC Davis Comprehensive Cancer Center, University of California, Davis, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Carlos Antonio Trindade da Silva</Name>
        <Affiliation>Department of Entomology and Nematology, UC Davis Comprehensive Cancer Center, University of California, Davis, CA, USA; Department of Genetics and Biochemistry, Federal University of Uberlandia, MG, Brazil.</Affiliation>
      </Author>
      <Author>
        <Name>Christophe Morisseau</Name>
        <Affiliation>Department of Entomology and Nematology, UC Davis Comprehensive Cancer Center, University of California, Davis, CA, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Bruce D. Hammock</Name>
        <Affiliation>Department of Entomology and Nematology, UC Davis Comprehensive Cancer Center, University of California, Davis, CA, USA. Electronic address: bdhammock@ucdavis.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Exposure to coplanar PCBs induces endothelial cell inflammation through epigenetic regulation of NF-κB subunit p65.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26519613</pubmedLink>
    <GrantList>
      <Grant>P42 ES007380</Grant>
      <Grant>8 P20 GM103527</Grant>
      <Grant>T32 ES007266</Grant>
      <Grant>P42ES007380</Grant>
      <Grant>P20 GM103527</Grant>
    </GrantList>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.10.015</DOI>
    <KeywordList>
      <Keywords>ER-α</Keywords>
      <Keywords>Epigenetics and vascular inflammation</Keywords>
      <Keywords>H3K9me3</Keywords>
      <Keywords>JMJD2B</Keywords>
      <Keywords>PCBs</Keywords>
      <Keywords>p65</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Dandan Liu</Name>
        <Affiliation>Superfund Research Center, University of Kentucky, Lexington, KY 40536, United States; Department of Animal and Food Sciences, College of Agriculture, Food and Environment, University of Kentucky, Lexington, KY 40536, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jordan T. Perkins</Name>
        <Affiliation>Superfund Research Center, University of Kentucky, Lexington, KY 40536, United States; Department of Animal and Food Sciences, College of Agriculture, Food and Environment, University of Kentucky, Lexington, KY 40536, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Michael C. Petriello</Name>
        <Affiliation>Superfund Research Center, University of Kentucky, Lexington, KY 40536, United States; Graduate Center for Toxicology and Cancer Biology, College of Medicine, University of Kentucky, Lexington, KY 40536, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Bernhard Hennig</Name>
        <Affiliation>Superfund Research Center, University of Kentucky, Lexington, KY 40536, United States; Department of Animal and Food Sciences, College of Agriculture, Food and Environment, University of Kentucky, Lexington, KY 40536, United States. Electronic address: bhennig@uky.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Resveratrol alleviates diabetes-induced testicular dysfunction by inhibiting oxidative stress and c-Jun N-terminal kinase signaling in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26499206</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.10.012</DOI>
    <KeywordList>
      <Keywords>Antioxidants</Keywords>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Hyperglycemia</Keywords>
      <Keywords>MAPKs</Keywords>
      <Keywords>Male Reproductive System</Keywords>
      <Keywords>Oxidative Stress</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Iman Faid</Name>
        <Affiliation>Department of Anatomy, Faculty of Medicine, Kuwait University, Kuwait.</Affiliation>
      </Author>
      <Author>
        <Name>Heba Al-Hussaini</Name>
        <Affiliation>Department of Anatomy, Faculty of Medicine, Kuwait University, Kuwait.</Affiliation>
      </Author>
      <Author>
        <Name>Narayana Kilarkaje</Name>
        <Affiliation>Department of Anatomy, Faculty of Medicine, Kuwait University, Kuwait. Electronic address: knarayana@hsc.edu.kw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effects of sexually dimorphic growth hormone secretory patterns on arachidonic acid metabolizing enzymes in rodent heart.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26493931</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.10.011</DOI>
    <KeywordList>
      <Keywords>Arachidonic acid</Keywords>
      <Keywords>Cytochrome P450</Keywords>
      <Keywords>Growth hormone</Keywords>
      <Keywords>Sexual dimorphism</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Furong Zhang</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xuming Yu</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunyan He</Name>
        <Affiliation>Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiufang Ouyang</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jinhua Wu</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jie Li</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Junjie Zhang</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xuejiao Duan</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yu Wan</Name>
        <Affiliation>Department of Physiology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jiang Yue</Name>
        <Affiliation>Department of Pharmacology, School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China. Electronic address: yuejiang@whu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Exposure to bisphenol A in young adult mice does not alter ovulation but does alter the fertilization ability of oocytes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26493930</pubmedLink>
    <GrantList>
      <Grant>P50-HD28934</Grant>
    </GrantList>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.10.010</DOI>
    <KeywordList>
      <Keywords>Bisphenol A</Keywords>
      <Keywords>In vitro fertilization</Keywords>
      <Keywords>In vivo fertilization</Keywords>
      <Keywords>Oocyte</Keywords>
      <Keywords>Ovulation</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Teresita Rocio Moore-Ambriz</Name>
        <Affiliation>Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav-IPN), Av. Instituto Politécnico Nacional 2508, Col. San Pedro Zacatenco, México D.F. 07360, México.</Affiliation>
      </Author>
      <Author>
        <Name>Deyanira Guadalupe Acuña-Hernández</Name>
        <Affiliation>Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav-IPN), Av. Instituto Politécnico Nacional 2508, Col. San Pedro Zacatenco, México D.F. 07360, México.</Affiliation>
      </Author>
      <Author>
        <Name>Brenda Ramos-Robles</Name>
        <Affiliation>Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav-IPN), Av. Instituto Politécnico Nacional 2508, Col. San Pedro Zacatenco, México D.F. 07360, México.</Affiliation>
      </Author>
      <Author>
        <Name>Manuel Sánchez-Gutiérrez</Name>
        <Affiliation>Área Académica de Medicina, Instituto de Ciencias de la Salud, Universidad Autónoma del Estado de Hidalgo, Pachuca, Hidalgo 42000, México.</Affiliation>
      </Author>
      <Author>
        <Name>Ramsés Santacruz-Márquez</Name>
        <Affiliation>Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav-IPN), Av. Instituto Politécnico Nacional 2508, Col. San Pedro Zacatenco, México D.F. 07360, México.</Affiliation>
      </Author>
      <Author>
        <Name>Adolfo Sierra-Santoyo</Name>
        <Affiliation>Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav-IPN), Av. Instituto Politécnico Nacional 2508, Col. San Pedro Zacatenco, México D.F. 07360, México.</Affiliation>
      </Author>
      <Author>
        <Name>Belem Piña-Guzmán</Name>
        <Affiliation>Instituto Politécnico Nacional-UPIBI, México D.F. 07738, México.</Affiliation>
      </Author>
      <Author>
        <Name>Mineko Shibayama</Name>
        <Affiliation>Departamento de Infectómica y Patogénesis Molecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav-IPN), Av. Instituto Politécnico Nacional 2508, Col. San Pedro Zacatenco, México D.F. 07360, México.</Affiliation>
      </Author>
      <Author>
        <Name>Isabel Hernández-Ochoa</Name>
        <Affiliation>Departamento de Toxicología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional (Cinvestav-IPN), Av. Instituto Politécnico Nacional 2508, Col. San Pedro Zacatenco, México D.F. 07360, México. Electronic address: mihernandez@cinvestav.mx.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Low dose evaluation of the antiandrogen flutamide following a Mode of Action approach.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26485406</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.10.009</DOI>
    <KeywordList>
      <Keywords>Flutamide</Keywords>
      <Keywords>Leydig cell hyperplasia</Keywords>
      <Keywords>Low-dose</Keywords>
      <Keywords>Mode of action</Keywords>
      <Keywords>Threshold</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>A. Sarrabay</Name>
        <Affiliation>INSERM, Université Paris-Sud, Faculté de Pharmacie, Châtenay-Malabry, France; UniverSud, INSERM, UMR-996 "Inflammation, Chemokines and Immunopathology", Châtenay-Malabry, France; Bayer SAS, 16, rue Jean Marie Leclair, 69009 Lyon, France.</Affiliation>
      </Author>
      <Author>
        <Name>C. Hilmi</Name>
        <Affiliation>Bayer SAS, 16, rue Jean Marie Leclair, 69009 Lyon, France.</Affiliation>
      </Author>
      <Author>
        <Name>H. Tinwell</Name>
        <Affiliation>Bayer SAS, 16, rue Jean Marie Leclair, 69009 Lyon, France.</Affiliation>
      </Author>
      <Author>
        <Name>F. Schorsch</Name>
        <Affiliation>Bayer SAS, 16, rue Jean Marie Leclair, 69009 Lyon, France.</Affiliation>
      </Author>
      <Author>
        <Name>M. Pallardy</Name>
        <Affiliation>INSERM, Université Paris-Sud, Faculté de Pharmacie, Châtenay-Malabry, France; UniverSud, INSERM, UMR-996 "Inflammation, Chemokines and Immunopathology", Châtenay-Malabry, France.</Affiliation>
      </Author>
      <Author>
        <Name>R. Bars</Name>
        <Affiliation>Bayer SAS, 16, rue Jean Marie Leclair, 69009 Lyon, France.</Affiliation>
      </Author>
      <Author>
        <Name>D. Rouquié</Name>
        <Affiliation>Bayer SAS, 16, rue Jean Marie Leclair, 69009 Lyon, France. Electronic address: david.rouquie@bayer.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Application of electroretinography (ERG) in early drug development for assessing retinal toxicity in rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26482841</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.10.008</DOI>
    <KeywordList>
      <Keywords>Electroretinography</Keywords>
      <Keywords>Pan-cyclin dependent kinase inhibitors</Keywords>
      <Keywords>Rats</Keywords>
      <Keywords>Retina</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Wenhu Huang</Name>
        <Affiliation>Drug Safety Research and Development, Pfizer Global Research and Development, San Diego, CA 92121, USA. Electronic address: wenhu.huang@pfizer.com.</Affiliation>
      </Author>
      <Author>
        <Name>Walter Collette</Name>
        <Affiliation>Drug Safety Research and Development, Pfizer Global Research and Development, San Diego, CA 92121, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michelle Twamley</Name>
        <Affiliation>Drug Safety Research and Development, Pfizer Global Research and Development, San Diego, CA 92121, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Shirley A. Aguirre</Name>
        <Affiliation>Drug Safety Research and Development, Pfizer Global Research and Development, San Diego, CA 92121, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Aida Sacaan</Name>
        <Affiliation>Drug Safety Research and Development, Pfizer Global Research and Development, San Diego, CA 92121, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Susceptibility to quantum dot induced lung inflammation differs widely among the Collaborative Cross founder mouse strains.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26476918</pubmedLink>
    <GrantList>
      <Grant>R01 ES016189</Grant>
      <Grant>R01ES016189</Grant>
      <Grant>U19ES019544</Grant>
      <Grant>T32 ES015459</Grant>
      <Grant>T32ES015459</Grant>
      <Grant>P30ES007033</Grant>
      <Grant>P30 ES007033</Grant>
      <Grant>U19 ES019545</Grant>
      <Grant>U19ES019545</Grant>
      <Grant>U19 ES019544</Grant>
    </GrantList>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.09.019</DOI>
    <KeywordList>
      <Keywords>Collaborative Cross mouse strains</Keywords>
      <Keywords>Genetics</Keywords>
      <Keywords>Heritability</Keywords>
      <Keywords>Lung inflammation</Keywords>
      <Keywords>Quantum dots</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>David K. Scoville</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA 98195, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Collin C. White</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA 98195, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Dianne Botta</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA 98195, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa A. McConnachie</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA 98195, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Megan E. Zadworny</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA 98195, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Stefanie C. Schmuck</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA 98195, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoge Hu</Name>
        <Affiliation>Department of Bioengineering, University of Washington, Seattle, WA 98195, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaohu Gao</Name>
        <Affiliation>Department of Bioengineering, University of Washington, Seattle, WA 98195, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jianbo Yu</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA 98195, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Russell L. Dills</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA 98195, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Lianne Sheppard</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA 98195, USA; Department of Biostatistics, University of Washington, Seattle, WA 98195, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Martha A. Delaney</Name>
        <Affiliation>Department of Comparative Medicine, University of Washington, Seattle, WA 98195, USA; Department of Pathology, University of Washington, Seattle, WA 98195, USA.</Affiliation>
      </Author>
      <Author>
        <Name>William C. Griffith</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA 98195, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard P. Beyer</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA 98195, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Richard C. Zangar</Name>
        <Affiliation>Systems Toxicology Group - Division of Biological Sciences, Pacific Northwest National Laboratory, Richland, WA 99352, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Joel G. Pounds</Name>
        <Affiliation>Systems Toxicology Group - Division of Biological Sciences, Pacific Northwest National Laboratory, Richland, WA 99352, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Elaine M. Faustman</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA 98195, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Terrance J. Kavanagh</Name>
        <Affiliation>Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA 98195, USA. Electronic address: tjkav@uw.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>MicroRNA as biomarkers of mitochondrial toxicity.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26476301</pubmedLink>
    <Year>2016</Year>
    <DOI>S0041-008X(15)30110-1</DOI>
    <KeywordList>
      <Keywords>Drug safety</Keywords>
      <Keywords>MicroRNA</Keywords>
      <Keywords>Mitochondria</Keywords>
      <Keywords>Toxicity</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Bethany R. Baumgart</Name>
        <Affiliation>Department of Toxicology, Drug Safety Evaluation, Bristol-Myers Squibb, 4401 Highway 62 East, Mount Vernon, IN 47620, USA. Electronic address: bethany.baumgart@bms.com.</Affiliation>
      </Author>
      <Author>
        <Name>Katherine L. Gray</Name>
        <Affiliation>Department of Toxicology, Drug Safety Evaluation, Bristol-Myers Squibb, 4401 Highway 62 East, Mount Vernon, IN 47620, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jochen Woicke</Name>
        <Affiliation>Department of Pathology, Drug Safety Evaluation, Bristol-Myers Squibb, 4401 Highway 62 East, Mount Vernon, IN 47620, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Roderick T. Bunch</Name>
        <Affiliation>Department of Toxicology, Drug Safety Evaluation, Bristol-Myers Squibb, 4401 Highway 62 East, Mount Vernon, IN 47620, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Thomas P. Sanderson</Name>
        <Affiliation>Department of Toxicology, Drug Safety Evaluation, Bristol-Myers Squibb, 4401 Highway 62 East, Mount Vernon, IN 47620, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Terry R. Van Vleet</Name>
        <Affiliation>Department of Investigative Toxicology and Pathology, Abbvie, 1 N. Waukegan Rd., North Chicago, IL 60064-6123, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Antioxidant role of glutathione S-transferases: 4-Hydroxynonenal, a key molecule in stress-mediated signaling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26476300</pubmedLink>
    <GrantList>
      <Grant>R01 AG032643</Grant>
      <Grant>R01 CA077495</Grant>
      <Grant>AG032643</Grant>
      <Grant>CA 77495</Grant>
    </GrantList>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.10.006</DOI>
    <KeywordList>
      <Keywords>4-Hydroxynonenal</Keywords>
      <Keywords>Glutathione S-transferase</Keywords>
      <Keywords>Glutathione-conjugates</Keywords>
      <Keywords>Lipid peroxidation</Keywords>
      <Keywords>RLIP76</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sharad S. Singhal</Name>
        <Affiliation>Department of Diabetes &amp; Metabolic Diseases Research, Beckman Research Institute of the City of Hope, Comprehensive Cancer Center, Duarte, CA 91010, United States. Electronic address: ssinghal@coh.org.</Affiliation>
      </Author>
      <Author>
        <Name>Sharda P. Singh</Name>
        <Affiliation>Pharmacology and Toxicology, University of Arkansas for Medical Sciences, and Central Arkansas Veterans Healthcare System, Little Rock, AR 72205, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Preeti Singhal</Name>
        <Affiliation>University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, United States.</Affiliation>
      </Author>
      <Author>
        <Name>David Horne</Name>
        <Affiliation>Department of Molecular Medicine, Beckman Research Institute of the City of Hope, Comprehensive Cancer Center, Duarte, CA 91010, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Jyotsana Singhal</Name>
        <Affiliation>Department of Diabetes &amp; Metabolic Diseases Research, Beckman Research Institute of the City of Hope, Comprehensive Cancer Center, Duarte, CA 91010, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Sanjay Awasthi</Name>
        <Affiliation>Department of Medical Oncology, Beckman Research Institute of the City of Hope, Comprehensive Cancer Center, Duarte, CA 91010, United States.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicological responses of environmental mixtures: Environmental metal mixtures display synergistic induction of metal-responsive and oxidative stress genes in placental cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26472158</pubmedLink>
    <GrantList>
      <Grant>T32-ES007126</Grant>
      <Grant>R01-ES019315</Grant>
      <Grant>T32 ES007126</Grant>
      <Grant>R01 ES019315</Grant>
      <Grant>P42-ES005948</Grant>
      <Grant>P42 ES005948</Grant>
    </GrantList>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.10.005</DOI>
    <KeywordList>
      <Keywords>Biomarkers</Keywords>
      <Keywords>Gene expression</Keywords>
      <Keywords>Real-world mixtures</Keywords>
      <Keywords>Synergism</Keywords>
      <Keywords>Toxicogenomics</Keywords>
      <Keywords>mRNA</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Oluwadamilare A. Adebambo</Name>
        <Affiliation>Department of Biological Sciences, North Carolina State University, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Paul D. Ray</Name>
        <Affiliation>Department of Environmental Sciences and Engineering, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Damian Shea</Name>
        <Affiliation>Department of Biological Sciences, North Carolina State University, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Rebecca C. Fry</Name>
        <Affiliation>Department of Environmental Sciences and Engineering, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, United States. Electronic address: rfry@unc.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Ancestral TCDD exposure promotes epigenetic transgenerational inheritance of imprinted gene Igf2: Methylation status and DNMTs.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26455773</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.09.024</DOI>
    <KeywordList>
      <Keywords>2,3,7,8-Tetrachlorodibenzo-p-Dioxin</Keywords>
      <Keywords>DNA methyltransferase</Keywords>
      <Keywords>Differentially methylated region</Keywords>
      <Keywords>Epigenetic transgenerational inheritance</Keywords>
      <Keywords>Imprinted gene</Keywords>
      <Keywords>Somatic tissue</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jing Ma</Name>
        <Affiliation>Department of Occupational and Environmental Health, School of Public Health, Tianjin Medical University, Tianjin 300070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xi Chen</Name>
        <Affiliation>Department of Occupational and Environmental Health, School of Public Health, Tianjin Medical University, Tianjin 300070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yanan Liu</Name>
        <Affiliation>Department of Occupational and Environmental Health, School of Public Health, Tianjin Medical University, Tianjin 300070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qunhui Xie</Name>
        <Affiliation>State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China.</Affiliation>
      </Author>
      <Author>
        <Name>Yawen Sun</Name>
        <Affiliation>Department of Occupational and Environmental Health, School of Public Health, Tianjin Medical University, Tianjin 300070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jingshan Chen</Name>
        <Affiliation>Department of Occupational and Environmental Health, School of Public Health, Tianjin Medical University, Tianjin 300070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ling Leng</Name>
        <Affiliation>Department of Occupational and Environmental Health, School of Public Health, Tianjin Medical University, Tianjin 300070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Huan Yan</Name>
        <Affiliation>Department of Occupational and Environmental Health, School of Public Health, Tianjin Medical University, Tianjin 300070, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bin Zhao</Name>
        <Affiliation>State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China. Electronic address: binzhao@rcees.ac.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Naijun Tang</Name>
        <Affiliation>Department of Occupational and Environmental Health, School of Public Health, Tianjin Medical University, Tianjin 300070, China. Electronic address: tangnaijun@tijmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A fluorescence high throughput screening method for the detection of reactive electrophiles as potential skin sensitizers.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26455772</pubmedLink>
    <GrantList>
      <Grant>U01 FD004246</Grant>
      <Grant>1U01FD004246-04</Grant>
    </GrantList>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.09.027</DOI>
    <KeywordList>
      <Keywords>Electrophiles,</Keywords>
      <Keywords>Fluorescence assay,</Keywords>
      <Keywords>High throughput screening</Keywords>
      <Keywords>In chemico alternative methods,</Keywords>
      <Keywords>Skin sensitization,</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Cristina Avonto</Name>
        <Affiliation>National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, School of Pharmacy, The University of Mississippi, University, MS 38677, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Amar G. Chittiboyina</Name>
        <Affiliation>National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, School of Pharmacy, The University of Mississippi, University, MS 38677, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Diego Rua</Name>
        <Affiliation>The Center for Food Safety and Applied Nutrition, US Food and Drug Administration, College Park, MD 20740, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Ikhlas A. Khan</Name>
        <Affiliation>National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, School of Pharmacy, The University of Mississippi, University, MS 38677, United States; Division of Pharmacognosy, Department of BioMolecular Sciences, School of Pharmacy, The University of Mississippi, University, MS 38677, United States. Electronic address: ikhan@olemiss.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Diacetyl and 2,3-pentanedione exposure of human cultured airway epithelial cells: Ion transport effects and metabolism of butter flavoring agents.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26454031</pubmedLink>
    <GrantList>
      <Grant>CC999999</Grant>
      <Grant>T32 HL090610</Grant>
      <Grant>5T32HL090610-05</Grant>
    </GrantList>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.10.004</DOI>
    <KeywordList>
      <Keywords>2,3-Pentanedione</Keywords>
      <Keywords>Diacetyl</Keywords>
      <Keywords>Dicarbonyl/l-xylulose reductase</Keywords>
      <Keywords>Human airway epithelial cells</Keywords>
      <Keywords>Ion transport</Keywords>
      <Keywords>Vapor exposure</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Eric J. Zaccone</Name>
        <Affiliation>Department of Pharmaceutical Sciences, West Virginia University, Morgantown, WV, USA.</Affiliation>
      </Author>
      <Author>
        <Name>W. Travis Goldsmith</Name>
        <Affiliation>Pathology and Physiology Research Branch, National Institute for Occupational Safety and Health, Morgantown, WV, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Michael J. Shimko</Name>
        <Affiliation>Department of Pharmaceutical Sciences, West Virginia University, Morgantown, WV, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. R. Wells</Name>
        <Affiliation>Pathology and Physiology Research Branch, National Institute for Occupational Safety and Health, Morgantown, WV, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Diane Schwegler-Berry</Name>
        <Affiliation>Pathology and Physiology Research Branch, National Institute for Occupational Safety and Health, Morgantown, WV, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Patsy A. Willard</Name>
        <Affiliation>Pathology and Physiology Research Branch, National Institute for Occupational Safety and Health, Morgantown, WV, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Shannon L. Case</Name>
        <Affiliation>Pathology and Physiology Research Branch, National Institute for Occupational Safety and Health, Morgantown, WV, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Janet A. Thompson</Name>
        <Affiliation>Pathology and Physiology Research Branch, National Institute for Occupational Safety and Health, Morgantown, WV, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey S. Fedan</Name>
        <Affiliation>Department of Pharmaceutical Sciences, West Virginia University, Morgantown, WV, USA; Pathology and Physiology Research Branch, National Institute for Occupational Safety and Health, Morgantown, WV, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>19-Hydroxyeicosatetraenoic acid and isoniazid protect against angiotensin II-induced cardiac hypertrophy.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26454030</pubmedLink>
    <GrantList>
      <Grant>106665</Grant>
    </GrantList>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.10.003</DOI>
    <KeywordList>
      <Keywords>Cardiac hypertrophy</Keywords>
      <Keywords>Cytochrome P450</Keywords>
      <Keywords>Epoxyeicosatrienoic acids</Keywords>
      <Keywords>Hydroxyeicosatetraenoic acids</Keywords>
      <Keywords>Isoniazid</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Samya Elkhatali</Name>
        <Affiliation>Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2E1, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Ahmed A. El-Sherbeni</Name>
        <Affiliation>Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2E1, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Osama H. Elshenawy</Name>
        <Affiliation>Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2E1, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Ghada Abdelhamid</Name>
        <Affiliation>Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2E1, Canada; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Helwan University, Helwan, Egypt.</Affiliation>
      </Author>
      <Author>
        <Name>Ayman O. S. El-Kadi</Name>
        <Affiliation>Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2E1, Canada. Electronic address: aelkadi@ualberta.ca.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Doxorubicin: Comparison between 3-h continuous and bolus intravenous administration paradigms on cardio-renal axis, mitochondrial sphingolipids and pathology.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26450648</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.10.002</DOI>
    <KeywordList>
      <Keywords>Cardiotoxicity</Keywords>
      <Keywords>Doxorubicin</Keywords>
      <Keywords>Intravenous infusion</Keywords>
      <Keywords>Mitochondrial toxicity</Keywords>
      <Keywords>Sphingolipids</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Harriet Kamendi</Name>
        <Affiliation>Drug Safety and Metabolism, AstraZeneca, Waltham, MA 02451, USA. Electronic address: harriet_kamendi@kandih.com.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Zhou</Name>
        <Affiliation>Oncology Innovative Medicines and Early Development, AstraZeneca, Waltham, MA 02451, USA. Electronic address: yingzhou526@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Meredith Crosby</Name>
        <Affiliation>Drug Safety and Metabolism, AstraZeneca, Waltham, MA 02451, USA. Electronic address: Meredith.crosby@astrazeneca.com.</Affiliation>
      </Author>
      <Author>
        <Name>Natalie Keirstead</Name>
        <Affiliation>Drug Safety and Metabolism, AstraZeneca, Waltham, MA 02451, USA. Electronic address: Nkeirstead@alnylam.com.</Affiliation>
      </Author>
      <Author>
        <Name>Debra Snow</Name>
        <Affiliation>Drug Safety and Metabolism, AstraZeneca, Waltham, MA 02451, USA. Electronic address: Debra.snow@astrazeneca.com.</Affiliation>
      </Author>
      <Author>
        <Name>Patricia Bentley</Name>
        <Affiliation>Drug Safety and Metabolism, AstraZeneca, Waltham, MA 02451, USA. Electronic address: patricia.bentley@abbvie.com.</Affiliation>
      </Author>
      <Author>
        <Name>Nilaben Patel</Name>
        <Affiliation>Drug Safety and Metabolism, AstraZeneca, Waltham, MA 02451, USA. Electronic address: patelnilaben@yahoo.com.</Affiliation>
      </Author>
      <Author>
        <Name>Herbert Barthlow</Name>
        <Affiliation>Drug Safety and Metabolism, AstraZeneca, Waltham, MA 02451, USA. Electronic address: Herbert.barthlow@astrazeneca.com.</Affiliation>
      </Author>
      <Author>
        <Name>Wenli Luo</Name>
        <Affiliation>Discovery Sciences, Innovative Medicines, AstraZeneca, Waltham, MA 02451, USA. Electronic address: Wenli.luo@astrazeneca.com.</Affiliation>
      </Author>
      <Author>
        <Name>Yvonne Dragan</Name>
        <Affiliation>Drug Safety and Metabolism, AstraZeneca, Waltham, MA 02451, USA. Electronic address: Yvonne.P.Dragan@takeda.com.</Affiliation>
      </Author>
      <Author>
        <Name>Russell Bialecki</Name>
        <Affiliation>Drug Safety and Metabolism, AstraZeneca, Waltham, MA 02451, USA. Electronic address: russell.bialecki@astrazeneca.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Totarol prevents neuronal injury in vitro and ameliorates brain ischemic stroke: Potential roles of Akt activation and HO-1 induction.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26440581</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.10.001</DOI>
    <KeywordList>
      <Keywords>Akt</Keywords>
      <Keywords>HO-1</Keywords>
      <Keywords>Neuroprotection</Keywords>
      <Keywords>Stroke</Keywords>
      <Keywords>Totarol</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yuanxue Gao</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaojun Xu</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Sai Chang</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yunjie Wang</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Yazhou Xu</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Siqi Ran</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhangjian Huang</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, China Pharmaceutical University, Nanjing 210009, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Ping Li</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Jia Li</Name>
        <Affiliation>National Center for Drug Screening, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 189 Guo Shoujing Road, Shanghai 201203, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Luyong Zhang</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, PR China.</Affiliation>
      </Author>
      <Author>
        <Name>Juan M. Saavedra</Name>
        <Affiliation>Department of Pharmacology and Physiology, Georgetown University Medical Center, Washington, DC 20057, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hong Liao</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, PR China. Electronic address: liaohong56@hotmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Tao Pang</Name>
        <Affiliation>Jiangsu Key Laboratory of Drug Screening, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, PR China; Department of Pharmacology and Physiology, Georgetown University Medical Center, Washington, DC 20057, USA. Electronic address: tpang@cpu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The effects of gestational and chronic atrazine exposure on motor behaviors and striatal dopamine in male Sprague-Dawley rats.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26440580</pubmedLink>
    <GrantList>
      <Grant>T32 GM092715</Grant>
    </GrantList>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.09.026</DOI>
    <KeywordList>
      <Keywords>Atrazine</Keywords>
      <Keywords>Behavior</Keywords>
      <Keywords>Dopamine</Keywords>
      <Keywords>Locomotor activity</Keywords>
      <Keywords>Motor function</Keywords>
      <Keywords>Striatum</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Jennifer L. Walters</Name>
        <Affiliation>Western Michigan University, Department of Psychology, 1903 W Michigan Ave, Kalamazoo, MI 49008-5439, United States. Electronic address: Jennifer.l.walters@wmich.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Theresa A. Lansdell</Name>
        <Affiliation>Michigan State University, Department of Pharmacology and Toxicology, 1355 Bogue Street, East Lansing, MI 48824, United States. Electronic address: lansdel1@msu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Keith J. Lookingland</Name>
        <Affiliation>Michigan State University, Department of Pharmacology and Toxicology, 1355 Bogue Street, East Lansing, MI 48824, United States. Electronic address: lookingl@msu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Lisa E. Baker</Name>
        <Affiliation>Western Michigan University, Department of Psychology, 1903 W Michigan Ave, Kalamazoo, MI 49008-5439, United States. Electronic address: lisa.baker@wmich.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Site specific modification of the human plasma proteome by methylglyoxal.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26435215</pubmedLink>
    <GrantList>
      <Grant>R24 DK083948</Grant>
      <Grant>P30 CA023074</Grant>
      <Grant>P30CA023074</Grant>
      <Grant>P30ES06694</Grant>
      <Grant>K23 HL107389</Grant>
      <Grant>P30ES006694</Grant>
      <Grant>T32 ES007091</Grant>
      <Grant>K23HL107389</Grant>
      <Grant>P30 ES006694</Grant>
      <Grant>R01GM070890</Grant>
      <Grant>R01 GM070890</Grant>
      <Grant>T32ES016652</Grant>
      <Grant>T32 ES016652</Grant>
      <Grant>1S10RR028868-01</Grant>
      <Grant>S10 RR028868</Grant>
      <Grant>T32ES007091</Grant>
      <Grant>R24DK090958</Grant>
    </GrantList>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.09.029</DOI>
    <KeywordList>
      <Keywords>Adducts</Keywords>
      <Keywords>Glyco-oxidation</Keywords>
      <Keywords>Methylglyoxal</Keywords>
      <Keywords>Proteomics</Keywords>
      <Keywords>Type 2 diabetes mellitus</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Michael J. Kimzey</Name>
        <Affiliation>Southwest Environmental Health Sciences Center, Department of Pharmacology &amp; Toxicology, College of Pharmacy, The University of Arizona, Tucson, AZ 85721, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Owen R. Kinsky</Name>
        <Affiliation>Southwest Environmental Health Sciences Center, Department of Pharmacology &amp; Toxicology, College of Pharmacy, The University of Arizona, Tucson, AZ 85721, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Hussein N. Yassine</Name>
        <Affiliation>Department of Medicine, The University of Arizona, Tucson, AZ 85721, United States.</Affiliation>
      </Author>
      <Author>
        <Name>George Tsaprailis</Name>
        <Affiliation>Southwest Environmental Health Sciences Center, Department of Pharmacology &amp; Toxicology, College of Pharmacy, The University of Arizona, Tucson, AZ 85721, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Craig S. Stump</Name>
        <Affiliation>Department of Medicine, The University of Arizona, Tucson, AZ 85721, United States; Southern Arizona VA Health Care System, Tucson, AZ 85723, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Terrence J. Monks</Name>
        <Affiliation>Southwest Environmental Health Sciences Center, Department of Pharmacology &amp; Toxicology, College of Pharmacy, The University of Arizona, Tucson, AZ 85721, United States.</Affiliation>
      </Author>
      <Author>
        <Name>Serrine S. Lau</Name>
        <Affiliation>Southwest Environmental Health Sciences Center, Department of Pharmacology &amp; Toxicology, College of Pharmacy, The University of Arizona, Tucson, AZ 85721, United States. Electronic address: lau@pharmacy.arizona.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26435214</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.09.028</DOI>
    <KeywordList>
      <Keywords>Apoptosis</Keywords>
      <Keywords>Liver fibrosis</Keywords>
      <Keywords>MALAT1</Keywords>
      <Keywords>Reversion</Keywords>
      <Keywords>SIRT1</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yuting Wu</Name>
        <Affiliation>School of Pharmacy, Anhui Medical University, Meishan Road, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University (AMU), China; Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China. Electronic address: wuyuting1302@sina.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xuejiao Liu</Name>
        <Affiliation>School of Pharmacy, Anhui Medical University, Meishan Road, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University (AMU), China; Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qun Zhou</Name>
        <Affiliation>School of Pharmacy, Anhui Medical University, Meishan Road, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University (AMU), China; Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Cheng Huang</Name>
        <Affiliation>School of Pharmacy, Anhui Medical University, Meishan Road, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University (AMU), China; Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaoming Meng</Name>
        <Affiliation>School of Pharmacy, Anhui Medical University, Meishan Road, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University (AMU), China; Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Fengyun Xu</Name>
        <Affiliation>School of Pharmacy, Anhui Medical University, Meishan Road, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University (AMU), China; Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Li</Name>
        <Affiliation>School of Pharmacy, Anhui Medical University, Meishan Road, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University (AMU), China; Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China. Electronic address: lj@ahmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>CPT-11 activates NLRP3 inflammasome through JNK and NF-κB signalings.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26431797</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.09.025</DOI>
    <KeywordList>
      <Keywords>CPT-11</Keywords>
      <Keywords>Delayed diarrhea</Keywords>
      <Keywords>Experimental colitis</Keywords>
      <Keywords>JNK</Keywords>
      <Keywords>NF-κB</Keywords>
      <Keywords>NLRP3 inflammasome</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Qian Li</Name>
        <Affiliation>Department of Oncology, The First Affiliated Hospital with Nanjing Medical University, 300, Guangzhou Road, Nanjing 210029, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiong Zhang</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing 210046, China.</Affiliation>
      </Author>
      <Author>
        <Name>Weicheng Wang</Name>
        <Affiliation>Department of Oncology, The First Affiliated Hospital with Nanjing Medical University, 300, Guangzhou Road, Nanjing 210029, China.</Affiliation>
      </Author>
      <Author>
        <Name>LeLe Li</Name>
        <Affiliation>Department of Oncology, The First Affiliated Hospital with Nanjing Medical University, 300, Guangzhou Road, Nanjing 210029, China.</Affiliation>
      </Author>
      <Author>
        <Name>Qiang Xu</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing 210046, China. Electronic address: molpharm@163.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xudong Wu</Name>
        <Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing 210046, China. Electronic address: xudongwu@nju.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Yanhong Gu</Name>
        <Affiliation>Department of Oncology, The First Affiliated Hospital with Nanjing Medical University, 300, Guangzhou Road, Nanjing 210029, China. Electronic address: guluer@163.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Mitochondrial protein adducts formation and mitochondrial dysfunction during N-acetyl-m-aminophenol (AMAP)-induced hepatotoxicity in primary human hepatocytes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26431796</pubmedLink>
    <GrantList>
      <Grant>T32 ES007079</Grant>
      <Grant>R01 AA012916</Grant>
      <Grant>R01 AA12916</Grant>
      <Grant>5P20RR021940-07</Grant>
      <Grant>P20 RR021940</Grant>
      <Grant>8 P20 GM103549-07</Grant>
      <Grant>T32 ES007079-26A2</Grant>
      <Grant>R01 DK102142</Grant>
      <Grant>P20 GM103549</Grant>
    </GrantList>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.09.022</DOI>
    <KeywordList>
      <Keywords>3′-Hydroxyacetanilide (AMAP)</Keywords>
      <Keywords>Acetaminophen</Keywords>
      <Keywords>Hepatotoxicity</Keywords>
      <Keywords>Mitochondrial dysfunction</Keywords>
      <Keywords>Protein adducts</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Yuchao Xie</Name>
        <Affiliation>Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS 66160, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Mitchell R. McGill</Name>
        <Affiliation>Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS 66160, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kuo Du</Name>
        <Affiliation>Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS 66160, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Kenneth Dorko</Name>
        <Affiliation>Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS 66160, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Sean C. Kumer</Name>
        <Affiliation>Department of Surgery, University of Kansas Medical Center, Kansas City, KS 66160, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Timothy M. Schmitt</Name>
        <Affiliation>Department of Surgery, University of Kansas Medical Center, Kansas City, KS 66160, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Wen Xing Ding</Name>
        <Affiliation>Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS 66160, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Hartmut Jaeschke</Name>
        <Affiliation>Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS 66160, USA. Electronic address: hjaeschke@kumc.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Assessment of global and gene-specific DNA methylation in rat liver and kidney in response to non-genotoxic carcinogen exposure.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26431795</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.09.023</DOI>
    <KeywordList>
      <Keywords>DNA methylation</Keywords>
      <Keywords>MeDIP-microarray</Keywords>
      <Keywords>Non-genotoxic carcinogen</Keywords>
      <Keywords>Rat kidney</Keywords>
      <Keywords>Rat liver</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Sibel Ozden</Name>
        <Affiliation>Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey. Electronic address: stopuz@istanbul.edu.tr.</Affiliation>
      </Author>
      <Author>
        <Name>Neslihan Turgut Kara</Name>
        <Affiliation>Department of Molecular Biology and Genetics, Faculty of Science, Istanbul University, Istanbul, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Osman Ugur Sezerman</Name>
        <Affiliation>Department of Biostatistics and Medical Informatics, Acibadem University, Istanbul, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>İlknur Melis Durasi</Name>
        <Affiliation>Biological Sciences and Bioengineering, Faculty of Engineering and Natural Sciences, Sabancı University, Istanbul, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Tao Chen</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Soochow University, Suzhou, China.</Affiliation>
      </Author>
      <Author>
        <Name>Goksun Demirel</Name>
        <Affiliation>Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>Buket Alpertunga</Name>
        <Affiliation>Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey.</Affiliation>
      </Author>
      <Author>
        <Name>J. Kevin Chipman</Name>
        <Affiliation>School of Biosciences, The University of Birmingham, Birmingham, UK.</Affiliation>
      </Author>
      <Author>
        <Name>Angela Mally</Name>
        <Affiliation>Department of Toxicology, University of Würzburg, Würzburg, Germany.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Environmentally persistent free radical-containing particulate matter competitively inhibits metabolism by cytochrome P450 1A2.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26423927</pubmedLink>
    <GrantList>
      <Grant>P42 ES013648</Grant>
      <Grant>R01 ES004344</Grant>
      <Grant>ES004344</Grant>
      <Grant>ES013648</Grant>
    </GrantList>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.09.021</DOI>
    <KeywordList>
      <Keywords>Cytochrome P450 1A2</Keywords>
      <Keywords>Environmentally persistent free radicals</Keywords>
      <Keywords>Inhibition</Keywords>
      <Keywords>Particulate matter</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>James R. Reed</Name>
        <Affiliation>Department of Pharmacology and Experimental Therapeutics and The Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, 533 Bolivar St., New Orleans, LA 70112, USA. Electronic address: rreed@lsuhsc.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Albert Leo N. dela Cruz</Name>
        <Affiliation>The Department of Environmental Sciences and LSU Superfund Research Center, Louisiana State University A&amp;M College, Baton Rouge, LA 70803, USA. Electronic address: adelac2@tigers.lsu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Slawo M. Lomnicki</Name>
        <Affiliation>The Department of Environmental Sciences and LSU Superfund Research Center, Louisiana State University A&amp;M College, Baton Rouge, LA 70803, USA. Electronic address: slomni1@lsu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Wayne L. Backes</Name>
        <Affiliation>Department of Pharmacology and Experimental Therapeutics and The Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, 533 Bolivar St., New Orleans, LA 70112, USA. Electronic address: wbacke@lsuhsc.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Continuous activation of Nrf2 and its target antioxidant enzymes leads to arsenite-induced malignant transformation of human bronchial epithelial cells.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26420645</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.09.020</DOI>
    <KeywordList>
      <Keywords>Antioxidant response</Keywords>
      <Keywords>Arsenite</Keywords>
      <Keywords>Carcinogenesis</Keywords>
      <Keywords>HBE cells</Keywords>
      <Keywords>Nrf2</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xu Yang</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Dapeng Wang</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou, Jiangsu, People's Republic of China; Department of Toxicology, School of Public Health, Guizhou Medical University, Guiyang, Guizhou, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yuan Ma</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiguo Xu</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Zhen Zhu</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaojuan Wang</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Hanyi Deng</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunchun Li</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Min Chen</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Jian Tong</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Kenzo Yamanaka</Name>
        <Affiliation>Laboratory of Environmental Toxicology and Carcinogenesis, School of Pharmacy, Nihon University, Chiba, Japan.</Affiliation>
      </Author>
      <Author>
        <Name>Yan An</Name>
        <Affiliation>Department of Toxicology, School of Public Health, Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, Medical College of Soochow University, Suzhou, Jiangsu, People's Republic of China. Electronic address: dranyan@126.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Redox cycling of endogenous copper by ferulic acid leads to cellular DNA breakage and consequent cell death: A putative cancer chemotherapy mechanism.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26415834</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.09.018</DOI>
    <KeywordList>
      <Keywords>Copper</Keywords>
      <Keywords>Cytotoxicity</Keywords>
      <Keywords>DNA breakage</Keywords>
      <Keywords>Ferulic acid</Keywords>
      <Keywords>Pro-oxidant</Keywords>
      <Keywords>ROS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tarique Sarwar</Name>
        <Affiliation>Department of Biochemistry, Faculty of Life Sciences, A.M. University, Aligarh, UP 202002, India.</Affiliation>
      </Author>
      <Author>
        <Name>Md Zafaryab</Name>
        <Affiliation>Genome Biology Lab, Department of Biosciences, Jamia Millia Islamia, Central University, New Delhi 110025, India.</Affiliation>
      </Author>
      <Author>
        <Name>Mohammed Amir Husain</Name>
        <Affiliation>Department of Biochemistry, Faculty of Life Sciences, A.M. University, Aligarh, UP 202002, India.</Affiliation>
      </Author>
      <Author>
        <Name>Hassan Mubarak Ishqi</Name>
        <Affiliation>Department of Biochemistry, Faculty of Life Sciences, A.M. University, Aligarh, UP 202002, India.</Affiliation>
      </Author>
      <Author>
        <Name>Sayeed Ur Rehman</Name>
        <Affiliation>Department of Biochemistry, Faculty of Life Sciences, A.M. University, Aligarh, UP 202002, India.</Affiliation>
      </Author>
      <Author>
        <Name>M. Moshahid Alam Rizvi</Name>
        <Affiliation>Genome Biology Lab, Department of Biosciences, Jamia Millia Islamia, Central University, New Delhi 110025, India.</Affiliation>
      </Author>
      <Author>
        <Name>Mohammad Tabish</Name>
        <Affiliation>Department of Biochemistry, Faculty of Life Sciences, A.M. University, Aligarh, UP 202002, India. Electronic address: tabish.bcmlab@gmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Compound- and sex-specific effects on programming of energy and immune homeostasis in adult C57BL/6JxFVB mice after perinatal TCDD and PCB 153.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26415833</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.09.017</DOI>
    <KeywordList>
      <Keywords>2,3,7,8-Tetrachlorodibenzo-p-dioxin</Keywords>
      <Keywords>Endocrine disrupting compounds</Keywords>
      <Keywords>Energy homeostasis</Keywords>
      <Keywords>Immune homeostasis</Keywords>
      <Keywords>Polychlorinated biphenyl 153</Keywords>
      <Keywords>Programming</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>J. C. J. van Esterik</Name>
        <Affiliation>Center for Health Protection, National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands; Department of Chemistry and Biology, Institute for Environmental Studies (IVM), VU University, De Boelelaan 1085, 1081 HV Amsterdam, The Netherlands. Electronic address: joantine.van.esterik@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>H. W. Verharen</Name>
        <Affiliation>Center for Health Protection, National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands. Electronic address: henny.verharen@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>H. M. Hodemaekers</Name>
        <Affiliation>Center for Health Protection, National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands. Electronic address: hennie.hodemaekers@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>E. R. Gremmer</Name>
        <Affiliation>Center for Health Protection, National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands. Electronic address: eric.gremmer@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>B. Nagarajah</Name>
        <Affiliation>Center for Health Protection, National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands. Electronic address: bhawani.nagarajah@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>J. H. Kamstra</Name>
        <Affiliation>Department of Chemistry and Biology, Institute for Environmental Studies (IVM), VU University, De Boelelaan 1085, 1081 HV Amsterdam, The Netherlands. Electronic address: jorke.kamstra@vu.nl.</Affiliation>
      </Author>
      <Author>
        <Name>M. E. T. Dollé</Name>
        <Affiliation>Center for Health Protection, National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands. Electronic address: martijn.dolle@rivm.nl.</Affiliation>
      </Author>
      <Author>
        <Name>J. Legler</Name>
        <Affiliation>Department of Chemistry and Biology, Institute for Environmental Studies (IVM), VU University, De Boelelaan 1085, 1081 HV Amsterdam, The Netherlands. Electronic address: juliette.legler@vu.nl.</Affiliation>
      </Author>
      <Author>
        <Name>L. T. M. van der Ven</Name>
        <Affiliation>Center for Health Protection, National Institute for Public Health and the Environment (RIVM), PO Box 1, 3720 BA Bilthoven, The Netherlands. Electronic address: leo.van.der.ven@rivm.nl.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Posttranscriptional silencing of the lncRNA MALAT1 by miR-217 inhibits the epithelial-mesenchymal transition via enhancer of zeste homolog 2 in the malignant transformation of HBE cells induced by cigarette smoke extract.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26415832</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.09.016</DOI>
    <KeywordList>
      <Keywords>Cigarette smoke extract (CSE)</Keywords>
      <Keywords>Epithelial–mesenchymal transition (EMT)</Keywords>
      <Keywords>lncRNAs</Keywords>
      <Keywords>miRNAs</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lu Lu</Name>
        <Affiliation>Institute of Toxicology, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Fei Luo</Name>
        <Affiliation>Institute of Toxicology, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Yi Liu</Name>
        <Affiliation>Institute of Toxicology, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xinlu Liu</Name>
        <Affiliation>Institute of Toxicology, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Le Shi</Name>
        <Affiliation>Institute of Toxicology, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaolin Lu</Name>
        <Affiliation>Institute of Toxicology, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China.</Affiliation>
      </Author>
      <Author>
        <Name>Qizhan Liu</Name>
        <Affiliation>Institute of Toxicology, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China; The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing 211166, Jiangsu, People's Republic of China. Electronic address: drqzliu@hotmail.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Effect of diosgenin on metabolic dysfunction: Role of ERβ in the regulation of PPARγ.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26408789</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.09.015</DOI>
    <KeywordList>
      <Keywords>Adipocyte differentiation</Keywords>
      <Keywords>Diosgenin</Keywords>
      <Keywords>Estrogen receptor β</Keywords>
      <Keywords>Metabolic dysfunction</Keywords>
      <Keywords>Peroxisome proliferator-activated receptor γ</Keywords>
      <Keywords>Retinoid X receptor α</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Xin Wang</Name>
        <Affiliation>Department of Toxicology, Shaanxi Key Lab of Free Radical Biology and Medicine, the Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Fourth Military Medical University, Xi'an 710032, China. Electronic address: xinwang@fmmu.edu.cn.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Liu</Name>
        <Affiliation>Department of Orthopedics, Lanzhou General Hospital of PLA, South Binhe Road, No. 333, Lanzhou 730050, China.</Affiliation>
      </Author>
      <Author>
        <Name>Zi Long</Name>
        <Affiliation>The First Student Brigade, Fourth Military Medical University, Xi'an, Shaanxi, 710032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Quangui Sun</Name>
        <Affiliation>The First Student Brigade, Fourth Military Medical University, Xi'an, Shaanxi, 710032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Ying Liu</Name>
        <Affiliation>Department of Toxicology, Shaanxi Key Lab of Free Radical Biology and Medicine, the Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Fourth Military Medical University, Xi'an 710032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lele Wang</Name>
        <Affiliation>Department of Toxicology, Shaanxi Key Lab of Free Radical Biology and Medicine, the Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Fourth Military Medical University, Xi'an 710032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiaodi Zhang</Name>
        <Affiliation>Department of Toxicology, Shaanxi Key Lab of Free Radical Biology and Medicine, the Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Fourth Military Medical University, Xi'an 710032, China.</Affiliation>
      </Author>
      <Author>
        <Name>Chunxu Hai</Name>
        <Affiliation>Department of Toxicology, Shaanxi Key Lab of Free Radical Biology and Medicine, the Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Fourth Military Medical University, Xi'an 710032, China. Electronic address: cx-hai@fmmu.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Thiol dependent NF-κB suppression and inhibition of T-cell mediated adaptive immune responses by a naturally occurring steroidal lactone Withaferin A.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26408225</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.09.014</DOI>
    <KeywordList>
      <Keywords>Anti-inflammatory</Keywords>
      <Keywords>Cytokines</Keywords>
      <Keywords>Graft-versus-host disease</Keywords>
      <Keywords>Pharmacokinetics</Keywords>
      <Keywords>ROS</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Lokesh Gambhir</Name>
        <Affiliation>Radiation Biology &amp; Health Sciences Division, Bio-science Group, Bhabha Atomic Research Centre, Mumbai, India.</Affiliation>
      </Author>
      <Author>
        <Name>Rahul Checker</Name>
        <Affiliation>Radiation Biology &amp; Health Sciences Division, Bio-science Group, Bhabha Atomic Research Centre, Mumbai, India.</Affiliation>
      </Author>
      <Author>
        <Name>Deepak Sharma</Name>
        <Affiliation>Radiation Biology &amp; Health Sciences Division, Bio-science Group, Bhabha Atomic Research Centre, Mumbai, India.</Affiliation>
      </Author>
      <Author>
        <Name>M. Thoh</Name>
        <Affiliation>Radiation Biology &amp; Health Sciences Division, Bio-science Group, Bhabha Atomic Research Centre, Mumbai, India.</Affiliation>
      </Author>
      <Author>
        <Name>Anand Patil</Name>
        <Affiliation>Advanced Centre for Treatment Research and Education in Cancer, Kharghar, Navi Mumbai, India.</Affiliation>
      </Author>
      <Author>
        <Name>M. Degani</Name>
        <Affiliation>Institute of Chemical Technology, Matunga, Mumbai, India.</Affiliation>
      </Author>
      <Author>
        <Name>Vikram Gota</Name>
        <Affiliation>Advanced Centre for Treatment Research and Education in Cancer, Kharghar, Navi Mumbai, India.</Affiliation>
      </Author>
      <Author>
        <Name>Santosh K. Sandur</Name>
        <Affiliation>Radiation Biology &amp; Health Sciences Division, Bio-science Group, Bhabha Atomic Research Centre, Mumbai, India. Electronic address: sskumar@barc.gov.in.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>A physical/psychological and biological stress combine to enhance endoplasmic reticulum stress.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26391182</pubmedLink>
    <GrantList>
      <Grant>U01 ES016014</Grant>
    </GrantList>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.09.013</DOI>
    <KeywordList>
      <Keywords>Autophagy</Keywords>
      <Keywords>Beta Adrenoceptor</Keywords>
      <Keywords>Listeria</Keywords>
      <Keywords>Neuroimmunology</Keywords>
      <Keywords>Oxidative stress</Keywords>
      <Keywords>Stress response</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Tapan Kumar Mondal</Name>
        <Affiliation>Wadsworth Center, New York State Department of Health, Albany, NY 12201.</Affiliation>
      </Author>
      <Author>
        <Name>Rebecca T. Emeny</Name>
        <Affiliation>Wadsworth Center, New York State Department of Health, Albany, NY 12201.</Affiliation>
      </Author>
      <Author>
        <Name>Donghong Gao</Name>
        <Affiliation>Wadsworth Center, New York State Department of Health, Albany, NY 12201.</Affiliation>
      </Author>
      <Author>
        <Name>Jeffrey G. Ault</Name>
        <Affiliation>Wadsworth Center, New York State Department of Health, Albany, NY 12201.</Affiliation>
      </Author>
      <Author>
        <Name>Jane Kasten-Jolly</Name>
        <Affiliation>Wadsworth Center, New York State Department of Health, Albany, NY 12201.</Affiliation>
      </Author>
      <Author>
        <Name>David A. Lawrence</Name>
        <Affiliation>Wadsworth Center, New York State Department of Health, Albany, NY 12201. Electronic address: david.lawrence@health.ny.gov.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Estimation of tetrabromobisphenol A (TBBPA) percutaneous uptake in humans using the parallelogram method.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26387765</pubmedLink>
    <GrantList>
      <Grant>Z99 CA999999</Grant>
      <Grant>ZIA BC011476-01</Grant>
      <Grant>ZIA BC 011476</Grant>
    </GrantList>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.09.012</DOI>
    <KeywordList>
      <Keywords>Brominated flame retardant</Keywords>
      <Keywords>Dermal bioavailability</Keywords>
      <Keywords>Parallelogram method</Keywords>
      <Keywords>Persistent organic pollutant</Keywords>
      <Keywords>Tetrabromobisphenol A</Keywords>
      <Keywords>Tetrabromobisphenol A (PubChem CID: 6618)</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Gabriel A. Knudsen</Name>
        <Affiliation>NCI at NIEHS, 111 T W Alexander Dr., Research Triangle Park, NC, USA. Electronic address: gabriel.knudsen@nih.gov.</Affiliation>
      </Author>
      <Author>
        <Name>Michael F. Hughes</Name>
        <Affiliation>Integrated Systems Toxicology Division, National Health and Environmental Effects Research Laboratory, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Katelyn L. McIntosh</Name>
        <Affiliation>NCI at NIEHS, 111 T W Alexander Dr., Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. Michael Sanders</Name>
        <Affiliation>NCI at NIEHS, 111 T W Alexander Dr., Research Triangle Park, NC, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Linda S. Birnbaum</Name>
        <Affiliation>NCI at NIEHS, 111 T W Alexander Dr., Research Triangle Park, NC, USA.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Toxicokinetics and toxicity of atorvastatin in dogs.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26386191</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.09.008</DOI>
    <KeywordList>
      <Keywords>Cholesterol</Keywords>
      <Keywords>Drug interaction</Keywords>
      <Keywords>Dyslipdemia</Keywords>
      <Keywords>GPR119</Keywords>
      <Keywords>NC3Rs</Keywords>
      <Keywords>Statin</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>C. E. Herron</Name>
        <Affiliation>Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>C. C. Brueckner</Name>
        <Affiliation>Scinovo, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. P. Chism</Name>
        <Affiliation>Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>D. C. Kemp</Name>
        <Affiliation>Safety Assessment, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>J. S. Prescott</Name>
        <Affiliation>Safety Assessment, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>G. A. Smith</Name>
        <Affiliation>Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>D. H. Melich</Name>
        <Affiliation>Safety Assessment, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, NC 27709, USA.</Affiliation>
      </Author>
      <Author>
        <Name>N. Oleas</Name>
        <Affiliation>Charles River Laboratories, Preclinical Services Montreal, 22022 Transcanadienne, Senneville, QC, Canada, H9X 3R3.</Affiliation>
      </Author>
      <Author>
        <Name>J. W. Polli</Name>
        <Affiliation>Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, NC 27709, USA. Electronic address: joseph.w.polli@gsk.com.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>HPW-RX40 restores anoikis sensitivity of human breast cancer cells by inhibiting integrin/FAK signaling.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26386190</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.09.011</DOI>
    <KeywordList>
      <Keywords>Anoikis</Keywords>
      <Keywords>Breast cancer</Keywords>
      <Keywords>FAK</Keywords>
      <Keywords>Integrin</Keywords>
      <Keywords>Metastasis</Keywords>
      <Keywords>β-Nitrostyrene</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>I. Hua Chen</Name>
        <Affiliation>Graduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Hsin Chu Shih</Name>
        <Affiliation>Graduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Pei Wen Hsieh</Name>
        <Affiliation>Graduate Institute of Natural Products, School of Traditional Chinese Medicine, and Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Fang Rong Chang</Name>
        <Affiliation>Graduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung, Taiwan; Cancer Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Yang Chang Wu</Name>
        <Affiliation>School of Pharmacy, College of Pharmacy, China Medical University, Taichung, Taiwan. Electronic address: yachwu@mail.cmu.edu.</Affiliation>
      </Author>
      <Author>
        <Name>Chin Chung Wu</Name>
        <Affiliation>Graduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Marine Biotechnology and Resources, National Sun Yat-sen University, Kaohsiung 80708, Taiwan; Research Center for Natural Products and Drug Development, Kaohsiung Medical University, Kaohsiung, Taiwan. Electronic address: ccwu@kmu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>The influence of N-acetyl-l-cysteine on damage of porcine oocyte exposed to zearalenone in vitro.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26386189</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.09.010</DOI>
    <KeywordList>
      <Keywords>Cumulus cells expansion</Keywords>
      <Keywords>Maturation in vitro</Keywords>
      <Keywords>N-acetyl-l-cysteine</Keywords>
      <Keywords>Oocyte</Keywords>
      <Keywords>Porcine</Keywords>
      <Keywords>Zearalenone</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Fang Nong Lai</Name>
        <Affiliation>College of Life Sciences, Qingdao Agricultural University, Qingdao 266109, China; Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Yu Ma</Name>
        <Affiliation>Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China; Key Laboratory of Animal Reproduction and Germplasm Enhancement in Universities of Shandong, College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jing Cai Liu</Name>
        <Affiliation>College of Life Sciences, Qingdao Agricultural University, Qingdao 266109, China; Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Jun Jie Wang</Name>
        <Affiliation>Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China; Key Laboratory of Animal Reproduction and Germplasm Enhancement in Universities of Shandong, College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Shun Feng Cheng</Name>
        <Affiliation>Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China; Key Laboratory of Animal Reproduction and Germplasm Enhancement in Universities of Shandong, College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Xiao Feng Sun</Name>
        <Affiliation>College of Life Sciences, Qingdao Agricultural University, Qingdao 266109, China; Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Lan Li</Name>
        <Affiliation>Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China; Key Laboratory of Animal Reproduction and Germplasm Enhancement in Universities of Shandong, College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation>
      </Author>
      <Author>
        <Name>Bo Li</Name>
        <Affiliation>Chengguo Station of Animal Husbandry and Veterinary, Laizhou 261437, China.</Affiliation>
      </Author>
      <Author>
        <Name>Charles Martin Nyachoti</Name>
        <Affiliation>Department of Animal Science, University of Manitoba, Winnipeg, MB R3T 2N2, Canada.</Affiliation>
      </Author>
      <Author>
        <Name>Wei Shen</Name>
        <Affiliation>Institute of Reproductive Sciences, Qingdao Agricultural University, Qingdao 266109, China; Key Laboratory of Animal Reproduction and Germplasm Enhancement in Universities of Shandong, College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, China. Electronic address: wshen@qau.edu.cn.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Induction of HO-1 by carbon monoxide releasing molecule-2 attenuates thrombin-induced COX-2 expression and hypertrophy in primary human cardiomyocytes.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26385185</pubmedLink>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.09.009</DOI>
    <KeywordList>
      <Keywords>CO</Keywords>
      <Keywords>CORM-2</Keywords>
      <Keywords>Cardiomyocyte hypertrophy</Keywords>
      <Keywords>HO-1</Keywords>
      <Keywords>Primary human ventricular cardiomyocyte</Keywords>
      <Keywords>Transcription factor</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Peter Tzu Yu Chien</Name>
        <Affiliation>Department of Physiology and Pharmacology and Health Ageing Research Center, Chang Gung University, Kwei-Shan, Tao-Yuan, Taiwan; Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Kwei-Shan, Tao-Yuan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chih Chung Lin</Name>
        <Affiliation>Department of Anesthetics, Chang Gung Memorial Hospital at Lin-Kou and College of Medicine, Chang Gung University, Kwei-San, Tao-Yuan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Li Der Hsiao</Name>
        <Affiliation>Department of Anesthetics, Chang Gung Memorial Hospital at Lin-Kou and College of Medicine, Chang Gung University, Kwei-San, Tao-Yuan, Taiwan.</Affiliation>
      </Author>
      <Author>
        <Name>Chuen Mao Yang</Name>
        <Affiliation>Department of Physiology and Pharmacology and Health Ageing Research Center, Chang Gung University, Kwei-Shan, Tao-Yuan, Taiwan; Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Kwei-Shan, Tao-Yuan, Taiwan; Research Center for Industry of Human Ecology and Graduate Institute of Health Industry Technology, Chang Gung University of Science and Technology, Tao-Yuan, Taiwan. Electronic address: chuenmao@mail.cgu.edu.tw.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
  <PubmedArticle>
    <ArticleTitle>Cadmium promotes the proliferation of triple-negative breast cancer cells through EGFR-mediated cell cycle regulation.</ArticleTitle>
    <JournalTitle>Toxicology and applied pharmacology</JournalTitle>
    <pubmedLink>https://pubmed.ncbi.nlm.nih.gov/26385184</pubmedLink>
    <GrantList>
      <Grant>P20 GM103430</Grant>
      <Grant>P20GM103430</Grant>
    </GrantList>
    <Year>2015</Year>
    <DOI>10.1016/j.taap.2015.09.006</DOI>
    <KeywordList>
      <Keywords>Cadmium</Keywords>
      <Keywords>Cell cycle</Keywords>
      <Keywords>Cell proliferation</Keywords>
      <Keywords>EGFR</Keywords>
      <Keywords>Triple-negative breast cancer cells</Keywords>
    </KeywordList>
    <AuthorList>
      <Author>
        <Name>Zhengxi Wei</Name>
        <Affiliation>Center for Molecular Toxicology, Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI, 02881, USA. Electronic address: weizhengxi@gmail.com.</Affiliation>
      </Author>
      <Author>
        <Name>Xiulong Song</Name>
        <Affiliation>Center for Molecular Toxicology, Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI, 02881, USA.</Affiliation>
      </Author>
      <Author>
        <Name>Zahir A. Shaikh</Name>
        <Affiliation>Center for Molecular Toxicology, Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI, 02881, USA. Electronic address: zshaikh@uri.edu.</Affiliation>
      </Author>
    </AuthorList>
  </PubmedArticle>
</PubmedArticleSet>
